WOC2010_FinalProgram

See youWOC®2010

World Ophthalmology Congress® 2010ICC, Berlin, Germany

XXXII International Congress of Ophthalmology 108th DOG Congress5 - 9 June 2010

AAD Congress 20103 - 6 June 2010

www.woc2010.orgFina

l Pro

gram

WOC® 2010M

ap IC

C

Main Entrance

Hall 7

Roof GardenHall 10Hall 9Hall 8

Hall 6

Hall 4/5

Hall 3

Rooms 42 - 46Room 56

Main Lobby

Kids Club (Room 35)

Press Office (Rooms 31-33)

WOC® 2010PCO CounterBVA Registration

RegistrationTerminals RegistrationTerminals

ICC Lounge

Entrance Level

Lobby Level

Hall 1

Hall 2 Salon 11/12

Salon 13/14

Salon 15/16Salon 17/18Salon 19Salon 20Salon 21Salon 22

Hall Level

Media Check

Rooms 31-40

Rooms 23-30

Hall 16Industrial Exhibition



Abu Dhabi

Hall 17Congress Bags

Radio Tower Lounge 1, Lounge 2

Hall 11Poster Exhibition

VIP Lounge 1 VIP Lounge 2

Rooms Madrid, Sydney, Hong Kong, Istanbul


Hall 13Industrial ExhibitionOslo


Sao Paulo

Stockholm

Lobby Level

When monotherapy is not enough

Control under pressure

GANFORT® (bimatoprost 0.03%/timolol 0.5%). AbbreviatedPrescribing Information. Presentation: Eye drop solution, one mlcontains 0.3mg bimatoprost and 5mg timolol (as maleate). Indications:Reduction of intraocular pressure (IOP) in patients with open-angleglaucoma or ocular hypertension who are insufficiently responsive totopical beta-blockers or prostaglandin analogues. Dosage andAdministration: Please refer to the Summary of Product Characteristicsbefore prescribing. Recommended dose is one drop in the affected eye(s)once daily, administered in the morning (evening dosing may beconsidered). If more than one topical ophthalmic product is to be used,each should be instilled at least 5 minutes apart. Not recommended inchildren or adolescents (under the age of 18). Use with caution in renal orhepatic impairment. Contraindications: Hypersensitivity to activesubstances or to any of the excipients. Reactive airway disease includingbronchial asthma or a history of bronchial asthma, severe chronicobstructive pulmonary disease. Sinus bradycardia, second or third degreeatrioventricular block, overt cardiac failure, cardiogenic shock.Warnings/Precautions: Ganfort may be absorbed systemically. Thesame types of cardiovascular and pulmonary adverse reactions as seenwith systemic beta-blockers may occur. Cardiac failure should beadequately controlled before beginning therapy. Patients with a history ofsevere cardiac disease should be watched for signs of cardiac failure andhave their pulse rates checked. Cardiac and respiratory reactions, includingdeath due to bronchospasm in patients with asthma, and, rarely, death inassociation with cardiac failures have been reported followingadministration of timolol maleate. Beta-blockers may also mask the signs

of hyperthyroidism and cause worsening of Prinzmetal angina, severeperipheral and central circulatory disorders and hypotension. Beta-adrenergic blocking agents should be administered with caution inpatients subject to spontaneous hypoglycemia or to diabetic patients(especially those with labile diabetes) as beta-blockers may mask thesigns and symptoms of acute hypoglycemia. While taking beta-blockers,patients with a history of atopy or a history of severe anaphylactic reactionto a variety of allergens may be unresponsive to the usual dose ofadrenaline used to treat anaphylactic reactions. In patients with a historyof mild liver disease or abnormal alanine amino transferase (ALT), aspartateamino transferase (AST) and/or bilirubin at baseline, bimatoprost had noadverse reactions on liver function over 24 months. There are no knownadverse reactions of ocular timolol on liver function. Before treatment isinitiated, patients should be informed of the possibility of eyelash growth,darkening of the eyelid skin and increased iris pigmentation since thesehave been observed during treatment with bimatoprost and Ganfort.Some of these changes may be permanent, and may lead to differencesin appearance between the eyes if only one eye is treated. Afterdiscontinuation of Ganfort, pigmentation of iris may be permanent. After12 months treatment with Ganfort, the incidence of iris pigmentation was0.2%. After 12 months treatment with bimatoprost eye drops alone, theincidence was 1.5% and did not increase following 3 years treatment.Cystoid macular oedema has been reported with Ganfort. Therefore,Ganfort should be used with caution in patients with known risk factorsfor macular oedema (e.g. aphakic patients, pseudophakic patients with atorn posterior lens capsule). The preservative in Ganfort, benzalkonium

chloride, may cause eye irritation. Contact lenses must be removed priorto application, with at least a 15-minute wait before reinsertion.Benzalkonium chloride is known to discolour soft contact lenses; avoidcontact. Benzalkonium chloride has been reported to cause punctatekeratopathy and/or toxic ulcerative keratopathy. Therefore monitoring isrequired with frequent or prolonged use of Ganfort in dry eye patients orwhere the cornea is compromised. Ganfort has not been studied inpatients with inflammatory ocular conditions, neovascular, inflammatory,angle-closure glaucoma, congenital glaucoma or narrow-angle glaucoma.Potential for additive effects resulting in hypotension, and/or markedbradycardia when eye drops containing timolol are administeredconcomitantly with oral calcium channel blockers, guanethidine, or beta-blocking agents, anti-arrhythmics, digitalis glycosides or para -sympathomimetics. The hypertensive reaction to sudden withdrawal ofclonidine can be potentiated when taking beta-blockers. There are noadequate data from the use of Ganfort in pregnant women. Do not useduring pregnancy unless clearly necessary. Ganfort should not be used bybreast-feeding women. Ganfort has negligible influence on ability to driveand use machines. Adverse Effects: No adverse drug reactions (ADRs)specific for Ganfort have been observed in clinical studies. The ADRs havebeen limited to those earlier reported for bimatoprost and timolol andthe majority were ocular, mild in severity and none were serious. Based on12-month clinical data, the most commonly reported ADR wasconjunctival hyperaemia (mostly trace to mild and thought to be of a non-inflammatory nature) in approximately 26% of patients and led todiscontinuation in 1.5% of patients. The following ADRs were reported

during clinical trials with Ganfort. Eye disorders: Very common (≥1/10):conjunctival hyperaemia, growth of eyelashes. Common (≥1/100 to<1/10): superficial punctuate keratitis, corneal erosion, burning sensation,eye pruritus, stinging sensation in the eye, foreign body sensation, eyedryness, eyelid erythema, eye pain, photophobia, eye discharge, visualdisturbance, eyelid pruritus. Skin and subcutaneous tissue disorders:Common: blepharal pigmentation. Additional adverse events that havebeen seen with one of the components and may potentially occur alsowith Ganfort. Please refer to Summary of Product Characteristics for fullinformation on side effects. Basic NHS Price: £13.95 per 3ml bottle.£37.59 for 3x3ml bottle. Marketing Authori sation Number:EU / 1 / 06 / 340 / 001-002. Marketing AuthorisationHolder: Allergan Pharmaceuticals Ireland, CastlebarRoad, Westport, Co. Mayo, Ireland. Legal Category:POM. Date of Preparation:March 2009. Furtherinformation is available from: Allergan Ltd,Marlow International, The Parkway,Marlow, Bucks, SL7 1YL.

Allergan Ltd, Marlow International, The Parkway, Marlow, Bucks, SL7 1YLTel: +44 (0)1628 494026 Fax: +44 (0)1628 494057 www.allergan.co.ukEU/0201/2010 Date of preparation: April 2010.

Adverse events should be reported to your local regulatory authority and Allergan office.

See youWOC®2010




Final Program

President WOC® 2010Professor Gerhard K. Lang

Congress VenueICC - Internationales Congress Centrum BerlinMessedamm 22, 14055 Berlin, Germanywww.icc-berlin.com

©2010 Alcon, Inc. 3/10 MIX10501JA

®

Sharing Your Commitment to Eye Care for 65 YearsThe global leader in eye care, Alcon is dedicated to discovering and developing breakthrough products that advance the treatment of eye disease.

3WOC® 2010

Table of contents

Welcome Addresses

Awards

Sponsors

Committees

Supporting Organizations

WOC History

Program

Social Program

Information

Organizing Societies

Welcome Address from the WOC® 2010 Honorary PresidentWelcome Address from the WOC® 2010 Congress PresidentWelcome Address from the WOC® 2010 Scientific Program Committee ChairWelcome Address from the WOC® 2010 Scientific Program Committee Co-ChairWelcome Address from the Federal Minister of Education and Research Welcome Address from Berlin's Governing Mayor

AwardsDOG Promotions and Awards

Acknowledgement to main Sponsors

WOC® 2010 Executive CommitteeProfessional Congress OrganizerWOC® 2010 Scientific Program CommitteeWOC® 2010 Scientific Program CoordinatorsWOC® 2010 Submitted Program Reviewing CommitteeICO Roster 2010 ICO Advisory CommitteeICO Foundation Council Board of DirectorsDOG Executive CommitteeAAD Executive Committee

WOC® 2010 Supporting Organizations

Past and future WOCs

HighlightsHow to Read the Scientific ProgramSubspecialty Days

Scientific ProgramSaturday, 5 June 2010 Sunday, 6 June 2010 Monday, 7 June 2010Tuesday, 8 June 2010 Wednesday, 9 June 2010

Courses and Wetlabs (incl. AAD-Courses – Joint Program)

Posters

Administrative MeetingsCompany SymposiaOther Symposia

Official Social Program Program for Accompanying Persons

Information for authors Travel and accommodation grants France 2010 – European SymposiumSponsors and ExhibitorsComplete ICC, Exhibition HallsInformation from A to ZPress Office WOC® 2010AdvertsAuthor IndexImprint

Page

4

57

8

91011

1318

19

21212122242525262728

29

31

375051

636387

129171213

237

263

325327335

337338

339343345349357361368369413

4 WOC® 2010

SponsorInternational Council of Ophthalmology (ICO) www.icoph.org

HostDeutsche Ophthalmologische Gesellschaft e. V.(DOG, German Society of Ophthalmology)www.dog.org

Co-HostAugenärztliche Akademie Deutschland (AAD, German Academy of Ophthalmology) www.augeninfo.de

Organizing Societies

5WOC® 2010

Wel

com

e Ad

dres

sWelcome Address from the President of the International Council of Ophthalmology

Dear Colleagues,

On behalf of the International Council of Ophthalmology, the sponsor of theWorld Ophthalmology Congress® 2010 (WOC® 2010), I am most pleased to welcome you to the exciting international city of Berlin, to the superbscientific program, organized under the leadership of Stephen Ryan and Gabriele Lang, and the extraordinary overall program and social events organized under Congress President Gerhard Lang.

We are thrilled to return the World Ophthalmology Congress® 2010 toEurope this year, following previous successful gatherings in Brussels in 1958,Munich in 1966, Paris in 1974, Rome in 1986, and Amsterdam in 1998.

As the world comes closer together, it is particularly so in ophthalmology. We heldour first international meeting in 1857 in Brussels and this meeting, 153 years later, is our 32nd World Congress. As the first true specialty in medicine, ophthalmologycontinues to be a leader in diagnostics, surgical innovation, education, certificationand certainly congeniality.

This World Congress is a chance for generalists in ophthalmology and subspecialistsin every field to learn from one another and to maintain a central commitment to ophthalmology as a specialty. We come together with the mutual goal of preven-ting and alleviating vision loss, and to face the challenge of 314 million people visually impaired.

On behalf of the International Council and the world’s ophthalmologists, I welcomeyou and wish for you a most successful Congress personally and professionally.

Bruce E. Spivey, M.D., M.S., M.Ed.President, International Council of Ophthalmology

Lotemax® 0.5% Eye Drops, Suspension Abbreviated Prescribing

Information UK (Please refer to full Summary of Product Characteristics

when Prescribing). Presentation: The suspension contains 0.5%

loteprednol etabonate (5 mg/ml). Each drop contains 0.19 mg loteprednol

etabonate. Uses: Treatment of post-operative inflammation following ocular

surgery. Dosage and administration: Ocular: Adults and elderly One to

two drops four times daily beginning 24 hours after surgery and continuing

throughout the post-operative period. The duration of treatment should not

exceed 2 weeks. Children and adolescents: Lotemax should not be used in

the paediatric age group until further data become available.

Contraindications: most viral diseases of the cornea and conjunctiva

including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia,

varicella, and also in mycobacterial infection of the eye and fungal diseases of

ocular structures; untreated purulent acute infections, ‘red eye’ with unknown

diagnosis and infection caused by amoeba. Hypersensitivity to the active

substance, to any of the excipients, and to other corticosteroids. Warnings

and Precautions: Prolonged use of corticosteroids may result in ocular

hypertension or glaucoma with damage to the optic nerve, defects in visual

acuity and fields of vision, and in posterior subcapsular cataract formation.

Steroids should be used with caution in the presence of glaucoma.

Prolonged use of corticosteroids may suppress the host response and may

increase the possibility of secondary ocular infections. In those diseases

causing thinning of the cornea or sclera, perforations have been known to

occur with the use of topical steroids. In acute purulent conditions of the eye,

steroids may mask infection or enhance existing infection. The use of steroids

after cataract surgery may delay healing and increase the incidence of bleb

formation. Long term treating with corticosteroids can cause fungal disease.

Fungal disease should be considered in the differential diagnosis when a

corneal ulcer persists. Contains benzalkonium chloride which may cause

eye irritation. In general patients should not wear contact lenses after cataract

surgery, unless contact lens wearing is medically indicated. Contact with soft

contact lenses should be avoided. Known to discolour soft contact lenses. If

signs and symptoms fail to improve after two days, the patient should be re-

evaluated. If this product is used for 10 days or longer, intraocular pressure

should be monitored. Interactions: the low potential of ocular loteprednol

etabonate eye drops to increase the intraocular pressure may be adversely

affected by systemically administered medicinal products with anticholinergic

activity. In patients receiving concomitant ocular hypotensive therapy, the

addition of loteprednol etabonate may increase intraocular pressure and

decrease the apparent ocular hypotensive effect of these medicinal

products. Concurrent administration of cycloplegics may increase the risk of

raised intraocular pressure. Undesirable effects: reactions associated with

ophthalmic steroids include elevated intraocular pressure in steroid

responsive patients, which may be associated with optic nerve damage,

visual acuity and field defects, posterior subcapsular cataract formation,

secondary ocular infection from pathogens including herpes simplex, and

perforation of the globe where there is thinning of the cornea or sclera. The

most common side-effects (>1/100, <1/10) during clinical trials with

loteprednol included the following: corneal defect, eye discharge, ocular

discomfort, dry eye, epiphora, foreign body sensation in eyes, conjunctival

hyperaemia and ocular itching. Instillation site burning, headache, rise in IOP

(see SPC for full details of adverse events). Use in pregnancy and lactation:

contraindicated. Overdosage: Acute overdosage is unlikely to occur via the

ophthalmic route. Basic NHS price: £5.50 Legal Category: POM

Product Licence number: PL17947/0001. Product Licence Holder:

Bausch & Lomb GmbH, Brunsbütteler Damm 165-173, 13581 Berlin,

Germany. Date of last revision: September 2009. Further Information is

available from: Bausch& Lomb UK Ltd 106-114 London Road, Kingston-

Upon-Thames, KT2 6QJ. Tel: 01748 828864. Trademark statement:

Lotemax is a registered trademark of Bausch& Lomb Incorporated.

Adverse events should be reported. Reporting forms and

Information can be found at www.yellowcard.gov.uk. Adverse

events should also be reported to Bausch & Lomb UK Ltd on

01748 828864.

* In a summation of controlled, randomized studies of individuals

treated for 28 days or longer with LOTEMAX, LOTEMAX

provided a lower incidence of IOP elevations 10 mm Hg vs

prednisolone acetate 1% (2.1%, 14/664 for LOTEMAX; 6.7%,

11/164 for prednisolone acetate 1%).

References:

1. Lotemax, German SPC, Dec. 2008.

2. Stewart R, Horwitz B, Howes J, Novack GD, Hart K, and the

Loteprednol Etabonate Post-operative Inflammation Study Group

1. Double-masked, placebo-controlled evaluation of loteprednol

etabonate 0.5% for postoperative inflammation. J Cataract Refract

Surg. 1998;24:1480-1489.

3. Beehler C, Bodner B, Bowman B, et al, for the Loteprednol

Etabonate Postoperative Inflammation Study Group 2. A

double-masked, placebo-controlled evaluation of 0.5%

loteprednol etabonate in the treatment of postoperative

inflammation. Ophthalmology. 1998;105:1780-1786.

4. Novack GD, Howes J, Crockett RS, Sherwood MB. Change in

intraocular pressure during long-term use of loteprednol

etabonate. J Glaucoma. 1998;7:266-269.

LOTEMAX is a registered trademark of Bausch + Lomb incorporated.

© 2009 Bausch + Lomb Incorporated

001-2010-05-Lotemax

Welcome Address from the WOC® 2010 Congress President

Dear colleagues and friends,

It is my pleasure and honor to welcome you to the World Congress of Ophthalmology WOC®2010, the 108th DOG Congress and the AAD Congress2010 in Berlin.For the third time the DOG will be host of this outstanding internationalcongress. Following Heidelberg in 1888 and Munich in 1966 this year ophthalmologists from all over the world will be meeting in Berlin.20 years after the German Reunification, Berlin, the cultural and politicalcenter of Germany, has become a unique symbol of the overcoming of globalfrontiers. It is thus predestined to host the World Congress WOC®2010: The necessity of international cooperation as well as responsibility-and

problem-orientated action are essential responsibilities of international ophthal-mology especially with regard to the discrepancy in quality in the treatment of eye diseases between industrialized and third world countries. The WOC®2010 willalso focus on this aspect.In an outstanding scientific program with numerous lectures, presentations,courses, posters, videos in over 3.000 sessions leading experts of all subspecialtieswill present the latest scientific knowledge in research and state of the art ophthal-mology. Subspecialty Days will prioritize retina, glaucoma, pediatric ophthalmologyas well as cataract and refractive surgery.In addition to the scientific discourse, the social program offers various possibilitiesfor a personal and cultural exchange: The opening ceremony will commemorate Albrecht von Graefe, co-founder of the German Society of Ophthalmology and theICO. You can look forward to a stunning presentation! On Monday evening we willinvite you to a typical Bavarian-like WOCtoberfest. A further highlight will be WOC in Concert on Sunday evening in the French Church of Friedrichstadt, whereophthalmologists will be perform for ophthalmologists.It is a special pleasure for me that numerous colleagues will be visiting theWOC®2010 with their families and I extent a cordial welcome to all of them. For those participants travelling with children, I would like to point out to the daycare for children offered free of charge in Room 35.It is my deep desire to thank everybody involved in the preparation of the congressand the scientific program. All in all 82 program coordinators, 55 societies and organizations, more than 1.100 speakers contribute to the success of this congress.My special thanks go to the coordinators of the scientific program, Prof. Steve Ryanand Prof. Gabriele Lang.Special thank also go to the sponsors and exhibitors for their various support. With-out their contributions this congress would not have been possible.Last but not least I would like to thank our friends of the ICO Council for their activeand long-standing support and I express my thanks to the members of the organiz-ing committee for more than eight years of active support and help in the planningand preparation of this congress.Let me again welcome you to Berlin also on behalf of the ICO. Let’s look forward toan interesting congress, a manifold collegial exchange, to meeting with old friendsand making new friends with ophthalmologists from all over the world.

Prof. Dr. Gerhard K. LangCongress President WOC®2010

7WOC® 2010

Wel

com

e Ad

dres

s

Welcome Address from the WOC® 2010 Scientific Program Committee Chair

It is with great pleasure that I add my words of welcome to the World Ophthalmology Congress® 2010 (WOC® 2010) in Berlin. We are all indebtedto the leading ophthalmologists from around the world who have con-tributed their time and organizational abilities as coordinators, chairs, mod-erators, and speakers. Their scientific contributions and active participationguarantee the success of the scientific program in the 32nd InternationalCongress of Ophthalmology. Our colleagues have expanded our core pro-grams including the latest in scientific practice with the newest cuttingedge treatments, ophthalmic drugs and devices. The leaders of industryfrom around the world join the leaders of ophthalmology in the outstandingCongress.

The WOC® 2010 provides a unique opportunity for scientific communication and exchange between the worlds’s leading specialists in the various fields of ophthal-mology. The cosmopolitan city of Berlin, Germany’s capital, invites you not only forits science but to show you the dynamics and development of the 20 years follow-ing reunification making it an ideal setting for our prestigious world congress. Wetake pride that ophthalmology has the longest history of any regular internationalmedical meeting. At the time of the first international meeting in Brussels in 1857,Berlin was the location for the remarkable contributions of von Helmholtz, vonGraefe, and others who provided the scientific basis for our specialty, ophthalmo-logy. We are fortunate to pursue the heritage they established in international ophthalmology.

More than 3,000 international experts will make their presentations in more than600 sessions. 81 coordinators have organized the chairs, moderators, and speakersin 31 specialties and separate areas in the scientific program. 58 separate oph-thalmic organizations from around the world actively participate in the scientificprogram. The quality of scientific program is even more impressive to me thanthese numbers.

The scientific program makes the WOC® 2010 professionally rewarding as well asenjoyable. Our colleagues of the German Society of Ophthalmology and the German Academy of Ophthalmology have been delightful colleagues with whom towork. We welcome you and look forward to an exciting scientific program in thisstimulating environment so that we may exchange the newest cutting edge ideas,and build stronger and better practices for our patients for the future. I am delighted to join in welcoming you to Berlin.

Stephen J. Ryan, MDScientific Program Committee Chair

8 WOC® 2010

Wel

com

e Ad

dres

s

Welcome Address from the President of the BVA

Dear Colleagues,

2010 marks a momentous year in the field of ophthalmology. For the firsttime in 44 years, the World Ophthalmology Congress® 2010 (WOC® 2010)will once again take place in Germany. The WOC® 2010 organizers have put together a comprehensive and informative program. Top-class speakers will update delegates on the most up-to-date practices and procedures inophthalmology, guaranteed to offer stimulated discussions.

The annual conference of the German Academy of Ophthalmology (AAD),the leading German-speaking conference in training and continuing education in the field of ophthalmology, will take place at the same time.

This is being hosted by the German Society of Ophthalmology (DOG) and the Professional Organisation of German Ophthalmologists (BVA).

The German ophthalmic community is delighted that their international colleaguesare coming to Berlin, Germany’s capital, to exchange ideas and share new perspecti-ves. German and international visitors alike - we cordially welcome you all at WOC®2010 and AAD!

Prof. Dr. Bernd BertramPresident Professional Association of German Ophthalmologists (BVA)

9WOC® 2010

Wel

com

e Ad

dres

s

Welcome Address from the Federal Minister of Education and Research

The field of ophthalmology is facing major challenges as a result of currentdemographic developments. We urgently need improved methods for the diagnosis and treatment of degenerative diseases in particular. Recent estimates have revealed that about ten million Europeans are at risk of losing their eyesight as a result of age-related degeneration of the macula.Such degeneration may lead to blindness, as do cataracts, glaucoma and retinopathy in patients with a history of diabetes. The growing number ofpeople suffering from diabetes in old age will exacerbate this negative trend.

Innovative technological solutions are being used in ophthalmology to improve patients' quality of life. It is not yet possible for blind patients to regain their eyesight, but impressive progress has already been made in the

development of electronic retinal prostheses.

The enormous progress made in basic biomedical research needs to be transferredto routine treatment more quickly so that patients can receive even better care inthe future. Smooth cooperation between all players in science, industry and healthcare requires the establishment of forums for the exchange of information and experience – forums where researchers and practitioners can meet, discuss theirchallenges and visions and work together to find solutions.

The World Ophthalmology Congress® 2010 is such a forum. It does not only providean excellent opportunity to learn about innovative techniques and new methods foruse in clinical practice; it is also a platform for the generation of promising projectideas and the creation of new cooperation networks. I wish the participants in thiscongress stimulating discussions and a productive exchange of ideas.

Prof. Dr. Annette Schavan, MdBFederal Minister of Education and Research

10 WOC® 2010

Wel

com

e Ad

dres

s

Welcome Address from Berlin’s Governing Mayor

We are delighted to welcome the participants in the World OphthalmologyCongress to Berlin. As both a conference venue and a science capital, our cityis honored to be hosting this major international congress and its discus-sions of the current state of research, study outcomes, and the prospects forophthalmology.

A good 20 years after the “peaceful revolution” and the fall of the Wall, Ger-many’s capital shows the impact of unprecedented change. Not only havethe two halves of the city been visibly reunited, leaving behind the long eraof division, but Berlin has discovered new strengths in many different areas.A magnet especially for talented and creative people from all over the world,

it owes its national and international appeal in large part to its many cultural insti-tutions and its renowned scientific landscape.

One of Berlin’s special strengths lies in medicine and the health care sector. Tradition and modern medical research are intertwined here. For instance, Berlin isthe birthplace of your discipline, ophthalmology. The festivities surrounding theBerlin Science Year in 2010 give us an especially vivid impression of the long historyof the sciences in our city. The Charité, for instance, Europe’s largest university hospi-tal, is celebrating its 300th anniversary this year. However, we are not just lookingback. The spotlight is also on our excellent universities and renowned scientific institutes, many of which do worldclass research and offer the next generation ofscholars and scientists a bright future. In other words, the World OphthalmologyCongress is taking place in an exciting environment.

In this spirit, I would again like to say “Welcome!” and to wish you not only manynew insights and productive professional exchange, but also the opportunity to round off your stay in Berlin with a cultural or culinary experience you will longremember.

Klaus WowereitGoverning Mayor of Berlin

11WOC® 2010

Wel

com

e Ad

dres

s

The Gonin Medal

The Gonin Medal has been instituted in 1937 and is the oldest but also the mostprestigious medal in ophthalmology. It is placed every year at the disposition of theBoard of the International Council of Ophthalmology by the University of Lausanne and the Swiss Ophthalmological Society.

Honoree: Alan Charles Bird (London/UK)

Laudatio: Bruce E. Spivey (ICO President)

Alan Bird started his ophthalmology residency at St Bartholomew’s Hospitalin London 1962. His first interest was neuro-ophthalmology and he workedfor one year as Senior House Officer at Guy’s/Maudsley Neurosurgical Unit.In 1965 he joined the staff of Moorfields Eye Hospital. In 1968-1969 he com-pleted a clinical fellowship at the Bascom Palmer Eye Institute, Miami. He became a close friend of Donald Gass who had a major influence on him. InAugust 1969 Alan returned to Moorfields Eye Hospital where he became anundisputed world leader in medical retina. In 1976 he became Professor ofClinical Ophthalmology and is since October 2006 Emeritus Professor. He isstill a Honorary Consultant at Moorfields Eye Hospital.

Dr. Bird’s main interests are age-related macular degeneration and retinaldystrophies. Together with John Marshall and Daniel Pauleikhoff he studied agingchanges in Bruch’s membrane. With A. Hoskins he was the first to recognize tears of the retinal pigment epithelium. His group described a number of genotype-phenotype correlations and identified new gene mutations in various retinal dystro-phies. With Fitzke and Holz he introduced fundus auto-fluorescence as a diagnostictool in retinal diseases. Professor Bird also worked on Sickle Cell disease in Jamaicaand on Onchocercosis in Africa.

His scientific production is amazing with over 400 papers in peer-reviewed journalsand over 80 contributions in books. He sits on the Editorial Board of InvestigativeOphthalmology and Vision Science and of a number of other journals. He is a foreign advisor to INSERM, member of the scientific committee on AMD of theDeutsche Forschungsgemeinschaft and an Ad Hoc member of the Board of Scienti-fic Counsellors of the NEI in Bethesda.

Alan Bird has delivered more than 60 named lectures, including the Duke-ElderLecture, the Doyne Lecture, the Jackson Memorial Lecture, the Donders Lecture, theBowman Lecture, the Jules François Lecture to name only some of the most presti-gious ones. He is a Honorary Fellow of the Royal Society of Medicine, of the RoyalCollege of Ophthalmology, of the American College of Surgeons, of the South African College of Ophthalmologists. He was the 2008 Laureate of the AmericanAcademy of Ophthalmology and obtained the 2003 ICO Golden Apple Award forteaching.

He is a gifted speaker and a superb teacher who trained numerous young ophthal-mologists from all over the world. The list of speakers at his career celebration inLondon in 2005 reads as a Who’s Who in world ophthalmology.

13WOC® 2010

Awar

ds

Jules François Golden Medal

The Jules François Golden Medal is awarded every four years by the Board of the In-ternational Council of Ophthalmology for ophthalmic work of high scientific quality.

Honoree: Gisèle Soubrane (Paris-Créteil/F)


Professor Soubrane obtained her MD degree in 1969 in Paris where she alsodid her residency under Professor Brégeat and Professor Coscas, followed by a fellowship in medical retina in Créteil. In 1992 she presented her Ph.D.thesis: "Ocular angiogenesis in normal and pathologic eyes. Implication ofbasic fibroblast growth factor" at the Faculté des Sciences Pierre et MarieCurie, Paris V. In 1987 she became Associate Professor and in 1993 Professor of Ophthalmology at the Eye University Clinic of Paris XII –Créteil. She succeeded Professor Coscas as chair of the department in 1996. Professor Soubrane is a world expert on age-related macular degeneration. Her scientific production is impressive with 243 papers in international journals, 85 articles in national ophthalmological journals, and more than 50 chapters in books. She co-authored 6 books or reports of the French Oph-

thalmological Societies and was the chief editor of the 2007 report on Age-relatedMacular Degeneration. She was instrumental in one of the first randomized study on laser photocoagulation of subretinal neovascular membranes, studied the natural history of occult new vessels and was the first to describe reticular pseudo-drusen. She delivered multiple lectures on her favourite topic all over he world.She serves on the editorial board of Graefes Archives of Ophthalmology, the European Journal of Ophthalmology, the Journal Français d'Ophtalmologie, the British Journal of Ophthalmology and Investigative Ophthalmology and Vision Science. She is past president of the European Board of Ophthalmology and of EVER,she served as Board member of the Gonin Club and as secretary-general of theFrench Ophthalmological Society of which she is still a Board member. She is mem-ber of 17 ophthalmological societies.Professor Soubrane was made Professor Honoris Causa of the University of Ulm in2000 and delivered 11 named lectures.Professor Soubrane is still active in clinical research improving the diagnosis of age-related macular degeneration and looking for new therapeutic approaches.

14 WOC® 2010

Awar

ds

International Duke Elder Medal

Lady Phyllis Duke Elder established a gold medal in honor of her late husband, Sir Stewart Duke Elder. This medal, which is called the International Duke Elder Medal isawarded every four years by the Board of the International Council of Ophthalmo-logy to an ophthalmologist who by his/her distinction, leadership and teaching hascontributed most to the development of international relations and friendship bet-ween ophthalmologists, and who has advanced the field by his/her contributions inwriting and organization in ophthalmology.

Honoree: Mohammad Daud Khan (Peshawar/PK)


Professor Daud Khan graduated in 1969 at the Khyber Medical College, Peshawar (Pakistan). He obtained his Diploma in Ophthalmology, Universityof London in 1971, became a fellow of the Royal College of Surgeons Edin-burgh in 1976, of the: Royal College of Ophthalmologists, London, in 1989, ofthe College of Physicians and Surgeons Pakistan in 1994, of the Pakistan Academy of Medical Sciences in1990, of the National Academy of MedicalSciences, Pakistan in 1996 and of the Bangladesh College of Physician & Surgeons in 2005.He was Professor of Ophthalmology Post Graduate Medical Institute/LadyReading Hospital, Peshawar (1984-1997), Chairman of the National SteeringCommittee for Prevention of Blindness (1994-2006), Chief Executive, HayatAbad Medical complex, Dean Post Graduate Medical Institute Peshawar,

2002-2003 and is the Founder Vice Chancellor, Khyber Medical University, Peshawar.He is currently the chairman of “CHEF International “an NGO which aims at provi-ding high quality health care and educational opportunities to the needy popula-tion in Pakistan and other developing countries and. Vice President of the College ofPhysicians and Surgeons of Pakistan. Professor Kahn served as President of the Asia-Pacific Academy of Ophthalmology, of the SAARC Academy of Ophthalmology, of theOphthalmological Society of Pakistan, of the Eye Bank Society, Peshawar, of the glau-coma interest group of Pakistan, was a Board member for 6 years of the ICO and isstill Vice Chairman of the International Agency for Prevention of Blindness (IAPB),East Mediterranean Region, Advisor to the WHO and Councilor, College of Physician& Surgeon of Pakistan (CPSP).He made huge contributions to teaching. He is credited with training over two hun-dred ophthalmologists and ophthalmic medical assistants. With the help of theWHO and a consortium of INDGOs, he established the Pakistan Institute of Commu-nity Ophthalmology (PICO) as a major regional resource centre in Community EyeHealth, Research and HRD and started Masters Course in community eye health.Professor Kahn published over 80 scientific papers and gave over 280 lectures in Pakistan and abroad. He served on the editorial board of 8 national and internatio-nal journals.He played a key role in initiating a major partnership between the government ofNorth West Frontier Province (NWFP) and a consortium of highly committed INGOsto start district comprehensive eye care program in Pakistan. The program started as a ten district initiative and is now covering over 80 districts. Professor Kahn conti-nues to serve on the Board of trustees of Layton Rahmatullah Benevolent Trust(LRBT) since 1984, one of the largest and the finest eye NGO in Pakistan and assistedLRBT to establish two eye hospitals in NGO sector in NWFP.Among the many awards received we should mention the President of PakistanAward for outstanding position in MBBS, the President of Pakistan Pride of Perfor-mance Award, the Prevention of Blindness Award APAO, the Prevention of BlindnessAward Saudi Ophthalmological Society, the APAO Jose Rizal Gold medal, the SARC ophthalmology Life time Achievement Award, the Pakistan Institute of CommunityOphthalmology Life time Achievement Award.

15WOC® 2010

Awar

ds

International Council of Ophthalmology Ophthalmic Pathology Award

The “Gottfried and Liselotte Naumann Foundation” was established in 1997 in Erlangen (Ger-many) as a non-profit organization to support Ophthalmic Pathology including Clinico-PathologicCorrelations. The Foundation has provided an amount at the disposition of the Board of the Inter-national Council of Ophthalmology. An International Committee of experts in Ophthalmic Patho-logy, selects three candidates from which the ICO Board elects every four years a laureate. Thefirst laureate TP Drija MD, received his award in 2006 at the Opening Ceremony of the WOC inSao Paulo.

Honoree: Ursula Schlötzer-Schrehardt


Ursula Schlötzer-Schrehardt is Associate Professor and Senior Scientist at theDepartment of Ophthalmology, University Erlangen-Nürnberg (Erlangen/D)She received a PhD (“summa cum laude”) in Biology (thesis “Ultrastructural in-vestigations on reproduction, development and structural organization of Py-gospio elegans (Polychaeta, Spionidae))” from the University ofErlangen-Nürnberg in 1992 and joined the Department of Ophthalmology,where she graduated 1998 in “Experimental Ophthal-mology” and became amember of the Faculty of Medicine. Her thesis on the subject of “Pseudoexfo-liation syndrome: histopathology and pathogenesis of a newly described sys-temic process of the extracellular matrix” was awarded as the best thesis ofthe Medical Faculty of this year. Since 2008, she also serves as a representativefor equal opportunities for the Faculty of Medicine.

By means of full integration into the clinical environment, Ursula Schlötzer-Schrehardt was, as abasic researcher, in a position to contribute greatly to the common and clinically relevant disorderof pseudoexfoliation (PEX) syndrome and to add a growing body of knowledge to this formerlyrather obscure entity. Comprehensive clinical-histopathological correlations helped to explain thecausative mechanisms of the frequent ocular complications including phacodonesis and lenssubluxation, pigment dispersion, poor mydriasis, blood-aqueous barrier dysfunction, and develop-ment of secondary glaucomas. The combination of clinical and her histopathological observati-ons led to the original description of a specific PEX-associated keratopathy. Theseclinical-pathological correlations not only increased our under-standing of this entity and allo-wed diagnosis of early stages, but also helped to prevent complications and to improve clinicalmanagement by close follow-up. One of her most outstanding contributions is the documenta-tion of PEX syndrome as a new systemic process affecting the heart, lungs, liver, kidney, cerebralmeninges and blood vessel walls, which appears to be associated with increased cardio-vascularand cerebrovascular morbidity. Lately, her pioneering analytic studies have provided new insightsinto the underlying molecular pathophysiology and resulted in the commonly accepted pathoge-netic concept of PEX syndrome as a stress-induced elastosis. This concept was recently substan-tiated by the identification of the LOXL1 (lysyl oxidase-like 1) gene, coding for a key enzyme inelastogenesis, as a principal genetic risk factor for both PEX syndrome and PEX glaucoma.Functional alterations of the LOXL1 risk variant, detected by her group, open new approaches forspecific treatment strategies in the future.Apart from being dedicated to pseudoexfoliation, her research interests also include corneal bio-logy/pathology and corneal stem cells, glaucoma basic science, extracellular matrix as well as ge-neral ophthalmic pathology and ultrastructural research. She also established an improvedculture technique supporting the preferential expansion and preservation of limbal stem cells forfuture therapeutic applications in patients with limbal stem cell deficiency.Her research projects have been continuously supported by the German Research Foundationsince 1990. From 1997 until 2009 she was principal investigator and scientific secretary of a Colla-borative Research Center “Glaucomas including Pseudoexfoliation Syndrome” (SFB 539). She isEditorial Board Member of the journal “Experimental Eye Research” and Scientific Advisory BoardMember of “The Glaucoma Foundation”, New York. She has published over 175 scientific articles inpeer-reviewed journals, including many describing the histopatho-logic features of ocular disea-ses, and 20 book chapters. She also received several awards including poster prizes.All in all, her work received broad recognition worldwide and substantiated her international posi-tion as the leading basic researcher in the field of pseudoexfoliation syndrome. Moreover, her per-sonality is gifted to allow exemplarily smooth cooperation so essential for the combination of basicand clinical research. In her spare time, she enjoys literature and the arts as well as scuba diving.

These awards will be conferred on Saturday, 5 June 2010 from 18:30 - 19:00 during the “Opening Ceremony” in Hall 1, ICC.

16 WOC® 2010

Awar

ds

Bernardo Streiff Gold Medal

In 1997, on behalf of friends and disciples, Professor Jean-François Cuendet was commissioned by the Academia Ophthalmologica Internationalis to create the "Bernardo Streiff Gold Medal." honoring the memory of Professor Bernardo Streiff (1908-1988),Head of the University Eye Clinic, Lausanne, Switzerland, and AOI member. The Bernardo Streiff Gold Medal is awarded by election of the Academia every fouryears to an ophthalmologist who has contributed most, through history, ethics and education,to the advance of ophthalmology.

Honoree: Gullapalli N. Rao

Laudatio: Peter G. Watson (AOI President)

Gullapalli Rao was educated at the Guntur Medical College, India; All India Institute of Medical Sciences, New Delhi; and at the Tufts Medical School; University of Connecticut; University of Rochester, U.S.A. He is a Diplomat ofthe American Board, FACS, FRCS, FNAMS, D.Sc. He is the Founder Director and Distinguished Chair of Eye Health, L V PrasadEye Institute of the L. V. Prasad Eye Institute, Hyderabad, India which is a com-plex of a modern eye hospital with advanced training programs for ophthal-mologists and paramedical personnel, an eye research centre, and alsoprovides a rehabilitation program. The L. V. Prasad Eye Institute has develo-ped high quality eye care models for underserved areas and regularly trainsnot only ophthalmologists but also hospital administrators and allied healthpersonnel from developing countries.

Professor Rao is also Adjunct Professor, University of New South Wales, Australia (1993 -), Adjunct Professor of Ophthalmology, University of Rochester, USA (2002 -), formerly Associate Clinical Professor of Ophthalmology, and Director, Cornea Research Labora-tory, University of Rochester, Rochester, New York and Medical Director, Rochester Eye Bank. His main scientific interests are corneal diseases and community eye health. He authored over 240published papers in journals all over the world, 18 chapters and one book. He sits on the editorial board of the American Journal of Ophthalmology, Cornea, The OcularSurgery, CLAO Journal, Ophthalmic Surgery and Lasers and a number of other journals. He is theformer Editor-in-Chief of the Indian Journal of Ophthalmology.Professor Rao has been a visiting professor at several Universities in the U.S., Japan, Europe, HongKong , South Korea, Australia, China, South Africa, Africa, South East Asia, South America andIndia . He gave lectures at many international ophthalmology research and public health mee-tings. He was the Academic and Clinical Supervisor for 20 fellows in Cornea at the University ofRochester and over 200 past and present fellows in Hyderabad, India, from all over the world.Professor Rao had and still has a wide number of national and international responsibilities:Medical Advisory Board, Eye Bank Association of America (1983-88 & 1996-99); Castroviejo In-ternational Corneal Society (Board of Directors, 1985-89 & 2009-); Hyderabad Eye Institute(Chairman, 1986-); Indo-American Eye Care, Inc. (Chairman, 1986-94); President, Eye Bank Asso-ciation of India (1995-98). From 2004 till 2004 he was the Chairman of the Board of Trusteesand President of the International Agency for the Prevention of Blindness (2004-2008).He received grants from many national and international governmental agencies and corporati-ons and non-governmental organizations as well as several honours and awards from many in-ternational organisations including All India Ophthalmological Society (1982, 1984, 1986); RanbaxyResearch Award for excellence in Clinical Research (1995); Senior Honour Award, American Aca-demy of Ophthalmology (1998); Member, Academia Ophthalmologica Internationalis (1998-),Doctor of Science honoris causa of the University of New South Wales, Australia (2001), PadmaShri from the Government of India -2002 (Republic Day Honours given by the President of India),Fellow qua Surgeon ad eundem of the Royal College of Physicians and Surgeons of Glasgow(2003); HRH Prince Abdulaziz bin Ahmed bin Abdulaziz Al-Saud for the Prevention of Blindness Award(2004), First "G. B. Bietti International Award for Prevention of Blindness" by the Italian Society forPrevention of Blindness (2005), International Blindness Prevention Award by the American Aca-demy of Ophthalmology (2006), Pisart Vision Award by Lighthouse International (2007), HonoraryDoctorate of Science from University of Melbourne, Australia (2007), AAO-Essilor Award for Out-standing International Contributions to global eye care by the American Academy of Optometry(2009) .

17WOC® 2010

Awar

ds

18 WOC® 2010

Prom

otio

ns a

nd A

war

ds European VisionAward Lecture2010

DOG Promotionsand Awards

Monday, 7 June 2010, 17:45 - 18:15, Room Stockholm

A systemic view on retinal ciliopathies: inherited retinal degeneration revisited.Speaker: Dr. Ronald Roepman (Nijmegen/NL) Welcome & Laudatio: Prof. E. Zrenner, Chairman European Vision InstituteKeynote Lecture Dr. Ronald Roepman

Promotions

Research Funding for Innovative Scientific Projects in Ophthalmologydonated by the DOG

Funding for Research in Tropical Ophthalmology donated by the DOGThe Award will be conferred on Sunday, 6 June 2010 from 16:00 – 17:30 at Hall 9, ICC.

Awards

Glaucoma Research Award donated by Pharm Allergan GmbH (Ettlingen/D)

Julius Springer Award for Ophthalmology donated by Springer Medizin Verlag (Heidelberg/D)

Kröner Research Award donated by the Kröner-Stiftung

Leonhard-Klein-Award donated by the Leonhard-Klein-Stiftung

Poster Award3 posters a day will be awarded, donated by the DOG

Promotional Award "Innovative developments and therapeutic attempts with age-related macular degeneration (AMD)" donated by Novartis Pharma GmbH (Nuremberg/D)

Research Award Bausch & Lomb donated by Bausch & Lomb GmbH (Berlin/D)

Senator-Hermann-Wacker-Award donated by Hermann Wacker Fonds

Three best German participants in the EBO exam

Tropical Ophthalmology Award donated by the German Committee for the Preven-tion of Blindness, URSAPHARM Arzneimittel GmbH & Co. KG (Saarbrücken/D), Novartis Pharma GmbH (Nuremberg/D), 1StQ Deutschland GmbH & Co. KG (Mann-heim/D) and WaveLight AG (Erlangen /D)The Award will be conferred on Sunday, 6 June 2010 from 16:00 – 17:30 at Hall 9, ICC.

Uveitis Award 2010 donated by LUX Bioscience, Inc. (Jersey City/USA) Allergan Inc. (Irvine/USA)The Award will be conferred on Monday, 7 June 2010 from 14:30 – 15:30 at Salon 21(Lilienthal).

Video Award donated by Carl Zeiss Meditec AG (Munich/D)The award will be conferred on Sunday, 6 June 2010 from 10:30 – 12:00 at Radio Tower Lounge.

Von Graefe Award donated by the DOG

Short-term Lectures

Short-term lectureships donated by the DOGThe Awards will be conferred on Sunday, 6 June 2010 from 16:00 – 17:00 at Hall 9

The DOG Promotions and Awards will be conferred on Wednesday, 9 June 2010 from 11:30 - 13:00 during the session “Award Ceremony and Handover of DOG Presidency" in the Hall “Roof Garden”, ICC (if not stated differently).

19WOC® 2010

Spon

sorsAcknowledgement to Package Sponsors

We cordially thank the following sponsors for their generous support of the WOC® 2010:

Sponsor City Country

Diamond Sponsor

Carl Zeiss Meditec AG Jena D

Gold Sponsors

Alcon Laboratories, Inc. Fort Worth, Texas USA

Bausch & Lomb Zug CHPharmaceuticals

Chibret Pharmazeutische GmbH Haar D

Merck, Sharp & Dohme White House Station, New Jersey USA

Pfizer Ophthalmics New York New York USA

Santen Pharmaceutical Co, Ltd Osaka J

Silver Sponsors

ALLERGAN AG Nordics UK

Novartis Pharma GmbH Basel CH

Bronze Sponsors

AMO Abbott Santa Ana USA

Heidelberg Engineering GmbH Heidelberg D

Sponsors

Aeon Astron Europe Leiden NLAbbott GmbH & Co. KG Wiesbaden DBayer Schering Pharma AG Berlin DGEUDER AG Heidelberg DOculentis GmbH Berlin DOCULUS Optikgeräte GmbH Wetzlar DSanofi Pasteur MSD Lyon FSixt Pullach DZiemer Group Port CH

Adverse events should be reported. Reporting forms and information

can be found at www.yellowcard.gov.uk. Adverse events should

also be reported to Pfi zer Medical Information on 01304 616161.

REFERENCES: 1. European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 2007;114:3–9. 2. Gordon MO, et al. The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714–20. 3. Heijl A, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):1268–79. 4. Advanced Glaucoma Intervention Study (AGIS) Investigators. AGIS: 7. The relationship between control of intraocular pressure and visual fi eld deterioration. Am J Ophthalmol. 2000;130:429–40.

* Re

gist

ratio

n in

the

UK 1

6/12

/199

6. D

ate

of p

repa

ratio

n: M

arch

201

0. X

LUO1

042A

Start with powerful IOP control for lasting patient success.1–4

I N O C U L A R H Y P E R T E N S I O N A N D G L A U C O M A

Protect what’s precious

FIND OUT HOW WE CAN HELP YOU PROTECT

JOIN OUR SYMPOSIUM: ‘FUNCTION, FUNCTIONING & QUALITY OF LIFE’

DATE: SATURDAY 05 JUNE TIME: 13:10–14:00LOCATION: THE ICC (HALL SAO PAULO)

Xalatan® 0.005% w/v eye drops solution Prescribing Information Please refer to the SmPC before prescribing Xalatan 0.005% w/v eye drops solution (latanoprost) Presentation Plastic bottle containing 2.5ml eye drops. Each 1ml contains latanoprost 50 micrograms (0.005%) and benzalkonium chloride. Indication Reduction of elevated intraocular pressure in patients with OAG and ocular hypertension. Dosage and Administration Adults including the Elderly: One eye drop into the affected eye(s) once daily in the evening. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes (see Precautions). Children: Not recommended. Contra-indications Known hypersensitivity to any component. Precautions Xalatan may increase brown pigment within the iris leading to a gradual change in eye colour usually within the fi rst 8 months of treatment, rarely during the second or third year, and has not been seen after the fourth year of treatment. The rate of progression of iris pigmentation decreases with time and is stable for fi ve years. The effect of increased pigmentation beyond fi ve years has not been evaluated. In an open 5-year latanoprost safety study, 33% of patients developed iris pigmentation. This has predominantly been seen in patients with mixed coloured irides and may be permanent. Patients should be examined regularly and treatment discontinued if appropriate. Unilateral treatment can result in permanent heterochromia. Exercise caution in patients with asthma, infl ammatory ocular conditions and other types of glaucoma, including chronic angle closure, OAG of pseudophakic patients and in pigmentary glaucoma. Also caution is recommended in aphakic patients, pseudophakic patients with torn posterior lens capsule or anterior chamber lenses or patients with known risk factors for cystoid macular oedema. Latanoprost may gradually change eyelashes and vellus hair in the treated eye and surrounding areas; these changes include increased length, thickness, pigmentation, number of lashes or hairs and misdirected growth of eyelashes. Eyelash changes are reversible upon discontinuation of treatment. Xalatan contains the preservative benzalkonium chloride which has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy, may cause eye

irritation and is known to discolour soft contact lenses. Close monitoring required with frequent or prolonged use of Xalatan in dry eye patients/ conditions where the cornea is compromised. Contact lenses may absorb benzalkonium chloride. These should be removed before applying Xalatan but may be reinserted after 15 minutes (see Dosage and Administration). Pregnancy Do not use. Lactation Do not use or stop breast feeding. Interactions Defi nitive data are not available. There have been reports of paradoxical elevations in intraocular pressure following the concomitant ophthalmic administration of two prostaglandin analogues. Therefore, the use of two or more prostaglandins, prostaglandin analogues or prostaglandin derivatives is not recommended. Any other eye drops should be administered fi ve minutes apart. Side Effects Ocular side effects - Very common (≥1/10): Increased iris pigmentation, mild to moderate conjunctival hyperaemia, eye irritation (burning, grittiness, itching, stinging and foreign body sensation), eyelash and vellus hair changes (increased length, thickness, pigmentation and number); Common (≥1/100 and <1/10): transient punctate epithelial erosions (mostly without symptoms), blepharitis, eye pain. Please refer to SmPC for other ocular side-effects. Non-ocular side-effects – Uncommon (≥1/1000 and <1/100): Skin rash; Rare (≥1/10,000 and <1/1000): Asthma, asthma exacerbation, dyspnoea, localised skin reaction on the eyelids, darkening of the palpebral skin of the eyelids; Very rare (<1/10,000): Aggravation of angina in patients with pre-existing disease, chest pain. There have been additional post-marketing spontaneous reports of: headache, dizziness, palpitations, myalgia and arthralgia Driving Instillation of eye drops may cause transient blurring of vision. Overdosage Symptomatic treatment. Pharmaceutical Precautions Store at 2°C - 8°C. Protect from light. Once opened, store at room temperature (≤25°C) and discard after 1 month. Legal category POM. Packaging Quantities and Basic NHS price 2.5 ml £12.48. PL number PL 00032/0220. PL Holder Pharmacia Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK. Date of preparation of PI January 2009. Further information is available on request from: Pfi zer Limited, Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS, UK.

21WOC® 2010

Com

mitt

eesWOC® 2010 Congress President

Gerhard K. Lang, MDDOG PresidentUlm, Germany

WOC® 2010 Executive Committee

President Gerhard K. Lang, MDUlm, Germany

Secretary General Anselm Kampik, MDMunich, Germany

Treasurer Jochen Kammann, MDDavos, Switzerland

Program Director Gabriele E. Lang, MDUlm, Germany

Executive Director of the DOGPhilip Gass, PhDGerman Society of OphthalmologyMunich, Germany

Professional Congress Organizer(PCO) Monika PorstmannPorstmann Kongresse [email protected], Germany

WOC® 2010 Honorary PresidentBruce E. Spivey, MDICO PresidentSan Francisco, USA

WOC® 2010 Scientific Program Committee

ChairStephen J. Ryan, MDLos Angeles, USA

Co-ChairBernd Bertram, MDAachen, Germany

Co-ChairGabriele E. Lang, MDUlm, Germany

Subspecialty Area Coordinators

Cataract Dennis Lam (Kowloon, Hong Kong/CN)Amar Agarwal (Chennai/IND)Joseph Colin (Bordeaux/F)Abhay R. Vasavada (Ahmenabad/IND)Thomas F. Neuhann (Munich/D)

Contact Lens and Refraction Albert Franceschetti (Meyrin/CH)Gudrun Bischoff (Hamburg/D)

Evidence Based Ophthalmology Richard L. Abbott (San Francisco/USA)Klaus Dieter Lemmen (Düsseldorf/D)

External Eye Disease, Cornea, EyeBank Abdulaziz AlRajhi (Riyadh/SA)Zbigniew Zagorski (Lublin/PL)Thomas Reinhard (Freiburg/D)

Eye Trauma and Emergencies Ferenc Kuhn (Birmingham/USA)Wolfgang F. Schrader (Nuremberg/D)

Glaucoma Robert Ritch (New York/USA)Clive Migdal (London/UK)Jian Ge (CN)Norbert Pfeiffer (Mainz/D)

Immunology, Molecular Biology, Microbiology Robert Nussenblatt (Bethesda/USA)

Arnd Heiligenhaus (Münster/D)

Low Vision August Colenbrander (Novato/USA)Susanne Trauzettel-Klosinski (Tübingen/D)

Neuro-Ophthalmology Christian Luco (Santiago/RCA)Klara Landau (Zurich/CH)Eberhart Zrenner (Tübingen/D)

NewTechnology: Bioengineering, Nanotechnology Shigeru Kinoshita (Kyoto/J)

Friedrich E. Kruse (Erlangen/D)

Oculoplasty, Lacrimal System,Orbit John Richard O. Collin (London/UK)Artur Klett (Tallinn/EST)Christoph Hintschich (Munich/D)Rudolf F. Guthoff (Rostock/D)

Oncology Jerry Shields (Philadelphia/USA)Tero Kivelä (Helsinki/FIN)Norbert Bornfeld (Essen/D)

Ophthalmic Epidemiology Jialiang Zhao (Beijing/CN)Paul Mitchell (Sydney/AUS)Norbert Pfeiffer (Mainz/D)

Pathology Tatsuro Ishibashi (Kyushu/J)Miguel N. Burnier Jr. (Montréal/CDN)Hans E. Grossniklaus (Atlanta/USA)Karin U. Löffler (Bonn/D)

Pediatric Ophthalmology, Genetics Marilyn Miller (Chicago/USA)Günther Rudolph (Munich/D)

Pharmacology, Ocular Drug Delivery Mark Blumenkranz (Stanford/USA)Karl Ulrich Bartz-Schmidt (Tübingen/D)

WOC®2010 Scientific Program Coordi-nators

22 WOC® 2010

Com

mitt

ees

Subspecialty Area Coordinators

Refractive Surgery Peter McDonnell (Baltimore/USA)Theo Seiler (Zurich/CH)Gernot I. W. Duncker (Halle/D)

Retina, Vitreous Xiao Xin Li (Beijing/CN)Zdenek J. Gregor (London/UK)Peter Wiedemann (Leipzig/D)

Strabismus Kanxing Zhao (Tianjin/CN)Eugene Helveston (Indianapolis/USA)Joachim Esser (Essen/D)

Teleophthalmology and Computers Jorge Valdez (Nuevo Leon/MEX)Georg Michelson (Erlangen/D)

Uveitis, Intraocular Inflammation Rubens Belfort Jr. (São Paulo/BR)Shigeaki Ohno (Sapporo/J)Manfred Zierhut (Tübingen/D)

Vision 2020 (Prevention of Blindness) Nathan Congdon (Baltimore/USA)Hugh R. Taylor (Melbourne/AUS)Volker Klauss (Munich/D)

Cataract and Refractive SurgerySubspecialty Day Douglas D. Koch (Houston/USA)

Jorge L. Alió (Alicante/E)Thomas Kohnen (Frankfurt/Main/D)

GlaucomaSubspecialty Day Clement C. Y. Tham (Hong Kong/CN)

Harry Quigley (Baltimore/USA)Franz Grehn (Würzburg/D)

Pediatric OphthalmologySubspecialty Day Birgit Lorenz (Giessen/D)

RetinaSubspecialty Day Michael T. Trese (Rochester/USA)

Alain Gaudric (Paris/F)William Aylward (London/UK)Anselm Kampik (Munich/D)

World Ophthalmic Educational Colloquium Marko Hawlina (Ljubljana/SLO)Pinar Aydin (Ankara/TR)Mark Tso (Baltimore/USA)Klaus Peter Steuhl (Essen/D)

World Forum of Journal Editors Andrew P. Schachat (Baltimore/USA)Alexander J. Brucker (Gladwyne/USA)Bernd Kirchhof (Cologne/D)

World Forum of Prevention of Blindness Hilel Lewis (New York/USA)Volker Klauss (Munich/D)Bruce Spivey (San Francisco/USA)

WOC®2010 Scientific Program Coordi-nators

23WOC® 2010

Com

mitt

ees

WOC® 2010 Submitted Program Reviewing Committee

Winfried M. Amoaku (Nottingham/GB)Rimvydas Asoklis (Vilnius/LT)Leonid I. Balashevich (St.Petersburg/RUS)Kristine Baumane (Riga/LV)Wolfgang Behrens-Baumann (Magdeburg/D)Amarildo Belshi (AL)Gudrun Bischoff (Hamburg/D)Nadija F. Bobrova (Odessa/UA)Norbert Bornfeld (Essen/D)Andrej Cernák (Bratislava/SK)Stefan Cornel (Bukarest/RO)H. Burkhard Dick (Bochum/D)Vjekoslav Dorn (Zagreb/HR)Brigita Drnovsek-Olup (Ljubljana/SI)Gernot I. W. Duncker (Halle/Saale/D)Carl Erb (Berlin/D)Christoph Faschinger (Graz/A)Michael Gräf (Giessen/D)Rolf Grewe (Münster/D)Steffen Heegaard (Copenhagen/DK)Frank G. Holz (Bonn/D)Raimond Hoxha (AL)Tatsiana Imshenetskaya (Minsk/BY)Antonia M. Joussen (Düsseldorf/D)Jozef Kaluzny (Bydgoszcz/PL)Jochen Kammann (Davos/CH)Volker Klauss (Munich/D)Gerold H. Kolling (Heidelberg/D)Lajos Kolozsvári (Szeged/H)Günther K. Krieglstein (Cologne/D)Friedrich E. Kruse (Erlangen/D)Morten La Cour (Glostrup/DK)Guna Laganovska (Riga/LV)Klara Landau (Zurich/CH)Klaus-Dieter Lemmen (Düsseldorf/D)Wolfgang E. Lieb (Karlsruhe/D)Karin U. Löffler (Bonn/D)Birgit Lorenz (Giessen/D)Dmitry J. Maitchuk (Moscow/RUS)Hans-Werner Meyer-Rüsenberg(Hagen/D)Georg Michelson (Erlangen/D)Christian Ohrloff (Francfort/Main/D)Dusica Pahor (Maribor/SI)Daniel Pauleikhoff (Münster/D)Iva Petkova (Sofia/BG)Norbert Pfeiffer (Mainz/D)Duy-Thoai Pham (Berlin/D)Maria Manuela Pires Carmona(Lisboa/P)Susanne Pitz (Mainz/D)Uwe Pleyer (Berlin/D)Thomas Reinhard (Freiburg/D)Gisbert Richard (Hamburg/D)Johann Roider (Kiel/D)Günther Rudolph (Munich/D)Ahmet Sarici (Cerrahpasa/TR)Reinier O. Schlingemann(Amsterdam/NL)Ursula Schmidt-Erfurth (Vienna/A)Berthold Seitz (Homburg/Saar/D)Daniela F. Selaru (Bucharest/RO)Eric Sellem (Lyon/F)

Halina Sitnik (Minsk/BY)Nelly Sivkova (Plovdiv/BG)Heimo Steffen (Würzburg/D)Josef Stoiber (Salzburg/A)Peter Strmen (Bratislava/SK)Jerzy Szaflik (Warszawa/PL)Nevbahar Tamcelik (Cerrahpasa/TR)Susanne Trauzettel-Klosinski (Tübingen/D)António Casa Nova Travassos (Coimbra/P)Zoran Vatavuk (Zagreb/HR)Catherine Vignal-Clermont (Paris/F)Christian K. Vorwerk (Magdeburg/D)Carroll A. B. Webers (Maastricht/NL)Helmut Wilhelm (Tübingen/D)Sebastian Wolf (Bern/CH)Aleksandra Zborovskaya (Odessa/UA)Eberhart Zrenner (Tübingen/D)Biro Zsolt (Pécs/H)

24 WOC® 2010

Com

mitt

ees

President Bruce E. Spivey, MD (San Francisco/USA) Vice President Akef El-Maghraby, MD (Jeddah/SA)Secretary General Jean-Jacques de Laey, MD (Ghent/B)Treasurer Hugh R. Taylor, AC, MD (Carlton/AUS)Executive Director William Felch, BA (Stinson Beach/USA)Immediate Past President Gottfried O. H. Naumann, MD, ML (Erlangen/D)Honorary Life President Akira Nakajima, MD (Tokyo/J)Honorary Life Member Benjamin F. Boyd, MD (Panama/PA)

Balder P. Gloor, MD (Zurich/CH)Bradley R. Straatsma, MD, JD (Los Angeles/USA)

Members Richard L. Abbott, MD (San Francisco/USA)Jean-Paul Adenis, MD (Limoges /F)Selwa A. F. Al Hazzaa, MD (Riyadh/SA) Abdulaziz AlRajhi, MD (Riyadh/SA) Rubens Belfort Jr., MD, PhD (São Paulo/BR)Susanne Binder, MD (Vienna/A)Daniel Etya'ale, MD (Genève/CH)Veit-Peter Gabel, MD (Regensburg/D)Enrique L. Graue Wiechers, MD (Mexico City/MEX)Adekunle Olubola Hassan, MD (Lagos/NGA) Tero Kivelä, MD (Helsinki/FIN) Volker Klauss, MD (Munich/D)Dennis S. C. Lam, MBBS (Kowloon/Hong Kong/CN)Gerhard K. Lang, MD (Ulm/D)Hilel Lewis, MD (New York/USA)Frank J. Martin, MBBS (Sydney/AUS)David W. Parke II, MD (San Francisco/USA)Jacob Pe'er, MD (Jerusalem/IL)Mohammed Babar Qureshi, BMBCh, MSc (Peshawar/(PK)Serge Resnikoff, MD, PhD (Clermont-Ferrand/F)Robert Ritch, MD (New York/USA)José A. Roca, MD (Lima/PE)Stephen J. Ryan, MD (Los Angeles/USA) Alfred Sommer, MD (Baltimore/USA)David Taylor, MB, ChB, DSc (Med) (London/UK)Mark O. M. Tso, MD, DSc (Baltimore/USA) Gabriel van Rij, MD, PhD (Rotterdam/NL)Abhay R. Vasavada, MD, MS (Ahmenabad/IND)Peter G. Watson, MB, BChir (Cambridge/UK)Zbigniew Zagórski, MD (Lublin/PL)Jialiang Zhao, MD (Beijing/CN)

Committee Chair Robert Ritch, MD (New York/USA)

Members Pinar Aydin, MD, PhD (Kavaklidere/Ankara/TR) Emilio Carlo Campos, MD (Bologna/I) August Colenbrander, MD (Novato/USA) Joseph Colin, MD (Bordeaux/F) John Richard O. Collin, MD (London/UK) Mohamed Alaa, El-Danasoury, MD (Jeddah/SA)Neeru Gupta, MD PhD (Toronto/CDN)Marko Hawlina, MD, PhD (Ljubljana/SLO)Ana Luisa Hofling-Lima, MD, PhD (Sao Paulo/BR)Tatsuro Ishibashi, MD (Fukuoka/J)Martine J. Jager, MD, PhD (Leiden/NL)Ivo Kocur, MD (Geneva/CH)Anthony Murray, MD (Cape Town/ZA)Amel Meddeb Ouertani, MD (Tunis/TN)Ramachandra Pararajasegaram, MD (Geneva/CH)N. Venkatesh Prajna, MBBS (Tamilnadu/IND) Stefan Seregard, MD, PhD (Stockholm/S)Peter Wiedemann, MD (Leipzig/D)

InternationalCouncil of Ophthalmology

Members of theBoard of TrusteesRoster 2010

Members of theAdvisory Committee to the Board of TrusteesICO AdvisoryCommittee

25WOC® 2010

Com

mitt

ees

26 WOC® 2010

Com

mitt

ees International

Council of OphthalmologyFoundation

Board of Directorsand ICO Members

President Bradley R. Straatsma, MD, JD (Los Angeles/USA)

Vice President Alfred Sommer, MD, MHS (Baltimore/USA)

Secretary Treasurer Bruce E. Spivey, MD (San Francisco/USA)

Members H. R. H. Prince Abdulaziz Ahmed Abdulaziz Al Saud (Riyadh/SA) Rubens Belfort Jr., MD PhD (São Paulo/BR)Kevin J. Buehler (Fort Worth/USA) Jean-Jacques de Laey, MD, PhD (Ghent/B) Akef El-Maghraby, MD (Jeddah/SA) Michael Kaschke, PhD (Oberkochen/D)Hilel Lewis, MD (New York/USA)Paul R. Lichter, MD (Ann Arbor/USA)James V. Mazzo (Santa Ana/USA)Alice R. McPherson, MD (Houston/USA)Takakazu Morita (Osaka/J)David E. I. Pyott (Irvine/USA)Stephan J. Ryan, MD (Los Angeles/USA)Timothy R. G. Sear (Fort Worth/USA)Paul A. Sieving, MD, PhD (Bethesda/USA)Hugh R. Taylor, AC, MD (Melbourne/AUS)

27WOC® 2010

Com

mitt

eesDOG Executive

CommitteePresident Professor Gerhard K. Lang (Ulm/D)

First Vice President Professor Thomas Reinhard (Freiburg/D)

Second Vice President Professor Peter Wiedemann (Leipzig/D)

Secretary General Professor Anselm Kampik (Munich/D)

Secretary Professor Franz Grehn (Würzburg/D)

Treasurer Professor Jochen Kammann (Davos/CH)

Executive Director Dr. Philip Gass (Munich/D)

DOG OfficePlatenstr. 1, 80336 MunichT +49 89 5505 768 14F +49 89 5505 768 11E [email protected]

For information about DOG membership please visit the DOGbooth located in the main foyer (1st floor) of the ICC or go towww.dog.org and click on “membership”.

28 WOC® 2010

Com

mitt

ees AAD Executive

CommitteePresident of the BVA Professor Bernd Bertram (Aachen/D)(Berufsverband der Augenärzte)

Vice President of Dr. Klaus Heckmann (Wiesbaden/D)the BVA

Secretary General of Professor Anselm Kampik (Munich/D)the DOG

Secretary of the DOG Professor Franz Grehn (Würzburg/D)

Scientific Board Professor Norbert Pfeiffer (Mainz/D)Member of the BVA

Delegate of Professor Joachim Esser (Essen/D)Strabismology and Neuroophthalmology

Manager of the BVA Christian Gante (Düsseldorf/D)

Assistant of the Claudia Werner (Düsseldorf/D)BVA Manager

For information about BVA membership please visit the BVA booth located in the entrance foyer of the ICC or please go to www.augeninfo.de/wir/formular.php (This site is only in German).

29WOC® 2010

Supp

ortin

g O

rgan

izat

ionsWOC® 2010

Supporting Organizations

Academia Ophthalmologica Internationalis (AOI) American Association for Pediatric Ophthalmology and Strabismus (AAPOS) American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS) American Academy of Ophthalmology (AAO) American Society of Retina Specialists (ASRS) Asian Oceanic Glaucoma Society (AOGS)Asia Pacific Academy of Ophthalmology (APAO) Asia Pacific Society of Ophthalmic Plastic & Reconstructive Surgery (APSOPRS) Asia Pacific Intraocular Inflammation Study Group (APIISG) Association for Research in Vision and Ophthalmology (ARVO) Barraquer Foundation Bielschowsky Society Black Sea Ophthalmological Society (BSOS) Club Jules Gonin Contact Lens Association of Ophthalmologists (CLAO) European Academy of Ophthalmology (EAO) European Association for Vision and Eye Research (EVER) European Board of Ophthalmology (EBO) European Contact Lens Society of Ophthalmologists (ECLSO) European Glaucoma Society (EGS) European Ophthalmic Oncology Group (EOOG) European Paediatric Ophthalmological Society (EPOS) European Society of Cataract and Refractive Surgery (ESCRS) European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) European Society of Ophthalmology (SOE) European Society of Retina Specialists (EURETINA) European Strabismological Association (ESA) European VitreoRetinal Society (EVRS) Federation of European Ophthalmology (FEOph) German Ophthalmic Surgeons (DOC) German Society of Intraocular Lens Implantation, Interventional and Refractive Surgery (DGII) Glaucoma Research Society (GRS) International Medical Contact Lens Council International Ocular Inflammation Society (IOIS) International Organization Against Trachoma (IOAT) International Society for Clinical Electrophysiology of Vision (ISCEV) International Society of Geographical and Epidemiological Ophthalmology (ISGEO) International Society of Low Vision Research and Rehabilitation (ISLRR) International Society of Ocular Oncology (ISOO) International Society of Ocular Trauma (ISOT) International Society for Ophthalmic Pathology International Society of Refractive Surgery of the American Academy of Ophthalmology (ISRS/AAO) International Strabismological Association (ISA) International Uveitis Study Group (IUSG) Julius Hirschberg Society Latin American Society of Cataract and Refractive Surgery (ALACCSA-R) Lindberg Society Middle East Africa Council of Ophthalmology (MEACO) Pan American Oculoplastic Society Pan American Association of Ophthalmology (PAAO) Retinological Society Sociedad Panamericana de Retina y Vítreo (SPRV) South East Asia Glaucoma Interest Group (SEAGIG) South East European Ophthalmological Society (SEEOS) Tear Film & Ocular Surface Society (TFOS) The Macula Society The Retina Society von Graefe Society World Glaucoma Association (WGA)

31WOC® 2010

WOC History2002 - 2014 WOC 2002

XXIX International Congress of Ophthalmology 21 - 25 April 2002, Sydney (AUS)President: Peter Hardy Smith, MD www.ophthalmology.aust.com

WOC 2006XXX International Congress of Ophthalmology19 - 24 February 2006, São Paulo (BR)President: Rubens Belfort, Jr., M.D., Ph.D.

WOC 2008XXXI International Congress of Ophthalmology28 June - 2 July 2008, Hong Kong (CN)President: Dennis S.C. Lam, MD, FRCOphth www.woc2008hongkong.org

WOC 2010 XXXII International Congress of Ophthalmology 5 - 9 June 2010, Berlin (D)President: Gerhard K. Lang, MD www.woc2010.org

WOC 2012XXXIII International Congress of Ophthalmology 16 - 20 February 2012, Abu Dhabi (UAE)President: Abdulaziz AlRahji, MD

WOC 2014XXXIV International Congress of Ophthalmology 2 - 6 April 2014, Tokyo (J)President: Tetsuro Oshika, MD

32

DOGDeutsche OphthalmologischeGesellschaft e.V.

Die wissenschaftliche Gesellschaftder Augenärzte

AnkündigungAnnouncement

Herausforderungen inder Augenheilkunde

109. DOG-Kongress29.9.-2.10.2011Estrel Hotel Berlin

Challenges in Ophthalmology109th DOG Congress29 September - 2 October 2011Estrel Hotel Berlin

PräsidentPresidentProf. Dr. Thomas Reinhard Direktor der Universitäts-Augenklinik Freiburg

33

Invitation to the DOG Congress 2011Einladung zum DOG-Kongress 2011

Dear Colleagues,

It is a special honour and pleasure for me to invite you to the 109th Congress of theGerman Society of Ophthalmology in Berlin, September 29th to October 2nd 2011. Our theme is

“Challenges in Ophthalmology”

and we will be highlighting diagnostic and therapeutic aspects in depth. We will address what constitutes the “cutting edge” in clinical and scientific-research terms, and economic and educational topics will also bepresented. Various symposia will form the backbone of the congress. This applies in particular to the “Subspeciality Day”, during which the latest topics regarding each ophthalmological section may be presented and discussed critically. Poster sessions will be given particularly close attention.Two “Keynote Lectures” and the “von Graefe Lecture” are further highlights. The congress offers a perfect forum for ophthalmologists, scientists, residents and the industry to exchange knowledge. Our congress has

traditionally had an international flair, which is why we express an especially warm welcome to guests and ophthalmological societies from all over the world. The congress is taking place in the Hotel Estrel in Berlin for the third time. This location offers a large number of conference rooms, an excellent infrastructure aswell as more than 2,000 beds.Together with the board of the German Society of Ophthalmology, I would be very pleased to welcome you in Berlin at the 109th congress.

Sehr geehrte, liebe Kolleginnen und Kollegen, verehrte Gäste, sehr geehrte Damen und Herren,

zum 109. Kongress der Deutschen Ophthalmologischen Gesellschaft vom 29. September bis zum 2. Oktober 2011 möchte ich Sie sehr herzlich nach Berlin einladen. Unter dem Thema des Kongresses

„Herausforderungen in der Augenheilkunde“

sollen diagnostische und therapeutische Aspekte unseres Faches umfassend beleuchtet werden. Dies wird die “Cutting Edges” in der Klinik und in der Forschung,aber auch gesundheitsökonomische Herausforderungen sowie Bereiche der Aus-,Weiter- und Fortbildung betreffen. Das Rückgrat des Kongresses stellen die zahlreichen Symposien dar. Dies gilt ganz besonders für den geplanten “Subspeciality Day“. Hier sollen aktuelle Themen des jeweiligen ophthalmologischen Schwerpunkts von allen Seiten dargestellt und kri-tisch hinterfragt werden. Daneben wird den aufgewerteten Postersitzungen beson-deres Augenmerk gewidmet. Besondere Highlights stellen wiederum zwei KeynoteLectures sowie die von Graefe-Vorlesung dar. Der Kongress bietet Klinikärzten, niedergelassenen Augenärzten, Wissenschaftlern,dem Nachwuchs und der Industrie eine hervorragende Gelegenheit zum Wissens-austausch. Der Tradition folgend ist der Kongress auch international ausgerichtet. So sind europäische und außereuropäische Referenten und Gäste, aber auch Fach -gesellschaften ganz besonders willkommen. Der Kongress findet zum dritten Mal im Estrel in Berlin statt. Diese Lokalität hat sichals Veranstaltungsort mit einer großen Zahl an Tagungs- und Ausstellungsräumen,mehr als 2.000 Hotelbetten, sowie einer exzellenten Infrastruktur sehr gut bewährt. Gemeinsam mit dem Geschäftsführenden Präsidium der Deutschen Ophthalmolo -gischen Gesellschaft würde ich mich sehr freuen, Sie in Berlin zum 109. Kongress begrüßen zu dürfen.

Prof. Dr. Thomas Reinhard First Vice President of the DOGErster Vizepräsident der DOG

34 WOC® 2010

The impressive memorial of the founder of the DOG, the German Society of Ophthalmology, Albrecht von Graefe (May 22nd 1828 - 20th July1870 in Berlin) is situated in front of the Charité at the corner Luisen-/Schumannstr. in Berlin-Mitte. On the initiative of the Medical Society of Berlin, the memorial was built by the sculptor Rudolf Leopold Siemering. It was originally positioned in the Charité´s garden whichwas von Graefe´s main place of work. Later the memorial was reestablished at its current location.As a founder of the German Society of Ophthalmology Albrecht vonGraefe proved visionary farsightedness. The German Society of Ophthalmology is the first and oldest scientific medical society of theworld.

The DOG wishes to thank all sponsors for the generous contribution to the restoration of the memorial:

*Acri.Tec AG

Bausch & Lomb GmbH

Chibret Pharmazeutische GmbH

HOYA Medical Europe GmbH

sowie Alcon Pharma GmbH, AMO Germany GmbH, Anteis GmbH, DOMILENS GmbH, GEUDER AG, Pharm-Allergan GmbH, Rayner Surgical GmbH, Santen GmbH, TECHNOMED GmbH

35WOC® 2010

36

BerlinWOC®2010




37

3 Congresses under one roof!

XXXII International Congress of Ophthalmology108th DOG CongressAAD Congress 2010

Scientific Program

- 738 sessions and courses- 1,204 invited speakers- 1,123 papers from the coordinators’ program- 1,120 posters- 618 free papers

Subspecialty Days

The subspecialty days on 6 and 7 June, 2010 provide the opportunity to discuss in depth new research approaches inthe areas of cataract, retina, glaucoma, refractive surgery andpediatric ophthalmology.

Symposia sponsored by Supporting Organizations

55 supporting organizations offer 70 Symposia covering various fields of modern ophthalmology.From the Academia Ophthalmologica Internationalis (AOI) tothe World Glaucoma Association (WGA) all leading ophthalmicassociations will be represented at the WOC®2010.

Submitted Scientific Program

559 free paper presentations1120 poster presentations33 video presentations

E-Posters

More than 1,120 posters can be viewed during the entire congress at e-workstations located within the exhibition areain Hall 17.

E-Videos

Videos are available for viewing at the e-poster and video terminals in Hall 17. Headphones will be provided.

E-Papers

Available online immediately after their presentation at the congress at the e-workstations in Hall 17.

Hig

hlig

hts

At MSD Ophthalmics, innovative science is in our DNA.

Heritage. Commitment. Vision.

Today’s MSD is working to help

the world be well. Through our

medicines, vaccines, biologic

therapies, and consumer and

animal products, we work with

customers and operate in more

than 140 countries to deliver

innovative health solutions.

We also demonstrate our

commitment to increasing access

to health care through far-reaching

programs that donate and deliver

our products to the people who

need them. For over 50 years,

MSD has been committed to

ophthalmic research. And this

commitment continues into our

future of ophthalmic research.

SAFLUTAN and COSOPT are trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. Copyright © 2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 3-11 CST-2010-W-1328400-J

Before prescribing SAFLUTAN™ and COSOPT™, please read the Prescribing Information available from your local MSD representative.

Visit us at MSD exhibit booth #14/06 or on the Worldwide Web at www.msd.com

TM

(dorzolamide HCI-timolol maleate ophthalmic solution, MSD)

SAFLUTAN is manufactured by Santen Oy, Finland.

39WOC® 2010

Opening CeremonySaturday, 5 June 201018:30-20:00ICC, Hall 1Followed by the WOC Reception 20:00-22:00ICC, Hall 2

Do not miss the WOC® 2010 Opening Ceremony, Saturday 5 June 2010 at 6.30pm

Follow us and discover past, present and future during the Opening Ceremony:– Pay tribute to our ancestor Albrecht von Graefe– Explore the iconic Berlin, the vibrant capital of Germany and its “Queen”– Look into the future with WOC® 2012 to be held in Abu Dhabi, United Arab

Emirates.

Join us in welcoming the “Who is Who” of ophthalmo-logy marching in and coming from across the world andbe part of the promotion of scientific excellence reflected throughout the International Award Ceremony.Featured in HD sequences, the beauty of the Eye will beomnipresent during the Opening Ceremony and strivesto represent the vision and mission of our fascinatingprofession. Admire the breathtaking pictures of EyelandDesign. Enjoy phantastic music and entertainment.

The WOC® Reception is the perfect get-together for theinternational ophthalmologist community and alliedspecialties to meet old friends and make new ones in afriendly atmosphere.

On behalf of the International Council of Ophthalmology, the German Society ofOphthalmology, the German Academy of Ophthalmology and both, the WOC® 2010Executive Committee and Scientific Programme Committee, we take pleasure inwelcoming you to this key event.

Prof. Dr. Gerhard K. Lang Bruce E. Spivey, MD, MS, MedPresident of the DOG International Council of OphthalmologyPresident WOC® 2010 President

Hig

hlig

hts

Oculus Optikgeräte GmbH • 35549 Wetzlar • GERMANY Tel. +49-641-2005-0 • Fax +49-641-2005-295 • www.oculus.de

The future of eye-diagnostics starts now !OCULUS – High tech devices emphasizing your competence

• Reliable - Instruments you can trust on during your daily tasks

• Innovative – Our philosophy for more than 115 years

• Customer-oriented – We consult, train and care all over the world

This is OCULUS – A family-owned enterprise with outlook

Look for us at the WOC 2010, booth #15A/10

41WOC® 2010

Hig

hlig

htsWOC in Concert

Sunday, 6 June 201020:00 – 21:30

French Church of Friedrichstadt (French Cathedral, Französische Friedrichstadtkirche)directly at the Gendarmenmarkt

Ophthalmologists play for OphthalmologistsThe musicians present masterpieces from

Carl Philipp Emmanuel Bach Léon BoëllmannLeopold MozartWolfgang Amadeus MozartJohann Joachim QuantzRobert SchumannLouis VierneLudwig van Beethoven

Organizers: Georg Fischer Varvitsiotis (Conductor) and Franz Grehn

Entrance open from 19:30

Admission free. Concert attendees are kindly requested to support the work of Stiftung Auge (the Eye Foundation) with a donation.

As the official airline network for World Ophthalmology Congress 2010, we’d like to thank you for choosing the Star Alliance™ network and hope that all goes really well for you here today.

Whilst you concentrate on the day’s events, we hope you’ll consider us the next time you need to attend a conference.

With over 19,700 flights a day to 1,077 airports across 175 countries, our 26 member airlines will extend a wide choice of flights to any futureconference you’re planning to attend. And no matter which of those airline’s frequent flyer programmes you belong to, you can earn andredeem miles across all of them.

So the next time you want to concentrate all your energies on your conference, we hope you’ll decide to leave the travel arrangements to us.

YOU’VE ONLY JUSTARRIVED & ALREADYWE’RE THINKING OF YOUR NEXT TRIP

www.staralliance.com

Information correct as at 01/2010

43WOC® 2010

Hig

hlig

htsWOC®toberfest

Monday, 7 June 201019:30-24:00

Hangar II at Tempelhof Airport

WOC®toberfest will be a typical Bavarian-like Oktoberfestwith beer, German food and entertainment. You should notmiss this special social highlight!

We cordially invite you to come and join us for a Bavarian-styleOktoberfest at the WOC®toberfest. With traditional Oktober-fest brass band music, beer and Bavarian specialties, we planto enjoy a lively, intercultural evening. Of course, there willalso be non-alcoholic drinks and vegetarian food. We are offering some other attractions for adults and children so as to celebrate this WOC®toberfest as a family party.

All participants are also most welcome to wear their own national dress at this event, as wearing different and colorfulnational dresses conveys a sense of friendly solidarity.

Our motto for the evening is: meet old friends and make newfriends in a relaxed and friendly atmosphere.

WOC®toberfest c 80Children from 7 to 14 years c 25(free up to 6 years)

Discover the Future of Ophthalmology …

ARVO Annual MeetingMay 1–5, 2011Fort Lauderdale, Florida

www.arvo.org/am

Diabetic Retinopathy: Neurovascular Dysfunction & ProtectionAugust 11–14, 2010Reykjavik, Iceland

www.arvo.org/serc

ARVO Summer Eye Reseach Conference

Photo courtesy of freefoto.com

VOARRVReseach Conference

VO Summer Eye Reseach Conference

Diabetic Retinopathy: Neurovascular Dysfunction & ProtectionAugust 11–14, 2010

Diabetic Retinopathy: Neurovascular Dysfunction & ProtectionAugust 11–14, 2010

August 11–14, 2010Reykjavik, Iceland

www

August 11–14, 2010Reykjavik, Iceland

vo.org/serc.arwww


ARVO Annual MeetingMay 1–5, 2011


ARVO Annual MeetingMay 1–5, 2011

May 1–5, 2011t Lauderdale, FloridaFor

www

May 1–5, 2011t Lauderdale, Florida

vo.org/am.arwww

45WOC® 2010

Academia Ophthalmologica Internationalis (AOI) Lecture

Sunday, 6 June 2010, 17:30-18:15Hall Oslo

“Galileo’s Blindness”

Chair: Paul R. Lichter (Ann Arbor/USA)

Introduction of the AOI Lecturer: Juan Verdaguer T. (Santiago/RCH)

Lecturer: Peter Watson (Cambridge/UK)

He was educated in medicine at the University of Cambridge and UniversityCollege London. After posts in general medicine, neurosurgery and plasticsurgery, he trained in Ophthalmology at Moorfields Eye Hospital. He later became Senior lecturer at Moorfields Eye Hospital and London University. He was Consultant Ophthalmologist at Addenbrooke's University Hospitaland Moorfields Eye Hospital until 1995. He was Boerhaave Professor of Ophthalmology University of Leiden The Netherlands from 1999 to 2004.

His specialty interests are in glaucoma transplantation and inflammatoryeye disease, especially scleritis. These interests have led to the developmentof Trabeculectomy in 1976 with John Cairns and the unravelling of the typesof Scleral Disease together with the developmentof effective treatments

for these conditions. The third edition of the "Sclera and Systemic Disorders" is currently in preparation.

He has also initiatited of the Cambridge Symposium now in its 40th year. This 2 daysymposium on a specific, sometimes minor topic, brings together basic scientistsand clinicians. It has been published as a separate issue of EYE since it started.

He was responsible for the initiation and development of the International CouncilAssessments for Ophthalmologists. Over 2000 candidates a year from 70 countriesnow take this exam.

Whilst Boerhaave Professor he was able to pursue his interest in Transplantationwhich led to the successful transplantation of Ciliary Body in the rabbit. His interestin portraiture has led him to investigate Galileo's blindness.

Hig

hlig

hts

46

Auction

Art

From above:Peter HalleyLaurence WeinerRosemarie Trockel

From above:Matt MullicanMarc Francis

Stiftung Auge weil Sehen wichtig ist

47

Hig

hlig

hts

WOC® 2010 Art Auction

Benefit Art Auction in aid of Stiftung Auge (the Eye Foundation) as part of the WOC® 2010.

3 – 9 June 2010Main foyer, ICC Berlin

Join the bidding for some eye-catching pieces of art work!Exclusive to WOC® 2010 you have the opportunity to purchase modern works centered on the theme of “Art in the Art of Healing”. In the works of art donated by Georg Thieme Verlag, renowned contemporary artists have dealt with the fascination of the human body, and also its fragility and limitations. This has resulted in the creation of impressive works of art, which are available for purchaseas hand-signed, numbered serigraphs (limited edition of 250).

Art is Seeing – Seeing is ArtFounded in 2008 by the German Society of Ophthalmology (DOG), Stiftung Auge is dedicated to fighting avoidable blindness and serious visual impairment. Its commitment is to raising awareness, training and the promotion of research to preserve vision. If you would like to support the work of Stiftung Auge, join thebidding and see what delights your eye. Stiftung Auge. Because sight is important.

The artistsPeter Halley, New YorkRosemarie Trockel, CologneMarc Francis, LondonLaurence Weiner, New YorkMatt Mullican, New York

Would you like to bid? It’s easy:At WOC® 2010, you have the opportunity to see the expression and power of theseworks of art for yourself. They will be on exhibition in the main foyer of the ICC nextto the Stiftung Auge stand. The value of each work is estimated at at least 1,300Euro. Join in by making an opening bid of 300 Euro.Should you wish to bid in the auction, you can have your name entered on a list ofbidders at the Stiftung Auge stand. Here, we will have some information on theworks of art to be auctioned, the current bidding situation and the foundation itself. Curious? Then come along during WOC and join the bidding.

48 WOC® 2010

49WOC® 2010

Hig

hlig

hts

The Eye Run – Because sight is important

Five-kilometer run in aid of Stiftung Auge (the Eye Foundation)as part of the World Ophthalmology Congress.

Start: Sunday, 6 June 2010, 7.00 a.m.at Mommsenstadion, near the ICC Berlin Waldschulallee 34, 14055 Berlin, Germany

Open your eyes – to a beautiful route and a good cause!Make a sporty start to Sunday morning together with somefellow runners and help to preserve the sense of sight at thesame time: this is the goal of the Eye Run on the occasion ofWOC® 2010. This breakfast-time run follows a flat course leading through city and forest. The start and finish are locatedat Mommsenstadion, 10 minutes’ walk from the Messe Berlin exhibition grounds and the ICC Berlin. An award ceremony willtake place following the run. Refreshments are provided andchanging rooms and sanitary facilities are available.

Support Stiftung Auge!Founded in 2008 by the German Society of Ophthalmology(DOG), Stiftung Auge is dedicated to fighting avoidable blind-ness and serious visual impairment. Its commitment is to raising awareness, training and the promotion of research topreserve vision. If you would like to support the work ofStiftung Auge, run with us on June 6, 2010 in the Eye Run!

You’d like to join in? It’s easy:All congress attendees and running enthusiasts are most welcome to take part in the Eye Run. Pay a 15 Euro donation feeand you’re off! Registrations can be made at the Stiftung Auge stand inthe main foyer of the ICC Berlin during WOC® 2010. Would youlike to do something for your health and support the workof Stiftung Auge? Then pack your running shoes and join in onJune 6, 2010 when the cry goes up: ‘On your marks, get set, go!’

WOC® 2010

How

to R

ead

the

Scie

ntifi

c Pro

gram

50

Scientific Program

Subs

peci

alty

Day

s

WOC® 2010 51

Zwei-Jahres-Abo: 22 Ausgaben für 166 Euro*. (inkl. jährl.

aktualisiertem Ophthalmo-Index)

Jahres-Abo: 11 Ausgaben für 83 Euro*. (inkl. jährl.

aktualisiertem Ophthalmo-Index)

Test-Abo: 3 Ausgaben für 20 Euro**.

Das Abonnement verlängert sich nur

dann um ein Jahr, wenn nach Erhalt der

2. Ausgabe keine schriftliche Kündigung

vorliegt.

Ermäßigtes Abo: 11 Ausgaben für 47 Euro, für Assistenzärzte

und Studenten. Nachweis beilegen.

*zzgl. Versand 16 Euro (inkl. MwSt.);

**inkl. Versand und MwSt.

Bestell-Service:Augenspiegel Leserservice

PressUp GmbH, Postfach 701311

22013 Hamburg, Fax: 040-41448-499

Telefon: 040-41448-460

E-Mail: [email protected]

WOC® 2010

Sund

ay, 6

June

Subs

peci

alty

Day

s

53

09:25 IL SU-02-02What is weak in present conventional perimetryand what can we do about itUlrich Schiefer (Tübingen/D)

09:35 IL SU-02-03Alternatives presently available (Flicker tests [FDT,Matrix, etc.], electrophysiology)Michael Bach (Freiburg/D)

09:45 IL SU-02-04What we need - the ideal new functional testBalwantray C. Chauhan (Halifax/CDN)

09:55Discussion

Stockholm

10:30 - 11:15 SU-03

Decisions for Treatment and Change in Treatment

Subspecialty Day GlaucomaGlaucoma Care: A Look into the Future

Section 2: Present and Future Approaches to Glaucoma Care

Chairs:Norbert Pfeiffer (Mainz/D)Augusto Azuara-Blanco (Aberdeen/UK)

10:30 IL SU-03-01Risk assessment and risk calculationSteven L. Mansberger (Portland/USA)

10:40 IL SU-03-02The impact of risk calculation on physician decisionsMichael Boland (Baltimore/USA)

10:50 IL SU-03-03Cost/benefit, Cost effectivenessAugusto Azuara-Blanco (Aberdeen/UK)

11:00 IL SU-03-04Practice patterns, too much or too littleNorbert Pfeiffer (Mainz/D)

11:10Discussion

Sunday, 6 June 2010

Stockholm

08:30 - 09:15 SU-01

Present and Future Imaging


Section 1: Structure and Function in Glaucoma Care

Chairs:Ted Garway-Heath (London/UK)Ester M. Hoffmann (Mainz/D)

08:30 IL SU-01-01What is most useful present imaging (HRT, OCT,GDx)Ester M. Hoffmann (Mainz/D)

08:40 IL SU-01-02Measuring progressive change with imaging:which stage, which strategy, which consequencesTed Garway-Heath (London/UK)

08:50 IL SU-01-03Ganglion cell visualization: animals and humansM. Francesca Cordeiro (London/UK)

09:00 IL SU-01-04Perspectives in retinal imaging: adaptive optics, en face OCT and full-field dopplerMichel Paques (Paris/F)

09:10Discussion

Stockholm

09:15 - 10:00 SU-02

Present and Future of Functional Diagnostics


Section 1: Structure and Function in Glaucoma Care

Chairs:Anders Heijl (Malmö/S)Ulrich Schiefer (Tübingen/D)

09:15 IL SU-02-01Useful strategies in present perimetryAnders Heijl (Malmö/S)

Stockholm

11:15 - 12:00 SU-04

New Approaches to Gathering Information AboutGlaucoma


Section 2:Present and Future Approaches to Glaucoma Care

Chairs:Alfred Sommer (Baltimore/USA)Richard Wormald (London/UK)

11:15 IL SU-04-01The challenge: conduct large-scale research withmany centersDon Budenz (Miami/USA)

11:25 IL SU-04-02Insurance database studies: strengths and wea-knessesJoshua D. Stein (Ann Arbor/USA)

11:35 IL SU-04-03Mining our hard drives (Lessons from Cochrane approach)Richard Wormald (London/UK)

11:45 IL SU-04-04How to do research cheaper and betterAlfred Sommer (Baltimore/USA)

12:05Discussion

Stockholm

14:00 - 14:45 SU-05

Adherence with Medical Therapy, the Dirty Secret


Section 3: Outlooks to Medical and Surgical Therapy

Chairs:Günther K. Krieglstein (Cologne/D)Jenny Lacey (Norwich/UK)

14:00 IL SU-05-01How bad is adherence now?Günther K. Krieglstein (Cologne/D)

14:10 IL SU-05-02Barriers to adherenceJenny Lacey (Norwich/UK)

14:20 IL SU-05-03How does physician communication affect adherence?Michael Boland (Baltimore/USA)

14:30 IL SU-05-04How much would be gained if we increased adherence?James C Tsai (/USA)

14:40Discussion

Stockholm

14:45 - 15:40 SU-06

Present and Future of Glaucoma Surgery – SurgicalChallenges


Section 3: Outlooks to Medical and Surgical Therapy

Chairs:Peng T. Khaw (London/UK)Tarek M. Shaarawy (Geneva/CH)George Baerveldt (Irvine/USA)

14:45 IL SU-06-01Developments making trabeculectomy saferPeng T. Khaw (London/UK)

14:55 IL SU-06-02Bleb classification and management of complicati-ons related to blebsFranz Grehn (Würzburg/D)

15:05 IL SU-06-03Non-penetrating glaucoma surgery techniques –has their time come or gone?Tarek M. Shaarawy (Geneva/CH)

15:15 IL SU-06-04Tubes: When, why, howKeith Barton (London/UK)

15:25 IL SU-06-05Angle surgery: status report on newer methodsGeorge Baerveldt (Irvine/USA)

15:35 IL SU-06-06Standardized reporting on surgical studiesMark Sherwood (Gainesville/USA)

Sunday, 6 June 2010

WOC® 2010

Sund

ay, 6

June

Subs

peci

alty

Day

s54

WOC® 2010

Sund

ay, 6

June

Subs

peci

alty

Day

s

55

Stockholm

16:10 - 16:50 SU-07

Childhood Glaucoma Care: the Patient who Livesup to 2100


Section 4: Neglected Areas: Where Can We Improve

Chairs:Jan Eric Jakobsen (Oslo/N)Franz Grehn (Würzburg/D)Jugnoo S. Rahi (London/UK)

16:10 IL SU-07-01Present and future surgical techniques: Innovationat the horizon?Jan Eric Jakobsen (Oslo/N)

16:20 IL SU-07-02Spontaneous resolution of congenital glaucoma –a natural help for surgeryFranz Grehn (Würzburg/D)

16:25 IL SU-07-03Developing vision: Amblyopia is a major challengeThomas Klink (Würzburg/D)

16:35 IL SU-07-04New aspects of secondary glaucoma after congenital cataract surgeryJugnoo S. Rahi (London/UK)

16:45Discussion

Stockholm

16:50 - 17:30 SU-08

Glaucoma Care in Developing Countries


Section 4: Neglected Areas: Where Can We Improve

Chairs:Paul Foster (London/UK)Clement C. Y. Tham (Hong Kong/CN)

16:50 IL SU-08-01The scope of the problemPaul Foster (London/UK)

16:55 IL SU-08-02What is done now for OAG in the developing worldKuldev Singh (Stanford/USA)

17:00 IL SU-08-03What is done now for ACG in the developing worldClement C. Y. Tham (Hong Kong/CN)

What should be done right now: 3 viewpoints17:05 IL SU-08-04We should apply the developed country modelTarek M. Shaarawy (Geneva/CH)

17:10 IL SU-08-05We should use different programs for different regionsTin Aung (Singapore/SGP)

17:15 IL SU-08-06We should use the center of excellence – pyramidmodelGarudadri Chandra Sekhar (Hyderabad/IND)

17:25 IL SU-08-07Where will we make the biggest short-term gainsin reducing impairmentMingguang He (Guangzhou/CN)

17:25Discussion

Abu Dhabi

08:30 - 10:00 SU-13

Correcting Presbyopia with IOLs

Subspecialty Day Cataract

Chairs:Jorge L. Alió (Alicante/E)Charles Claoué (Brentwood/UK)Thomas F. Neuhann (Munich/D)

08:30 IL SU-13-01MonovisionThomas F. Neuhann (Munich/D)

08:40 IL SU-13-02Multifocal, refractiveCharles Claoué (Brentwood/UK)

08:50 IL SU-13-03Mulitfocal, diffractiveJosé F. Alfonso (Miami/USA)

09:00 IL SU-13-04Accommodating, monoopticMilind Pande (North Ferriby/UK)

Sunday, 6 June 2010

09:10 IL SU-13-05Accommodating, dualopticIvan L. Ossma-Gomez (Bucaramanga/CO)

09:20 IL SU-13-06Managing astigmatism and residual ametropiaMichael C. Knorz (Mannheim/D)

09:30Discussion

Abu Dhabi

10:30 - 12:00 SU-14

Managing Complex Cases


Chairs:Boris Malyugin (Moscow/RUS)Hiroko Bissen-Miyajima (Tokyo/J)Duy-Thoai Pham (Berlin/D)

10:30 IL SU-14-01Incisional issuesAmar Agarwal (Chennai/IND)

10:40 IL SU-14-02Dense nucleiDuy-Thoai Pham (Berlin/D)

10:50 IL SU-14-03Small pupilsBoris Malyugin (Moscow/RUS)

11:00 IL SU-14-05Ruptured posterior capsuleHiroko Bissen-Miyajima (Tokyo/J)

11:10 IL SU-14-06Iris defects (aniridia, coloboma, traumatic)Stephan Kohnen (Aachen/D)

11:20 IL SU-14-07Dislocated iolsTBA

11:30Discussion

Abu Dhabi

14:00 - 15:30 SU-15

New Monofocal IOL Designs


Chairs:Rudy Nuijts (Maastricht/NL)Liliana Werner (Berlin/D)Thomas Kohnen (Frankfurt am Main/D)

14:00 IL SU-15-01AsphericThomas Kohnen (Frankfurt am Main/D)

14:10 IL SU-15-02Toric overviewRudy Nuijts (Maastricht/NL)

14:20 IL SU-15-03Surgical pearls for toric IOLsDavid Spalton (London/UK)

14:30 IL SU-15-04Extreme casesGerd U. Auffarth (Heidelberg/D)

14:40 IL SU-15-05Light-adjustableFritz Hengerer (Bochum/D)

14:50 IL SU-15-06New IOL biomaterialsLiliana Werner (Berlin/D)

15:00Discussion

Abu Dhabi

16:00 - 17:30 SU-16

Emerging Technology in Cataract Surgery


Chairs:Mats Lundström (Karlskrona/S)Douglas D. Koch (Houston/USA)Oliver Findl (Vienna/A)

16:00 IL SU-16-01Advances in techniques for patient assessmentOliver Findl (Vienna/A)

16:10 IL SU-16-02IOL calculations, technology?, formulas - Haigis,IOL calculations after refractive surgery - DDKJaime Aramberri Agesta (Vitoria-Gasteiz/E)

Sunday, 6 June 2010

WOC® 2010

Sund

ay, 6

June

Subs

peci

alty

Day

s56

WOC® 2010

Sund

ay, 6

June

Subs

peci

alty

Day

s

57

16:20 IL SU-16-03Phaco technologyBarry S. Seibel (Los Angeles/USA)

16:30 IL SU-16-04Prevention of PCOManfred Tetz (Berlin/D)

16:40 IL SU-16-05Prevention of endophthalmitisMats Lundström (Karlskrona/S)

16:50 IL SU-16-06Small-incision ECCE" to "Modern Manual CataractSrinivas K. Rao (Chennai/IND)

17:00Discussion

Hall 3

08:30 - 10:00 SU-48

Retinal Detachment and PVR

Subspecialty Day Retina

Chairs:George William Aylward (London/UK)Alain Gaudric (Paris/F)

08:30 IL SU-48-01Surgical instrumentation for RD and PVR repair(20, 23, 25 g etc.)Constantin J. Pournaras (Geneva/CH)

08:40 IL SU-48-02Which new drugs can treat PVR?Louisa Wickham (London/UK)

08:50 IL SU-48-03Is there still place for scleral buckling in primarysurgery for RD?Heinrich Heimann (Liverpool/UK)

09:00 IL SU-48-04Management after failure of primary RD-repairPeriklis Brazitikos (Athens/GR)

09:10 IL SU-48-05Prevention of RD: are there cases in which it isworthwhile?Fred Hendrikse (Maastricht/NL)

09:20 IL SU-48-06Management of second eye in vitreoretinal dystrophiesAntonio Capone (Oakland/USA)

9:30 IL SU-48-07Trauma and vitreoretinal surgery – timing and managementMasahito Ohji (Otsu/J)

09:40 IL SU-48-08Intraocular tamponade – what’s new?David Wong (Pok Fu Lam/HK)

09:50 IL SU-48-09“Hot topic” (last minute announcement)TBA

10:00Discussion

Hall 3

10:30 - 12:00 SU-49

Vitreoretinal Interface – Epiretinal Macular Surgery


Chairs:Alain Gaudric (Paris/F)Michael T. Trese (Royal Oak/USA)

10:30 IL SU-49-01Pathology of the vitreoretinal interface: Implicati-ons for surgeryArnd Gandorfer (Munich/D)

10:40 IL SU-49-02Pharmacologic vitreolysis and vitreodynamicsMatthew Benz (Houston/USA)

10:50 IL SU-49-03Progress in epiretinal surgery: vital stainsChristos Haritoglou (Munich/D)

11:00 IL SU-49-04Macular hole surgery: is face -down positioningstill necessary?D. Alistair H. Laidlaw (London/UK)

11:10 IL SU-49-05Macular hole surgery: is ILM peeling always useful?Ramin Tadayoni (Paris/F)

11:20 IL SU-49-06ERM and VMTS surgery: cases which failThomas J. Wolfensberger (Lausanne/CH)

11:30 IL SU-49-07Vitreoretinal interface in AMDSusanne Binder (Vienna/A)

Sunday, 6 June 2010

WOC® 2010

Sund

ay, 6

June

Subs

peci

alty

Day

s58

11:40 IL SU-49-08Vitreoretinal Interface in children – therapeuticimplicationsMichael T. Trese (Royal Oak/USA)


12:00Discussion

Hall 3

14:00 - 15:30 SU-50

Retinal Vascular Diseases: Diabetic Retinopathy /Vein Occlusions


Chairs:Michael T. Trese (Royal Oak/USA)Anselm Kampik (Munich/D)

14:00 IL SU-50-01Retinal oximetry in diabetic retinopathy and reti-nal vein occlusionsEinar Stefánsson (Reykjavik/IS)

14:10 IL SU-50-02Steroids vs laser in DMEPascale Massin (Paris/F)

14:20 IL SU-50-03Anti VEGFs vs Steroids in DMEJulia A. Haller (Philadelphia/USA)

14:30 IL SU-50-04Slow release steroids in DMEFrank G. Holz (Bonn/D)

14:40 IL SU-50-05Combination of pharmacology and VR surgery in DRJ. Fernando Arevalo (Caracas/Y)

14:50 IL SU-50-06Does early intravitreal drug therapy change thecourse of BRVO and CVROFrancesco Bandello (Milano/I)

15:00 IL SU-50-07Is surgery useful in BRVO and CRVO?José García Arumí (Barcelona/E)



Hall 3

16:00 - 17:30 SU-51

AMD


Chairs:Anselm Kampik (Munich/D)George William Aylward (London/UK)

16:00 IL SU-51-01When to stop anti VEGF therapy?Adnan Tufail (London/UK)

16:10 IL SU-51-02Update on Clinical Trials of Intravitreal Drugs forNeovascular AMDAlexander J. Brucker (Philadelphia/USA)

16:20 IL SU-51-03Geographic atrophy: Imaging Metrics and Progression DeterminantsFrank G. Holz (Bonn/D)

16:30 IL SU-51-04Future drugs for treatment of dry AMDSalvatore Grisanti (Lübeck/D)

16:40 IL SU-51-05Genetics and prevention of AMDHendrik Peter Nicolas Scholl (Bonn/D)

16:50 IL SU-51-06Is there a place for surgery in AMD?Jan van Meurs (Rotterdam/NL)

17:00 IL SU-51-07Cell therapy for AMDTBA

17:10 IL SU-51-08How to prevent endophthalmitis in intravitrealtherapy?Thierry C. Verstraeten (Pittsburgh/USA)


Sunday, 6 June 2010

WOC® 2010

Mon

day,

7 Ju

ne

Subs

peci

alty

Day

s

59

Sao Paulo

08:30 - 10:00 MO-04

Update on Retinopathy of Prematurity: New Approaches for Research, Diagnosis and Treatment

Subspecialty Day Pediatric Ophthalmology

Chairs:Andrea Zin (Rio de Janeiro/BR) Anand Vinekar (Bangalore/IND) Birgit Lorenz (Giessen/D)

08:30 IL MO-04-01 New research areas in ROP diagnosis and managementAnn Hellstrom (Gothenburg/S)

08:40 IL MO-04-02Organizing national screening programs for ROPAndrea Zin (Rio de Janeiro/BR)

08:50 IL MO-04-03ROP Screening in VietnamNguyen Xuan Tinh (Hanoi/VN)

09:00 IL MO-04-04Telemedicine as an option for screening: The expert´s view on WFDI in ROPMichael Chiang (New York/USA)

09:10 IL MO-04-05Telemedicine in ROP: The Indian ExperienceAnand Vinekar (Bangalore/IND)

09:20 IL MO-04-06WFDI in ROP. Opportunity for automated imageanalysisAlistair Fielder (London/UK)

09:30 IL MO-04-07Anti-VEGF and ROPHelen A. Mintz-Hittner (Houston/USA)

09:40Discussion

Sao Paulo

10:30 - 12:00 MO-05

Surgical Challenges in Pediatric Anterior SegmentDiseases


Chairs:Birgit Lorenz (Giessen/D) Marie-José Tassignon (Antwerp/B) Ken K. Nischal (London/UK)

10:30 IL MO-05-01Best choice surgery in pediatric cataractMarie-José Tassignon (Antwerb/B)

10:45 IL MO-05-02Alternatives to penetrating keratoplasty in pediatric corneal diseaseKen K. Nischal (London/UK)

11:00 IL MO-05-03Pediatric Corneal Transplantation: Experiencesfrom a large tertiary referral center in IndiaPravin V. Krishna (Hyderabad/IND)

11:15 IL MO-05-04The choice and effectiveness of surgery in differentclinical forms of congenital glaucomaAnton Gerinec (Bratislava/SK)

11:30 IL MO-05-05Pediatric perforating injuries of the globe: timingof surgical stepsRobert Stegmann (Pretoria/ZA)

11:45Discussion

Sao Paulo

14:00 - 15:30 MO-06

Update on Infantile Nystagmus: Clinics, Genetics,and Treatment


Chairs:Irene Gottlob (Leicester/UK) Christina Zeitz (Paris/F) Birgit Lorenz (Giessen/D)

14:00 IL MO-06-01Modern work-up in infantile nystagmusBirgit Lorenz (Giessen/D)

14:15 IL MO-06-02Genetics of X-linked idiopathic nystagmusIrene Gottlob (Leicester/UK)

14:30 IL MO-06-03Genetics of cone dysfunction disordersSusanne Kohl (Tübingen/D)

14:45 IL MO-06-04Genetic and clinical hetereogeneity of congenitalforms of night blindnessChristina Zeitz (Paris/F)

15:00 IL MO-06-05Medical and surgical treatment optionsAnil Kumar (Leicester/UK)

Monday, 7 June 2010

15:15 IL MO-06-06Gene therapy provides cure for achromatopsiaKnut Stieger (Giessen/D)

Sao Paulo

16:00 - 17:30 MO-07

EPOS Symposium: Vision 2020 in Pediatric Ophthalmology. Dreams and Realities in Eliminating Avoidable Childhood Blindness


Chairs:Birgit Lorenz (Giessen/D) Clare Gilbert (London/UK) David Taylor (London/UK)

16:00 IL MO-07-01VISION 2020 and children: achievements and challengesClare Gilbert (London/UK)

16:15 IL MO-07-02 Pediatric cataract: can we improve on what wehave achieved?Michael O’Keefe (Dublin/IRL)

16:30 IL MO-07-03 Pediatric glaucoma. Holes, tubes and morePeng T. Khaw (London/UK)

16:45 IL MO-07-04 Pediatric infectious eye diseases: Prevention andtreatmentPerumalsamy Vijayalakshmi (Madurai/IND)

17:00 IL MO-07-05 Predictions of genotype and phenotype in pediatric hereditary diseases: present achievements and future challengesJosseline Kaplan (Paris/F)

17:15 IL MO-07-06 Retinal dystrophies: hopes for cureBirgit Lorenz (Giessen/D)

Hall 3

08:30 - 10:00 MO-37

Corneal Approaches for Addressing Presbyopia

Subspecialty Day Refractive Surgery

Chairs:Douglas D. Koch (Houston/USA) Emanuel S. Rosen (Manchester/UK) Thomas F. Neuhann (Munich/D)

08:30 IL MO-37-01Corneal Techniques (Monovision)Thomas F. Neuhann (Munich/D)

08:45 IL MO-37-02 Corneal PseudoaccommodationDouglas D. Koch (Houston/USA)

09:00 IL MO-37-03 Presby-LasikDamián Gatinel (Paris/F)

09:15 IL MO-37-04 Intracorneal LensesEmanuel S. Rosen (Manchester/UK)

09:30 IL MO-37-05Small Aperture DevicesGeorge Waring (Atlanta/USA)

09:45Discussion

Hall 3

10:30 - 12:00 MO-38

Corneal Laser Refractive Surgery


Chairs:Günther Grabner (Salzburg/A)J. Bradley Randleman (Atlanta/USA)Michael C. Knorz (Mannheim/D)

10:30 IL MO-38-01Femtosecond Laser TechnologyGünther Grabner (Salzburg/A)

10:40 IL MO-38-02Excimer Laser TechnologyTheo Seiler (Zurich/CH)

10:50 IL MO-38-03Other New Technologies for Ablation and FlapCreationHolger Lubatschowski (Hannover/D)

Monday, 7 June 2010

WOC® 2010

Mon

day,

7 Ju

ne

Subs

peci

alty

Day

s60

WOC® 2010

Mon

day,

7 Ju

ne

Subs

peci

alty

Day

s

61

11:00 IL MO-38-04Eye-TrackingMichael Mrochen (Zurich/CH)

11:10 IL MO-38-05LASIK Techniques and ComplicationsMichael C. Knorz (Mannheim/D)

11:20 IL MO-38-06Surface Techniques and ComplicationsMarguerite McDonald (New Orleans/USA)

11:30 IL MO-38-07EctasiaJ. Bradley Randleman (Atlanta/USA)

11:40Discussion

Hall 3

14:00 - 15:30 MO-39

Corneal Physiology and Biomechanics


Chairs:Jorge L. Alió (Alicante/E)William J. Dupps Jr. (Cleveland/USA)Theo Seiler (Zurich/CH)

14:00 IL MO-39-01BiomechanicsWilliam J. Dupps Jr. (Cleveland/USA)

14:10 IL MO-39-02Accommodation and presbyopiaAdrian Glasser (Houston/USA)

14:20 IL MO-39-03Normal wavefront error as function of age, pupilsize and anatomyJorge L. Alió (Alicante/E)

14:30 IL MO-39-04Retinal image quality in refractive surgeryJack T. Holladay (Bellaire/USA)

14:40 IL MO-39-05Laser tissue interactionRonald R. Krueger (Cleveland/USA)

14:50 IL MO-39-06New advances in corneal imagingMitchell P. Weikert (Houston/USA)

15:00Discussion

Hall 3

16:00 - 17:30 MO-40

Managing High Refractive Errors


Chairs:Joseph Colin (Bordeaux/F)Roberto Zaldivar (Buenos Aires/RA)Thomas Kohnen (Frankfurt am Main/D)

16:00 IL MO-40-01Phakic iols vs corneal refractive surgeryJosé L. Güell (Barcelona/E)

16:10 IL MO-40-02Angle-supportedThomas Kohnen (Frankfurt am Main/D)

16:20 IL MO-40-03Iris-fixatedCamille Budo (Melveren/B)

16:30 IL MO-40-04Sulcus-fixatedRoberto Zaldivar (Buenos Aires/RA)

16:40 IL MO-40-05Phakic IOLs: complicationsJoseph Colin (Bordeaux/F)

16:50 IL MO-40-06Refractive lens exchangeAntonio A. P. Marinho (Porto/P)

17:00 IL MO-40-07IOL selection for refractive lens exchangeRoberto Bellucci (Verona/I)

17:10 Discussion

Monday, 7 June 2010

EVERCrete Oct 6-9

2010www.ever.be

21 CME CREDITS

Join EVER• Largest annual european eye research meeting• Keynote lectures• Special interest symposia• Free paper sessions and posters• Workshops and courses• Commercial Interest Symposia• New attractive location every three years

Become an active member• Reduced fee for annual meeting• Organizing Special Interest Symposia (SIS) during the

annual meeting• Voting rights for the election of Board Members• Free access to Acta Ophthalmologica• Travel grants• Quarterly E-Newsletter

European Association for Vision and Eye Research

23/03/2010

Keynote - Plenary LecturesKeynote Lectures - David TAYLOR, UK - Alan BIRD, UK - Stefan SEREGARD, SwedenEVER - Acta Lecture - Wolfgang DREXLER, AustriaEVER Lecture - Charles RIVA, SwitzerlandEuropean Ophthalmic Heritage LectureOphthalmic Research LectureEVI Prize and Lecture

Pre-congress Courses• COS - Optical coherence tomography applications in anterior segment eye diseases Edward WYLEGALA

- Corneal infectious disease - Jean-Jacques

GICQUEL, Harminder S DUA

- Facial nerve palsy: anatomy, etiology, evaluation, and management Ioannis MAVRIKAKIS

• IM - EBO Review Course 1: Intraocular infl ammation and infection - Bahram BODAGHI,

Carl P HERBORT

- EBO Review Course 2: Intraocular infl ammation and infection - Bahram BODAGHI,

Carl P HERBORT

• LC - Anaesthesia in ocular surgery - Kati GOMBOS

• NSPH - Common neuro-ophthalmic pitfalls: case- based studies - Valerie PURVIN, Aki KAWASAKI

• PO - Diagnostic of ophthalmic tumors - Laurence

DEJARDINS, Bertil DAMATO

- Proper use of words and numbers in scientifi c writing - Bertil DAMATO, Tero KIVELÄ

- Simple and effective alternatives to textbook surgical procedures for treatment of trichiasis, removal of orbital tumors and evisceration - Mordechai ROSNER, Nachum ROSEN

• RV - Retinal detachment: how to improve our success rate? - Caherine CREUZOT, Constantin

POURNARAS

- Retinal imaging: fi rst to describe and then to analyse - Caherine CREUZOT, Gisèle SOUBRANE

Special Interest Symposia/workshopsin the following scienti c sections:• Anatomy / Cell Biology - ACB• Cornea / Ocular Surface - COS• Glaucoma - G• Immunology / Microbiology - IM• Lens and Cataract - LC• Molecular Biology / Genetics / Epidemiology - MBGE• Neuro-ophthalmology / Strabismology/ Paediatric Ophthalmology / History of Ophthalmology - NSPH• Pathology / Oncology - PO• Physiology/Biochemistry/Pharmacology - PBP• Retina / Vitreous - RV• Vision Sciences / Electrophysiology / Physiol. Optic - VEP

Dates to rememberAbstract submission deadline: June 14, 2010Final programme online: July 15, 2010Early registration deadline: September 1, 2010

EVER 2010 Hosts: ARVO - ESCRS - EURETINA - FRO - ISCEV - MEACO - OOG - SOIE

Science for Sight

Scientific ProgramScientific Program Schedule

Saturday, 5 June 2010 Satu

rday

, 5 Ju

ne

WOC® 2010 63

Satu

rday

, 5 Ju

neH

ighl

ight

Sym

posi

umFr

ee P

aper

WO

C Co

urse

Indu

stry

Sym

posi

umM

eetin

gs

ICC

Hal

l 1

Hal

l 2

Hal

l 6

Hal

l 7

Hal

l 8

Hal

l 9

Hal

l 10

Roof

Gar

den

Salo

n 11

/12

Salo

n 13

/14

Salo

n 15

/16

Room

34

Room

44

Room

56

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

SA-0

0 O

peni

ng

Cere

mon

ySA

-33

Bruc

ker, S

oubr

ane,

Hol

zU

pdat

e on

Man

agem

ent

of A

MD

SA-3

4 Li

, Ban

dello

, Sch

mid

t-Er

furt

h U

pdat

e in

Dia

betic

Retin

opat

hy

Lunc

h Sy

mpo

sium

Alco

n

WO

C-AA

D-C

-17 Z

ierh

ut

Epis

cler

itis a

nd S

cler

itis

WO

C-AA

D-C

-18 K

irchh

of

Diag

nosi

s and

Trea

tmen

t of

Perip

hera

l Ret

inal

Deg

ener

.

WO

C-AA

D-C

-19 B

ehre

ns-

Baum

ann

Diag

nosi

s and

Trea

tmen

t of K

erat

omyc

oses

Lunc

h Sy

mpo

sium

Baus

ch&

Lom

b

Ocu

lus U

ser

Mee

ting

Brea

kfas

t Sy

mpo

sium

Ziem

erW

OC-

C-10

Wor

mal

d, V

irgili

Ev

iden

ce-B

ased

Oph

thal

-m

olog

y

WO

C-AA

D-C

-11 C

ursi

efen

Cr

ossl

inki

ng o

f the

Cor

nea:

Whe

n, H

ow a

nd W

hy?

WO

C-C-

12 C

hakr

abar

ti Ad

vanc

ed B

iaxi

al M

icro

phac

oan

d Co

axia

l Pha

co

Mitg

liede

rver

s.Bi

elsc

how

sky-

Ges

ells

chaf

tSi

tzun

g de

r Sek

tion

DOG

-Gla

ukom

WO

C-AA

D-C

-20

Gre

hn

Gla

ucom

a Su

rger

y Fo

llow

-up

Care

SA-3

7 Ko

llman

n, Il

ako,

Nku

mbe

Afr

ica:

Can

we

suc-

ceed

in th

e gr

eate

st ch

all.

SA-3

8 La

ndau

, Zre

nner

, Lee

,Lu

co P

anel

: Neu

ro-O

phth

al-

mol

ogic

al P

robl

ems

SA-15

Fran

cesc

hett

i, Kho

o,Ku

hn P

anel

: Con

tact

Lens

esan

d Ch

ildre

n

SA-16

Kin

oshi

ta, F

iol-S

ilva,

Gut

hoff

Cor

neal

Imag

ing:

New

Ver

sus U

sefu

lIC

O W

orld

Oph

thal

mol

ogy

Roun

dtab

le o

n Le

ader

ship

De

velo

pmen

t (W

ORL

D) a

nd IC

O G

ener

al A

ssem

bly

SA-4

0 Ro

senb

aum

, M

acke

nsen

, Gul

G

enet

ics a

nd U

veiti

s

SA-4

1 Are

valo

, Wilk

inso

n, R

oca

PAAO

Sym

posi

um: R

etin

alan

d Ch

oroi

dal M

anife

st.

Brea

kfas

t Sy

mpo

sium

Aeon

Astr

onW

OC-

C-13

Em

mer

ich

The

Agin

g Li

d –

Func

tiona

lEf

fect

s and

thei

r Tre

atm

ent

WO

C-C-

14 G

eerli

ng, G

rehn

,M

ülle

r Man

agem

ent o

f Co

mpl

ex G

lauc

oma

WO

C-C-

15 S

chm

idt-

Erfu

rth

Mod

ern

OCT

imag

ing:

Clin

i-ca

l val

ue a

nd p

ersp

ectiv

es

WO

C-AA

D-C

-16 K

ohne

n KR

C Ad

vanc

ed C

ours

e fo

r the

Refr

activ

e Su

rger

yLu

nch

Sym

posi

umZe

iss

SA-0

5 M

enap

ace,

Fish

kind

,Ar

tal A

dvan

ces i

n Ca

tara

ctan

d IO

L Tec

hnol

ogy

SA-0

6 O

'Brie

n, B

arry

, Bar

tz-

Schm

idt

Endo

phth

alm

itis

SA-0

7 Ag

arw

al, K

ohne

n Ph

aco

Nig

htm

ares

and

Wor

stCa

se S

cena

rios

SA-0

8 W

akef

ield

, Pav

esio

,Th

urau

Unm

et N

eeds

in

Diag

nosi

s of U

veiti

sAr

beits

grup

pe In

tern

et

und

med

izin

isch

e In

form

a-tio

nsve

rarb

eitu

ng

Sitz

ung

der S

ektio

n DO

G-G

eweb

e-tr

ansp

lant

atio

n un

d Bi

otec

hnol

ogie

ICO

Oph

thal

mol

ogic

So

ciet

y Ad

voca

tes L

unch

WO

C-AA

D-C

-09

Völc

ker

Corn

eal D

egen

erat

ion

/ Dy

stro

phy

19:0

0-20

:00

Vors

tand

ssitz

ung

DGII

DOCH

-Mee

ting

Satu

rday

, 5 Ju

ne

Lunc

h Sy

mpo

sium

Alle

rgan

Oph

thal

-m

olog

y

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

Mes

se

Stoc

khol

m

Sao

Paul

o

Abu

Dhab

i

Osl

o

Room

Mad

rid

Room

Syd

ney

Room

Hon

g Ko

ng

Room

Ista

nbul

VIP

Loun

ge 1

VIP

Loun

ge 2

Radi

o To

wer

Lo

unge

1

Radi

o To

wer

Loun

ge 2

Hal

l 11

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

SA-0

1 Hol

lada

y H

ot To

pics

in R

efra

ctiv

e Su

rger

y

SA-0

2 Kr

uege

r, Sek

undo

20

10 W

OC

Fem

tose

cond

Lase

r Rev

iew

Lunc

h Sy

mpo

sium

Geu

der A

GSA

-03

Zarb

in, M

acLa

ren,

Bind

er S

OE

Sym

p:

Cell

Deriv

ed T

hera

pies

SA-0

4 Re

inst

ein,

Rab

inov

itz,

Preu

ßner

Saf

ety

of R

efr.

Sur-

gery

usin

g N

ew D

iagn

. Tec

hn.

SA-2

9 M

iche

lson

, Chi

ang,

Ols

on, T

ost C

linic

al A

spec

ts:

Scre

enin

g, D

iagn

osin

g, …

SA-3

0 G

oldb

erg,

Roj

anap

ong-

pun,

Fang

SEA

GIG

Sym

p.:

Angl

e-Cl

osur

e G

lauc

oma

Lunc

h Sy

mpo

sium

Pfiz

erW

OC-

AAD

-C-0

1 Lan

g Di

ffere

ntia

l Dia

gnos

is o

fM

acul

ar D

isea

ses

WO

C-AA

D-C

-02

Die

tlein

G

lauc

oma

with

out h

igh

Pres

-su

re –

Nor

mal

-ten

sion

Gla

uc.

WO

C-AA

D-C

-03

Kam

pik

Diab

etic

Ret

inop

athy

WO

C-AA

D-C

-04

Schr

oete

r O

ptic

disc

ele

vatio

n –

Diffe

r-en

tial D

iagn

osis

and

Wor

k U

pSA

-35

Mie

ler, J

ager

, Foe

rste

r Re

tinal

Sho

wca

seSA

-36

D'A

mic

o, va

n M

eurs

,W

iede

man

n W

hat's

New

on

Man

agem

ent o

f Ret

i. Di

seas

e

SA-2

5 M

iele

r, Mur

ray,

Roid

er

Retin

a: D

iagn

ostic

s 1SA

-26

Knor

z, El

Dan

asou

ry,

Neu

hann

Ref

ract

ive

surg

ery/

Refr

actio

n 1

SA-0

9 D

esja

rdin

s, Si

lva,

Lohm

ann

Ocu

lar T

umor

s in

Child

hood

– D

evel

op. E

ye D

is.

SA-10

Dut

ton,

Fazz

i, Lor

enz

Cere

bral

Vis

ual I

mpa

irmen

tSA

-11 K

riegl

stei

n, G

ando

lfi,

Fant

es Tr

abec

ulec

tom

y:

Prob

lem

s and

Sol

utio

ns

SA-12

Ritc

h, Jo

nas,

Flam

mer

Pr

essu

re-in

depe

nden

t Fa

ctor

s in

Gla

ucom

aSA

-42

Colli

n, H

ints

chic

h, K

lett

Co

ngen

ital a

nd A

cqui

red

Lid

Mal

Pos

ition

s

SA-4

3 Is

hiba

shi, G

ross

nikl

aus,

Dith

mar

Ret

inal

Dis

ease

s and

Dege

nera

tions

SA-13

Koh

lhaa

s, Ka

npol

at,

Neu

hann

Basic

Res

earc

h,U

pd. o

n Tr

eatm

. and

Opt

. Cor

.

SA-14

Bis

chof

f, Key

,Bi

alas

iew

icz C

linic

al M

anag

.of

Con

tact

Lens

Com

plic

a.SA

-17 Ts

eng,

Mel

ler

Amni

otic

Mem

bran

e Tr

ansp

lant

atio

n

SA-18

Lisc

h, M

unie

r Co

rnea

l Dys

trop

hies

SA-19

Rei

nhar

d, S

eitz

, AlR

ajhi

La

ser-a

ssis

ted

Kera

topl

asty

SA-2

0 Kn

op, K

nop,

Bro

n M

eibo

mia

n G

land

Ana

tom

y,Ph

ysio

logy

and

Dis

ease

SA-2

1 Wor

mal

d, K

riegl

stei

n,Ri

tch

Evid

ence

-bas

ed

Man

agem

ent o

f Gla

ucom

a

SA-2

2 Ku

pper

man

n, S

paid

e,Zi

emss

en P

anel

: Cha

lleng

esan

d Pe

rsp.

of I

ntra

vit.

Drug

s

SA-2

3 Pf

eiffe

r, Frie

dman

, Zha

o Ep

idem

iolo

gica

l Res

earc

h in

Eye

Dise

ase

SA-2

4 Pf

eiffe

r, Frie

dman

, Pe

rula

sam

y N

ew C

halle

nges

to V

isio

n 20

20W

OC-

C-05

Koh

nen

Wet

Lab

Refr

activ

e Su

rger

y 1

WO

C-C-

06 D

unck

er

Wet

lab

Refr

activ

e Su

rger

y 2

WO

C-C-

07 R

icha

rd,

Corc

oste

gui, W

ong

Wet

lab:

En

dota

mpo

nade

s in

Vitr

eor.

WO

C-C-

08 S

truc

k, Sc

hrag

e,Ki

raly

Wet

lab

Surg

ical

Mea

s-ur

emen

t in

the

Early

Pha

seSA

-27

Bret

thau

er, B

eiko

, Tab

in

Cata

ract

/bio

met

ry 1

SA-2

8 Sp

iege

l, Krie

glst

ein,

Re

itsam

er

Gla

ucom

a: B

asic

s 1

Mitg

liede

rver

sam

mlu

ng d

erSe

ktio

n DO

G-K

orne

a

SA-3

1 Aun

g, C

hise

lita,

Ja

nson

ius

Gla

ucom

a: D

iagn

ostic

s

SA-3

2 Bi

nder

, Fra

mm

e, Li

pshi

tz

Retin

a: A

MD

1AO

I Mee

ting

and

Lunc

heon

(AO

I Ora

tion)

SA-4

4 AP

SORP

S Sym

posiu

m

SA-4

7 Re

pka,

Tho

uven

in, E

hrt

Ambl

yopi

a: e

arly

det

ectio

nan

d sc

reen

ing

prog

ram

s

SA-4

8 Th

ulas

iraj, G

ilber

t, Et

ya'a

leCh

angi

ng R

ealit

ies i

n Ey

e Ca

reSA

-45

Engl

e, , N

euge

baue

r Co

ngen

ital C

rani

al D

ysin

ner-

vatio

n Di

sord

ers (

CCDD

)

SA-4

6 Pe

'er, P

raus

e, G

utho

ff O

rbita

l, Ad

nexa

l and

Co

njun

ctiv

al Tu

mor

sPo

ster

exh

ibiti

on o

f Pos

ter

P-SA

-001

to P

-SA-

282

Interested?

Subscribe FREE* to the following products from Ophthalmology Times Europe

Magazine | Digital Digest | E-news | Web seminars

Ophthalmology Times Europe is a comprehensive publication covering all of the latest developments within the ophthalmic industry with a broad focus on cataract, corneal and refractive

surgery, glaucoma and vitreoretinal conditions.

To subscribe for FREE* visit www.oteurope.com/subscribe*Free to qualifying readers in Europe

Stockholm

08:30 - 10:00 SA-01

Hot Topics in Refractive Surgery

SymposiumRefractive Surgery

Chair:Jack T. Holladay (Bellaire/USA)

08:30 IL SA-01-01Patient Satisfaction With Laser Vision Correctionas Performed by a Large Corporate ProviderSteven C. Schallhorn (San Diego/USA)

08:40 IL SA-01-02Wavefront Analysis: When Do We Need It?Jack T. Holladay (Bellaire/USA)

08:50 IL SA-01-03Optics and Causes of Rainbow GlareRonald R. Krueger (Cleveland/USA)

09:00 IL SA-01-04Managing the Not Quite Emmetropic PostcornealLaser PatientJulian D. Stevens (London/UK)

09:10 IL SA-01-05Six-Month Results of All-in-One FemtosecondLaser Refractive SurgeryRupal S. Shah (Vadodara/IND)

09:20 IL SA-01-06Corneal Biomechanics, Refraction, and CornealAberrometry in Keratoconus: An Integrated Diagnostic StudyJorge L. Alió (Alicante/E)

09:30 IL SA-01-07Outcome of Refractive Surgery in Keratoconus Suspect EyesDamián Gatinel, Alain Saad (Paris/F)

09:40 IL SA-01-08Femtolaser Deep Anterior Keratoplasty with Baring of Descemet Membrane in Keratoconus and Post-LASIK EctasiaMohamed Alaa El Danasoury (Jeddah/SA)

09:50Discussion

Stockholm

10:30 - 12:00 SA-02

2010 WOC Femtosecond Laser Review


Chairs:Ronald R. Krueger (Cleveland/USA)Walter Sekundo (Marburg/D)

10:30 IL SA-02-01Personal Experience with several fs laser platforms and review of current status of all fs lasers for corneal surgeryGünther Grabner (Salzburg/A)

10:40 IL SA-02-02Use of FS lasers for cataract surgeryRamon Naranjo-Tackman (Vadodara/IND)

10:50 IL SA-02-03FS laser surgery for presbyopiaMike P. Holzer (Heidelberg/D)

11:00 IL SA-02-04FLEX Surgical ResultsRupal S. Shah (Vadodara/IND)

11:10 IL SA-02-05FS Lasers for Corneal TransplantationYaron Rabinovitz (Los Angeles/USA)

11:20Discussion

Stockholm

14:00 - 15:30 SA-03

SOE Symposium: Cell Derived Therapies for RetinalDegeneration

SymposiumRetina

Chairs:Marco Zarbin (Roseland/USA)Robert E. MacLaren (London/UK)Susanne Binder (Vienna/A)

14:00 IL SA-03-01Cell based therapy for AMDMarco Zarbin (Roseland/USA)

14:10 IL SA-03-02Current status of Human RPE transplantationSusanne Binder (Vienna/A)

Saturday, 5 June 2010

67

Satu

rday

, 5 Ju

ne

67

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

14:20 IL SA-03-03Rejuvenation of retinal pigment epithelial cellsKerstin Steindl (Vienna/A)

14:30 IL SA-03-04Novel aspects of cell-based non viral gene therapyGabriele Thumann (Aachen/D)

14:40 IL SA-03-05Tissue engineering and cellular replacement strategies of the RPEBoris V. Stanzel (Bonn/D)

14:50 IL SA-03-06How close are we in stem cell therapy in retinaldisorder?Taraprasad P. Das (Hyderabad/IND)

15:00Discussion

Stockholm

16:00 - 17:30 SA-04

Safety of Refractive Surgery Using New DiagnosticTechnologies


Chairs:Dan Z. Reinstein (London/UK)Paul-Rolf Preußner (Mainz/D)

16:00 IL SA-04-01Phakic-IOL sizing and monitoring technologyCarlo F. Lovisolo (Milan/I)

16:15 IL SA-04-02Keratoconus screening – is the back surface of benefit?Renato Ambrósio Jr. (Rio de Janeiro/BR)

16:30 IL SA-04-03Epithelial thickness profiles in sub-surface keratoconus screeningTimothy C. Archer (London/UK)

16:45 IL SA-04-04Surface and sub-surface corneal diagnostic technology in refractive surgery complicationsDan Z. Reinstein (London/UK)

17:00 IL SA-04-05Everything you ever wanted to know about dryeye evaluation technology and LASIKIlpo Tuisku (Hus/FIN)

17:15Discussion

Abu Dhabi

08:30 - 10:00 SA-25

Retina: Diagnostics 1

Free PaperRetina

Chairs:William F. Mieler (Chicago/USA)Timothy G. Murray (Miami/USA)Johann Roider (Kiel/D)

08:30 FP SA-25-01Pathological Changes of Cerebral and Ocular Hemodynamics in Optic Nerve AtrophyEkaterina Kravchuk, Tatyana Kiseleva(Moscow/RUS)

08:37 FP SA-25-02Analysis of indocyanine green angiography in myopic choroidal neovascularizationHyoung Jun Koh, Jong Uk Yoon, Yong Min Kim, Yeo Jue Byun (Seoul/ROK)

08:44 FP SA-25-03A preliminary study on the value of autofluores-cence photography in observing inherited fundusdiseasesKai Ma, Feng Zhang, Ning Pu Liu (Beijing/CN)

08:51 FP SA-25-04High-speed, high-penetration, swept-source optical coherence tomography at 1 micrometer wa-velength band for posterior eye diseases.Yasushi Ikuno, Yoshiaki Yasuno, Miki Sawa, Motokazu Tsujikawa, Fumi Gomi (Suita/J)

08:58 FP SA-25-05Spectral-domain Optical Coherence Tomographyfor gas-filled eyesMakoto Inoue, Kimihiko Sano, Shutaro Taniuchi,Akito Hirakata (Tokyo/J)

09:05 FP SA-25-06Analysis of retinal layers in patients with sympto-matic central serous chorioretinopathy (CSC) byhigh resolution spectral domain OCT (SD-OCT)Mark Saeger, Carsten Klatt, Felix Treumer, Anne Wissen, Johann Roider (Kiel/D)

09:12 FP SA-25-07Simultaneous Infrared cSLO and Spectral Domain-OCT Imaging of RPE TearsHans-Martin Helb, Sandeep Saxena, Frank G. Holz,Carsten H. Meyer (Bonn/D)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne68

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

69

09:19 FP SA-25-08Macular volume is decreased in Multiple Sclerosisdepending on the disease stage – an OCT studyAndrea Hassenstein, Maria-Katharina Wölbert,Armin Julius Wulff, Benedikt Große Darrelmann,Jana Pöttgen, Rüdiger Schwartz, Sven Schippling(Hamburg/D)

09:26 FP SA-25-09Diffuse diabetic macular edema using Spectral-Domain Optical Coherence TomographyAvinoam Ophir, Michael R. Martinez, Paola Mosqueda, Aaron Trevino (Hadera/IL)

09:33 FP SA-25-10Evaluating retinal and vitreoretinal pathology with en-face optical coherence tomographyDesislava Koleva-Georgieva, Nelly Sivkova (Plovdiv/BG)

09:40Discussion

Abu Dhabi

10:30 - 12:00 SA-26

Refractive Surgery/Refraction 1

Free PaperRefractive Surgery

Chairs:Michael C. Knorz (Mannheim/D)Mohamed Alaa El Danasoury (Jeddah/SA)Thomas F. Neuhann (Munich/D)

10:30 FP SA-26-01Objective Assessment of Quality of vision and LensStability after Toric Posterior Chamber Phakic IOLImplantationAlaa El Danasoury (Jeddah/SA)

10:37 FP SA-26-02Refractive Outcomes with Toric ICL ImplantsDandapani Ramamurthy (Coimbatore/IND)

10:44 FP SA-26-03All-In-One Femtosecond Laser (Flex and Smile) forthe correction of myopia and astigmatismOsama Ibrahim (Alexandria/ET)

10:51 FP SA-26-04Changes of higher order aberrations after surfaceablation of highly aberrated corneasStefan Pieh, Gerald Schmidinger, Christian Skorpik(Vienna/A)

10:58 SL SA-26-05Clinical evaluation of the IntraCOR intrastromalfemtosecond laser procedure to correct presbyopiaMichael C. Knorz (Mannheim/D)

11:07 FP SA-26-06Reading performance after implantation of theAcuFocus Corneal Inlay (ACI) for the surgical correction of presbyopia – a two year follow-upAlois Dexl, Orang Seyeddain, Wolfgang Riha, Melchior Hohensinn, Gerhard Nix, Günther Grabner (Salzburg/A)

11:14 FP SA-26-07Our results with Epilasik in Thin CorneasChitra Ramamurthy (Coimbatore/IND)

11:21 FP SA-26-08Thin corneas: how safe in laser refractive surgery?Hassan Al Arrayed (Manama/BRN)

11:28 FP SA-26-10Advanced surface ablation at DR. Yap Eye HospitalYogyakarta – three years experienceSiti Sundari, Suhardjo Suhardjo, Nurfifi Arliani(Yogyakarta/RI)

11:35Discussion

Abu Dhabi

14:00 - 15:30 SA-35

Retinal Showcase

SymposiumRetina

Chairs:William F. Mieler (Chicago/USA)Martine J. Jager (Leiden/NL)Michael H. Foerster (Berlin/D)

14:00 IL SA-35-01Macrophages and angiogenesisRajendra Apte (Rotterdam/NL)

14:10 IL SA-35-02Angiogenesis in uveal melanomaNikolaos E. Bechrakis (Innsbruck/A)

14:20 IL SA-35-03Macrophages and agingMartine J. Jager (Leiden/NL)

14:30 IL SA-35-04Angiogenesis in retinoblastomaTimothy G. Murray (Miami/USA)

14:40 IL SA-35-05Von Hippel Lindau disease: why does it develop?Klaus-Martin Kreusel (Berlin/D)


14:50 IL SA-35-06Therapy of choroidal and retinal hemangiomasMichael H. Foerster (Berlin/D)

15:00Discussion

Abu Dhabi

16:00 - 17:30 SA-36

What's New on Management of Retinal Disease

SymposiumRetina

Chairs:Donald J. D'Amico (New York/USA)Jan van Meurs (Rotterdam/NL)Peter Wiedemann (Leipzig/D)

16:00 IL SA-36-01Comparison of AMD Treatment Trial: Lucentisverus Avastin – Current Status (CATT)TBA

16:10 IL SA-36-02Direct Ophthalmic Artery Delivery of Chemotherapy for Retinoblastoma – 4 Year ResultsDavid H. Abramson (NY/USA)

16:20 IL SA-36-03Pharmacologic Agents in the Management of Radition RetinopathyCarol L. Shields (Philadelphia/USA)

16:30 IL SA-36-04The Case For and Against Complement in the Pa-thogenesis of AMDAnthony P. Adamis (Boston/USA)

16:40 IL SA-36-05Modulation of the Subretinal Fluid in Retinal Detachment PatientsMarc A. Veckeneer (Rotterdam/NL)

16:50 IL SA-36-06New Surgical Treatments for AMDRobert E. MacLaren (London/UK)

17:00 IL SA-36-07Liquid Expansile Vetreous Endotamponades: anAvenue To Pursue?Bernd Kirchhof (Cologne/D)

17:10Discussion

Oslo

08:30 - 10:00 SA-09

Ocular Tumors in Childhood – Developmental EyeDiseases

SymposiumPediatric Ophthalmology, Genetics

Chairs:Laurence Desjardins (Paris/F)Eduardo Silva (Coimbra/P)Dietmar Lohmann (Essen/D)

08:30 IL SA-09-01Genetic of retinoblastomaDietmar Lohmann (Essen/D)

08:40 IL SA-09-02Treatment of retinoblastomaFrancis Munier (Lausanne/CH)

08:50 IL SA-09-03Orbital tumors of childhoodJerry Shields (Philadelphia/USA)

09:00 IL SA-09-04Medulloepitheloma in childhoodLaurence Desjardins (Paris/F)

09:10 IL SA-09-05Conjunctival and lid tumorsChristine Levy (Paris/F)

09:20 IL SA-09-06Cytogenetic and molecular findings in develop-mental eye diseases. A complex puzzleEduardo Silva (Coimbra/P)

09:30Discussion

Oslo

10:30 - 12:00 SA-10

Cerebral Visual Impairment

SymposiumLow Vision

Chairs:Gordon Dutton (Glasgow/UK)Elisa Fazzi (Brescia/I)Birgit Lorenz (Giessen/D)

10:30 IL SA-10-01Cerebral Visual Impairment – a Common Cause ofVisual Impairment in ChildhoodGordon Dutton (Glasgow/UK)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne70

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

71

10:45 IL SA-10-02Visual routes to knowledge and actionMel Goodale (Ontario/CDN)

11:00 IL SA-10-03Spectrum of visual disorders with cerebral visualimpairmentElisa Fazzi (Pavia/I)

11:15 IL SA-10-04Cerebral Visual Impairment (CVI) Schools needclear information on clinical findings for assess-ment of visual processing problemsLea Hyvärinen (Helsinki/FIN)

11:30 IL SA-10-05Visual field defects and compensating mechanismsassociated with pre-and perinatal brain damageLena Jacobson (Stockholm/S)

11:45Discussion

Oslo

14:00 - 15:30 SA-11

Trabeculectomy: Problems and Solutions

SymposiumGlaucoma

Chairs:Günther K. Krieglstein (Cologne/D)Stefano Gandolfi (Parma/I)Francisco Fantes (Miami/USA)

14:00 IL SA-11-01Patients' selection: which patients, which risksStefano Gandolfi (Parma/I)

14:10 IL SA-11-02Intra-operative complicationsFrancisco Fantes (Miami/USA)

14:20 IL SA-11-03Short-term post-operative complicationsCarlo E. Traverso (Genova/I)

14:30 IL SA-11-05Long-term post-operative complicationsRoberto Carassa (Milano/I)

14:40 IL SA-11-05Why and how do blebs fail in the long-term?Franz Grehn (Würzburg/D)

14:50 IL SA-11-06Trabeculectomy: still a worthwhile surgeryGünther K. Krieglstein (Cologne/D)

15:00 Discussion

Oslo

16:00 - 17:30 SA-12

Graefe Society SymposionPressure-independent Factors in Glaucoma

SymposiumGlaucoma

Chairs:Robert Ritch (New York/USA)Jost B. Jonas (Mannheim/D)Josef Flammer (Basel/CH)

16:00 IL SA-12-01Genetics and epidemiology of normal-tensionglaucomaPaul Mitchell (Sydney/AUS)

16:10 IL SA-12-02Significance of optic disc hemorrhagesGustavo de Moraes (New York/USA)

16:20 IL SA-12-03Peripapillary atrophy and its importanceJost B. Jonas (Mannheim/D)

16:30 IL SA-12-04Vacular risk factors in normal-tension glaucomaJosef Flammer (Basel/CH)

16:40 IL SA-12-05Circadian fluctuation of IOP in normal-tensionglaucomaYaniv Barkana (Zerifin/IL)

16:50 IL SA-12-06The role of neuroimaging in normal-tension glaucomaY. L. Dexter Leung (Hong Kong/CN)

17:00 IL SA-12-07Summary: basic workup of NTG. What to do whenand whyTheodore Krupin (Chicago/USA)

17:10Discussion


Room Madrid

08:30 - 10:00 SA-13

Basic Research, Update on Treatment and OpticalCorrection of Keratoconus

SymposiumContact Lens and Refraction

Chairs:Markus Kohlhaas (Dortmund/D)Ayfer Kanpolat (Ankara/TR)Thomas F. Neuhann (Munich/D)

08:30 IL SA-13-01Surgical treatment of keratoconusMarkus Kohlhaas (Dortmund/D)

08:45 IL SA-13-02Causes end etiology of keratoconusTBA

09:00 IL SA-13-03Biomechanics and keratoconus – problems and solutions of contact lensEberhard Spörl (Dresden/D)

09:15 IL SA-13-04Fitting for keratoconusGudrun Bischoff (Hamburg/D)

09:30 IL SA-13-05Keratoconus – which examination is the bestJens Bühren (Frankfurt/D)

09:45Discussion

Room Madrid

10:30 - 12:00 SA-14

Clinical Management of Contact Lens Complications


Chairs:Gudrun Bischoff (Hamburg/D)James E. Key (Houston/USA)Alexander A. Bialasiewicz (Doha/QAT)

10:30 IL SA-14-01The Peter Halberg Lecture: efficacy of disinfectingsolutions against acanthamoebaJames E. Key (Houston/USA)

10:40 IL SA-14-02Why do complications happen?Newton Kara-José (Sao Paulo/BR)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne72

10:50 IL SA-14-03Complications regarding Contact Lens hygiene,handling and equipmentElena Rybakova (Mokau/RUS)

11:00 IL SA-14-04Contact lens related inflammation – recent insightsChristina Grupcheva (Varna/BG)

11:10 IL SA-14-05Global change of pathogens infectiousness: howdoes it affect contact lens wearing?Alexander A. Bialasiewicz (Doha/QAT)

11:20 IL SA-14-06Contact lens induced infectious keratitis – Reviewof recent dataRené Mély (Saarlouis/D)

11:30 IL SA-14-07Microsporidia Keratitis in Contact Lens Wearers inSingapore – an Emerging TrendCordelia M. L. Chan (Singapore/SGP)

11:40Discussion

Room Madrid

14:00 - 15:30 SA-42

Congenital and Acquired Lid Mal Positions

SymposiumOculoplasty, Lacrimal System, Orbit

Chairs:John Richard O. Collin (London/UK)Christoph Hintschich (Munich/D)Artur Klett (Tallinn/EST)

14:00 IL SA-42-01EntropionArtur Klett (Tallinn/EST)

14:15 IL SA-42-02EctropionAngelo Tsirbas (Los Angeles/USA)

14:30 IL SA-42-03PtosisFrancesco Quaranta-Leoni (Rome/I)

14:45 IL SA-42-04RetractionChristoph Hintschich (Munich/D)

15:00 IL SA-42-05ColobomaJohn Richard O. Collin (London/UK)

15:15Discussion

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

73

Room Madrid

16:00 - 17:30 SA-43

Retinal Diseases and Degenerations

SymposiumRetina

Chairs:Tatsuro Ishibashi (Fukuoka/J)Hans E. Grossniklaus (Atlanta/USA)Stefan Dithmar (Heidelberg/D)

16:00 IL SA-43-01Macular holesToshio Hisatomi (Fukuoka/J)

16:15 IL SA-43-02Age-related macular degenerationHans E. Grossniklaus (Atlanta/USA)

16:30 IL SA-43-03Retinal Imaging Today: FA, ICG and OCTStefan Dithmar (Heidelberg/D)

16:45 IL SA-43-04Fundus autofluorescenceFrank G. Holz (Bonn/D)

17:00 IL SA-43-05Diabetic retinopathyGabriele E. Lang (Ulm/D)

17:15 IL SA-43-06Lebers optic neuropathyCornelia M. Mooy (Dordecht/NL)

17:30Discussion

Room Sydney

08:30 - 10:00 SA-17

Amniotic Membrane Transplantation

SymposiumExternal Eye Disease, Cornea

Chairs:Scheffer C. G. Tseng (Miami/USA)Daniel Meller (Essen/D)

08:30 IL SA-17-01Sutureless Amniotic Membrane Transplantationvia ProKera for High-risk Penetrating KeratoplastySamuel C. Yiu (Los Angeles/USA)

08:40 IL SA-17-02Amniotic Membrane Transplantation to Augment the Success of Conjunctival Autograft for PterygiumViktor L. Perez (Miami/USA)

08:50 IL SA-17-03Biochemical Purification and Characterization ofHC-HA Complex as the Active Component fromAmniotic MembraneScheffer C. G. Tseng (Miami/USA)

09:00 IL SA-17-04Clinical Efficacy of Amniotic Membrane Transplan-tation for Acute Stevens Johnson Syndrome/ToxicEpidermal NecrolysisDarren G. Gregory (Denver/USA)

09:10 IL SA-17-05Impact of Different Preservation Methods on Clinical Important Features of Amniotic MembraneHenning Thomasen (Essen/D)

09:20 IL SA-17-06Amniotic Membrane Transplantation in AcuteBurnsHenrike Westekemper (Essen)

09:30 IL SA-17-07Anti-angiogenic Factors in Amniotic MembraneMikk Pauklin (Essen/D)

09:40Discussion

Room Sydney

10:30 - 12:00 SA-18

Corneal Dystrophies


Chairs:Walter Lisch (Hanau/D)Francis Munier (Lausanne/CH)

10:30 IL SA-18-01IC3D classification of corneal dystrophies(CD) – a new guide for the ophthalmologistFrancis Munier (Lausanne/CH)

10:40 IL SA-18-02The molecular pathomechanism of CD – where weare staying?Daniel Schorderet (Sion/CH)

10:50 IL SA-18-03Gene therapy for diseases of the corneaKeryn A. Williams (Bredford Park/AUS)


11:00 IL SA-18-04Indications and results of electrolysis in TGFBI related CDAkira Kobayashi (Kanazawa/J)

11:10 IL SA-18-05Surgical and laser-mediated therapies in CDBerthold Seitz (Homburg/D)

11:20 IL SA-18-06Light-, electronmicroscopical and immunohisto-chemical findings of Franceschetti corneal dystrophyClaudia Auw-Hädrich (Freiburg/D)

11:30Discussion

Room Sydney

14:00 - 15:30 SA-19

Laser-assisted Keratoplasty (Symposium of theSection Cornea of the German OphthalmologicalSociety)


Chairs:Thomas Reinhard (Freiburg/D)Berthold Seitz (Homburg(Saar)/D)Abdulaziz AlRajhi (Riyadh/SA)

14:00 IL SA-19-01Basics of Laser KeratoplastyAchim Langenbucher (Erlangen/D)

14:10 IL SA-19-02Femtosecond Laser Keratoplasty – The Freiburg ExperienceThomas Reinhard (Freiburg/D)

14:20 IL SA-19-03Femtosecond Laser Keratoplasty – The Munich ExperienceThomas F. Neuhann (Munich/D)

14:30 IL SA-19-04Femtosecond Laser Keratoplasty – The Bochum ExperienceH. Burkhard Dick, Astrid Willert (Bochum/D)

14:40 IL SA-19-05Advantages of Excimer Laser KeratoplastyBerthold Seitz (Homburg/D)

14:50Discussion

Room Sydney

16:00 - 17:30 SA-20

Meibomian Gland Anatomy, Physiology andDisease


Chairs:Erich Knop (Berlin/D)Nadja Knop (Hannover/D)Anthony Bron (Oxford/UK)

16:00 IL SA-20-01Anatomy and Embryology of the Meibomian glandErich Knop (Berlin/D)

16:10 IL SA-20-02Meibomian gland physiology: factors influencingocular surface integrityAnthony Bron (Oxford/UK)

16:20 IL SA-20-03Keratinization of the Meibomian gland as a majorcause for obstructive MGDNadja Knop (Hannover/D)

16:30 IL SA-20-04Regulation of the Meibomian gland in health anddiseaseDavid Sullivan (La Jolla/USA)

16:40 IL SA-20-05New insight into Meibomian gland function fromgene expression experimentsFrank Schirra (Homburg/D)

16:50 IL SA-20-06New treatments for Meibomian gland diseasesStefano Barabino (Genova/I)

17:00Discussion

Room Hong Kong

08:30 - 10:00 SA-21

Evidence-based Management of Glaucoma

SymposiumEvidence Based Ophthalmology

Chairs:Richard Wormald (London/UK)Günther K. Krieglstein (Cologne/D)Robert Ritch (New York/USA)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne74

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

75

08:30 IL SA-21-01Is there current evidence for effective neuropro-tection in glaucoma?Robert N. Weinreb (La Jolla/USA)

08:40 IL SA-21-02The role of the ocular and systemic circulation inglaucoma progressionJosef Flammer (Basel/CH)

08:50 IL SA-21-03Tubes versus trabeculectomyStephen Gedde (Miami/USA)

09:00 IL SA-21-04The treatment of acute and chronic angle-closureClement C. Y. Tham (Hong Kong/CN)

09:10 IL SA-21-05Antimetabolites for glaucoma surgery revisitedJonathan C. K. Clarke (London/UK)

09:20 IL SA-21-06Feasibility of a randomised trial of glaucoma screeningJennifer Burr (Aberdeen/UK)

09:30 IL SA-21-07Evidence of selective laser trabeculoplastyDetlev Spiegel (Augsburg/D)

09:40Discussion

Room Hong Kong

10:30 - 12:00 SA-22

Panel: Challenges and Perspectives of IntravitrealDrugs – Differences in Biological and Functional Effects

PanelPharmacology, Ocular Drug Delivery

Panel list:Baruch D. Kuppermann (Irvine/USA)Richard F. Spaide (New York/USA)Focke Ziemssen (Tübingen/D)Peter K. Kaiser (Cleveland)

Combination therapy: what and when to combine?Fixed regimen vs. adjusted dosing as needed?Disease parameter: what to consider being rele-vant?Risk profile and cardiovascular health: reasonablecare or unjustified hysteria?

Room Hong Kong

14:00 - 15:30 SA-23

Epidemiological Research in Eye Disease

SymposiumOphthalmic Epidemiology

Chairs:Norbert Pfeiffer (Mainz/D)David Friedman (Baltimore/USA)Jialiang Zhao (Beijing/CN)

14:00 IL SA-23-01Epidemiology: Basic Principles to Solve Problems in OphthalmologyAlfred Sommer (Baltimore/USA)

14:15 IL SA-23-02Epidemiological research in glaucomaDavid Friedman (Baltimore/USA)

14:30 IL SA-23-03Problems in the design of epidemiological studiesRichard Wormald (London/UK)

14:45 IL SA-23-04The survey of blindness and visual impairment inChinaJialiang Zhao (Beijing/CN)

15:00Discussion

Room Hong Kong

16:00 - 17:30 SA-24

New Challenges to Vision 2020: Glaucoma andDiabetic Retinopathy

SymposiumVision 2020 – Prevention of Blindness

Chairs:Norbert Pfeiffer (Mainz/D)David Friedman (Baltimore/USA)Nam Perulasamy (Madurai/IND)

16:00 IL SA-24-01How does glaucoma fit into Vision 2020 and howshould it fit in?TBA

16:15 IL SA-24-02Is Vision 2020 Ready for Glaucoma?James E. Standefer (White Bear Lake/USA)



WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

76

14:37 SL SA-27-06New concepts of multifocal IOLs designKhristo Takhchidi (Moscow/RUS)

14:46 FP SA-27-07Diffractive add-on IOL as a secondary implant inpseudophakic eyes: first resultsGeorg Gerten, Omid Kermani, Karl Schmiedt, Elham Farvili, Uwe Oberheide (Köln/D)

14:53 FP SA-27-08The implantation of bifocal prismatic IOL in patients with age-related macular degenerationAlmazbek Botbaev, A. Eshmambetov (Bishkek/KIS)

15:00 FP SA-27-09Visual Quality and Ocular Aberrations with Aspheric Single Piece and Spherical Multi-PieceIOL; Contralateral comparative studyAhmed Assaf (Cairo/ET)

15:07 FP SA-27-10Femtosecond Laser-Assisted Cataract Surgery(FLACS): A new paradigm for refractive cataractsurgery?Jonathan H. Talamo (Waltham/USA)

15:14 FP SA-27-11Optical analysis, reading performance and qualityof life evaluation after implantation of theAcri.Lisa 366D multifocal intraocular lensAna Belen Plaza, David Pablo Piñero Llorens, Ramon Jimenez, Francisco Amparo, Jose Luis Rodriguez Prats (Alicante/E)

15:21Discussion

VIP Lounge 1

16:00 - 17:30 SA-28

Glaucoma: Basics 1

Free PaperGlaucoma

Chairs:Detlev Spiegel (Augsburg/D)Günther K. Krieglstein (Cologne/D)Herbert Reitsamer (Salzburg/A)

16:00 SL SA-28-01Different aspects on the significance of ocularblood flow for glaucomaHerbert Reitsamer (Salzburg/A)

16:09 FP SA-28-02Assessment of Intraocular Pressure in response toisokinetic exerciseCamila Netto, Marcelo Conte, Marinho Scarpi (Rio de Janeiro/BR, São Paulo/BR)

16:30 IL SA-24-03The Aravind telemedicine system for detectingand treating DRNam Perulasamy (Madurai/IND)

16:45 IL SA-24-04Innovations in technology to improve screening efficiency for DRMichael Abramoff (Iowa/USA)

17:00 IL SA-24-05Launching two new DR screening projects in Indo-nesia and Bangladesh: challenges and successesDavid Friedman (Baltimore/USA)

17:15Discussion

VIP Lounge 1

14:00 - 15:30 SA-27

Cataract/Biometry 1

Free PaperCataract

Chairs:Georg Bretthauer (Karlsruhe/D)George Beiko (St. Catharines/CDN)Huck Holz (Santa Clara/USA)

14:00 SL SA-27-01Restoring human accommodation – the role ofmechatronics and microtechnologyGeorg Bretthauer (Karlsruhe/D)

14:09 FP SA-27-02Protein Profiling of Human Aqueous Humour by Mass Spectrometry – A Comparative and Quantitative StudyMarion Funk, Keiryn Bennett, Melanie Planyavsky,Ceereena Ubaida Mohien, Andreas Pollreisz, StefanSacu, Michael Georgopoulos, André Müller, ZlatkoTrajanoski, Jacques Colinge, Giulio Superti-Furga,Ursula Schmidt-Erfurth (Vienna/A)

14:16 FP SA-27-03Synchrony dual optic accommodating IOL: 4 year resultsRicardo Alarcon, Victor Bohorquez (Bogota/CO)

14:23 FP SA-27-04Comparison of vision with accommodating IOLsversus minimonovison with a standard IOLGeorge Beiko (St. Catharines/CDN)

14:30 FP SA-27-05Binovision – A New Approach to Presbiopia Correction with the Calhoun LALSylvia Paulig (Cottbus/D)

Satu

rday

, Jun

e 5


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

77

VIP Lounge 2

08:30 - 10:00 SA-29

Clinical Aspects: Screening, Diagnosing, Treatmentand Medical Workflow, Medical Education

SymposiumTeleophthalmology and Computers

Chairs:Georg Michelson (Erlangen/D)Michael Chiang (New York/USA)John Olson (Aberdeen/UK)Frank H. W. Tost (Greifswald/D)

08:30 IL SA-29-01Worldwide Access to online Education-Atlas ofOphthalmologyLudwig Maximilian Heindl (Erlangen/D)

08:45 IL SA-29-02How computers educate glaucoma patientsCatherina Goltz, Stefan Clemens, Frank H. W. Tost(Greifswald/D)

09:00 IL SA-29-03Telemedical glaucoma home monitoring: blessing or curse?Clemens Jürgens (Greifswald/D)

09:15 IL SA-29-04Automated evaluation of the optic nerve head inrespect to glaucoma in colour imagesRüdiger Bock (Erlangen/D)

09:30 IL SA-29-05A regional Tele-ophthalmological Network evaluating retinal vessels and the optic nerve headGeorg Michelson (Erlangen/D)

09:45Discussion

16:16 FP SA-28-03Corneal Hysteresis and Corneal Resistance Factorare not associated with occurrence of Disc Haemorrhage in Patients with Normal TensionGlaucomaNafees B. Baig, Dexter Yu-lung Leung, Douglas Lam (Hong Kong/HK)

16:23 FP SA-28-04Immunoproteomics of tears as a diagnostic tool inglaucomaFranz Grus, Nils Boehm, Sabine Beck, MarkusSchlich, Ulrike Lossbrandt, Ulrike Lossbrandt, Norbert Pfeiffer (Mainz/D)

16:30 FP SA-28-05Oxidative Stress Markers in Patients with Primary Open-angle GlaucomaAsaad Ghanem, Lamiaa Arafa, Ayman El-Baz (Mansoura/ET)

16:37 FP SA-28-06Immunization with optic nerve antigens causesloss of retinal ganglion cells and elevated antibodyreactivity against ocular tissuesPanagiotis Laspas, Stephanie C. Joachim, Oliver W. Gramlich, Philip F. Gottschling, Clemens Cuny, Norbert Pfeiffer, Franz H. Grus (Halandri/GR, Mainz/D)

16:44 FP SA-28-07Serum endothelin-1 levels in patients with glaucomaDaria Nefedova, Yury Astakhov, Irina Birulya, Margarita Kadinskaya (St. Petersburg/RUS)

16:51 FP SA-28-08Genomic (epigenetic) DNA methylation in patients with open-angle glaucomaAnselm G. M. Jünemann, Bernd Lenz, Ursula Schlötzer-Schrehardt, Robert Rejdak, Johannes Kornhuber, Friedrich Kruse, Stefan Bleich (Erlangen/D, Lublin/PL)

16:58 FP SA-28-09CYP1B1 mutations In South Korean Patients With Primary Congenital Glaucoma: Genotype –Phenotype CorrelationsWool Suh, Sung Chul Park, Michael S. Kook, Yong Yeon Kim, Chan Yun Kim, Chang Sik Kim, Ki Ho Park, Chan Kee Park, Hee Jung Kim, ChangSeok Ki, Changwon Kee (Seoul/ROK)

17:05 FP SA-28-10Global Gene Expression and Protein Profiling of Young and Elderly Retinas Exposed to ElevatedIntraocular PressuresMolly Walsh (Durham/USA)

17:12Discussion

Satu

rday

, 5 Ju

ne


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

VIP Lounge 2

14:00 - 15:30 SA-31

Glaucoma: Diagnostics

Free PaperGlaucoma

Chairs:Tin Aung (Singapore/SGP)Dorin Chiselita (Iasi/RO)Nomdo M. Jansonius (Groningen/NL)

14:00 SL SA-31-01Glaucoma progressionDorin Chiselita (Iasi/RO)

14:09 SL SA-31-02On the accuracy of measuring rates of visual fieldchange in glaucomaNomdo Jansonius (Groningen/NL)

14:18 FP SA-31-03RNFL thickness analysis with fourier domain OCTcompared to time domain OCTAnna Nowinska, Edward Wylegala, Janiszewska Dominika, Dariusz Dobrowolski (Katowice/PL)

14:25 FP SA-31-04Comparison of slitlamp adapted 1310nm OCT and high-frequency ultrasound in the evaluationof Schlemm’s Canal and suture traction after CanaloplastyJoshua Torrent Despouy, Anne Bruggemann,Swaantje Peters, Salvatore Grisanti, Maya Müller(Lübeck/D)

14:32 FP SA-31-05A new darkroom provocative test using anteriorsegment optical coherence tomography (AS-OCT)Li Dejiao (Beijing/CN)

14:39 FP SA-31-06Retrobulber imaging in glaucoma with diffusiontensor MRI / optic tractography and fMRI: structural and functional analysisKaya N Engin, Bülent Yemisci, Nurten Turan, Sibel Bayramog lu, Onur Özyurt, Esin Karahan, Cengizhan Öztürk (Istanbul/TR)

14:46 FP SA-31-07Progression of glaucomatous visual field loss inprimary angle closure glaucoma with intraocularpressure which has decreased to normal rangeNoriko Toyokawa, Shinichiro Kuroda, Hideya Kimura, Atsuko Fukumoto, Makoto Nagata (Nara/J)

14:53 FP SA-31-08Frequency of the origin of open-angle glaucoma inpatients with hypothyroidismPavel Bezdetko, Alla Saveleva, Julia Babak (Kharkov/UA)

VIP Lounge 2

10:30 - 12:00 SA-30

SEAGIG Symposium: Angle-Closure Glaucoma

SymposiumGlaucoma

Chairs:Ivan Goldberg (Sydney/AUS)Prin Rojanapongpun (Bangkok/T)Seng Kheong Fang (Sydney/AUS)

10:30 IL SA-30-01Definitions, classifications, epidemiologyRamanjit Sihota (New Delhi/IND)

10:38 IL SA-30-02Angle assessmentPaul Chew (Singapore/SGP)

10:46 IL SA-30-03Mechanisms of angle closurePrin Rojanapongpun (Bangkok/T)

10:54 IL SA-30-04Initial Management of PACGKi Ho Park (Seoul/ROK)

11:09 IL SA-30-05Surgical management of PACGClement C. Y. Tham (Hong Kong/CN)

11:24 IL SA-30-06Management of acute PACPaul Healey (Sydney/AUS)

11:32 IL SA-30-07Secondary ACGSeng Kheong Fang (Sydney/AUS)

11:40 IL SA-30-08Newly designed provocative test for detectingangle closureNing-li Wang (Beijing/CN)

11:48Discussion

Satu

rday

, 5 Ju

ne78


WOC® 2010 79

Scie

ntifi

c Pro

gram

Sch

edul

e

16:37 FP SA-32-06Prevalence and Significance of Subretinal Drusenoid Deposits (Reticular Pseudodrusen) inAge-Related Macular DegenerationSandrine Anne Zweifel, Yutaka Imamura, Theodore C Spaide, Takamitsu Fujiwara, Richard F Spaide (New York/USA)

16:44 FP SA-32-07Anti Oxidant Therapy in Dry Age Related MacularDegeneration: A Hope for VisionSwati Tomar (Jaipur/IND)

16:51 FP SA-32-08LMI – Intra Ocular Mirror Telescopic Projector forAMDIsaac Lipshitz, Amar Agarwal (Hertzlia/IL)

16:58 FP SA-32-09Retinal Sensitivity in age related macular degene-ration using Scanning Laser Ophthalmoscope imaging stabilized MicroperimetryKathrin Hartmann, Jae Suk Kim, Helaina Klein, Sylvia Hsueh, Laura Gomez, Paym Amini, Lingyun Cheng, Dirk-Uwe Bartsch, William R. Freeman (San Diego/USA)

17:05 FP SA-32-10Vitreomacular interface and posterior vitreomacu-lar adhesion in exsudative age-related macular degeneration (AMD): A Spectralis-OCT-StudyMathias Maier, Sarah Pfrommer, Sophie Burzer, Nikolaus Feucht, Christoph Winkler von Mohrenfels, Chris Lohmann (Munich/D)

17:12Discussion

Hall 2

08:30 - 10:00 SA-33

Update on Management of AMD

SymposiumRetina

Chairs:Alexander J. Brucker (Philadelphia/USA)Gisèle Soubrane (Créteil/F)Frank G. Holz (Bonn/D)

08:30 IL SA-33-01Recent clinical trial results on management ofneovascular AMDGisèle Soubrane (Créteil/F)

08:40 IL SA-33-02Role of diagnostic tools for assessing patients’ responseDaniel Pauleikhoff (Münster/D)

15:00 FP SA-31-09Angle closure in Caucasians – a pilot, clinic-basedstudyYaniv Barkana, Inbal Dekel (Shoham/IL)

15:07 SL SA-31-10The diurnal variation of intraocular pressure – themost important symptom for early detection andfollow-up of the glaucomasJörg Albert Draeger (Hamburg/D)

15:16Discussion

VIP Lounge 2

16:00 - 17:30 SA-32

Retina: AMD 1

Free PaperRetina

Chairs:Susanne Binder (Vienna/A)Carsten Framme (Bern/CH)Isaac Lipshitz (Tel Aviv/IL)

16:00 SL SA-32-01Posterior hyaloid behavior in age-related maculardegenerationSusanne Binder (Winn/A)

16:09 FP SA-32-02Interobserver variability for re-treatment indicati-ons after Ranibizumab upload in neovascular age-related macular degenerationCarsten Framme, Georgios Panagakis, Andreas Walter, Aandrea Gamulescu, Wolfgang Herrmann,Horst Helbig (Bern/CH, Regensburg/D)

16:16 FP SA-32-03Intravitreal injection of Bevacizumab for treat-ment of CNV associated with AMD in ChineseLei Gao, Wenjie Liu, Changxia Dong, Huajun Yu(Yantai/CN)

16:23 FP SA-32-04Three Major Loci involved in age-related maculardegeneration are also associated with polypoidalchoroidal vasculopathyLuiz H Lima, Carl Schubert, Daniela Ferrara, Joanna Merriam, Yutaka Imamura, K. Bailey Freund,Richard F. Spaide, Lawrence Yannuzzi, Rando Allikmets (New York/USA)

16:30 FP SA-32-05Small Hard Macular Drusen and Peripheral Drusen:Associations with AMD Genotypes in the Inter99Eye StudyInger Christine Munch (Glostrup/DK)

Satu

rday

, 5 Ju

ne

08:50 IL SA-33-03Combined treatment approaches to wet AMD?Anat Loewenstein (Tel Aviv/IL)

09:00 IL SA-33-04Predictors of disease: current treatment guidelinesPaolo Lanzetta (Udine/I)

09:10 IL SA-33-05Management of pigment epithelial detachmentsand PCV in the era of anti-VEGF-therapyRichard F. Spaide (New York/USA)

09:20 IL SA-33-06Imaging progression and treatment approachesfor geographic atrophyFrank G. Holz (Bonn/D)

09:30Discussion

Hall 2

10:30 - 12:00 SA-34

Update in Diabetic Retinopathy

SymposiumRetina

Chairs:Xiaoxin Li (Beijing/CN)Francesco Bandello (Milano/I)Ursula Schmidt-Erfurth (Vienna/A)

10:30 IL SA-34-01Information technology in diabetic eye screeningEinar Stefánsson (Reykjavik/IS)

10:40 IL SA-34-02Inflammatory processes in diabetic retinopathyTimothy Kern (Cleveland/USA)

10:50 IL SA-34-03Intravitreal steroids in diabetic macular diseaseAlbert J. Augustin (Karlsruhe/D)

11:00 IL SA-34-04Antiangiogenic strategies in diabetic macular andretinal diseaseUrsula Schmidt-Erfurth (Vienna/A)

11:10 IL SA-34-05The presence and future of laser therapy in diabetesFrancesco Bandello (Milano/I)

11:20 IL SA-34-06Modern surgery in diabetic diseaseDavid S. H. Wong (Hong Kong/HK)

11:30 IL SA-34-07Carotid endarterectomy for treatmend of ischemicdiabetic retinopathyXiaoxin Li (Beijing/CN)

11:40Discussion

Hall 6

08:30 - 10:00 SA-37

Africa: Can We Succeed in the Greatest Challengeto Blindness Prevention?


Chairs:K. H. Martin Kollmann (Nairobi/EAK)Dunera Rahel Ilako (Nairobi/EAK)Henry Nkumbe (Antananarivo/RM)

08:30 IL SA-37-01Introduction a) Why is Africa the "greatest challenge"?b) What is success in this context?c) How do we succeed in blindness prevention?K. H. Martin Kollmann, Henry Nkumbe(Nairobi/EAK, Antananarivo/RM)

08:40 IL SA-37-02Co-Ordinated Planning (Global, Regional and National)K. H. Martin Kollmann, Kovin Naidoo, Hannah Faal,Daniel Etya'ale (Nairobi/EAK, Durban/ZA, Accra/GH,Geneva/CH)

08:50 IL SA-37-03Advocacy & Resource MobilisationDunera Rahel Ilako, Doulaye Sacko, Adekunle Olubola Hassan, Amir Bedri, Gullapali N. Rao(Nairobi/EAK, Lagos/WAN, Addis Abeba/ETH, Hyderabad/IND)

09:00 IL SA-37-04Control of Avoidable Blindness: The EvidenceHenry Nkumbe, Wanjiku Mathenge, SusanLewallen, Asiwome Seneadza (Antananarivo/RM,Moshi/EAT)

09:10 IL SA-37-05Human Resource Development (Incld. Management)K. H. Martin Kollmann, Kayode, Volker Klauss,Adekunle Olubola Hassan (Nairobi/EAK, Munich/D,Lagos/WAN)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne80

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

81

09:20 IL SA-37-06Infrastructure and Appropriate TechnologyDunera Rahel Ilako, Kolawole Ogundimu, Ingrid Mason, Adekunle Olubola Hassan, Wanjiku Mathenge (Nairobi/EAK, Accra/GH, Lagos/WAN)

09:30 IL SA-37-07Community ParticipationHenry Nkumbe, Ngoy Janvier Kilangalanga, PaulCourtright, Asiwome Seneadza (Antananarivo/RM,Kinshasa/ZRE, Moshi/EAT)

09:40 IL SA-37-08Conclusions / Wrap-UpK. H. Martin Kollmann (Nairobi/EAK)

Hall 6

10:30 - 12:00 SA-38

Panel: Neuro-Ophthalmological Problems (Handling of NNO, AION, and Benign Tumors;Neuro-Ophthalmology in Children)

Panel Neuro-Ophthalmology

Chairs:Klara Landau (Zurich/CH)Eberhart Zrenner (Tübingen/D)Andrew G. Lee (Houston/USA)Christian Luco (Santiago/RCH)

Panel List:Klara Landau (Zurich/CH)Eberhart Zrenner (Tübingen/D)Christian Luco (Santiago/RCH)Andrew G. Lee (Houston/USA)Emely Karam (Caracas/Y)Michael Gräf (Giessen/D)Gordon Plant (London/UK)Helmut Wilhelm (Tübingen/D)Caroline Tilikete (Lyon/F)Michael Bach (Freiburg/D)Thomas R. Hedges (Boston/USA)Pinar Aydin (Kavaklidere/Ankara/TR)Carlos Mendoza (Ciudad de la Habana/C)

Hall 6

14:00 - 15:30 SA-15

Panel: Contact Lenses and Children – Indications,Fitting Rules and Benefits

Panel Contact Lens and Refraction

Chairs:Albert Franceschetti (Meyrin (Geneva)/CH)Chong Yew Khoo (Singapore/SGP)Dorothea Kuhn (Riedlingen/D)

14:00 IL SA-15-01The Jonathan Kersley Lecture: Children have a right to contact lensesAlbert Franceschetti (Meyrin/CH)

14:20 IL SA-15-02Success with RGP-lensfitting in children. First result of the BVA Juneor ProjectDorothea Kuhn (Riedlingen/D)

14:30 IL SA-15-03Contact lense in Pediatrics (CLIP) Study in SingaporeLi Lim (Singapore/SGP)

14:40 IL SA-15-04RGPs for Children with High Myopia and HighAstigmatismJenny Deva (Selangor/MAL)

14:50 IL SA-15-05Effect of ON-K RGP lenses on the Cornea Curvatures ans Axial Length of Myopic Children – a cross-over studyChong Yew Khoo (Singapore/SGP)


Hall 6

16:00 - 17:30 SA-16

Corneal Imaging: New Versus Useful


Chairs:Shigeru Kinoshita (Kyoto/J)Zoraida Fiol-Silva (Philadelphia/USA)Rudolf F. Guthoff (Rostock/D)

16:00 IL SA-16-01IMCLC Special Lecture: Medical Use of ContactLens: An Effective Tool for Ocular Surface SurgeryShigeru Kinoshita (Kyoto/J)

16:10 IL SA-16-02Diagnostic and Imaging of the Ocular Surface inContact LensJacek P. Szaflik (Warsaw/PL)

16:20 IL SA-16-03HRT 2 Confocal Image In Corneal EpitheliumChristina Jacobi (Erlangen/D)

16:30 IL SA-16-04Is It Keratoconus or CL Warpage?Stephen D. Klyce (New Orleans/USA)

16:40 IL SA-16-05Tear Film Disrupted or Protected By Contact Len-ses; How To CopeMarek Habela (Piaseczno/PL)

Hall 7

08:30 - 10:00 SA-40

Genetics and Uveitis

SymposiumUveitis, Intraocular Inflammation

Chairs:James T. Rosenbaum (Portland/USA)Friederike Mackensen (Heidelberg/D)Ahmet Gul (Istanbul/TR)

08:30 IL SA-40-01Overview on genome wide scanningJürgen Braun (Herne/D)

08:40 IL SA-40-02HLA-B27 associated UveitisTammy Martin (Portland/USA)

08:50 IL SA-40-03Blau SyndromeJames T. Rosenbaum (Portland/USA)

09:00 IL SA-40-04KIR genes and uveitisRalph D. Levinson (Los Angeles/USA)

09:10 IL SA-40-05TINU-SyndromeFriederike Mackensen (Heidelberg/D)

09:20 IL SA-40-06Genetic of Behcet´s DiseaseAhmet Gul (Istanbul/TR)

09:30Discussion

Hall 7

10:30 - 12:00 SA-41

PAAO Symposium: Retinal and Choroidal Manifes-tations of Selected Systemic Diseases 2010

SymposiumRetina

Chairs:J. Fernando Arevalo (Caracas/Y)Charles P. Wilkinson (San Fransisco/USA)José Roca (Lima/PE)

10:30 IL SA-41-01IntroductionJ. Fernando Arevalo (Caracas/Y)

10:40 IL SA-41-02AIDS UpdateRubens Belfort, Jr. (São Paulo/BR)

10:50 IL SA-41-03PhacomatosisCarol L. Shields (Philadelphia/USA)

11:00 IL SA-41-04Retinal and Choroidal Manifestations of SLECareen Y. Lowder (Cleveland/USA)

11:10 IL SA-41-05Diffuse Unilateral Subacute Neuroretinitis (DUSN)J. Fernando Arevalo (Caracas/Y)

11:20 IL SA-41-06Intraocular LymphomaLihteh Wu (West Chester/USA)

11:30 IL SA-41-07Choroidal and Retinal MetastasisJerry Shields (Philadelphia/USA)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne82

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

83

11:40 IL SA-41-08Retinal-Choroidal Toxicity of Systemic DrugsWilliam F. Mieler (Chicago/USA)

11:50 IL SA-41-09Final considerationsCharles P. Wilkinson (San Fransisco/USA)

Roof Garden

08:30 - 10:00 SA-05

Advances in Cataract and IOL Technology

SymposiumCataract

Chairs:Rupert Menapace (Vienna/A)William J. Fishkind (Tucson/USA)Pablo Artal (Murcia/E)

08:30 IL SA-05-01AspheresPablo Artal (Murcia/E)

08:40 IL SA-05-02Light Adjustable LensJosé L. Güell (Barcelona/E)

08:50 IL SA-05-03Telescope LensesIsaac Lipshitz (Tel Aviv/IL)

09:00 IL SA-05-04MICS: gimmick or progressRupert Menapace (Vienna/A)

09:10 IL SA-05-05non-US phacoPeter Rieck (Berlin/D)

09:20 IL SA-05-06US-phaco: Technical state of the artWilliam J. Fishkind (Tucson/USA)

09:30Discussion

Roof Garden

10:30 - 12:00 SA-06

Endophthalmitis

SymposiumCataract

Chairs:Terrence O'Brien (Palm Beach/USA)Peter Barry (Dublin/IRL)Karl Ulrich Bartz-Schmidt (Tübingen/D)

10:30 IL SA-06-01Why we do not use intracameral cefuroxime at theend of cataract surgery?Terrence O'Brien (Palm Beach/USA)

10:50 IL SA-06-02The clinical implications of the ESCRS Endophthal-mitis studyPeter Barry (Dublin/IRL)

11:10 IL SA-06-03Why we do use intracameral cefuroxime at theend of cataract surgery?Jean-François Korobelnik (Bordeaux/F)

11:30Discussion

Roof Garden

14:00 - 15:30 SA-07

Phaco Nightmares and Worst Case Scenarios: AVideo-based Symposium

SymposiumCataract

Various complications can occur in phaco surgerybut the worst case scenarios are dropped lensesand nuclei. In this course presentation of variouscases will be shown of crazy cases and their management. The usage of diamond tipped for-ceps in the removal of dropped IOL’s will also beshown. Difficult cases like subluxated lenses, pos-terior polar cataracts, colobomas and complicati-ons will also be shown on videos. Management ofIFIS, Implantation of the glued IOL will also betaught with endoacapsular rings and capsule re-tractors.

Chairmen: Amar Agarwal, Thomas Kohnen

Faculty:Thomas KohnenAmar Agarwal Athiya Agarwal


Roof Garden

16:00 - 17:30 SA-08

Unmet Needs in Diagnosis of Uveitis


Chairs:Denis Wakefield (Sydney/AUS)Carlos Pavesio (London/UK)Stephan Thurau (Munich/D)

16:00 IL SA-08-01HLA B27 AU – what we know and what we don’tknowDenis Wakefield (Sydney/AUS)

16:10 IL SA-08-02Treatment of CME in uveitis – other options thansteroids and acetazolamideCarlos Pavesio (London/UK)

16:20 IL SA-08-03Topical antiinflammatory medication beyond steroids – how to avoid medication-induced glaucoma and cataractManfred Zierhut (Tübingen/D)

16:30 IL SA-08-04Imaging - what would we like to see that fluorescein and ICG don’t showCarl P. Herbort (Lausanne/CH)

16:40 IL SA-08-05New perspectives for treatment of human uveitisfrom animal modelsGerhild Wildner (Munich/D)

16:50 IL SA-08-06How to optimize the diagnostic use of intraocularspecimensBahram Bodaghi (Paris/F)

17:00 IL SA-08-07The problem of retinal vasculitisElisabetta Miserocchi (Milano/I)

17:10Discussion

Radio Tower Lounge 1

16:00 - 17:30 SA-44

APSOPRS Symposium: Oculoplastic and OrbitalSurgery


Chairs:XianQun Fan (Shanghai/CN)Yip Chee Chew (Singapore/SGP)Ashok Kumar Grover (New Delhi/IND)

16:00 IL SA-44-01The new concepts of diagnosis and treatment onorbital diseasesSun Fengyuan (Tianjin/CN)

16:10 IL SA-44-02Eyelid anatomy: An updateHirohiko Kakizaki (Aichi-ken/J)

16:20 IL SA-44-03Thyroid Myopathy, morbidity and treatmentSeah Lay Leng (Singapore/SGP)

16:30 IL SA-44-04Rejuvenation of the peri-orbital regionYip Chee Chew (Singapore/SGP)

16:40 IL SA-44-05Management of jaw winking ptosis – no longer aproblem!Ashok Kumar Grover (New Delhi/IND)

16:50 IL SA-44-06Microendoscopy of the lacrimal pathwaysReynaldo M. Javate (Manila/RP)

17:00 IL SA-44-07Lower lid horizontal laxity correctionChai Teck Choo (Singapore/SGP)

17:10 IL SA-44-08Clinical therapy on congenital anophthalmia andmicrophthalmiaXian Qun Fan (Shanghai/CN)

17:20Discussion


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne84

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne

85


08:30 - 10:00 SA-45

Congenital Cranial Dysinnervation Disorders(CCDD)

SymposiumStrabismus

Chairs:Elizabeth Engle (Boston/USA)Antje Neugebauer (Cologne/D)

08:30 IL SA-45-01Genetics in strabismologyBirgit Lorenz (Giessen/D)

08:50 IL SA-45-02CCDDs – the development of a developmental conceptElizabeth Engle (Boston/USA)

09:20 IL SA-45-03Surgical management of CCDDsDavid G. Hunter (Boston/USA)

09:40 IL SA-45-04CCDDs - perspectivesAntje Neugebauer (Cologne/D)


10:30 - 12:00 SA-46

Orbital, Adnexal and Conjunctival Tumors

SymposiumOncology

Chairs:Jacob Pe'er (Jerusalem/IL)Jan Ulrik Prause (Copenhagen/DK)Rudolf F. Guthoff (Rostock/D)

10:30 IL SA-46-01Treatment of epithelial and melanocytic conjunctival tumorsJacob Pe'er (Jerusalem/IL)

10:40 IL SA-46-02Epithelial Eyelid TumorsMordechai Rosner (Tel-Hashomer/IL)

10:50 IL SA-46-03Eyelid stromal tumorsGeeta Vemuganti (Hyderabad/IND)

11:00 IL SA-46-04Systemic association of eyelid and conjunctival tumorsArun D. Singh (Cleveland/USA)

11:10 IL SA-46-05Phantom eye syndromeMarie Louise Roed Rasmussen (Copenhagen/DK)

11:20 IL SA-46-06Optic Nerve tumorsJan Ulrik Prause (Copenhagen/DK)

11:30 IL SA-46-07Lacrimal gland tumorsGeoffrey Rose (London/UK)

11:40 IL SA-46-08Fusion oncogenes in lacrimal gland adenoid cysticcarcinomaSarah Linea von Holstein (Copenhagen/DK)

11:50 IL SA-46-09The anophthalmic socket: prevention and treat-ment of the post enucleation socket syndromeRudolf F. Guthoff (Rostock/D)


14:00 - 15:30 SA-47

Amblyopia: Early Detection and Screening Programs

SymposiumStrabismus

Chairs:Michael X. Repka (Baltimore/USA)Dominique Thouvenin (Toulouse/F)Oliver Ehrt (Munich/D)

14:00 IL SA-47-01Effectiveness of Screening Preschool Children forAmblyopiaWolf A. Lagrèze (Freiburg/D)

14:10 IL SA-47-02Impact of Amblyopia on Quality of LifeJill Carlton (Sheffield/UK)

14:20 IL SA-47-03Cost-effectiveness of Screening Programmes forAmblyopiaJill Carlton (Sheffield/UK)

14:30 IL SA-47-04Brückner test: scope and limitsMichael Gräf (Giessen/D)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Satu

rday

, 5 Ju

ne86

14:40 IL SA-47-05Detection of Refractive Errors, Strabismus and Cataract with the Plusoptix S04Oliver Ehrt (Munich/D)

14:50 IL SA-47-06Screening Based on Visual Acuity TestingMichael X. Repka (Baltimore/USA)


16:00 - 17:30 SA-48

Changing Realities in Eye Care: What is NeededMost to Prevent Blindness in Developing Countries


Chairs:R. D. Thulasiraj (Madurai/IND)Clare Gilbert (London/UK)Daniel Etya'ale (Genève/CH)

16:00 IL SA-48-01Tertiary vs. Primary care ophthalmology – equal orunequal emphasis?Daniel Etya'ale (Genève/CH)

16:15 IL SA-48-02Are we making any progress in combating cataractin the developing world? Should we be trainingOphthalmologists or PEC workers and non MD-Cataract Surgeons?Alfred Sommer (Baltimore/USA)

16:30 IL SA-48-03Vertical vs. Integrated approach? Satellite eye clinics in rural areas vs. Integrating eye care intoprimary health care. What about urban areas?Susan Lewallen (Moshi/EAT)

16:45 IL SA-48-04The challenges of strengthening health systems todeliver eye careHannah Faal (Accra/GH)

17:00 IL SA-48-05Integrating Ophthalmology and OptometryKovin Naidoo (Durban/ZA)

17:15Discussion



Sunday, 6 June 2010

WOC® 2010 87

Sund

ay, 6

June

Sund

ay, 6

June

SU-4

7 G

rabn

er, D

unck

er,

Gat

inel

Ref

ract

ive

surg

ery/

Refr

actio

n 3

Even

ing

Sym

posi

um

Mer

ck

Even

ing

Sym

posi

um

Zeis

s

SEAG

IG B

oard

Mee

ting

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

ICC

Hal

l 2

Hal

l 3

Hal

l 6

Hal

l 7

Hal

l 8

Hal

l 9

Hal

l 10

Roof

Gar

den

Salo

n 19

Salo

n 20

Salo

n 22

Room

44

Room

45

Room

46

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

SU-7

4 Kl

auß,

Fing

er

Visi

on 2

020

– Pr

even

tion

ofBl

indn

ess 1

SU-7

5 Be

rta,

Ser

egar

d, S

itnik

Co

rnea

/Ext

erna

l Dis

ease

:Su

rgic

al th

erap

y 2

ICO

Com

mitt

ee: E

duca

tion

Com

mitt

ee

SU-5

9 Ra

ndle

man

, El

Dan

asou

ry, H

afez

i Po

st-L

ASIK

corn

eal e

ctas

ia

SU-6

0M

cRae

,Che

ng,M

roch

enIs

a Cu

stom

. Abl

. Pro

f. th

e Be

stfo

r Sta

nd. R

efr.

Corr

ectio

ns

Lunc

h Sy

mpo

sium

Alco

nSU

-58

Colin

, Kol

ler

Reha

bilit

atio

n in

Prim

ary

Kera

tect

asia

SU-5

7 Bu

rnie

r, Rao

, Hol

bach

U

veiti

s

Brea

kfas

t Sym

posi

um Z

eiss SU

-73

Pfei

ffer, Z

hao,

Wol

fram

Ep

idem

iolo

gica

l Stu

dies

SU-4

9 G

audr

ic, T

rese

Vi

treo

retin

al In

terf

ace

–Ep

iretin

al M

acul

ar S

urge

ry

SU-5

0 Tr

ese,

Kam

pik

Retin

alVa

scul

ar D

isea

ses:

Diab

etic

Retin

opat

hy /

Vein

Occ

lu.

SU-5

1 Kam

pik,

Aylw

ard

AMD

Lunc

h Sy

mpo

sium

Sant

en

SU-4

8 Ay

lwar

d, G

audr

ic

Retin

al D

etac

hmen

t and

PVR

SU-5

3Sch

acha

t,La

ng, S

tefá

ns-

son

Revi

ewer

s

SU-7

8 Pr

ice,

Curs

iefe

n,

Rein

hard

Pos

terio

r Lam

ella

rKe

rato

plas

ty

SU-5

3Sch

acha

t,La

ng, S

tefá

ns-

son

Jour

. Pub

lic.

SU-5

6 N

aum

ann,

Lang

, Vö

lcke

r An

atom

y/pa

thol

ogy

SU-5

2 Rep

ka,D

el M

onte

,Jaaf

ar

AAPO

S Sy

mpo

sium

: Em

ergi

ng C

once

pts

SU-3

4 Be

chra

kis,

Kive

lä,

Hee

gaar

d O

ncol

ogy

1

SU-3

5 Bar

abin

o, Lo

hman

n, D

ua

Corn

ea/E

xter

nal D

isea

se:

Surg

ical

ther

apy

1

SU-3

6 Co

lin, C

oche

ner, S

lade

Re

frac

tive

surg

ery/

Refr

ac-

tion

2

SU-3

7 H

olop

aine

n, N

émet

h,Za

górs

ki

Exte

rnal

Dis

ease

, Dry

Eye

WO

C-AA

D-C

-24

Mes

smer

Co

rnea

l Ulc

ers a

nd C

onju

nc-

tival

Sca

rrin

g. W

hat t

o do

?

WO

C-AA

D-C-

25 S

chie

fer

Visu

al A

gnos

ia a

nd o

ther

Ce

ntra

l Visu

al Im

pairm

ents

SU-6

1 Rud

olph

, Zei

tz, Z

in

Stra

bism

usW

OC-

AAD

-C-2

3 Pl

eyer

Im

mun

olog

y of

the

Eye:

In

trao

cula

r Inf

lam

mat

ions

SU-6

4 Be

lfort

, Vas

silev

a, Fin

ger

Beyo

nd V

ertic

al P

rogr

ams:

Chal

. and

Suc

cess

in B

uild

ing

SU-6

5 Tay

lor, K

lauß

, Koc

ur

Visio

n 20

20: 1

0 Ye

ars o

n, 10

Year

s to

go

SU-6

3 Su

lliva

n, B

ron,

Foul

ks

TFO

S Sy

mp.

: A R

epor

t fro

mth

e In

tern

. Wor

ksho

p

SU-6

2 M

iche

lson

, Sch

rage

Tele

opht

halm

olog

y

SU-6

8 Sh

etta

, Hun

ter, S

eitz

Eg

yptia

n Ge

rman

Sym

p: C

om-

bine

d Su

rger

ies i

n O

phth

alm

.

SU-6

9 Th

anos

, Gat

ziou

fas,

Seitz

Gre

ek G

erm

an S

ymp:

From

Gla

ucom

a to

Neu

ropr

.

SU-6

7 Pe

'er, C

oupl

and,

Ve

mug

anti

ISO

O S

ympo

sium

:O

cula

r Lym

phom

aSU

-71 E

mm

eric

h, Ja

vate

,O

estr

eich

er N

ew D

iagn

.and

Ther

ap. A

spec

ts o

f Lac

ri. D

is.

SU-7

0 Ba

rraq

uer, B

arra

quer

, Bar

raqu

er

Hig

hlig

hts o

f Ant

erio

r Seg

men

t Sur

gery

& R

efra

ctiv

e Su

rger

yW

OC-

AAD

-C-2

7 Pi

tz T

he In

-te

rdis

cipl

. Con

text

of M

ult.

Scle

rosi

s and

Mya

sth

Gra

vis

WO

C-AA

D-C

-26

Scha

udig

Co

mpl

ic. i

n Pl

astic

-Rec

onst

r.an

d Ae

sthe

tic S

urge

ry

WO

C-AA

D-C

-28

Klau

ss

Oph

thal

mic

Con

ditio

ns in

Third

Wor

ld co

untr

ies

Mee

ting

BVA-

Leitl

inie

nkom

issi

onSi

tzun

g de

r Sek

tion

DOG

-Inte

rnat

iona

le O

phth

al-

mol

ogie

Sitz

ung

der M

akul

akom

mis

sion

Stud

ient

reffe

n zu

rFA

NCY

-Stu

die

Brea

kfas

t Sym

po-

sium

Ocu

lus

Opt

ikge

räte

Gm

bH

SU-7

2 La

grèz

e, M

ojon

, Bes

ch

Stra

t. in

Sur

gica

l Tre

atm

ent

of E

ye D

isea

ses i

n Ch

ildho

odW

OC-

AAD

-C-2

9 G

erdi

ng

Retin

op. o

f Pre

mat

urity

–Cl

inic

. Dia

gn. a

nd Tr

eatm

ent

Sund

ay, 6

June

Even

ing

Sym

posi

um

Pfiz

er

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

Mes

se

Stoc

khol

m

Sao

Paul

o

Abu

Dhab

i

Osl

o H

all

Room

Mad

rid

Room

Syd

ney

Room

Hon

g Ko

ng

Room

Ista

nbul

VIP

Loun

ge 1

VIP

Loun

ge 2

Radi

o To

wer

Lo

unge

1

Radi

o To

wer

Loun

ge 2

Hal

l 11

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

Brea

kfas

t Sym

po-

sium

San

ten

SU-0

1 Zan

gwill

,Ga

rway

-Hea

th,

Hof

fman

n

SU-0

2 H

eijl,

Schi

efer

Func

-tio

nal D

iagn

.

Lunc

h Sy

mpo

sium

Hei

delb

erg

Engi

neer

ing

SU-0

3 Pf

eiffe

r,Az

uara

-Bla

nco

Dec.

for T

reat

.

SU-0

4 So

m-

mer

, Wor

mal

d N

ew A

ppro

a.

SU-0

5 Kr

iegl

-st

ein,

Lace

yAd

here

nce

SU-0

6 Kh

aw,

Shaa

raw

y,Ba

erve

ldt

SU-0

7 Ja

kob-

sen,

Gre

hn,

Rahi

Child

h.

SU-0

8 Fo

ster

,Th

am G

lau-

com

a Ca

re

Lunc

h Sy

mpo

sium

Nov

artis

Pha

rma

AGSU

-21

AOI L

ectu

re

SU-0

9 Ko

ffler

, Asb

ell, B

erza

s N

ext G

ener

atio

ns o

f Sili

cone

Hyd

roge

l Con

tact

Lens

es

SU-10

Alió

, Auf

fart

h AA

OSy

mpo

sium

: Exc

elle

nce

inCa

tara

ct S

urge

ry

SU-11

Haw

lina,

Hol

der, B

ach

SOE/

ISCE

V Sy

mp:

Use

of E

lec-

trop

hysi

olog

ical

Met

hods

SU-12

Löffl

er, K

lintw

orth

,Sa

orni

l Eye

lid, O

cula

r Ad-

nexa

l and

Con

junc

t. Tu

mor

sSU

-13 A

lió, C

laou

é, N

euha

nn

Corr

ectin

g Pr

esby

opia

with

IOLs

SU-14

Mal

yugi

n, B

isse

n-M

iyaj

ima,

Pha

m

Man

agin

g Co

mpl

ex C

ases

SU-15

Nui

jts, W

erne

r, Koh

nen

New

Mon

ofoc

al IO

L Des

igns

SU-16

Lund

strö

m, K

och,

Find

l Em

ergi

ng Te

chno

logy

inCa

tara

ct S

urge

ryLu

nch

Sym

posi

umBa

yer

SU-17

Cer

nák,

Krus

e Co

rnea

/Ext

erna

l Dis

ease

: Ba

sics

SU-18

Luco

, Grä

f, Pla

nt

Ocu

lar M

otor

Pro

blem

sSU

-19 A

rmita

ge, B

öhrin

ger,

Duq

uesn

oy M

atch

ing

in

Pene

trat

ing

Kera

topl

asty

SU-2

0 W

atso

n, V

erda

guer

,Li

chte

r AO

I Sym

p: D

ealin

gw

ith C

ompl

ic. o

f Ant

erio

r SU

-22

Kikk

awa,

Bal

desc

hi,

Ecks

tein

G

rave

s' Di

seas

e

SU-2

3 G

ottlo

b, M

ojon

, Pie

h Pa

nel:

Case

pre

sent

atio

nsSU

-24

Rao,

Gar

weg

, Ple

yer

Infe

ctio

us U

veiti

sSU

-25

Stou

t, Sa

hel, Z

renn

er

Rece

nt D

evel

opm

ent i

n In

herit

ed R

etin

al D

isea

ses

SU-7

7 Kr

use,

Güe

ll N

ew Te

chno

logi

es fo

r Ke

rato

plas

ty

SU-2

7 H

eilig

enha

us, B

odag

hi,

Beck

er U

veiti

s/in

trao

c. in

-fla

m.,

mic

rob.

/im

mun

olog

y 1

SU-2

8 Be

hren

s-Ba

uman

n,D

art,

Ném

eth

Corn

eal I

nfec

tions

SU-2

9 W

ilhel

m, K

ashi

i, Lee

N

euro

-oph

thal

mic

Em

erge

n-ci

esSU

-30

Yoge

san,

Lam

min

en,

Paul

us P

anel

: Fut

ure

Aspe

cts

– Ad

vanc

ed In

f., W

ay-fo

rwar

d

SU-3

1 Nus

senb

latt

, For

rest

er,

Wild

ner C

urre

nt O

pini

on in

Imm

unol

ogy

of U

veiti

s

SU-3

2 Hop

kins

, Gut

hoff,

Fost

er

Onc

hoce

rcia

sis:

Mov

ing

toel

imin

atio

n

SU-3

3 Pl

eyer

, Bod

aghi

EV

ER S

ymp:

The

rapy

in n

on-

inf.

ocul

ar in

flam

mat

ion

WO

C-C-

21 D

unck

er W

etla

bBa

sic C

ours

e on

Pen

etra

ting

Corn

eal G

raft

ing

Tech

niqu

es

WO

C-C-

22 D

unck

er

Wet

lab

for t

he A

dvan

ced:

Lam

ella

r Gra

ftin

g Te

chni

ques

WO

C-C-

36 K

och,

Bor

nfel

d,Kr

üger

Mod

ern

Pars

pla

naVi

trec

tom

y Dr

yLab

(Bas

ics)

WO

C-C-

37 K

och,

Kos

s M

oder

n Pa

rs p

lana

Vitr

ec-

tom

y Dr

yLab

(Adv

ance

d)SU

-44

Plan

t, W

ilhel

m, W

ie

Neu

ro-O

phth

alm

olog

y 1

SU-4

6 Fr

ance

sche

tti, J

okl,

Krog

man

n Ju

lius H

irsch

berg

Soc

iety

SU-7

6 Ab

bott

, Bea

cons

field

,Le

mm

en In

corp

. Evi

denc

e-ba

sed

Clin

. Pra

ctic

e G

uide

l.SU

-38

Born

feld

, Zes

chni

gk, D

esja

rdin

s W

orks

hop:

Uve

al M

elan

oma

Gen

etic

Test

ing

SU-5

5 Bo

brov

a, G

ottlo

b,M

iller

Ped

iatr

ic O

phth

alm

ol-

ogy

& G

enet

ics 2

SU-3

9 Ki

nosh

ita, G

utho

ff,

Andr

ews

Nan

otec

hnol

ogy

1SU

-40

Belfo

rt, J

r., G

olni

k,Ka

shii

Mis

cella

neou

s 1

SU-4

1 Ger

inec

, Lor

enz,

Yetik

Pe

diat

ric O

phth

alm

olog

y &

Gen

etic

s 1

SU-4

2 Be

lshi

, Mey

er-R

üsen

-be

rg O

culo

plas

ty/o

rbita

/lid

s/la

crim

al sy

stem

1

SU-4

3 Si

ngh

PAAO

Sym

p:Ch

alle

ngin

g Ca

ses –

Clin

ico-

Path

olog

ic C

orre

latio

nSU

-45

Roid

er, D

ick,

Klin

k Vi

deo

Sess

ion

3 an

d Pr

esen

-ta

tion

of V

ideo

Aw

ards

SU-7

9 H

elbi

g, W

agne

r Vi

deo

Sess

ion

1: Ca

tara

ctSU

-80

Schr

ader

, Hol

zer

Vide

o Se

ssio

n 2:

M

isce

llane

ous 1

SU-8

1 Ste

uhl

Vide

o Se

ssio

n 4;

M

isce

llane

ous 2

Post

er e

xhib

ition

of P

oste

r P-

SU-0

01 to

P-S

U-2

77

Frankfurt/Main10. – 12. März 2011mit Wet-Lab’s, KursveranstaltungenProgramm für das Pflegepersonal

Frankfurt/Main10. – 12. März 2011mit Wet-Lab’s, KursveranstaltungenProgramm für das Pflegepersonal

www.dgii.orgwww.dgii.org

25. KongressDeutschsprachigen Gesellschaft

für Intraokularlinsen-Implantation,interventionelle und refraktive Chirurgie

Vorankündigung2011

25. KongressDeutschsprachigen Gesellschaft

für Intraokularlinsen-Implantation,interventionelle und refraktive Chirurgie

Kongressleitung:

Prof. Dr. med. Michael AmonKrankenhaus Barmherzige Brüder

Abteilung für Augenheilkunde

Johannes-von-Gott-Platz 1

A–1020 Wien

Telefon: (+43) 1 – 21121 – 1140

Telefax: (+43) 1 – 21121 – 1144

Organisation:

Congress-Organisation Gerling GmbHWerftstraße 23, D-40549 Düsseldorf

Telefon: (+49) 211 – 59 22 44

Telefax: (+49) 211 – 59 35 60

E-Mail: [email protected]

Internet: www.congresse.de

©PIA Stadt Frankfurt am Main

Foto: Tanja Schäfer

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Stockholm

08:30 - 09:15 SU-01

Present and Future Imaging

Subspecialty Day GlaucomaSection 1: Structure and Function in Glaucoma Care

Chairs:Ted Garway-Heath (London/UK)Esther M. Hoffmann (Mainz/D)

08:30 IL SU-01-01What is most useful present imaging (HRT, OCT,GDx)Esther M. Hoffmann (Mainz/D)

08:40 IL SU-01-02Measuring progressive change with imaging:which stage, which strategy, which consequencesTed Garway-Heath (London/UK)

08:50 IL SU-01-03Ganglion cell visualization: animals and humansM. Francesca Cordeiro (London/UK)

09:00 IL SU-01-04Perspectives in retinal imaging: adaptive optics, enface OCT and full-field dopplerMichel Paques (Paris/F)

09:10 Discussion

Stockholm

09:15 - 10:00 SU-02

Present and Future of Functional Diagnostics

Subspecialty Day GlaucomaSection 1: Structure and Function in Glaucoma Care

Chairs:Anders Heijl (Malmö/S)Ulrich Schiefer (Tübingen/D)

09:15 IL SU-02-01Useful strategies in present perimetryAnders Heijl (Malmö/S)

09:25 IL SU-02-02What is weak in present conventional perimetryand what can we do about itUlrich Schiefer (Tübingen/D)

09:35 IL SU-02-03Alternatives presently available (Flicker tests [FDT,Matrix, etc.], electrophysiology)Michael Bach (Freiburg/D)

09:45 IL SU-02-04What we need – the ideal new functional testBalwantray C. Chauhan (Halifax/CDN)

09:55Discussion

Stockholm

10:30 - 11:15 SU-03

Decisions for Treatment and Change in Treatment

Subspecialty Day GlaucomaSection 2: Present and Future Approaches to Glau-coma Care

Chairs:Norbert Pfeiffer (Mainz/D)Augusto Azuara-Blanco (Aberdeen/UK)

10:30 IL SU-03-01Risk assessment and risk calculationSteven L. Mansberger (Portland/USA)

10:40 IL SU-03-02The impact of risk calculation on physician deci-sionsMichael Boland (Baltimore/USA)

10:50 IL SU-03-03Cost/benefit, Cost effectivenessAugusto Azuara-Blanco (Aberdeen/UK)

11:00 IL SU-03-04Practice patterns, too much or too littleNorbert Pfeiffer (Mainz/D)

11:10Discussion

Stockholm

11:15 - 12:00 SU-04

New Approaches to Gathering Information aboutGlaucoma

Subspecialty Day GlaucomaSection 2: Present and Future Approaches to Glau-coma Care

Chairs:Alfred Sommer (Baltimore/USA)Richard Wormald (London/UK)

11:15 IL SU-04-01The challenge: conduct large-scale research withmany centersDon Budenz (Miami/USA)

Sunday, 6 June 2010

Sund

ay, 6

June

91

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:25 IL SU-04-02Insurance database studies: strengths and weaknessesJoshua D. Stein (Ann Arbor/USA)

11:35 IL SU-04-03Mining our hard drives (Lessons from Cochrane approach)Richard Wormald (London/UK)

11:45 IL SU-04-04How to do research cheaper and betterAlfred Sommer (Baltimore/USA)

11:55Discussion

Stockholm

14:00 - 14:45 SU-05

Adherence with Medical Therapy, the Dirty Secret

Subspecialty Day GlaucomaSection 3: Outlooks to Medical and Surgical Therapy

Chairs:Günther K. Krieglstein (Cologne/D)Jenny Lacey (Norwich/UK)

14:00 IL SU-05-01How bad is adherence now?Günther K. Krieglstein (Cologne/D)

14:10 IL SU-05-02Barriers to adherenceJenny Lacey (Norwich/UK)

14:20 IL SU-05-03How does physician communication affect adherence?David Friedman (Baltimore/USA)

14:30 IL SU-05-04How much would be gained if we increased adherence?James C Tsai (New Haven/USA)

14:40Discussion

Stockholm

14:45 - 15:40 SU-06

Present and Future of Glaucoma Surgery – SurgicalChallenges

Subspecialty Day GlaucomaSection 3: Outlooks to Medical and Surgical Therapy

Chairs:Peng T. Khaw (London/UK)Tarek M. Shaarawy (Geneva/CH)George Baerveldt (Irvine/USA)

14:45 IL SU-06-01Developments making trabeculectomy saferPeng T. Khaw (London/UK)

14:55 IL SU-06-02Bleb classification and management of complications related to blebsFranz Grehn (Würzburg/D)

15:05 IL SU-06-03Non-penetrating glaucoma surgery techniques –has their time come or gone?Tarek M. Shaarawy (Geneva/CH)

15:15 IL SU-06-04Tubes: When, why, howKeith Barton (London/UK)

15:25 IL SU-06-05Angle surgery: status report on newer methodsGeorge Baerveldt (Irvine/USA)

15:35 IL SU-06-06Standardized reporting on surgical studiesMark Sherwood (Gainesville/USA)

Stockholm

16:10 - 16:50 SU-07

Childhood Glaucoma Care: the Patient Who LivesUp to 2100

Subspecialty Day GlaucomaSection 4: Neglected Areas: Where Can We Improve

Chairs:Jan Eric Jakobsen (Oslo/N)Franz Grehn (Würzburg/D)Jugnoo S. Rahi (London/UK)

16:10 IL SU-07-01Present and future surgical techniques: Innovationat the horizon?Jan Eric Jakobsen (Oslo/N)

Sunday, 6 June 2010

Sund

ay, 6

June

92

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

16:20 IL SU-07-02Spontaneous resolution of congenital glaucoma –a natural help for surgeryFranz Grehn (Würzburg/D)

16:25 IL SU-07-03Developing vision: Amblyopia is a major challengeThomas Klink (Würzburg/D)

16:35 IL SU-07-04New aspects of secondary glaucoma after congenital cataract surgeryJugnoo S. Rahi (London/UK)

16:45Discussion

Stockholm

16:50 - 17:30 SU-08

Glaucoma Care in Developing Countries

Subspecialty Day GlaucomaSection 4: Neglected Areas: Where Can We Improve

Chairs:Paul Foster (London/UK)Clement C. Y. Tham (Hong Kong/CN)

16:50 IL SU-08-01The scope of the problemPaul Foster (London/UK)

16:55 IL SU-08-02What is done now for OAG in the developing worldKuldev Singh (Stanford/USA)

17:00 IL SU-08-03What is done now for ACG in the developing worldClement C. Y. Tham (Hong Kong/CN)

What should be done right now: 3 viewpoints17:05 IL SU-08-04We should apply the developed country modelTarek M. Shaarawy (Geneva/CH)

17:10 IL SU-08-05We should use different programs for different regionsTin Aung (Singapore/SGP)

17:15 IL SU-08-06We should use the center of excellence - pyramidmodelPaul Foster (London/UK)

17:20 IL SU-08-07Where will we make the biggest short-term gainsin reducing impairmentMingguang He (Guangzhou/CN)

17:25Discussion

Sao Paulo

08:30 - 10:00 SU-09

Next Generations of Silicone Hydrogel ContactLenses


Chairs:Bruce H. Koffler (Lexington/USA)Cornelius Berzas (Offenbach/D)

08:30 IL SU-09-01The Oliver Dabezies Lecture; Oliver Dabezies Jr.M.D.: A True GentlemanJane Sparholt (Rønne/DK)

08:40 IL SU-09-02Is it safe to wear extended – and continuous wearlenses?Mihály Végh (Szeged/H)

08:50 IL SU-09-03Silicone hydrogel multifocal lenses for the presbyopeEbru Toker (Istanbul/TR)

09:00 IL SU-09-04Ophthalmic Drug Delivery by contact lensesAnuj Chauhan (Florida/USA)

09:10 IL SU-09-05Silicone hydrogel for ectatic (& irregular) corneasUrsula Vogt (London/UK)

09:20 IL SU-09-06Next generations of silicone-HydrogelsBruce H. Koffler (Lexington/USA)

09:30 IL SU-09-07Treatment and Management of Contact Lens infectious complications; Pseudonomas infectionand melting and acanthamoeba ceratitiesAndrena McElvanney (London/UK)

09:40 IL SU-09-08Therapeutic uses of Silicone Hydrogels in OcularSurface DiseaseAntonio Elizondo (San Pedro/MEX)

09:50Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

93

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Sao Paulo

10:30 - 12:00 SU-10

AAO Symposium: Excellence in Cataract Surgery:What We Should Demand in 2010?

SymposiumCataract

Chairs:Jorge L. Alió (Alicante/E)Gerd U. Auffarth (Heidelberg/D)

10:30 IL SU-10-01Excellence in IncisionJorge L. Alió (Alicante/E)

10:40 IL SU-10-02Excellence in OutcomesTBA

10:50 IL SU-10-03Excellence in Restoring Near Vision FunctionTBA

11:00 IL SU-10-04Excellence in Restoring Visual OpticsDouglas D. Koch (Houston/USA)

11:10 IL SU-10-05Excellence in Astigmatic Correction duringCataract SurgeryGerd U. Auffarth (Heidelberg/D)

11:20 IL SU-10-06Excellence in Phaco EngineeringMichael Colvard (Los Angeles/USA)

11:30Discussion

Sao Paulo

14:00 - 15:30 SU-11

SOE/ISCEV Symposium: Use of ElectrophysiologicalMethods in Acquired Retinal and Optic Nerve Diseases

SymposiumElectrophysiology

Chairs:Marko Hawlina (Ljubljana/SLO)Graham E. Holder (London/UK)Michael Bach (Freiburg/D)

14:00 IL SU-11-01Electrophysiology and imaging in retinal diseasesUlrich Kellner (Siegburg/D)

14:15 IL SU-11-02What can we learn from electrophysiology in AMD patientsThomas Meigen (Würzburg/D)

14:30 IL SU-11-03The differentiation between optic nerve and macular dysfunctionMarko Hawlina (Ljubljana/SI)

14:45 IL SU-11-04Electrophysiology in glaucomaMichael Bach (Freiburg/D

15:00 IL SU-11-05Electrophysiology in inflammatory and autoimmune diseasesGraham E. Holder (London/UK)

15:15Discussion

Sao Paulo

16:00 - 17:30 SU-12

Eyelid, Ocular Adnexal and Conjunctival Tumors

SymposiumPathology

Chairs:Karin U. Löffler (Bonn/D)Gordon Klintworth (Morrisville/USA)Maria Antonia Saornil (Valladolid/E)

16:00 IL SU-12-01Eyelid malignancies: conventional and new thera-peutic modalitiesGonzalo Blanco-Mateos (Valladolid/E)

16:10 IL SU-12-02Sebaceous carcinomaTom Cummings (Durham/USA)

16:20 IL SU-12-03In vivo confocal microscopy of conjunctival lesionswith histopathologic correlationElisabeth M. Messmer (Munich/D)

16:30 IL SU-12-04Conjunctival intraepithelial neoplasia: risk factors,prophylaxis and treatmentClaudia Auw-Hädrich (Freiburg/D)

16:40 IL SU-12-05New classification of primary acquired melanosis(PAM)Sarah E. Coupland (Liverpool/UK)

Sunday, 6 June 2010

Sund

ay, 6

June

94

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

16:50 IL SU-12-06What is this caruncular tumor?Steffen Heegaard (Copenhagen/DK)

17:00 IL SU-12-07Case presentationsJerry Shields (Philadelphia/USA)

17:10Discussion

Abu Dhabi

08:30 - 10:00 SU-13

Correcting Presbyopia with IOLs


Chairs:Jorge L. Alió (Alicante/E)Charles Claoué (Brentwood/UK)Thomas F. Neuhann (Munich/D)

08:30 IL SU-13-01MonovisionThomas F. Neuhann (Munich/D)

08:40 IL SU-13-02Multifocal, refractiveCharles Claoué (Brentwood/UK)

08:50 IL SU-13-03Mulitfocal, diffractiveJosé F. Alfonso (Oviedo/E)

09:00 IL SU-13-04Accommodating, monoopticMilind Pande (North Ferriby/UK)

09:10 IL SU-13-05Accommodating, dualopticIvan L. Ossma-Gomez (Bucaramanga/CO)

09:20 IL SU-13-06Managing astigmatism and residual ametropiaMichael C. Knorz (Mannheim/D)

09:30Discussion

Abu Dhabi

10:30 - 12:00 SU-14

Managing Complex Cases


Chairs:Boris Malyugin (Moscow/RUS)Hiroko Bissen-Miyajima (Tokyo/J)Duy-Thoai Pham (Berlin/D)

10:30 IL SU-14-01Incisional issuesAmar Agarwal (Chennai/IND)

10:40 IL SU-14-02Dense nucleiDuy-Thoai Pham (Berlin/D)

10:50 IL SU-14-04Small pupilsBoris Malyugin (Moscow/RUS)

11:00 IL SU-14-05Ruptured posterior capsuleHiroko Bissen-Miyajima (Tokyo/J)

11:10 IL SU-14-06Iris defects (aniridia, coloboma, traumatic)Stephan Kohnen (Aachen/D)

11:20 IL SU-14-07Dislocated IOLsTBA

11:30Discussion

Abu Dhabi

14:00 - 15:30 SU-15

New Monofocal IOL Designs


Chairs:Rudy Nuijts (Maastricht/NL)Liliana Werner (Berlin/D)Thomas Kohnen (Frankfurt/D)

14:00 IL SU-15-01AsphericThomas Kohnen (Frankfurt/D)

14:10 IL SU-15-02Toric overviewRudy Nuijts (Maastricht/NL)

Sunday, 6 June 2010

Sund

ay, 6

June

95

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:20 IL SU-15-03Surgical pearls for toric IOLsDavid Spalton (London/UK)

14:30 IL SU-15-04Extreme casesGerd U. Auffarth (Heidelberg/D)

14:40 IL SU-15-05Light-adjustableFritz Hengerer (Bochum/D)

14:50 IL SU-15-06New IOL biomaterialsLiliana Werner (Berlin/D)

15:00Discussion

Abu Dhabi

16:00 - 17:30 SU-16

Emerging Technology in Cataract Surgery


Chairs:Mats Lundström (Karlskrona/S)Douglas D. Koch (Houston/USA)Oliver Findl (Vienna/A)

16:00 IL SU-16-01Advances in techniques for patient assessmentOliver Findl (Vienna/A)

16:10 IL SU-16-02IOL calculations, technology? formulas – Haigis,IOL calculations after refractive surgery – DDKJaime Aramberri Agesta (Vitoria-Gasteiz/E)

16:20 IL SU-16-03Phaco technologyBarry S. Seibel (Los Angeles/USA)

16:30 IL SU-16-04Prevention of PCOManfred Tetz (Berlin/D)

16:40 IL SU-16-05Prevention of endophthalmitisMats Lundström (Karlskrona/S)

16:50 IL SU-16-06Small-incision ECCE" to "Modern Manual CataractTBA

17:00Discussion

Oslo

08:30 - 10:00 SU-17

Cornea/External Disease: Basics

Free PaperCornea, External Disease

Chairs:Andrej Cernák (Bratislava/SK)Rupert Strauß (Linz/A)

08:30 FP SU-17-01Donor corneal tissue characteristics and graft survivalTatyana Hergeldzhieva-Fileva, Petja Ivanova Vassileva, Nickolai Surchev, Yordanka Kirilova(Sofia/BG)

08:37 FP SU-17-02The effect of human and rabbit serum on the recovery of the wounded corneal surface in the Ex vivo Eye Irritation testB. Kranz-Opgen-Rhein, Norbert Schrage, M. Frentz (Aachen/D, Köln/D)

08:44 FP SU-17-03Immunocytochemical analysis after treatmentwith osmoprotective lubricant in patients withdysfunctional tear syndromeRossen M. Hazarbassanov (Sao Paulo/BR)

08:51 FP SU-17-04Osmoprotectants can protect corneal epithelialcells from death after exposure to hyper-osmolarsolutionsMark Willcox, Qian Garrett, Sharon Shih, Joseph Vehige, Peter Simmons (Sydney/AUS,Irvine/USA)

08:58 FP SU-17-05Keratoconus experimentally induced in mice usingcollagenaseMahsa Hadipour Jahromy, Farhad Adhami-moghadam, Simin Fazelipour,Shahrzad Khakpour, Mohammadsadegh Younesian(Tehran/IR)

09:05 FP SU-17-06Differentiation of human bone mesenchymal stem cells into keratocytes in vitroDong Shi, Yuji Tanaka, Akira Kubota, Kohji Nishida(Sendai/J)

09:12 FP SU-17-07Atomic Force Microscopy of the corneal ultrastruc-ture before and after corneal crosslinkingRupert Strauß, David Diesenberger, MartinDirisamer, Manfred Dichtl, Andreas Wedrich, Kurt Schilcher, Siegfried G. Priglinger (Linz/A)

Sunday, 6 June 2010

Sund

ay, 6

June

96

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

09:19 FP SU-17-08Monitoring osmotic stress within a new in vitrodry eye modelFelix Spöler, Markus Frentz, Heinrich Kurz, Norbert Schrage (Aachen/D, Köln/D)

09:26 FP SU-17-09Bone Marrow-Derived Endothelial Progenitor Cells:a Promising Therapeutic Alternative for CornealEndothelial DysfunctionChunyi Shao, Yao Fu, Wenjuan Lu, Xianqun Fan(Shanghai/CN)

09:33 FP SU-17-10Expression of Tim-3 in high risk murine model ofcorneal graft rejectionWei Kun Hu, Nan Xiang, Rong Liu, Jing Yuan(Wuhan/CN)

09:40 SL SU-17-11Tomographic normal values for elevation andpachymetry in a hyperopic populationMichael W. Belin, Michael Cortese (Marana/USA, Albany/USA)

09:49Discussion

Oslo

10:30 - 12:00 SU-18

Ocular Motor Problems

SymposiumNeuro-Ophthalmology

Chairs:Christian Luco (Santiago/RCH)Michael Gräf (Giessen/D)Gordon Plant (London/UK)

10:30 IL SU-18-01Localizing value of nystagmusChristian Luco (Santiago/RCH)

10:40 IL SU-18-02Cryptic Ocular motor PalsiesEmely Karam (Caracas/Y)

10:50 IL SU-18-03Congenital and acquired paretic strabismusMichael Gräf (Giessen/D)

11:00 IL SU-18-04Differential diagnosis of diplopiaOliver Ehrt (Munich/D)

11:10 IL SU-18-05Localising value of disorders of saccadesCaroline Tilikete (Lyon/F)

11:20 IL SU-18-06Paroxysmal diplopiaGordon Plant (London/UK)

11:30Discussion

Oslo

14:00 - 15:30 SU-19

Matching in Penetrating Keratoplasty


Chairs:John Armitage (Bristol/UK)Daniel Böhringer (Freiburg/D)René J. Duquesnoy (Pittsburgh/USA)

14:00 IL SU-19-01HLA matching in keratoplasty: The Bristol experienceJohn Armitage (Bristol/UK)

14:15 IL SU-19-02HLA matching in keratoplasty: The Freiburg experienceDaniel Böhringer (Freiburg/)

14:30 IL SU-19-03HLA matching at the epitope level: a new ap-proach to select transplant donorsRené J. Duquesnoy (Pittsburgh/USA)

14:45 IL SU-19-04Minor transplantation antigensEric Spierings (Utrecht/NL)

15:00 IL SU-19-05Pathophysiology of corneal graft rejectionJohn V. Forrester (Aberdeen/UK)

15:15Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

97

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Oslo

16:00 - 17:30 SU-20

AOI Symposium: Dealing with Complications ofAnterior Segment Surgery

SymposiumCataract

Chairs:Peter G. Watson (Cambridge/UK)Juan Verdaguer (Santiago/RCH)Paul R. Lichter (Ann Arbor/USA)

16:00 IL SU-20-01Dealing with infections after LASIKRichard L. Abbott (San Francisco/USA)

16:10 IL SU-20-02Management of post-Lasik corneal ectasiaJorge L. Alió (Alicante/E)

16:20 IL SU-20-03Dealing with zonular dialysis during phacoemulsi-ficationMarie-José Tassignon (Antwerb/B)

16:30 IL SU-20-04Dealing with non filtering, flat or encapsulatedblebsPaul R. Lichter (Ann Arbor/USA)

16:40 IL SU-20-05Intraocular lens implantation in the absence ofcapsular supportEnrique Malbrán (Buenos Aires/RA)

16:50 IL SU-20-06Dealing with early-onset endophthalmitis aftercataract surgeryPran Nath Nagpal (Ahmedabad/IND)

17:00 IL SU-20-07Late-onset endophthalmitis after cataract surgeryRubens Belfort, Jr. (São Paulo/BR)

17:10 IL SU-20-08Cystoid macular edema in early pseudophakiaKenasaku Miyake (Nagoya/J)

17:20 IL SU-20-09Management of suprachoroidal hemorrhage afteranterior segment surgeryWilliam F. Mieler (Chicago/USA)

Oslo

17:30 - 18:15 SU-21

Academia Ophthalmologica Internationalis Lecture

Highlights

Chairs:Paul R. Lichter (Ann Arbor/USA)Juan Verdaguer (Santiago/RCH)

17:30 IL SU-21-01IntroductionJuan Verdaguer (Santiago/RCH)

17:35 IL SU-21-02Galileo's BlindnessPeter G. Watson (Cambridge/UK)

Room Madrid

08:30 - 10:00 SU-22

Graves' Disease

SymposiumStrabismus

Chairs:Don O. Kikkawa (La Jolla/USA)Lelio Baldeschi (Amsterdam/NL)Anja K. Eckstein (Essen/D)

08:30 IL SU-22-01Pathogenesis of GOMarian Ludgate (Cardiff/UK)

08:40 IL SU-22-02Symptoms and assessment of GOAlison J. Dickenson (New Castle/UK)

08:50 IL SU-22-03EUGOGO Management Plan of GOAnja K. Eckstein (Essen/D)

09:00 IL SU-22-04Orbital surgeryLelio Baldeschi (Amsterdam/NL)

09:10 IL SU-22-05Eye muscle surgeryJoachim Esser (Essen/D)

09:20 IL SU-22-06Lid surgeryDon O. Kikkawa (La Jolla/USA)

09:30Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

98

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Room Madrid

10:30 - 12:00 SU-23

Panel: Case Presentations

SymposiumStrabismus

Chairs:Irene Gottlob (Leicester/UK)Daniel Mojon (St. Gallen/CH)Christina Pieh (Freiburg/D)

10:30 IL SU-23-01Elevation of one eye during tooth brushingIrene Gottlob (Leicester/UK)

10:40 IL SU-23-02Complications of botulinum toxin injection in aninfant: remaining mydriasisClaude Speeg-Schatz (Strasbourg/F)

10:50 IL SU-23-03Vertical angle "kappa"Klara Landau (Zurich/CH)

11:00 IL SU-23-04Unilateral exophthalmos – surprise, surpriseAndrea Langmann (Graz/A)

11:10 IL SU-23-05"I don´t like to ride my bike anymore!"Bettina K. Wabbels (Bonn/D)

11:20 IL SU-23-06"I wish I hadn´t done this!"Heimo Steffen (Würzburg/D)

11:30 IL SU-23-07Synergistic adduction in a 5-year-old girlChristina Pieh (Freiburg/D)

11:40Discussion

Room Madrid

14:00 - 15:30 SU-24

Infectious Uveitis


Chairs:Narsing A. Rao (Los Angeles/USA)Justus G. Garweg (Bern/CH)Uwe Pleyer (Berlin/D)

14:00 IL SU-24-01Pathophysiology and Diagnostics for Toxo-plasmosisMichael E. Grigg (Bethesda/USA)

14:10 IL SU-24-02Challenges in the Diagnosis and Management ofOcular ToxoplasmosisJustus G. Garweg (Bern/CH)

14:20 IL SU-24-03Pathophysiology and Diagnostics for Lyme´s DiseaseVolker Fingerle (Oberschleißheim/D)

14:30 IL SU-24-04Challenges in the Diagnosis and Management ofOcular Lyme’s DiseaseUwe Pleyer (Berlin/D)

14:40 IL SU-24-05Pathophysiology and Diagnostics for TuberculosisDaniel Vítor Vasconcelos Santos (Belo Horizonte/BR)

14:50 IL SU-24-06Challenges in the Diagnosis and Management ofOcular TuberculosisNarsing A. Rao (Los Angeles/USA)

15:00Discussion

Room Madrid

16:00 - 17:30 SU-25

Recent Development in Inherited Retinal Diseases

SymposiumRetina, Vitreous

Chairs:Tim Stout (Portland/USA)José-Alain Sahel (Paris/F)Eberhart Zrenner (Tübingen/D)

16:00 IL SU-25-01Gene Replacement Therapy for Inherited RetinalDiseaseJames W. B. Bainbridge (London/UK)

16:10 IL SU-25-02Stem Cell TherapyPeter J. Francis (Portland/USA)

16:20 IL SU-25-03The Future of High-Throughput Ophthalmic DNADiagnosticsBernhard H. F. Weber (Regensburg/D)

Sunday, 6 June 2010

Sund

ay, 6

June

99

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

16:30 IL SU-25-04Rod derived Cone ViabilityJosé-Alain Sahel (Paris/F)

16:40 IL SU-25-05Control of VEGF Gene ExpressionTim Stout (Portland/USA)

16:50 IL SU-25-06Outer retina – a role for channels and connectionsin degenerative diseasesMathias Seeliger (Tübingen/D)

17:00Discussion

Room Sydney

08:30 - 10:00 SU-77

New Technologies for Keratoplasty

SymposiumNew Technology, Bioengineering

Chairs:Friedrich E. Kruse (Erlangen/D)José L. Güell (Barcelona/E)

08:30 IL SU-77-01A New Collagen Implant to Treat Corneal DefectsBjörn Bachmann (Erlangen/D)

08:40 IL SU-77-02New Developments in DALKDonald T. H. Tan (Singapore/SGP)

08:50 IL SU-77-03Mushroom Keratoplasty for High, Irregular Astigmatism After Penetrating KeratoplastyGabriel van Rij (Rotterdam/NL)

09:00 IL SU-77-04Long-term Results of DSAEK in 1000 EyesFrancis W. Price (Indianapolis/USA)

09:10 IL SU-77-05Visual Rehabilitation after DASEK and DMEKFriedrich E. Kruse (Erlangen/D)

09:20 IL SU-77-06DELK, DASEK, DMEK, the Thinner the BetterGerrit R. J. Melles (Rotterdam/NL)

09:30 IL SU-77-07Future Options for Endothelial TransplantationShigeru Kinoshita (Kyoto/J)

09:40Discussion

Room Sydney

10:30 - 12:00 SU-27

Uveitis/Intraocular Inflammation,Microbiology/Immunology 1


Chairs:Arnd Heiligenhaus (Münster/D)Bahram Bodaghi (Paris/F)Matthias D. Becker (Zurich/CH)

10:30 FP SU-27-01Rationale and Study Design of a Phase III ClinicalTrial Evaluating IL-17A Inhibition with AIN457 in Patients with Posterior Segment Uveitis Secondaryto Behçet’s DiseaseYonca Akova (Ankara/TR)

10:37 FP SU-27-02Experience with Adalimumab for the treatment of non-infectious uveitisBianca Dobner, Regina Max, Matthias D. Becker,Carsten Heinz, Talin Barisani-Asenbauer, Arnd Heiligenhaus, Friederike Mackensen (Heidelberg/D, Vienna/A, Zurich/CH, Münster/D)

10:44 FP SU-27-03An Open-Label Trial to Assess the Efficacy ofAIN457, a Monoclonal Antibody Against IL-17A, inNoninfectious UveitisC. Stephen Foster, Rosa Kim, C. Michael Samson,Naomi Falk, David Chu, David Callahan, Quan Dong Nguyen, Thaddeus P. Dryja (Cambridge/USA)

10:51 FP SU-27-04Safety Profile of LX211 (Luveniq™/voclosporin oral capsule) in Sight-Threatening NoninfectiousUveitis as reported in the LUMINATE StudiesChristoph Deuter, on behalf of the LUMINATEStudy Group (Tübingen/D)

10:58 FP SU-27-06Uveitis refractive to cyclosporine A improves withadditional everolimus: a pilot studyArnd Heiligenhaus (Münster/D)

11:05 FP SU-27-07Acute retinal necrosis – a national survey in GermanySibylle Winterhalter, Antonia M Joussen, Uwe Pleyer, Arnd Heiligenhaus, Friederike Mackensen, Manfred Zierhut, Anna-Karina Maier,Thomas Ness (Berlin/D, Münster/D, Heidelberg/D,Freiburg/D, Tübingen/D)

Sunday, 6 June 2010

Sund

ay, 6

June

100

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:12 FP SU-27-08Twenty five gauge pars plana vitrectomy for vitre-ous opacities secondary to ocular toxoplasmosisClaudio Garcia, Tiago Arantes, Fabio Barreto,Cristina Muccioli (Sao Paulo/BR)

11:19 FP SU-27-09Long-term follow-up of patients with Behcet’s disease: Apropos one caseMirsad Ibisevic (Sarajevo/BIH)

11:26 FP SU-27-10Severe cases of occlusive retinal vasculitisAnne Wissen, Mark Saeger, Johann Roider, Bernhard Nölle (Kiel/D)

11:33Discussion

Room Sydney

14:00 - 15:30 SU-28

Corneal Infections


Chairs:Wolfgang Behrens-Baumann (Magdeburg/D)John K. G. Dart (London/UK)Janos Németh (Budapest/H)

14:00 IL SU-28-01Problem solving for progressive microbial keratitisJohn K. G. Dart (London/UK)

14:15 IL SU-28-02Current aspects of keratomycosisWolfgang Behrens-Baumann (Magdeburg/D)

14:30 IL SU-28-03The Challenge of Acanthamoeba KeratitisElmer Tu (Chicago/USA)

14:45 IL SU-28-04Mycobacterial keratitisPrashant Garg (Hyderabad/IND)

15:00 IL SU-28-05Herpetic keratitisLies Remeijer (Rotterdam/NL)

15:15Discussion

Room Sydney

16:00 - 17:30 SU-29

Neuro-Ophthalmic Emergencies


Chairs:Helmut Wilhelm (Tübingen/D)Satoshi Kashii (Osaka/J)Andrew G. Lee (Houston/USA)

16:00 IL SU-29-02Acute eye painSatoshi Kashii (Osaka/J)

16:15 IL SU-29-03Perilous pupilsHelmut Wilhelm (Tübingen/D)

16:30 IL SU-29-04Traumatic Optic Neuropathy: Is there an evidencebased recommendation for management?Andrew G. Lee (Houston/USA)

16:45 IL SU-29-05Giant cell ArteriitisAki Kawasaki (Lausanne/CH)

17:00 IL SU-29-06Abnormal eye movements that should not bemissedFrancois Borruat (Lausanne/CH)

17:15Discussion

Room Hong Kong

08:30 - 10:00 SU-30

Panel: Future Aspects – Advanced Information,Way-forward


Chairs:Kanagasingam Yogesan (Nedlands/AUS)Heikki Lamminen (Tampere/FIN)Dietrich Paulus (Koblenz/D)

08:30 IL SU-30-01Round table discussionKanagasingam Yogesan (Nedlands/AUS)

08:50 IL SU-30-02Current status and way forwardSajeesh Kumar (Pittsburgh/USA)

Sunday, 6 June 2010

Sund

ay, 6

June

101

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

09:10 IL SU-30-03Round table discussionHeikki Lamminen (Tampere/FIN)

09:30 IL SU-30-04Round table discussionDietrich Paulus, Kanagasingam Yogesan, Heikki Lamminen (Koblenz/D, Nedlands/AUS, Pittsburgh/USA, Tampere/FIN)

Room Hong Kong

10:30 - 12:00 SU-31

Current Opinion in Immunology of Uveitis

SymposiumImmunology, Molecular Biology, Microbiology

Chairs:Robert Nussenblatt (Bethesda/USA)John V. Forrester (Aberdeen/UK)Gerhild Wildner (Munich/D)

10:30 IL SU-31-01Recent developments of experimental uveitis inmiceRachel R. Caspi (Bethesda/USA)

10:40 IL SU-31-02Recent developments of experimental uveitis inratsGerhild Wildner (Munich/D)

10:50 IL SU-31-03Intraocular immune response in human uveitisS. John Curnow (Birmingham/UK)

11:00 IL SU-31-04Leukocyte migration in uveitisIsabel J. Crane (Aberdeen/UK)

11:10 IL SU-31-05How is uveitis initiated?John V. Forrester (Aberdeen/UK)

11:20 IL SU-31-06"Immunologicals" as therapy for uveitisRobert Nussenblatt (Bethesda/USA)

11:30Discussion

Room Hong Kong

14:00 - 15:30 SU-32

Onchocerciasis: Moving to Elimination

SymposiumPrevention of Blindness

Chairs:Adrian Dennis Hopkins (Decatur/USA)Rudolf F. Guthoff (Rostock/D)Allen Foster (London/UK)

14:00 IL SU-32-01Onchocerciasis – Eye pathology and current under-standingTony Ukety (Geneva/CH)

14:10 IL SU-32-02Elimination of Onchocerciasis in the Americas oncourse for 2012Mauricio Sauerbrey (San Salvador/ES)

14:20 IL SU-32-03A paradigm shift from Control to Elimination inAfricaAdenike Abiose (Ibadan/WAN)

14:30 IL SU-32-04Community Directed Interventions; Onchocerciasiscontrol leads the way in Public HealthUche Amazigo (Ouagadougou/HV)

14:40 IL SU-32-05Current research: What do we need to know toeliminate the disease?Frank Richards (Atlanta/USA)

14:50 IL SU-32-06Neglected Tropical Diseases and Onchocerciasis:can widening the vision lose focus?Adrian Dennis Hopkins (Decatur/USA)

15:00Discussion

Room Hong Kong

16:00 - 17:30 SU-33

EVER Symposium: Therapy in Noninfectious OcularInflammation: Recent Developements


Chairs:Uwe Pleyer (Berlin/D)Bahram Bodaghi (Paris/F)

Sunday, 6 June 2010

Sund

ay, 6

June

102

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

16:00 IL SU-33-01Principles and new targets in immunemodulationTBA

16:15 IL SU-33-02Biologicals: Beyond anti-TNF treatmentMarc D. de Smet (Antwerpen/B)

16:30 IL SU-33-03Immunosuppression in children (JIA)Bahram Bodaghi (Paris/F)

16:45 IL SU-33-04Corticosteroids: old agents – new optionsUwe Pleyer (Berlin/D)

17:00 IL SU-33-05Optimised monitoring of inflammation suppres-sive therapy (IST)Carl P. Herbort (Lausanne/CH)

17:15Discussion

VIP Lounge 1

08:30 - 10:00 SU-44

Neuro-Ophthalmology 1

Free Paper Neuro-Ophthalmology

Chairs:Gordon Plant (London/UK)Helmut Wilhelm (Tübingen/D)Shihui Wei (Beijing/CN)

08:30 SL SU-44-01Relaticity analysis of rhinogenous ocular manifestationsShihui Wei (Beijing/CN)

08:39 FP SU-44-02Neuroprotective effect on retinal ganglion cells by transpupillary laser irradiation of the opticnerve headLibin Jiang (Beijing/CN)

08:46 FP SU-44-03Clinical analysis of 52 cases with ophthalmologicsigns in vertebral-basilar insufficiencyShihui Wei (Beijing/CN)

08:53 FP SU-44-04Are we neglecting visual neglect?Shu Jeng Ting, Alex Pollock, Fergus Doubal, Gordon Dutton, Shu Wei Ting, Bal Dhillon, Thompson Michelle (Glasgow/UK)

Sunday, 6 June 2010

Sund

ay, 6

June

103

09:00 FP SU-44-05Saccade dynamics in peripheral vs central fourthnerve palsiesTao Fu, Alan Blakeman, Manokaraananthan Chandrakumar, Herbert Goltz, Agnes M. F. Wong(Beijing/CN)

09:07 FP SU-44-06Restoration of vision: non-invasive current stimulation enhances brain synchronization after optic nerve damage – a retrospective, observational study with 446 patientsAnton Fedorov, Sandra Jobke, Alexandra N.Chibisova, Julia M. Chibisova, Carolin Gall, Bernhard Sabel (Magdeburg/D, St. Petersburg/RUS)

09:14 FP SU-44-07Neuroplasticity in acute optic neuritis: an Functional magnetic resonance imaging (fMRI)studyAnoop Kishore Gupta, Senthil kumaran, Rohit Saxena, Vimla Menon, Pradeep Sharma,Pradeep Sharma (Dehli/IND)

09:21 FP SU-44-08Restoration of vision: Non-invasive current stimulation for the treatment of visual field defects in optic neuropathy – as single-centerprospective trialBernhard A. Sabel, Anton B. Fedorov, Christoph Herrmann, Carolin Gall (Magdeburg/D)

09:28 FP SU-44-09Automated morphometry of the visual pathway inprimary open-angle glaucomaAditya Hernowo, Christine Boucard, Nomdo Jansonius, Johanna Hooymans, Frans Cornelissen (Groningen/NL)

09:35 FP SU-44-10Dissemination of glioblastoma multiforme masquerading multiple sclerosisNikolai Holak, Heinrich Holak, S. Pfeifenbring, S. Baumgarten (Salzgitter/D)

09:42Discussion

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

VIP Lounge 1

14:00 - 15:30 SU-46

Julius Hirschberg Society: Symposion Contributionto Hundred and Fifty Years of Ophthalmology

Symposium International Ophthalmology

Chairs:Albert Franceschetti (Meyrin/CH)Danny Hirsch-Kauffmann Jokl (New York/USA)Frank Krogmann (Thüngersheim/D)

14:00 IL SU-46-01An ophthalmologist's trip to IndiaGregor Wollensak (Halle/D)

14:10 IL SU-46-02Swiss contribution to International OphthalmologyBalder P. Gloor (Zurich/CH)

14:20 IL SU-46-03The first female medical studentsAlbert Franceschetti (Meyrin/CH)

14:30 IL SU-46-04Albrecht von Graefe- previously unrecognized contributions to modern OphthalmologyDanny Hirsch-Kauffmann Jokl (New York/USA)

14:40 IL SU-46-05Vienna and its significance in worldwide ophthalmologyFrank Krogmann (Thüngersheim/D)

14:50 IL SU-46-06Glaucoma und migraine – a historical reviewCarl Erb (Berlin/D)

15:00 IL SU-46-07Ludwik Zamenhof – One of the most famous ophthalmologists in the world’s CultureAndrzej Grzybowski (Poznan/PL)

15:10Discussion

VIP Lounge 1

16:00 - 17:30 SU-76

Incorporating Evidence-based Clinical PracticeGuidelines into the Care of our Patients

SymposiumEvidence-based Ophthalmology

Chairs:Richard L. Abbott (San Francisco/USA)Michèle Beaconsfield (London/UK)Klaus-Dieter Lemmen (Düsseldorf/D)

16:00 IL SU-76-01Incorporating evidence based clinical practiceguidelines into patient careRichard Wormald (London/UK)

16:15 IL SU-76-02Guideline development in the absence of evidenceMichèle Beaconsfield (London/UK)

16:30 IL SU-76-04Evidence Based Clinical Guidelines in StrabismusEmilio Carlo Campos (Bologna/I)

16:45 IL SU-76-05Diabetic Retinopathy: an international problemwith national clinical practice guidelinesKlaus-Dieter Lemmen (Düsseldorf/D)

17:00 IL SU-76-06Promoting and Implementing Clinical PracticeGuidelines in Developing Countries: What We havelearned from the China ExperienceRichard L. Abbott (San Francisco/USA)

17:15Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

104

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

VIP Lounge 2

08:30 - 12:00 SU-39

Workshop: Uveal Melanoma Genetic Testing

WorkshopOncology

Session 1: Uveal Melanoma Prognostic Testing

Chairs:Norbert Bornfeld (Essen/D)Jacob Pe'er (Jerusalem/IL)

08:30 IL SU-39-01IntroductionNorbert Bornfeld (Essen/D)

08:45 IL SU-39-02Prognosis Assessment by Genome Wide Profilingin Uveal MelanomaJerome Couturier (Paris/F)

09:00 IL SU-39-03MSA and MLPA for Genetic Testing of UvealMelanomaMichael Zeschnigk (Essen/D)

09:15 IL SU-39-04Follow-Up Study of 347 Patients with UvealMelanoma Tested by Microsatellite AnalysisStefanie Thomas (Essen/D)

09:30 IL SU-39-05Genetic Changes and Expression Profiling in UvealMelanoma: Markers of Patient SurvivalHanneke Mensink (Rotterdam/NL)

09:45 IL SU-39-06High PTP4A3 Phosphatase Expression Correlateswith Uveal Melanoma MetastasisSimon Saule (Paris/F)

Session 2: Taking Biopsy

Chairs:Michael Zeschnigk (Essen/D)Laurence Desjardins (Paris/F)

10:30 IL SU-39-07Serum MarkersJacob Pe'er (Jerusalem/IL)

10:45 IL SU-39-08To Biopsy or Not to BiopsyStefan Seregard (Stockholm/S)

11:00 IL SU-39-09Clinical Application of Genetic Studies onChoroidal MelanomaBertil D. Damato (Liverpool/UK)

11:15 IL SU-39-10Techniques for Harvesting Fresh Tumor Tissue forGenetic StudiesJerry Shields (Philadelphia/USA)

11:30 IL SU-39-11Fine Needle Aspiration Biopsy for Genetic Testingof Uveal Melanoma in 500 CasesCarol L. Shields (Philadelphia/USA)

VIP Lounge 2

14:00 - 15:30 SU-55

Pediatric Ophthalmology & Genetics 2

Free PaperPediatric Ophthalmology, Genetics

Chairs:Nadija F. Bobrova (Odessa/UA)Irene Gottlob (Leicester/UK)Marilyn Miller (Chicago/USA)

14:00 SL SU-55-01Pediatrics Ophthalmology – New ApproachesNadiya Bobrova (Odessa/UA)

14:09 FP SU-55-02Incidence of retinopathy of prematurity in Bahrain,2002-2008Ebtisam K. Al Alawi, Mohamed Shaker Omran (Isa Town/BRN)

14:16 FP SU-55-03Effect of Two Months Oral CDP-Choline on VisualFunction in Amblyopic Patients: Long-Term ResultsEmilio Carlo Campos, Michela Fresina (Bologna/I)

14:23 FP SU-55-04Infants implantation surgery specific featuresNadiya Bobrova, Oleksii Zhekov, Anna Dembovetskaya (Odessa/UA)

14:30 FP SU-55-05Systemic Exposure and Safety of Latanoprost0.005% in Infants with GlaucomaSusan Raber, Tomoko Maeda-Chubachi, Rachel Courtney, Brad Simons, Sharon Freedman,Barbara Wirostko (San Diego/USA)

14:37 FP SU-55-06Demyelinating optic neuritis in Asian children:clinical features and risk of multiple sclerosisYoon Jeon Kim, Joo Hyun Choi, Hyun Taek Lim(Seoul/ROK)

14:44 FP SU-55-07OCT charecteristics of the macula and optic disc inhigh myopic childrenMichal Szuminski, Alina Bakunowicz-Lazarczyk (Bialystok/PL)

Sunday, 6 June 2010

Sund

ay, 6

June

105

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:51 FP SU-55-08Earlier visual rehabilitation in pediatric cataracts –Role of cataract surgery with primary posteriorcapsulotomy with anterior vitrectomy primary IOLimplantationSeema Deshmukh, Vikas Mahatme (Nagpur/IND)

14:58 FP SU-55-09Prevention of oxygen induced retinopathy by highdoses of vitamin A in the newborn ratXanthi Couroucli, Yan-hong Wei, Weiwu Jiang, Bhagavatula Moorthy (Houston/USA)

15:05 FP SU-55-10Neonatal Dacryostenosis as a Risk Factor for AnisometropiaBrian Mohney, Joshua Piotrowski (Rochester/USA)

15:12Discussion

VIP Lounge 2

16:00 - 17:30 SU-38

New technology, Bioengineering, Nanotechnology 1

Free PaperNew Technology, Bioengineering

Chairs:Shigeru Kinoshita (Kyoto/J)Rudolf F. Guthoff (Rostock/D)Russell Andrews (Los Gatos/USA)

16:00 FP SU-38-01Image Quality of a Novel Navigated Retina Laser(NAVILAS®)Aljoscha Neubauer, Marcus Kernt, Christos Haritoglou, Michael Ulbig, Anselm Kampik, Igor Kozak, Stephen Oster, Katrin Hartmann, Jae Suk Kim, William R Freeman (Munich/D, San Diego/USA, La Jolla/USA)

16:07 FP SU-38-02Benefit of NAVILAS® Retina Navigation in Chal-lenging Retinal PathologiesAlexandra Hoeh, Thomas Ach, Mira Ruppenstein,Giovanni Staurenghi, Stefan Dithmar (Heidelberg/D, Milano/I)

16:14 FP SU-38-03Different ways to treat Presbiopia, including thenew PresbV (Vejarano Method)L. Felipe Vejarano (Popayán/CO)

16:21 FP SU-38-04Assessing the functionality and biocompatibilityof a wireless contact lens sensor for 24 hour-intraocular pressure monitoring in volunteers: preliminary results.Stefan De Smedt, Sylvain Roy, André Mermoud,Joseph Geinoz, Philippe Seira, Jeanette Lindell,Corinne Schnyder (Lausanne/CH)

16:28 FP SU-38-05Pupillometer-Based Objective Chromatic PerimetryPreliminary EvaluationYgal Rotenstreich, Andrew Kolker, ShlomoMelamed, Michael Belkin, Alon Skaat (Kfar Bilu/IL,Tel Hashomer/IL)

16:35 FP SU-38-06Gene Therapy to Modulate Apoptosis and PreventLoss of Corneal Endothelial CellsThomas Fuchsluger, Ula Jurkunas, Andrius Kazlauskas, Reza Dana (Essen/D, Boston/USA)

16:42 FP SU-38-07Photography of meibomian glands with scanninglaser ophthalmoscopeTakashi Sone, Kazufumi Kaneda, Atsushi Hirota, Hiroshi Nakamoto, Ryotaro Toda, Kaori Ideguchi,Yoshiaki Kiuchi (Hiroshima/J, Yamaguchi/J)

16:49 FP SU-38-08Surgical Media Centre, a scientific tool in Phacotraining programmeNavneet Toshniwal (Solapur/IND)

16:56 FP SU-38-09A new computer assisted technique to correct thepost-enucleation socket syndromeMartin Rücker, Harald Essig, Isabella Rücker, HorstKokemueller, Frank Tavassol, Nils-Claudius Gellrich(Hannover/D)

17:03 FP SU-38-10Reconstruction of conjunctival epithelium bytrans-differentiated human amniotic epithelialcellsJian Chen (Guangzhou/CN)

17:10Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

106

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 2

08:30 - 10:00 SU-57

Uveitis

SymposiumPathology

Chairs:Miguel Noel Burnier (Montreal/CDN)Narsing A. Rao (Los Angeles/USA)Leonard M. Holbach (Erlangen/D)

08:30 IL SU-57-01Role of pathology in diagnosis and managementof uveitisRubens Belfort Neto (São Paulo/BR)

08:40 IL SU-57-02Role of vitreous biopsy specimen in intraocular inflammationMiguel Noel Burnier (Montreal/CDN)

08:50 IL SU-57-03Role of extraocular tissue biopsy in uveitisKalpana Babu (Bangalore/IND)

09:00 IL SU-57-04Retina and choroidal biopsy in the diagnosis of recalcitrant uveitisHans E. Grossniklaus (Atlanta/USA)

09:10 IL SU-57-05Role of aqueous humor microscopic examinationin uveitisHiroshi Goto (Shinjuku-ku/J)

09:20 IL SU-57-06Iris biopsy in management of uveitisAnita S. Yee Chan (Los Angeles/USA)

09:30Discussion

Hall 2

10:30 - 12:00 SU-58

Rehabilitation in Primary Keratectasia (Keratoconus, Pellucid Marginal Degeneration)


Chairs:Joseph Colin (Bordeaux/F)Tobias Koller (Dietikon/CH)

10:30 IL SU-58-01Differentiation and Diagnostics in Different Formsof KeratectasiaJoseph Colin (Bordeaux/F)

10:45 IL SU-58-02Intrastromal RingsJonathan H. Talamo (Waltham/USA)

11:00 IL SU-58-03Corneal Crosslinking (CLX)Paolo Vinciguerra (Milano/I)

11:15 IL SU-58-04Lamellar KeratoplastyRudy Nuijts (Maastricht/NL)

11:30 IL SU-58-05Decision Tree for Management of KeratectasiaTheo Seiler (Zurich/CH)

11:45Discussion

Hall 2

14:00 - 15:30 SU-59

Post-LASIK Corneal Ectasia: Understanding andTreating


Chairs:J. Bradley Randleman (Atlanta/USA)Mohamed Alaa El Danasoury (Jeddah/SA)Farhad Hafezi (Fribourg/CH)

14:00 IL SU-59-01Ectasia: BiomechanicsWilliam J. Dupps Jr. (Cleveland/USA)

14:10 IL SU-59-02Ectasia: Diagnosis & ScreeningJ. Bradley Randleman (Atlanta/USA)

14:20 IL SU-59-03Advanced topographic/diagnostic indicesRenato Ambrósio Jr. (Rio de Janeiro/BR)

14:30 IL SU-59-04Ectasia treatment: CXL: CXL in iatrogenic keratec-tasia: long-term resultsFarhad Hafezi (Fribourg/CH)

14:40 IL SU-59-05Ectasia treatment: ICRSJorge L. Alió (Alicante/E)

Sunday, 6 June 2010

Sund

ay, 6

June

107

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:50 IL SU-59-06Ectasia Treatment: Corneal Transplantation: Intralase Enabled DALK with Big Bubble "iDALK" isthe best for advanced ectasia; 1 year resultsMohamed Alaa El Danasoury (Jeddah/SA)

15:00Discussion

Hall 2

16:00 - 17:30 SU-60

Is a Customized Ablation Profile the Best for Standard Refractive Correction?


Chairs:Scott McRae (Rochester/USA)Arthur C. Cheng (Hong Kong/CN)Michael Mrochen (Zurich/CH)

16:00 IL SU-60-01Clinical advantages and limitations of wavefrontsensingRonald R. Krueger (Cleveland/USA)

16:10 IL SU-60-02Optical aberrations and vision, which aberrationsmatter?Pablo Artal (Murcia/E)

16:20 IL SU-60-03Clinical outcomes with "standard/wavefront optimized" refractive treatmentsKarl G. Stonecipher (Greensboro/USA)

16:30 IL SU-60-04Topography based treatments indications and limitationsTheo Seiler (Zurich/CH)

16:40 IL SU-60-05Clinical outcomes wavefront guided treatmentswith different platformsStephen G. Slade (Houston/USA)

16:50 IL SU-60-06Ray tracing, the missing link between wavefrontand topography guided treatmentMichael Mrochen (Zurich/CH)

17:00Discussion


08:30 - 10:00 SU-40

Miscellaneous 1

Free PaperMiscellaneous

Chairs:Rubens Belfort (São Paulo/BR)Karl Golnik (Cincinatti/USA)Satoshi Kashii (Osaka/J)

08:30 FP SU-40-02New trainees in ophthalmology – their experiences and perspectives from the UKNishant Kumar, Robert Cheeseman (London/UK)

08:37 FP SU-40-03The Training of Para-ophthalmic Personnel – A Caribbean ExperienceMarilyn Watkins (Bridgetown/BDS)

08:44 FP SU-40-04Aspects of Educational Inclusion in Brazilian publicschools: Students’ Experience with Special NeedColleaguesM. Cristina de O. Regina (Campinas/BR)

08:51 FP SU-40-05Perioperative Anaesthetic Management in Ophthalmologic Surgery – Current changes inguidelines and clinical practiceJan-Peer Rogmann, Michael Goerig, Alwin E. Goetz(Hamburg/D)

08:58 FP SU-40-06Study the functional statement of the visual analyzer in patients with chronic vertebral-basilarinsufficiencyRamazanova Lyia (Moscow/RUS)

09:05 F SU-40-07First Demonstration of Fermentation and Putrefaction by Ambient Bacteria (TheodorSchwann 1837)Dieter Schmidt (Freiburg/D)

09:12Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

108

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e


10:30 - 12:00 SU-41


Free PaperPediatric Ophthalmology, Genetics

Chairs:Anton Gerinec (Bratislava/SK)Birgit Lorenz (Giessen/D)Huseyin Yetik (Istanbul/TR)

10:30 SL SU-41-01Retinopathy of prematurity (ROP): What we knowand what we should know about?Huseyin Yetik (Istanbul/TR)

10:39 FP SU-41-02Computer quantitative assessment of retinal vessel measures in predicting the outcome ofretinopathy of prematurityWai Ching Lam, Crystal Cheung, Ziad Nasser, Nasrin Tehrani (Toronto/CDN)

10:46 FP SU-41-03Predictive Value of Pre-plus Disease in Retinopathyof PrematurityDavid Wallace, Sharon Freedman, Mary ElizabethHartnett, Graham Quinn (Durham/USA)

10:53 FP SU-41-04Mutational Screening of the RB1 gene in ChinesePatients with RetinoblastomaBin Li (Beijing/CN)

11:00 FP SU-41-07Tumor necrosis factor alpha blockers in the therapy of uveitis in childhoodL. A. Katargina, Ekaterina Denisova, A. V. Starikova, N. V. Lubimova (Moscow/RUS)

11:07 FP SU-41-08To know the awareness amongst the children &their parents regarding the conditions causingchildhood blindness between age-group 0-18years.Vikas Mahatme (Nagpur/IND)

11:14 FP SU-41-09Results of late onset amblyopia therapy in excen-tric fixationGabriele Gusek-Schneider (Erlangen/D)

11:21 FP SU-41-10When good is not good enough – visual acuity, refractive error and visual quality in school childrenAlicja Krawczyk, Jacek P. Szaflik, Urszula Malinowska, Jerzy Szaflik (Warsaw/PL)

11:28 FP SU-41-11Photoleukocoria Study: Encouraging the Early Detection of Retinoblastoma and Childhood BlindnessAshwin Mallipatna, Helen Dimaras, Cynthia VandenHoven, Lindsay Hampejsková,Maria Pezzente, Brenda Gallie (Bangalore/IND,Toronto/CDN)

11:35Discussion


14:00 - 15:30 SU-42

Oculoplasty/Orbita/Lids/Lacrimal System 1

Free PaperOculoplasty, Orbita, Lids

Chairs:Amarildo Belshi (Tirana/AL)Luigi Colangelo (Chieti/I)Hans-Werner Meyer-Rüsenberg (Hagen/D)

14:00 SL SU-42-01Palpebral Reconstructive SurgeryAmarildo Belshi (Tirana/AL)

14:09 FP SU-42-02Combined Endoscopic and Transconjunctival Approach to the Orbital ApexGonzalo Blanco-Mateos, Jaime Santos-Pérez, Eduardo J. Duarte Silva, Marta Alonso Mesonero(Valladolid/E)

14:16 FP SU-42-03Divided nevus of the eyelids – a 10 year experiencewith 73 Chinese casesRenbing Jia (Shanghai/CN)

14:23 FP SU-42-04Eye'dentifying correctable impaired visual acuity and visual field loss in patients undergoingelective lower limb arthroplasty surgeryJaswant Sandhu, Kwok Yin Chan, Philip Roberts(Wolverhampton/UK)

14:30 FP SU-42-05Eyelid Malposition in Patients with Isolated Congenital and Childhood Acquired Facial PalsyAdel Alsuhaibani, Yasser Elfakey, Robert Goldberg(Riyadh/SA)

14:37 FP SU-42-06Dual delivery of VEGF and BMP2 enhances angiogenesis and bone regeneration in critical-sizeorbital wall defectsCaiwen Xiao, Xianqun Fan (Shanghai/CN)

Sunday, 6 June 2010

Sund

ay, 6

June

109

Scie

ntifi

c Pro

gram

Sch

edul

e

Sund

ay, 6

June

110110

Sunday, 6 June 2010

WOC® 2010

16:40 IL SU-43-06Choroidal MCTDavid Pelayes (Buenos Aires/RA)

16:48 IL SU-43-07BDUMPErnest Rand Simpson (Toronto/CDN)

16:56 IL SU-43-08Ciliary body massArun D. Singh (Cleveland/USA)

17:04 IL SU-43-09Cytogenetic analysis of choroidal melanoma afterradiotherapyWerner Wackernagel (Graz/A)

17:12Discussion


08:30 - 10:00 SU-79

Video Session 1: Cataract

Free Paper

Chairs:Horst Helbig (Regensburg/D)Peter Wagner (Ulm/D)

08:30 VF SU-79-01Automated Foot-controlled Lens InsertionJohn Smiles (Canberra/AUS)

08:40 VF SU-79-02Complicated IOL insertions: just when you thoughtyour surgery went smoothly...Naira Pereyra-Munoz, Jaun Manuel Paulin-Huerta,Jaime Zapata, Eduardo Chavez-Mondragon (Mexico City/MEX)

08:50 VF SU-79-03Implantation technique for the Toric ArtiflexCamille Budo (Sint-Truiden/B)

09:00 VF SU-79-04In-Situ Phaco a newer concept is a preferred choice in difficult situationsNavneet Toshniwal (Solapur/IND)

09:10 VF SU-79-05Rock 'n Roll phacoemulsificationDetlef Uthoff (Kiel/D)

14:44 FP SU-42-07Evaluation of an Integrated Orbital Tissue Expander in Congenital Anophthalmos: Report ofPreliminary Clinical ExperienceDavid Tse, Mohammad Hafez, Marcia Orozco, Len Pinchuk (Miami/USA)

14:51 FP SU-42-08Endonasal dacryocystorhinostomy in children lessthan 2 years of ageAngelo Tsirbas (Bondi Junction/AUS)

14:58 FP SU-42-09Nitrogen-containing bisphosphonates: an attractive alternative to surgery in periobital fibrous dysplasiaR. J. W. de Keizer (Leiden/NL)

15:05 FP SU-42-10Palpebral lipogranuloma caused by transcanalicu-lar ointment injection after laser canaliculoplastyXianqun Fan, Yefei Wang, Xiaoping Bi(Shanghai/CN)

15:12Discussion


16:00 - 17:30 SU-43

PAAO Symposium: Challenging Cases – Clinico-Pathologic Correlation

Symposium Pathology

Chairs:Arun D. Singh (Cleveland/USA)

16:00 IL SU-43-01Angiogenesis in Uveal MelnomaNikolaos E. Bechrakis (Innsbruck/A)

16:08 IL SU-43-02Choroidal massNorbert Bornfeld (Essen/D)

16:16 IL SU-43-03Choroidal OsteomaMichael H. Foerster (Berlin/D)

16:24 IL SU-43-04Corneal tumorHans E. Grossniklaus (Atlanta/USA)

16:32 IL SU-43-05The course of a metastasizing conjunctivalmelanom followed over a period of 15 yearsPeter Karl Lommatzsch (Leipzig/D)

Sunday, 6 June 2010

WOC® 2010


14:00 - 15:30 SU-45

Video Session 3: Presentation of Video Awards

Free Paper

Chairs:Johann Roider (Kiel/D)H. Burkhard Dick (Bochum/D)Thomas Klink (Würzburg/D)

14:00 VF SU-45-01Blind Date: Reencountering Ophthalmology ExcellanceVictor Cvintal, Jose Ricardo C. L. Rehder, Paulo C. Sampaio (Sao Paulo/BR)

14:10 VF SU-45-02Adjuvant use of a novel releasable suture Technique in 20-G Trocar vitrectomy for preventionof imcompetent wound closureByung Ro Lee, Yumi Song, Young Hee Yoon(Seoul/ROK)

14:20 VF SU-45-03Ipsilateral autologous rotating lamellar keratoplasty with femtosecondlaserHans-Jürgen Buchwald, Sebastian Kupferschmid,Gerhard K. Lang (Ulm/D)

14:30 VF SU-45-04Microincisional surgery of subluxed lenses withthe modified capsular tension ringBoris Malyugin (Moscow/RUS)

14:40 VF SU-45-05Pediatric Cataract SurprisesTanja M. Rabsilber, Mike P. Holzer, Maria J. Sanchez,Dragana Vucic, Gerd U. Auffarth (Heidelberg/D, Knjazevac/SRB)

14:50 VF SU-45-06Treatment of complex ocular trauma with 25/23gauge systemsCesare Forlini, Paolo Rossini (Ravenna/I)

15:00 VF SU-45-07Glued IOL ReloadedAmar Agarwal (Chennai/IND)

15:10Video Award of the DOG,donated by Carl Zeiss Meditec AG (Munich/D)

09:20 VF SU-79-06The MultiKeratome for Cataract Surgery – Curvedwith Multiple Points – Engineered to Seal Betterand to Minimize the Induced AstigmatismTom Schossau, Matthew Giegengack, Shree K. Kurup, Gerald W. Zaidman (Scarsdale/USA)

09:30 VF SU-79-07Cataract surgery 30 years after excision of a melanotic iris tumorPeter Wagner, Ingo Conzelmann, Gerhard K. Lang(Ulm/D)


10:30 - 12:00 SU-80

Video Session 2: Miscellaneous 1

Free Paper

Chairs:Wolfgang F. Schrader (Nürnberg/D)Mike P. Holzer (Heidelberg/D)

10:30 VF SU-80-01Outcome of hole and chop technique phacoemul-cification on hard cataractsKeembiyage Dayawansa (Kandy/CL)

10:40 VF SU-80-02Orientation of toric IOL (TIOL) – The evolution from Screen Transparencies (STACY) to standardized limbal and axis tracking (Z-ALIGN)Detlev Breyer (Düsseldorf/D)

10:50 VF SU-80-03Corneoplastique: ART of Vision SurgeryArun Gulani (Jacksonville/USA)

11:00 VF SU-80-04Microendoscopic lacrimal duct surgeryStefan Clemens, Frank Tost, Martin Küstner (Greifswald/D)

11:10 VF SU-80-05CO2 Laser Surgery for OphthalmologyNobuyuki Miyata, Eiichi Okada (Yokohama/J)

11:20 VF SU-80-06Overcoming pediatric challengesManish Mahendra (Kanpur/IND)

11:30 VF SU-80-07Hynrid Technique using conventional illuminatedInfusion Cannula in any Gauge Trocar VitrectomyByung Ro Lee, Yumi Song, Yong Woon Shin(Seoul/ROK)

Scie

ntifi

c Pro

gram

Sch

edul

e

Sund

ay, 6

June

111

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e


16:00 - 17:30 SU-81

Video Session 4: Miscellaneous 2

Free Paper

Chairs:Hans-Jürgen Buchwald (Ulm/D)Klaus-Peter Steuhl (Essen/D)

16:00 VF SU-81-01Parachute KeratoplastyWesley Herman, Oren N. Fass (Dallas/USA)

16:10 VF SU-81-02Ahmed Glaucoma Valve-Prime,Implant andReprimeDipanjan Pal, Alokesh Ganguly (Kolkata/IND)

16:20 VF SU-81-03Superficial Lateral Canthopexy to Correct LateralCanthal Tendon DisinsertionErin Shriver, David Tse (Palm Beach Gardens/USA,Miami/USA)

16:30 VF SU-81-04Surgical approach in acute retinal necrosisIlian Shandurkov, Petja Vassileva, TatyanaHergeldzhieva, Daniela Paskaleva (Sofia/BG)

16:40 VF SU-81-05Diagnostic image-guide for indentification of earlyacute retinal necrosisByung Ro Lee, Yong Woon Shin (Seoul/ROK)

16:50 VF SU-81-06Half day for eye screening – cures blindness inmanyRekha Khandelwal, Shashank Bidaye, D. Kose, Mohana Majumdar, Shivani Bidaye (Nagpur/IND)

17:00 VF SU-81-07Jesus and the Eye: New Testament Miracles of VisionAhmad Mansour, Ahmad Nasri, Rami Santini, Majd Akar (Beirut/RL)

Hall 3

08:30 - 10:00 SU-48

Retinal Detachment and PVR


Chairs:George William Aylward (London/UK)Alain Gaudric (Paris/F)

08:30 IL SU-48-01Surgical instrumentation for RD and PVR repair(20, 23, 25 g etc.)Constantin J. Pournaras (Geneva/CH)

08:40 IL SU-48-02Which new drugs can treat PVR?Louisa Wickham (London/UK)

08:50 IL SU-48-03Is there still place for scleral buckling in primarysurgery for RD?Heinrich Heimann (Liverpool/UK)

09:00 IL SU-48-04Management after failure of primary RD-repairPeriklis Brazitikos (Athens/GR)

09:10 IL SU-48-05Prevention of RD: are there cases in which it isworthwhileFred Hendrikse (Maastricht/NL)

09:20 IL SU-48-06Management of second eye in vitreoretinal dystrophiesAntonio Capone (Oakland/USA)

09:30 IL SU-48-07Trauma and vitreoretinal surgery – timing andmanagementMasahito Ohji (Otsu/J)

09:40 IL SU-48-08Intraocular tamponade – what’s newDavid Wong (Pok Fu Lam/HK)


Sunday, 6 June 2010

Sund

ay, 6

June

112

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 3

10:30 - 12:00 SU-49

Vitreoretinal Interface – Epiretinal Macular Surgery


Chairs:Alain Gaudric (Paris/F)Michael T. Trese (Royal Oak/USA)

10:30 IL SU-49-01Pathology of the vitreoretinal interface: Implications for surgeryArnd Gandorfer (Munich/D)

10:40 IL SU-49-02Microplasmin to treat vitreomacular traction: results of a phase III clinical trial (MIVI-006)Matthew S. Benz (Houston/USA)

10:50 IL SU-49-03Progress in epiretinal surgery: vital stainsChristos Haritoglou (Munich)

11:00 IL SU-49-04Macular hole surgery: is face -down positioningstill necessary?D. Alistair H. Laidlaw (London/UK)

11:10 IL SU-49-05Macular hole surgery: is ILM peeling always useful?Ramin Tadayoni (Paris/F)

11:20 IL SU-49-06ERM and VMTS surgery: cases which failThomas J. Wolfensberger (Lausanne/CH)

11:30 IL SU-49-07Vitreoretinal interface in AMDSusanne Binder (Vienna/A)

11:40 IL SU-49-08Vitreoretinal Interface in children – therapeuticimplicationsMichael T. Trese (Royal Oak/USA)


Hall 3

14:00 - 15:30 SU-50

Retinal Vascular Diseases: Diabetic Retinopathy /Vein Occlusions


Chairs:Michael T. Trese (Royal Oak/USA)Anselm Kampik (Munich/D)

14:00 IL SU-50-01Retinal oximetry in diabetic retinopathy and retinal vein occlusionsEinar Stefánsson (Reykjavik/IS)

14:10 IL SU-50-02Steroids vs laser in DMEPascale Massin (Paris/F)

14:20 IL SU-50-03Anti VEGFs vs Steroids in DMEJulia A. Haller (Philadelphia/USA)

14:30 IL SU-50-04Slow release steroids in DMEFrank G. Holz (Bonn/D)

14:40 IL SU-50-05Combination of pharmacology and VR surgery inDRJ. Fernando Arevalo (Caracas/Y)

14:50 IL SU-50-06Does early intravitreal drug therapy change thecourse of BRVO and CVROFrancesco Bandello (Milano/I)

15:00 IL SU-50-07Is surgery useful in BRVO and CRVOJosé García Arumí (Barcelona/E)



Sunday, 6 June 2010

Sund

ay, 6

June

113

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 3

16:00 - 17:30 SU-51

AMD


Chairs:Anselm Kampik (Munich/D)George William Aylward (London/UK)

16:00 IL SU-51-01When to stop anti VEGF therapy?Adnan Tufail (London/UK)

16:10 IL SU-51-02Update on Clinical Trials of Intravitreal Drugs forNeovascular AMDAlexander J. Brucker (Philadelphia/USA)

16:20 IL SU-51-03Geographic atrophy: Imaging Metrics and Progres-sion DeterminantsFrank G. Holz (Bonn/D)

16:30 IL SU-51-04Future drugs for treatment of dry AMDSalvatore Grisanti (Lübeck/D)

16:40 IL SU-51-05Genetics and prevention of AMDHendrik Peter Nicolas Scholl (Bonn/D)

16:50 IL SU-51-06Is there a place for surgery in AMD?Jan van Meurs (Rotterdam/NL)

17:00 IL SU-51-07Cell therapy for AMDTBA

17:10 IL SU-51-08How to prevent endophthalmitis in intravitrealtherapy?Thierry C. Verstraeten (Pittsburgh/USA)


Hall 6

08:30 - 10:00 SU-52

AAPOS Symposium: Emerging Concepts in Amblyopia and Strabismus – 2010: Recognizing Gunter K. von Noorden, MD

SymposiumStrabismus

Chairs:Michael X. Repka (Baltimore/USA)Monte A. Del Monte (Ann Arbor/USA)Mohamad Jaafar (Washington/USA)

08:30 IL SU-52-01Treatment of bilateral superior oblique palsyDerek Sprunger (Indianapolis/USA)

08:40 IL SU-52-02Brown Syndrome: When and How to InterveneMohamad Jaafar (Washington/USA)

08:50 IL SU-52-03The Goal of Treatment in "Organic Amblyopia"Robert LaRoche (Halifax/CDN)

09:00 IL SU-52-04Lessons Learned in Strabismus Diagnosis fromTelemedicineEugene Helvestone (Indianapolis/USA)

09:10 IL SU-52-05Atropine Treatment for Severe AmblyopiaMichael X. Repka (Baltimore/USA)

09:20 IL SU-52-06TBDJan-Tjeerd de Faber (Rotterdam/NL)

09:30 IL SU-52-07Strabismus in patients with posterior fossa tumorsJane C. Edmond (Houston/USA)

09:40Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

114

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 6

10:30 - 11:15 SU-53

Journal Publications, As a Mean to Evaluate Scientists: He/She Publishes in Good Journals

SymposiumWorld Forum of Journal Editors

Chairs:Martine J. Jager (Leiden/NL)Gerhard K. Lang (Ulm/D)

10:30 IL SU-53-01Journal independent evaluation of scientists and faculties by citation countsHolger Schwechheimer (Bielefeld/D)

10:40 IL SU-53-02The Better Way to Evaluate Researchers Martine J. Jager (Leiden/NL)

10:50 IL SU-53-03Is there a future to Non-English scientific journals?Gerhard K. Lang (Ulm/D)

11:00Discussion

Hall 6

11:15 - 12:00 SU-54

Reviewers, Contents Language


Chairs:Martine J. Jager (Leiden/NL)Einar Stefánsson (Reykjavik/IS)Gerhard K. Lang (Ulm/D)

11:15 IL SU-54-01How to find suitable reviewersMartijn J. Schuemie (Rotterdam/NL)

11:25 IL SU-54-02Is the presentation of a theory sufficient to justifypublication?Einar Stefánsson (Reykjavik/IS)

11:35 IL SU-54-03Current situation and prospects of Chinese ophthalmological journals’ internationalizationXiu-Wen Hu (Xi´an/CN)

11:45Discussion

Hall 6

14:00 - 15:30 SU-78

Posterior Lamellar Keratoplasty


Chairs:Francis W. Price (Indianapolis/USA)Claus Cursiefen (Erlangen/D)Thomas Reinhard (Freiburg/D)

14:00 IL SU-78 -01Long-term results of DSEK/DSAEK in over 1300 cases: endothelial cell counts, incidence of rejection, visual acuity, glaucomaFrancis W. Price (Indianapolis/USA)

14:10 IL SU-78 -02DSAEK in Asian Eyes: The Singapore PerspectiveDonald T. H. Tan (Singapore/SGP)

14:20 IL SU-78 -03Femtosecond laser-assisted DSAEKPhilip Maier (Freiburg/D)

14:30 IL SU-78 -04Is DMEK the preferred method of PLK? How can corneal surgeons begin doing this?Gerrit R. J. Melles (Rotterdam/NL)

14:40 IL SU-78 -05Advances in EK techniquesMassimo Busin (Forli/I)

14:50 IL SU-78 -06Results of his hybrid DSEK/DMEK techniquePavel Studeny (Sokolov/CZ)

15:00 IL SU-78 -07The German DMEK ExperienceFriedrich E. Kruse (Erlangen/D)

15:10 IL SU-78 -08Scuba Technique for DMEK: Results and PearlsArt Giebel (Chehalis/USA)

15:20 IL SU-78 -09Cultivated Endothelial Cell Transplantation: The Future?Shigeru Kinoshita (Kyoto/J)

Sunday, 6 June 2010

Sund

ay, 6

June

115

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 6

16:00 - 17:30 SU-56

Anatomy/Pathology

Free PaperAnatomy/Pathology

Chairs:Gottfried O. H. Naumann (Erlangen/D)Gerhard K. Lang (Ulm/D)Hans Eberhard Völcker (Heidelberg/D)

16:00 FP SU-56-01Diagnosis and differential diagnosis of orbitalspindle cell tumoursYongping Li (Guangzhou/CN)

16:07 FP SU-56-02Applied anatomy of endoscopic transnasallacrimal duct reconstruction with grafting of autogenous tissueHai Tao (Beijing/CN)

16:14 FP SU-56-03Analysis of p53 mutations and the expression ofp53 and p21WAF1/CIP1 protein in sebaceous carci-noma of the eyelidKunihiro Kiyosaki, Chisato Nakada, MasamotoImaizumi, Masatsugu Moriyama, Toshiaki Kubota(Yufu/J)

16:21 FP SU-56-04Alterations of the cornea and retina in a mousemodel of Niemann-Pick disease type C1Marine Hovakimyan, Oliver Stachs, Mariya Reichard,Arndt Rolfs, Jan Lukas, Moriz Frech, Rudolf Guthoff,Martin Witt, Andreas Wree (Rostock/D)

16:28 FP SU-56-05Clinical and pathologic studies on nanophthalmoscomplicated with uveal effusionJing Tao, Naiqing Weng, Ningli Wang, Bowen Zhao,Qian Liu (Beijing/CN)

16:35 SL SU-56-06Value of ocular pathology in clinical practiceGerhard K. Lang (Ulm/D)

16:44 FP SU-56-07IntroductionGottfried Naumann (Erlangen/D)

16:49 FP SU-56-08Ophthalmic Pathology AwardUrsula Schlötzer-Schrehardt (Erlangen/D)

Hall 7

08:30 - 10:00 SU-34

Oncology 1

Free PaperOncology

Chairs:Nikolaos E. Bechrakis (Innsbruck /A)Tero Kivelä (Helsinki/FIN)Steffen Heegaard (Copenhagen/DK)

08:30 SL SU-34-01Ophthalmic Oncology and PathologySteffen Heegaard (Copenhagen/DK)

08:39 SL SU-34-02Hemodynamic modifications of the choroid andthe retina in ocular oncologyLeonidas Zografos, A. Schalenbourg, L. Chamot(Lausanne/CH)

08:48 FP SU-34-03The role of transpupillary thermotherapy in treatment of residual and recurrent choroidalmelanomasSvetlana V. Saakyan, Vladimir V. Valsky, Ekaterina A. Semenova (Moscow/RUS)

08:55 FP SU-34-04SD OCT and Auto-Fluorescence Features of Indeterminate Choroidal Melanocytic LesionsArun Singh, Rubens Belfort, Kaori Sayanagi, Peter Kaiser (Cleveland/USA, São Paulo/BR)

09:02 FP SU-34-05Changing concepts regarding management of or-bital extension of uveal melanomaJerry Shields, Carol Shields, Ralph C. Eagle (Philadelphia/USA)

09:09 FP SU-34-06Receiver Operating Characteristic (ROC) Curve forthe Marker “Melanoma inhibitory activity” (MIA)in Patients with Metastatic Uveal MelanomaAnnemarie Klingenstein, Ingrid Haritoglou, Markus Schaumberger, Martin Nentwich, Hein Rüdiger, Ulrich Christoph Schaller (Munich/D)

09:16 FP SU-34-07Choroidal Melanocytic Clusters: A Distinct ClinicalEntity?James J. Augsburger, Zelia M. Corrêa, Camila C. Simões (Cincinnati/USA)

09:23 FP SU-34-08Imaging of anterior segment tumoursLubna Razzaq, Marina Marinkovic, G. Luyten, J. C. Bleeker, R. J. W. de Keizer (Leiden/NL)

Sunday, 6 June 2010

Sund

ay, 6

June

116

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

09:30 FP SU-34-09Metastasis of iris, ciliary body, and choroidalmelanoma in 8033 patientsCarol Shields, Minoru Furuta, Archana Thangappan,Saya Nagori, Rishita Nutheti, Arman Mashayekhi,Jerry Shields (Philadelphia/USA)

09:37 FP SU-34-10Role of episcleral brachytherapy as adjuvant therapy in conjunctival tumorsAlejandro Portero-Benito, Carmen Valverde-Collar,Ester Carreño, Maria Antonia Saornil, Ciro Garcia-Alvarez, Jesus M. Frutos, Patricia Diez-Andino, Francisco J Lopez-Lara (Valladolid/E)

09:44 FP SU-34-11Clinical profile of epithelial conjunctival tumors atan ocular oncology unitEster Carreño, Alejandro Portero-Benito, FernandoSánchez-Mannarelli, María Antonia Saornil, MaríaFe Muñoz, Ciro García-Álvarez (Valladolid/E)

09:51Discussion

Hall 7

10:30 - 12:00 SU-35

Cornea/External Disease: Surgical therapy 1


Chairs:Stefano Barabino (Genova/I)Chris Patrick Lohmann (Munich/D)

10:30 FP SU-35-01Crosslinking and Topography-guided Surface Ablation for Keratoconus-121 EyesTassos Georgiou, Pavlos Greveniotis, Soula Michael,Panayiotis Neophytou (Nicosia/CY)

10:37 FP SU-35-02Effect of an irregular anterior surface on a lamellarfemtosecond laser cutRobert Fintelmann, Michele Bloomer, Bennie Jeng(San Francisco/USA)

10:44 FP SU-35-03Cross-Linking for Progressive Keratoconus in PediatricsAldo Caporossi, Cosimo Mazzotta, Stefano Baiocchi,Rosario Denaro (Siena/I)

10:51 FP SU-35-04Keratoprosthesis. 40-year experience of study andapplication in the Filatov Institute (analysis of1000 operations)Stanislav Iakymenko (Odessa/UA)

10:58 FP SU-35-05Descemet’s Membrane Endothelial Keratoplasty(DMEK): safety and outcomesAruna Dharmasena (Manchster/UK)

11:05 FP SU-35-06New method of destructive corneal diseases treat-ment by using cellular technologyDaria Danilova, Ekaterina Chentsova, Irina Saburina, Irina Maklakova (Moscow/RUS)

11:12 FP SU-35-07Corneal aberrometric and refractive performanceof 2 intrastromal corneal ring segment models inearly and moderate ectatic diseaseDavid Pablo Piñero Llorens, Jorge Alió (Alicante/E)

11:19 FP SU-35-08Corneal Intrastromal Implantation Surgery (CISIS)vs. Keratoplasty for the treatment of KeratokonusAlbert Daxer (Ybbs/A)

11:26 FP SU-35-09Effectiveness of Triple Procedure in Severe Bacter-ial KeratitisShamurad Amansakhatov, Maya Zhutdieva(Seyidi/TUR)

11:33 FP SU-35-10Cultured oral epithelium in treatment of limbalstem cell deficiency in aniridiaDariusz Dobrowolski, Edward Wylegala (Sos-nowiec/PL, Katowice/PL)

11:40 FP SU-35-11Quadruple-procedure for Correction of CongenitalAniridia with Cataract and Corneal ScarringAlexey Dashevsky, Konstantin Kotliar (Munich/D)

11:47Discussion

Hall 7

14:00 - 15:30 SU-36



Chairs:Joseph Colin (Bordeaux/F)Béatrice Cochener (Brest/F)Stephen G. Slade (Houston/USA)

14:00 SL SU-36-01Keys for Successful phakic IOLs implantationBéatrice Cochener, Pierre Marie Josselin, Mathieu Lamard (Brest/F)

Sunday, 6 June 2010

Sund

ay, 6

June

117

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:09 FP SU-36-02Corneal stromal ablation by femtosecond UVpulses: in vivo studyEgle Danieliene, Romualdas Danielius, Egle Gabryte, Osvaldas Ruksenas, Agne Vaiceliunaite, Mikas Vengris (Vilnius/LT)

14:16 FP SU-36-03Results of All-in-One Femtosecond Laser Surgeryfor correction of myopia and myopic astigmatismRupal Shah (Vadodara/IND)

14:23 FP SU-36-04The functional results of the Sub-Bowmen Femto-keratomileusis (SBFK) & Tissue Saving Ablation (TSA)Alexander Doga, Galina Kachalina, Nataliya Maychuk (Moscow/RUS)

14:30 FP SU-36-05Comparison of postoperative pain, reepithelializa-tion speed and early visual and refractive out-comes between PRK with mechanical epithelialremoval and integrated transepithelial custom ablation in treatment of low to moderate myopiaXiangjun Chen (Oslo/N)

14:37 FP SU-36-06Tunnel Keratoplasty with Different IntracornealImplants in Myopia and Myopic Astigmatism Correction, 20-Year-Old ExperienceYuriy Shusterov (Karaganda/KZ)

14:44 FP SU-36-07Theoretical relationship between surgical parameters and refractive correction of conductive keratoplastyXiaobing Wang (Beijing/CN)

14:51 FP SU-36-08Use of an Image-Guided Femtosecond Laser in Cataract Surgery with Accommodating or Multi-Focal IOLStephen Slade (Houston/USA)

14:58 FP SU-36-09Position-depending pseudo-accommodation ofretropupillary fixed iris claw lensesKilian Schöpfer, Alexandra Berger, Bernhard M. Stoffelns, Walter Sekundo (Mainz/D,Marburg/D)

15:05 FP SU-36-10Effects of Pterygium on Ocular AberrationsSiamak Zarei-Ghanavati, Mohammad Zare, Mohammad-Reza Ansari-Astaneh, Alireza Baradaran-Rafiee, Bahram Einolahi (Mashhad/IR)

15:12Discussion

Hall 7

16:00 - 17:30 SU-37

External Disease, Dry Eye


Chairs:Juha M. Holopainen (Helsinki/FIN)Janos Németh (Budapest/H)Zbigniew Zagórski (Lublin/PL)

16:00 SL SU-37-01Molecular pathogenesis of dry eyeJuha Holopainen (Helsinki/FIN)

16:09 SL SU-37-02New diagnostic methods in dry eyeJanos Németh (Budapest/H)

16:18 FP SU-37-03Results of phase 1 tolerability study of LX214 (0.2% Voclosporin topical solution) in healthy volunteers and subjects with KeratoconjunctivitisSicca (KCS)Thomas Reinhard, Daniel Böhringer, Sid Weiss, Eddy Anglade (Freiburg/D, Jersey City/USA)

16:25 FP SU-37-04Biomarkers for Dry Eye Tested in Two Patient PopulationsRoger Beuerman, Choi Mun Chan, Lei Zhou, Louis Tong, Michael Stern, Xiaor Li, Shao Zhao (Sin-gapore/SGP)

16:32 FP SU-37-05Assessment of Dry Eye Treatment EffectivenessUsing the TearLab Osmolarity SystemTimothy Albert, Marco Nardi, Chiara Posarelli, Umberto Benelli (Pisa/I)

16:39 FP SU-37-06Immune Response in Conjunctival Epithelium ofDry Eye PatientsStefano Barabino (San Remo/I)

16:46 FP SU-37-07Permanent punctal occlusion for severe dry eyesyndrome – a new approachChedly Bouzouaya, Peter Raus (Tunis/TN, Mol/B)

16:53 FP SU-37-08Liposomes spray versus non preserved tears substitutes in patients with meibomian gland dysfunctionMaria Elena Langman, Nathalie Amouroux-Gicquel,Jean-Jacques Gicquel (Poitiers/F)

Sunday, 6 June 2010

Sund

ay, 6

June

118

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

17:00 FP SU-37-09Role of Ultrasound Bio-Microscopy (UBM) in the diagnosis of subconjunctival cysticercosisBipasha Mukherjee (Chennai/IND)

17:07Discussion

Hall 8

10:30 - 12:00 SU-61

Strabismus

Free PaperStrabismus

Chairs:Günther Rudolph (Munich/D)Oliver Zeitz (Berlin/D)Andrea Zin (Rio de Janeiro/BR)

10:30 FP SU-61-01Multifocal VEP, Bifoveal Fusion and Stereopsis inChildren with EsotropiaWei Zhang (Tianjin/CN)

10:37 FP SU-61-02Comparisons of cryo therapy and laser therapywith simple follow-up in globe perforation meanwhile strabismus surgery in an animal modelAbbas Bagheri (Teheran/IR)

10:44 FP SU-61-03CFEOM – Congenital fibrosis of the extraocularmuscles. Clinical phenotypes and molecular mechanisms.Günther Rudolph, Alfons Meindl, Michael Nentwich, Heide Hellebrand (Munich/D)

10:51 FP SU-61-04Analysis of patients with congenital fibrosis of the extraocular muscles: clinical, tomographic andgenetic findings.Naira Pereyra-Munoz, Claudia Murillo-Correa, Sanjuanita Flores-Limas, Juan Carlos Zenteno Ruiz(Mexico City/MEX)

10:58 FP SU-61-05Ultrarapid School Vision Screening Using theBrückner testMihir Kothari (Mumbai/IND)

11:05 FP SU-61-06Inverse occlusion a therapy option bei eccentricfixation – 20 years follow-upSamad Abri, E. Windischbauer, E. Kramar, T. K. Keindl,B. Neudorfer, Siegfried Priglinger (Salzburg/A,Linz/A)

11:12 FP SU-61-07Superior Oblique Palsy – A Review of 817 CasesZe Wang (Nanjing/CN)

11:19 FP SU-61-08Treatment of potentially amblyopia inducing earlychildhood eyelid hemangioma with systemicpropanololRike Michels, Kathrin Schaeffer, Veit Sturm, MarcelMenke, Klara Landau, Clemens Schiestl (Zurich/CH)

11:26 FP SU-61-09Diplopia after orbital floor fracture: Look for thecausative muscle away from the floor in somecasesAkmal Rizk (Cairo/ET)

11:33 FP SU-61-10Triamcinolone acetonide loaded PLGA nanoparti-cles pharmacokinetics characterization and application in actue extraocular muscle injuryHong Yan, Lihua Sun (Xi'an/CN)

11:40Discussion

Hall 9

08:30 - 10:00 SU-62

Teleophthalmology

Free PaperTeleophthalmology

Chairs:Georg Michelson (Erlangen/D)Norbert Franz Schrage (Cologne/D)

08:30 FP SU-62-01Automated Estimation of Image-Level Vessel Tortuosity in Retinal ImagesAlfredo Ruggeri, Giovanni Ughi, Enrico Grisan,Tunde Peto (Padua/I, London/UK)

08:37 FP SU-62-02Telemedicine diabetic retinopathy assessment inthe US: Impediments to wide-scale adoptionIngrid E. Zimmer-Galler, Ran Zeimer (Frederick/USA)

08:44 FP SU-62-03Tele-ophthalmology as a screening tool for Diabetic retinopathy in a rural populationRodney John Morris, Narendran Venkatapathy(Coimbatore/IND, Tamilnadu/IND)

Sunday, 6 June 2010

Sund

ay, 6

June

119

120

Sunday, 6 June 2010

10:50 IL SU-63-03Definition and Classification of MGDGary Foulks (Louisville/USA)

11:00 IL SU-63-04Epidemiology of, and Associated Risk Factors for,MGDDavid Sullivan (Boston/USA)

11:10 IL SU-63-05Evaluation, Diagnosis and Grading of Severity ofMGDAnthony Bron (Oxford/UK)

11:20 IL SU-63-06Design and Conduct of Clinical TrialsKerstin Wickstrom (Uppsala/S)

11:30 IL SU-63-07Management and Therapy of MGDGerd Geerling (Würzburg/D)

11:40Discussion

Hall 9

14:00 - 15:30 SU-64

Beyond Vertical Programs: Challenges and Successin Building in Comprehensive Eye Care Within aHealth Care System


Chairs:Rubens Belfort, Jr. (São Paulo/BR)Petja Ivanova Vassileva (Sofia/BG)Robert P. Finger (Bonn/D)

14:00 IL SU-64-01Eye care services in the Republic of KosovoGazmend Kaçaniku (Prishtina/KS)

14:10 IL SU-64-02WetLab educational system for ophthalmic microsurgery – the Russian experienceBoris Malyugin (Moscow/RUS)

14:20 IL SU-64-03Providing comprehensive eye care within underfinanced health care systemTatyana G. Hergeldzhieva-Fileva (Sofia/BG)

14:30 IL SU-64-04TBAPaulo Henrique Morales (São Paulo/BR)

14:40 IL SU-64-05The Cuban Eye Care Program as innovative publicmodel of health systemMarcelino Rio Torres (Ciudad Habana/C)

08:51 FP SU-62-04Automated Image Analysis and Disease Stratification in RISANet: a Web-Based Telemedi-cine Network in the Southern United StatesThomas Karnowski, Kenneth Tobin, Luca Giancardo,Yaqin Li, Seema Garg, Michael Abramoff, Matthew Tennant, Karen Fox, Edward Chaum (Oak Ridge/USA)

08:58 FP SU-62-07Comparing the accuracy of a RETCAM Trained Technician versus a Pediatric Ophthalmologist-in-training in diagnosing Retinopathy of Prematurity(ROP) using wide-field digital imagingMayuri Bhargava, Anand Vinekar, Ravindra Battu, P. Devika, Bhujang Shetty, Siva Kumar(Bangalore/IND)

09:05 SL SU-62-08First clinical application of the ACTO online visualevaluationNorbert Schrage, B. Seeliger, F. Simsonsen (Köln/D)

09:14 FP SU-62-09Telemedicine in ophthalmic practice – our experience with Cyber-Sight®Nikolay Surchev, Petja Vassileva, TatyanaHergeldzhieva-Fileva, Yordanka Kirilova, Ilian Shandurkov (Sofia/BG)

09:21Discussion

Hall 9

10:30 - 12:00 SU-63

Tear Film & Ocular Surface Society Symposium: A Report from the International Workshop on Meibomian Gland Dysfunction


Chairs:David Sullivan (Boston/USA)Anthony Bron (Oxford/UK)Gary Foulks (Louisville/USA)

10:30 IL SU-63-01Anatomy, Physiology and Pathophysiology of theMeibomian GlandErich Knop (Berlin/D)

10:40 IL SU-63-02Tear Film Lipids, and Lipid-Protein Interactions, inHealth and DiseaseFriedrich Paulsen (Halle/D)

WOC® 2010Su

nday

, 6 Ju

ne

Scie

ntifi

c Pro

gram

Sch

edul

e

Sunday, 6 June 2010

Hall 10

10:30 - 12:00 SU-67

ISOO Symposium: Ocular Lymphoma

SymposiumOncology

Chairs:Jacob Pe'er (Jerusalem/IL)Sarah E. Coupland (Liverpool/UK)Geeta Vemuganti (Hyderabad/IND)

10:30 IL SU-67-01Overview on ocular adnexal lymphomaLene Dissing Sjo (Copenhagen/DK)

10:40 IL SU-67-02Update on ocular adnexal MALT lymphomaEstelle Chanudet (Cambridge/UK)

10:50 IL SU-67-03Unusual Ocular Andexal LymphomasGeeta Vemuganti (Hyderabad/IND)

11:00 IL SU-67-04TNM staging of ocular adnexal lymphomaSarah E. Coupland (Liverpool/UK)

11:10 IL SU-67-05Treatment of ocular adnexal lymphomaBita Esmaeli (Houston/USA)

11:20 IL SU-67-06Overview of intraocular lymphomaJustine R. Smith (Portland/USA)

11:30 IL SU-67-07Clinical presentations of intraocular lymphomaNathalie Cassoux (Paris/F)

11:40 IL SU-67-08Treatment of vitreoretinal lymphoma withmethotrexateJacob Pe'er (Jerusalem/IL)

11:50 IL SU-67-09Treatment of Vitreoretinal lymphoma with rituximabJose S. Pulido (Rochester/USA)

14:50 IL SU-64-06Comprehensive eye care at the Sankara Eye FoundationR. V. Ramani (Coimbatore/IND)

15:00 IL SU-64-07Vision 2020 in Latin AmericaRainaldo Duerksen (Asunción/PY)

15:10Discussion

Hall 9

16:00 - 17:30 SU-65

Vision 2020: 10 Years on, 10 Years to go


Chairs:Hugh R. Taylor (Carlton/AUS)Volker Klauss (Munich/D)Ivo Kocur (Geneva/CH)

16:00 IL SU-65-01Why VISION 2020 was InitiatedAllen Foster (London/UK)

16:10 IL SU-65-02How VISION 2020 DevelopedGullapali N. Rao (Hyderabad/IND)

16:20 IL SU-65-03VISION 2020 in Africa – the Challenge in Developing CountriesDaniel Etya'ale (Geneva/CH)

16:30 IL SU-65-04VISION 2020 in Latin America – the Challenge inMid Level CountriesRainaldo Duerksen (Asunción/PY)

16:40 IL SU-65-05VISION 2020 in Australia – the Challenge in Developed CountriesHugh R. Taylor (Carlton/AUS)

16:50 IL SU-65-06The Role of Advocacy and Political LeadershipAbdulaziz AlRajhi (Riyadh/SA)

17:00 IL SU-65-07Lessons Learnt and the Way ForwardIvo Kocur (Geneva/CH)

17:10Discussion

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Sund

ay, 6

June

121

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 10

14:00 - 15:30 SU-68

Egyptian German Symposium: Combined Surgeriesin Ophthalmology

SymposiumInternational Ophthalmology

Chairs:Sherif Shetta (Cairo/ET)Mostafa Hunter (Bonn/D)Berthold Seitz (Homburg/D)

14:00 IL SU-68-01International Public Private Partnership in EyeHealthcare, a Success Story between Egypt andGermanyMostafa Hunter (Bonn/D)

14:10 IL SU-68-02Sustainable Relationships between Egyptian and German Pediatric and Rehabilitative OphthalmologyBarbara Käsmann-Kellner (Homburg/D)

14:20 IL SU-68-03Combined Scleral Buckling and Pars Plana Vitrectomy in the Management of Primary RetinalDetachmentSherif Shetta (Cairo/ET)

14:30 IL SU-68-04Temporary Keratoprosthesis in the Managementof Posterior Segment Problems in Eyes withOpaque CorneasHassan Mortada (Cairo/ET)

14:40 IL SU-68-05Combined Procedures in Diabetic VitrectomyMahmoud Soliman (Cairo/ET)

14:50 IL SU-68-06Simultaneous Glaucoma and Cataract SurgeryChristian-Paul Jonescu-Cuypers (Homburg/D)

15:00 IL SU-68-07Combined Corneal Transplantation and CataractSurgery (“The Triple Procedure”)Berthold Seitz (Homburg/D)

15:10Discussion

Hall 10

16:00 - 17:30 SU-69

Greek German Symposium: From Γλαυχοµαto Neuroprotection – a Long Journey in Under-standing Glaucoma

SymposiumGlaucoma

Chairs:Solon Thanos (Münster/D)Zisis Gatzioufas (Homburg/D)Berthold Seitz (Homburg/D)

16:00 IL SU-69-01Congenital glaucoma todayNikolaos Kozeis (Thessaloniki/GR)

16:10 IL SU-69-02The spectrum of pediatric glaucoma beyond buphthalmiaBarbara Käsmann-Kellner (Homburg/D)

16:20 IL SU-69-03Sclerotrabeculectomy for better IOP controlVassilios Kozobolis (Alexandroupoli/GR)

16:30 IL SU-69-04Glaucoma management before and after kerato-plastyChristian-Paul Jonescu-Cuypers (Homburg/D)

16:40 IL SU-69-05Present and future role of fixed combinations inglaucoma therapyAnastasios Konstas (Thessaloniki/GR)

16:50 IL SU-69-06Neuroprotection in glaucoma: reality soon ordream?Solon Thanos (Münster/D)

17:00Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

122

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Roof Garden

10:30 - 12:30 SU-70

Highlights of Anterior Segment Surgery & Refractive Surgery

SymposiumCataract, Refractive Surgery

Chairs:Joaquin Barraquer (Barcelona/E)Rafael Barraquer (Barcelona/E)Maria-Elena Barraquer (Barcelona/E)

This 120-minutes multi-authored Symposium is divided in five different sections: 1. Cataract Sur-gery; 2. Corneal Surgery; 3. Refractive Surgery(Cornea and Lens); 4. Surgical Management ofGlaucoma; and 5. Management of Ocular Injuries.Each section comprises several “rapid fire contribu-tions” of different members of the team fromBarcelona, illustrated with didactic material andchallenging casuistics. Cataract surgery is reviewedfrom the suction cup procedure for intracapsularextraction, called Phacoerysis, invented in 1917, in-clusion of intraocular anterior chamber lenses tocorrect aphakia (1954) and enzymatic zonulolysis toovercome zonular resistence prior to the extraction(1958), to modern techniques such as sonophacoand injectable lenses with due consideration tomanagement of certain complications, such as secondary cataract and intraoperative small pupil.In the Section on Corneal Surgery the techniquesof anterior and posterior lamellar procedures arepresented. The topics discussed in the Section onRefractive surgery (Cornea and Lens) include mold-ing of the cornea (crosslinking), photokeratomileu-sis for astigmatismus, tectonic and refractive largediameter penetrating keratoplasties, clear lens extraction and multifocal IOL. In Glaucoma Surgery,besides advances in goniotomy and iridotomy, theprocedure of non-perforating deep sclerecotomywith intrascleral T-Flux implantation is highlighted.The Section of Management of Ocular Injuries in-cludes modern approach of severe physical (explo-sion) and chemical trauma.

Cataract Surgery

10:30 IL SU-70-01IntroductionJoaquin Barraquer (Barcelona/E)

10:31 IL SU-70-02Phacoeresis of Professor Ignacio BarraquerMaria-Elena Barraquer (Barcelona/E)

10:33 IL SU-70-03Enzymatic ZonulolysisJoaquin Barraquer (Barcelona/E)

10:37 IL SU-70-04Strampelli’s anterior chamber IOLJoaquin Barraquer (Barcelona/E)

10:38 IL SU-70-05Sonophaco & injectable lensesMaria-Elena Barraquer (Barcelona/E)

10:42 IL SU-70-06YAG Laser capsulotomy for secondary cataractIsabel Canut (Barcelona/E)

10:43 IL SU-70-07Management of intraoperative small pupilRafael Barraquer (Barcelona/E)

10:49Discussion

Corneal Surgery

10:58 IL SU-70-08Lamellar anterior keratoplastyRafael Barraquer (Barcelona/E)

11:03 IL SU-70-09Lamellar posterior keratoplastyJ. P. Alvarez de Toledo (Barcelona/E)

11:08Discussion

Refractive Surgery

11:13 IL SU-70-10Molding of the cornea from intracorneal segmentsto collagen crosslinkingRafael Barraquer (Barcelona/E)

11:22 IL SU-70-11Photokeratomileusis in astigmatismus induced bykeratoplastyJ. P. Alvarez de Toledo (Barcelona/E)

11:25 IL SU-70-12Large diameter penetrating keratoplasties (Tectonic and refractive)Joaquin Barraquer, Mercé Uxó (Barcelona/E)

11:37 IL SU-70-13Clear lens extraction and multifocal IOLMaria-Elena Barraquer (Barcelona/E)

11:42Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

123

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Surgical Management of Glaucoma

11:47 IL SU-70-14GoniotomyIgnacio García-Barberán, Joaquin Barraquer(Barcelona/E)

11:49 IL SU-70-15Peripheral IridotomyMuhsen Samaan (Barcelona/E)

11:50 IL SU-70-16Non-perforating deep sclerectomy with intrascleral implantation of T-FluxIsabel Canut, Joaquin Barraquer (Barcelona/E)

11:55Discussion

Management of Ocular Injuries

12:00 IL SU-70-17Bomb explosion affecting both eyesJoaquin Barraquer, Mercé Uxó (Barcelona/E)

12:14 IL SU-70-18Alkali burn with extensive ocular surface alterationsJuan P. Alvarez de Toledo, Mª de la Paz (Barcelona/E)

12:21 IL SU-70-19KeratoprosthesisJoaquin Barraquer, José Temprano (Barcelona/E)

12:25Discussion

Roof Garden

14:00 - 15:30 SU-71

New Diagnostic and Therapeutic Aspects ofLacrimal Diseases


Chairs:Karl-Heinz Emmerich (Darmstadt/D)Reynaldo M. Javate (Manila/RP)James Oestreicher (Toronto/CDN)

14:00 IL SU-71-01Clinical and Imaging Evaluation of the Tearing PatientJames Oestreicher (Toronto/CDN)

14:10 IL SU-71-02Congenital Lacrimal DisordersFranz Josef Steinkogler (Vienna/A)

14:20 IL SU-71-03Management of Lacrimal TraumaHunter K. L. Yuen (Kowloon/HK)

14:30 IL SU-71-04Current Techniques in DCRYannis Ntountas (GR)

14:40 IL SU-71-05Microendoscopy of the Lacrimal Outflow System –Efficacy of Endoscopic Lacrimal Duct Recanaliza-tion using MicroendoscopeReynaldo M. Javate (Manila/RP)

14:50 IL SU-71-06Influence of Microendoscopic Techniques toLacrimal SurgeryKarl-Heinz Emmerich (Darmstadt/D)

15:00Discussion

Roof Garden

16:00 - 17:30 SU-72

Strategies in Surgical Treatment of Eye Diseases inChildhood

SymposiumPediatric Ophthalmology

Chairs:Wolf A. Lagrèze (Freiburg/D)Daniel Mojon (St. Gallen/CH)Herbert Jägle (Regensburg/D)

16:00 IL SU-72-01Minimally invasive strabismus surgeryDaniel Mojon (St. Gallen/CH)

16:15 IL SU-72-02Advances in the treatment of pediatric glaucomaPeng T. Khaw (London/UK)

16:30 IL SU-72-03Current management of pediatric cataractWolf A. Lagrèze (Freiburg/D)

16:45 IL SU-72-04Current management of capillary hemangiomaHerbert Jägle (Regensburg/D)

17:00 IL SU-72-05Anti VEGF for ROPMichael T. Trese (Royal Oak/USA)

17:15Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

124

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Room 44

08:30 - 10:00 SU-73

Epidemiological Studies

Free PaperEpidemiological Studies

Chairs:Norbert Pfeiffer (Mainz/D)Jialiang Zhao (Beijing/CN)Christian Wolfram (Mainz/D)

08:30 FP SU-73-01Adenoviral Eye Infections at the Main Tertiary Eye Center in KuwaitMaya Pandova (Kuwait/KWT)

08:37 FP SU-73-02Retinopathy in Persons without Diabetes: The Handan Eye StudyFenghua Wang (Beijing/CN)

08:44 FP SU-73-03Alcohol Consumption and the Long-term Incidence of Cataract and Cataract Surgery – TheBlue Mountains Eye StudyGowri Kanthan, Paul Mitchell, George Burlutsky, Jie Jin Wang (Strathfield/AUS)

08:51 FP SU-73-04Choroidal nevi prevalence in a Portuguese population – series of 80.000 patientsEsmeralda Costa, Luís Miguel Cristóvão, Rui Proença (Coimbra/P)

08:58 FP SU-73-05Longitudinal study of visual acuity changes in cone and cone-rod dystrophiesElena Prokofyeva, Eric Tröger, Robert Wilke, Eberhart Zrenner (Tübingen/D)

09:05 FP SU-73-06The 5 year incidence of visual impairment in adult Chinese. The Beijing Eye StudyQisheng You, Liang Xu, Jost B. Jonas (Beijing/CN,Mannheim/D)

09:12 FP SU-73-07Improving the detection and early management ofblindness in childhood: findings from the BritishChildhood Vision Impairment StudyPhillippa Cumberland, Catherine Peckham, Jugnoo S. Rahi (London/UK)

09:19 FP SU-73-08Blindness in the state of Northrhine now and in2030Robert P. Finger, Rolf Fimmers, Hendrik P. N. Scholl,Frank G. Holz (Bonn/D)

09:26 FP SU-73-09Rapid Assessment of Avoidable Blindness in TribalAreas of Andhra Pradesh State in IndiaSrinivasa Pallerla (Hyderabad/IND)

09:33Discussion

Room 44

10:30 - 12:00 SU-74

Vision 2020 – Prevention of Blindness 1

Free PaperVision 2020 – Prevention of Blindness

Chairs:Volker Klauss (Munich/D)Robert P. Finger (Bonn/D)

10:30 FP SU-74-01Trachoma in Brazil – a nationwide school surveyMaria de Fatima Lopes, Karen Brock, Helen Freitas,Norma Helen Medina, Expedito Luna, Ligia Caligaris, Maria Regina Alves, Inês Koizumi,Neusa Bernardes (Brasilia/BR, Nova Lima/BR, São Paulo/BR, Palmas Tocantins/BR)

10:37 FP SU-74-02Using Digital Cameras to Elicit Red-Reflexes for theDetection of Childhood BlindnessAlefia Merchant, Brenda Gallie, Helen Dimaras,Maria Pezzente, Robert Downie, Cynthia Vanden-Hoven, Lindsay Hampejsková, K. Vasudha, Kaushik Hegde, Nasrin Najm-Tehrani, Pradeep Banandur, Ashwin Mallipatna (Bangalore/IND,Toronto/CDN)

10:44 FP SU-74-03Reaching rural Africans with eye care services:Findings from primary eye care approaches inRwandaAndreas Mueller, Janvier Murenzi, Wanjiku Mathenge, Joseph Munana, Paul Courtright (South Melbourne/AUS, Gisenyi/RWA, Nairobi/EAK,Kigali/RWA, Moshi/EAT)

10:51 FP SU-74-04Utilisation of Eye Care Services in a Rural AdultPopulation of South-Western NigeriaBolutife Olusanya, A. O. Ashaye, B. G. K. Ajayi, E. Owoaje (Ibadan/WAN)

10:58 FP SU-74-05Factors Affecting Uptake of Cataract Surgical Services at University College Hospital Ibadan,Nigeria by Patients Screened in Outreach CampsCharles Bekibele, G. V. S. Murthy (Ibadan/WAN)

Sunday, 6 June 2010

Sund

ay, 6

June

125

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:05 FP SU-74-06Profile of Patients with Retinopathy of Prematu-rity at a Pediatric Low Vision Service in BrazilGalton Carvalho Vasconcelos, Cristina HelenaToledo de Paula, Clovis Correa de Carvalho, Jose Herculano De Carvalho, Luciene Chaves Fernandes (Belo Horizonte/BR)

11:12 FP SU-74-07Analysis of Correlation Factors Concerning Early Visual Acuity of High Volume Cataract Surgery inChinaKai Wang, Yong Zhen Bao, Xian Ru Hou, Xiao Xin Li(Beijing/CN)

11:19 FP SU-74-08Eye Care Development as a Tool for StimulatingGeneral Health Care DevelopmentKolawole Ogundimu, Suleiman Buhari (Accra/GH)

11:26 FP SU-74-09Expression and Biological Activity Identification ofHuman Pigment Epithelium-derived FactorYi Dai, Wenjing Shi, Yuxiong Wang, Chao Chen, Min Yu (Shanghai/CN)

11:33 FP SU-74-10Ophthalmologic short-term operations in theBlack Continent – Namibia and Mali: What makessense?Andreas Künster, Thomas Schwarz (Traben-Trarbach/D)

11:40Discussion

Room 44

14:00 - 15:30 SU-75

Cornea/External Disease: Surgical Therapy 2


Chairs:András Berta (Debrecen/H)Stefan Seregard (Stockholm/S)Halina Sitnik (Minsk/BY)

14:00 FP SU-75-01Phototherapeutic keratectomy in the treatment of corneal dystrophies and degenerations – ownresultsEwa Mrukwa-Kominek (Katowice/PL)

14:07 FP SU-75-02DMEK-S surgery in patients with posterior polymorphous corneal dystrophyKaterina Liehneova, Deli Sivekova, Andrej Farkas,Michal Hyndrak, Pavel Studeny (Prague/CZ)

14:14 FP SU-75-03Combining treatments to control advanced keratoconic aberropiaSergio Kandelman (Rio de Janeiro/BR)

14:21 FP SU-75-04Post-DALK corneal endothelial assessment by confocal microscopy and manual morphometrySven Jonuscheit, Michael J. Doughty, Kanna Ramaesh (Glasgow/UK)

14:28 FP SU-75-05Anterior lamellar keratectomy using the GebauermikrokeratomToam Katz, Gisbert Richard, Stephan Linke (Hamburg/D)

14:35 SL SU-75-06Proteolytic enzymes in corneal wound healingAndras Berta (Debrecen/H)

14:44 FP SU-75-07Pre Cut Tissue: Organ culture preservation of OCTguided femtosecond laser lamellar dissectedcorneasLutz Blomberg, Konstantinos Zinelis, Frank Will,Holger Lubatschowski, Rolf Winter (Hannover/D)

14:51 SL SU-75-08Combined surgical treatment of severe corneal ulcers and perforationsHalina Sitnik (Minsk/BY)

15:00 FP SU-75-09Corneal patch grafts as a primary treatment forcorneal perforationsRobin Rios (Guayaquil/EC)

15:07 FP SU-75-10Epidermal Growth Factor Variations in CultureReady Amniotic MembranesJean-Jacques Gicquel, A. Brodie, A. Hopkinson, I. Mohammed, H. Suleman, E. Lazutina, D. K. James,Harminder S. Dua (Poitiers/F, Nottingham/UK)

15:14Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

126

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Room 44

16:00 - 17:30 SU-47


Free Paper Refractive Surgery

Chairs:Günther Grabner (Salzburg/A)Gernot I. W. Duncker (Halle/D)Damián Gatinel (Paris/F)

16:00 FP SU-47-01The evaluation of the magnitude of cyclotorsionusing the Advanced Control Eyetracking (ACE)technology in the Technolas Excimer Workstation217PEon-hee Bae, Keon-uk Park, Jong-ook Kim, Chul-min Woo (Daegu/ROK)

16:07 FP SU-47-02Comparison of hyperopic lasik using Femto laserand mechanical microkeratomeMaja Bohac, Nikica Gabric, Iva Dekaris (Zagreb/HR)

16:14 FP SU-47-03LASIK for moderate and high myopia. A compari-son of eyes operated using a Moria M2 micro-keratome and a Visumax femto-second laserJesper Hjortdal, Anders Ivarsen, Sven Asp, Mikkel Lyngholm (Aarhus/DK)

16:21 FP SU-47-04Influence of wavefront aberrations on visual performance after conventional LASIK and wave-front-guided LASIK with iris-registrationJing Zhang, Yue-hua Zhou, Rui Li, Lei Tian(Beijing/CN)

16:28 FP SU-47-05Optical performance of multifocal lenses withcombined capsular tension ring implantationTobias Neuhann (Munich/D)

16:35 FP SU-47-06Comparison of different types of multifocal intraocular lenses after clear lens extractionNikica Gabric, Iva Dekaris, Maja Bohac, Ante Barisic(Zagreb/HR)

16:42 FP SU-47-07ICL vault assessment in patients with high myopiaKhristo Takhchidi (Moscow/RUS)

16:49 FP SU-47-08Correction of Presbyopia in Hyperopic and MyopicPatients with Biaspheric Multifocal AblationMounir Khalifa, Tarek A. Wahab (Alexandria/ET)

16:56 FP SU-47-09Binocular interaction in visual evoked responses: a presbyopic treatment studyKimiya Shimizu, Misae Ito (Sagamihara/J)

17:03 FP SU-47-10Results of Conventional, OATz, and OPDCAT LASIKfor the treatment of high astigmatism with thecross cylinder technique.Tamer Gamaly (Muscat/MAO)

17:10Discussion

Sunday, 6 June 2010

Sund

ay, 6

June

127

INVITATION Scientific Programme

Chair: Gabriele Lang (Germany) 12.30 Epidemiology & current evidence for treatment of diabetic macular edema patients in the Phase II RESOLVE study Gabriele Lang (Germany)

12:40 Improving vision in patients with visual impairment due to diabetic macular edema in the Phase III RESTORE study Paul Mitchell (Australia)

13:05 Further clinical trial evidence of treating patients with diabetic macular edema Neil M Bressler (USA)

13:30 Close

Novartis-sponsored symposium at the 32nd World Ophthalmology Congress (WOC),Berlin, Germany, 5–9 June 2010

Improving vision for patients with DME:Compelling New Evidence

Abu Dhabi Room, International Congress Centrum6 June 2010, 12:30–13:30

Mon

day,

7 Ju

ne


Monday, 7 June 2010

WOC® 2010 129

Mon

day,

7 Ju

ne

EVIC

R.ne

t Mee

ting

EVI S

teer

ing

Com

mitt

ee

Brea

kfas

t Sym

po-

sium

OD-

OS

Even

ing

Sym

posi

um

Sant

en

Gen

eral

Ass

embl

y of

the

DOG

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

ICC

Hal

l 3

Hal

l 4/5

Hal

l 6

Hal

l 7

Hal

l 8

Hal

l 9

Hal

l 10

ICC

Loun

ge

Roof

Gar

den

Salo

n 11

/12

Salo

n 19

Salo

n 20

Salo

n 21

Salo

n 22

Room

37

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

MO

-37

Koch

, Ros

en, N

euha

nnCo

rnea

l App

roac

hes f

or

Addr

essi

ng P

resb

yopi

a

MO

-38

Gra

bner

, Ran

dlem

an,

Knor

z Cor

neal

Lase

r Ref

rac-

tive

Surg

ery

MO

-39

Alió

, Dup

ps, S

eile

r Co

rnea

l Phy

siol

ogy

and

Bio-

mec

hani

cs

MO

-40

Colin

, Zal

diva

r,Ko

hnen

Man

agin

g H

igh

Refr

activ

e Er

rors

MO

-41 G

olni

k, Ay

din,

Ste

uhl

Wor

ldw

ide

Prog

ram

of

Teac

hing

Dire

ctor

s of O

phth

.

MO

-42

Lee,

Haw

lina,

Gab

el

The

New

Fron

tier o

f Cha

ng-

ing

Para

met

ers o

f Res

iden

cy

MO

-43 T

so, E

dwar

d, Lö

ffler

In

nova

tive

Tech

nolo

gies

for

Teac

hing

Oph

thal

mol

ogy

MO

-44

May

orga

Arg

añar

az,

Tso,

Löffl

erEm

ergi

ng Te

chn.

for O

phth

.Tea

chin

gan

dLe

arn.

MO

-49

Hei

ligen

haus

, Ki

nosh

ita

Cica

triz

ing

Conj

unct

iviti

s

MO

-50

Belfo

rt, J

r., Lo

ewen

-st

ein,

Neß

In

tra-

Ocu

lar T

hera

py

MO

-51 C

ongd

on, E

hrt,

Gilb

ert

Com

batin

g Ch

ildho

od B

lind-

ness

MO

-52

Lee,

Keef

fe T

he E

co-

nom

ics o

f Blin

dnes

s: W

hat

Does

Lost

Vis

ion

Cost

MO

-54

Mig

dal, G

oñi F

onci

l-la

s, Th

yges

en E

GS

Sym

p:G

lauc

oma

Man

agem

ent

MO

-55

Haw

lina,

Acl

iman

dos,

Tass

igno

nEB

O S

ymp

From

Nat

. tow

ards

Eur

op. t

rain

ing

MO

-56

Cons

tabl

e, La

i, Li

APAO

Sym

p: A

ge-r

elat

edM

acul

ar D

egen

erat

ion

MO

-58

Vald

ez, T

uulo

nen,

Jan,

Obe

rach

er-V

elte

n O

rgan

isat

iona

l Asp

ects

MO

-59

Astle

, Bis

chof

f JC

AHPO

Sym

posi

um: T

each

-in

g al

lied

Hea

lth P

erso

nnel

MO

-60

Schl

ötze

r-Sch

reha

rdt,

Irkec

, Hol

lóLi

ndbe

rg S

ocie

tySy

mp:

Exf

olia

tion

Synd

rom

e

MO

-63

Gra

goud

asM

acul

a So

ciet

y Sy

mp:

Non

-su

rgic

al Tr

eatm

ent

MO

-64

Tan,

Gee

rling

, AlR

ajhi

Pt

eryg

ium

Sur

gery

MO

-65 T

sai, B

arto

n, T

hiem

e AA

O S

ymp:

Gla

ucom

a im

-pl

ants

: now

and

the

futu

re

MO

-66

Moj

on, A

lió

Min

imal

ly In

vasi

ve O

ph-

thal

mic

Sur

gery

MO

-67

Mey

er, S

oubr

ane,

Wol

fens

berg

er

Retin

a: V

ascu

lar D

isea

se 1

MO

-82

Perr

os, H

ints

chic

h,D

icki

nson

, Lud

gate

EU

GO

GO

Sym

posi

umM

O-4

5 H

olz,

Cunh

a-Va

z,Ch

akra

vart

hy

Edito

rial M

anag

emen

t

MO

-46

Nus

senb

latt

, For

rest

er,

Zier

hut I

USG

Sym

p: U

pdat

eof

new

Dev

elop

men

tsM

O-4

7 Ri

tch,

Zar

bin

Nan

otec

hnol

ogy

Lunc

h Sy

mpo

sium

Zeis

sM

O-6

9 Sp

rung

er, M

artin

, de

Fabe

r, Sch

iavi

ISA

Sym

p: C

lini-

cal C

halle

nges

in S

trab

ism

us

MO

-70T

arya

m,S

hett

a,Ki

rchh

of

MEA

CO S

ymp:

Man

agem

ent

of R

etin

a an

d M

acul

ar

MO

-71 W

iggs

, Hun

ter

ARVO

Sym

posi

um: G

enet

ics

of E

ye D

isea

seIC

O Fe

llow

ship

s Alu

mni

Re

cept

ion

MO

-81 L

uco

Disa

ster

Re

spon

se: O

phth

alm

olog

y’s

Org

aniz

atio

nal R

ole

Tref

fen

der W

oche

des

Se

hens

Tref

fen

der V

isio

n 20

20 In

itiat

ivgr

uppe

Mitg

liede

rver

sam

mlu

ng d

erSe

ktio

n DO

G-U

veiti

s

Her

ausg

eber

sitz

ung

Der O

phth

alm

olog

e 20

10Ko

mm

issi

onss

itzun

g Re

frak

tive

Chiru

rgie

EBO

Exe

cutiv

e Bo

ard

Uve

itis A

war

d20

10EV

I Gen

eral

Ass

embl

y

MO

-53

Khaw

, Mic

hels

on

ARVO

Sym

p: Tr

ansl.

Res

earc

h –

Deve

lop.

Inno

v. N

ew Tr

eatm

.M

O-5

7 de

Frei

tas,

Abbo

tt

PAAO

Sym

p: A

clos

e lo

ok in

toth

e fu

ture

MO

-26

Paho

r, Tak

hchi

di, L

anzl

M

isce

llane

ous 2

MO

-48

Korw

itz, S

chac

hat,

Kirc

hhof

Goo

gle'

s App

roac

h,O

pen

Acce

ss P

ublis

hing

MO

-72 W

u, A

ugus

tin

AAO

Sym

posi

um: R

etin

alPh

arm

acot

hera

py

Mon

day,

7 Ju

neH

ighl

ight

Sym

posi

umFr

ee P

aper

WO

C Co

urse

Indu

stry

Sym

posi

umM

eetin

gs

Room

42

Room

43

Room

44

Room

45

Mes

se

Stoc

khol

m

Sao

Paul

o

Abu

Dhab

i

Osl

o H

all

Room

Mad

rid

Room

Syd

ney

Room

Hon

g Ko

ng

Room

Ista

nbul

VIP

Loun

ge 1

VIP

Loun

ge 2

Radi

o To

wer

Lo

unge

1

Radi

o To

wer

Loun

ge 2

Hal

l 11

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

WO

C-C-

38 M

ark

Upd

ate

on To

nom

etry

WO

C-C-

39 D

axer

, Mah

moo

d A

Flex

ible

Rin

g in

a C

orne

alPo

cket

for t

he Tr

eatm

ent

WO

C-C-

40 B

arra

quer

, Bar

ra-

quer

, Nad

al M

oder

n Su

rg.o

fth

e Po

ster

ior S

egm

. of t

he Ey

e

WO

C-C-

41 W

ong,

Sulli

van,

Bart

z-Sc

hmid

t Com

plica

tions

in V

itreo

retin

al Su

rger

y

MO

-73

Ahm

ed, G

erin

ec,

Pillu

nat

Gla

ucom

a: B

asic

s 2

MO

-74

Gar

weg

, Gul

, Bis

was

U

veiti

s/in

trao

. inf

lam

mat

ion,

mic

rob.

/im

mun

olog

y 2

MO

-75

Bart

z-Sc

hmid

t, Sa

hel,

Schm

idt-

Erfu

rth

Retin

a: M

isce

llane

ous 1

MO

-76

Chan

, Dec

audi

n, Z

ierh

ut

Uve

itis/

intr

ao. i

nfla

mm

atio

n,m

icro

biol

./im

mun

olog

y 3

CEVG

Inte

rnat

iona

l Adv

isor

y G

roup

MO

-77

Born

feld

, Gal

lie,

Rom

anow

ska-

Dix

on

Onc

olog

y 2

MO

-78

Drn

ovse

k-O

lup,

Em

mer

ich,

Tse

Ocu

lopl

./or

bita

/lid

s/la

crim

al sy

stem

2

MO

-79

van

Rij, X

iao,

Zarb

in

New

tech

nolo

gy, B

ioen

gine

er-

ing,

Nan

otec

hnol

ogy 2

ICO

Adv

isor

y G

roup

on

Sub-

Saha

ran

Afric

a

Brea

kfas

t Sym

po-

sium

San

ten

MO

-01 N

guye

n, O

gura

,Jo

usse

n Re

tina

and

Angi

ogen

esis

MO

-02

Leys

, Lan

g, G

rego

r Re

tinal

Cas

es w

ith D

iscu

s-si

on

MO

-03

Belfo

rt, G

raha

m,

Dith

mar

Ret

inal

and

Chor

oida

l Man

ifest

atio

ns

Lunc

h Sy

mpo

sium

Sant

enM

O-6

1 Ric

hard

, Cun

ha-V

az,

Dre

xler

Eu

retin

a Sy

mpo

sium

Brea

kfas

t Sym

po-

sium

Pfiz

erM

O-0

4 Zi

n, V

inek

ar, L

oren

z U

pdat

e on

Ret

inop

athy

of

Prem

atur

ity

MO

-05

Lore

nz, T

assi

gnon

,N

isch

alSu

rgica

l Cha

lleng

es in

Paed

iatr

ic An

terio

r Seg

m. D

is.

MO

-06

Got

tlob,

Zei

tz, L

oren

z U

pdat

e on

Infa

ntile

Nys

tag-

mus

MO

-07

Lore

nz, G

ilber

t, Ta

ylor

EP

OS

Sym

p: V

isio

n 20

20 in

paed

iatr

ic o

phth

alm

olog

yM

O-0

8 G

rehn

, Qui

gley

, Tha

m

Gla

ucom

a Re

sear

ch S

ocie

tySy

mpo

sium

MO

-09

Özk

an, L

ee, S

chia

vi

ESA

Sym

posiu

m: H

ot To

pics

in S

trab

ismus

and

Am

blyo

pia

MO

-10 va

n Re

ns, R

ubin

ISLR

R Sy

mp:

Vis

ion

on Lo

wVi

sion

Res

earc

h

MO

-11 K

ampi

k, Be

acon

sfie

ld

FEO

ph S

ympo

sium

: Uve

itis

Brea

kfas

t Sym

po-

sium

Hoy

a Su

rgic

alO

ptic

s Gm

bH

MO

-12 K

rupi

n, H

omm

er,

Jüne

man

n M

edica

l and

Lase

rTr

e. o

f Ope

n-An

gle

Gla

ucom

a

MO

-13 Li

ebm

ann,

Coh

n, H

off-

man

n Pa

nel:

Pred

ictin

g an

dDe

term

. Rat

es o

f Gla

uc. P

ro.

MO

-14 H

eijl,

Gar

way

-Hea

th,

Schi

efer

Pe

rimet

ry: N

ow a

nd Fu

ture

MO

-15 S

uare

z, O

ssm

a-G

omez

,Al

ió, A

lfons

o AL

ACCS

A-R

Sym

posi

umBr

eakf

ast S

ympo

-si

um A

llerg

anO

phth

alm

olog

y

MO

-16 A

ugus

tin, R

izzo

,M

iele

r Vitr

eo-R

etin

al C

onsi

d-er

atio

ns in

Cat

arac

t Sur

gery

MO

-17 D

ua, K

ruse

, Pel

legr

ini

Ocu

lar S

urfa

ce R

econ

stru

c-tio

n

MO

-18 C

oupl

and,

Hol

bach

,Se

rega

rd

Tum

ors o

f the

Ocu

lar S

urfa

ce

MO

-19 R

osen

, Dic

k As

tigm

atis

m M

anag

emen

t in

Cata

ract

Sur

gery

WO

C-C-

30 H

atte

nbac

h Su

ture

less

= H

appi

ness

? W

OC-

C-31

Bur

k, Ch

auha

n,Bu

rgoy

ne H

RT a

nd S

pect

ral

OCT

in G

lauc

oma

WO

C-C-

32 La

ng

Lase

r Tre

atm

ent o

f Ret

inal

Dise

ases

WO

C-C-

33 R

iede

l Bl

epha

ropl

asty

of t

he U

pper

and

Low

er E

ye Li

dsM

O-2

0 Ta

ssig

non,

van

Rij

SOE

Sym

posi

um: S

lips,

Tric

ksan

d Fa

ll

MO

-21 L

iese

gang

, Ver

jans

,H

eilig

enha

us

DNA

Viru

ses a

nd th

e Ey

e

MO

-22

Arai

e, G

rus,

Med

eiro

s AO

GS

Sym

posi

um: N

orm

al-

tens

ion

Gla

ucom

a

MO

-23

Cole

nbra

nder

,Ro

hrsc

hnei

der, v

an R

ens

Pane

l: Vi

sion

Reh

abili

tatio

nW

OC-

C-34

Pfe

iffer

W

etla

b G

lauc

oma

Surg

ery

for B

egin

ners

WO

C-C-

35 P

feiff

er

Wet

lab

Gla

ucom

a Su

rger

yfo

r the

Adv

ance

dM

O-2

4 Fo

erst

er, Im

shen

et-

skay

a, O

hno-

Mat

sui

Retin

a: S

urgi

cal t

hera

py 1

MO

-32

Belfo

rt, L

oew

enst

ein

Retin

a: M

edic

al th

erap

y 1

MO

-25

Laga

novs

ka, M

andi

c,St

ark

Cata

ract

/bio

met

ry 2

MO

-62 T

rimm

el, K

ibat

a,Bu

ehle

rNG

O/P

rivat

e Se

ctor

Part

ners

hips

: WIN

/WIN

MO

-27

Kirc

hhof

, Wal

ter,

Scho

ll Re

tina:

Dia

gnos

tics 2

MO

-28

Schr

ader

, Siv

kova

Tr

aum

a

MO

-29

D'A

mic

o, W

olfe

ns-

berg

er, W

iede

man

n Cl

ub Ju

les G

onin

Sym

posi

um

MO

-30

Birn

baum

, Wyl

egal

a,Al

Rajh

i Sur

gica

l The

rapy

of

Kera

toco

nus

MO

-31 B

arto

n, S

tein

, +Fl

am-

mer

G

lauc

oma:

Sur

gica

l the

rapy

1

MO

-68

Hol

z, Ra

deck

a,Su

lzba

cher

Re

tina:

AM

D 2

MO

-33

Gro

ssni

klau

s, Bu

rnie

r,Au

w-H

ädric

h In

trao

cula

r Tum

ors

MO

-34

Rose

, Gut

hoff,

Kat

owitz

New

Dia

gn. a

nd Th

erap

eutic

Aspe

cts o

f Orb

ital D

iseas

es

MO

-35

Dar

t, Se

itz, S

pier

ings

Co

rnea

/Ext

erna

l Dis

ease

: Di-

agno

stic

s

MO

-36

Szur

man

, Roi

der,

Spitz

er

Ocu

lar P

harm

acol

ogy

Euro

pean

Visio

nAw

ard

Post

er e

xhib

ition

of P

oste

r P-

MO

-001

to P

-MO

-298

117th Congressof the French Society of Ophthalmology

7 - 10 May 2011Paris

www.sfo.asso.fr

Welcome to Paris

Offi cial languages: French - English

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Stockholm

08:30 - 10:00 MO-01

Retina and Angiogenesis

SymposiumRetina

Chairs:Quan Dong Nguyen (Baltimore/USA)Yuichiro Ogura (Nagoya/J)Antonia M. Joussen (Berlin/D)

08:30 IL MO-01-01The role of cathepsin L from bone marrow-derivedcells in retinal angiogenesisKyoko Ohno-Matsui (Tokyo/J)

08:40 IL MO-01-02How to promote regeneration of functional capil-laries in the ischemic retinaAkiyoshi Uemura (Kobe/J)

08:50 IL MO-01-03Modulation of Retinal Angiogenesis by RetinalGanglion Cells: Implications for ProliferativeRetinopathies Mike Sapieha (Montreal(CDN)

09:00 IL MO-01-04Can VEGF Blockade Result in Regression ofChoroidal Neovascularization?Diana Do (Baltimore/USA)

09:10 IL MO-01-05Advanced glycation endproducts in vascular diseaseAlan Stitt (Belfast/UK)

09:20 IL MO-01-06Inflammation in AngiogenesisJohn V. Forrester (Aberdeen/UK)

09:30Discussion

Stockholm

10:30 - 12:00 MO-02

Retinal Cases with Discussion

SymposiumRetina

Chairs:Anita Leys (Leuven/B)Gabriele E. Lang (Ulm/D)Zdenek J. Gregor (London/UK)

10:30 IL MO-02-01Radiation retinopathy: what to do?Zdenek J. Gregor (London/UK)

10:40 IL MO-02-02Light chain deposition diseaseAnita Leys (Leuven/B)

10:50 IL MO-02-03A man with recurrent macular hermorrhageTimothy Lai (Hong Kong/CN)

11:00 IL MO-02-04Mystery caseWilliam F. Mieler (Chicago/USA)

11:10 IL MO-02-05Brain melanoma: How did it get there?Jerry Shields (Philadelphia/USA)

11:20 IL MO-02-06Mystery CaseJ. Fernando Arevalo (Caracas/Y)

11:30 IL MO-02-07Mystery CaseAndries Stulting (Bloemfontein/ZA)

11:40 IL MO-02-08Mysterious macular diseaseGabriele E. Lang (Ulm/D)

11:50 IL MO-02-09Mystery casePeter Wiedemann (Leipzig/D)

Stockholm

14:00 - 15:30 MO-03

Retinal and Choroidal Manifestations of SystemicDiseases

SymposiumRetina

Chairs:Rubens Belfort, Jr. (São Paulo/BR)Elisabeth Graham (London/UK)Stefan Dithmar (Heidelberg/D)

14:00 IL MO-03-01Metabolic diseases: DiabetesPaul Mitchell (Sydney/AUS)

14:10 IL MO-03-02Metabolic diseases: non diabetic diseasesElisabeth Graham (London/UK)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

133

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:20 IL MO-03-03RetinochoroiditisRubens Belfort, Jr. (São Paulo/BR)

14:30 IL MO-03-04VasculitisQuan Dong Nguyen (Baltimore/USA)

14:40 IL MO-03-05Neurological diseasesAlfredo Sadun (Los Angeles/USA)

14:50 IL MO-03-06Oncological entitiesNikolaos E. Bechrakis (Innsbruck/A)

15:00Discussion

Stockholm

16:00 - 17:30 MO-61

Euretina Symposium: Retinal Imaging with OpticalCoherence Tomography / Future of Imaging

SymposiumRetina

Chairs:Gisbert Richard (Hamburg/D)José Cunha-Vaz (Coimbra/P)Wolfgang Drexler (Cardiff/UK)

16:00 IL MO-61-01OCT in Macula PathologiesGisbert Richard (Hamburg/D)

16:10 IL MO-61-02Multimodal Macula MappingJosé Cunha-Vaz (Coimbra/P)

16:20 IL MO-61-03Cellular Resolution Retinal Imaging and OptophysiologyWolfgang Drexler (Cardiff/UK)

16:30 IL MO-61-04Polarization Sensitive Retinal OCTChristoph Hitzenberger (Vienna/A)

16:40 IL MO-61-05Ultrahigh speed retinal OCTJames G. Fujimoto (Cambridge/USA)

16:50 IL MO-61-06Retinal OCT at 1060nmYoshiaki Yasuno (Ibaraki/J)

17:00Discussion

Stockholm

17:45 - 18:15 MO-83

European Vision Award 2010 Lecture

see also p. 18

Sao Paulo

08:30 - 10:00 MO-04

Update on Retinopathy of Prematurity: New Approaches for Research, Diagnosis and Treatment


Chairs:Andrea Zin (Rio de Janeiro/BR)Anand Vinekar (Bangalore/IND)Birgit Lorenz (Giessen/D)

08:30 IL MO-04-01New research areas in ROP diagnosis and managementAnn Hellstrom (Gothenburg/S)

08:40 IL MO-04-02Organizing national screening programs for ROPAndrea Zin (Rio de Janeiro/BR)

08:50 IL MO-04-03ROP Screening in VietnamNguyen Xuan Tinh (Hanoi/VN)

09:00 IL MO-04-04Telemedicine as an option for screening: The ex-pert´s view on WFDI in ROPMichael Chiang (New York/USA)

09:10 IL MO-04-05Telemedicine in ROP: The Indian ExperienceAnand Vinekar (Bangalore/IND)

09:20 IL MO-04-06WFDI in ROP: Opportunity for automated imageanalysisAlistair Fielder (London/UK)

09:30 IL MO-04-07Anti-VEGF and ROPHelen A. Mintz-Hittner (Houston/USA)

09:40Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne134

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Sao Paulo

10:30 - 12:00 MO-05

Surgical Challenges in Pediatric Anterior Segment Diseases


Chairs:Birgit Lorenz (Giessen/D)Marie-José Tassignon (Antwerp/B)Ken K. Nischal (London/UK)

10:30 IL MO-05-01Best choice surgery in pediatric cataractMarie-José Tassignon (Antwerp/B)

10:450 IL MO-05-02Alternatives to penetrating keratoplasty in pediatric corneal diseaseKen K. Nischal (London/UK)

11:00 IL MO-05-03Pediatric Corneal Transplantation: Experiencesfrom a large tertiary referral center in India.Pravin V. Krishna (Hyderabad/IND)

11:15 IL MO-05-04The choice and effectiveness of surgery in differentclinical forms of congenital glaucomaAnton Gerinec (Bratislava/SK)

11:30 IL MO-05-05Pediatric perforating injuries of the globe: timingof surgical stepsRobert Stegmann (Pretoria/ZA)

11:45Discussion

Sao Paulo

14:00 - 15:30 MO-06

Update on Infantile Nystagmus: Clinics, Genetics,and Treatment


Chairs:Irene Gottlob (Leicester/UK)Christina Zeitz (Paris/F)Birgit Lorenz (Giessen/D)

14:00 IL MO-06-01Modern work-up in infantile nystagmusBirgit Lorenz (Giessen/D)

14:15 IL MO-06-02Genetics of X-linked idiopathic nystagmusIrene Gottlob (Leicester/UK)

14:30 IL MO-06-03Genetics of cone dysfunction disordersSusanne Kohl (Tübingen/D)

14:45 IL MO-06-04Genetic and clinical hetereogeneity of congenitalforms of night blindnessChristina Zeitz (Paris/F)

15:00 IL MO-06-05Medical and surgical treatment optionsAnil Kumar (Leicester/UK)

15:15 IL MO-06-06Gene therapy provides cure for achromatopsiaKnut Stieger (Giessen/D)

Sao Paulo

16:00 - 17:30 MO-07

EPOS Symposium: Vision 2020 in Pediatric Ophthalmology. Dreams and Realities in Eliminating Avoidable Childhood Blindness


Chairs:Birgit Lorenz (Giessen/D)Clare Gilbert (London/UK)David Taylor (London/UK)

16:00 IL MO-07-01VISION 2020 and children: achievements and challengesClare Gilbert (London/UK)

16:15 IL MO-07-02Pediatric cataract: can we improve on what wehave achieved?Michael O´Keefe (Dublin/IRL)

16:30 IL MO-07-03Pediatric glaucoma. Holes, tubes and more.Peng T. Khaw (London/UK)

16:45 IL MO-07-04Pediatric infectious eye diseases: Prevention andtreatmentPerumalsamy Vijayalakshmi (Madurai/IND)

17:00 IL MO-07-05Predictions of genotype and phenotype in pediatric hereditary diseases: present achievements and future challengesJosseline Kaplan (Paris/F)

17:15 IL MO-07-06Retinal dystrophies: hopes for cureBirgit Lorenz (Giessen/D)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

135

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Abu Dhabi

08:30 - 10:00 MO-08

Glaucoma Research Society Symposium: The Impact of Glaucoma on Real Life

SymposiumGlaucoma

Chairs:Franz Grehn (Würzburg/D)Clement C. Y. Tham (Hong Kong/CN)

08:30 IL MO-08-01Functional impairment in glaucomaPradeep Ramulu (Baltimore/USA)

08:40 IL MO-08-02Psychology of glaucoma and blindnessRobert Dolgoff (Berkeley/USA)

08:50 IL MO-08-03Assessing Quality of Life in Glaucoma PatientsIvan Goldberg (Sydney/AUS)

09:00 IL MO-08-04Patient Presentation – Living with GlaucomaJoseph Cohen (New York/USA)

09:10 IL MO-08-05Patient Presentation – Living with GlaucomaJeffrey Kassel (USA)

09:20 IL MO-08-06Patient presentation – living with glaucomaMaria Gorby (Waterford/USA)

09:30 IL MO-08-07How to start a glaucoma support groupBeverly Lindsell (Crows Nest/AUS)

09:40Discussion

Abu Dhabi

10:30 - 12:00 MO-09

ESA Symposium: Hot Topics in Strabismus and Amblyopia

SymposiumStrabismus

Chairs:Seyhan B. Özkan (Aydin/TR)John P. Lee (London/UK)Costantino Schiavi (Bologna/I)

10:30 IL MO-09-01Accommodation and strabismusEmilio Carlo Campos (Bologna/I)

10:40 IL MO-09-02Amblyopia beyond acuityJohn Sloper (London/UK)

10:50 IL MO-09-03How do the extraocular muscles function – do weknow all?Costantino Schiavi (Bologna/I)

11:00 IL MO-09-04Surgical strategies for incomitanceJohn P. Lee (London/UK)

11:10 IL MO-09-05Lateral rectus orbital wall fixation – where andhow to use?Seyhan B. Özkan (Aydin/TR)

11:20 IL MO-09-06Botulinum toxin versus surgery in treatment of infantile esotropiaRosario Gomez de Liano (Madrid/E)

12:30Discussion

Abu Dhabi

14:00 - 15:30 MO-10

ISLRR Symposium: Vision on Low Vision Research

SymposiumLow Vision

Chairs:Ger van Rens (Amsterdam/NL)Gary S. Rubin (London/UK)Veera Ramani (Coimbatore/IND)

14:00 IL MO-10-01Rehabilitation and quality of lifeRuth M. A. van Nispen (Amsterdam/NL)

14:10 IL MO-10-02Effects of CCTV trainingMarloes C. Burggraaff (Amsterdam/NL)

14:20 IL MO-10-03CCTV and vision related quality of lifeGer van Rens (Amsterdam/NL)

14:30 IL MO-10-04Low vision related research in the UKGary S. Rubin (London/UK)

Monday, 7 June 2010

Mon

day,

7 Ju

ne136

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:40 IL MO-10-05Development and use of the preferred retinallocusMichael D. Crossland (London/UK)

14:50 IL MO-10-06DAI, outcome of a pilot studyJanna Bruijning (Amsterdam /NL)

15:00Discussion

Abu Dhabi

16:00 - 17:30 MO-11

FEOph Symposium: Uveitis


Chairs:Anselm Kampik (Munich/D)Michèle Beaconsfield (London/UK)

16:00 IL MO-11-01HLA A29 and B27: Hypotheses and Links to DiseaseMechanism in UveitisDominique Monnet (Paris/F)

16:10 IL MO-11-02Th17 in the Pathogenesis of UveitisRafael Grajewski (Gänheim/D)

16:20 IL MO-11-03Aqueous Humor Neutrophil Gelatinase-associatedLipocalin Levels in Patients with Acute AnteriorUveitisDavid Salom (Valencia/E)

16:30 IL MO-11-04Aqueous Humor Analysis for the Differential Diagnosis of UveitisUwe Pleyer (Berlin/D)

16:40 IL MO-11-05Occurence and Long-term Surgical Outcome in Sec-ondary Glaucoma in Juvenile Idiopathic Arthritis-associated UveitisCarsten Heinz (Münster/D)

16:50 IL MO-11-06Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-associated UveitisArnd Heiligenhaus (Münster/D)

17:00 IL MO-11-07Birdshot Chorioretinopathy: A Model for the Long-term Follow-up of Patients with PosteriorUveitisAntoine Brezin (Paris/F)

17:10 IL MO-11-08Differential Diagnosis of Anterior UveitisPhilip I. Murray (Birmingham/UK)

17:20 IL MO-11-09Adalimumab Therapy for Refractory Uveitis – A Multicenter StudyManuel Díaz-Llopis (Valencia/E)

Oslo

08:30 - 10:00 MO-12

Medical and Laser Treatment of Open-Angle Glaucoma

SymposiumGlaucoma

Chairs:Theodore Krupin (Chicago/USA)Anton Bernhard Hommer (Vienna/A)Anselm G. M. Jünemann (Erlangen/D)

08:30 IL MO-12-01Who needs treatment, who needs observation onlyAnselm G. M. Jünemann (Erlangen/D)

08:40 IL MO-12-02Medication is the first step in glaucoma treatmentAnton Bernhard Hommer (Vienna/A)

08:50 IL MO-12-03The different methods of Laser trabeculoplastyHerbert Reitsamer (Salzburg/A)

09:00 IL MO-12-04Don't forget iridoplasty in your therapeutic consid-erationsChristoph Faschinger (Graz/A)

09:10 IL MO-12-05Pressure independent treatmentTheodore Krupin (Chicago/USA)

09:20 IL MO-12-06Combination therapyAnastasios Konstas (Thessaloniki/GR)

09:30Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne

137

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Oslo

10:30 - 12:00 MO-13

Panel: Predicting and Determining Rates of Glaucoma Progression

Panel Glaucoma

Chairs:Jeffrey M. Liebmann (New York/USA)Howard C. Cohn (Paris/F)Esther M. Hoffmann (Mainz/D)

10:30 IL MO-13-01Optic disc and Nerve fiber layer features that predict future progressionChristopher A. Girkin (Birmingham/USA)

10:40 IL MO-13-02Detection of retinal nerve fiber layer progressionSek Tien Hoh (Singapore/SGP)

10:50 IL MO-13-03Detection of optic disc progressionRemo Susanna, Jr (São Paulo/BR)

11:00 IL MO-13-04Detection of visual field progressionBoel Bengtsson (Malmö/S)

11:10 IL MO-13-05Optic disc hemorrhage: Progression endpoint orpredictor?Gustavo de Moraes (New York/USA)

11:20 IL MO-13-06What constitutes clinically significant structuralprogression?Robert Fechtner (Newark/USA)

11:30 IL MO-13-07What constitutes clinically significant functionalprogression?Norbert Pfeiffer (Mainz/D)

11:40 IL MO-13-08Using structure and funciton information in clinical practiceRobert N. Weinreb (La Jolla/USA)

11:50Discussion

Oslo

14:00 - 15:30 MO-14

Perimetry: Now and Future

SymposiumGlaucoma

Chairs:Anders Heijl (Malmö/S)Ted Garway-Heath (London/UK)Ulrich Schiefer (Tübingen/D)

14:00 IL MO-14-01Do new psychophysical tests have any advantagesof SAP?John G. Flanagan (Toronto/CDN)

14:10 IL MO-14-02Visual field progression in glaucoma - definitionand assessmentBoel Bengtsson (Malmö/S)

14:20 IL MO-14-03The importance of signal-to-noise ratio in measuring progressionPaul Artes (Halifax/CDN)

14:30 IL MO-14-04The relation of visual field loss to quality of lifeand disabilityDavid P. Crabb (London/UK)

14:40 IL MO-14-05STAT3 and retinal ganglion cell protection

Samuel Shao-Min Zhang (New Haven/USA)

14:50 IL MO-14-06What can structure add to function in identifyingearly glaucoma and progresssion?Ted Garway-Heath (London/UK)

15:00 IL MO-14-07Visual field assessment in advanced glaucomaUlrich Schiefer (Tübingen/D)

15:10Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne138

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Oslo

16:00 - 17:30 MO-15

ALACCSA-R Symposium: Presbyopia CorrectingIOLS: The Best Option

SymposiumCataract

Chairs:Enrique Suarez (Caracas/Y)Ivan L. Ossma-Gomez (Bucaramanga/CO)Jorge L. Alió (Alicante/E)José F. Alfonso (Oviedo/E)

16:00 IL MO-15-01A New concept in Multifocal IOLs: The M Plus OculentisJorge L. Alió (Alicante/E)

16:10 IL MO-15-02Presbyopia correction with PseudoaccommodativeIOLEnrique Suarez (Caracas/Y)

16:20 IL MO-15-03Lens based reversal of presbyopiaIvan L. Ossma-Gomez (Bucaramanga/CO)

16:30 IL MO-15-04Comparative study of quality of vision with OKASin Multifocal IOLs vs Accommodative IOLsCarlos Palomino (Madrid/E)

16:40 IL MO-15-05TEK-CLEAR Clinical ResultsJose M. Vargas (Valencia/Y)

16:50 IL MO-15-06Restor and LasikAngel Pineda Fernandez (Caracas/Y)

17:00 IL MO-15-07Results with New Difractives Multifocal IOLs:Restor +3 vs TecnisLuis Izquierdo (Lima/PE)

17:10 IL MO-15-08Monocular RestorJuan Manuel Paulin Huerta (Mexico City/MEX)

17:20 IL MO-15-09Cataract Surgery: Challenging casesJorge Villar Kuri (Mexico City/MEX)

Room Madrid

08:30 - 10:00 MO-16

Vitreo-Retinal Considerations in Cataract Surgery

SymposiumCataract

Chairs:Albert J. Augustin (Karlsruhe/D)Stanislao Rizzo (Pisa/I)William F. Mieler (Chicago/USA)

08:30 IL MO-16-01Bifocal lenses and the vitreoretinal surgeonStanislao Rizzo (Pisa/I)

08:40 IL MO-16-02DR and CE: How to prepare the eye with diabeticretinopathy for CEWilliam F. Mieler (Chicago/USA)

08:50 IL MO-16-03AMD and CE: Progression/preventionAlbert J. Augustin (Karlsruhe/D)

09:00 IL MO-16-04Pucker and phaco: combined or sequentialBernd Kirchhof (Cologne/D)

09:10 IL MO-16-05CME after CEAnat Loewenstein (Tel Aviv/IL)

09:20 IL MO-16-06RD in high myopes after phacoIrmingard Neuhann (Tübingen/D)

09:30Discussion

Room Madrid

10:30 - 12:00 MO-17

Ocular Surface Reconstruction


Chairs:Harminder S. Dua (Nottingham/UK)Friedrich E. Kruse (Erlangen/D)Graziella Pellegrini (Modena/I)

10:30 IL MO-17-01Oral mucosa cells for ocular surface reconstructionShigeru Kinoshita (Kyoto/J)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

139

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

10:40 IL MO-17-02Decision making for ocular surface reconstructionBjörn Bachmann (Erlangen/D)

10:50 IL MO-17-03The role of amniotic membrane in ocular surfacereconstructionHarminder S. Dua (Nottingham/UK)

11:00 IL MO-17-04Principles and perspectives of cell based ocularsurface reconstructionFriedrich E. Kruse (Erlangen/D)

11:10 IL MO-17-05Ex vivo expanded limbal stem cells for ocular surface reconstructionPaolo Rama (Venice/I)

11:20 IL MO-17-06Bridging anterior and posterior ocular surfacesIqbal Ahmad (New Haven/USA)11:30

Discussion

Room Madrid

14:00 - 15:30 MO-18

Tumors of the Ocular Surface


Chairs:Sarah E. Coupland (Liverpool/UK)Leonard M. Holbach (Erlangen/D)Stefan Seregard (Stockholm/S)

14:00 IL MO-18-01Epidemiology of conjunctival melanomaStefan Seregard (Stockholm/S)

14:10 IL MO-18-02Management of conjunctival melanomaBertil D. Damato (Liverpool/UK)

14:20 IL MO-18-03Management of conjunctival carcinomaLeonard M. Holbach (Erlangen/D)

14:30 IL MO-18-04Why I prefer 5-FU for topical chemotherapyEdoardo Midena (Padova/I)

14:40 IL MO-18-05Why I prefer mitomycin for topical chemotherapyJacob Pe'er (Jerusalem/IL)

14:50 IL MO-18-06Ocular surface reconstructionFriedrich E. Kruse (Erlangen/D)

15:00Discussion

Room Madrid

16:00 - 17:30 MO-19

Astigmatism Management in Cataract Surgery

SymposiumCataract

Chairs:Emanuel S. Rosen (Manchester/UK)H. Burkhard Dick (Bochum/D)

16:00 IL MO-19-01Current options of astigmatism correction incataract surgery: a critical overviewEmanuel S. Rosen (Manchester/UK)

16:20 IL MO-19-02On-axis versus temporal clear corneal incisions –Which to choose?Edmund Borasio (London/UK)

16:40 IL MO-19-03Toric IOLs: a wide variety of optionsH. Burkhard Dick (Bochum/D)

17:00 IL MO-19-04Changes in astigmatism after congenital cataractsurgery and IOL implantationAbraham Spierer (Tel-Hashomer/IL)

17:20Discussion

Room Hong Kong

08:30 - 10:00 MO-20

SOE Symposium: Slips, Tricks and Falls in CataractSurgery

SymposiumCataract

Chairs:Marie-José Tassignon (Antwerp/B)Gabriel van Rij (Rotterdam/NL)

08:30 IL MO-20-01Basic phacoemulsificationDavid Allen (Newcastle on Tyne/UK)

Monday, 7 June 2010

Mon

day,

7 Ju

ne140

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

08:50 IL MO-20-02IOL calculation after refractive surgeryWolfgang Haigis (Würzburg/D)

09:10 IL MO-20-03Basic phacoemulsificationKhiun F. Tjia (Zwolle/NL)

09:30 IL MO-20-04Calibration, sizing and centration of the anteriorcapsulorhexisMarie-José Tassignon (Antwerp/B)

09:50Discussion

Room Hong Kong

10:30 - 12:00 MO-21

DNA Viruses and the Eye


Chairs:Thomas J. Liesegang (Jacksonville/USA)G. M. G. M. Verjans (Rotterdam/NL)Arnd Heiligenhaus (Münster/D)

10:30 IL MO-21-01CMV retinitis, clinicalGary N. Holland (Los Angeles/USA)

10:40 IL MO-21-02Adenoviruses of the Cornea; Virology and TreatmentEric G. Romanowski (Pittsburgh/USA)

10:50 IL MO-21-03Fundamentals of herpetic keratitisG. M. G. M. Verjans (Rotterdam/NL)

11:00 IL MO-21-04Diagnosis and treatment of herpetic keratitis, acyclivir resistanceLies Remeijer (Rotterdam/NL)

11:10 IL MO-21-05Herpes zoster Ophthalmicus and ComplicationsArnd Heiligenhaus (Münster/D)

11:20 IL MO-21-06Herpes Zoster: Epidemiology, risk factors and pre-vention through vaccinationThomas J. Liesegang (Jacksonville/USA)

11:30Discussion

Room Hong Kong

14:00 - 15:30 MO-22

AOGS Symposium: Normal-tension Glaucoma

SymposiumGlaucoma

Chairs:Makoto Araie (Tokyo/J)Franz H. Grus (Mainz/D)Felipe A. Medeiros (La Jolla/USA)

14:00 IL MO-22-01Ocular blood flow in normal tension glaucomaLeopold Schmetterer (Vienna/A)

14:10 IL MO-22-02Managing Glaucoma in Patients with KeratoprosthesesJoshua D. Stein (Ann Arbor/USA)

14:20 IL MO-22-03Genetic aspect of normal tension glaucomaKenji Kashiwagi (Yamanashi/J)

14:30 IL MO-22-04Central corneal thickness in NTG: Measurementerror or risk factor?Michael Kook (Seoul/ROK)

14:40 IL MO-22-05Autoimmune phenomena in glaucomaFranz H. Grus (Mainz/D)

14:50 IL MO-22-06IOP dynamics in NTG: Water loading and posturalchangeMakoto Araie (Tokyo/J)

15:00 IL MO-22-07Treatment of normal-tension glaucoma – IOPJian Ge (Guangzhou/CN)

15:10 IL MO-22-08Treatment of normal tension glaucoma – Non IOPCatherine Liu (Taipei/TJ)

15:20Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne

141

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Room Hong Kong

16:00 - 17:30 MO-23

Panel: Vision Rehabilitation – Demands and Chal-lenges in the 21st Century

Panel Low Vision

Chairs:August Colenbrander (Novato/USA)Klaus Rohrschneider (Heidelberg/D)Ger van Rens (Amsterdam/NL)

16:00 IL MO-23-01Comprehensive Vision RehabilitationAugust Colenbrander (Novato/USA)

16:10 IL MO-23-02Rehabilitation Guidelines for General Ophthalmol-ogists; Development and Follow-upGer van Rens (Amsterdam/NL)

16:20 IL MO-23-03Comprehensive Low Vision Rehabilitation in Ger-many Now and in the FutureKlaus Rohrschneider (Heidelberg/D)

16:30 IL MO-23-04Low Vision Rehabilitation Model at the L V PrasadEye Institute, IndiaVijaya Kumari Gothwal (Hyderabad/IND)

16:40 IL MO-23-05Bridging gaps in Low Vision Care in the PhilippinesSheila Santos-Jimenez (Quezon City/RP)

16:50 IL MO-23-06Successes in the Development Low Vision Servicesin Latin AmericaRosario Espinoza (Lima/PE)

17:00 IL MO-23-07Expanding Low Vision benefits in TurkeyKardircan Keskinbora (Tekirdag/TR)

17:10 IL MO-23-08Multidisciplinary Rehabilitation and Resident EducationMary Lou Jackson (Boston/USA)

17:20Discussion

VIP Lounge 1

10:30 - 12:00 MO-24

Retina: Surgical Therapy 1

Free PaperRetina

Chairs:Michael H. Foerster (Berlin/D)Tatsiana Imshenetskaya (Minsk/BY)Kyoko Ohno-Matsui (Tokyo/J)

10:30 FP MO-24-01Pars-plana vitrectomy alone versus vitrectomywith scleral buckling for primary rhegmatogenouspseudophakic retinal detachmentKhalifa Al Sawidi (Triploi/LAR)

10:37 FP MO-24-02The clinical outcomes of short-term heavy siliconoil (Densiron-68) intraocular tamponade.Li-bo Ma, Tie-hong Chen, Zhi Zhng, Jian-dongZhang, Ju Wen (Shenyang/CN)

10:44 FP MO-24-03Surgical outcomes in vitrectomy for myopicfoveoschisisMichael Engelbert, D. Kar, S. Chang (New York/USA)

10:51 SL MO-24-04Rhegmatogenous retinal detachment: philosophyof surgical delicacyTatsiana Imshenetskaya, Volha Yarmak (Minsk/BY)

10:58 FP MO-24-05Postoperative results of vitrectomy with ICG assisted ILM-peeling from idiopathic macularholes stage 4 and with baseline visual acuity ≥ 0,2Mete Gök, Harun Akgül, Michael Freistühler,Theodora Gkika, Norbert Bornfeld (Essen/D)

11:05 FP MO-24-06Staining properties, anatomical and functionaloutcome in Brilliant Blue G ChromovitrectomyPaul Bernhard Henrich (Basel/CH)

11:12 FP MO-24-07Surgical Management of Coats’ disease – presen-tation of a modified techniqueSabine Aisenbrey, Daniela Suesskind, K. UlrichBartz-Schmidt (Tübingen/D)

11:19 FP MO-24-08Randomized Trial of Transpupillary ThermotherapyVersus Sham Treatment for Central Serous Chorioretinopathy (TTT4CSC): Long-term resultsHarvey Uy (Makati City/RP)

Monday, 7 June 2010

Mon

day,

7 Ju

ne142

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:26 FP MO-24-09Combined Cataract Extraction, PCIOL, Pars PlanaVitrectomy, Retisert Implant, and Pars Plana Tubein Chronic Advanced Non-Infectious Uveitis withCataract and Glaucoma. The CPR-PT ProcedureTamer Mahmoud (Troy/USA)

11:33 FP MO-24-10"Re-flow" surgical strategy with one pars planaport for the treatment of epiretinal disesases:sutdy of the endothelial cells lossCesare Forlini, Paolo Rossini, Matteo Forlini(Ravenna/I)

11:40Discussion

VIP Lounge 1

16:00 - 17:30 MO-32

Retina: Medical Therapy 1

Free PaperRetina

Chairs:Rubens Belfort, Jr. (São Paulo/BR)Anat Loewenstein (Tel Aviv/IL)

16:00 FP MO-32-01Benefits of Early Treatment with DexamethasoneIntravitreal Implant in Patients with MacularEdema due to BRVO or CRVO over 12 MonthsRubens Belfort, Jeffrey Heier, Julia A. Haller, Mark S. Blumenkranz, Francesco Bandello, Anat Loewentstein, Young-Hee Yoon, Jenny Jiao, Xiao-Yan Li, Scott M. Whitcup (Sao Paulo/BR, Stanford/USA, Milano/I, Philadelphia/USA, Tel Aviv/IL, Boston/USA, Irvine/USA, Seoul/ROK)

16:07 FP MO-32-0212-month Evaluation of Dexamethasone Intravitreal Implant in Patients with MacularEdema due to Branch Retinal Vein OcclusionAnat Loewenstein, Julia A. Haller, Mark S. Blu-menkranz, Francesco Bandello, Rubens Belfort, Jr.,Mark Gillies, Jeffrey Heier, Young-Hee Yoon, Jenny Jiao, Xiao-Yan (Joanne) Li, Scott M. Whitcup(Tel-Aviv/IL, Stanford/USA, Milano/I, Sao Paulo/BR,Vienna/A, Philadelphia/USA, Sydney/AUS,Boston/USA, Seoul/ROK, Irvine/USA)

16:14 FP MO-32-03Prospective Study of Intravitreal Ranibizumab as aTreatment for Decreased Visual Acuity Secondaryto Central Retinal Vein OcclusionRichard Spaide, Louis Chang, James Klancnik,Lawrence Yannuzzi, John Sorenson, Jason Slakter(New York/USA)

16:21 FP MO-32-04Verteporfin photodynamic therapy in combinationwith ranibizumab or alone versus ranibizumabmonotherapy for symptomatic macular polypoidalchoroidal vasculopathy (PCV): Anatomical out-comes of the EVEREST studyTock Han Lim, on behalf of the EVEREST studygroup (Singapore/SGP)

16:28 FP MO-32-05Peribulbar Triamcinolone for Diabetic MacularEdema: Efficacy and Effects on Glycemic ControlJelliti Bechir, Attia Sonia, Kahloun Rym, Ammari Wafa, Messaoud Riadh, Moncef Khairallah (Monastir/TN)

16:35 FP MO-32-06A randomized clinical trial to compare the efficacyand safety of isolated or combined intravitreal injection of Triamcinolone Acetonide and Bevacizumab for diabetic macular edemaHermelino Oliveira Neto, Rafael Ernane Andrade,Cristina Muccioli, Antonio Marcelo Casella, Mario Junqueira Nobrega, Michel Eid Farah, Rubens Belfort (Feira de Santana-Bahia/BR)

16:42 FP MO-32-07Comparison of intravitreally applied Bevacizumaband Triamcinolone on diabetic macular edemaSonja G. Prager, Katharina Kriechbaum, Georgios Mylonas, Georg Rainer, Ursula Schmidt-Erfurth (Vienna/A)

16:49 FP MO-32-08Does the Prevention of Dark adaptation affect thecourse of Diabetic Macular Oedema?Sobha Sivaprasad, Sreedhar Jyothi, Geoffrey Arden(London/UK)

16:56 FP MO-32-09Syringes, needles, and techniques for intravitrealinjections in retinal pharmacotherapyEduardo Rodrigues, Octaviano Magalhaes, Eduardo Dib, Fernando M. Penha, Carsten H. Meyer,Quan D. Nguyen, Mauricio Maia, Michel Eid Farah(Florianopolis/BR, São Paulo/BR, Bonn/D, Baltimore/USA)

17:03 FP MO-32-10Intravitreal Growth Factors in AMD, DME and RVOMichael Koss, Marcel Pfister, Florian Rothweiler, Jindrich Cinatl, Martin Michaelis, Frank Koch (Frankfurt/D)

17:10Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne

143

Monday, 7 June 2010Sc

ient

ific P

rogr

am S

ched

ule

WOC® 2010M

onda

y, 7

June

144

09:41 FP MO-25-10B Guided Versus Contact A-mode Biometry for Accurate Measurement of Axial Length and I.O.LPower Calculation in Siliconized EyesMervat H Shalaby, Khaled G. Abu El Einen, Hoda Elshiwy Elshiwy (Cairo/ET)

09:48Discussion

VIP Lounge 2

10:30 - 12:00 MO-62

NGO/Private Sector Partnerships: WIN/WIN orConflicting Agendas?


Chairs:Johannes Trimmel (Vienna/A)Amos Kibata (Uheal/EAK)Kevin J. Buehler (Fort Worth/USA)

10:30 IL MO-62-01Introduction to the SessionKevin J. Buehler (Fort Worth/USA)

10:35 IL MO-62-02Introduction to the SpeakersJohannes Trimmel (Vienna/A)

10:40 IL MO-62-03Corporate Social Responsibility-an opportunity forNGO/Private Sector partnershipsRoy Acosta (Fort Worth/USA)

10:50 IL MO-62-04How Do You Bridge Competing Interests?Joanna Conlon (London/UK)

11:00 IL MO-62-05How Private Ophthalmologist Engage with NGO –the Kikuyu Eye Unit ModelAmos Kibata (Uheal/EAK)

11:10 IL MO-62-06How NGOs Participate in Developing OphthalmicMarketsJohn M. Barrows (Kensington/USA)

11:20 IL MO-62-07Key Successes and Never Dos in NGO/Private Sector PartnershipsPeter Ackland (London/UK)

11:30 IL MO-62-08Question / Answer SessionAmos Kibata (Uheal/EAK)

VIP Lounge 2

08:30 - 10:00 MO-25

Cataract/Biometry 2

Free paperCataract

Chairs:Guna Laganovska (Riga/LV)Zdravko Mandic (Zagreb/HR)Walter Stark (Baltimore/USA)

08:30 SL MO-25-01Surgical technique for suture fixation of an acrylicintraocular lens in the absence of capsule supportWalter Stark (Baltimore/USA)

08:39 FP MO-25-02Correction of medium-to-high myopia and myopic astigmatism with AcrySof Cachet phakicintraocular lens and limbal relaxing incisionsThomas Kohnen, Oliver Klaproth (Frankfurt/D)

08:46 SL MO-25-03Treatment of lens dislocationGuna Laganovska (Riga/LV)

08:55 FP MO-25-04Comparative study of corneal endothelial protection characteristics between dispersive andadaptive OVDsRandall Olson (Salt Lake City/USA)

09:02 FP MO-25-05Vitrectomy and Retropupillar Artisan IOLs in theManagement of Aphakia and Luxated Cataractwith Insufficient Zonular SupportJustus G. Garweg, Markus Halberstadt (Bern/CH)

09:09 SL MO-25-06Contemporary aproach to the combined glaucomaand cataract procedureZdravko Mandic (Zagreb/HR)

09:18 FP MO-25-07Comparison of torsional mode and conventionalultrasound mode phacoemulisification for cataractsurgeryJing Ji, Min Luo, Xianqun Fan, Yilei Pan, Jianfeng Lu(Shanghai/CN)

09:25 SL MO-25-08Coaxial MICS – an important step in phacoemulsi-fication developmentWojciech Omulecki (L⸍ódz/PL)

09:34 FP MO-25-09outcome of hole and chop technique phaco onhard cataractsKeembiyage Dayawansa (Kandy/CL)

145

Monday, 7 June 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Mon

day,

7 Ju

ne

14:42 FP MO-27-07Comparison of microperimetry and conventionalcomputer perimetry in patients with macular holeAlexander Shpak, Galina Kachalina, Elena Pedanova(Moscow/RUS)

14:49 FP MO-27-08Optical coherence tomography findings in shakenadult syndromeVolha Yarmak, Tatsiana Imshenetskaya, GalinaVashkevich, Vladimir Rubis (Zaslavl/BY, Minsk/BY)

14:56 FP MO-27-09Maculopathy After Long-Term Chloroquine Treatment – A Microperimetry and MF-ERG-StudyChristina Springer, Petra Weimer, DorotheaThiemeyer, Regina Max, Klaus Rohrschneider,Friederike Mackensen (Zurich/CH, Heidelberg/D)

15:03 FP MO-27-10Visual prognosis of Purtscher’s-retinopathy-likecentral retinal artery occlusionHiroyuki Iijima (Yamanashi/J)

15:10Discussion

VIP Lounge 2

16:00 - 17:30 MO-28

Trauma

Free PaperTrauma

Chairs:Wolfgang F. Schrader (Nürnberg/D)Nelly Sivkova (Plovdiv/BG)

16:00 FP MO-28-01The influence of alcohol abuse on the etiology andseverity of open globe injuriesFlorian Rüfer, Andrea Peters, Alexa Klettner, Felix Treumer, Johann Roider (Kiel/D)

16:07 SL MO-28-02War and Eye Trauma in West Darfur (Sudan)Mohamed Siddig (Elafuon/SUD)

16:16 FP MO-28-03Intraocular metal foreign body: personal experienceNelly Sivkova (Plovdiv/BG)

16:23 FP MO-28-04Is There Ocular Primary Blast Injury?Richard Blanch, Robert A. H. Scott, David R. J. Snead(Birmingham/UK)

VIP Lounge 2

14:00 - 15:30 MO-27


Free PaperRetina

Chairs:Bernd Kirchhof (Cologne/D)Peter Walter (Aachen/D)Hendrik P. N. Scholl (Baltimore/USA)

14:00 FP MO-27-01Detection of Drusen using Polarization-sensitiveOptical Coherence TomographyFerdinand Georg Schlanitz, Bernhard Baumann,Christian Ahlers, Sabine Schriefl, Tobias Spalek, Isabelle Golbaz, Michael Pircher, Erich Götzinger,Christoph Hitzenberger, Ursula Schmidt-Erfurth(Vienna/A)

14:07 FP MO-27-02Automated detection and quantification of hardexudates in diabetic macular edema using polar-ization sensitive optical coherence tomographyJan Lammer, Matthias Bolz, Bernhard Baumann,Michael Pircher, Barbara Wetzel, Christoph Hitzenberger, Ursula Schmidt-Erfurth (Vienna/A)

14:14 FP MO-27-03Retinal Cellular Imaging using a New Clinical UltraHigh Resolution Confocal Microscope with UltraHigh Speed Spectral Domain OCTRichard Rosen, Patricia Garcia, Gennady Landa,Mark Hathaway, John Rogers, Rishard Weitz,Thomas Muldoon, Ronald Gentile, Alfonso Ponce,Joseph Walsh (New York/USA)

14:21 FP MO-27-04Spectral domain OCT in central serous chorioretinopathy – description of retinal changesVeronique Valet, Mathias Maier, Chris PatrickLohmann (Munich/D)

14:28 FP MO-27-05Spectral OCT observations of non full thickness defects of the foveaJanusz Michalewski, Zofia Michalewska, Dominik Odrobina, Slawomir Cisiecki, Krzysztof Dziegielewski, Zbigniew Pikulski, Jerzy Nawrocki (L⸍ódz/PL)

14:35 FP MO-27-06Structure-Function Correlation of the Human Central RetinaHendrik P. N. Scholl, Peter Charbel Issa, Eric Tröger,Robert P. Finger, Frank G. Holz, Robert Wilke (Baltimore/USA, Bonn/D)

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

16:30 FP MO-28-05A comparitive study of visual outcome, ocular survival and complications of open globe injuriesin age groups of <18 yr and >18 year old individualsLavanya Rao, Krishna Rao, Manali Hazarika, Sulatha Bhandary (Manipal/IND)

16:37 FP MO-28-06Location of the canalicular laceration and the clinical outcome after surgical repairShi Wodong (Shanghai/CN)

16:44 FP MO-28-07Phakoanaphylactic Endophthalmitis 67 years aftertraumaFabian Höhn, Alireza Mirshahi, Lars-Olof Hattenbach (Mannheim/D, Ludwigshafen/D,Mainz/D)

16:51 FP MO-28-08Multi-local exposure within the Ex Vivo Eye Irritation Test (EVEIT)Norbert Schrage, M. Frentz, F. Spöler (Köln/D)

16:58 FP MO-28-09Long-term results after endonasal microsurgicaldecompression of the optic nerveHartmut Möbius, Lothar Bauer, Hans-JürgenWelkoborsky, Burkhard Wiechens (Hannover/D)

17:05 FP MO-28-10Vitreous metastasis in cutaneous malignantmelanomaIsabella Rücker, Fariba Mohammadi Rad, Christine Förster, Ludwig Wilkens, BurkhardWiechens (Hannover/D)

17:12 SL MO-28-11Post-traumatic eyelid repairBrigita Drnovsek-Olup (Ljubljana/SI)

17:21Discussion


08:30 - 10:00 MO-29

Club Jules Gonin Symposium: Surgical Management of Macular Diseases

SymposiumRetina

Chairs:Donald J. D'Amico (New York/USA)Thomas J. Wolfensberger (Lausanne/CH)Peter Wiedemann (Leipzig/D)

08:30 IL MO-29-01Anti-VEGF therapy and surgery for PDRPascale Massin (Paris/F)

08:40 IL MO-29-02Anti-VEGF therapy and surgery for ROPAntonio Capone (Oakland/USA)

08:50 IL MO-29-03Intraoperative use of Plasmin for vitreoretinal surgeryMichael T. Trese (Royal Oak/USA)

09:00 IL MO-29-04Perioperative use of steroids and lasers in vitreoretinal surgeryMark S. Blumenkranz (Stanford/USA)

09:10 IL MO-29-05Pharmacological adjuvants in retinal detachmentsurgeryGeorge William Aylward (London/UK)

09:20 IL MO-29-06Role of t-PA in vitreoretinal surgeryJosé García Arumí (Barcelona/E)

09:30 IL MO-29-07State of the Art management of endophthalmitisThomas J. Wolfensberger (Lausanne/CH)

09:40Discussion


10:30 - 12:00 MO-30

Surgical Therapy of Keratoconus


Chairs:Florian Birnbaum (Freiburg/D)Edward Wylegala (Katowice/PL)Abdulaziz AlRajhi (Riyadh/SA)

10:30 IL MO-30-01Crosslinking treatment to stopp keratoconus progressionPhilip Maier (Freiburg)

10:40 IL MO-30-02Excimer laser assisted penetrating keratoplasty inadvanced keratoconusBerthold Seitz (Homburg/D)

10:50 IL MO-30-03Deep anterior lamellar keratoplaty vs. penetratingkeratoplasty in advanced keratoconusEdward Wylegala (Katowice/PL)

Monday, 7 June 2010

Mon

day,

7 Ju

ne146

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:00 IL MO-30-04Femtosecondlaser assisted penetrating keratoplasty in keratoconusFlorian Birnbaum (Freiburg/D)

11:10 IL MO-30-05Intracorneal ring segments in keratoconus patientsEfekan Coskunseven (Istanbul/TR))

11:20 IL MO-30-06Treatment of keratoconus recurrenceTBA

11:30Discussion


14:00 - 15:30 MO-31

Glaucoma: Surgical Therapy 1

Free PaperGlaucoma

Chairs:Keith Barton (London/UK)Joshua D. Stein (Ann Arbor/USA)Josef Flammer (Basel/CH)

14:00 FP MO-31-01Investigation of the Efficacy of Selective Laser Trabeculoplasty (=“SLT“) particularly its health-economic Aspects. Presentation of 12 Month Postoperative ResultsJuergen Reese, Mark Tomalla (Duisburg/D)

14:07 FP MO-31-02Selective Laser Trabeculoplasty (SLT) in Patientswith inadequate Reduction of Intraocular Pressureunder maximum tolerated Drug Therapy.Results12-month postoperativeCornelia Hirn, Sandrine Zweifel, Annette Hediger,Marc Töteberg-Harms, Jens Funk (Zurich/CH)

14:14 FP MO-31-03Comparision of Trabeculectomy With and WithoutAmniotic Membrane – A Pilot StudyDipanjan Pal, Alokesh Ganguly (Kolkata/IND)

14:21 FP MO-31-04The outcome of combined endoscopic cyclophoto-coagulation and phacoemulsification in treatmentof medically controlled primary open angle glau-coma patientsHon Seng Wong , Ropilah Abdul Rahman (Kuala Lumpur/MAL)

14:28 FP MO-31-05How does viscocanaloplasty work? In vivo anteriorsegment ultrasound to explain the mechanism.Jan Olivier, Robert Stegmann (Pretoria/ZA)

14:35 FP MO-31-06Conventinal Trabeculectomy versus ExPressShunt(R) Filtering surgery both with 5-FU: aprospective clinical ramdomized trialGangolf Sauder (Stuttgart/D)

14:42 FP MO-31-07Does the size of the subconjunctival preparationinfluence the outcome of trabeculectomy withmitomycin C?Joanna Wasielica-Poslednik, Daniel Herzog, Esther Hoffmann, Shakhsanam Aliyeva, Norbert Pfeiffer (Mainz/D)

14:49 FP MO-31-08Outcome of Repeat TrabeculectomiesCarpi Olali, Alan Rotchord, Anthony J. King(Boston/UK)

14:56 FP MO-31-10Vitrectomy does not influence the incidence of ocular hypertension or open-angle glaucoma – a 5-year follow-upAlice Yu, Wolfgang Brummeisl, Anselm Kampik, Ulrich Welge-Lüßen (Munich/D, Erlangen/D)

15:03 FP MO-31-11Optimizing the detection of visual field changeusing automated pointwise linear regressionanalysis: the “truncated” trend-event based approachGustavo V. De Moraes, C. Tello, Robert Ritch, J. M.Liebmann (New York/USA)

15:10Discussion


16:00 - 17:30 MO-68

Retina: AMD 2

Free PaperRetina

Chairs:Frank G. Holz (Bonn/D)Liga Radecka (Riga/LV)Florian Sulzbacher (Vienna/A)

16:00 SL MO-68-01ARMD and Cataract SurgeryLiga Radecka (Riga/LV)

16:09 FP MO-68-02Safety profiles of diabetic versus non-diabeticAMD patients in randomized controlled clinicalstudies with ranibizumabFrank G. Holz, Gabriela Burian, Andreas Weichsel-berger, Yehia Hashad (Bonn/D, Basel/D)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

147

Monday, 7 June 2010

WOC® 2010148M

onda

y, 7

June

17:05 FP MO-68-10One-Year’s Treatment Result of Chinese with Neovascular Age-related Macular Degenerationwith Intra-vitreal Ranibizumab in Clinical SettingThomas Tai Ka Fat (Hong Kong/HK)

17:12Discussion


08:30 - 10:00 MO-33

Intraocular Tumors

SymposiumPathology

Chairs:Hans E. Grossniklaus (Atlanta/USA)Miguel Noel Burnier (Montreal/CDN)Claudia Auw-Hädrich (Freiburg/D)

08:30 IL MO-33-01MelanomaMiguel Noel Burnier (Montreal/CDN)

08:40 IL MO-33-02Ciliary body tumorsClaudia Auw-Hädrich (Freiburg/D)

08:50 IL MO-33-03Primary intraocular lymphomaSarah E. Coupland (Liverpool/UK)

09:00 IL MO-33-04RetinoblastomaRalph C. Eagle (Philadelphia /USA)

09:10 IL MO-33-05Mimickers of intraocular tumorsTero Kivelä (Helsinki/FIN)

09:20 IL MO-33-06Metastatic intraocular tumorsRubens Belfort Neto (São Paulo/BR)

09:30 IL MO-33-07Mystery intraocular tumorsJerry Shields (Philadelphia/USA)

09:40Discussion

16:16 FP MO-68-03SDOCT-morphology and the corresponding retinal function in neovascular age-related macular degeneration (nAMD)Florian Sulzbacher, Christopher Kiss, Marion Munk,Stefan Eisenkoelbl, Stefan Sacu, Ursula Schmidt-Erfurth (Vienna/A)

16:23 FP MO-68-04Safety and efficacy of OZURDEX™ (Dexametha-sone Intravitreal Implant) as adjunctive therapy to Lucentis® in patients with Choroidal Neovascu-larization (CNV) secondary to Age-Related MacularDegeneration (AMD)Baruch Kuppermann, Michael Singer, Dov Weinberger, Anat Loewenstein, Ching-chi Liu,Jean Lou, Xiao-Yan (Joanne) Li, Scott M. Whitcup(Irvine/USA, Tel-Aviv/IL)

16:30 FP MO-68-05Targeting the alternative pathway of complementin AMD with a factor D selective antibodyMenno van Lookeren Campagne, Kenneth J.Katschke, Ping Wu, Christian Wiesmann, Robert F. Kelley, Kelly Loyet, Laura DeForge, Philip E. Hass, Peter Haughney, Lisa A. Damico (San Francisco/USA)

16:37 FP MO-68-06Microperimetry as a method for monitoring macular function in patients with dry age-relatedmacular degenerationYuri Astakhov, Alla Lisochkina, Pavel Nechiporenko(Saint-Petersburg/RUS)

16:44 FP MO-68-07Activity Loss Predicts Cognitive Decline in Age-Related Macular Degeneration (AMD)William Tasman, Barry Rovner, Robin Castin (Wyndmoor/USA, Philadelphia/USA)

16:51 FP MO-68-08Senile Local Eye Amyloidosis Risk Factor for Age-related Macular DegenerationVictor Ermilov (Volgograd/RUS)

16:58 FP MO-68-09A prospective study on different methods of treat-ment for choroidal neovascularization. The efficacyof verteporfin photodynamic therapy (PDT), intravitreal bevacizumab and transpupillarythermo therapy (TTT) in patients with neovascularAMDMichal Nowak, Piotr Jurowski, Roman Gos,Miroslaw Pastuszka, Andrzej Kapica, JanuszSmigielski (L⸍ódz/PL)

Scie

ntifi

c Pro

gram

Sch

edul

e

Monday, 7 June 2010

WOC® 2010


14:00 - 15:30 MO-35

Cornea/External Disease: Diagnostics


Chairs:John K. G. Dart (London/UK)Berthold Seitz (Homburg/D)Eric Spierings (Utrecht/NL)

14:00 FP MO-35-01Multicenter Study of the Herpes Simplex Virus Immunochromatography Kit for the Diagnosis ofHerpetic Epithelilal KeratitisYoshitsugu Inoue, Yoshikazu Shimomura, Masahiko Fukuda, HSV kit study group (Yonago/J,Osaka-Sayama/J)

14:07 FP MO-35-02Impact of voriconazole in fungal keratitis in East-ern IndiaSuman Saha, Jayangshu Sengupta, Debdulal Banerjee, Archana Khetan (Kolkata/IND)

14:14 FP MO-35-03Intraocular pressure survey in patients who underwent lamellar keratoplastyJaniszewska Dominika, Edward Wylegala, Anna Nowinska, Dariusz Dobrowolski(Katowice/PL)

14:21 FP MO-35-04Distribution of antigen presenting cells in humancorneas with different pathologic entities – correlation of confocal in vivo microscopy and immunofluorescence histochemistryMarc Mackert, Nicole Kranebitter, Elisabeth Messmer, Martin Grüterich, Daniel Kook, Armin Wolf, Anselm Kampik, Eveline Irschick, Wolfgang Mayer (Munich/D)

14:28 FP MO-35-05Confocal microscopic evaluation of cornealchanges after riboflavin-UVA corneal collagencross-linking for keratoconusLaurence Lim, Roger Beuerman, Li Lim, Donald Tan(Singapore/SGP)

14:35 FP MO-35-06Repeatability of corneal wavefront measurementswith the Orbscan IIz topographer in normal andkeratoconus eyesYasemin Tanyildizi (Frankfurt/D)

14:42 FP MO-35-07Detection of subclinical keratconus using conven-tional and corneal wavefront-based metricsJens Bühren, Daniel Kook, Thomas Kohnen (Frankfurt/D)


10:30 - 12:00 MO-34

New Diagnostic and Therapeutic Aspects of OrbitalDiseases


Chairs:Geoffrey Rose (London/UK)Rudolf F. Guthoff (Rostock/D)James A. Katowitz (Philadelphia/USA)

10:30 IL MO-34-01Ab-externo lateral wall decompression for thyroideye diseaseGeoffrey Rose (London/UK)

10:40 IL MO-34-03The significance of Orbit Imaging particulary with regard to differential diagnosis and therapyplaning of orbital diseasesVolker Hingst (Rostock/D)

10:50 IL MO-34-04Compressive neuropathy in thyroid eye disease –diagnostic features and therapeutic strategiesNicole Fichter (Olten/CH)

11:00 IL MO-34-05Orbital space occupying lesions – decision orientated strategiesRudolf F. Guthoff (Rostock/D)

11:10 IL MO-34-06Innovative uses for dermis fat grafting in orbitalreconstructionJames A. Katowitz (Philadelphia/USA)

11:20 IL MO-34-07Angiodysplasia of the Orbit or Complications of Orbital Surgery – How to AvoidSerge Morax (Neuilly-sur-Seine/F)

11:30Discussion

Scie

ntifi

c Pro

gram

Sch

edul

e

149

Mon

day,

7 Ju

ne

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:49 FP MO-35-08Peculiarities of corneal changes of patients withdiabetes mellitus depending on the compensationof diabetesOlesya Zavoloka, Pavlo Bezditko, Maryna Shchadnykh, Darya Zubkova (Kharkiv/UA)

14:56 FP MO-35-09Clinical and ultrasound biomicroscopy (UBM) fea-tures predictive of growth in iris melanocytic lesionsGian Paolo Giuliari, Hatem Krema, E. Rand Simpson,Charles J. Pavlin (Toronto/CDN)

15:03 SL MO-35-10Experience of corneal collagen cross-linking withriboflavin and ultraviolet-A light for progressivekeratoconus: one year follow-up in Pakistani populationWajid Khan (Rawalpindi/PK)

15:10Discussion


16:00 - 17:30 MO-36

Ocular Pharmacology: Preclinical Safety and Efficacy Testing

SymposiumPharmacology, Ocular Drug Delivery

Chairs:Peter Szurman (Tübingen/D)Johann Roider (Kiel/D)Martin S. Spitzer (Tübingen/D)

16:00 IL MO-36-01Preclinical drug evaluation – more than a simplebiocompatibility testing?Peter Szurman (Tübingen/D)

16:10 IL MO-36-02Ocular cell culture – the cheap and easy way totest preclinical safety and efficacyMartin S. Spitzer (Tübingen/D)

16:20 IL MO-36-03VEGF Inhibitor efficacy – can cell culture experi-ments tell us which of them is the best?Johann Roider (Kiel/D)

16:30 IL MO-36-04Penetration and distribution of VEGF-Inhibitorsafter intravitreal injectionSwaantje Peters (Lübeck/D)

16:40 IL MO-36-05Superfused isolated bovine retina – testing intrav-itreal drugs in-vivo without sacrificing animalsMatthias Lüke (Lübeck/D)

16:50 IL MO-36-06In-vivo veritas – animal models for ocular drugtestingPeter Heiduschka (Tübingen/D)

17:00 IL MO-36-07Optic nerve crush testing – Evaluation of neuro-protective drugsFrank Schüttauf (Tübingen/D)

17:10Discussion

Hall 3

08:30 - 10:00 MO-37

Corneal Approaches for Addressing Presbyopia


Chairs:Douglas D. Koch (Houston/USA)Emanuel S. Rosen (Manchester/UK)Thomas F. Neuhann (Munich/D)

08:30 IL MO-37-01Corneal Techniques (Monovision)Thomas F. Neuhann (Munich/D)

08:45 IL MO-37-02Corneal PseudoaccommodationDouglas D. Koch (Houston/USA)

09:00 IL MO-37-03Presby-LasikDamián Gatinel (Paris/F)

09:15 IL MO-37-04Intracorneal LensesEmanuel S. Rosen (Manchester/UK)

09:30 IL MO-37-05Small Aperture DevicesGeorge Waring (Atlanta/USA)

09:45Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne150

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 3

10:30 - 12:00 MO-38

Corneal Laser Refractive Surgery


Chairs:Günther Grabner (Salzburg/A)J. Bradley Randleman (Atlanta/USA)Michael C. Knorz (Mannheim/D)

10:30 IL MO-38-01Femtosecond Laser TechnologyGünther Grabner (Salzburg/A)

10:40 IL MO-38-02Excimer Laser TechnologyTheo Seiler (Zurich/CH)

10:50 IL MO-38-03Femtosecond Laser: More Than a Flap MakerHolger Lubatschowski (Hannover/D)

11:00 IL MO-38-04Eye-trackingMichael Mrochen (Zurich/CH)

11:10 IL MO-38-05LASIK Techniques and ComplicationsMichael C. Knorz (Mannheim/D)

11:20 IL MO-38-06Surface Techniques and ComplicationsMarguerite McDonald (New Orleans/USA)

11:30 IL MO-38-07EctasiaJ. Bradley Randleman (Atlanta/USA)

11:40Discussion

Hall 3

14:00 - 15:30 MO-39

Corneal Physiology and Biomechanics


Chairs:Jorge L. Alió (Alicante/E)William J. Dupps Jr. (Cleveland/USA)Theo Seiler (Zurich/CH)

14:00 IL MO-39-01BiomechanicsWilliam J. Dupps Jr. (Cleveland/USA)

14:10 IL MO-39-02Accommodation and presbyopiaAdrian Glasser (Houston/USA)

14:20 IL MO-39-03Normal wavefront error as function of age, pupilsize and anatomyJorge L. Alió (Alicante/E)

14:30 IL MO-39-04Retinal image quality in refractive surgeryJack T. Holladay (Bellaire/USA)

14:40 IL MO-39-05Laser tissue interactionRonald R. Krueger (Cleveland/USA)

14:50 IL MO-39-06New advances in corneal imagingMitchell P. Weikert (Houston/USA)

15:00Discussion

Hall 3

16:00 - 17:30 MO-40

Managing High Refractive Errors


Chairs:Joseph Colin (Bordeaux/F)Roberto Zaldivar (Buenos Aires/RA)Thomas Kohnen (Frankfurt/D)

16:00 IL MO-40-01Phakic IOLs vs Corneal Refractive SurgeryJosé L. Güell (Barcelona/E)

16:10 IL MO-40-02Angle-supportedThomas Kohnen (Frankfurt/D)

16:20 IL MO-40-03Iris-fixatedCamille Budo (Sint-Truiden/B)

16:30 IL MO-40-04Sulcus-fixatedRoberto Zaldivar (Buenos Aires/RA)

16:40 IL MO-40-05Phakic IOLs: ComplicationsJoseph Colin (Bordeaux/F)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

151

Monday, 7 June 2010

WOC® 2010

Hall 4/5

16:00 - 17:30 MO-64

Pterygium Surgery


Chairs:Donald T. H. Tan (Singapore/SGP)Gerd Geerling (Würzburg/D)Abdulaziz AlRajhi (Riyadh/SA)

16:00 IL MO-64-01Epidemiology and EtiologyHugh R. Taylor (Carlton/AUS)

16:16 IL MO-64-02Current Understanding of Pterygium PathogenesisNick Di Girolamo (Sydney/AUS)

16:32 IL MO-64-03Mind the Gap – Surgical Pearls for Primary and Recurrent PterygiaScheffer C. G. Tseng (Miami/USA)

16:48 IL MO-64-04EBM Review of Surgical Trials in PterygiaCordelia M. L. Chan (Singapore/SGP)

17:04 IL MO-64-05Anti-angiogenic Treatment ModalitiesGerd Geerling (Würzburg/D)

17:14 IL MO-64-06Management of Complications of Pterygium SurgeryDonald T. H. Tan (Singapore/SGP)

Hall 6

08:30 - 10:00 MO-49

Cicatrizing Conjunctivitis


Chairs:Arnd Heiligenhaus (Münster/D)Shigeru Kinoshita (Kyoto/J)

08:30 IL MO-49-01Stevens Johnson syndrome and toxic epidermalnecrolysis; management in the acute phase withimmunosuppression, steroids, and AMTShigeru Kinoshita (Kyoto/J)

08:40 IL MO-49-02Pathogenesis, autoantigens, diagnostics of mucousmembrane pemphigoidDetlef Zillikens (Lübeck/D)

16:50 IL MO-40-06Refractive Lens ExchangeAntonio A. P. Marinho (Porto/P)

17:00 IL MO-40-07IOL Selection for Refractive Lens ExchangeRoberto Bellucci (Verona/I)

17:10Discussion

Hall 4/5

14:00 - 15:30 MO-63

Macula Society Symposium: Nonsurgical Treatment of Macular Diseases

SymposiumRetina

Chairs:Evangelos S. Gragoudas (Boston/USA)

14:00 IL MO-63-01New developments in pharmacotherapy for AMDAnthony P. Adamis (Chicago/USA)

14:10 IL MO-63-02Treatment of diabetic macular dedmaLloyd Paul Aiello (Boston/USA)

14:20 IL MO-63-03Management of macula edema in branch an central retinal vein occlusionThomas Friberg (Pittsburgh/USA)

14:30 IL MO-63-04Management of dry AMDIvana Kim (Boston/USA)

14:40 IL MO-63-05Treatment of geographic atrophyMichael L. Klein (Portland/USA)

14:50 IL MO-63-06Treatment of macular telangiectasia type 2Joan Miller (Boston/USA)

15:00Discussion

152M

onda

y, 7

June

Scie

ntifi

c Pro

gram

Sch

edul

e

Monday, 7 June 2010

WOC® 2010

11:30 IL MO-50-07Intraocular antibiotic therapyDenise Freitas (Sao Paulo/BR)

11:40Discussion

Hall 6

14:00 - 15:30 MO-51

Combating Childhood Blindness: Strategies of Prevention, Detection and Treatment


Chairs:Nathan G. Congdon (Baltimore/USA)Oliver Ehrt (Munich/D)Clare Gilbert (London/UK)

14:00 IL MO-51-01Combating Childhood Blindness: Overview of theavoidable causes of blindness in childrenClare Gilbert (London/UK)

14:10 IL MO-51-02Prevention: Strategies for preventing retinopathyof prematurityLuz Gordillo (Lima/PE)

14:20 IL MO-51-03Early detection: Neonatal screening: experiencesfrom BrazilAndrea Zin (Rio de Janeiro/BR)

14:30 IL MO-51-04Early detection: Key informant method for identifying blind childrenMohammad Muhit (Dhaka/BD)

14:40 IL MO-51-05Treatment: Optimising the outcome of cataractsurgery in children – clinical aspectsPerumalsamy Vijayalakshmi (Madurai/IND)

14:50 IL MO-51-06Treatment: Optimising the outcome of cataractsurgery in children – non-clinical aspectsPaul Courtright (Moshi/EAT)

15:00 IL MO-51-07Treatment: Lessons learnt from school eye healthprogram programmesNathan G. Congdon (Baltimore/USA)

15:10Discussion

08:50 IL MO-49-03Immunosuppression and immunoglobulins in cicatrizing conjunctivitisManfred Zierhut (Tübingen/D)

09:00 IL MO-49-04Stem cell deficiency and fornix reconstruction incicatrizing conjunctivitisDaniel Meller (Essen/D)

09:10 IL MO-49-05Clinic and management of other cicatrizing conjunctivitisThanh Hoang-Xuan (Paris/F)

09:20 IL MO-49-06Mucous membrane pemphigoid: making the diagnosisJohn K. G. Dart (London/UK)

09:30Discussion

Hall 6

10:30 - 12:00 MO-50

Intra-Ocular Therapy


Chairs:Rubens Belfort, Jr. (São Paulo/BR)Anat Loewenstein (Tel Aviv/IL)Thomas Ness (Freiburg/D)

10:30 IL MO-50-01Intraocular implantsRubens Belfort, Jr. (São Paulo/BR)

10:40 IL MO-50-02Vitrectomy in uveitisAnat Loewenstein (Tel Aviv/IL)

10:50 IL MO-50-03Bevacizumab and Rainbizumab in uveitisAhmad Mansour (Beirut/RL)

11:00 IL MO-50-04Glaucoma devices in uveitisThomas Ness (Freiburg/D)

11:10 IL MO-50-05Antiviral therapyCareen Y. Lowder (Cleveland/USA)

11:20 IL MO-50-06Cataract surgery in uveitisSoon Phaik Chee (Singapore/SGP)

153

Scie

ntifi

c Pro

gram

Sch

edul

e

Mon

day,

7 Ju

ne

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 6

16:00 - 17:30 MO-52

The Economics of Blindness: What Does Lost VisionCost, How Much Can Prevention Save?


Chairs:Paul Lee (Durham/USA)Jill Keeffe (Melbourne/AUS)

16:00 IL MO-52-01The need for good epidemiological data on causes,prevalence and incidence of vision impairment foron vision impairment analysesPaul Lee (Durham/USA)

16:15 IL MO-52-02Is there a role for public health in promoting visualscreening? Cost-effectiveness results from theUnited StatesDavid B. Rein (Atlanta/USA)

16:30 IL MO-52-03Modeling changes in mean deviation in glaucoma– Bringing together the results of the CIGTS, OHTS,and AGIS studies using decision analytic methodsSteven M. Kymes (St. Louis/USA)

16:45 IL MO-52-04Willingness to pay for cataract surgery in ruralChinaMingguang He (Guangzhou/CN)

17:00 IL MO-52-05What are the sources of data that we use to establish costs?Jill Keeffe (Melbourne/AUS)

17:15Discussion

Hall 7

06:45 - 08:15

World Ophthalmic Education Colloquium BreakfastAttendance upon invitation only

Hall 7

08:30 - 10:00 MO-53

ARVO Symposium: Translational Research – Developing Innovative New Treatments for Glaucoma

SymposiumGlaucoma

Chairs:Peng T. Khaw (London/UK)Georg Michelson (Erlangen/D)

08:30 IL MO-53-01Tissue bioengineeringDong Feng Chen (Boston/USA)

08:40 IL MO-53-02Neuroprotection of retinal ganglion cellsHenry Klassen (Irvine/USA)

08:50 IL MO-53-03Gene therapy for glaucomaKeith Martin (Cambridge/UK)

09:00 IL MO-53-04CNS implications of glaucoma damage and potential therapiesNeeru Gupta (Toronto/CDN)

09:10 IL MO-53-05Nanostrategies to restore neurons in glaucomaRutledge G. Ellis-Behnke (Cambridge/USA)

09:20 IL MO-53-06New methods of preventing scarringPeng T. Khaw (London/UK)

09:30 IL MO-53-07Identifying pressure response genes in the trabecular meshworkTerete Borras (Chapel Hill/USA)

09:40Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne154

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 7

10:30 - 12:00 MO-54

EGS Symposium: Glaucoma Management: Hot Topics from the new EGS Guidelines

SymposiumGlaucoma

Chairs:Clive Migdal (London/UK)Francisco Javier Goñi Foncillas (Barcelona/E)John Thygesen (Copenhagen/DK)

10:30 IL MO-54-01Progression is the key; where are we going withperimetryFrancisco Javier Goñi Foncillas (Barcelona/E)

10:50 IL MO-54-02Target IOP – where are we now?John Thygesen (Copenhagen/DK)

11:10 IL MO-54-03The combined approach to glaucoma medicationsAnton Bernhard Hommer (Vienna/A)

11:30 IL MO-54-04The cutting edge – glaucoma incisional surgeryTarek M. Shaarawy (Geneva/CH)

11:50Discussion

Hall 7

14:00 - 15:30 MO-55

EBO Symposium: From National towards EuropeanTraining in Ophthalmology


Chairs:Marko Hawlina (Ljubljana/SI)Wagih Aclimandos (London/UK)Marie-José Tassignon (Antwerp/B)

14:00 IL MO-55-01European Board of Ophthalmology-what and whyPeter J. Ringens (Amsterdam/NL)

14:10 IL MO-55-02European Board of Ophthalmology diploma examination (EBOD)Catherine Creuzot-Garcher (Dijon/F)

14:20 IL MO-55-03European CME accreditationGordana Sunaric-Megevand (Genève/CH)

14:30 IL MO-55-04European accreditation of training centersWagih Aclimandos (London/UK)

14:40 IL MO-55-05ENET unifying European subspecialty SocietiesMarie-José Tassignon (Antwerp/B)

14:50 IL MO-55-06"Concordia pro visu": education meets researchTero Kivelä (Helsinki/FIN)

15:00 IL MO-55-07Harmonisation of training accross EuropeMarko Hawlina (Ljubljana/SI)

15:10Discussion

Hall 7

16:00 - 17:30 MO-56

APAO Symposium: Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asia-Pacific Region

SymposiumRetina

Chairs:Ian Constable (Nedlands/AUS)Timothy Lai (Hong Kong/CN)Xiaoxin Li (Beijing/CN)

16:00 IL MO-56-01Epidemiology of AMD and PCV in the Asia-PacificregionTien Ying Wong (Singapore/SGP)

16:10 IL MO-56-02Molecular genetics of Asian AMD and PCVChi-Pui Pang (Hong Kong/CN)

16:20 IL MO-56-03Comparison of angiographic features in neovascular AMD and PCVAdrian Koh (Singapore/SGP)

16:30 IL MO-56-04Optical coherence tomography imaging in AMDand PCVWon-Ki Lee (Seoul/ROK)

16:40 IL MO-56-05Pharmacotherapy for neovascular AMDTaraprasad P. Das (Hyderabad/IND)

16:50 IL MO-56-06Role of Photodynamic therapy and Transpupillarythermal therapy in PCVXiaoxin Li (Beijing/CN)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

155

Monday, 7 June 2010Sc

ient

ific P

rogr

am S

ched

ule

WOC® 2010

Hall 8

10:30 - 12:00 MO-58

Organisational Aspects: Training, Policy, Economics,Legal, Regulations, Interoperability

Symposium

Chairs:Anja Tuulonen (Oulu/FIN)Jiri Jan (Brno/CZ)Isabel Oberacher-Velten (Regensburg/D)

10:30 IL MO-58-01Screening for retinopathy of prematurity – a telemedicine project in BavariaIsabel Oberacher-Velten (Regensburg/D)

10:45 IL MO-58-02The experiences of the EyeMo (mobile eye unit) inNorthern Finland: process, quality end economicsAnja Tuulonen (Oulu/FIN)

11:00 IL MO-58-03Signal analysis in functional OCTLeopold Schmetterer (Vienna/A)

11:15 IL MO-58-04Correcting Motion Artifacts of OCT Volume Scansby using a Novel Software Registration MethodMarkus Meier (Erlangen/D)

11:30Discussion

17:00 IL MO-56-07Long-term outcome of monotherapy withverteporfin photodynamic therapy for PCVMitsuko Yuzawa (Tokyo/J)

17:10 IL MO-56-08Anti-VEGF and combination therapy for PCVTimothy Lai (Hong Kong/CN)

17:20 IL MO-56-09Prevention of AMD and PCVPaul Mitchell (Sydney/AUS)

Hall 8

08:30 - 10:00 MO-57

PAAO Symposium: A Close Look Into the Future:Pearls on New Cornea and External Diseases Techniques and Strategies of Treatment


Chairs:Denise de Freitas (São Paulo/BR)Richard L. Abbott (San Francisco/USA)

08:30 IL MO-57-01Update in the treatment of Acanthamoeba keratitisDenise de Freitas (São Paulo/BR)

08:40 IL MO-57-02New approaches for the treatment and kerato-conus and keratectasia. What is the best choice?Joaquim Neto Murta (Lisboa/P)

08:50 IL MO-57-03Platelet rich plasm in the treatment of ocular surface disease and corneal ulcersJorge L. Alió (Alicante/E)

09:00 IL MO-57-04Molecular biology technique for keratitis diagnosisMauro Nishi (São Paulo/BR)

09:10 IL MO-57-05Current Developments and strategies on lamelarcorneal transplantsLuis Isquierdo Jr. (Lima/PE)

09:20 IL MO-57-06Corneal cross-linking combined with topography-guided laser treatmentMirko R. Jankov (Belgrado/SRB)

09:30Discussion

156M

onda

y, 7

June

Monday, 7 June 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Hall 8

16:00 - 17:30 MO-60

Lindberg Society Symposium: Exfoliation Syndrome – From Molecules to Manifestations

SymposiumMiscellaneous

Chairs:Ursula Schlötzer-Schrehardt (Erlangen/D)Murat Irkec (Istanbul/TR)Gábor Holló (Budapest/H)

16:00 IL MO-60-01The LOXL1 gene – function and implicationsFridbert Jonasson (Reykjavik/IS)

16:10 IL MO-60-02Molecular pathophysiology of XFS – closer to a solution?Ursula Schlötzer-Schrehardt (Erlangen/D)

16:20 IL MO-60-03Exfoliative glaucoma – an open window to neurodegeneration and neuroprotectionRobert Ritch (New York/USA)

16:30 IL MO-60-04Systemic associations and vascular dysfunctionMurat Irkec (Istanbul/TR)

16:40 IL MO-60-05Ocular manifestations of XFS – beyond glaucomaGábor Holló (Budapest/H)

16:50 IL MO-60-06Exfoliative glaucoma – clinical features and cur-rent treatmentAnastasios G. P. Konstas (Thessaloniki/GR)

17:00 IL MO-60-07Asymmetry in manifestation – still an enigmaTero Kivelä (Helsinki/FIN)

17:10 IL MO-60-08Cataract extraction in XFS: Management and prevention of complicationsRupert Menapace (Vienna/A)

17:20Discussion

Hall 8

14:00 - 15:30 MO-59

JCAHPO Symposium: Teaching Allied Health Personnel


Chairs:William F. Astle (Calgary/CDN)Gudrun Bischoff (Hamburg/D)

14:00 IL MO-59-01Introduction & IJCAHPO Overview– Teaching vs. training– Training & CertificationWilliam H. Ehlers (Farmington/USA)

14:10 IL MO-59-02Accreditation & International Standards for Education ProgramsPeter Donshik (Bloomfield/USA)

14:25 IL MO-59-03International Core Curriculum – ICO & IJCAHPO– A teaching model for training the eye care team – Foundation of knowledge & principles– Resources: ICO, IJCAHPO, ATPO, CSOMP, COTP,

OthersWilliam F. Astle (Calgary/CDN)

14:40 IL MO-59-04Implementing the ICO Curriculum in Africa– A teaching model for training the eye care teaBoateng Wiafe (Kasoa/GH)

14:55 IL MO-59-05Teaching Methods – Best Practices– Synchronous– Asynchronous– Clinical – Experiential learningKarl Golnik (Cincinatti/USA)

14:10 IL MO-59-06Retinoscopy Action Learning Presentation– Provide attendees an interactive learning

experience on retinoscopy – Attendees will receive a course syllabus,

checklist, training resources – Course will demonstrate use of resources:

online, simulationWilliam H. Ehlers, William F. Astle(Farmington/USA, Calgary/CDN)

15:25 IL MO-59-07Conclusion & DiscussionGudrun Bischoff (Hamburg/D)

Mon

day,

7 Ju

ne

157

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 9

08:30 - 10:00 MO-41

Worldwide Program of Teaching Directors of Ophthalmic Residency Programs

SymposiumWorld Ophthalmic Educational Colloquium

Chairs:Karl Golnik (Cincinatti/USA)Pinar Aydin (Ankara/TR)Klaus-Peter Steuhl (Essen/D)

08:30 IL MO-41-01IntroductionKarl Golnik (Cincinatti/USA)

08:40 IL MO-41-02Principles of Performance AssessmentEduardo Mayorga Argañaraz (Buenos Aires/RA)

08:50 IL MO-41-03ICO International Basic Science and Clinical Sciences Assessments for OphthalmologistsDavid Taylor (London/UK)

09:00 IL MO-41-04Resident Assessment: Objective Structured ClinicalExamination (OSCE)Pinar Aydin (Ankara/TR)

09:10 IL MO-41-05The 360 Degree EvaluationGabriela Palis (Buenos Aires/RA)

09:20 IL MO-41-06Can Professionalism and Communication Skills beTaught and Assessed?Andrew G. Lee (Houston/USA)

09:30 IL MO-41-07Videos/Vignettes for Teaching ProfessionalismKarl Golnik (Cincinatti/USA)

09:40Discussion

Hall 9

10:30 - 12:00 MO-42

The New Frontier of Changing Parameters of Residency Education


Chairs:Andrew G. Lee (Houston/USA)Marko Hawlina (Ljubljana/SI)Veit-Peter Gabel (Regensburg/D)

10:30 IL MO-42-01IntroductionAndrew G. Lee (Houston/USA)

10:40 IL MO-42-02Harmonisation of Residency Education in EuropeMarko Hawlina (Ljubljana/SI)

10:50 IL MO-42-03Generational Learning: Teaching When the TimesAre ChangingGabriela Palis (Buenos Aires/RA)

11:00 IL MO-42-04New Models for Ophthalmic Educational Assessments: Dreyfus, Ericsson, and SchonAndrew G. Lee (Houston/USA)

11:10 IL MO-42-05Teaching ≠ Learning: Changing Parameters in Resident EducationKarl Golnik (Cincinatti/USA)

11:20 IL MO-42-06Curriculum: More Than Just Words: Paradigm Shiftin the Structured Learning Plan for ResidentsEduardo Mayorga Argañaraz (Buenos Aires/RA)

11:30 IL MO-42-07Competency vs. Striving for Excellence in SurgicalTeaching, Specifically CataractsSusan Ksiazek (Chicago/USA)

11:40 IL MO-42-08Selecting the Next Generation of OphthalmologistsSusan H. Day (San Francisco/USA)

11:50Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne158

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 9

14:00 - 15:30 MO-43

Innovative Technologies for Teaching Ophthalmology


Chairs:Mark O. M. Tso (Baltimore/USA)Deepak P. Edward (Akron/USA)Karin U. Löffler (Bonn/D)

14:00 IL MO-43-01We are in the Age of Innovative TechnologiesMark O. M. Tso (Baltimore/USA)

14:10 IL MO-43-02A Spectrum of Innovative Technologies for Teaching OphthalmologyHans-Martin Helb (Bonn/D)

14:20 IL MO-43-03Simulators In Ophthalmic Surgery: Are we thereyet?Deepak P. Edward (Akron/USA)

14:30 IL MO-43-04Animations in Teaching OphthalmologyOliver Findl (Vienna/A)

14:40 IL MO-43-05Teaching Refraction through Animation TechnologyWilliam H. Ehlers (Farmington/USA)

14:50 IL MO-43-063D Teaching Systems in Ophthalmology: Retina &Optic NerveWico W. Lai (Hong Kong/CN)

15:00 IL MO-43-07How to teach Ophthalmic Pathology using Innovative TechnologiesDeepak P. Edward (Akron/USA)

15:10 IL MO-43-08The Neuro-Ophthalmology Virtual Education Library: NOVELSusan Ksiazek (Chicago/USA)

15:20 IL MO-43-09ConclusionsDeepak P. Edward (Akron/USA)

Hall 9

16:00 - 17:30 MO-44

Emerging Technologies for Ophthalmic Teachingand Learning: Internet Tools for Teaching – Teaching Without Classrooms


Chairs:Eduardo Mayorga Argañaraz (Buenos Aires/RA)Mark O. M. Tso (Baltimore/USA)Karin U. Löffler (Bonn/D)

16:00 IL MO-44-01IntroductionEduardo Mayorga Argañaraz, Mark O. M. Tso(Buenos Aires/RA, Baltimore/USA)

16:10 IL MO-44-02Coping With Lack of Knowledge: An Online Tool toDiagnose Conditions You Never Knew ExistedBertil D. Damato (Liverpool/UK)

16:20 IL MO-44-03Interactive Teaching and Audience Response SystemsHelmut Wilhelm (Tübingen/D)

16:30 IL MO-44-04Concept Mapping Software for Enhancing Teaching and Learning – Selection and ApplicationGabriela Palis (Buenos Aires/RA)

16:40 IL MO-44-05Synchronous E-learning – Considerations for Selecting the Right SoftwareKarl Golnik (Cincinatti/USA)

16:50 IL MO-44-06Using the Web 2.0 Tool Box for OphthalmologyTeaching and LearningHelena Filipi (Lisbon/P)

17:00 IL MO-44-07Training Ophthalmic Technicians in the 21st

CenturyWilliam H. Ehlers (Farmington/USA)

17:10 IL MO-44-08Simulation in Ophthalmic Surgical TrainingColin A. McCannel (Los Angeles/USA)

17:20Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne

159

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 10

08:30 - 10:00 MO-65

AAO Symposium: Glaucoma Implants: Now andthe Future

SymposiumGlaucoma

Chairs:James C Tsai (New Haven/USA)Keith Barton (London/UK)Hagen Thieme (Mainz/D)

08:30 IL MO-65-01Tube vs Trabeculectomy and other studiesKuldev Singh (Stanford/USA)

08:40 IL MO-65-02Flow dynamics of aqueous shunts. What do theydo?Sheng Lim (London/UK)

08:50 IL MO-65-03Surface modification of shunts. Does it matter?Hagen Thieme (Mainz/D)

09:00 IL MO-65-04Size matters, but small is betterMarlene Moster (Bala Cynwyd/USA)

09:10 IL MO-65-05Not yet shunting to the suprachoroidal spaceWalter Konen (Cologne/D)

09:20 IL MO-65-06Implanting the Baerveldt Shunt without ligationKeith Barton (London/UK)

09:30 IL MO-65-07Ahmed Implantation TechniqueJames C. Tsai (New Haven/USA)

09:40 IL MO-65-08Conclusion and Future of aqeous shuntsKeith Barton (London/UK)

09:50Discussion

Hall 10

10:30 - 12:00 MO-66

Minimally Invasive Ophthalmic Surgery


Chairs:Daniel Mojon (St. Gallen/CH)Jorge L. Alió (Alicante/E)

10:30 IL MO-66-01Introduction to the session: Minimally invasive,the present and future of ophthalmic surgeryDaniel Mojon, Jorge L. Alió (St. Gallen/CH, Alicante/E)

10:40 IL MO-66-02Minimally invasive vitreoretinal surgeryAnselm Kampik (Munich/D)

10:50 IL MO-66-03Minimally invasive strabismus surgeryDaniel Mojon (St. Gallen/CH)

11:00 IL MO-66-04Minimally invasive refractive surgeryJorge L. Alió (Alicante/E)

11:10 IL MO-66-05Minimally invasive corneal surgeryRoger Steinert (Orange/USA)

11:20 IL MO-66-06Minimally invasive cataract surgeryH. Burkhard Dick (Bochum/D)

11:30 IL MO-66-07Minimally invasive glaucoma surgeryJulian Garciá-Feijoó (Madrid/E)

11:40 IL MO-66-08Minimally invasive ocular surface surgeryShigeru Kinoshita (Kyoto/J)

11:50 IL MO-66-09Mimimally invasive tumor treatmentArun D. Singh (Cleveland/USA)

Monday, 7 June 2010

Mon

day,

7 Ju

ne160

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 10

14:00 - 15:30 MO-67

Retina: Vascular Disease 1

Free PaperRetina

Chairs:Carsten H. Meyer (Bonn/D)Gisèle Soubrane (Créteil/F)Thomas J. Wolfensberger (Lausanne/CH)

14:00 SL MO-67-01Macular teleanciectasisUte Wolf-Schnurrbusch (Bern/CH)

14:09 FP MO-67-02Pharmacokinetics and pharmacodynamics of the sustained-release dexamethasone intravitrealimplantDevin Welty, Joan-En Chang Lin, Mayssa Attar, Andrew Acheampong, Michael Robinson, Scott M. Whitcup (Irvine/USA)

14:16 FP MO-67-03Retinal Vascular Events After Anti-Vascular Endothelial Growth FactorsAhmad Mansour, Therese von Hanno, Peter Kofoed,Shree Kurup, Michel Shami, Eric Chen, Jad Akesby,Sabine Aisenbrey, Focke Ziemssen, Alay Banker,Wael Soliman, Zei-Lun Huang, Ozgur Artunay,Hamid Hosseini, Sami Uwaydat, Padmamalini Mahendradas, Leon Bynoe (Beirut/RL)

14:23 FP MO-67-04Spatial distribution of intraocular oxygen in advanced diabetic retinopathyClemens Lange, Panagiotis Stavrakas, Julian da Silva, Ulrich Luhmann, Zdenek Gregor,James Bainbridge (London/UK)

14:30 FP MO-67-05Prevalence of retinopathy in patients with type 2diabetes – Preliminary report from BNDC trial, BIRDEM, BangladeshM. K. Goswami (Dhaka/BD)

14:37 FP MO-67-06Efficacy outcomes of the CRUISE study of intravitreal ranibizumab in patients with macularedema secondary to central retinal vein occlusionLeonard Feiner, Roman G. Rubio, Namrata Saroj,Zhengrong Li, Amy Chen Rundle, Sarah Gray, Wendy Yee Murahashi (Kenilworth/USA, San Fran-cisco/USA)

14:44 FP MO-67-07Intravitreal ranibizumab for the treatment of significant macular edema secondary to acutebranch retinal vein occlusionStefan Sacu, Gerlinde Matt, Wolf Bühl, Roman Dunavölgyi, Erna Schranz, Christian Prünte,Ursula Schmidt-Erfurth (Vienna/A)

14:51 FP MO-67-08A case of retinal regeneration in Norrie's diseaseYun-Sik Yang, Seong-Min Hong, Ji-Yun Yang, Eun-Heui Jin (Icksan/ROK)

14:58 FP MO-67-09Incidence of damage to the crystalline lens andretina during intravitreal injectionsCarsten H. Meyer, Stefan Michels, Hans-Martin Helb, Stefan Mennel, Jörg C. Schmidt,Annette Hager, Eduardo B. Rodrigues (Bonn/D,Duisburg/D, Marburg/D, Zurich/CH, Hamburg/D)

15:05 FP MO-67-10Amalric Sign and CRAO-A ReviewSribhargava Natesh, Mayuri Bhargava, Naresh Kumar Yadav, Rohit Shetty, Bhajung Shetty(Bangalore/IND)

15:12Discussion

Hall 10

16:00 - 17:30 MO-82

EUGOGO Symposium

SymposiumStrabismus

Chairs:Petros Perros (Newcastle upon Tyne/UK)Christoph Hintschich (Munich/D)Alison Dickinson (Newcastle upon Tyne/UK)Marian Ludgate (Cardiff/UK)

16:00 IL MO-82-01From Science to Clinical Management to Politics:Amsterdam DeclarationPetros Perros (Newcastle upon Tyne/UK)

16:20 IL MO-82-02Evidence Based Medical Management of ThyroidDysfunction and OrbitopathyMario G. Salvi (Milan/I)

16:40 IL MO-82-03EUGOGO Consensus Statement and Surgical ManagementLelio Baldeschi, Susanne Pitz, Anja K. Eckstein (Amsterdam/NL, Mainz/D, Essen/D)

17:00Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne

161

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Salon 21

10:30 - 12:00 MO-26

Miscellaneous 2

Free PaperMiscellaneous

Chairs:Dušica Pahor (Maribor/SI)Khristo P. Takhchidi (Moscow/RUS)Ines M. Lanzl (Munich/D)

10:30 SL MO-26-01Impact of U.S. Economic Stimulus Funding on Vision ResearchJames Jorkasky (Rockville/USA)

10:39 SL MO-26-02Ocular findings in Hemodialysis PatientsDušica Pahor (Maribor/SI)

10:48 SL MO-26-03Ocular involvement in lysosomal storage diseasesInes Lanzl (Munich/D)

10:57 SL MO-26-04Modern ocular biomechanics as an effective toolfor evaluation of advanced directions in clinicaland experimental researchKonstantin Kotliar, Elena Iomdina, Ivan Koshitz,Svetlana Bauer, Ines Lanzl (Munich/D)

11:06 SL MO-26-05Five millions surgeries in the S. Fyodorov Eye Microsurgery Federal State InstitutionKhristo Takhchidi, Alexander Doga (Moscow/RUS)

11:15 FP MO-26-06Medically Unexplained Visual Loss (MUVL) inSingaporeLeonard Yuen, Lisa Ong, Maria Goh, Tan Zhen Kiat,James Cullen (Singapore/SGP)

11:22Discussion

Roof Garden

08:30 - 10:00 MO-69

ISA Symposium: Clinical Challenges in Strabismus

SymposiumStrabismus

Chairs:Derek Sprunger (Indianapolis/USA)Frank Martin (Sydney/AUS)Jan-Tjeerd de Faber (Rotterdam/NL)Costantino Schiavi (Bologna/I)

08:30 IL MO-69-01Surgery for Duane SyndromeFrank Martin (Sydney/AUS)

08:40 IL MO-69-02Surgery for Dissociated StrabismusAnthony Murray (Cape Town/ZA)

08:50 IL MO-69-031) Congenital ET; Surgery vs toxin2) Choice of Surgery for NystagmusCostantino Schiavi (Bologna/I)

09:00 IL MO-69-041) Strabismus Surgery in High Myopia2) Acute Ocular Trauma; Strabismus ConcernsJan-Tjeerd de Faber (Rotterdam/NL)

09:10 IL MO-69-05Surgery for Superior Oblique PalsyMiho Sato (Hamamatsu/J)

09:20 IL MO-69-06Topical Anesthesia in Strabismus SurgerySonal Farzavandi (Singapore/SGP)

09:30Discussion

Roof Garden

10:30 - 12:00 MO-70

MEACO Symposium: Management of Macular andRetinal Vascular Diseases

SymposiumRetina

Chairs:Manal Omran Taryam (Dubai/UAE)Sherif Shetta (Cairo/ET)Bernd Kirchhof (Cologne/D)

10:30 IL MO-70-01Introduction to Diabetic Macular edemaHassan A. Dhibi (Riyadh/SA)

10:45 IL MO-70-0224 Hours Pre operative Intravitreal Bevacizumabfor Repair of Retinal Detachment in Eyes with Active Proliferative Diabetic RetinopathyMassan Mortada (Cairo/ET)

11:00 IL MO-70-03Staining epiretinal membranesManal Omran Taryam (Dubai/UAE)

11:15 IL MO-70-04Vitrectomy for traction maculopathySherif Shetta (Cairo/ET)

Monday, 7 June 2010

Mon

day,

7 Ju

ne162

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:30 IL MO-70-05Vitrectomy: intraoperative complications and howto deal with themBernd Kirchhof (Cologne/D)

11:45Discussion

Roof Garden

14:00 - 15:30 MO-71

ARVO Symposium: Genetics of Eye Disease: Current Clinical Perspective

SymposiumGenetics

Chairs:Janey L. Wiggs (Boston/USA)David G. Hunter (Boston/USA)

14:00 IL MO-71-01Ocular Genetics NEI PerspectiveIntroduction and OverviewDavid G. Hunter (Boston/USA)

14:04 IL MO-71-02Ocular Genetics: NEI PerspectivePaul Sieving (Bethesda/USA)

14:16 IL MO-71-03Genetics of StrabismusElizabeth Engle (Boston/USA)

14:28 IL MO-71-04Genetics of Leber's Congenital AmaurosisElise Heon (Toronto/CDN)

14:40 IL MO-71-05Glaucoma GeneticsDavid Mackey (East Melbourne/AUS)

14:52 IL MO-71-06AMD Genes and Risk FactorsEric Souied (Créteil/F)

15:04 IL MO-71-07Pharmacogenomics and Approaches to Personalized MedicineLouis R. Pasquale (Boston/USA)

15:16Open discussion and concluding remarks

Roof Garden

16:00 - 17:30 MO-72

AAO Symposium: Retinal Pharmacotherapy

SymposiumRetina

Chairs:Lihteh Wu (San Jose/CR)Albert J. Augustin (Karlsruhe/D)

16:00 IL MO-72-01Anti-VEGF in Central Retinal Vein OcclusionsLihteh Wu (San Jose/CR)

16:10 IL MO-72-02Update Regarding Extended Drug Delivery to thePosterior SegmentWilliam F. Mieler (Chicago/USA)

16:20 IL MO-72-03Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: The Pan-American Collaborative Retina Study Group ResultsJ. Fernando Arevalo (Caracas/Y)

16:30 IL MO-72-04Intravitreal Bevacizumab for Choroidal Neovascu-larization secondary to multifocal choroiditisFrancesco Bandello (Milano/I)

16:40 IL MO-72-05Suprachoroidal Drug Delivery via CatheterAlbert J. Augustin (Karlsruhe/D)

16:50 IL MO-72-06The Ability of In-Office Genetic Testing for Exudative Macular Degeneratione to Predict Response to Anti-VEGF TherapyTarek S. Hassan (Royal Oak/USA)

17:00 IL MO-72-07A State of the Art in Antiangiogenic Therapy – Evidence and ConclusionsUrsula Schmidt-Erfurth (Vienna/A)

17:10 IL MO-72-08Macrophages and AMD – Rationale for Treatmentor EpiphenomenonAntonia M. Joussen (Berlin/D)

17:20Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne

163

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

ICC Lounge

08:30 - 10:00 MO-45

Editorial Management


Chairs:Frank G. Holz (Bonn/D)José Cunha-Vaz (Coimbra/P)Alexander J. Brucker (Philadelphia/USA)

08:30 IL MO-45-01Ethical dilemmas in scientific publications: pitfalls and solutions for editorsDiana Epstein (Glasgow/UK)

08:40 IL MO-45-02Self-citationsWolfgang Glänzel (Leuven/B)

08:50 IL MO-45-03Meeting abstracts, tabloids and peer-reviewed articles – duplicate publications?Frank G. Holz (Bonn/D)

09:00 IL MO-45-04Affiliations of journals with scientific societies –pros and consJosé Cunha-Vaz (Coimbra/P)

09:10 IL MO-45-05Editorship – the publishers' perspectiveEsther Wieland (Heidelberg/D)

09:20 IL MO-45-06Role of the editorial board – expectations and limitationsAlexander J. Brucker (Philadelphia/USA)

09:30Discussion

ICC Lounge

10:30 - 12:00 MO-46

IUSG Symposium: Update on New TreatmentAgainst Uveitis


Chairs:Robert Nussenblatt (Bethesda/USA)Manfred Zierhut (Tübingen/D)

10:30 IL MO-46-01DaclizumabRobert Nussenblatt (Bethesda/USA)

10:45 IL MO-46-02VoclosporinQuan Dong Nguyen (Baltimore/USA)

11:00 IL MO-46-03OzurdexMarc D. de Smet (Amsterdam/NL)

11:15 IL MO-46-04Interferon alphaChristoph M. E. Deuter (Tübingen/D)

11:30 IL MO-46-05Anti-TNF-alpha blocking AntibodiesEmmett T. Cunnigham (San Francisco/USA)

11:45Discussion

ICC Lounge

14:00 - 15:30 MO-47

Nanotechnology


Chairs:Robert Ritch (New York/USA)Marco Zarbin (Roseland/USA)

14:00 IL MO-47-01Building contact lenses with integrated radios andbiosensorsBabak Amir Parviz (Seattle/USA)

14:10 IL MO-47-02Intravitreal cell-encoated drug therapy for neuroprotection and anti-angiogenesisJost B. Jonas (Mannheim/D)

14:20 IL MO-47-03Nanotechnology-mediated targeted nonviral genetherapy approaches to treat corneal diseasesRajiv R. Mohan (Columbia/USA)

14:30 IL MO-47-04Functionalized nanoparticles for targeted drugand gene deliveryUday B. Kompella (Aurora/USA)

14:40 IL MO-47-05Using nanotechnology to control ocular inflammationRutledge G. Ellis-Behnke (Cambridge/USA)

14:50 IL MO-47-06Therapeutic potential of stem cells for retinal regenerationTing Xie (Kansas City/USA)

Monday, 7 June 2010

Mon

day,

7 Ju

ne164

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

15:00 IL MO-47-07Eye-Opening Retinal Prostheses: Nanotechnologyand the Neural-Electrical InterfaceRussell Andrews (Los Gatos/USA)

15:10 IL MO-47-08Nanotheragnostics in normal-tension glaucomaSung Chul Park (Seoul/ROK)

15:20 IL MO-47-09Keynote Speech: Nanomedicine – where is itheaded?Carlo Montemagno (Cincinnati/USA)

ICC Lounge

16:00 - 17:30 MO-48

Google's Approach, Open Access Publishing


Chairs:Ulrich Korwitz (Cologne/D)Harald Müller (Heidelberg/D)Bernd Kirchhof (Cologne/D)

16:00 IL MO-48-01Goals of GoogleStefan Keuchel (Hamburg/D)

16:10 IL MO-48-02Google´s digital books: ContraJessica Sänger (Munich/D)

16:20 IL MO-48-03Digital books: ProHarald Müller (Heidelberg/D)

16:30 IL MO-48-04Open access publishing in MedicineUlrich Korwitz (Cologne/D)

16:40 IL MO-48-05Open Access to Research DataAnita Eppelin (Cologne/D)

16:50 IL MO-48-06A film repositoryBernd Kirchhof (Cologne/D)

17:00Discussion

Salon 11/12

14:00 - 15:30 MO-81

Disaster Response: Ophthalmology’s Organizational Role


Chairs:Christian Luco (Santiago/RCH)

14:00 IL MO-81-01Collaboration with Host National SocietyMildred M. G. Olivier (Hoffman Estates/USA)

14:10 IL MO-81-02Relationships with NGOs and Governmental OrganizationsMichael W. Brennan (Burlington/USA)

14:20 IL MO-81-03Haiti Experience; Immediate ResponseNatalio Izquierdo (San Juan/PR)

14:30 IL MO-81-04Concepcion ExperienceChristian Luco (Santiago/RCH)

14:40 IL MO-81-05Tsunami ExperienceS. Natarajan (Mumbai/IND)

14:50 IL MO-81-06Strategies for Donor SolicitationStephanie J. Marioneaux (Chesapeake/USA)

15:00 IL MO-81-07Volunteer RealitiesPhilip R. Rizzuto (Providence/USA)

15:10 IL MO-81-08Assistance to War Displaced PhysiciansManal Omran Taryam (Dubai/UAE)

15:20 IL MO-81-09Global Ophthalmology in Disaster Relief EffortsStefan Seregard (Stockholm/S)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

165

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Room 42

08:30 - 10:00 MO-73

Glaucoma: Basics 2

Free PaperGlaucoma

Chairs:Anton Gerinec (Bratislava/SK)Lutz E. Pillunat (Dresden/D)

08:30 SL MO-73-01The new possibilities for exploiting of the genotype-phenotype correlation in primary congenital glaucomaAnton Gerinec (Bratislava/SK)

08:39 FP MO-73-02Atherogenic risk factors and Primary Open AngleGlaucomaLuís Abegão Pinto, Joana Ferreira, Ana Amaral,Paula Leitão, Isabel Domingues, João Lisboa(Belas/P)

08:46 FP MO-73-03Cerebrospinal fluid dynamics and subarachnoidspace diameter in normal-tension glaucomaHanspeter Killer, Gregor Jaggi, Neil Miller, Josef Flammer, Angel Mironow, Luca Remonda(Aarau/CH)

08:53 FP MO-73-04The photoreceptor layer appears intact in ad-vanced glaucomatous optic neuropathy: a spectraldomain OCT studyImran Masood, Trushar Patel, Simon Longstaff (UK)

09:00 FP MO-73-05Elevated intraocular pressure reduces aquaporin-9expression in rat optic nerve head and retina.Makoto Nakamura, Maiko Naka, Akiyasu Kanamori,Akira Negi (Kobe/J)

09:07 FP MO-73-06Comparison of Glaucomatous Optic Neuropathyand Blindness in Symptomatic and AsymptomaticPrimary Angle Closure Glaucoma in Central India.Rekha Khandelwal, Shivani Bidaye, Suresh Ughade,Ketaki Shah (Nagpur/IND)

09:14 FP MO-73-07Increased Expression of Cellular Senescence in Cultured Trabecular Meshwork Cells by TGF-betaUlrich Welge-Lüßen (Erlangen/D)

09:21 FP MO-73-08Does Intraocular Pressure (IOP) Reduction AffectIntracranial Pressure (ICP)? An animal ModelMorteza Mehdizadeh (Shiraz/IR)

09:28 FP MO-73-09Immune-mediated injury and the retinal ganglioncell survivalPing Huang, Yan-Jiao Huo, Hong Li, Samuel Shao-Min Zhang, Chun Zhang (Beijing/CN)

09:35 FP MO-73-10Analysis of IgM autoantibody patterns as marker for acute phase immunoreactions in pseudoexfoliation glaucomaKatrin Lorenz, Marcus Schlich, Nils Böhm, Christina Kramann, Norbert Pfeiffer, Franz Grus(Mainz/D)

09:42Discussion

Room 42

10:30 - 12:00 MO-74


Free PaperUveitis, Intraocular Inflammation

Chairs:Justus G. Garweg (Bern/CH)Ahmet Gul (Istanbul/TR)Jyotirmay Biswas (Chennai/IND)

10:30 FP MO-74-01Anti-Inflammatory Effects of Topical Application ofCurcuma Longa Extract in Experimental UveitisPuneet Agarwal, Renu Agarwal, S. K. Gupta, Sushma Srivastava, Rohit Saxena, S. S. Agrawal(Kuala Lumpur/MAL, New Delhi/IND)

10:37 FP MO-74-02Mesenchymal Stem Cells Ameliorate ExperimentalAutoimmune Uveitis by Modulation of the Th1-dependent Immune ResponseXiaomin Zhang, Xinjun Ren, Shaozhen Zhao, Xiaorong Li (Tianjin/CN)

10:44 FP MO-74-03Intravitreal Adalimumab for Uveitis-Related Macular EdemaAnna Praidou, Sofia Androudi, Evangelia Tsironi,Christos Kalogeropoulos, Athina Theodoridou,Periklis Brazitikos (Thessaloniki/GR)

10:51 FP MO-74-04Risk factors for the development of macularedema in non-infectious uveitisMartin Rösel, Anne Ruttig, Claudia Schumacher,Carsten Heinz, Arnd Heiligenhaus (Münster/D)

Monday, 7 June 2010

Mon

day,

7 Ju

ne166

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

10:58 FP MO-74-05Young age as risk factor for complicated courseand visual outcomes in intermediate uveitis inchildren.Viera Kalinina Ayuso, Hermine ten Cate, Patricia van den Does, Aniki Rothova, Joke de Boer (Utrecht/NL)

11:05 FP MO-74-06Cataract Formation in Patients Treated with LX211 (Luveniq™/voclosporin oral capsules) withNon-Infectious UveitisUwe Pleyer (Berlin/D)

11:12 FP MO-74-07Elevated laser flare values correlate with complicated course of anterior uveitis in patientswith juvenile idiopathic arthritisChristoph Tappeiner, Carsten Heinz, Martin Roesel,Arnd Heiligenhaus (Bern/CH, Münster/D)

11:19 FP MO-74-08The Many Faces of Ocular Tuberculosis and ShortCourse Oral Isoniazid Trial: a UKMMC ExperienceSiew Yuen Goh, Wan Haslina Wah, Hon Seng Wong,Othmaliza Othman, Muhaya Mohamed (KualaLumpur/MAL)

11:26 FP MO-74-09The expression of VEGF of OCM-1 cell line ofhuman choroidal melanoma and OCM-1 cell linetumor implanted in nude miceHaiyan Liu (Shanghai/CN)

11:33 FP MO-74-10Role of Quantiferon TB GOLD test in serpiginouslike choroiditisJyotirmay Biswas, Swapnesh D. Sawant, S. Sudharshan, R. Gayathri, Lily K. Therese, H. N. Madhavan (Chennai/IND)

11:40Discussion

Room 42

14:00 - 15:30 MO-75

Retina: Miscellaneous 1

Free PaperRetina

Chairs:Karl Ulrich Bartz-Schmidt (Tübingen/D)José-Alain Sahel (Paris/F)Ursula Schmidt-Erfurth (Vienna/A)

14:00 SL MO-75-01How can we manage uveal melanoma in 2010Laurence Desjardins (Paris/F)

14:09 FP MO-75-02Lanreotide Autogel® for persistent diabetic macular edema: a prospective study of effective-ness and quality of lifeMaria C. Hernaez-Ortega, Enrique Soto-Pedre, Jose A. Pinies (Castro-Urdiales/E)

14:16 FP MO-75-03NAVILAS®: A New Paradigm in Retina EducationMichael Ober, Michael Ulbig, Aljoscha Neubauer,Anselm Kampik (Southfield/USA, Munich/D)

14:23 FP MO-75-04Natural history of visual acuity changes in sham-treated patients in a randomized, controlled trialof Dexamethasone intravitreal implant in patientswith Macular Edema (ME) due to branch or centralRetinal Vein Occlusion (RVO)Mark Gillies, Julia A. Haller, Mark S. Blumenkranz,Francesco Bandello, Rubens Belfort, Jeffrey Heier,Anat Loewentstein, Young-Hee Yoon, Jenny Jiao,Xiao-Yan (Joanne) Li, Scott M. Whitcup(Sydney/AUS, Philadelphia/USA, Milano/I, São Paulo/BR, Stanford/USA, Tel Aviv/IL,Boston/USA, Seoul/ROK, Irvine/USA)

14:30 FP MO-75-05Effect of dexamethasone intravitreal implant on patient-reported visual functioning for thetreatment of macular edema following retinal vein occlusionJonathan W. Kowalski, Anne Rentz, Dennis Revicki,Francesco Bandello, Mark Gillies, Young-Hee Yoon,Charlie Liu, Scott M. Whitcup (Irvine/USA,Cologne/D, Bethesda/USA, Milano/I, Sydney/AUS,Seoul/ROK)

14:37 FP MO-75-06Kenalog-40 Induces Inflammatory Cytokines andOther Proteins in Eyes after Intravitreal Injectionand In Human Macrophages: Biomarkers of SterileEndophthalmitisJeffrey L. Edelman, Maria Castro-Paiz, Quan DongNguyen, Diana Do, Michael Robinson (Irvine/USA)

14:44 FP MO-75-07Effectiveness of dexamethasone intravitreal implant in an animal model of chronic retinal neovascularization.James Burke, Yong Li, Ton Lin, Corine Ghosn,Scott M. Whitcup, Larry Wheeler, Abhiram Vilupuru,

Susan Tsai, Alexandra Almazan (Irvine/USA)

14:51 FP MO-75-08Influence of anti-VEGF treatment on retinal vesseldiametersChristos Chryssafis, S. Asteriades, Paraschos Tranos,A. Vakalis, Aljoscha Neubauer (Thessaloniki/GR,Munich/D)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

167

Monday, 7 June 2010

WOC® 2010

16:28 FP MO-76-05LX211 (Luveniq™/voclosporin oral capsules) as in Clinically Quiescent Sight-Threatening Non-Infectious Uveitis: Results of the LX211-02 Study ofthe LUMINATE Clinical ProgramManfred Zierhut, on behalf of the LUMINATE StudyGroup (Tübingen/D)

16:35 FP MO-76-06Visual acuity and quality of life in patients treatedwith LX211 (Luveniq™/Voclosporin Oral Capsules) inan active uveitis affecting the posterior segmentsTalin Barisani-Asenbauer (Vienna/A)

16:42 FP MO-76-07Prevalence of hepatitis B & C in patients scheduledfor cataract surgery – A Hospital Based StudyShahid Shaikh (Karachi/PK)

16:49 FP MO-76-08Serologic Strain-typing of Toxoplasma Gondii Associated with Ocular Toxoplasmosis in theUnited States.Partho Kalyani, Chloe Gottlieb, Patrick Coady, Amy Liu, Michael Zegans, Fei Yu, H. Nida Sen, Robert Nussenblatt, Gary Holland, Michael Grigg(Los Angeles/USA, Bethesda/USA)

16:56 FP MO-76-09Clinical profile of CMV-associated anterior uveitisin immunocompetent patientsMartina Angi, Flore Rozenberg, Phuc LeHoang,Bahram Bodaghi (Roma/I, Paris/F)

17:03 FP MO-76-10Ocular disease awareness and pattern of ocularmanifestation in patients with biopsy proven lungsarcoidosisMaria Pefkianaki, Sofia Androudi, Vasileios Sourlas,Epameinondas Zakynthinos, Maria Kotoula, Konstantinos Gourgoulianis, Zoe Daniil, Evangelia Tsironi (Larissa/GR)

17:10Discussion

14:58 FP MO-75-09R213W mutation in the XLRS1 gene causes severe retinoschisis with vitreous hemorrhage in a Chinese familyJun Xu, Hong Gu, Ningpu Liu (Beijing/CN)

15:05 FP MO-75-10Punctate inner choroidopathy: A case report with improvement after combined intraocularanti-VEGF and photodynamic therapySebastian Weiß, Michael Meyer, KonstantinosZinelis, Rolf Winter (Hannover/D)

15:12Discussion

Room 42

16:00 - 17:30 MO-76


Free PaperUveitis, Intraocular Inflammation

Chairs:Chi Chao Chan (Bethesda/USA)Didier Decaudin (Paris/F)Manfred Zierhut (Tübingen/D)

16:00 FP MO-76-01Improvement of uveitis with everolimus is associated with Treg cellsMaren Hennig, Susanne Wasmuth, Dirk Bauer, Martin Busch, Beatrix Zureck-Imhoff, Solon Thanos,Arnd Heiligenhaus (Münster/D)

16:07 FP MO-76-02Evaluation of OCT as a Measure of Response to LX211 (Luveniq™/Voclosporin Oral Capsules)Therapy in Active Non-Infectious UveitisCarlos Pavesio (London/UK)

16:14 FP MO-76-03LX211 (Luveniq™/voclosporin oral capsules) for Active Sight-Threatening Non-Infectious UveitisInvolving the Posterior Segment: Results of theLX211-01 Study of the LUMINATE ProgramFriederike Mackensen, for the LUMINATE investigators (Heidelberg/D)

16:21 FP MO-76-04The Multicenter Uveitis Steroid Treatment (MUST)Trial: Design and Baseline CharacteristicsJohn H. Kempen, Michael M. Altaweel, Janet T. Holbroook, Douglas A. Jabs, Elizabeth A. Sugar (Philadelphia/USA)

Scie

ntifi

c Pro

gram

Sch

edul

e

Mon

day,

7 Ju

ne168

Monday, 7 June 2010

WOC® 2010

11:21 FP MO-77-08Clinical and pathologic characteristics of irismelanomas: results of a multicenter internationalstudySamira Khan, Paul Finger, Per Sandkull, Stefan Seregard, Daniel Gologorsky, Amy Schefler,Sander Dubovy, Timothy Murray, Tero Kivela, Sebastian Eskelin, Robert Raut, Christine Corriveau(New York/USA, Stockholm/S, Miami/USA,Helsinki/FIN, Montreal/CDN)

11:28 FP MO-77-09Conjunctival tumor in Hispanic population. Clinical serie in 100 patients from ChileMaria Manquez (Santiago/RCH)

11:35 FP MO-77-10Primary orbital malignant melanoma in ChineseXiaolin Xu (Beijing/CN)

11:42Discussion

Room 44

14:00 - 15:30 MO-78

Oculoplasty/Orbita/Lids/Lacrimal System 2

Free PaperOculoplasty, Orbita, Lids

Chairs:Brigita Drnovšek-Olup (Ljubljana/SI)Karl-Heinz Emmerich (Darmstadt/D)David Tse (Miami/USA)

14:00 SL MO-78-01The use of Titanium T-Plate as platform for globealignment in severe paralytic strabismusDavid Tse, Erin Shriver, Kenneth Krantz, Jeffrey Tse,Hilda Capo, Craig McKeown (Miami/USA)

14:09 FP MO-78-02Composite (hydroxyapatite-silicon) integrated orbital implants – experience with 80 casesArkadiusz Pogrzebielski, Anna Michalik-Wójcik,Anna Markiewicz, Bożena Romanowska-Dixon(Kraków/PL)

14:16 FP MO-78-03Clinical impact of virtual models for computer-assisted planning and surgery in orbital recon-structionNils-Claudius Gellrich, Martin Rücker, Harald Essig,Horst Kokemüller, Frank Tavassol, André Eckardt,Alexander Schramm (Hannover/D)

14:23 FP MO-78-04Functional evaluation of patients with globe dislocationsYaroslav Grusha (Moscow/RUS)

Room 44

10:30 - 12:00 MO-77

Oncology 2

Free PaperChairs:Norbert Bornfeld (Essen/D)Brenda L. Gallie (Toronto/CDN)Bożena Romanowska-Dixon (Krakow/PL)

10:30 SL MO-77-01TTT in intraocular tumorsBożena Romanowska-Dixon (Krakow/PL)

10:39 FP MO-77-02Vascular changes in uveal melanoma after radiotherapyAnush Amiryan (Moscow/RUS)

10:46 FP MO-77-03Long-term follow-up on patients treated with photodynamic therapy for amelanotic choroidalmelanomaIrene Barbazetto, Thomas Lee, Reza Iranmanesh,James Klancnick, Brian Maar, David H. Abramson(New York/USA)

10:53 FP MO-77-04Comparison of different treatment modalities intherapy of juxtapapillary uveal melanomasMichael Freistühler, Harun Akgül, Theodora Gkika,Dirk Flühs, Wolfgang Sauerwein, Norbert Bornfeld(Essen/D)

11:00 FP MO-77-05Integrative Analysis of Differentially ExpressedGenes from Choroidal Melanoma Fine NeedleBiopsiesTara McCannel, Barry L. Burgess, Nagesh P. Rao, StanF. Nelson, Bradley R. Straatsma (Los Angeles/USA)

11:07 FP MO-77-06Reinterpreting the evidence: Is better survival ofpatients with smaller uveal melanomas evidenceof a treatment benefit?Zelia Correa, James J. Augsburger, Camila Simoes(Cincinnati/USA)

11:14 FP MO-77-07Optical Coherence Tomography in 18 Cases of Subfoveolar Choroidal Osteoma. Evidence for Photoreceptor Atrophy over the Decalcified Portion of the TumorBenjamin Perez, Carol Shields, Jerry Shields (Mexico City/MEX, Philadelphia/USA)

169

Mon

day,

7 Ju

ne

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:30 FP MO-78-05Levator Excision with Fascia Lata Sling Surgery inJaw Winking Ptosis by a Modified TechniqueAshok Grover (New Delhi/IND)

14:37 FP MO-78-06Treatment of lagophthalmos with hyaluronic acidgel injectionElena Agafonova, Yaroslav Grusha, Dilyara Ismailova, Yulia Ivanchenko (Moscow/RUS)

14:44 FP MO-78-07Morphologic analysis of interpalpebral adhesionsin different lateral tarsorraphy techniquesYulia Ivanchenko, Yaroslav Grucha, Anatoly Fyodorov (Moscow/RUS)

14:51 FP MO-78-08Exposure Keratopathy Associated with Thyroid EyeDiseaseDilyara Ismailova, Yaroslav Grusha, Arkady Kasparov(Moscow/RUS)

14:58 FP MO-78-09The “Mini Tarsal Strip” Lateral Canthopexy – Indications, Technique and Complications in 634CasesJames Oestreicher, Kia Tarassoly (Toronto/CDN)

15:05 FP MO-78-10Transcanalicular Laser-DCR with 5 mm Ballon-DilatationKarl-Heinz Emmerich, Ralf Ungerechts,Hans-Werner Meyer-Rüsenberg (Darmstadt/D, Hagen/D)

15:12Discussion

Room 44

16:00 - 17:30 MO-79

New Technology, Bioengineering, Nanotechnology 2

Free PaperNew Technology, Bioengineering

Chairs:Gabriel van Rij (Rotterdam/NL)Caiwen Xiao (Shanghai/CN)Marco Zarbin (Roseland/USA)

16:00 FP MO-79-01Laser-actived gold-nanoparticles as a potentialnew treatment modality for exsudative age-related macular-degenerationIna Hahn, Florian Levold, Claudine Strack, Jürgen Groll, Heidrun Keul, Gereon Hüttmann, Florian Rudnitzki, Elmar Endl, Nicole Eter (Bonn/D)

16:07 FP MO-79-02EUREQUO – a multinational project for improvingoutcomes in cataract and refractive surgeryMats Lundström (Karlskrona/S)

16:14 FP MO-79-03The MultiKeratome for cataract surgery – curvedwith multiple points – engineered to seal betterand to minimize the induced astigmatismTom Schossau, Matthew Giegengack, Gerald W. Zaidman, Shree K. Kurup (Scarsdale/USA)

16:21 FP MO-79-04OCT-Camera assisted intraoperative anterior andposterior segment surgery – First results of thenew intraoperative OCT (iOCT)Maya Müller, Philipp Steven, Eva Lankenau, Marc Krug, Emrah Acidereli, Stephan Oelckers, Reginald Birngruber, Salvatore Grisanti, GereonHüttmann (Lübeck/D)

16:28 FP MO-79-05Multimodal imaging of corneal cross-linking effectsOliver Stachs, Marine Hovakimyan, Rudolf F Guthoff, Gereon Hüttmann, Alexander Krüger, Philipp Steven (Rostock/D,Lübeck/D)

16:35 FP MO-79-06Evaluation of cortical activation patterns andwhite matter tracts in cases of amblyopia usingfMRIRohit Saxena, Shikha Gupta, Senthil Kumaran,Vimla Menon, Pradeep Sharma (New Delhi/IND)

16:42 FP MO-79-07Simulation of the accommodation demand to estimate the power consumption of the artificialaccommodation systemJörg Nagel, Ulrich Gengenbach, Helmut Guth,Gerog Bretthauer, Rudolf Guthoff (Eggenstein-Leopoldshafen/D, Karlsruhe/D, Rostock/D)

16:49 FP MO-79-08Optimized sensor concept for the Artificial Accommodation SystemLiane Rheinschmitt, Fabian Ritter, Jörg André Nagel,Ulrich Gengenbach, Georg Bretthauer, Rudolf F. Guthoff (Eggenstein-Leopoldshafen/D,Karlsruhe/D, Rostock/D)

16:56 SL MO-79-09Reconstruction of orbital wall defects with tissue-engineered bone enhanced by human bonemorphogenetic protein 2 in a canine modelCaiwen Xiao (Shanghai/CN)

17:05Discussion

Monday, 7 June 2010

Mon

day,

7 Ju

ne170


Tuesday, 8 June 2010 Tues

day,

8 Ju

ne

WOC® 2010 171

Tues

day,

8 Ju

ne

TU-5

8 St

reiff

Lect

ure

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

ICC

Hal

l 3

Hal

l 4/5

Hal

l 6

Hal

l 7

Hal

l 8

Hal

l 9

Hal

l 10

ICC

Loun

ge

Roof

Gar

den

Salo

n 11

/12

Salo

n 19

Salo

n 20

Room

42

Room

43

Room

44

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

TU-4

5 D

'Am

ico,

Ligg

ett,

Bind

er R

etin

a So

ciet

y Sy

mp:

Adva

nces

in In

stru

men

tatio

n

TU-4

6 Ag

arw

al, L

ang,

Lang

,Ry

an, S

pive

y O

phth

alm

ic

Prem

ier L

eagu

e (O

PL)

TU-4

7 Ku

pper

man

n, M

urra

y,Pl

eyer

U

veiti

s a G

loba

l Cha

lleng

e

TU-4

8 G

arcí

a Ar

umí,

Pour

nara

s, Bi

nder

Cur

rent

Trea

tmen

t Opt

ions

TU-4

9 Ba

udou

in, M

essm

er,

Zagó

rski

Iatr

ogen

ic D

isea

ses

of O

cula

r Sur

face

TU-5

0 Ba

risan

i-Ase

nbau

er,

Boda

ghi, H

eilig

enha

us

IOIS

Sym

p: P

edia

tric

Uve

itis

TU-4

1 Coc

hene

r, Bea

cons

field

,G

arcí

a-D

elpe

ch, G

alle

nga,

Kam

pik

FEO

ph S

ymp.

TU-5

6 H

ubba

rd, A

bram

off,

Hor

negg

erTe

chni

cal A

spec

ts:

Tele

com

mun

icatio

n, C

ompu

t.

TU-5

7 G

ilber

t, Kl

auß

Br

aind

rain

: Cha

lleng

es a

ndSo

lutio

ns

TU-5

9 H

elve

ston

e, Pa

ris, G

räf

Ther

apy

of A

cqui

red

Stra

bis-

mus

TU-6

0 Bo

dagh

i, Che

e, H

einz

Vi

ral U

veiti

s

TU-6

1 Ver

gés,

Zald

ivar

,Ko

hnen

Pa

nel:

Phak

ic IO

Ls

TU-6

2 Se

iler

The

Fem

tose

cond

Face

-off

TU-6

3 Jo

rdan

, Cap

rioli,

Thie

me

G

lauc

oma:

Sur

gica

l the

rapy

2

TU-6

4 Ja

nkov

, Sei

ler

Ther

apeu

tic C

usto

miz

ed

Abla

tion

TU-6

5 Ay

din,

Ligh

tman

, Glo

orA

New

App

roac

h to

Teac

hing

Oph

thal

mol

ogy

TU-6

6 As

tle, F

ield

er, A

nder

-so

n Th

e Tr

aini

ng o

f Par

a-op

h-th

alm

ic P

erso

nnel

TU-6

7 Ver

dagu

er, S

traa

tsm

a,Za

górs

ki Im

prov

ing

Cont

inu-

ing

Educ

atio

n W

orld

wid

e

TU-6

8 O

lson

, Tas

sign

on,

Nau

man

n Se

ttin

g U

p N

ewPa

ram

. for

Teac

hing

Oph

th.

TU-6

9 W

ilkin

son,

Ayl

war

d,Et

er C

urre

nt C

once

pts i

nRe

tinal

Det

achm

ent S

urge

ry

TU-7

0 Kl

intw

orth

, Mes

smer

,H

eega

ard

ISO

P Sy

mp:

Oph

-th

alm

ic P

atho

logy

Upd

ate

TU-7

1 Cos

cas I

OAT

Sym

po-

sium

: “Te

n Ye

ars t

o G

o” to

the

Glo

bal E

limin

atio

nTU

-72

Mód

is G

erm

an, P

olis

h,Da

nish

and

Hun

garia

n Sy

m-

posi

um o

n Ke

rato

conu

s

WO

C-C-

61 C

osca

s SD

-OCT

and

AM

D Tr

eatm

ent

and

Follo

w U

p

TU-7

3 O

hno,

Chee

, McC

lusk

ey

APIIS

G S

ympo

sium

: Uve

itis

Whi

ch O

ne S

houl

d N

ot M

iss

TU-7

4 Va

rgas

, Tse

ng, C

arria

zo,

Alfo

nso

ALAC

CSA-

R Sy

mp:

Corn

ea a

nd O

cula

r Sur

face

TU-5

2 Wol

fram

, Wes

t, Zh

aoCu

rren

t Epi

dem

iolo

gica

l Eye

Stud

ies

TU-5

3 Ch

an, C

oupl

and,

Deu

ter

Intr

aocu

lar l

ymph

oma

TU-5

4 Bl

umen

kran

z O

cula

r Pha

rmac

olog

y fo

rPo

ster

ior S

egm

ent D

isea

ses

TU-7

5 N

ishi

, Hae

flige

r, Goe

s M

ultif

ocal

and

Acc

omm

odat

-in

g IO

L’s

TU-7

6 G

üell,

Tass

igno

n,Ze

tter

strö

m E

SCRS

Sym

po-

sium

: New

IOL C

once

pts

TU-7

7 Jü

nem

ann,

Rej

dak

Rege

nera

tion

and

repa

ir in

retin

al d

egen

erat

ion

WO

C-C-

63 G

arci

a-M

arco

s Fe

mto

seco

nd (F

S) C

ours

e in

Oph

thal

mol

ogy

TU-8

3 Zi

erhu

t IU

SG W

orks

hop:

Dia

gnos

tic C

riter

ia o

f Viru

s-in

duce

d An

terio

r Uve

itis

Mee

ting

der I

nter

natio

nal A

genc

y fo

r the

Pre

vent

ion

of B

lindn

ess

WO

C-C-

47 W

yleg

ala,

Ba

udou

in, G

utho

ff Co

rnea

l Im

agin

g

WO

C-C-

46 Fe

inba

um, P

atel

,M

rukw

a-Ko

min

ek

Achi

evin

g Ex

celle

nce

WO

C-C-

48 H

atte

nbac

h Cu

rren

t Con

cept

s in

the

Man

ag. o

f Ret

. Ves

sel O

cclu

.

TU-7

9 M

urub

e de

l Cas

tillo

,U

gurb

as, G

eerli

ng D

ry E

ye:

Late

st A

dv. i

n Su

rfoc

. Dry

ness

WO

C-C-

50 V

iest

enz,

Kuhn

M

anag

emen

t of t

he

rupt

ured

Glo

be

WO

C-C-

49 H

oera

uf

Curr

ent M

anag

emen

t of

Diab

etic

Mac

ular

Ede

ma

WO

C-C-

51 La

ng

Chal

leng

ing

Case

s in

Ante

-rio

r Seg

men

t Sur

gery

WO

C-C-

52 M

eyer

-Rüs

enbe

rg

Blep

haro

plas

ty II

TU-8

1 Arm

itage

, Birn

baum

,G

otts

ch C

orne

a/Ex

tern

al D

is-ea

se: M

isc., S

urgi

cal t

hera

py 3

TU-8

0 H

olla

day,

Rein

stei

n,M

cDon

nell

Refr

activ

e su

rger

y/Re

frac

tion

4

WO

C-C-

54 S

cheu

erle

The

optic

dis

c – fu

ndus

c., p

erim

e-tr

y, la

ser s

cann

ing

opht

halm

.

TU-8

2 H

aigi

s, Ph

am,

Mal

yugi

n

Cata

ract

/bio

met

ry 4

TU-5

5 Lo

renz

, Mau

men

eeLe

ber C

onge

nita

l Am

auro

sis

TU-7

8 Vi

ncig

uerr

a, K

eziri

an,

Epst

ein

Be

st E

xcim

er La

ser

Tues

day,

8 Ju

neH

ighl

ight

Sym

posi

umFr

ee P

aper

WO

C Co

urse

Indu

stry

Sym

posi

umM

eetin

gs

Mes

se

Stoc

khol

m

Sao

Paul

o

Abu

Dhab

i

Osl

o H

all

Room

Mad

rid

Room

Syd

ney

Room

Hon

g Ko

ng

Room

Ista

nbul

VIP

Loun

ge 1

VIP

Loun

ge 2

Radi

o To

wer

Lo

unge

1

Radi

o To

wer

Loun

ge 2

Hal

l 11

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

TU-0

1 Luc

ke, D

ucou

rnau

EVRS

Sym

p: In

nov.

Tech

-ni

ques

in V

itreo

r. Su

rger

y

TU-0

2 Vas

sile

va, N

émet

h,Ka

skal

oglu

SEE

OS/

BSO

SSy

mp:

Cou

ntrie

s in

Tran

sitio

n

TU-0

3 H

aefli

ger, K

irchh

of,

Scha

rrer

DO

C Sy

mpo

sium

:O

cula

r Sur

gery

TU-0

4 O

bstb

aum

, Tet

z Co

mbi

natio

ns C

atar

act a

ndO

ther

Sur

gerie

s

TU-8

4G

oing

Blin

d

TU-0

6 Ad

enis,

Mey

er-R

üsen

-be

rg, S

eiff

Oph

thal

m. C

hal-

leng

es in

Aes

thet

ic S

urge

ry

TU-0

7 Lo

renz

Pedi

atric

Cat

arac

t Sur

gery

TU-0

8 La

ndau

, Sch

iefe

r,Ay

din

U

nexp

lain

ed V

isua

l Los

sTU

-09

Born

feld

, Lem

men

Vi

treo

retin

ales

Upd

ate

der

Retin

olog

isch

en G

esel

lsch

aft

TU-10

Ols

en, H

olla

day,

Hai

gis

Get

ting

the

Pow

er R

ight

: IO

LPo

wer

Cal

cula

tions

TU-11

Wol

f, Lan

g, d

e La

ey

Net

zhau

t-Fa

llkon

fere

nzTU

-12 S

eitz

Co

nsili

um d

iagn

ostic

um

TU-13

Ahm

ed, S

haar

awy,

Erb

Su

rgic

al V

ideo

s and

Pan

elDi

scus

sion

TU-14

Ngu

yen,

Fle

tche

r, Ond

i-ve

eran

Inte

rven

tions

in A

MD

– Be

yond

Intr

av. I

njec

tions

TU-15

Gup

ta, C

orde

iro, V

orw

-er

k N

eura

l Bas

ed Ta

rget

ing

inG

lauc

oma

TU-16

Org

ül, G

ram

er, H

arris

O

cula

r Blo

od F

low

– C

linic

alRe

leva

nce

for G

lauc

oma

TU-17

Nus

senb

latt

, Cur

now

,Th

urau

Prot

eom

ics a

nd

Gen

omic

s in

Uve

itis

TU-18

Has

san,

Kai

ser, H

u-m

ayun

ASR

S Sy

mp:

The

Fu-

ture

of S

urg.

and

Med

. Ret

ina

TU-19

Cer

nák,

Mai

er E

yeBa

nkin

g: O

ptim

izin

g Te

ch-

niqu

es a

nd Q

ualit

y Co

ntro

l

TU-2

0 La

rkin

, Ple

yer, S

awat

zki

Imm

unol

ogy

of K

erat

opla

sty

TU-2

1 For

sott

, Ehl

ers,

Dun

cker

RGP

Lens

es: N

on S

urgi

cal

Trea

tm. o

f Ref

ra. E

rror

s

TU-2

2 Sh

ield

s, D

amat

o, Bo

rnfe

ld

Pane

l: U

veal

Tum

ors

TU-2

3 Bh

isitk

ul, A

ylw

ard,

Hei

man

n Ev

iden

ce-b

ased

Man

agem

. of R

etin

al D

isea

se

TU-2

4 Pr

ajna

, Neu

hann

M

oder

n M

anua

l Cat

arac

tSu

rger

yTU

-25

Arte

aga,

Kam

man

n,Ze

tter

strö

m

Cata

ract

/bio

met

ry 3

TU-2

6 G

olds

tein

, Mél

y, To

stTh

erap

. Con

tact

Lens

es: B

and.

Lens

es a

nd D

rug

Rele

ase

TU-2

7 Sc

hrag

e, La

nger

, Gin

i H

ot To

pics

in O

cula

r Tra

uma-

tolo

g

TU-2

8 Ku

hn, S

chra

der,

Sulli

van

Glo

be R

econ

stru

c-tio

n af

ter S

ever

e Ey

e In

jury

WO

C-C-

42 T

hiem

e W

etla

b G

lauc

oma

Drai

n Im

plan

ts

WO

C-C-

43 A

uffa

rth,

Dic

k W

etla

b Ph

aco

Cour

se fo

r Be

ginn

ers

WO

C-C-

44 A

uffa

rth

Wet

lab

Phac

o Co

urse

for t

heAd

vanc

ed

WO

C-C-

45 A

uffa

rth,

Dic

k W

etla

b Bi

axia

l and

Mic

ro-

coax

ial P

haco

emul

sific

atio

nTU

-29

Hat

tenb

ach,

Cos

cas,

Stou

t Re

tina:

Vas

cula

r Dis

ease

2

TU-3

0 Ba

erve

ldt,

Wor

mal

d,Yo

ung

Gla

ucom

a: M

edic

al th

erap

y

TU-3

1 Bau

doui

n, R

einh

ard

Corn

ea/E

xter

nal D

isea

se:

Med

ical

ther

apy

TU-3

2 H

elbi

g, P

asye

chni

kova

,Ri

char

d Re

tina:

Sur

gica

l the

rapy

3TU

-33

Jous

sen,

The

elen

Re

tina:

Dia

gnos

tics 3

TU-3

4 Le

mm

en, P

ourn

aras

Retin

a: S

urgi

cal t

hera

py 2

TU-3

5 Fi

nger

, Mitc

hell,

Band

ello

Re

tina:

Med

ical

ther

apy

2

TU-3

6 Li

, Mac

Lare

n,

Wie

dem

ann

Retin

a: B

asic

sTU

-37 T

hum

ann,

Kai

ser,

Paul

eikh

off

Retin

a: A

MD

3

TU-3

8 Pl

eyer

EV

ER S

ympo

sium

: How

toge

t you

r wor

k pu

blis

hed?

TU-3

9 Al

ió, S

eile

rIS

RS/A

AO S

ympo

sium

: Cu

ttin

g Ed

ge P

rogr

ess

TU-4

0 Fi

nger

, Ser

egar

d, K

ivel

äAJ

CC/U

ICC

Sym

p: TN

M b

ased

Clas

sif. S

yst.

for O

nc. O

ncol

ogy

TU-4

2 Ka

mpi

k, Be

dri, Q

ures

hiSu

stai

nabl

e Ey

e H

ealth

Pr

ogra

ms

TU-4

3 Su

sann

a, Jr

, Sin

gh,

Hea

ley

WGA

Sym

p: M

anag

-in

g Ad

vanc

ed G

lauc

oma

TU-4

4 Cu

nha-

Vaz,

Sahe

l,Pf

eiffe

r Net

wor

king

for C

lini-

cal T

rial R

esea

rch

in E

urop

ePo

ster

exh

ibiti

on o

f Pos

ter

P-TU

-001

to P

-TU

-265

S I X T R E N T

A C A R

Y K L S

Looking sharp means facing Sixt!

(Sixt – the official car rental partner of the World Ophthalmology Congress)

Reservations and information:From Europe: +49(0)180/5 25 25 25 (0,14 per min. from the German landlines,

prices from mobile phones max. 0,42 per min)

From North America: 1-888-SIXTCARFrom South America: 0800-772 SIXT (from Brazil; toll free)

From Australia: 3 9824 2273

or www.sixt.com

Tuesday, 8 June 2010

WOC® 2010

Stockholm

10:30 - 12:00 TU-02

SEEOS/BSOS Symposium: Countries in Transition –Challenges and Achievements in Eye Care


Chairs:Petja Ivanova Vassileva (Sofia/BG)Janos Németh (Budapest/H)Mahmut Kaskaloglu (Izmir/TR)

10:30 IL TU-02-01Challenges of Diabetic Rethinopathy treatment inSerbia todaySlobodanka Latinovic (Novi Sad/SRB)

10:40 IL TU-02-02Mini-invasive vitrectomy: expanded indications incomplex casesCesare Forlini (Ravenna/I)

10:50 IL TU-02-03The current state of ophthalmology in TurkeyMahmut Kaskaloglu (Izmir/TR)

11:00 IL TU-02-04Clear lens extraction – 6 years follow-upNikica Gabric (Zagreb/HR)

11:10 IL TU-02-05East meets West, South meets North – harmonisa-tion of ophthalmology training in EuropeMarko Hawlina (Ljubljana/SI)

11:20 IL TU-02-06Prevention of blindness and visual rehabilitationJanos Németh (Budapest/H)

11:30 IL TU-02-07Russian experience in quality ophthalmic careElena Khristovna Takhchidi (Moscow/RUS)

11:40 IL TU-02-08Cross-borders Education and Blindness PreventionPetja Ivanova Vassileva (Sofia/BG)

11:50Discussion

Stockholm

08:30 - 10:00 TU-01

EVRS Symposium: Innovative Techniques in Vitreoretinal Surgery

SymposiumRetina

Chairs:Klaus Lucke (Bremen/D)Didier Ducournau (Nantes/F)

08:30 IL TU-01-01Membrane Peeling without VitrectomyFabio Patelli (Milan/I)

08:40 IL TU-01-02Brilliant blue vs. ICG in macular hole surgeryKlaus Lucke (Bremen/D)

08:50 IL TU-01-03ILM Peeling in Macular EdemaDidier Ducournau (Nantes/F)

09:00 IL TU-01-04A New Theory of Lamellar Macular HoleJerzy Nawrocki (Lodz/PL)

09:10 IL TU-01-05Posterior Hyaloid Peeling in Myopic FoveoschisisHassan Mortada (Cairo/ET)

09:20 IL TU-01-06ILM Peeling in diabetic RetinopathyGiampaolo Gini (Prato/I)

09:30 IL TU-01-07PVR Prophylaxis in TraumaFerenc Kuhn (Birmingham/USA)

09:40 IL TU-01-08cPPV and PVD Induction – Back to the Future?Frank Koch (Frankfurt/D)

09:50Discussion

175

Tues

day,

8 Ju

ne

Scie

ntifi

c Pro

gram

Sch

edul

e

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne176 WOC® 2010

Stockholm

14:00 - 15:30 TU-03

DOC Symposium: Ocular Surgery – Progress andPerspective

SymposiumOcular Surgery

Chairs:Eduard A. Haefliger (Binningen/CH)Bernd Kirchhof (Cologne/D)Armin Scharrer (Fürth/D)

14:00 IL TU-03-01Part I: Defining the"State of the art": GlaucomaSurgery – what makes a gold standard?Günther K. Krieglstein (Cologne/D)

14:10 IL TU-03-02After-cataract prevention: Evaluating the standardand defining the gold standardRupert Menapace (Vienna/A)

14:20 IL TU-03-03Avastin in wet AMD: State of the art or goodenough for the savings?Susanne Binder (Vienna/A)

14:30 IL TU-03-04Surgical correction of Presbyopia: What can we doand what should we not do?Thomas F. Neuhann (Munich/D)

14:40 IL TU-03-05Part II: Assuring the quality: Guidelines for refrac-tive surgery in Germany: 15 years of experiencewith the KRCThomas Kohnen (Frankfurt/D)

14:50 IL TU-03-06Providing highest quality LASIK – the “LASIKTUEV” certification and quality labelMichael C. Knorz (Mannheim/D)

15:00 IL TU-03-07Tailoring indication to surgery to patients satisfactionJan van Meurs (Rotterdam/NL)

15:10 IL TU-03-08Outcome of quality assessment and benchmarkingin external cataract surgery: Rationale for using asurvey versus a prospective follow-up designBurkhard Awe, Ursula Hahn, Stefanie Schmickler(Wilhelmshaven/D, Düsseldorf/D, Ahaus/D)

15:20Discussion

Stockholm

16:00 - 17:30 TU-04

Combinations Cataract and Other Surgeries

SymposiumCataract

Chairs:Stephen A. Obstbaum (New York/USA)Manfred Tetz (Berlin/D)

16:00 IL TU-04-01Cataract and Glaucoma SurgeryStephen A. Obstbaum (New York/USA)

16:20 IL TU-04-02Cataract and CanaloplastyManfred Tetz (Berlin/D)

16:40 IL TU-04-03Cataract Surgery and KeratoplastyMarc Muraine (Rouen/F)

17:00 IL TU-04-04Combined Trabeculectomy and Cataract Extraction Versus Trabeculectomy Alone in PrimaryAngle-closure GlaucomaHin Yeung Tsai (Taichung/TJ)

Stockholm

18:00 - 20:00 TU-84

Going Blind


There are too many people with vision loss whocould benefit from much earlier diagnosis and intervention and dramatically increased awarenessof what's possible in vision rehabilitation. I wouldask that physicians don't wait until we've lostmuch of our vision before they talk to us about vision rehabilitation, including the services and resources that can help us live most effectively andplan positively for the future.

Please refer us to these specialists and don't evertell patients that there is nothing more that can be done! There are always new skills to learn. Enor-mous progress has come through the power ofstrong advocates. We have many disability rolemodels who broke the rules and made stunningprogress! We need to do the same to increase public awareness of sight loss!


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

177WOC® 2010

Sao Paulo

10:30 - 12:00 TU-06

Ophthalmological Challenges in Aesthetic Surgery

SymposiumOculoplasty

Chairs:Jean-Paul Adenis (Limoges/F)Hans-Werner Meyer-Rüsenberg (Hagen/D)Stuart Seiff (San Francisco/USA)

10:30 IL TU-06-01Brow liftStuart Seiff (San Francisco/USA)

10:45 IL TU-06-02Lower lid blepharoplasty and midface liftJean-Paul Adenis (Limoges/F)

11:00 IL TU-06-03Laser blepharoplastyHans-Werner Meyer-Rüsenberg (Hagen/D)

11:15 IL TU-06-04Minimal invasive surgery in aestheticRaymond Douglas (Ann Arbor/USA)

11:30 IL TU-06-05Aesthetic oculofacial rejuvenation in AsiansReynaldo M. Javate (Manila/RP)

11:45Discussion

Sao Paulo

14:00 - 15:30 TU-07

Pediatric Cataract Surgery

SymposiumCataract

Chairs:Birgit Lorenz (Giessen/D)

14:00 IL TU-07-01Sutureless pars plana anterior vitrectomy and capsulotomy for significant PCO in young childrenTBA

14:10 IL TU-07-02Sutured IOL'sEdward G. Buckley (Durham/USA)

14:20 IL TU-07-03Congenital Idiopathic Microcoria in an infant,IOL implantation in children with uveitisScott R. Lambert (Atlanta/USA)

14:30 IL TU-07-04Combined Procedure for Treatment of Aphakia andGlaucoma after Infantile Cataract SurgeryDavid A. Plager (Indianapolis/USA)

14:40 IL TU-07-05Secondary infantile cataract associated with presumed intrauterine infectionBirgit Lorenz (Giessen)

14:50 IL TU-07-06Anterior and Posterior Capsulorexis in ChildrenCharlotta Zetterström (Oslo/N)

15:00Discussion

Sao Paulo

16:00 - 17:30 TU-08

Unexplained Visual Loss


Chairs:Klara Landau (Zurich/CH)Ulrich Schiefer (Tübingen/D)Pinar Aydin (Ankara/TR)

16:00 IL TU-08-01Optical pitfallsOliver Job (Lucerne/CH)

16:10 IL TU-08-02Seven easy steps to managing unexplained visuallossAndrew G. Lee (Houston/USA)

16:20 IL TU-08-03Easily Missed Retinal DisordersMurat Karacorlu (Istanbul/TR)

16:30 IL TU-08-04The How and the Why of non-organic visual lossGordon Plant (London/UK)

16:40 IL TU-08-05Panel discussion / Case demonstrationKlara Landau, Ulrich Schiefer, Pinar Aydin, GordonPlant, Andrew G. Lee, Oliver Job, Murat Karacorlu(Zurich/CH, Tübingen, Ankara/TR, London/UK,Houston/USA, Lucerne/CH, Istanbul/TR)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne178 WOC® 2010

Abu Dhabi

08:30 - 10:00 TU-09

Vitreoretinal update Retinological Society(Session in German)

SymposiumRetina

Chairs:Norbert Bornfeld (Essen/D)Klaus-Dieter Lemmen (Düsseldorf/D)

08:30 IL TU-09-01Strategien zur Versorgung kombinierter Verletzun-gen von Vorder- und Hinterabschnitt aus der Sichtdes Vorderabschnitts-ChirurgenThomas Kohnen (Frankfurt/D)

08:45 IL TU-09-02Strategien zur Versorgung kombinierter Verletzun-gen von Vorder- und Hinterabschnitt aus der Sichtdes Hinterabschnitts-ChirurgenPeter Szurman (Tübingen/D)

09:00 IL TU-09-03Wehrmedizinische Aspekte der Versorgung ein-satzbedingter schwerer AugenverletzungenHermann O. C. Gümbel (Ulm/D)

09:15 IL TU-09-04Makulaödem bei diabetischer Retinopathie undbei retinalen Venenverschlüssen: Gewebsdestruk-tive oder medikamentöse Therapie?Horst Helbig (Regensburg/D)

09:40 IL TU-09-05Netzhautkomplikationen bei refraktiver ChirurgieAlbrecht Lommatzsch, Daniel Pauleikhoff (Mün-ster/D)

Abu Dhabi

10:30 - 12:00 TU-10

Getting the Power Right: IOL Power Calculations

SymposiumCataract

Chairs:Thomas Olsen (Aarhus/DK)Jack T. Holladay (Bellaire/USA)Wolfgang Haigis (Würzburg/D)

10:30 IL TU-10-01Intraocular lens power calculations following keratorefractive surgeryJack T. Holladay (Bellaire/USA)

10:45 IL TU-10-02IOL calculation using paraxial matrix opticsWolfgang Haigis (Würzburg/D)

11:00 IL TU-10-03Intraocular lens calculation in extreme ametropiaMichel Puech (Paris/F)

11:15 IL TU-10-04Comparing ultrasound biometry with partial coherence interferometry for intraocular lenspower calculationsThomas Olsen (Aarhus/DK)

11:30Discussion

Abu Dhabi

14:00 - 15:30 TU-11

Retina Case Presentations with Focus on Fluorescein Angiography and Optical CoherenceTomography(Session in German)

SymposiumRetina

Chairs:Sebastian Wolf (Bern/CH)Gabriele E. Lang (Ulm/D)Jean-Jacques de Laey (Gent/B)

In this interactive conference interesting fluores-cein angiographic and OCT findings are discussed.Short case presentations will be given includinganamnesis and the important findings. Especiallyrare and dubious cases shall be discussed.

Abu Dhabi

16:00 - 17:30 TU-12

Consilium diagnosticum(Session in German)

Symposium

Chairs:Berthold Seitz (Homburg/D)Hans Hoerauf (Göttingen)

Panel:Hans Hoerauf (Göttingen/D)Arnd Heiligenhaus (Münster/D)Barbara Käsmann-Kellner (Homburg/D)Daniel Mojon (St. Gallen/CH)Jan E. E. Keunen (Nijmegen/NL)Nelly Sivkova (Plovdiv/BG)Berthold Seitz (Homburg/D)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

179WOC® 2010

In dem Symposium werden ungewöhnlicheKrankheitsbilder vorgestellt. Ein internationalesPanel und das Auditorium werden um diagnos -tischen und therapeutischen Rat gebeten.

Oslo

08:30 - 10:00 TU-13

Surgical Videos and Panel Discussion

SymposiumGlaucoma

Chairs:Tarek M. Shaarawy (Geneva/CH)Carl Erb (Berlin/D)

08:30 IL TU-13-01CanaloplastyNorbert Korber (Cologne/D)

08:40 IL TU-13-02Glaukos iStentDetlev Spiegel (Augsburg/D)

08:50 IL TU-13-03ExPressLeon W. Herndon (Durham/USA)

09:00 IL TU-13-04SOLX Gold shuntShlomo Melamed (Tel Hashomer/IL)

09:10 IL TU-13-05TrabectomeSteven D. Vold (Rogers/USA)

09:20 IL TU-13-06Ahmed Glaucoma valveTarek M. Shaarawy (Geneva/CH)

09:30 IL TU-13-07Baerveldt glaucoma implantKeith Barton (London/UK)

09:40 IL TU-13-08EndocyclophotocoagulationTBA

09:50Discussion

Oslo

10:30 - 12:00 TU-14

Interventions in AMD – Beyond Intravitreal Injections

SymposiumRetina

Chairs:Nhung Xuan Nguyen (Tübingen/D)Daniel Fletcher (San Francisco/USA)Veera Ramani Ondiveeran (Selangor DarulEhsan/MAL)

10:30 IL TU-14-01Effectiveness of magnifying low vision aids in patients with age-related macular degenerationNhung Xuan Nguyen (Tübingen/D)

10:40 IL TU-14-02Practical Ways to Help Patients Become Aware ofMacular Scotomas and Minimize Their Impact onReadingDaniel Fletcher (San Francisco/USA)

10:50 IL TU-14-03Changing trends in Management of AMD-Malaysian PerspectiveVeera Ramani Ondiveeran (Selangor DarulEhsan/MAL)

11:00 IL TU-14-04Quality of life and age-related macular degeneration: Does Anti-VEGF treatment in day today settings impact vision-related QoL in AMD?Robert P. Finger (Bonn/D)

11:10 IL TU-14-05Can diet reduce the genetic risk of AMD?Carolin Klaver (Rotterdam/NL)

11:20 IL TU-14-06Italian Smith-Kettlewell Read Test to assess reading difficulties in AMDGianfrancesco Villani (Verona/I)

11:30Discussion


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne180 WOC® 2010

Oslo

14:00 - 15:30 TU-15

Neural Based Targeting in Glaucoma

SymposiumGlaucoma

Chairs:Neeru Gupta (Toronto/CDN)M. Francesca Cordeiro (London/UK)Christian K. Vorwerk (Magdeburg/D)

14:00 IL TU-15-01Mitochondrial targets in glaucomaNeville N. Osborne (Oxford/UK)

14:10 IL TU-15-02Targeting RGCs and dendrites in glaucomaM. Francesca Cordeiro (London/UK)

14:20 IL TU-15-03Targeting the brain in glaucomaNeeru Gupta (Toronto/CDN)

14:30 IL TU-15-04Emerging stem cell therapies for glaucomaChristian K. Vorwerk (Magdeburg/D)

14:40 IL TU-15-05Regenerative approaches for glaucomaMichael J. Young (Boston/USA)

14:50 IL TU-15-06Nano-strategies to protect neurons in glaucomaRutledge G. Ellis-Behnke (Cambridge/USA)

15:00Discussion

Oslo

16:00 - 17:30 TU-16

Ocular Blood Flow – Clinical Relevance for Glaucoma

SymposiumGlaucoma

Chairs:Selim Orgül (Basel/CH)Eugen Gramer (Würzburg/D)Alon Harris (Indianapolis/USA)

16:00 IL TU-16-01Population based studies: perfusion pressure andblood flow in glaucomaAlon Harris (Indianapolis/USA)

16:10 IL TU-16-02Measurements of ocular blood flowIngrida Janulevciene (Kaunas/LT)

16:20 IL TU-16-03The ischemic optic nerve in glaucomaJost B. Jonas (Mannheim/D)

16:30 IL TU-16-04Genetic markers for ischemia in glaucomaLouis R. Pasquale (Boston/USA)

16:40 IL TU-16-05Circadian blood pressure and perfusion pressure inthe glaucoma patientVital P. Costa (São Paulo/BR)

16:50 IL TU-16-06Systemic medications and ocular blood flow in theglaucoma patientMakoto Araie (Tokyo/J)

17:00Discussion

Room Madrid

08:30 - 10:00 TU-17

Proteomics and Genomics in Uveitis


Chairs:Robert Nussenblatt (Bethesda/USA)S. John Curnow (Birmingham/UK)Stephan Thurau (Munich/D)

08:30 IL TU-17-01GenomicsTammy Martin (Portland/USA)

08:45 IL TU-17-02Profiling of the human retinal endothelial cell; implications for the pathogenesis of uveitisJustine R. Smith (Portland/USA)

09:00 IL TU-17-03Gene expression profiles in patients with noninfectious uveitisRobert Nussenblatt (Bethesda/USA)

09:15 IL TU-17-04Gene expression of pathogenic T cells in EAUGerhild Wildner (Munich/D)

09:30 IL TU-17-05Proteomics in equine uveitisCornelia A. Deeg (Munich/D)

09:45Discussion


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

181WOC® 2010

Room Madrid

10:30 - 12:00 TU-18

ASRS Symposium: The Future of Surgical and Medical Retina: Where Do We Go Next?

SymposiumRetina

Chairs:Tarek S. Hassan (Royal Oak/USA)Peter K. Kaiser (Cleveland/USA)Mark Humayun (Los Angeles/USA)

10:30 IL TU-18-01Evolving techniques of vitreous removal: Pharmacologic and Portable VitrectomyTarek S. Hassan (Royal Oak/USA)

10:40 IL TU-18-02The Future of Pharmacologic Treatment of Age-Related Macular DegenerationPeter K. Kaiser (Cleveland/USA)

10:50 IL TU-18-03The Retinal Prosthesis: Epiretinal ApproachMark Humayun (Los Angeles/USA)

11:00 IL TU-18-04Neuroprotection for Retinal DiseaseBaruch D. Kuppermann (Irvine/USA)

11:10 IL TU-18-05Next-generation Vitrectomy Devices: Essential FeaturesCarl C. Awh (Nashville/USA)

11:20 IL TU-18-06Genetic testing for AMD – Is the Future here?David Chow (Reston/CDN)

11:30 IL TU-18-07Automation: Augmented Reality & RoboticsSteven Schwartz (Los Angeles/USA)

11:40 IL TU-18-08Physical Determinants of Ocular Trauma Suber Huang (Shaker/USA)

11:50 IL TU-18-09The Future of Vitrectomy Systems Philip Ferrone (Riverhead/USA)

Room Madrid

14:00 - 15:30 TU-19

Eye Banking: Optimizing Techniques and QualityControl


Chairs:Andrej Cernák (Bratislava/SK)Philip Maier (Freiburg/D)

14:00 IL TU-19-01Notification and evaluation of SAR and SEE UKmodelJohn Armitage (Bristol/UK)

14:10 IL TU-19-02Serious adverse reactions and events in the USAPatricia Dahl (Healdsburg/USA)

14:20 IL TU-19-03Quality control in eye banking, European versusUSA modelDiego Ponzin (Venice/I)

14:30 IL TU-19-04Clinical follow-up registration and eye banking:the Australian Graft registryKeryn A. Williams (Bredford Park/AUS)

14:40 IL TU-19-05Clinical follow-up registration and eye banking inEuropeDaniel Böhringer (Freiburg/D)

14:50 IL TU-19-06Implementation of the European Tissue Guidelinesin different member statesVincent Borderie (Paris/F)

15:00 IL TU-19-07Eu Directories and international allocation ofcorneal graftsArlinke G. Bokhorst (Leiden/NL)

15:10 IL TU-19-08Serum-free medium for orgen cultureKatrin Engelmann (Chemnitz/D)

15:20 IL TU-19-09Precut tissue for lamellar keratoplastySonja Ute Heinzelmann (Freiburg/D)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne182 WOC® 2010

Room Madrid

16:00 - 17:30 TU-20

Immunology of Keratoplasty


Chairs:Daniel Frank P. Larkin (London/UK)Uwe Pleyer (Berlin/D)Birgit Sawatzki (Berlin/D)

16:00 IL TU-20-01HLA class IITBA

16:15 IL TU-20-02Immunology of corneal graft rejection: current understandingDaniel Frank P. Larkin (London/UK)

16:30 IL TU-20-03Future approaches on immunmodulationUwe Pleyer (Berlin/D)

16:45 IL TU-20-04Tolerance induction: insights from the immunologists perspectiveBirgit Sawatzki (Berlin/D)

17:00 IL TU-20-05Immunpharmacology: Update on clinical and experimental dataThomas Reinhard (Freiburg/D)

17:15Discussion

Room Sydney

08:30 - 10:00 TU-21

RGP Lenses: Non Surgical Treatment of RefractiveErrors and Ectatic Corneas


Chairs:William H. Ehlers (Farmington/USA)Gernot I. W. Duncker (Halle/D)Lance Forsott

08:30 IL TU-21-01Toric Contact Lenses/Correction of astigmatismwith contact lensesAyfer Kanpolat (Ankara/TR)

08:40 IL TU-21-02Contact Lens fitting after KeratoplastyÖmur Uçakhan Gündüz (Ankara/TR)

08:50 IL TU-21-03The use of semi-scleral contact lensesOrestes Miraglia (Belo Horizonte/BR)

09:00 IL TU-21-04Contact lenses and ectasiasCesar Lipener (Sao Paulo/BR)

09:10 IL TU-21-05Thin corneas and refractive surgeryJulieta Goncalves (Porto Alegre/BR)

09:20 IL TU-21-06Anterior corneal "microfolds" in orthokeratologySami El Hage (Houston/USA)

09:30 IL TU-21-07Clinical record of toric RGP lenses prescribed in theadvanced astigmatic eyesKajita Masayoshi (Fukushima/J)

Room Sydney

10:30 - 12:00 TU-22

Panel: Uveal Tumors

PanelOncology

Chairs:Jerry Shields (Philadelphia/USA)Bertil D. Damato (Liverpool/UK)Norbert Bornfeld (Essen/D)

Panellist:Minoru Furuta (Fukushima/J)Michael Giblin (Sydney/AUS)Hans E. Grossniklaus (Atlanta/USA)Tero Kivelä (Helsinki/FIN)Maria E. Manquez (Santiago/RCH)Timothy G. Murray (Miami/USA)Jacob Pe'er (Jerusalem/IL)Carol L. Shields (Philadelphia/USA)Leonidas Zografos (Lausanne/CH)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

183WOC® 2010

Room Sydney

14:00 - 15:30 TU-23

Evidence-based Management of Retinal Diseases

SymposiumEvidence Based Ophthalmology

Chairs:Robert B. Bhisitkul (San Francisco/USA)George William Aylward (London/UK)Heinrich Heimann (Liverpool/UK)

14:00 IL TU-23-01EBM in retinal practiceRichard Wormald (London/UK)

14:10 IL TU-23-02Prophylaxis of retinal detachmentGeorge William Aylward (London/UK)

14:20 IL TU-23-03Initial treatment of rhegmatogenous retinal detachmentHeinrich Heimann (Liverpool/UK)

14:30 IL TU-23-04Clinical trial results in the medical and surgicalmanagement of diabetic retinopathyRajendra Apte (Saint Louis/USA)

14:40 IL TU-23-05Update on retinal venous occlusive diseaseHorst Helbig (Regensburg/D)

14:50 IL TU-23-06Evidence based comparisons of variable andmonthly anti-VEGF therapy in AMDRobert B. Bhisitkul (San Francisco/USA)

15:00Discussion

Room Sydney

16:00 - 17:30 TU-24

Modern Manual Cataract Surgery

SymposiumCataract

Chairs:Srinivas Kamalakara Rao (Chennai/IND)N. Venkatesh Prajna (Madurai/IND)Thomas F. Neuhann (Munich/D)

16:00 IL TU-24-01Key issues in manual cataract surgical techniquesSrinivas Kamalakara Rao (Chennai/IND)

16:10 IL TU-24-02Manual small incision cataract surgery (M-SICS):my technique and resultsHuck Holz (Santa Clara/USA)

16:20 IL TU-24-03Sutureless large incision manual cataract extrac-tion (SLIMCE): technique and resultsSrinivas Kamalakara Rao (Chennai/IND)

16:30 IL TU-24-04M-SICS: the fishhook technique and tips for avoiding complicationsAlbrecht Hennig (Kathmandu Lahan/NEP)

16:40 IL TU-24-05Comparing outcomes of SLIMCE with phacoemulsificationYingpeng Liu (Shantou/CN)

TU-24-06The Need for and the Approach to teaching manual cataract surgeryN. Venkatesh Prajna (Madurai/IND)

17:00 IL TU-24-07The approach adopted by “Project Vision” in training doctors to perform manual cataract surgerySrinivas Kamalakara Rao (Chennai/IND)

17:10Discussion



WOC® 2010

09:19 FP TU-25-08Alkylphosphocholines for Intraocular Lens CoatingKirsten Eibl, Raffael Liegl, Marcus Kernt, Katja Obholzer, Armin Wolf, Ricarda Schumann,Christos Haritoglou, Anselm Kampik (Munich/D)

09:26 SL TU-25-09Contact lenses in children: indications and complicationsSusanne Marx-Gross (Mainz/D)

09:35 SL TU-25-1012-Month Results after Implantation of a New Accommodative IOL that Works with one focus

9:42Discussion

Room Hong Kong

10:30 - 12:00 TU-26

Therapeutic Contact Lenses: Bandage Lenses andDrug Release


Chairs:Michael H. Goldstein (Boston/USA)René Mély (Saarlouis/D)Frank H. W. Tost (Greifswald/D)

10:30 IL TU-26-01The Hikaro Hamano Lecture: Pathophysiologicchanges of ocular surface by contact lens wearMitsuro Sawa (Tokyo/J)

10:50 IL TU-26-02General Principles and Current Indications in Medical Contactology Peter Donshik (Bloomfield/USA)

11:00 IL TU-26-03When not to use Bandage Lenses Chong Yew Khoo (Singapore/SGP)

11:10 IL TU-26-04Scleral Lenses for Ocular Surface DiseasesDeborah S. Jacobs (Needham/USA)

11:20 IL TU-26-05The vicious circle story: dry-eye surface – contactlensesGurdal Canan (Ankara/TR)

11:30 IL TU-26-06Extensions of Indications of bandage lensesRené Mély (Saarlouis/D)

Room Hong Kong

08:30 - 10:00 TU-25

Cataract/Biometry 3

Free PaperCataract

Chairs:Arturo Perez Arteaga (Tlalnepantla/MEX)Jochen Kammann (Davos/CH)Charlotta Zetterström (Oslo/N)

08:30 FP TU-25-01Application of the ESCRS recommendations on antibiotics for postoperative endophthalmitis prophylaxis following cataract surgery in the UKSalman Waqar, Salem Murjaneh, Maan Kasmiya,Julia Elizabeth Hale, Anthony Quinn (Exeter/UK)

08:37 FP TU-25-02Comparison of various torsional handpieces inMCCS – Comparison of Mini-Flared 30° Kelman andMini-Flared 45° Kelman and Reverse Mini-Flared30° Kelman attending torsional phaco casesChoun-ki Joo, Kim Eun-kyoung (Seoul/ROK)

08:44 FP TU-25-03How to seal clear cornea incisions after cataractsurgery: the role of a liquid ocular bendageMatteo Piovella (Monza/I)

08:51 FP TU-25-04Postoperative Refractive Error by Using A-scan inCataract Surgery After VitrectomySeok Joon Kong, Seungbum Kang, Sung Kun Chung(Seoul/ROK)

08:58 FP TU-25-05Complications of couching and visual outcomeafter IOL implantation – A study of 60 patients inSudan DarfurMohamed Siddig (Elafuon/SUD)

09:05 FP TU-25-06The use of the Eyesi surgical simulator in trainingphacoemulsification for medical students in KingFaisal University, Saudi ArabiaMohamed Morsy (Hufuf/SA)

09:12 FP TU-25-07Prospective multicenter masked bilateral con-trolled randomized trial of YAG laser photolysis:the laser capsule opacity prevention (LCOP) studyGeorge Waring, Wolfram Wehner, Burkhard Dick,Siegfried Priglinger, Jorge Alió, Pavel Stodulka, Reinhardt Thyzel, Rudolf Walker (Atlanta/USA,Nürnberg/D, Linz/A, Alicante/E)

184

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne


WOC® 2010

Room Hong Kong

16:00 - 17:30 TU-28

Globe Reconstruction after Severe Eye Injury

SymposiumEye Trauma and Emergencies

Chairs:Ferenc Kuhn (Birmingham/USA)Wolfgang F. Schrader (Nürnberg/D)Paul Sullivan (London/UK)

16:00 IL TU-28-01A. Combined topical anesthesia and sedation foropen-globe injuries in selected patients B. Partial vitrectomy in the management of open-globe injuriesFrancesco Boscia (Bari/I)

16:10 IL TU-28-02Choosing Wisely: How Does Initial Management ofOpen Globe Injuries Affect Ultimate Outcome?Vytautas Al Pakalnis (Columbia/USA)

16:20 IL TU-28-03Ocular trauma in outdoor sportsRon Adelman (New Haven/USA)

16:30 IL TU-28-04Outcomes of surgery for posterior segment intraocular foreign bodies – a retrospective reviewof 17 years of clinical experience.Paul Sullivan (London/UK)

16:40 IL TU-28-05Primary silicone oil tamponade in the manage-ment of severe intraocular foreign body injuries:an 8-year follow-upPeter Szurman (Tübingen/D)

16:50 IL TU-28-06Results of early vitrectomy in severe open globeinjuriesWolfgang F. Schrader (Nürnberg/D)

17:00 IL TU-28-07Combined anterior and posterior segment injuriesin childrenPetra Meier (Leipzig/D)

17:10 IL TU-28-08Pearls and pitfalls in the treatment of severe ocu-lar traumaFerenc Kuhn (Birmingham/USA)

17:20Discussion

11:40 IL TU-26-07Use of therapeutic contact lenses for drug release:current statusFrank H. W. Tost (Greifswald/D)

11:50 IL TU-26-08Therapeutic uses of tinted lensesZoraida Fiol-Silva (Philadelphia/USA)

Room Hong Kong

14:00 - 15:30 TU-27

Hot Topics in Ocular Traumatology


Chairs:Norbert Franz Schrage (Cologne/D)Paul D. Langer (Newark/USA)Giampaolo Gini (Prato/I)

14:00 IL TU-27-01Management of Incompletely Repaired OrbitalFracturesPaul D. Langer (Newark/USA)

14:10 IL TU-27-02Management of occult and non-occult orbitocranial penetrating injuriesRoger Turbin (Newark/USA)

14:20 IL TU-27-03Secondary repair of anterior-posterior trauma ofthe globeAndreas Kay Cordes (Cologne/D)

14:30 IL TU-27-04Chemical traumaNorbert Franz Schrage (Cologne/D)

14:50 IL TU-27-05Rational approach to open globe injuriesGiampaolo Gini (Prato/I)

15:00 IL TU-27-06Round Table: Concensus Paper on treatment ofchemical injuriesPaul D. Langer, Roger Turbin, Andreas Kay Cordes,Norbert Franz Schrage, Giampaolo Gini, HaroldMerle, Christopher A. Paterson (Newark/USA,Cologne/D, Prato/I, Fort de France/F)

185

Tues

day,

8 Ju

ne

Scie

ntifi

c Pro

gram

Sch

edul

e


WOC® 2010

09:21 FP TU-29-08Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (R.A.B.A.M.E.S.) –a prospective randomized multicenter trialLars-Olof Hattenbach, Nicolas Feltgen, Amelie Pielen, Lutz Hansen, Katrin Lorenz, Norbert Pfeiffer, Hans Hoerauf, Caroline Jünemann,Fabian Höhn, Thomas Kreutzer, Siegfried G.Priglinger Jr., Alireza Mirshahi (Ludwigshafen/D,Göttingen/D, Freiburg/D, Mainz/D, Mannheim/D,Munich/D, Linz/A)

09:28 FP TU-29-09Efficacy Outcomes of the BRAVO Study of Intravit-real Ranibizumab in Patients with Macular EdemaSecondary to Branch Retinal Vein OcclusionQuan Dong Nguyen, Sarah Gray, Wendy Yee Murahashi, Namrata Saroj, Amy Chen Rundle,Roman G. Rubio (Baltimore/USA, SanFrancisco/USA)

09:35 SL TU-29-10How fast does the Avastin concentration fall away in the eye? Measurements of the pharmaco-kinetics of Bevacizumab in the human eyesCarsten H. Meyer, Tim Krohne, Frank G. Holz(Bonn/D)

09:42Discussion

VIP Lounge 1

10:30 - 12:00 TU-30

Glaucoma: Medical Therapy

Free PaperGlaucoma

Chairs:George Baerveldt (Irvine/USA)Richard Wormald (London/UK)Michael J. Young (Boston/USA)

10:30 FP TU-30-01Control of intraocular pressure and intraocularpressure hluctuation with fixed combination Brimonidine–Timolol versus Brimonidine or Timolol monotherapyGeorge L. Spaeth, Joseph Caprioli, Paula Bernstein,Rhett M. Schiffman (Philadelphia/USA)

10:37 FP TU-30-02A Randomized, Controlled Comparison of Conjunctival Hyperemia in Patients Treated with Bimatoprost 0.01% or Vehicle Who Were Previously Controlled on LatanoprostE. Randy Craven, Anup K. Khatana, Thomas K. Mundorf, Ching-chi Liu, Amy L. Batoosingh (Parker/USA)

VIP Lounge 1

08:30 - 10:00 TU-29

Retina: Vascular Disease 2

Free PaperRetina

Chairs:Lars-Olof Hattenbach (Ludwigshafen/D)Gabriel J. Coscas (Créteil/F)Tim Stout (Portland/USA)

08:30 SL TU-29-01CMV Retinitis Managed at the Primary Care Level in a Resource-Poor Setting by Non-Ophthal-mologists: A description of an NGO program inMyanmarHeiden David (San Francisco/USA)

08:39 FP TU-29-02The Association of Serum Apolipoproteins and CReactive Protein with the Severity of DiabeticRetinopathyMuhammad Bayu Sasongko, Tien Yin Wong, Ryo Kawasaki, Jonathan Shaw, Alicia Jenkins, Jie Jin Wang (Melbourne/AUS)

08:46 FP TU-29-03Cost-effeciveness of automated algorithms versus manual grading for the detection of referable diabetic retinopathyGraham Scotland, Paul McNamee, Alan D Fleming,Keith Goatman, Sam Philip, Gordon J. Prescott, Peter F. Sharp, Graeme J. Williams, William Wykes,Graeme P. Leese, John A. Olson (Aberdeen/UK)

08:53 FP TU-29-04Intravitreal anti-VEGF therapy in diabetic macularedemaStanislav Rodin, Veronika Aslanova (Odessa/UA)

09:00 FP TU-29-05Monotherapy for diffuse diabetic macular edema:Photocoagulation or BevacizumabVladimir Poposki, D. Vilaplana, D. Poposka, I. Alarcón I., O. Marínez-Giralt, M. Castilla(Barcelona/E)

09:07 FP TU-29-06Intravitreal anti-VEGF therapy for retinal macroa-neurysms with macular exsudationMagdalena Tönz, Stephan Michels, Rike Michels,Lukas Pfenninger (Zurich/CH)

09:14 FP TU-29-07Intraocular concentrations of growth factors andcytokines in diabetic macular edema and macularedema due to retinal vein occlusionHeeyoon Cho, Byung Ro Lee (Guri-city/ROK)

186

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne


WOC® 2010

11:33 FP TU-30-10Role of Herbal Drugs in the Management of Glaucoma – An Experimental StudySuresh Gupta, Renu Agarwal, Sushma Srivastava,Rohit Saxena (New Delhi/IND, Kuala Lumpur/MAL)

11:40Discussion

VIP Lounge 1

14:00 - 15:30 TU-31

Cornea/External Disease: Medical therapy


Chairs:Christophe Baudouin (Paris/F)Thomas Reinhard (Freiburg/D)

14:00 FP TU-31-01Visual rehabilitation after Descemet MembraneEndothelial Keratoplasty (DMEK) – Results of thefirst 100 casesKonstantinos Droutsas, Lisanne Ham, IsabelDapena, Kyros Moutsouris, Jaqueline van der Wees,Gerrit R. J. Melles (Rotterdam/NL)

14:07 FP TU-31-02Optimization of the Refractive Results of CornealCollagen Crosslinking (CXL).Andriy Kovalov, Oksana Averyanova (Kiev/UA)

14:14 FP TU-31-03Collagen Crosslinking for Bullouse Keratopathy: 1,5 Year Follow-UpGuzel Bikbova, Mukharram Bikbov (Ufa/RUS)

14:21 FP TU-31-04Effect of topical application of terbinafine on fungal keratitisQingfeng Liang, Xiu-ying Jin (Beijing/CN)

14:28 FP TU-31-05The effect of subconjunctival bevacizumab forcorneal neovascularizationBerraho Amina, Adil Megzari (Rabat/MA)

14:35 FP TU-31-06Low-Concentration Bevacizumab Topical Solutionin Treatment of Corneal NeovascularizationJacek P. Szaflik, Urszula Kolodziejska, Anna Kaminska, Justyna Izdebska, Jerzy Szaflik(Warszawa/PL)

10:44 FP TU-30-03Randomized, Investigator-Masked Study Comparing the Efficacy and Tolerability of Bimatoprost and Latanoprost in Patients After Initial Latanoprost TreatmentEhsan Sadri, Ronald Frenkel, Joseph Caprioli, Jason Bacharach, Ching-chi Liu, Amy L. Batoosingh(Newport Beach/USA)

10:51 FP TU-30-04Intraocular pressure-lowering efficacy of brinzolamide compared with placebo when addedto travoprost/timolol fixed combination as adjunc-tive therapy in primary open-angle glaucoma orocular hypertensive patientsIvan Goldberg, Jonathan Crowston, Barbara Cvenkel, Mark C. Jasek, Jeanette A. Stewart, William C. Stewart (Sydney/AUS)

10:58 FP TU-30-05Twelve-month, Randomized, Controlled Trial of theEfficacy and Safety of Bimatoprost 0.01%, 0.0125%,and 0.03% in Patients With Glaucoma or OcularHypertensionMichael Tepedino, L. Jay Katz, John S. Cohen, Amy L. Batoosingh, Carlos Felix, Vincent Shu, Rhett M. Schiffman (High Point/USA, Irvine/USA)

11:05 FP TU-30-06The effects of Combigan versus Cosopt on ocularperfusion pressure and blood flow in patients withopen angle glaucomaYochai Shoshani, Brent Siesky, Rita Ehrlich, Louis Cantor, Darrell WuDunn, Chi Wah Yung, Lynne McCranor, John Abrams, Julia Williams, David Hollander, Alon Harris (Indianapolis/USA)

11:12 FP TU-30-07Aqueous humor VEGF levels before and after in-travitreal bevacizumab in eyes with neovascularglaucoma: a two-dose comparative studyYuzuru Sasamoto, Yusuke Oshima, Taku Wakabayashi, Atsuya Miki, Kenji Matsushita,Motohiro Kamei (Suita/J)

11:19 FP TU-30-08Trabeculectomy with Mitomycin-C versus trabeculectomy with 5-Fluorouracil for the treat-ment of childhood glaucomaOsama Badeeb (Jeddah/SA)

11:26 FP TU-30-09The success rate of trabeculectomy bleb needlingaugmented with 5-FluorouracilKaveh Vahdani, Adam Paget Booth, Aristeidis Konstantinidis (Plymouth/UK)

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

187


WOC® 2010

16:16 FP TU-32-03Histology of fibrovascular membranes of proliferative diabetic rerinopathy after the intravitreal injection of bevacizumabToshiaki Kubota, Hirofumi Morita, Norihiko Tou,Norikazu Nitta, Kenichi Kimoto, Akihiko Tawara, Hitoshi Satoh, Shohei Shimajiri (Yufu-shi/J)

16:23 FP TU-32-04Vitreous surgery combined with Brilliant blue-Gdye assisted ILM peel for traumatic macular holesAtul Kumar, Varun Gogia (New Dehli/IND)

16:30 FP TU-32-05Heavy Silicone Oil versus Standard Silicone Oil inas vitreous tamponade in Inferior PVR (HSOStudy): Interim Analysis of 94 consecutive patientsAntonia M. Joussen, Christina Ocklenburg, Norbert Schrage, Bernd Kirchhof, Ralf-DieterHilgers (Berlin/D, Köln/D, Aachen/D)

16:37 FP TU-32-06Transcleral Posterior Chamber Paracentesis for Posterior Chamber Gas Entrapment with AnteriorChamber Angle Collapse Following IntravitrealC3F8 Injection in a Phakic EyeYi-Ting Hsieh (Xindian/TJ)

16:44 FP TU-32-07High-resolution Fourier-domain Optical CoherenceTomography Findings in Eyes with SurgicallyClosed Macular Hole: Correlation between VisualAcuity Outcome and Inner Macular VolumeSusanna Park (Sacramento/USA)

16:51 FP TU-32-08Vitreoretinal complications of regressed retinopathy of prematurityTakao Endo (Suita/J)

16:58 FP TU-32-09Safety testing of indocyanine green with differentsurgical light sources and the protective effect ofoptical filtersJost Hillenkamp, Sofia Dydykina, Alexa Klettner,Felix Treumer, Rudolf Vasold, Wolfgang Bäumler, Johann Roider (Kiel/D)

17:05 SL TU-32-10New technologies in the treatment of pathologyof eye fundusAndrii R. Korol (Odessa/UA)

17:14Discussion

14:42 FP TU-31-07Topical Bevacizumab eye drops for corneal neovascularisation – preliminary resultsPavel Studeny, Deli Sivekova, Magdalena Vokrojova,Andrej Farkas, Magdalena Netukova, PavelKuchynka (Prague/CZ)

14:49 FP TU-31-08An Ocular Surface Prosthesis for Visual Rehabilita-tion of Corneal EctasiaDeborah S. Jacobs, James Bradley, Inna Baran,Fateme Alipour, Perry Rosenthal (Needham/USA)

14:56 FP TU-31-09Fixed, dilated pupil, iris atrophy, cataract, and secondary glaucoma in Acanthamoeba keratitisDenise Freitas, Elcio Sato, Luiz Antonio Vieira, Patricia Contarini, Fabio Ramos, Annette Foronda(Sao Paulo/BR)

15:03 FP TU-31-10Oral pilocarpine for the treatment of dry eyesymptoms in patients with aqueous-deficient andevaporative dry eyeTatsuro Miyamoto, Hiroshi Eguchi (Tokushima/J)

15:10Discussion

VIP Lounge 1

16:00 - 17:30 TU-32


Free PaperRetina

Chairs:Horst Helbig (Regensburg/D)Gisbert Richard (Hamburg/D)Carol L. Shields (Philadelphia/USA)

16:00 SL TU-32-0112-month evaluation of Dexamethasone intravitreal implant in patients with macularedema due to central retinal vein occlusionFrancesco Bandello, Julia A. Haller, Mark S. Blumenkranz, Rubens Belfort, Mark Gillies, Jeffrey Heier, Anat Loewentstein, Young-Hee Yoon,Jenny Jiao, Xiao-Yan Li, Scott M. Whitcup (Milano/I,São Paulo/BR, Sydney/AUS, Philadelphia/USA, Stanford/USA, Tel Aviv/IL, Boston/USA, Irvine/USA,Seoul/ROK)

16:09 FP TU-32-02Intravitreal triamcinolone acetonide and intravitreal bevacizumab (Avastin) in diffuse diabetic macular edema (A comparative study).Rasheed El-Lakkany, Maha Shahin (Mansoura/ET)

188

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne


WOC® 2010

VIP Lounge 2

08:30 - 10:00 TU-33


Free PaperRetina

Chairs:Antonia M. Joussen (Berlin/D)Thomas Theelen (Nijmegen/NL)

08:30 FP TU-33-02Functional impairment of pigment epithelial detachments determined by microperimetryCarolin Milojcic, Christoph Clemens, Nicole Eter,Frank G. Holz (Bonn/D)

08:37 FP TU-33-03Quantitative computerized colour vision testing indiabetic retinopathy – a possible screening tool?Rashid Alsaeidi, Christos Haritoglou, Thomas Kreutzer, Günther Rudolph, Michael Ulbig,Aljoscha Neubauer, Anselm Kampik (Munich/D)

08:44 FP TU-33-04Clinical Applications of Ultrasound in the Evaluation of Posterior Hyaloid DetachmentPeter Stalmans (Leuven/B)

08:51 FP TU-33-05Fluorescein Angiography Changes after IntravitrealInjection of Bevacizumab (Avastin)Maha Shahin (Mansoura/ET)

08:58 FP TU-33-06Does internal longitudinal microstructure of retinal arteries and veins change with age in medically healthy persons?Konstantin Kotliar, Ali Kharoubi, Arno Schmidt-Trucksäss, Martin Halle, Ines Lanzl (Munich/D)

09:05 FP TU-33-07Fundus autofluorescence at two different wavelengths in patients with dry age-related macular degenerationPavel Nechiporenko, Alla Lisochkina, Yuri Astakhov(Saint-Petersburg/RUS)

09:12 FP TU-33-08Fundus autofluorescence of congenital and acquired loss of macular pigmentThomas Theelen, Tos T. J. M. Berendschot, JohannesR. M. Cruysberg, B. Jeroen Klevering, Carel B. Hoyng(Nijmegen/NL)

09:19 FP TU-33-09The Relevance of Near-Infrared Autofluorescencein the Evaluation of Chorioretinal Diseases: 4 yearsexperienceUlrich Kellner, Simone Kellner, Silke Weinitz, ElenaTorres Suarez, Azadeh Golshahi (Bonn/D, Sieg-burg/D, Cologne/D)

09:26 FP TU-33-10Changes in macular morphology after macularhole closure visualized with Spectral Optical Coherence TomographyZofia Michalewska, Janusz Michalewski, JerzyNawrocki (Lodz/PL)

09:33Discussion

VIP Lounge 2

10:30 - 12:00 TU-34


Free PaperRetina

Chairs:Klaus-Dieter Lemmen (Düsseldorf/D)Constantin J. Pournaras (Geneva/CH)

10:30 SL TU-34-01Macular surgery: The ILM storyConstantin J. Pournaras (Geneva/CH)

10:39 FP TU-34-02Complications in 208 consecutive cases of laser vitreolysis for symptomatic vitreous opacitiesScott Geller (Fort Myers/USA)

10:46 FP TU-34-03Vitreoretinal surgery, choice of endotamponade inProliferative Diabetic RetinopathyTatjana Josifova (Basel/CH)

10:53 FP TU-34-04The Heavy Tamponade Densiron-68® For Persistent Macular HolesAlexandra Lappas, Albert Caramoy, Andreas M. H. Foerster, Bernd Kirchhof (Köln/D)

11:00 FP TU-34-06Partial liquefaction of the vitreous gel and vitreo-retinal separation by intraocular injection of heparinWilli Halfter, Wingard Jeremy, Eller Andrew (Pittsburgh/USA)

189

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne


VIP Lounge 2

14:00 - 15:30 TU-35

Retina: Medical Therapy 2

Free PaperRetina

Chairs:Paul T. Finger (New York City/USA)Paul Mitchell (Sydney/AUS)Francesco Bandello (Milano/I)

14:00 FP TU-35-01Evaluation of the re-treatment criteria effective-ness in the RESOLVE studyFrancesco Bandello, Yehia Hashad, Gabriela Burian,Andreas Weichselberger (Milano/I, Basel/CH)

14:07 FP TU-35-02Intravitreal Lucentis (ranibizumab) for radiationmaculopathy: A pilot studyPaul Finger, Kimberly Chin (New York/USA)

14:14 FP TU-35-03Intravitreal Bevacizumab (Avastin) treatment Trialin Macula Oedema of Retinal Venous OcclusiveDiseasesMuthusamy Malaravan, Dushyantha Wariyapola(Dehiwala/CL)

14:21 FP TU-35-05Alteration of the foveal avascular zone after intra-vitreal anti-VEGF application in patients with branchretinal vein occlusion or diabetic macular diseaseNikolaus Feucht, Mathias Maier, Konstantin Kotliar,Sarah Pfrommer, Ines Lanzl, Chris Patrick Lohmann (Munich/D)

14:28 FP TU-35-07Randomized clinical trial comparing grid laser, intravitreal triamcinolone, and combined triamcinolone and sequential grid laser for diabetic macular edema: one-year outcomesShaheeda Mohamed, Carmen K. M. Chan, Dennis S. C. Lam (Hong Kong/HK)

14:35 FP TU-35-08Monthly Ranibizumab for non-proliferative macular telangiectasia type 2 (RAMA trial): A one-year prospective studyPeter Charbel Issa, Robert P. Finger, Kathrin Kruse,Sönke Baumüller, Hendrik P. N. Scholl, Frank G. Holz(Oxford/UK, Bonn/D)

11:07 FP TU-34-07LED technology for intraoperative vitreoretinal illuminationStefan Dithmar, Alexandra Eva Hoeh, Mira Ruppenstein, Roman Amberger, Thomas Ach(Heidelberg/D)

11:14 FP TU-34-08Direct Artery Massage for Central Retinal ArteryOcclusion: The Experimental and Clinical ResearchLili Zhao, Ningli Wang, Ning Lu (Beijing/CN)

11:21 FP TU-34-09The transchoroidal implantation of subretinal ac-tive visual prostheses in blind RP patients: Surgicalresults in the first 12 patients. Potential and safetyof this new complex surgical procedure allowingreproducible usable visual percepts.Helmut Sachs, Karl Ulrich Bartz-Schmidt, Florian Gekeler, Dorothea Besch, Uschi Brunner,Barbara Wilhelm, Robert Wilke, Walter Wrobel, Veit-Peter Gabel, Eberhart Zrenner (Tübingen/D)

11:28 FP TU-34-10Macular EpiRetinal brachytherapy in treated age-related macular degeneration patients (MERITAGE): interim resultsTim Jackson, Pravin Dugel, Robert Petrarca, Jeff Nau(London/UK, Phoenix/USA, Freemont/USA)

11:35 FP TU-34-11Clinical treatment accuracy in diabetic macularedema using navigated laser photocoagulatorNAVILAS®: A multicentered clinical trial.Igor Kozak, Stephen Oster, Marco Cortes, Kathrin Hartmann, Jae Suk Kim, Aljosha Neubauer,Anselm Kampik, William Freeman (La Jolla/USA)

11:42Discussion

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010190Tu

esda

y, 8

June

191


16:21 FP TU-36-04Apoptosis Rate and Mitochondria RespirationFunction of Photoreceptor Cells of Rats Exposed byTolueneSyntia Nusanti (Jakarta/RI)

16:28 FP TU-36-05Astrocyte hypoxic response is essential for pathological but not developmental angiogenesisof the retinaTim U. Krohne, Alexander Weidemann, Edith Aguilar, Toshihide Kurihara, Norihiko Takeda,Michael I. Dorrell, M. Celeste Simon, Volker H. Haase, Randall S. Johnson, Martin Friedlander (La Jolla/USA)

16:35 FP TU-36-06Time-related expression of glial fibrillary acidicprotein in a non-intraocular-pressure related glaucoma modelVanessa D. Stahl, Stephanie C. Joachim, Oliver W. Gramlich, Laspas Panos, Norbert Pfeiffer,Franz H. Grus (Mainz/D)

16:42 FP TU-36-07Effects of growth factors bFGF, IGF-1 and VEGF165on permeability and tight-junctions in microvascu-lar retinal endothelial cellsHeidrun Deissler, Gabriele E. Lang (Ulm/D)

16:49 FP TU-36-08VEGF and PEDF secretions over time following various laser irradiations on an RPE organ cultureYoko Miura, Felix Treumer, Alexa Klettner, Jost Hillenkamp, Ralf Brinkmann, Reginald Birngruber, Johann Roider (Lübeck/D, Kiel/D)

16:56 FP TU-36-09The influence of high glucose concentrations andelastin derived peptides on metalloproteinases(MMP-1, 2 and 9) and their inhibitors (TIMP-1, 2, 3,4) expression in human retinal pigment cells.Mariola Dorecka, Tomasz Francuz, Wojciech Garczorz, Wanda Romaniuk, Jan Gminski(Bedzin/PL)

17:03Discussion

14:42 FP TU-35-09Efficacy and safety of intravitreal triamcinolone atthe end of phacoemulsification surgery in patientswith significant diabetic macular edemaEnrique Rodriguez de la Rua, David Galarreta, Maria Isabel Lopez Galvez, Belen Carrasco, Lucia Manzanas, Cristina Perez Fernandez, Nestor Cortes Mora, Maria Teresa Sanchez Sanchez(Valladolid/E)

14:49 FP TU-35-10The Change of Vision Related Quality of Life After Panretinal Photocoagulation in Patients withDiabetic RetinopathyAngela Nurini Agni, Muhd Zafran Muhd Zafran bin Shamsudin (Yogyakarta/RI)

14:56 FP TU-35-11Double-Masked, Sham-Controlled, RandomizedStudy of Dexamethasone Intravitreal Implant forthe Treatment of UveitisSue Lightman, Rubens Belfort, Careen Lowder,Steven Foster, Michael Robinson, Rhett M. Schiff-man, Xiao-Yan Li, Harry Cui, Scott M. Whitcup (Lon-don/UK, São Paulo/BR, Cleveland/USA, Irvine/USA)

15:03Discussion

VIP Lounge 2

16:00 - 17:30 TU-36

Retina: Basics

Free PaperRetina

Chairs:Robert E. MacLaren (London/UK)Peter Wiedemann (Leipzig/D)

16:00 FP TU-36-01Vascular endothelial growth factor (VEGF) clearance in rabbit eyes with posterior vitreous detachment inductionWei-Chi Wu (Kweishan/TJ)

16:07 FP TU-36-02Specific expression of Erythrocyte tropomodulin inthe retina of E-Tmod+/lacZ and E-Tmod-/- miceLin Xie (ChongQing/CN)

16:14 FP TU-36-03Microglia invasion in retina during retinal ganglion cell loss in animals with experimental autoimmune glaucomaOliver Gramlich, Stephanie C. Joachim, Vanessa D. Stahl, Clemens Cuny, Philip F.Gottschling, Norbert Pfeiffer, Franz H. Grus(Mainz/D)

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Tues

day,

8 Ju

ne

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e


08:30 - 10:00 TU-37

Retina: AMD 3

Free PaperRetina

Chairs:Gabriele Thumann (Aachen/D)Peter K. Kaiser (Cleveland/USA)Daniel Pauleikhoff (Münster/D)

08:30 FP TU-37-01Efficacy and safety of verteporfin PDT in combina-tion with ranibizumab compared to ranibizumabmonotherapy in AMD: 12-month outcome of theDENALI studyPeter Kaiser, on behalf of the DENALI study group(Cleveland/USA)

08:37 FP TU-37-02Design and Rationale for the Phase 3 Study: VEGFTrap-Eye Investigation of Efficacy and Safety inWet AMD (VIEW 2)Yuichiro Ogura, the VIEW 2 investigators (Nagoya/J)

08:44 FP TU-37-03What determines the functional outcome of AMDtreated with Lucentis?Heinrich Gerding, Melanie Timmermann, Lars Hefner, Juliane Riese, Vlassios Loukopoulos(Olten/CH)

08:51 FP TU-37-04Levels of aqueous humour trace elements in patients with age-related macular degenerationRobert Rejdak, Bernhard Michalke, Anwar Chaudhri,Piotr Stopa, Ursula Schlötzer-Schrehardt, Friedrich Kruse, Eberhart Zrenner, Anselm G. M.Jünemann (Lublin/PL, Erlangen/D, TübingenD)

08:58 FP TU-37-05Automatic Segmentation of Subretinal Fluid in Patients with Choroidal Neovascularization using Polarization-Sensitive Optical Coherence TomographyChristopher Schütze, Christian Ahlers,Bernhard Baumann, Michael Pircher, ErichGötzinger, René Donner, Joachim Ofner, Christoph Hitzenberger, Ursula Schmidt-Erfurth(Vienna/A)

09:05 FP TU-37-06Targeting Complement Factor 5 in combinationwith Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related MacularDegeneration (AMD) – a Phase 1 StudyDavid S. Boyer (Los Angeles/USA)

09:12 FP TU-37-07Development of a gene therapy based on transfection of pigment epithelial cells with PEDFGabriele Thumann, Olga Kazanskaya, Peter Walter,Sandra Johnen (Aachen/D)

09:19 FP TU-37-08Analysis of drusen SD-OCT (Spectral Domain Optical Coherence Tomography) characteristicsand correspondent FAF (fundus autofluorescence)changes in dry AMD patients.Gennady Landa, Richard Rosen, John Pilavas, Patricia Garcia, Jeanne Rosenthal, Alfonso Ponce,Thomas Muldoon, Joseph Walsh (New York/USA)

09:26 FP TU-37-09Characteristics of Fixation in Patients with Geographic Atrophy recorded with the MP-1 MicroperimeterJulia-Sophie Kroisamer, Ramzi G. Sayegh, Christian Simader, Ulla Scheschy, Christopher Kiss,Christian Prünte, Ursula Schmidt-Erfurth(Vienna/A)

09:33Discussion


10:30 - 12:00 TU-38

EVER Symposium: How to Get Your Work Published?


Chairs:Uwe Pleyer (Berlin/D)

10:30 IL TU-38-01Characteristics of a good paperEinar Stefánsson (Reykjavik/IS)

10:50 IL TU-38-02Ethical concerns in sientific publicationsPinar Aydin (Ankara/TR)

11:10 IL TU-38-03The challenge to be a reviewer (view of the Editorand beyond ..)Uwe Pleyer (Berlin/D)

11:30Discussion


Tues

day,

8 Ju

ne192

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e


14:00 - 15:30 TU-39

ISRS/AAO Symposium: Cutting Edge Progress – All What the Practical Refractive Surgeon needs toKnow


Chairs:Jorge L. Alió (Alicante/E)Theo Seiler (Zurich/CH)

14:00 IL TU-39-01Cutting Edge in Surface AblationGustavo Tamayo (Bogota/CO)

14:10 IL TU-39-02Cutting Edge in FemtolasersRonald R. Krueger (Cleveland/USA)

14:20 IL TU-39-03Application of Retinal Stem Cells in Treating Retinal Degenerative DiseasesTing Xie (Kansas City/USA)

14:30 IL TU-39-04Cutting Edge in Phakic IOLsJorge L. Alió (Alicante/E)

14:40 IL TU-39-05Cutting Edge in Cataract SurgeryAmar Agarwal (Chennai/IND)

14:50 IL TU-39-06Cutting Edge in Corneal SurgeryMohamed Alaa El Danasoury (Jeddah/SA)

15:00 IL TU-39-07Femto Laser Refractive Cataract SurgeryStephen G. Slade (Houston/USA)

15:10Discussion


16:00 - 17:30 TU-40

AJCC/UICC Symposium: TNM based ClassificationSystem for Oncular Oncology

SymposiumOncology

Chairs:Paul T. Finger (New York City/USA)Stefan Seregard (Stockholm/S)Tero Kivelä (Helsinki/FIN)

16:00 IL TU-40-01Do You Speak Ocular Tumor? How using the 7th

editon AJCC-UICC Eye Cancer Staging System willCan Save LivesPaul T. Finger (New York City/USA)

16:08 IL TU-40-02The 7th edition AJCC-UICC Staging System for Ocular Adnexal Lymphoma: Use to Predict Systemic LymphomaSarah E. Coupland (Liverpool/UK)

16:16 IL TU-40-03How to use the 7th edition AJCC Staging ofMelanoma of the Conjunctiva and Cornea to predict Local Control and MetastasisBertil D. Damato (Liverpool/UK)

16:24 IL TU-40-04Internet-based, High resolution Cases IllustratingHow to Use 7th edition AJCC Cancer StagingDeepak P. Edward (Akron/USA)

16:37 IL TU-40-057th Edition AJCC-UICC Staging Used to Predict Outcomes for Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland: A MulticenterCollaborative StudyBita Esmaeli (Houston/USA)

16:40 IL TU-40-06Application of the AJCC 7th Edition Carcinoma ofthe Eyelid staging system: A Medical Centerpathology based, 15 year reviewColby Fernelius (Tacoma/USA)

16:48 IL TU-40-07Incorporating the “7th Edition AJCC-UICC Staging of Ocular Squamous Carcinoma into your ClinicalPracticeLeonard M. Holbach (Erlangen/D)


Tues

day,

8 Ju

ne

193



14:00 - 15:30 TU-43

WGA Symposium: Managing Advanced Glaucoma

SymposiumGlaucoma

Chairs:Remo Susanna, Jr (São Paulo/BR)Kuldev Singh (Stanford/USA)Paul Healey (Sydney/AUS)

14:00 IL TU-43-01Who gets advanced glaucoma and why?Jamie Craig (Adelaide/AUS)

14:10 IL TU-43-02Predicting advanced glaucomaAnders Heijl (Malmö/S)

14:20 IL TU-43-03Achieving Target pressures in advanced glaucoma – when to operateIvan Goldberg (Sydney/AUS)

14:30 IL TU-43-04Surgical options for advanced pediatric glaucomaAnil Kumar Mandal (Hyderabad/IND)

14:40 IL TU-43-05Novel surgical options in advanced diseaseFabian Lerner (Buenos Aires/RA)

14:50 IL TU-43-06Management of Advanced NTGMakoto Araie (Tokyo/J)

15:00 IL TU-43-07Now the pressure is low, what then?Robert Ritch (New York/USA)

15:10 IL TU-43-08Maximizing quality of life in advanced glaucomaGeorge L. Spaeth (Philadelphia/USA)

15:20Discussion

16:56 IL TU-40-087th Edition AJCC-UICC Staging Predict Survival ofPatients with Iris, Ciliary body and ChoroidalmelanomaEmma Kujala (Helsinki/FIN)

17:04 IL TU-40-09Retinoblastoma Care, Implementation of the 7th

edition AJCC-UICC Staging System for E-CancerCare in Canada, Kenya and IndiaAshwin Mallipatna (Bangalore/IND)

17:12 IL TU-40-107th edition AJCC-UICC Staging Software for UvealMelanomaErnest Rand Simpson (Toronto/CDN)

17:20Discussion


10:30 - 12:00 TU-42

Sustainable Eye Health Programs: Where Does theGovernment Fit In?


Chairs:Anselm Kampik (Munich/D)Amir Bedri (Addis Adaba/ETH)Mohammed Babar Qureshi (Peshawar/PK)

10:30 IL TU-42-01Can programs be sustainable without Government participationAdekunle Olubola Hassan (Lagos/WAN)

10:45 IL TU-42-02High Impact, large scale NGO sector models of eyecare deliveryR. D. Thulasiraj (Madurai/IND)

11:00 IL TU-42-03Comprehensive eye care programs, A model withinthe Government structuresMohammed Daud Khan (Peshawar/PK)

11:15 IL TU-42-04An NGO having tried both approaches (Government and NGO sector)Mohammed Babar Qureshi (Peshawar/PK)

11:30Discussion

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010194Tu

esda

y, 8

June

195


Hall 3

08:30 - 10:00 TU-45

Retina Society Symposium: Advances in Instrumentation and Adjuvant Pharmacology inVitreoretinal Surgery

SymposiumRetina

Chairs:Donald J. D'Amico (New York/USA)Peter Liggett (New Haven/USA)Susanne Binder (Vienna/A)

08:30 IL TU-45-01Anti-VEGF Agents and Vitreoretinal Surgery for Proliferative Diabetic Retinopathy: Are ThereSurgical and Outcome Benefits?J. Fernando Arevalo (Caracas/Y)

08:40 IL TU-45-02Triamcinolone in Epiretinal Membrane Surgery:Surgical Visualization and Pharmacological ActionsThomas J. Wolfensberger (Lausanne/CH)

08:50 IL TU-45-03Advances in Posterior Segment Drug DeliveryEugene de Juan, Jr. (San Fransisco/USA)

09:00 IL TU-45-04Portable Vitrectomy with Plasmic Enzyme Assistance: An Evolving ApproachTarek S. Hassan (Royal Oak/USA)

09:10 IL TU-45-05Advances in Instrumentation of Vitreoretinal SurgeryMark Humayun (Los Angeles/USA)

09:20 IL TU-45-06Combined MIVS 23 Gauge Vitrectomy and Pha-coemulsification in the Management of ComplexMacular PathologyTimothy G. Murray (Miami/USA)

09:30 IL TU-45-07Endoscopic Visualization for Complex VitreoretinalPathologyChristopher D. Riemann (Cincinnati/USA)

09:40 IL TU-45-08Current Status of Heavy Tamponade LiquidsEric R. Holz (Houston/USA)

09:50 IL TU-45-09Beyond 25 Gauge: Pros and Cons of 27 Gauge Macular Pucker SurgeryFabio Patelli (Milan/I)


16:00 - 17:30 TU-44

Networking for Clinical Trial Research in Europe


Chairs:José Cunha-Vaz (Coimbra/P)José-Alain Sahel (Paris/F)Norbert Pfeiffer (Mainz/D)

16:00 IL TU-44-01EVI.CRnet. the European Network for Clinical ResearchJosé Cunha-Vaz (Coimbra/P)

16:10 IL TU-44-02Perspectives for Investigator-Driven Clinical Trialsin Retinal DiseaseJosé-Alain Sahel (Paris/F)

16:20 IL TU-44-03Perspectives for Investigator-Driven Clinical Trialsin GlaucomaNorbert Pfeiffer (Mainz/D)

16:30 IL TU-44-04Perspectives for Investigator-Driven Clinical Trialsin Ocular Surface and InflammationIlse Claerhout (Gent/B)

16:40 IL TU-44-05Perspectives for an European Reading Centre NetworkTunde Peto (London/UK)

16:50 IL TU-44-06Perspectives for Investigator-Driven Clinical Trialsin Cornea, Cataract and Refractive SurgeryJorge L. Alió (Alicante/E)

17:00Discussion

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Tues

day,

8 Ju

ne

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne196 WOC® 2010

Hall 3

10:30 - 12:00 TU-46

Ophthalmic Premier League (OPL)

SymposiumCataract

This is a session called the Ophthalmic PremierLeague (OPL) to be conducted in the WOC® 2010 inBerlin. This is similar to the European leaguegames but with a difference as the OPL is con-nected to ophthalmology. There will be 4 teamswith 4 captains, and each will have a total of 4members in the team. Each team member will begiven 4 minutes to show his or her most challeng-ing cataract / complication cataract case usingvideos. In the video the speaker will need to showhow he or she managed this case. There will be agood discussion on each case for the remainingtime. There will be an ARS (Automatic responsesystem) if available for audience to enjoy and votewhich is the best team. All the speakers will haveto be top class with excellent videos.

Moderator:Amar Agarwal (Chennai/IND)

Chairmen and Judges:Gerhard K. Lang (Ulm/D)Stephen J. Ryan (Los Angeles/USA)Bruce E. Spivey (San Francisco/USA)Gabriele E. Lang (Ulm/D)

The Surgeless SultansKeiki R. Mehta (Mumbai/IND) – CaptainThomas F. Neuhann (Munich/D) – Vice CaptainThomas Kohnen (Frankfurt/D) John Hovanesian (Laguna Hills/USA)

The Chopping ConquerorsUday Devgan (Los Angeles/USA) – CaptainGabor Scharioth (Recklinghausen/D) – Vice CaptainAthiya Agarwal (Bangalore/IND)Brian Little (London/UK)

The Diffractive DareDevilsMohan Rajan (Chennai/IND) – CaptainMahipal S. Sachdev (New Delhi/IND) – Vice CaptainDandapani Ramamurthy (Coimbatore/IND)George Beiko (St. Catharines/CDN)

The Bursting BuccaneersRoger Steinert (Orange/USA) – CaptainJoseph Colin (Bordeaux/F) – Vice CaptainBoris Malyugin (Moscow/RUS)Jorge L. Alió (Alicante/E)

Hall 3

14:00 - 15:30 TU-47

Uveitis a Global Challenge

SymposiumRetina

Chairs:Baruch D. Kuppermann (Irvine/USA)Philip I. Murray (Birmingham/UK)Uwe Pleyer (Berlin/D)

14:00 IL TU-47-01New insights: Clinical manifestations and progno-sis of herpetic posterior uveitisAniki Rothova (Utrecht/NL)

14:10 IL TU-47-02How "typical" is "typical"? Atypical presentationsof ocular toxoplasmosisMiles R. Stanford (London/UK)

14:20 IL TU-47-03Ocular sarcoidosis – definite, probable, possibleManabu Mochizuki (Tokyo/J)

14:30 IL TU-47-04Birdshot chorioretinopathy – recent insightsRalph D. Levinson (Los Angeles/USA)

14:40 IL TU-47-05Eales' disease: a forgotten disorder?Jyotirmay Biswas (Chennai/IND)

14:50 IL TU-47-06Surgical treatment of posterior segment complications of uveitis in ChinaWu Liu (Beijing/CN)

15:00Discussion

Hall 3

16:00 - 17:30 TU-48

Current Treatment Options for Retinal VascularDisease

SymposiumRetina

Chairs:José García Arumí (Barcelona/E)Constantin J. Pournaras (Geneva/CH)Susanne Binder (Vienna/A)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

197WOC® 2010

16:00 IL TU-48-01The results of the EAGLE-Study for central arteryocclusion of the retinaHansjürgen T. Agostini (Freiburg/D)

16:15 IL TU-48-02Treatment of branch retinal vein occlusion in theantiangiogenic eraMarta S. Figueroa (Madrid/E)

16:30 IL TU-48-03Anti-VEGF treatment options in retinal vein occlusionConstantin J. Pournaras (Geneva/CH)

16:45 IL TU-48-04Results of the ROVO-StudySusanne Binder (Vienna/A)

17:00 IL TU-48-05The management of retinal artery occlusionJosé García Arumí (Barcelona/E)

17:15Discussion

Hall 4/5

08:30 - 10:00 TU-49

Iatrogenic Diseases of Ocular Surface


Chairs:Christophe Baudouin (Paris/F)Elisabeth M. Messmer (Munich/D)Zbigniew Zagórski (Lublin/PL)

08:30 IL TU-49-01IntroductionZbigniew Zagórski (Lublin/PL)

08:35 IL TU-49-02Ocular surface toxicity: iatrogenic and factitiousdiseaseJohn K. G. Dart (London/UK)

08:45 IL TU-49-03The ocular surface of glaucoma patients treaytedover the long-termChristophe Baudouin (Paris/F)

08:55 IL TU-49-04Ocular surface disease and systemic medicationsCatherine Creuzot-Garcher (Dijon/F)

09:05 IL TU-49-05Ocular surgery resulting in ocular surface diseaseElisabeth M. Messmer (Munich/D)

09:15 IL TU-49-06Acute iatrogenic damage to the anterior segment:case reportsRimvydas Asoklis (Vilnius/LT)

09:25Discussion

Hall 4/5

10:30 - 12:00 TU-50

IOIS Symposium: Pediatric Uveitis – in MemoriamDavid Benezra


Chairs:Talin Barisani-Asenbauer (Vienna/A)Bahram Bodaghi (Paris/F)Arnd Heiligenhaus (Münster/D)

10:30 IL TU-50-01JIA and UveitisPaula Pivetti, Massimo Accorinti (Rom/I)

10:40 IL TU-50-02Outcome measures on uveitis in juvenile idiopathic arthritis: proposed guidelines from theinternational interdisciplinary working group foruveitis in childhoodArnd Heiligenhaus (Münster/D)

10:50 IL TU-50-03Congenital ToxoplasmosisJustus G. Garweg (Bern/CH)

11:00 IL TU-50-04Imaging in Pediatric UveitisBahram Bodaghi (Paris/F)

11:10 IL TU-50-05Results of an European Multicenter Survey on juvenile UveitisFriederike Mackensen (Heidelberg/D)

11:20 IL TU-50-06QoL and Coping Mechanisms in Pediatric UveitisTalin Barisani-Asenbauer (Vienna/A)

11:30Discussion


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne198 WOC® 2010

Hall 4/5

14:00 - 15:30 TU-41

FEOph Symposium: Cutting Edge in Ophthalmology


Chairs:Béatrice Cochener (Brest/F)Michèle Beaconsfield (London/UK)Salvador García-Delpech (Valencia/E)Pier Enrico Gallenga (Chieti/I)Anselm Kampik (Munich/D)

14:00 IL TU-41-01News in Presbyopic Surgery: Corneal Compensa-tion of PresbyopiaJorge L. Alió (Alicante/E)

14:06 IL TU-41-02News in Enzymatic Vitreolisys: MicroplasminAnselm Kampik (Munich/D)

14:12 IL TU-41-03News in Enzymatic Vitreolisys: Autologous PlasminPatricia Udaondo (Valencia/E)

14:18 IL TU-41-04News in Presbyopic Surgery: New Multifocal IOLsMatteo Piovella (Monza/I)

14:24 IL TU-41-05News Treating Corneal Neovascularization: Resultsfrom GermanyClaus Cursiefen (Erlangen/D)

14:30 IL TU-41-06News Treating Corneal Neovascularization: Resultsfrom SpainSalvador García-Delpech (Valencia/E)

14:36 IL TU-41-07News Treating Retinal Diseases: Some New IdeasJosé-Alain Sahel (Paris/F)

14:42 IL TU-41-08News Treating Retinal Diseases: ChoroidalMelanomasLaurence Desjardins (Paris/F)

14:48 IL TU-41-09Ocular Surface News: New concepts, New Drugs,New approachesD. Juan Murube del Castillo (Madrid/E)

14:54 IL TU-41-10News in Glaucoma: Minimally Invasive Repair ofPost-trabeculectomy HypotonyNorbert Pfeiffer (Mainz/D)

15:00 IL TU-41-11News in Glaucoma: New Surgical DevicesDavid Salom (Valencia/E)

15:06 IL TU-41-12News in Oculoplastics: Non Surgical Treatment ofBasal Cell CarcinomaMichèle Beaconsfield (London/UK)

15:12 IL TU-41-13News in Oculoplastics: OrbitJean-Paul Adenis (Limoges/F)

15:18 Discussion

Hall 6

08:30 - 10:00 TU-56

Technical Aspects: Telecommunication, Computer-aided Diagnosis Systems, Image Processing andAnalysis, Process Flow, Electronic Patient Charts


Chairs:Larry D. Hubbard (Madison/USA)Michael Abramoff (Iowa/USA)Joachim Hornegger (Erlangen/D)

08:30 IL TU-56-01Vessel structure segmentation via matched filtering and neural fibre layer detection using texture analysisJiri Jan (Brno/CZ)

08:40 IL TU-56-02Computer-aided Diagnosis of Diabetic RetinopathyMichael Abramoff (Iowa/USA)

08:50 IL TU-56-03Improving DR Algorithms Through Online CompetitionGwénolé Quellec (Brest/F)

09:00 IL TU-56-04Quantification of Diabetic Retinopathy Lesions,Methodological Problems and Clinical SignificanceToke Bek (Århus/DK)

09:10 IL TU-56-05A large-scale Verification of Automated Gradingfor Diabetic Retinopathy using Arbitration by Sen-ior OphthalmologistsAlan D. Fleming (Aberdeen/UK)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

09:20 IL TU-56-06Automated Detection of New Vessels on the OpticDisc Using Retinal PhotographyKeith Goatman (Aberdeen/UK)

09:30Discussion

Hall 6

10:30 - 12:00 TU-57

Braindrain: Challenges and Solutions

SymposiumVision 2020 – Preventation of Blindness

Chairs:Suzanne Gilbert (Berkeley/USA)Volker Klauss (Munich/D)

10:30 IL TU-57-01Training of Medical Personnel and the Predicament of Brain DrainHans Werner Mundt (Berlin/D)

10:40 IL TU-57-02Challenges and Solutions from IndiaN. Venkatesh Prajna (Madurai/IND)

10:50 IL TU-57-03Conditions that keep African Ophthalmologists in Africa/ Prevent Brain DrainVolker Klauss (Munich/D)

11:00 IL TU-57-04Recent Findings on Task-Shifting to optimize ophthalmologists’ service deliveryKhumbo Kalua (Blantyre/MW)

11:10 IL TU-57-05Plenty of Ophthalmologists; How about Equity?Rainaldo Duerksen (Asunción/PY)

11:20 IL TU-57-06Management & IT Strategies to Enhance Ophthal-mologist Effectiveness and SatisfactionSuzanne Gilbert (Berkeley/USA)

11:30 IL TU-57-07Contribution of Paramedical team membersAdrian Dennis Hopkins (Decatur/USA)

11:40Discussion


Hall 6

12:15 - 12:45 TU-58

Streiff Lecture

Chairs:Suzanne Gilbert (Berkeley/USA)Volker Klauss (Munich/D)

Global Blindness Control – What Can We PossiblyAchieve by 2020?Gullapali N. Rao (Hyderabad/IND)

Hall 6

14:00 - 15:30 TU-59

Therapy of Acquired Strabismus

SymposiumStrabismus

Chairs:Eugene Helvestone (Indianapolis/USA)Vincent Paris (Liège/B)Michael Gräf (Giessen/D)

14:00 IL TU-59-01N.III palsySaxena Rohit (New Delhi/IND)

14:10 IL TU-59-02N.IV palsyEugene Helvestone (Indianapolis/USA)

14:20 IL TU-59-03TraumaJohn P. Lee (London/UK)

14:30 IL TU-59-04High myopiaTsuranu Yokoyama (Osaka/J)

14:40 IL TU-59-05BotulinumRosario Gomez de Liano (Madrid/E)

14:50 IL TU-59-06Prism therapyJan Roelof Polling (Rotterdam/NL)

15:00Discussion

Tues

day,

8 Ju

ne

199

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 6

16:00 - 17:30 TU-60

Viral Uveitis


Chairs:Bahram Bodaghi (Paris/F)Soon Phaik Chee (Singapore/SGP)Carsten Heinz (Münster/D)

16:00 IL TU-60-01Diagnostic and therapeutic challenges in herpeticanterior uveitisEmmet T. Cunnigham (Hillsborough/USA)

16:10 IL TU-60-02Acute retinal necrosis syndromeBahram Bodaghi (Paris/F)

16:20 IL TU-60-03CMV and anterior uveitisSoon Phaik Chee (Singapore/SGP)

16:30 IL TU-60-04HIV associated uveitis in the era of HAARTGary N. Holland (Los Angeles/USA)

16:40 IL TU-60-05Emerging viruses and West Nile VirusMoncef Khairallah (Monastir/TN)

16:50 IL TU-60-06HTLV1, EBV and HHV6 associated uveitisManabu Mochizuki (Tokyo/J)

17:00 IL TU-60-07Parvovirus and other non herpetic virusesCarsten Heinz (Münster/D)

17:10Discussion

Hall 7

08:30 - 10:00 TU-61

Panel: Phakic IOLs

PanelRefractive Surgery

Chairs:Carlos Vergés (Barcelona/E)Roberto Zaldivar (Buenos Aires/RA)Thomas Kohnen (Frankfurt/D)

08:30 IL TU-61-01Angle-supported PIOLThomas Kohnen (Frankfurt/D)

08:40 IL TU-61-02Iris-fixated PIOLGernot I. W. Duncker (Halle/D)

08:50 IL TU-61-03CL/PRLRoberto Zaldivar (Buenos Aires/RA)

09:00 IL TU-61-04Complications of PIOLCarlos Vergés (Barcelona/E)

09:10 IL TU-61-05Discussion – usefulness of PIOL in the spectrum ofrefractive optionsThomas Kohnen, Roberto Zaldivar, Carlos Vergés,Gernot I. W. Duncker (Frankfurt//D, Houston/USA,Buenos Aires/RA, Barcelona/E, Halle/D)

Hall 7

10:30 - 12:00 TU-62

The Femtosecond Face-off


Chairs:George Waring (Atlanta/USA)Theo Seiler (Zurich/CH)

10:30 IL TU-62-01Introduction:i. Physics of femtosecond mechanism of actionii. Descriptions of the 4 major lasersiii. Highlights of major physics differences

between lasersMichael Mrochen (Zurich/CH)


Tues

day,

8 Ju

ne200

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

201WOC® 2010

10:40 IL TU-62-02IntralaseGeorge Waring (Atlanta/USA)

10:50 IL TU-62-03FemtecMike P. Holzer (Heidelberg/D)

11:00 IL TU-62-03VisumaxDan Z. Reinstein (London/UK)

11:10 IL TU-62-05ZiemerTheo Seiler (Zurich/CH)

11:20Discussion

Hall 7

14:00 - 15:30 TU-63


Free PaperGlaucoma

Chairs:Jens F. Jordan (Freiburg/D)Joseph Caprioli (Los Angeles/USA)Hagen Thieme (Mainz/D)

14:00 FP TU-63-01Using Ex-press Implant in a Patient with Congenital GlaucomaDida Kazakova (Sofia/BG)

14:07 FP TU-63-02Successful tube-extender implantation to control congenital glaucoma awaiting penetratingkeratoplasty surgeryCarolina Pallás (Barcelonas/E)

14:14 FP TU-63-03Trypane blue test after incisional glaucoma surgeryGabor Scharioth (Recklinghausen/D)

14:21 FP TU-63-04Trabeculectomy Using Biodegradable CollagenMatrix Implant in Chronic Primary Glaucoma Patients: A Preliminary StudyAstrianda Suryono (Jakarta/RI)

14:28 FP TU-63-05Trabeculectomy and retrobulbar hemodynamics inglaucomaAndreas Remky, Marion Kaup, Anke Weber, Niklas Plange (Regensburg/D)

14:35 FP TU-63-06The Trabectome – clinical feasibility and first results.Jens Jordan, Matthias Neuburger, Thomas Reinhard(Freiburg/D)

14:42 FP TU-63-07Therapeutic Effect of a Combined Laser Techniquefor Plateau Iris Glaucoma – 18 months follow-upPoopalaratnam Sriharanathan (Colombo/CL)

14:49 FP TU-63-08Long-term results after Selective Laser Trabeculo-plasty (=“SLT“) in various forms of glaucoma. Presentation of 12-year postoperative resultsPeter Kaulen (Berlin/D)

14:56 FP TU-63-09Our methods of surgical treatment of refractorypostburn glaucomaPetro Kostenko, S. Iakymenko (Odessa/UA)

15:03 FP TU-63-10Combined phacoemulsification and non-penetrating glaucoma surgery (NPGS) with goniosynechiolysis ab internoAlireza Mirshahi, Gabor Scharioth (Mainz/D, Recklinghausen/D)

15:10Discussion

Hall 7

16:00 - 17:30 TU-64

Therapeutic Customized Ablation


Chairs:Mirko R. Jankov (Belgrade/SRB)Theo Seiler (Zurich/CH)

16:00 IL TU-64-01Technological requirements for therapeutic customized treatmentsPaulo Schor (Sao Paulo/BR)

16:15 IL TU-64-02Wavefront vs topography guided treatments.Which one is better?Renato Ambrósio Jr. (Rio de Janeiro/BR)

16:30 IL TU-64-03Surface ablation vs LASIK. Which one makes moresense?Arthur C. Cheng (Hong Kong/CN)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne202 WOC® 2010

16:45 IL TU-64-04Dealing with previous failures of refractive surgery: small optical zones, decentrations, etc.Mohamed Alaa El Danasoury (Jeddah/SA)

17:00 IL TU-64-05How to treat corneal scars, PKP etc.Arthur Cummings (Dublin/IRL)

17:15 IL TU-64-06Laser ablation and corneal collagen cross-linking.Can we make it?Aleksandr Stojanovic (Tromsø/N)

Hall 8

08:30 - 10:00 TU-65

A New Approach to Teaching Ophthalmology toMedical Students: Strengths and Improvement forthe New ICO Medical Student Handbook


Chairs:Pinar Aydin (Ankara/TR)Susan Lightman (London/UK)Balder P. Gloor (Zurich/CH)

08:30 IL TU-65-01Teaching: A Skill or a Talent?Pinar Aydin (Ankara/TR)

08:40 IL TU-65-02Teaching the Basic KnowledgeSusan Lightman (London/UK)

08:50 IL TU-65-03Teaching Clinical SkillsSimon Taylor (London/UK)

09:00 IL TU-65-04Teaching Emergency Ophthalmology to MedicalStudentsRichard Andrews (London/UK)

09:10 IL TU-65-05Using a Virtual Eye ClinicPeter McCluskey (Sydney/AUS)

09:20 IL TU-65-06Using the ICO Undergraduate BookletJasmin Singh (London/UK)

09:30 IL TU-65-07Designing an E-learning Module in OphthalmologyLavnish Joshi (London/UK)

09:40Discussion

Hall 8

10:30 - 12:00 TU-66

The Training of Para-ophthalmic Personnel withthe Improved ICO Curriculum: Review of New Experiences


Chairs:William F. Astle (Calgary/CDN)Alistair Fielder (London/UK)Lynn D. Anderson (Saint Paul/USA)

10:30 IL TU-66-01IntroductionWilliam F. Astle (Calgary/CDN)

10:40 IL TU-66-02ICO Curriculum for Ophthalmic Assistants: A Teach-ing Model for Training the Eye Care TeamWilliam F. Astle (Calgary/CDN)

10:50 IL TU-66-03Visual Fields – Education for Ophthalmic NursesLene Martin (Stockholm/S)

11:00 IL TU-66-04Teaching Optometrists in ChinaLu Fan (Wenzhou/CN)

11:10 IL TU-66-05Implementing the ICO Curriculum in AfricaBoateng Wiafe (Kasoa/GH)

11:20 IL TU-66-06Implementing the ICO Curriculum in BarbadosSonja Johnston, Marilyn Watkins (Arima/TT,Bridgetown/BDS)

11:30 IL TU-66-07Development of an Accredited Training Programwith Certification of GraduatesEmad Abboud (Riyadh/SA)

11:40Discussion


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

203WOC® 2010

Hall 8

14:00 - 15:30 TU-67

Improving Continuing Education Worldwide withICO Programs


Chairs:Juan Verdaguer (Santiago/RCH)Bradley R. Straatsma (Los Angeles/USA)Zbigniew Zagórski (Lublin/PL)

14:00 IL TU-67-01IntroductionJuan Verdaguer (Santiago/RCH)

14:10 IL TU-67-02Principles of Continuing Professional DevelopmentBradley R. Straatsma (Los Angeles/USA)

14:20 IL TU-67-03The Role of ICO Guidelines for Planning CME ProgramsZbigniew Zagórski (Lublin/PL)

14:30 IL TU-67-04Continuing Medical Education in GermanyFriedrich Flohr (Hamburg/D)

14:40 IL TU-67-05ICO Programs for Continuing Medical Education inDeveloping CountriesJuan Verdaguer (Santiago/RCH)

14:50 IL TU-67-06My Experience as an ICO Visiting Professor in TanzaniaAnthony Murray (Cape Town/ZA)

15:00 IL TU-67-07My Experience as an ICO Professor in AlgeriaGabriel J. Coscas (Créteil/F)

15:10Discussion

Hall 8

16:00 - 17:30 TU-68

Setting Up New Parameters for Teaching Ophthalmic Subspecialties in Developing and Developed Countries


Chairs:Randall J. Olson (Salt Lake City/USA)Marie-José Tassignon (Antwerp/B)Gottfried O. H. Naumann (Erlangen/D)

16:00 IL TU-68-01Strategies to Develop Ophthalmic Subspecialty Education WorldwideStuart Seiff (San Francisco/USA)

16:10 IL TU-68-02Organization of Teaching Programs of Glaucomafor the Worldwide Ophthalmic CommunityRobert Ritch (New York/USA)

16:20 IL TU-68-03Establishing Training Programs of Pediatric Ophthalmology Across the ContinentsAnthony Murray (Cape Town/ZA)

16:30 IL TU-68-04Teaching Oculoplastic Surgery in Developed andDeveloping CountriesJohn Richard O. Collin (London/UK)

16:40 IL TU-68-05How The Fellowship Compliance Committee of theAssociation of University Professors of Ophthal-mology (USA) came to be a Voluntary ComplianceProcess in the USAAlfredo Sadun (Los Angeles/USA)

16:50 IL TU-68-06Our Experience with the Compliance Process of the Fellowship Compliance Committee in the USAHans E. Grossniklaus (Atlanta/USA)

17:00 IL TU-68-07The Education of Cataract and Research in Chinavs. SwedenPer Soderberg, MD

17:10 IL TU-68-08Training of Cataract Surgeons Across the ContinentsRandall J. Olson, MD

17:20Discussion


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne204 WOC® 2010

Hall 9

10:30 - 12:00 TU-69

Current Concepts in Retinal Detachment Surgery

SymposiumRetina

Chairs:Charles P. Wilkinson (Baltimore/USA)George William Aylward (London/UK)Nicole Eter (Bonn/D)

10:30 IL TU-69-01Interventions for preventing retinal detachmentJan van Meurs (Rotterdam/NL)

10:40 IL TU-69-02Pneumatic retinopexy: the first choice?Charles P. Wilkinson (Baltimore/USA)

10:50 IL TU-69-03Buckle surgery in times of vitrectomyThomas J. Wolfensberger (Lausanne/CH)

11:00 IL TU-69-04Transconjunctival vitrectomy for retinal detachment surgery: How small shall we get?Nicole Eter (Bonn/D)

11:10 IL TU-69-05What have we learned from the SPR Study?Heinrich Heimann (Liverpool/UK)

11:20 IL TU-69-06Update on how to deal with PVRGeorge William Aylward (London/UK)

11:30Discussion

Hall 9

14:00 - 15:30 TU-70

ISOP Symposium: Ophthalmic Pathology Update

SymposiumPathology

Chairs:Gordon Klintworth (Morrisville/USA)Elisabeth M. Messmer (Munich/D)Steffen Heegaard (Copenhagen/DK)

14:00 IL TU-70-01Recent advances in corneal dystrophiesGordon Klintworth (Morrisville/USA)

14:10 IL TU-70-02Histopathology of crosslinking for keratoconusElisabeth M. Messmer (Munich/D)

14:20 IL TU-70-03Pathology of LASIK/DSEKHans E. Grossniklaus (Atlanta/USA)

14:30 IL TU-70-04Lacrimal drainage system pathologySteffen Heegaard (Copenhagen/DK)

14:40 IL TU-70-05Lacrimal gland tumorsJ. Oscar Croxatto (Buenos Aires/RA)

14:50 IL TU-70-06Optic nerve gliomaTom Cummings (Durham/USA)

15:00 IL TU-70-07Orbital tumorsTom Cummings (Durham/USA)

15:10Discussion

Hall 9

16:00 - 17:30 TU-71

IOAT Symposium: “Ten Years to Go” to the GlobalElimination of Blinding Trachoma

SymposiumCornea

Chairs:Gabriel J. Coscas (Créteil/F)

16:00 IL TU-71-01Opening of the MeetingGabriel J. Coscas (Créteil/F)

16:05 IL TU-71-02Priorities for the global trachoma elimination and its certificationSilvio P. Mariotti, Ivo Kocur (Geneva/CH)

16:20 IL TU-71-03Challenges in the elimination of pockets of trachoma and implications on certificationHugh R. Taylor (Carlton/AUS)

16:35 IL TU-71-04Challenges that will be faced by ITI for the trachoma eliminationDanny Haddad (Decatur/USA)


Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne

205WOC® 2010

16:50 IL TU-71-05Challenges in trachoma elimination in low-incomecountriesAmza Abdou (Niamey/RN)

17:05 IL TU-71-06Epidemiological dynamics of trachoma in the perspective of a global trachoma eliminationThomas M. Lietman (San Francisco/USA)

17:20Discussion

Hall 10

08:30 - 10:00 TU-72

German, Polish, Danish and Hungarian Symposiumon Keratoconus

SymposiumCornea

Chairs:László Módis (Debrecen/H)

08:30 IL TU-72-01New imaging techniquesJacek P. Szaflik (Warsaw/PL)

08:45 IL TU-72-02Collegene cross-linking and biomechanicsJesper Hjortdahl (Aarhus/DK)

09:00 IL TU-72-03Lasers and keratoconusZoltán Zsolt Nagy (Budapest/H)

09:15 IL TU-72-04Surgical treatmentPhilip Maier (Freiburg/D)

09:30 IL TU-72-05Acute keratoconusLászló Módis (Debrecen/H)

09:45Discussion

Hall 10

14:00 - 15:30 TU-73

APIISG Symposium: Uveitis Which One Should NotMiss


Chairs:Shigeaki Ohno (Sapporo/J)Soon Phaik Chee (Singapore/SGP)Peter McCluskey (Sydney/AUS)

14:00 IL TU-73-01TuberculosisNarsing A. Rao (Los Angeles/USA)

14:10 IL TU-73-02ToxoplasmosisKhalid F. Tabbara (Riyadh/SA)

14:20 IL TU-73-03CMV UveitisSoon Phaik Chee (Singapore/SGP)

14:30 IL TU-73-04Acute Retinal NecrosisHiroshi Goto (Shinjuku-ku/J)

14:40 IL TU-73-05Behcet's DiseaseShigeaki Ohno (Sapporo/J)

14:50 IL TU-73-06VKH DiseasePeizeng Yang (Chongqing/CN)

15:00 IL TU-73-07SclerouveitisPeter McCluskey (Sydney/AUS)

15:10 IL TU-73-08SarcoidosisAnnabelle A. Okada (Tokyo/J)

15:20 Discussion


Tuesday, 8 June 2010Sc

ient

ific P

rogr

am S

ched

ule

WOC® 2010

Roof Garden

08:30 - 10:00 TU-75

Multifocal and Accommodating IOL’s

SymposiumCataract

Chairs:Okihiro Nishi (Osaka/J)Eduard A. Haefliger (Binningen/CH)Frank J. Goes (Antwerp/B)

08:30 IL TU-75-01Lens Refilling: How Close to Nature Can We GetEduard A. Haefliger (Binningen/CH)

08:40 IL TU-75-02NuLensJorge L. Alió (Alicante/E)

08:50 IL TU-75-03Prediction of satisfaction ("happy patient project")Thomas F. Neuhann (Munich/D)

09:00 IL TU-75-04Mix and match optionsFrank J. Goes (Antwerp/B)

09:10 IL TU-75-05Bifocal lensesPaul H. Ernest (Jackson/USA)

09:20 IL TU-75-06Shift IOL: They don't workOliver Findl (Vienna/A)

09:30 IL TU-75-07Shift IOL: They do workStephen G. Slade (Houston/USA)

09:40Discussion

Roof Garden

10:30 - 12:00 TU-76

ESCRS Symposium: New IOL Concepts in Cataractand Refractive Surgery

SymposiumCataract

Chairs:José L. Güell (Barcelona/E)Marie-José Tassignon (Antwerp/B)Charlotta Zetterström (Oslo/N)

Hall 10

16:00 - 17:30 TU-74

ALACCSA-R Symposium: Cornea and Ocular Surface: What's new?

SymposiumCornea

Chairs:Jose M. Vargas (Valencia/Y)Scheffer C. G. Tseng (Miami/USA)Cesar Carriazo (Barranquilla/CO)José F. Alfonso (Oviedo/E)

16:00 IL TU-74-01Fibrin glue for pterigium surgeryLuis Izquierdo (Lima/PE)

16:10 IL TU-74-02Clinical significance of lid margin pathologies inocular surface reconstructionScheffer C. G. Tseng (Miami/USA)

16:20 IL TU-74-03Dohlman Kpro personal ExperienceJose M. Vargas (Valencia/Y)

16:30 IL TU-74-04Have we Over-Diagnosed Limbal Stem Cell Deficiency?Scheffer C. G. Tseng (Miami/USA)

16:40 IL TU-74-05Controlling Advanced Keratoconic AberropiaSergio Kandelman (Rio de Janeiro/BR)

16:50 IL TU-74-06Management of infectious keratitis with AMJose M. Vargas (Valencia/Y)

17:00 IL TU-74-07Pterigium: Surgical ManagementAlonso Otto Solorzano (Cuernavaea/MEX)

206Tu

esda

y, 8

June

207


Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

14:08 IL TU-77-02Inner retina: Chronic degeneration in glaucoma-tous optic neuropathy – Diagnostics for the minimal functional and morphological damageAnselm G. M. Jünemann (Erlangen/D)

14:16 IL TU-77-03Inner retina: Chronic degeneration in glaucoma-tous optic neuropathy – New neuroprotectivestrategies in glaucomaPawel Grieb (Warsaw/PL)

14:24 IL TU-77-04Inner retina: Acute degeneration in retinal ischemia/trauma – Characterization of acute neurodegeneration in different animal modelsFrank Schüttauf (Tübingen/D)

14:32 IL TU-77-05Inner retina: Acute degeneration in retinal ischemia/trauma – The role of new drugs and alimentation in acute degenerationTomasz Zarnowski (Lublin/PL)

14:40 IL TU-77-06Outer retina: Acute retinal degeneration in retinaldetachment – Toxicity of vital dyesSebastian Thaler (Tübingen/D)

14:48 IL TU-77-07Outer retina: Chronic retinal degeneration – Evolution of vitreoretinal surgery – the smaller thebetter?Frank Koch (Frankfurt/D)

14:56 IL TU-77-08Outer retina: Chronic retinal degeneration –Intrectomy – clinical and preclinical resultsMichael Janusz Koss (Frankfurt/D)

15:04 IL TU-77-09Outer retina: Acute retinal degeneration in retinaldetachment – Biomarkers for neurodegenerationTBA

15:12 IL TU-77-10Outer retina: Acute retinal degeneration in retinaldetachment – Does retina regenerate- SpectralOCT dataJerzy Nawrocki (Lodz/PL)

15:20 IL TU-77-11Outer retina: Chronic retinal degeneration – Mechanisms of photoreceptor degeneration andvisual repairEberhart Zrenner (Tübingen/D)

10:30 IL TU-76-01Best haptic design?Oliver Findl (Vienna/A)

10:40 IL TU-76-02Latest advances in the iris-claw style IOLJosé L. Güell (Barcelona/E)

10:50 IL TU-76-03Clinical outcomes and functional visual performance in new designs of multifocal IOLs: the Lentis MplusJoaquim Neto Murta (Lisboa/P)

11:00 IL TU-76-04New trifocal diffractive IOL for a better intermedi-ate and qualitative visionBéatrice Cochener (Brest/F)

11:10 IL TU-76-05Presbyopia treatment using second generation ac-commodative and multifocal IOLMatteo Piovella (Monza/I)

11:20 IL TU-76-06Lens refilling: how far we areIoannis G. Pallikaris (Voutes, Heraklion/GR)

11:30 IL TU-76-07Novel implants for aniridiaDaniel Epstein (Bern/CH)

11:40 IL TU-76-08Implants for Ectopia LentisCharlotta Zelterström (Oslo/N)

11:50 IL TU-76-08Artificial capsuleMarie-José Tassignon (Antwerp/B)

11:50Discussion

Roof Garden

14:00 - 15:30 TU-77

Regeneration and Repair in Retinal Degeneration:Mechanisms and Approaches (RRR Symposium)

SymposiumRetina

Chairs:Anselm G. M. Jünemann (Erlangen/D)Robert Rejdak (Lublin/PL)

14:00 IL TU-77-01Inner retina: Chronic degeneration in glaucoma-tous optic neuropathy – New aspects of retinalganglion cell loss mechanismsRobert Rejdak (Lublin/PL)

Tues

day,

8 Ju

ne

Scie

ntifi

c Pro

gram

Sch

edul

e

Tues

day,

8 Ju

ne208 WOC® 2010

Roof Garden

16:00 - 17:30 TU-78

Best Excimer Laser


Chairs:Paolo Vinciguerra (Milano/I)Guy M. Kezirian (Scottsdale/USA)Daniel Epstein (Bern/CH)

16:00 IL TU-78-01IntroductionDaniel Epstein (Bern/CH)

16:05 IL TU-78-02Survey of current excimer platformsJorge L. Alió (Alicante/E)

16:15 IL TU-78-03Diverging approaches in excimer laser vision cor-rection – aberrometry, topography or other modal-ities?Charles P. Lin (Boston/USA)

16:25 IL TU-78-04Criteria for safety and efficacy in excimer laser surgeryGuy M. Kezirian (Scottsdale/USA)

16:35 IL TU-78-05All excimers are not created equalChristoph Binder (Schramberg/D)

16:45 IL TU-78-06Improvement potential and limits of excimer lasertreatmentsGeorge Waring (Atlanta/USA)

16:55 IL TU-78-07Laser correction of astigmatism: what does workand what does not?Peter McDonnell (Baltimore/USA)

17:05 IL TU-78-08Session highlightsPaolo Vinciguerra (Milano/I)

17:15Discussion

ICC Lounge

08:30 - 10:00 TU-52

Current Epidemiological Eye Studies

SymposiumOphthalmic Epidemiology

Chairs:Christian Wolfram (Mainz/D)Sheila West (Baltimore/USA)Jialiang Zhao (Beijing/CN)

08:30 IL TU-52-01Results of the Latino eye studyRohit Varma (Los Angeles/USA)

08:45 IL TU-52-02The prevalence and impact on quality of life of uncorrected refractive error in a Latino populationSheila West (Baltimore/USA)

09:00 IL TU-52-03Neglected Areas of Research in Developing CountriesR. D. Thulasiraj (Madurai/IND)

09:15 IL TU-52-04Early detection of primary open angle closureglaucomaJialiang Zhao (Beijing/CN)

09:30Discussion

ICC Lounge

10:30 - 12:00 TU-53

Intraocular Lymphoma


Chairs:Chi Chao Chan (Bethesda/USA)Sarah E. Coupland (Liverpool/UK)Christoph M. E. Deuter (Tübingen/D)

10:30 IL TU-53-01Classification and molecular biology of intraocularlymphomasSarah E. Coupland (Liverpool/UK)

10:40 IL TU-53-02Epidemiology and racial differences in intraocularlymphomasJose S. Pulido (Rochester/USA)


WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

10:50 IL TU-53-03Signs and symptoms of intraocular lymphomasJustine R. Smith (Portland/USA)

11:00 IL TU-53-04Diagnosis of intraocular lymphomasChi Chao Chan (Bethesda/USA)

11:10 IL TU-53-05Overview of treatment of intraocular lymphomaDidier Decaudin (Paris/F)

11:20 IL TU-53-06Experience of intraocular lymphoma withmethotrexateChristoph M. E. Deuter (Tübingen/D)

11:30Discussion

ICC Lounge

14:00 - 15:30 TU-54

Ocular Pharmacology for Posterior Segment Diseases


Chairs:Mark S. Blumenkranz (Stanford/USA)

14:00 IL TU-54-01Effect of ocular steroids on retinal wound healingfollowing laser photocoagulationDaniel Palanker (Stanford/USA)

14:10 IL TU-54-02Non-viral methods of ocular cell transfection: extended drug delivery to the posterior poleTBA

14:20 IL TU-54-03Radiation targeting and dose verification for age-related macular degenerationDarius Moshfeghi (Stanford/USA)

14:30 IL TU-54-04Use of Lentivirus vectors for treatment ofchoroidal neovascularization by modified genetherapyYusuke Murakami, Y. Ikeda, Tatsuro Ishibashi(Fukuoka/J)

14:40 IL TU-54-05Treatment of retinal venous occlusive disease withextended delivery formulation of dexamethasoneMark S. Blumenkranz (Stanford/USA)

14:50 IL TU-54-06Treatment of choroidal neovascularization withmodified gene therapy employing AAV and solubleFLT receptorIan Constable (Nedlands/AUS)

15:00 Discussion

ICC Lounge

16:00 - 17:30 TU-55

Leber Congenital Amaurosis: Classification andTreatment of Childhood Onset Severe Retinal Dystrophies


Chairs:Birgit Lorenz (Giessen/D)Irene H. Maumenee (Baltimore/USA)

16:00 IL TU-55-01Leber congenital amaurosis in Puerto Rico: naturalhistory of LCA1, LCA6 and LCA8 and search for newgenesIrene H. Maumenee (Baltimore/USA)

16:15 IL TU-55-03Laboratory Diagnosis of LCAGovindasamy Kumaramanickavel (Bangalore/IND)

16:30 IL TU-55-04The phenotypic spectrum of RPE65 mutationsBirgit Lorenz (Giessen/D)

16:45 IL TU-55-05Safety aspects of gene therapyKnut Stieger (Giessen/D)

17:00 IL TU-55-06The challenge of quantifiying morphology andfunction in LCA to monitor the effect of gene therapyFrederick W. Fitzke (London/UK)

17:15Discussion


Tues

day,

8 Ju

ne

209

Tuesday, 8 June 2010Sc

ient

ific P

rogr

am S

ched

ule

WOC® 2010210

Room 44

08:30 - 10:00 TU-80



Chairs:Jack T. Holladay (Bellaire/USA)Dan Z. Reinstein (London/UK)Peter McDonnell (Baltimore/USA)

08:30 FP TU-80-01Predicting Visual Quality Post-Laser Vision CorrectionJack Holladay (Bellaire/USA)

08:37 FP TU-80-02FLEx refractive corrections for hyperopia – Latestresults of the clinical trialsMarcus Blum, Kathleen Kunert, Urs Vossmerbaeumer, Walter Sekundo (Erfurt/D,Marburg/D)

08:44 FP TU-80-03Clinical Results of Aspheric Wavefront-guidedLASIKSuphi Taneri, Saskia Oehler (Münster/D)

08:51 FP TU-80-04Corneal Vertex Versus Entrance Pupil Centrationfor hyperopic Corneal AblationsTimothy Archer, Dan Reinstein, Marine Gobbe (London/UK)

08:58 FP TU-80-05Long-term follow-up of PRK for myopia. A comparative study between excimer lasersWaldir Neira, Timo Tervo, Juha Holopainen(Helsinki/FIN)

09:05 FP TU-80-06Corneal modulation with excimer laser for simul-taneous correction of Presbyopia & Ammetropia:Preliminary results after 3 months.Detlef Uthoff, Daniel Hepper, Markus Poelzl, Detlef Holland (Kiel/D)

09:12 FP TU-80-07Clinical measure of the quality of vision using anovel technique based on Moiré pattern interfer-ometry in patients treated with presbyLASIK andan accommodative IOL: A preliminary study.Sudi Patel, Jorge Alió (Edinburgh/UK, Alicante/E)

09:19 FP TU-80-08Ray tracing analysis of corneas operated with aPresbyLASIK technique (PresbyMax®)Luis Moreno, Jorge Alió, Esperanza Sala(Alicante/ES)

Room 42

16:00 - 17:30 TU-79

Dry Eye: Latest Advances in Surfocular Dryness

SymposiumCornea, External Disease

Chairs:D. Juan Murube del Castillo (Madrid/E)Suat H. Ugurbas (Zonguldak/TR)Gerd Geerling (Würzburg/D)

16:00 IL TU-79-01Modern concept of Dry EyeD. Juan Murube del Castillo (Madrid/E)

16:10 IL TU-79-02Diagnostic Tests to Select the Treatment: Part IJosé M. Benítez del Castillo Sánchez (Madrid/E)

16:20 IL TU-79-03Diagnostic Tests to Select the Treatment: Part IIJesus Merayo-Lloves (Madrid/E)

16:30 IL TU-79-04Psychological and environmental treatmentGysbert van Setten (Danderyd/S)

16:40 IL TU-79-05Medical treatment: Etiologic, pathogenic and tear-stimulantSuat H. Ugurbas (Zonguldak/TR)

16:50 IL TU-79-06Medical treatment: Substitutive: artificial tearsLuigi Bauchiero (Torino/I)

17:00 IL TU-79-07Medical Treatment, Autologous Serum, CyA, AntiinflammAshley Behrens (Baltimore/USA)

17:10 IL TU-79-08Surgical treatment of Mild and Medium Dry EyePeter P. M. Raus (Mol/B)

17:20 IL TU-79-09Surgical Treatment of Severe Dry EyeGerd Geerling (Würzburg/D)

Tues

day,

8 Ju

ne

211


Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Tues

day,

8 Ju

ne

11:00 FP TU-81-05Comparison of Simultaneous and Sequential procedures in Combination Treatments for Kerato-conus using Intrastromal Corneal Ring segmentswith Collagen Cross-LinkingJuan Grandin (Mendoza/RA)

11:07 FP TU-81-06Two-year results of corneal collagen cross-linkingusing riboflavin and ultraviolet-A light for progressive keratoconus.Mashhoor Alfayez (Jeddah/SA)

11:14 FP TU-81-07Amniotic membrane transplantation on the ocularsurface: A meta-analysisHanif Suleman, E. Lazutina, J. J. Gicquel, A. M. Yeung,I. Mohammed, N. L. Tint, P. Desai , Harminder S. Dua(Nottingham/UK)

11:21 FP TU-81-08Surgical methods of treatment of post-burn persistent corneal ulcerationOleksiy Buznyk, Stanislav Iakymenko, Sergiy Shchypun (Odessa/UA)

11:28 FP TU-81-09Riboflavin-UVA induced cross-linking treatmentfor keratoconus and LASIK keratectasia – an AsianperspectiveLi Lim, Hla Myint Htoon, Donald Tan, Lennard Yuen (Singapore/SGP)

11:35 FP TU-81-10Ophthalmologic tissue donation Changes and effects from German Tissue Law on example ofMitteldeutsche Corneabank Halle – Update 2010Diana Wille (Hannover/D)

11:42Discussion

Room 44

16:00 - 17:30 TU-82

Cataract/Biometry 4

Free PaperCataract

Chairs:Wolfgang Haigis (Würzburg/D)Duy-Thoai Pham (Berlin/D)Boris Malyugin (Moscow/RUS)

16:00 SL TU-82-01Application of closing-capsular injection of viscous and arc capsulectomy in small-incisionwith non-phaco extra-capsular cataract extractionfor hyper-mature cataractBaolinghuang Huang (Wuhu/CN)

09:26 FP TU-80-09Surgical correction of presbyopia with INTRACOR™Cati Albou-Ganem, D. A. Lebuisson, Jean-JacquesSaragoussi, Raphael Amar (Paris/F)

09:33 FP TU-80-10Quality of vision after presbyopic LASIK: contrastsensitivity and stereo acuityDan Reinstein, Timothy Archer, Marine Gobbe (London/UK)

09:40 FP TU-80-11Surgical correction of presbyopia with the AcuFocus Corneal Inlay – a two year follow-upMelchior Hohensinn (Salzburg/A)

09:47Discussion

Room 44

10:30 - 12:00 TU-81

Cornea/External Disease: Miscellaneous, SurgicalTherapy 3


Chairs:John Armitage (Bristol/UK)Florian Birnbaum (Freiburg/D)John D. Gottsch (Baltimore/USA)

10:30 SL TU-81-01What we have learned abouts Fuchs corneal dystrophy in the 100 years since Ernst Fuchs' initialdescriptionJohn D. Gottsch (Baltimore/USA)

10:39 FP TU-81-02The opacity patterns of Lisch corneal dystrophySusanne Butros, Gerhard K. Lang, Gabriele E. Lang,Juan Alvarez de Toledo, Ulrich Teimann, Jens M. Rohrbach, Walter Lisch (Ulm/D,Barcelona/E, Tübingen/D, Hanau/D, Dortmund/D)

10:46 FP TU-81-03High-risk corneal transplantation – what's new?Iva Dekaris, Nikica Gabric, Natasa Draca, Ante Barisic, Maja Pauk, Marija Anticic (Zagreb/HR)

10:53 FP TU-81-04Deep Anterior Lamellar Keratoplasty with Big Bubble Technique, assisted by Femtosecond laser,to treat keratoconusAdriana Lotfi (Mendoza/RA)


Salon 19

08:30 - 18:00 TU-83

IUSG Workshop: Diagnostic Criteria of Virus-induced Anterior Uveitis

SymposiumUveitis

Chairs:Soon Phaik Chee (Singapore/SGP)Jolanda de Groot (Utrecht/NL)Aniki Rothova (Utrecht/NL)Bahram Bodaghi (Paris/F)Philip Murray (Birmingham/UK)Manfred Zierhut (Tübingen/D)

Program

09:00 – 11:00Virology and the Eye1. Viruses and their clinical eye manifestations Jolanda de Groot-Mijnes2. Herpesviruses and the immune systemMaaike Ressing3. Pathology of virus-induced anterior uveitisKalpana Babu

11:15 – 13:15AC-tap for VIAU 1. Techniques and pitfalls of AC tap analysisJolanda de Groot-Mijnes2. Antibody determination from the AC tap: Pro and Contra Justus Garweg3. PCR determination from AC tap: Pro and ContraColin Fink

Literature Research:4. Use of AC tap for detection of HSV: Colin Fink,Janet Davis5. Use of AC tap for detection of VZV: Jolanda deGroot-Mijnes, Phil Murray6. Use of AC tap for detection of Rubella virus:Jolanda de Groot-Mijnes, Aniki Rothova 7. Use of AC tap for detection of CMV: Justus Garweg

14:00 – 16:00HSV

16:15 – 17:15 Rubella

In case of interest please contact Phil Murray:[email protected]

The second part of the workshop will take place onWednesday, 9 June 8:30 to 18:00

Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

16:09 FP TU-82-02Kinostat™ reduces the clinical onset and development of cataracts in diabetic dogs – implications for humans?Peter Kador, Milton Wyman, Terah Webb, Dineli Bras, Kerry Ketring (Omaha/USA, Powell/USA,Worthington/USA, Cincinnati/USA)

16:16 FP TU-82-03Calculation of zero power lenses with current IOLpower formulasWolfgang Haigis, Jose R. Villada (Würzburg/D, Albacete/E)

16:23 FP TU-82-04IOL calculation in very long eyesPaul-Rolf Preußner, Peter Hoffmann, Jochen Wahl(Mainz/D)

16:30 FP TU-82-05Optimizing Torsional Phaco with OZil IPDavid Allen (Newcastle on Tyne/UK)

16:37 FP TU-82-06Laser cataract surgery: nucleus liquefaction usingthe LenSx intraocular femtosecond laserMichael C. Knorz (Mannheim/D)

16:44 FP TU-82-07Optical and clinical outcomes with the LENTISMplus LS-312 MF intraocular lensAna Belen Plaza, Jorge Alió, Luis Moreno, Antonio Fimia, Mercedes Laguía, Roque Madrigal(Alicante/E)

16:51 FP TU-82-0822Gauge Bi-Axial Technology for Lens Extractionwithout Ultrasonic Power for Soft NucleusArturo Pèrez-Arteaga (Tlalnepantla/MEX)

16:58 FP TU-82-09Optimized Diffractive Multifocal Intraocular LensCentration Using A New Surgery Guidance SystemOmid Kermani, Uwe Oberheide (Köln/D)

17:05 FP TU-82-10Assessment of cyclotorsion errors in marker basedtoric IOL implantationRudy Nuijts, Nienke Visser (Maastricht/NL)

17:12 FP TU-82-11Phacoemulsification in Subluxed Lenses with theModified Capsular Tension RingBoris Malyugin (Moscow/RUS)

17:19Discussion

212Tu

esda

y, 8

June

Wed

nesd

ay, 9

June


Wednesday, 9 June 2010

WOC® 2010 213

Wed

nesd

ay, 9

June

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

ICC

Hal

l 3

Hal

l 4/5

Hal

l 6

Hal

l 7

Hal

l 8

Hal

l 9

Hal

l 10

ICC

Loun

ge

Roof

Gar

den

Salo

n 11

/12

Salo

n 19

Salo

n 21

Room

42

Room

43

Room

44

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

WE-

09 H

olm

strö

m, T

rese

,Th

urau

Ret

inop

athy

of

Prem

atur

ity –

Uve

itis

WE-

10 K

ohne

nG

erm

an S

ocie

ty o

f Int

ra-

ocul

ar Le

ns Im

plan

tatio

n

WE-

11 Co

scas

, Kam

pik

EAO

Sym

p: Im

pact

of r

ecen

t de

vel.

on cl

inic

al p

ract

ice

WE-

31

Awar

d Ce

rem

ony

and

Han

dove

r of D

OG

Pre

side

ncy

WE-

12 C

ollin

, Gut

hoff,

Kre

iner

Pane

l: Im

plan

t Mat

eria

ls a

ndTi

ssue

Inte

ract

ion

WE-

13 W

einr

eb, K

onst

as,

Pfei

ffer

Gla

ucom

a Rh

ythm

s

WE-

14 Z

renn

er, M

acLa

ren

Rest

orin

g Si

ght b

y Im

pl. a

ndTi

ssue

Eng

in. o

f the

Ret

ina

WE-

17 A

garw

al, K

och

Wha

t Will

You

Do?

WE-

18 S

char

ioth

, Alió

M

icro

inci

sion

Cat

arac

t Su

rger

y

WE-

19 R

ao, S

tegm

ann,

Mes

ter T

he M

alpo

sitio

ned

IOL a

nd IO

L Im

plan

t. in

Eye

s W

E-20

Zre

nner

, Moj

on,

Hed

ges A

sses

sing

Str

uct.

and

Func

t. in

Neu

ro-O

phth

alm

.

WE-

21 S

chae

fer, S

eitz

W

avef

ront

and

Abe

rrat

ion.

WE-

22 Fo

ulks

, Hol

zchu

h,Ka

erch

erU

pdat

e on

Saf

ety

and

Effic

acy

of C

ont.

Lens

Sol

.W

E-23

Kiv

elä,

Hun

gerf

ord,

Des

jard

ins O

OG

Sym

p: C

om-

plic

. of O

cula

r Irr

adia

tion

WE-

24 G

allie

, Des

jard

ins,

Bech

raki

sTum

ors o

f the

Retin

a an

d Re

t. Pi

gm. E

pith

.

WE-

25 S

pahn

, Gar

ms,

Rao

The

New

Rea

litie

s of N

on-

Gov

ernm

enta

l Dev

elop

men

tW

E-26

Kuh

n, S

chra

der

Man

agem

ent o

f the

Rup

-tu

red

Eye

WE-

27 K

uhn,

Sch

rade

r,Pe

laye

s ISO

T Sy

mp:

Ocu

lar

trau

mat

olog

y: T

he B

asic

s

WE-

28 K

uhn,

Bar

ak, M

orta

daM

inis

ympo

sium

: Ocu

lar

trau

ma

WO

C-C-

56 W

olff

Re

frac

tive

Lens

Sur

gery

WE-

29 A

reva

lo, R

oca,

Wu

SPRV

Sym

posi

um: U

pdat

e on

Ped

iatr

ic R

etin

a

WE-

30 M

urra

y, Sm

ith, B

isw

asPa

nel D

iscu

ssio

n –

The

Teac

h-in

g of

Uve

itis

WE-

16 A

lRaj

hi, E

l-Mag

hrab

y,Sp

ivey

Vis

ion

2020

– P

reve

n-tio

n of

Blin

dnes

s 2

WE-

15 S

chra

erm

eyer

, Beh

ar,

Farr

ar O

cula

r Dru

g De

liver

yto

the

Post

erio

r Seg

men

t

WO

C-C-

62 K

reis

sig,

Ayl

war

d,Li

ncof

f Pre

sent

Opt

ions

inth

e M

anag

emen

t W

E-42

Zie

rhut

IU

SG W

orks

hop:

Dia

gnos

tic C

riter

ia o

f Viru

s-in

duce

d An

terio

r Uve

itis

Sitz

ung

Klin

isch

e M

onat

sblä

tter

für A

ugen

heilk

unde

WO

C-C-

57 K

aise

r, Wol

f, H

oera

uf La

ser i

n Re

tinal

Di

seas

es D

os a

nd D

onts

WO

C-C-

58 N

aren

dran

, Aza

d,D

ogra

Cur

rent

Tren

ds in

Man

agem

. of R

etin

opat

hy

WE-

38 A

zad,

Mitc

hell,

Kais

er

Brea

king

New

s in

Retin

a

WO

C-C-

59 C

arva

lho

Vasc

on-

celo

s, Ke

effe

Intr

oduc

ing

Pedi

atric

Low

Vis

ion

WE-

39 B

urgo

yne,

Sekh

ar,

Hor

nyke

wyc

z G

lauc

oma:

Sur

gica

l the

rapy

3

WO

C-C-

60 G

iblin

, Kiv

elä,

Fo

erst

erDi

agno

sing

Mel

ano-

cytic

Tum

ours

of t

he U

vea

WE-

40 M

itche

ll, Pi

tz

Epid

emio

logy

WE-

41 A

rnol

d, Z

renn

er

Neu

ro-O

phth

alm

olog

y 2

Wed

nesd

ay, 9

June

WE-

01 K

norz

, Alió

Man

age-

men

t of C

ompl

icat

ions

inLA

SIK

and

Surf

ace

Abla

tion

WE-

02 M

cDon

ald,

Mar

shal

l,D

ick

Why

Do

We

Still

Per

-fo

rm S

urfa

ce A

blat

ions

?

WE-

03 W

ilson

, Sei

tz

The

Refr

activ

e Co

rnea

: Sc

ienc

e Pr

ogre

ss

Hig

hlig

htSy

mpo

sium

Free

Pap

erW

OC

Cour

seIn

dust

ry S

ympo

sium

Mee

tings

Mes

se

Stoc

khol

m

Sao

Paul

o

Osl

o H

all

Radi

o To

wer

Lo

unge

1

Radi

o To

wer

Loun

ge 2

0715

3045

0815

3045

0915

3045

1015

3045

1115

3045

1215

3045

1315

3045

1415

3045

1515

3045

1615

3045

1715

3045

1815

3045

WO

C-C-

55 A

gost

ini, F

eltg

en

Man

agem

ent o

f Vas

cula

r O

cula

r Em

erge

ncie

s

WE-

35 H

eim

ann,

Moo

re

Retin

a: M

isce

llane

ous 2

WE-

04 Tr

auze

ttel

, Sub

ram

an-

ian,

Gan

dhi H

emia

nopi

a:Fe

atur

es a

nd In

terv

entio

ns

WE-

05 M

elle

r, Tsa

i, Wyl

egal

a M

anag

emen

t of L

imba

l Ste

mCe

ll De

ficie

ncy

WE-

07 P

illun

at, F

echt

ner,

Zeye

n As

sess

men

t of t

heO

ptic

Ner

ve H

ead

WE-

08 C

hong

, Wed

rich,

Kirc

hhof

Sub

mac

ular

H

emor

rhag

e M

anag

emen

tW

E-33

Bea

cons

field

, Col

lin,

Hin

tsch

ich

ESO

PRS

Sym

p:M

anag

. of P

erio

c. Tu

mou

rs

WE-

34 E

ter, S

inge

r Re

tina:

AM

D 4

WE-

36 Fr

öhlic

h, C

ongd

on,

Nai

doo

Refr.

Err

or fr

omSc

hool

Age

thr.

Pres

byop

ia

WE-

37 A

zad,

Des

jard

ins,

Kara

corlu

Pedi

atric

Oph

thal

-m

olog

y &

Gen

etic

s 3

APAO Central Secretariat:Tel: (852) 2762 3040 Fax: (852) 2715 9490

Email: [email protected]

Host Secretariat:Tel: (86) 10 8515 8141 Fax: (86) 10 6512 3754Email: [email protected]

www.apao2010beijing.orgwww.apao2010beijing.org

September 16-20, 2010China National Convention CenterBeijing, China

September 16-20, 2010China National Convention CenterBeijing, China

held in conjunction with The 15th Congress of the Chinese Ophthalmological Society

held in conjunction with The 15th Congress of the Chinese Ophthalmological Society

* Over 500 international top-notch speakers

* Over 8000 delegates (4000 international, 4000 from China)

Scientific Program Committee Scientific Program CommitteeChair: Dennis LamCo-Chairs: Xiaoxin Li / Charles McGheeSenior Secretary: Clement Tham

18 Miscellaneous Dennis Lam / Xiaoxin Li / Charles McGhee / Clement Tham

Secretary(from APAO Central)

InternationalCoordinator

AsiaCoordinator

Pacific RimCoordinator

HostCoordinator

Stanley Chang Chi Chun Lai Andrew Chang Zhizhong Ma17 Retina (Surgical) Zdenek Gregor Vincent Lee

Alexander Brucker Taraprasad Das Diane Sharp Xiaoxin Li16 Retina (Medical) Ian Constable

Michael Knorz Kazuo Tsubota Michael Lawless Jia Qu15 Refractive Surgery Ronald Krueger Vishal Jhanji

Akira Murakami Garry Brian Youxin Chen14 Prevention of Blindness R Pararajasegaram Dennis Lam

Marilyn Miller May May Choo Craig Donaldson Kanxing Zhao13 Pediatric Ophthalmology & Strabismus Frank Martin Dorothy Fan

Michael Grant Yoon-Duck Kim Tim Sullivan Xianqun Fan12 Orbits and Oculoplastics David Tse Hunter Yuen

Paul Foster Hidetoshi Yamashita Paul Mitchell Jialiang Zhao11 Ophthalmic Epidemiology Tien Wong Nathan Congdon

Peter McCluskey Mingwei Zhao10 Ophthalmic Education Mark Tso Nancy Yuen

Tero Kivelä Santosh Honavar Sehu Weng Wei Wang9 Ocular Pathology & Tumors Jerry Shields David Liu

David Hwang Srinivas Rao Kathy McClellan Xuguang Sun8 Ocular Microbiology and Ocular Infectious Diseases Terrence O’Brien Ben Lam

Neeru Gupta Tin Aung Dipika Patel Ningli Wang7 Ocular Imaging Charles McGhee Christopher Leung

Andy Lee Navin Jayakumar Helen Danesh-Meyer Shihui Wei6 Neuro-ophthalmology Neil Miller Carmen Chan

Terete Borras Susumu Ishida Mark Gillies Zhengqin Yin5 Laboratory Eye Research Vincent Raymond Calvin Pang

Susan Lightman Shigeaki Ohno Sam Lertsumitkul Peizeng Yang4 Intraocular Inflammation, Uveitis & Scleritis Narsing Rao Timothy Lai

Jost Jonas Makoto Araie Paul Healey Jian Ge3 Glaucoma Robert Ritch Clement Tham

Ke Yao

2 Cornea and External Eye Disease Shigeru Kinoshita Alvin Young Michael Belin Donald Tan Gerard Sutton Lixin Xie

Philip Lam Richard Packard Abhay Vasavada Tim Roberts

Subspecialty Convener

1 Cataract David Chang

Timothy Lai

Gondhowiardjo TjahjonoEduardo Mayorga Argañaraz

Mohamed Babar Qureshi

Advance Registration Deadline: Aug 31, 2010Advance Registration Deadline: Aug 31, 2010

www.apao2010beijing.orgwww.apao2010beijing.org

SSeppteteembbeer 16CChininna NaNaattioioonnal CoCoon

heheeldld iin ccoonjuuncnccttioioon wwiitth

TThhe 155

nj

6-6-2-220,0, 2010nvnveveennttioioon CeCeennteteer

held in conjunction with

5tth CoCoonnggrereesss oof tthehe 5

CChhinineneesse OOpphthtthhaalmlm

momoololooggiciccaal SoSooccieieetyty

BeBeeijijinnng,g, CChininna

AAdvdvavanncece ReReeggisissttraraa

ttioioon DeDeeaadlinnnee: AAugug 3

31, 220010

Scientific ProgramScientific ProgramSSccieeentnttifiific Proroograram

ytlaicepsbuS

AdAdvvvanccece ReReegisisttrra

wwww .appaoao2o201www

m Committeem Committeem CoCoommititttteteee

)lartneCOAPAmorf(yraterceSrenevnoC

tttiooon DDeeaddlineee: AuAug 3

0bbeijijing.orgrg

rotanidrooClanoitanretnI

rotanidrooCaisA

oCaP

31, 20010

rotanidrooimRcifica

rotanidrooCtsoH

Email: [email protected]: (852) 2762 3040 Fax: (852) 2715 9490

.apao201.apao201wwwwwwEmail: [email protected]

Tel: (852) 2762 3040 Fax: (852) 2715 9490APAO Central Secretariat:

www .appaoao2o20201www

0beijing.org0beijing.orgEmail: [email protected]: (86) 10 8515 8141 Fax: (86) 10 6512 3754Host Secretariat:

0bbeijijinng.oorgrg

Tel: (86) 10 8515 8141 Fax: (86) 10 6512 3754

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Stockholm

08:30 - 10:00 WE-01

Management of Complications in LASIK and Surface Ablation


Chairs:Michael C. Knorz (Mannheim/D)Jorge L. Alió (Alicante/E)

08:30 IL WE-01-01Ocular surface syndrome-dry eyeSteven E. Wilson (Cleveland/USA)

08:40 IL WE-01-02Incidence of complications in a chain of high-volume surgical centersJan Venter (London/UK)

08:50 IL WE-01-03Impact of complications in quality of lifeKonrad Pesudovs (Adelaide/AUS)

09:00 IL WE-01-04Prevention of ectasia – a grading system is necessaryR. Doyle Stulting (Atlanta/USA)

09:10 IL WE-01-05Management of KeratectasiaTheo Seiler (Zurich/CH)

09:20 IL WE-01-06When and how should we use mitomcin C?H. Burkhard Dick (Bochum/D)

09:30Discussion

Stockholm

10:30 - 12:00 WE-02

Why Do We Still Perform Surface Ablations?


Chairs:Marguerite McDonald (New Orleans/USA)John Marshall (London/UK)H. Burkhard Dick (Bochum/D)

10:30 IL WE-02-01The Pros and Cons of Surface Ablation in 2010Paolo Vinciguerra (Milano/I)


Wed

nesd

ay, 9

June

217

10:40 IL WE-02-02Patient Selection for Surface AblationThomas Claringbold (Clare/USA)

10:50 IL WE-02-03Pain Control for Surface AblationAleksander Stojanovic (Tromsø/N)

11:00 IL WE-02-04Epi-LASIK in 2010Ioannis G. Pallikaris (Voutes, Heraklion/GR)

11:10 IL WE-02-06Surface Ablation to Enhance Premium (Presbyopia-correcting) IOLsGeorge Waring (Atlanta/USA)

11:20 IL WE-02-07Recent Advances in Surface Ablation ResearchMarguerite McDonald (New Orleans/USA)

11:30Discussion

Stockholm

13:00 - 14:30 WE-03

The Refractive Cornea: Science Progress for theCorneal Refractive Surgeon


Chairs:Steven E. Wilson (Cleveland/USA)Berthold Seitz (Homburg/D)

13:00 IL WE-03-01Advances in corneal biomechanicsWilliam J. Dupps Jr. (Cleveland/USA)

13:10 IL WE-03-02New insights into cytokine control of myofibrob-last development, persistence and death in the de-velopment and disappearance of haze after PRKSteven E. Wilson (Cleveland/USA)

13:20 IL WE-03-03Customized ablation – wavefront-guided or wavefront-optimized?Michael C. Knorz (Mannheim/D)

13:30 IL WE-03-04Optical changes of the cornea after refractive surgery – impact on IOL power calculationAchim Langenbucher (Homburg/D)

Wednesday, 9 June 2010Sc

ient

ific P

rogr

am S

ched

ule

WOC® 2010

Sao Paulo

10:30 - 12:00 WE-05

Management of Limbal Stem Cell Deficiency


Chairs:Daniel Meller (Essen/D)Ray Jui-Fang Tsai (Taipei/TJ)Edward Wylegala (Katowice/PL)

10:30 IL WE-05-01Novel Ex Vivo Expansion based on Preservation ofLimbal Stem Cells and their Native Niche CellsScheffer C. G. Tseng (Miami/USA)

10:40 IL WE-05-02Biologic view of ex vivo expansion for Limbal stemcellsGraziella Pellegrini (Venezia/I)

10:50 IL WE-05-03Clinical application of ex vivo expansion of limbalstem cells and the mechanism for successRay Jui-Fang Tsai (Taipei/CN)

11:00 IL WE-05-04Ex vivo expansion of autologous mucosal epithe-lial stem cells for limbal stem cell deficiencyTsutomu Inatomi (Kyoto/J)

11:10 IL WE-05-05Reconstruction of ocular surface using living related limbal grafts in childrenEdward Wylegala (Katowice/PL)

11:20 IL WE-05-06Keratinocytes for limbal stem cell replacement -insights into corneal epithelial differentiationFriedrich E. Kruse (Erlangen/D)

11:30 IL WE-05-07Midterm Results of Cultivated Autologous and Al-logeneic Limbal Epithelial Transplantation in Lim-bal Stem Cell DeficiencyDaniel Meller (Essen/D)

11:40Discussion

13:40 IL WE-03-05Efficacy of the combination of UV-Riboflavincrosslinking and PRKTheo Seiler (Zurich/CH)

13:50 IL WE-03-06The US trials on UV-Riboflavin crosslinkingStephen D. Klyce (Port Washington/USA)

14:00 IL WE-03-07Current limits of corneal laser surgeryThomas Kohnen (Frankfurt/D)

14:10Discussion

Sao Paulo

08:30 - 10:00 WE-04

Hemianopia: Features and Interventions

SymposiumLow Vision

Chairs:Susanne Trauzettel-Klosinski (Tübingen/D)Prem Subramanian (Baltimore/USA)Rashmin Gandhi (Chennai/IND)

08:30 IL WE-04-01Training in HemianopiaSusanne Trauzettel-Klosinski (Tübingen/D)

08:40 IL WE-04-02Development of a Neuro hemifield testPrem Subramanian (Baltimore/USA)

08:50 IL WE-04-03Bitemporal Hemianopia – Neuro Ophthalmic Features and InvestigationRashmin Gandhi (Chennai/IND)

09:00 IL WE-04-04Epidemiology of Homonymous HemianopiaSachin Kedar (Jackson/USA)

09:10 IL WE-04-05Hemianopia in neurosurgical practice: causes, features, outcomesNatalia Serova (Moscow/RUS)

09:20 IL WE-04-06The Roadmap of the Visual Pathway- Have youever seen *i*?Satoshi Kashii (Osaka/J)

09:30Discussion

218W

edne

sday

, 9 Ju

ne


Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Oslo

08:30 - 10:00 WE-07

Assessment of the Optic Nerve Head and LaminaCribrosa

SymposiumGlaucoma

Chairs:Lutz E. Pillunat (Dresden/D)Robert Fechtner (Newark/USA)Thierry Zeyen (Leuven/B)

08:30 IL WE-07-01Ophthalmoscopic evaluation of the optic diskJost B. Jonas (Mannheim/D)

08:40 IL WE-07-02The role of optic disc stereophotographsThierry Zeyen (Leuven/B)

08:50 IL WE-07-03Digitized optic disc imaging for glaucoma diagnosisJoseph Caprioli (Los Angeles/USA)

09:00 IL WE-07-04Digitized optic disc imaging for glaucoma progresssionTed Garway-Heath (London/UK)

09:10 IL WE-07-05Correlation between structure and functionRobert Fechtner (Newark/USA)

09:20 IL WE-07-06Biomechanics of the lamina cribrosaEberhard Spörl (Dresden/D)

09:30 IL WE-07-07In vivo biochemechanics of the optic discClaude Burgoyne (Portland/USA)

09:40 IL WE-07-08Optic nerve blood flow in glaucomaLutz E. Pillunat (Dresden/D)

09:50Discussion

Wed

nesd

ay, 9

June

219

Oslo

10:30 - 12:00 WE-08

Submacular Hemorrhage Management

SymposiumRetina

Chairs:Lawrence P. Chong (Los Angeles/USA)Andreas Wedrich (Graz/A)Bernd Kirchhof (Cologne/D)

10:30 IL WE-08-01Natural History of macular subretinal hemorrhagein age-related macular degenerationGisèle Soubrane (Créteil/F)

10:40 IL WE-08-0223g Vitrectomy with r-TPA and Gas for submacularhemorrhageAnton Haas (Graz/A)

10:50 IL WE-08-03Intravitreal Bevacizumab for neovascular age-related macular degeneration with large submacular hemorrhageUrsula Schmidt-Erfurth (Vienna/A)

11:00 IL WE-08-04Effects of intravitreal gas with or without tissueplasminogen activator on submacular haemor-rhage in age-related macular degenerationChang-Hao Yang (Taipei/TJ)

11:10 IL WE-08-05Pigmentepithelium Transplantation in massivesubmacular hemorrhagePeter Szurman (Tübingen/D)

11:20 IL WE-08-06Displacement of Submacular Hemorrhage by injection of Tissue Plasminogen Activator andexpansile gasWilson Heriot (Templestowe Lower/AUS)

11:30Discussion

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e


10:30 - 12:00 WE-33

ESOPRS Symposium: Management of PeriocularTumours


Chairs:Michèle Beaconsfield (London/UK)John Richard O. Collin (London/UK)Christoph Hintschich (Munich/D)

10:30 IL WE-33-01Diagnosis and differential diagnosisMarco Puccioni (Florence/I)

10:40 IL WE-33-02AetiologyTim Sullivan (Bernardsville/USA)

10:50 IL WE-33-03Surgical therapy (tumour clearance, local and distant)Michèle Beaconsfield (London/UK)

11:00 IL WE-33-04Principles of eyelid reconstructionMehmet Unal (Ankara/TR)

11:10 IL WE-33-05Alternative (non-surgical) therapiesChristoph Hintschich (Munich/D)

11:20 IL WE-33-06Treatment of local and distant recurrencesJohn Richard O. Collin (London/UK)

11:30Discussion


13:00 - 14:30 WE-34

Retina: AMD 4

Free PaperRetina

Chairs:Nicole Eter (Bonn/D)Michael Singer (San Antonio/USA)

13:00 SL WE-34-01Update on the molecular genetics of age relatedmacular degenerationAndrew Lotery (Southampton/UK)

13:09 FP WE-34-02HORIZON Extension Trial of Ranibizumab (LUCEN-TIS) for Neovascular Age-related Macular Degeneration (AMD): Two-year Safety and EfficacyResultsMichael Singer, Pamela Wong, Lisa Tuomi (San Antonio/USA)

13:16 FP WE-34-03Can intravitreal ranibizumab injection in AMDcause blindness?Mohamed El-Ashry, Gerasimos Lascaratos, Archana Vani, Anna-Marie Ambrecht, BaljeanDhillon (Edinburgh/UK)

13:23 FP WE-34-04Bonn Ophthalmology Online Network (BOON): first results of a pilot studyNicole Eter, Carolin Milojcic, Hans-Martin Helb(Bonn/D)

13:30 FP WE-34-05Intravitreal Ranibizumab Versus Bevacizumab InCNVM Due to ARMD – A Prospective StudyPartha Biswas, Subhrangshu Sengupta, SubhankarHome, Ajoy Paul, Ruby Choudhary (Kolkata/IND)

13:37 FP WE-34-06Comparison of combined treatment of intravitrealbevacizumab or intravitreal recombinant tissueplasminogen activator with expansile gas for large subretinal fovea involving haemorraghessecondary to age related neovascular macular degenerationWolfgang Mayer, Imad Hakim, Christos Haritoglou,Arnd Gandorfer, Michael Ulbig, Anselm Kampik,Armin Wolf (München/D)

13:44 FP WE-34-07Using aspheric monofocal intraocular lenses as intraocular low vision devise for eyes with maculardamageCosme Ildefonso Naval, Analyn T. Suntay, CarmelaQ. Olivares (San Juan/RP)

13:51 FP WE-34-08Optical coherence tomography and autofluore-scence findings in areas with geographic atrophydue to age-related macular degenerationSteffen Schmitz Valckenberg, Monika Fleckenstein,Arno P. Göbel, Thomas Hohman, Frank G. Holz(Bonn/D)

13:58 FP WE-34-09Influence of antocianozidi on ocular blood flow inpatients with non-exudative age-related maculadegenerationTatyana Kiseleva, Ekaterina Kravchuk, Sergey Vlasov(Moscow/RUS)


Wed

nesd

ay, 9

June

220

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

14:05 FP WE-34-10Fundus Autofluorescence Abnormalities and Local Macular Pigment DensitySimon Rothenbuehler, Ute Wolf-Schnurrbusch, Sebastian Wolf (Bern/CH)

14:12Discussion


08:30 - 10:00 WE-35

Retina: Miscellaneous 2

Free PaperRetina

Chairs:Heinrich Heimann (Liverpool/UK)Anthony T. Moore (London/UK)

08:30 FP WE-35-01Retinoblastoma in sub-Saharan African: Challenges and prospectsDupe Ademola-Popoola, Foluso Owoeye, Sunday Abuh (Ilorin/WAN)

08:37 FP WE-35-02The results of risk-adapted therapy in patiens withunilateral retinoblastomaTatiana Ushakova, Igor Dolgopolov, Olga Gopovtzova, Alentina Pavlovskaya, Irina Matveeva,Igor Glekov, Vladimir Polyakov, Geordge Mentkevich(Moscow/RUS)

08:44 SL WE-35-03Inherited macular diseaseAnthony T. Moore (London/UK)

08:53 FP WE-35-04Normative comparison of generic- and vision-targeted health-related quality of life (HRQL) out-comes in patients with vision loss due to macularedema following retinal vein occlusionAnne Rentz, Jonathan W. Kowalski, Dennis Revicki,Anat Loewentstein, Scott M. Whitcup (Köln/D,Irvine/USA, Tel Aviv/IL)

09:00 FP WE-35-05Clinical Effect of Valproic Acid in Patients with RPand ARMDShalesh Kaushal (Worcester/USA)

09:07 FP WE-35-06The regeneration of adult retinal ganglion cellsthrough improper targetsSarah Pfrommer, Solon Thanos (München/D)

09:14 FP WE-35-07Which Vessel Segments are Suited for Measure-ments with the Retinal Vessel Analyzer?Christoph Wirtz (Bochum/D)

09:21 FP WE-35-08Natural Evolution from Macular Retinoschisis toFull-thickness Macular Hole in Highly Myopic EyesChuan-bin Sun, Zhe Liu, Ke Yao (Hangzhou/CN)

09:28 FP WE-35-09Prophylaxis of Retinal Detachment: To do, not todo, to observeBojimir Petrovski (Sofia/BG)

09:35 FP WE-35-10Momolayer RPE transplantation for treatment ofhemorrhagic ARMD An expanding procedure ofRPE-Bruch’s membrane complex transplantationChangguan Wang, Yuntao Hu, Hongliang Dou, Xuefeng Feng (Beijing/CN)

09:42Discussion


10:30 - 12:00 WE-36

Refractive Error from School Age through Presbyopia: Combating the World's Leading Causeof Visual Disability


Chairs:Stephan J. Fröhlich (Nürnberg/D)Nathan G. Congdon (Baltimore/USA)Kovin Naidoo (Durban/ZA)

10:30 IL WE-36-01Population density and myopia risk among Chinese childrenNathan G. Congdon (Baltimore/USA)

10:40 IL WE-36-02The ICEE Approach to Vision CentresBrien A. Holden (Sydney/AUS)

10:50 IL WE-36-03New evidence for the impact of environment onrefractive error in ChildrenPaul Mitchell (Sydney/AUS)

11:00 IL WE-36-04The accuracy of self-refraction among Chinese secondary school childrenHe Mingguang (Guangzhou/CN)


Wed

nesd

ay, 9

June

221

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:10 IL WE-36-05The potential role of adjustable-power spectaclesin refractive correction programsGraeme E. Mackenzie (Oxford/UK)

11:20 IL WE-36-06Human resources in refractive error programs:training, motivation, retentionKovin Naidoo (Durban/ZA)

11:30 IL WE-36-07Refractive error in GermanyStephan J. Fröhlich (Nürnberg/D)

11:40Discussion


13:00 - 14:30 WE-37


Free PaperPediatric Ophthalmology

Chairs:Rajvardhan Azad (New Delhi/IND)Laurence Desjardins (Paris/F)Murat Karacorlu (Istanbul/TR)

13:00 FP WE-37-01Phakic(iris-Fixated) IOLs for anisomyopic amblyopia in children: pilot studyMustafa Ibrahim (Dammam/SA)

13:07 FP WE-37-02An Independent Long Term Outcome Study of Bilateral Pseudophakia in ChildrenMalcolm Ing (Honolulu/USA)

13:14 FP WE-37-03Breaking down barriers in communicating complex Retinoblastoma information: can picturesbe the solution?Hannah Chiu, Helen Dimaras, Rob Downie, Brenda Gallie (Richmond Hill/CDN)

13:21 FP WE-37-04International Intraocular Retinoblastoma Classification and histopathology classificationJunyang Zhao (Beijing/CN)

13:28 FP WE-37-05Visual function in children with hypoxic-ischemicencephalopathyDorota Pojda-Wilczek (Katowice/PL)

13:35 FP WE-37-06First experiences in the treatment of ROP withVEGF-inhibitorsSynke Meltendorf, Thoralf Wecke, Simone Tuchen,Sven Walter, Arne Viestenz, Wolfgang Behrens-Baumann (Magdeburg/D)

13:42 FP WE-37-07Visual perceptual and neurocognition deficits invisually impaired children – do we overlook theobvious?Barbara Käsmann-Kellner, Christine Basel, Berthold Seitz (Homburg/D)

13:49 SL WE-37-09Batten Disease – one disease but many diagnosesFrank Stehr (Hamburg/D)

13:58Discussion

Hall 3

08:30 - 10:00 WE-09

Retinopathy of Prematurity – Uveitis


Chairs:Gerd Holmström (Uppsala/S)Michael T. Trese (Royal Oak/USA)Stephan Thurau (Munich/D)

08:30 IL WE-09-01ROP in premature and extremely premature infantsGerd Holmström (Uppsala/S)

08:45 IL WE-09-02Role of digital imaging in ROPAnna Ells (Calgary/CDN)

09:00 IL WE-09-03Indications and options for treatmentMichael T. Trese (Royal Oak/USA)

09:15 IL WE-09-04Uveitis in childhood – TherapyStephan Thurau (Munich/D)

09:30 IL WE-09-05Uveitis in childhood – Indication for surgeryBahram Bodaghi (Paris/F)

09:45Discussion


Wed

nesd

ay, 9

June

222

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 3

10:30 - 12:00 WE-10

Update Deutschsprachige Gesellschaft für Intraokularlinsen-Implantation, interventionelleund refraktive ChirurgieGerman Society of Intraocular Lens Implantation,Interventional and Refractive Surgery(Session in German)

SymposiumCataract

Chairs:Thomas Kohnen (Frankfurt/D)Duy-Thoai Pham (Berlin/D)

10:30 IL WE-10-01State of the Art – Standard IOLStephan Kohnen (Aachen/D)

10:40 IL WE-10-02Premium IOL – ÜberblickGerd U. Auffarth (Heidelberg/D)

10:50 IL WE-10-03Nachbehandlung nach refraktivchirurgischen EingriffenThomas Kohnen (Frankfurt/D)

11:00 IL WE-10-04Qualitätsmanagent in der refraktiven und KataraktchirurgieEkkehard Fabian (Rosenheim/D)

11:10 IL WE-10-05Trabekulektomie vs KanaloplastikMaya Müller (Lübeck/D)

11:20 IL WE-10-06Neue InjektorsystemeJörn Kuchenbecker (Berlin/D)

11:30 IL WE-10-07Intraokulare MedikamenteneinbringungManfred Tetz (Berlin/D)

11:40 IL WE-10-08OCT-Diagnostik am vorderen AugenabschnittChristopher Wirbelauer (Frankfurt(Oder)/D)

Hall 3

13:00 - 14:30 WE-11

EAO Symposium: Impact of Recent Developmentson Clinical Practice


Chairs:Gabriel J. Coscas (Créteil/F)Anselm Kampik (Munich/D)

13:00 IL WE-11-01Surgical RetinaAnselm Kampik (Munich/D)

13:10 IL WE-11-02Medical RetinaGabriel J. Coscas (Créteil/F)

13:20 IL WE-11-03GlaucomaJosef Flammer (Basel/CH)

13:30 IL WE-11-04CorneaJorge L. Alió (Alicante/E)

13:40 IL WE-11-05Cataract SurgeryMarie-José Tassignon (Antwerp/B)

13:50 IL WE-11-06NeuroophthalmologyKlara Landau (Zurich/CH)

14:00 IL WE-11-07Ocular SurfaceJoaquim Neto Murta (Lisboa/P)

14:10 IL WE-11-08Rare DiseasesJosé-Alain Sahel (Paris/F)

14:20Discussion


Wed

nesd

ay, 9

June

223

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 4/5

08:30 - 10:00 WE-12

Panel: Implant Materials and Tissue Interaction inOphthalmic Plastic and Reconstructive Surgery

Panel Oculoplasty, Lacrimal System, Orbit

Chairs:John Richard O. Collin (London/UK)Rudolf F. Guthoff (Rostock/D)Christine F. Kreiner (Hennigsdorf/D)

08:30 IL WE-12-01Osmoexpansion of orbital structures – a 10 yearsexperienceRudolf F. Guthoff (Rostock/D)

08:40 IL WE-12-02Applied features of different orbital implantsMichail Kataev (Moscow/RUS)

08:50 IL WE-12-03Implant exposure and its managementJean-Paul Adenis (Limoges/F)

09:00 IL WE-12-04Minimal invasive application of osmoexpandersand its local tissue reactionMichael P. Schittkowski (Göttingen/D)

09:10 IL WE-12-05Tissue reactions in filler therapyChristine F. Kreiner (Hennigsdorf/D)

09:20 IL WE-12-06Frontalis sling materialsJohn Richard O. Collin (London/UK)

09:30 IL WE-12-07Biomaterials as medpore in orbital floor fracturesLuigi Colangelo (Chieti/I)

09:40 IL WE-12-08Jones Tubes for lacrimal canalicular obstructionsDaniel Weil (Buenos Aires/RA)

09:50Discussion

Hall 4/5

10:30 - 12:00 WE-13

Glaucoma Rhythms

SymposiumGlaucoma

Chairs:Robert N. Weinreb (La Jolla/USA)Anastasios G. P. Konstas (Thessaloniki/GR)Norbert Pfeiffer (Mainz/D)

10:30 IL WE-13-01Circadian rhythms in human health and diseaseNeeru Gupta (Toronto/CDN)

10:40 IL WE-13-02What have we learned about IOP from the sleeplaboratory?Jonathan Liu (Omaha/USA)

10:50 IL WE-13-03Aqueous humor rhythmsArthur J. Sit (Rochester/USA)

11:00 IL WE-13-04Should the one-eye therapeutic trial be abandoned?Anthony Realini (Morgantown/USA)

11:10 IL WE-13-05Are blood pressure and perfusion pressure risk factors for glaucoma?Selim Orgül (Basel/CH)

11:20 IL WE-13-06Continuous monitoring of IOP with a contact lensMatteo Leonardi (Lausanne/CH)

11:30 IL WE-13-07Continuous monitoring of IOP with an implantabledeviceSamir A. Melki (Brookline/USA)

11:40 IL WE-13-08Implications for glaucoma managementRobert N. Weinreb (La Jolla/USA)

11:50Discussion


Wed

nesd

ay, 9

June

224

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 4/5

13:00 - 14:30 WE-14

Restoring Sight by Implants and Tissue Engineering of the Retina


Chairs:Eberhart Zrenner (Tübingen/D)Robert E. MacLaren (London/UK)

13:00 IL WE-14-01Retinal prostesisMark Humayun (Los Angeles/USA)

13:10 IL WE-14-02Seeing with subretinal electronic implantsEberhart Zrenner (Tübingen/D)

13:20 IL WE-14-03Trans-corneal electrical stimulation to rescue thedeath of retinal neuronsTakashi Fujikado (Osaka/J)

13:30 IL WE-14-04How mechanisms of retinal disease will guideforthcomming gene therapy approachesRobert E. MacLaren (London/UK)

13:40 IL WE-14-05Retinitis pigmentosa and iPS cellsMasayo Takahashi (Kobe/J)

13:50 IL WE-14-06Seoul Artificial Retina ProjectHum Chung (Seoul/ROK)

14:00Discussion

Hall 6

08:30 - 10:00 WE-17

What Will You Do?

SymposiumCataract

Chairs:Amar Agarwal (Chennai/IND)Hans-Reinhard Koch (Bonn/D)

This Symposium will teach important pearls andmanagement strategies when a clinician is facedwith a difficult clinical scenario. This will be highlighted with the help of surgical videos. Each speaker will share an interesting clinical case which will be discussed with other faculties and the audiance.

Chairs:Amar Agarwal (Chennai/IND)Hans-Reinhard Koch (Bonn/D)

08:30 IL WE-17-01Management of zonulopathy in Marfan'sTim Roberts (Chatswood/AUS)

08:40 IL WE-17-02VideoSuhas Haldipurkar (Panvel/IND)

08:50 IL WE-17-03To keep or not to keep the capsular bagMarie-José Tassignon (Antwerp/B)

09:00 IL WE-17-04VideoBiro Zsolt (Pécs/H)

09:10 IL WE-17-05VideoHadi Prakoso (Jakarta/RI)

09:20 IL WE-17-06VideoHans-Reinhard Koch (Bonn/D)

09:30Discussion


Wed

nesd

ay, 9

June

225

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 6

10:30 - 12:00 WE-18

Microincision Cataract Surgery: Mastering thePhakonit / Mics Technique

SymposiumCataract

This symposium will highlight different aspects ofMicro Incision Cataract surgery. It would includeMicro phakonit biaxial and coaxial Micro Inicionsurgery. The experts will also teach applications ofdifferent techniques in difficult as well as routinecataract cases.

Chairs:Gabor B. Scharioth (Recklinghausen/D)Jorge L. Alió (Alicante/E)

10:30 IL WE-18-01Ideal tips and power modulation for MICSTakayuki Akahoshi (Tokyo/J)

10:40 IL WE-18-02A Low Fluidics Strategy for Micro-coaxial TorsionalPhaco for Dense CataractsKhiun F. Tjia (Zwolle/NL)

10:50 IL WE-18-03Microphakonit: 700 micron cataract surgery intough casesAmar Agarwal (Chennai/IND)

11:00 IL WE-18-04Step by Step: Surgical Advantages of 700 micronTechnology during Lens ExtractionArturo Perez Arteaga (Tlalnepantla/MEX)

11:10 IL WE-18-05Is it possible to Manage any Cataract Case with Biaxial technique?L. Felipe Vejarano (Popayán/CO)

11:20 IL WE-18-06MICS with the Infiniti Vision SystemGeorge Beiko (St. Catharines/CDN)

11:30Discussion

Hall 6

13:00 - 14:30 WE-19

The Malpositioned IOL and IOL Implantation inEyes with Deficient Capsules

SymposiumCataract

Chairs:Srinivas Kamalakara Rao (Chennai/IND)Robert Stegmann (Pretoria/ZA)Ulrich Mester (Sulzbach/D)

13:00 IL WE-19-01Secondary IOL implantation in eyes with partial orcomplete capsular supportRobert Stegmann (Pretoria/ZA)

13:10 IL WE-19-02Iris fixation of IOLs in aphakic eyesTBA

13:20 IL WE-19-03Anterior chamber IOL placement in aphakic eyes –what to do and what not to doTBA

13:30 IL WE-19-04Scleral fixation of the IOL into the sulcus – techniques and pearlsSrinivas Kamalakara Rao (Chennai/IND)

13:40 IL WE-19-05Comparison of AC and scleral fixated IOLsTBA

13:50 IL WE-19-06Dealing with the malpositioned IOLTBA

14:00 IL WE-19-07Influence on optical quality on malpositioned IOLUlrich Mester (Sulzbach/D)

14:10 ILTechniques in retrieving and fixing a posterior dislocated IOLVincent Y. W. Lee (Hong Kong/CN)

14:20Discussion


Wed

nesd

ay, 9

June

226

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 7

08:30 - 10:00 WE-20

Assessing Structure and Function in Neuro-Ophthalmology


Chairs:Eberhart Zrenner (Tübingen/D)Daniel Mojon (St. Gallen/CH)Thomas R. Hedges (Boston/USA)

08:30 IL WE-20-01Using OCT for Neuro-ophthalmic disordersCarlos Mendoza (Ciudad de la Habana/C)

08:40 IL WE-20-02Using OCT and ERG to Distinguish Retinopathyfrom Optic NeuropathyThomas R. Hedges (Boston/USA)

08:50 IL WE-20-03What can a comparison of multifocal ERG and OCTresults tell us about the locus/nature of visual de-fects?TBA

09:00 IL WE-20-04Visual hallucinations: who, what, when, why?Francois Borruat (Lausanne/CH)

09:10 IL WE-20-05Chromatic pupillometry in patients with outerphotoreceptor disease: correlation with ERG andvisual fieldAki Kawasaki (Lausanne/CH)

09:20 IL WE-20-06Objective visual assessment along the visual pathway: optophysiology and electrophysiologyMichael Bach (Freiburg/D)

09:30Discussion

Hall 7

10:30 - 12:00 WE-21

Wavefront and Aberration. How to Optimize"Quality of Vision" in Contactology


Chairs:Tanja Schaefer (Curitiba/P)Berthold Seitz (Homburg/D)

10:30 IL WE-21-01Newton Kara José Lecture; Keratoconus. Contactlenses and cross-linkingCleusa Coral-Ghanem (Joinville/BR)

10:40 IL WE-21-02The corneal aberrometry and contact lensTanja Schaefer (Curitiba/P)

10:50 IL WE-21-03Wavefront in Presbyopia and Contact LensesNilo Holzchuh (São Paulo/BR)

11:00 IL WE-21-04Wavefront. What equipment?Paulo Ricardo (Goiania/BR)

11:10 IL WE-21-05Corneal Topography and Abberometer Measurement in RGP Lens WearNaoyuki Maeda (Osaka/J)

11:20 IL WE-21-06Thirty Years of Follow Up and the New PossibilitiesUsing the WavefrontAri de Souza Pena (Niteroi/BR)

11:30Discussion

Hall 7

13:00 - 14:30 WE-22

Update on Safety and Efficacy of Contact Lens Solutions


Chairs:Gary Foulks (Louisville/USA)Nilo Holzchuh (São Paulo/BR)Thomas Kaercher (Heidelberg/D)

13:00 IL WE-22-01Solution compatibility with silicone lensesEbru Toker (Istanbul/TR)


Wed

nesd

ay, 9

June

227


ient

ific P

rogr

am S

ched

ule

WOC® 2010

09:00 IL WE-23-05How to prevent the complications of proton beamirradiation of the ocular surfaceLeonidas Zografos (Lausanne/CH)

09:10 IL WE-23-06Retinal complications of brachytherapy and protonbeam irradiation: dosage and irradiation fieldMichael H. Foerster (Berlin/D)

09:20 IL WE-23-07The treatment of persisting serous retinal detachment due to irradiationBertil D. Damato (Liverpool/UK)

09:30 IL WE-23-08Radiation optic neuropathy: if prevention failsRaffaele Parrozzani (Padova/I)

09:40 IL WE-23-09Thoughts on Management of Radiation MacularEdemaCarol L. Shields (Philadelphia/USA)

09:50Discussion

Hall 8

10:30 - 12:00 WE-24

Tumors of the Retina and Retinal Pigment Epithelium

SymposiumOncology

Chairs:Brenda L. Gallie (Toronto/CDN)Laurence Desjardins (Paris/F)Nikolaos E. Bechrakis (Innsbruck /A)

10:30 IL WE-24-01Genetics and diagnosis of retinoblastomaLaurence Desjardins (Paris/F)

10:40 IL WE-24-02Retinoblastoma in developing countriesVikas Khetan (Tamil Nadu/IND)

10:50 IL WE-24-03Optimizing radiotherapy of retinoblastomaNorbert Bornfeld (Essen/D)

11:00 IL WE-24-04Systemic chemotherapeutic protocols inretinoblastomaJohn Hungerford (London/UK)

13:10 IL WE-22-02Contact lens disinfection compliance in BrazilPaulo Ricardo (Goiania/BR)

13:20 IL WE-22-03Update on contact lense disinfection systems inUSABruce H. Koffler (Lexington/USA)

13:30 IL WE-22-04Contact lens disinfection system performance inJapanRioji Yanai (Yamaguthi/J)

13:40 IL WE-22-05Role of osmolarity in contact wear and careMichael A. Lemp (Lake Wales/USA)

13:50 IL WE-22-06Corneal infections related to Contact LensesYoshikazu Shimonura (Osakasayama-shi/J)

14:00 IL WE-22-07Influence of Cosmetics and Cleansing Products forthe Eyes on Soft Contact LensesJunko Tsukiyama (Wakayama/J)

14:10Discussion

Hall 8

08:30 - 10:00 WE-23

OOG Symposium: Complications of Ocular Irradiation: Prevention and Treatment

SymposiumOncology

Chairs:Tero Kivelä (Helsinki/FIN)John Hungerford (London/UK)Laurence Desjardins (Paris/F)

08:30 IL WE-23-01Pathology of radiation induced ocular complicationsStefan Seregard (Stockholm/S)

08:40 IL WE-23-02Complications of direct ocular irradiation: the clinical scenarioArun D. Singh (Cleveland/USA)

08:50 IL WE-23-04The eye as an indirect target of orbital and periorbital irradiationEdoardo Midena (Padova/I)

228W

edne

sday

, 9 Ju

ne


Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

14:00 IL WE-25-07Elevating the priority of Eye Care within WHOAla Alwan (Geneve/CH)

14:10Discussion

Hall 9

08:30 - 10:00 WE-26

Management of the Ruptured Eye


Chairs:Ferenc Kuhn (Birmingham/USA)Wolfgang F. Schrader (Nürnberg/D)

08:30 IL WE-26-01VideoPeter Szurman (Tübingen/D)

08:40 IL WE-26-02VideoFerenc Kuhn (Birmingham/USA)

08:50 IL WE-26-03VideoCesare Forlini (Ravenna/I)

09:00 IL WE-26-04Video: Combined pars plana vitrectomy and artifi-cial iris diaphragm implant after globe ruptureTommaso Rossi (Rome/I)

09:10 IL WE-26-05Video: Ab interno' intravitreal suturing of a largetraumatic scleral perforation at the posterior poleJörg Christian Schmidt (Duisburg/D)

09:20 IL WE-26-06Panel discussion on cases presented by the moderatorsFerenc Kuhn (Birmingham/USA)

11:10 IL WE-24-05Intraarteral chemotherapy in retinoblatoma: ProDavid H. Abramson (New York/USA)

11:20 IL WE-24-06Intraarteral chemotherapy in retinoblatoma: ContraBrenda L. Gallie (Toronto/CDN)

11:30 IL WE-24-07RPE and ciliary epithelium tumorsLeonidas Zografos (Lausanne/CH)

11:40 IL WE-24-08Retinal vascular tumorsNikolaos E. Bechrakis (Innsbruck/A)

11:50Discussion

Hall 8

13:00 - 14:30 WE-25

The New Realities of Non-Governmental Development in 2010 and Beyond

SymposiumWorld Forum of Prevention of Blindness

Chairs:Kathy Spahn (New York/USA)Christian Garms (Bensheim/D)Gullapali N. Rao (Hyderabad/IND)

13:00 IL WE-25-01Introduction, and Fundraising in the New DecadeKathy Spahn (New York/USA)

13:10 IL WE-25-02The Need to Reach Beyond the Eye Care World andPartner with Other InitiativesGullapali N. Rao (Hyderabad/IND)

13:20 IL WE-25-03Partnering with Disability InitiativesJohannes Trimmel (Vienna/A)

13:30 IL WE-25-04Partnering with Infectious Disease InitiativesDanny Haddad (Decatur/USA)

13:40 IL WE-25-05Partnering with Chronic Disease InitiativesHugh R. Taylor (Carlton/AUS)

13:50 IL WE-25-06Partnering with Poverty Alleviation Initiatives andthe MDGsHuck Holz (Santa Clara/USA)

Wed

nesd

ay, 9

June

229

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 9

10:30 - 12:00 WE-27

ISOT Symposium: Ocular Traumatology: The Basics

SymposiumTrauma

Chairs:Ferenc Kuhn (Birmingham/USA)Wolfgang F. Schrader (Nürnberg/D)David Pelayes (Buenos Aires/RA)

10:30 IL WE-27-01Counseling and DiagnosticsFerenc Kuhn (Birmingham/USA)

10:40 IL WE-27-02How to exercise for trauma surgery on the animaleyeSiegfried Priglinger (Linz/A)

10:50 IL WE-27-03Primary anterior segment surgeryFrank Wilhelm (Schwerin/D)

11:00 IL WE-27-04Prevention and treatment of posttraumatic endophthalmitisDavid Pelayes (Buenos Aires/RA)

11:10 IL WE-27-05Primary and secondary posterior segment surgeryWolfgang F. Schrader (Nürnberg/D)

11:20 IL WE-27-06Pole to pole surgeryCesare Forlini (Ravenna/I)

11:30 IL WE-27-07Ocular tension variations in trauma injuriesGiampaolo Gini (Prato/I)

11:40Discussion

Hall 9

13:00 - 14:30 WE-28

Minisymposium: Ocular Trauma Caused by Warand Terrorist Attacks


Chairs:Ferenc Kuhn (Birmingham/USA)Adiel Barak (Tel-Aviv/IL)Hassan Mortada (Cairo/ET)

13:00 IL WE-28-01Ophthalmic combat injuries in the German sectorof Northern Afghanistan 2003-2009, Managementand outcomeHermann O. C. Gümbel (Ulm/D)

13:10 IL WE-28-02Management of war and terror related eye injurieson the British mainland and in her theatres of warRobert A. Scott (Birmingham/UK)

13:20 IL WE-28-03Treating concept for mass casualties in RussiaErnest V. Boiko (Sankt Petersburg/RUS)

13:30 IL WE-28-04Experience from Terror attacks in IndiaS. Natarajan (Mumbai/IND)

13:40 IL WE-28-05Experience from war and terror related eye injuriesin EgyptHassan Mortada (Cairo/ET)

13:50 IL WE-28-06Management of eye injuries after terror attacks inIsraelAdiel Barak (Tel-Aviv/IL)

14:00 IL WE-28-07Terror related open-globe injuries in turkeyGüngör Sobaci (Ankara/TR)

14:10 IL WE-28-08ConclusionFerenc Kuhn (Birmingham/USA)


Wed

nesd

ay, 9

June

230

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Hall 10

10:30 - 12:00 WE-29

SPRV Symposium: Update on Pediatric Retina

SymposiumRetina

Chairs:J. Fernando Arevalo (Caracas/Y)José Roca (Lima/PE)Lihteh Wu (San Jose/CR)

10:30 IL WE-29-01Vitreo-Retinal Surgery in Children with UveitisJ. Fernando Arevalo (Caracas/Y)

10:40 IL WE-29-02Coat’s DiseaseJosé Roca (Lima/PE)

10:50 IL WE-29-03Familial exudative vitreoretinopathyLihteh Wu (San Jose/CR)

11:00 IL WE-29-04Small-gauge Vitrectomy for Pediatric Retinal DetachmentAndres Kychenthal (Vitacura/RCH)

11:10 IL WE-29-05Stage 5 retinopathy of prematurity: then and nowMichael T. Trese (Royal Oak/USA)

11:20 IL WE-29-06Anti-angiogenics in ROPHugo Quiroz-Mercado (Mexico City/MEX)

11:30 IL WE-29-07Plasmin enzyme-assisted vitreoretinal surgery incongenital X-linked retinoschisisKimbely A. Drenser (Royal Oak/USA)

11:40 IL WE-29-08Choroidal Neovascularization in ChildrenAudina Berrocal (Miami/USA)

11:50Discussion

Hall 10

13:00 - 14:30 WE-30

Panel Discussion – The Teaching of Uveitis at Residency Level and Fellowships

PanelUveitis, Intraocular Inflammation

Chairs:Philip I. Murray (Birmingham/UK)Ronald E. Smith (Los Angeles/USA)Jyotirmay Biswas (Chennai/IND)

13:00 IL WE-30-01Education in BrasilCristina Mucchioli (Brooklyn/USA)

13:15 IL WE-30-02Education in JapanShigeaki Ohno (Sapporo/J)

13:30 IL WE-30-03Education in IndiaJyotirmay Biswas (Chennai/IND)

13:45 IL WE-30-04Education in USARonald E. Smith (Los Angeles/USA)

14:00 IL WE-30-05Education in UKPhilip I. Murray (Birmingham/UK)

14:15 IL WE-30-06Education in GermanyChristoph M. E. Deuter (Tübingen/D)

Roof Garden

11:30 - 13:00 WE-31

Awards and Fundings (list of the awards available at page 18)

Bestowal of the Honorary Membership of the DOG to Prof. Petja Ivanova Vassileva, Bulgaria

Handover of DOG Presidency to Prof. Thomas Reinhard, Freiburg

Photo Shooting Award Winners


Wed

nesd

ay, 9

June

231


ient

ific P

rogr

am S

ched

ule

WOC® 2010

13:00 FP WE-16-01Diabetic Eye Disease in the Pacific: a problem de-manding attention nowKonstanze Fischer-Harder, Garry Brian, Jaqueline Ramke, Louise Maher, Biu Sikivou, John Szetu (Suva/FJI)

13:07 FP WE-16-02Cataract surgical outcomes during micro surgicaltraining in ChinaGuan Chunhong , Richard LeMesurier, Andreas Mueller (South Melbourne/AUS, Nanchang City/CN)

13:14 FP WE-16-03AGENT (Afro-German-Eye-Net) Program for Continuous Medical Education of Ophthalmolo-gists in AfricaMartin M. Nentwich, Michaela Wilke, Katrin Winter,Ulrich C. Schaller, Anselm Kampik, Volker Klauss(Munich/D)

13:21 FP WE-16-04Rapid assessment of avoidable blindness in theOccupied Palestinian Territories (East Jerusalem,West Bank and Gaza) – a population-based survey.Far Chiang, Hannah Kuper, Robert Lindfield, Tiarnan Keenan, Na'el Seyam, Denise Magauran,Nasrallah Khalilia, Habes Batta, Ziad Abdeen,Nicholas Sargent (London/UK, Northolt/UK)

13:28 FP WE-16-06Developing international research capacity for VISION 2020.Robert Lindfield, Shaheen Shah, Clare Gilbert (London/UK)

13:35 FP WE-16-07Ongoing Community Eye Health Status of the People Affected with Leprosy in some of the SARCCountriesSwapan K. Samanta (Tamluk/IND)

13:42 FP WE-16-08Prevalence of low vision amongst students attending all the Schools for the blind in OyoState, Nigeria, and the need for visual aids.Adedamola Mosuro (Lagos/WAN)

13:49 FP WE-16-09Ophthalmic subspecialization in Ibadan, WestAfricaTunji Oluleye, Benedictus Ajayi, Adeyinka Ashaye,Ronke Baiyeroju, Ayotunde Ajaiyeoba, Charles Bekibele, Oluyemi Fasina, Bolutife Olusanya, Bade Ogundipe, Olufunmi Ogun, Sola Olawoye,Olutoke Ayorinde (Ibadan/WAN)

13:56Discussion

ICC Lounge

08:30 - 10:00 WE-15

Ocular Drug Delivery to the Posterior Segment


Chairs:Ulrich Schraermeyer (Tübingen/D)Francine Behar (Paris/F)Jane Farrar (Dublin/IRL)

08:30 IL WE-15-01Transport of intravitreally injected proteinsthrough the retinaUlrich Schraermeyer (Tübingen/D)

08:40 IL WE-15-02Non-viral ocular gene therapyFrancine Behar (Paris/F)

08:50 IL WE-15-03Aspects of ocular gene therapy work with siRNAJane Farrar (Dublin/IRL)

09:00 IL WE-15-04Transporter and receptor targeted drug delivery tothe retinaAshim K. Mitra (Kansas City/USA)

09:10 IL WE-15-05Drug delivery platforms, drug sensorsMark Humayun (Los Angeles/USA)

09:20 IL WE-15-06Drug Transporters in Corneal Epithelium and Retinal Pigment Epithelial Cells: Potential Role inDrug DeliveryArto Urtti (Helsink/FIN)

09:30Discussion

ICC Lounge

13:00 - 14:30 WE-16

Vision 2020 – Prevention of Blindness 2

Free PaperVision 2020 – Prevention of Blindness

Chairs:Abdulaziz AlRajhi (Riyadh/SA)Akef El-Maghraby (Jeddah/SA)Bruce E. Spivey (San Francisco/USA)

232W

edne

sday

, 9 Ju

ne


Scie

ntifi

c Pro

gram

Sch

edul

e

WOC® 2010

Room 43

10:30 - 12:00 WE-39


Free PaperGlaucoma

Chairs:Claude Burgoyne (Portland/USA)Karin Hornykewycz (Dresden/D)

10:30 FP WE-39-01Drainage of the anterior and vitreous chamberwith Ahmed glaucoma valve in uncontrolled pediatric and adult glaucomaRoman Troyanovsky, Oleg Sinyavsky, SvetlanaSolonina, Julia Antipova, Alexandr Golovin (St-Petersburg/RUS)

10:37 FP WE-39-02Canaloplasty as alternative to goniotrepanationand deep sclerectomy – clinical experienceMaren Klemm, Claudia Rebel, Johannes Steinberg,Mario Matthaei (Hamburg/D)

10:44 FP WE-39-03Tabeculectomy without suturing the conjuntivaJosef Weindler (Esslingen/D)

10:51 FP WE-39-04Longtime Efficiency of Combined Cataract-Surgeryand Excimer-Laser-Trabeculotomy in GlaucomaSurgery – 12 month resultsMarc Töteberg-Harms, Peter Paul Ciechanowski,Cornelia Hirn, Jens Funk (Zurich/CH)

10:58 FP WE-39-05Effect of Selective-Laser-Trabeculoplasty (SLT) onocular hemodynamics in glaucomaKarin Hornykewycz, Eberhard Spoerl, Richard Stodtmeister, Lutz E. Pillunat (Dresden/D)

11:05 FP WE-39-06Clinical study on Ahmed glaucoma valve implanta-tion for 12 eyes with glaucoma after vitrectomyHong-Ping Cui, Xin-Rui Gao, Qian Li, Xin Liao, Fang Wang (Shanghai/CN)

11:12 FP WE-39-07One-site versus two-site fornix based phacotrabeculectomy in patients with cataractand pseudoexfoliative glaucomaZdravko Mandic, Mia Zoric Geber, Katia Novak Laus,Ivanka Petric Vickovic (Zagreb/HR)

Room 42

13:00 - 14:30 WE-38

Breaking News in Retina

SymposiumRetina, Vitreous

Chairs:Rajvardhan Azad (New Delhi/IND)Paul Mitchell (Sydney/AUS)Peter K. Kaiser (Cleveland/USA)

13:00 IL WE-38-01VEGF Trap-Eye for Diabetic Macular Edema: The DA VINCI StudyDiana Do (Baltimore/USA)

13:15 IL WE-38-02Efficacy and safety of intravitreal ranibizumab asadjunctive therapy to laser photocoagulation or as monotherapy in diabetic macular edema: 12-month results from the RESTORE studyPaul Mitchell (Sydney/AUS)

13:30 IL WE-38-03The phase 1 results of KH902 a improved version of VEGF TrapPeter K. Kaiser (Cleveland/USA)

13:45 IL WE-38-04Epimacular Brachytheryp in the treatment of exsudative age-related macular degnerationPravin Dugel (Phoenix/USA)

14:00 IL WE-38-05Pfizer A5751013 Trial, A Phase 2/3 Randomized, Controlled, Double-Masked, Multi-Center, Comparative Trial, in Parallel Groups, Compares the Safety and Efficacy of Intravitreous Injectionsof 0.3 mg Pegaptanib Sodium (Macugen®), Given as Often as Every 6 Weeks for 2 years, toSham Injections, in Subjects with Diabetic Macular Edema (DME).Frank G. Holz (Bonn/D)

14:15 IL WE-38-06Pascal Laser in DME Pain vs. PerformanceRajvardhan Azad (New Delhi/IND)

Wed

nesd

ay, 9

June

233

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

11:19 FP WE-39-08Posterior chamber aspiration as an adjuvant of intravitreal bevacizumab for the treatment of decompensated neovascular glaucomaWalter Noske, Hermann Burau (Brandenburg/D)

11:26 FP WE-39-09Safety and efficacy of topical bevacizumab in theearly bleb failure after trabeculectomyTomasz Zarnowski, Justyna Klos-Rola, Maria Tulidowicz-Bielak, Anselm Jünemann(Lublin/PL, Erlangen/D)

11:33 FP WE-39-10The result of management in primary angle closure glaucoma for Indonesian’s eyesIkke Wiyogo (Jakarta/RI)

11:40Discussion

Room 44

08:30 - 10:00 WE-40

Epidemiology

Free PaperEpidemiology

Chairs:Paul Mitchell (Sydney/AUS)Susanne Pitz (Mainz/D)

08:30 FP WE-40-01Ocular manifestations of Fabry’s disease: an update from the Fabry Outcome Survey with focuson longitudinal and pediatric dataSusanne Pitz, Andrea Sodi, Pauline Wilson, Roberto Ebner, Roberto Ebner, Gere Sunder-Plassmann (Mainz/D)

08:37 FP WE-40-02Regional Differences in Rates of Exfoliation Syndrome Throughout the United StatesJoshua D. Stein, Nidhi Talwar, Julia E. Richards,Denise S. Kim, David M. Reed, Bin Nan, Jae Hee Kang, Janey L. Wiggs, Louis Pasquale (Ann Arbor/USA)

08:44 FP WE-40-03Agricultural pesticide use and childhood orbitalmalignant tumorJayanta Das (Guwahati/IND)

08:51 FP WE-40-04Prevalence and risk factors of undercorrected refractive errors among Singaporean Malay adults:the Singapore Malay Eye StudyMohamad Rosman, Tien Yin Wong, Wan Ting Tay,Louis Tong, Seang Mei Saw (Singapore/SGP)

08:58 FP WE-40-05High Coverage with Azithromycin and effect on Trachoma and C. trachomatis infection inmesoendemic villages in TanzaniaSheila West (Baltimore/USA)

09:05 FP WE-40-06Retinal Detachment after Phaco Cataract Extraction with posterior capsular defektUlrich Giers (Detmold/D)

09:12 FP WE-40-07Identifying the content for a novel vision-relatedquality of life questionnaire for visually impairedchildren and young peopleValerie Tadic, Sarah Keeley, Gillian Lewando-Hundt,Jugnoo Rahi (London/UK, Coventry/UK)

09:19 FP WE-40-08The Incidence of Neonatal Endophthalmitis in theUnited States May Be DecliningAndrew Moshfeghi, Resmi Charalel, Tina Hernandez-Boussard, John Morton, Darius Moshfeghi (Palm Beach Gardens/USA)

09:26 FP WE-40-09Australian National Survey of Diabetic Retinopathy Management by General Practitioners and OptometristsDaniel Ting, Joshua Yuen, Antony Clark, Jonathan Ng, Nigel Morlet, Hugh Taylor, David Preen (Perth/AUS)

09:33 FP WE-40-10Complicated diabetic retinopathy among EgyptianpatientsKhaled G. Abu El Einen, Hany Hamed El Defrawy El Defrawy, hany elmekawey, Yasser Sayed Saif Saif,Mahmoud Gamal Elboraey Elboraey, Hoda IbrahimRizk Rizk (Giza/ET)

09:40Discussion


Wed

nesd

ay, 9

June

234

WOC® 2010

Scie

ntifi

c Pro

gram

Sch

edul

e

Room 44

10:30 - 12:00 WE-41

Neuro-Ophthalmology 2

Free PaperNeuro-Ophthalmology

Chairs:Anthony C. Arnold (Los Angeles/USA)Eberhart Zrenner (Tübingen/D)

10:30 FP WE-41-01Juvenile pilocytic astrocytomas do not undergospontaneous malignant transformationCameron F. Parsa (Baltimore/USA)

10:37 FP WE-41-02Charles Bonnet syndrome in a Low Vision depart-mentHeike Elflein, Susanne Pitz (Mainz/D)

10:44 SL WE-41-03Restoration of vision: restoration hot spots inhemianopia after stroke are influenced by localtopographic interactionsBernhard A. Sabel, Iris Mueller, Markus Preuss, Fred Wolf, Tobias Guenther (Magdeburg/D)

10:53 FP WE-41-04Clinical analysis of empty sella syndrome with visual disturbanceLI Juanjuan (Kunming/CN)

11:00 FP WE-41-05Pulfrich Pendulum Phenomenon in Patients with aDemyelinating Optic NeuropathyJoana Ferreira, Luís Abegão Pinto, Duarte Amado,João Paulo Cunha (Lisboa/P)

11:07 FP WE-41-06Clinical features of acute & subacute optic neuri-tis/ perineuritis in Hong Kong Chinese patientsChing Yan Noel Chan (Hongkong/HK)

11:14 FP WE-41-07Proportion and Characteristics of DyschromatopsiaAmong Glue SniffersEmil Sjahreza, Muhammad Sidik (Jakarta/RI)

11:21 FP WE-41-08Spectrum of neuro-ophthalmic diseases and challenges encountered in an indigenous blackpopulation in West-Africa: A tertiary hospital-based review.Olufunmilola A. Ogun, Benedictus Ajayi, CharlesBekibele, Ayotunde Ajaiyeoba (Northampton/UK,Ibadan/WAN)

11:28 FP WE-41-09Sildenafil Citrate Therapy for Pulmonary ArterialHypertension: Ocular Safety AssessmentBarbara Wirostko, Charles Tressler, Lie-Ju Hwang,Gary Burgess, Alan M. Laties (New York/USA)

11:35Discussion

Salon 19

08:30 - 18:00 WE-42

IUSG Workshop: Diagnostic Criteria of Virus-Induced Anterior Uveitis

SymposiumUveitis

Chairs:Soon Phaik Chee (Singapore/SGP)Jolanda de Groot (Utrecht/NL)Aniki Rothova (Utrecht/NL)Bahram Bodaghi (Paris/F)Philip Murray (Birmingham/UK)Manfred Zierhut (Tübingen/D)

09:00 – 10:30CMV

10:45 – 12:15VZV

13:30 – 18:00Planning of the Validation Study for all 3 Viruses

In case of interest please contact Phil Murray:[email protected]

The first part of the workshop will take place onTuesday, 8 June 8:30 to 18:00.


Wed

nesd

ay, 9

June

235

Secretariatc/o Congress CorporationKohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo 102-8481, JapanPhone: +81-3-5216-5551 Fax: +81-3-5216-5552 E-mail: [email protected]

President

Tetsuro Oshika, M.D.Professor and Chairman, Department of OphthalmologyInstitute of Clinical Medicine, University of Tsukuba

WOC2014Tokyo

XXXIV International Congress of Ophthalmology

World Ophthalmology Congress 2014 Tokyo

Venue: Tokyo International Forum / Imperial Hotel TokyoApril 2 6, 2014

www.woc2014.org

Courses an Wetlabs

WOC® 2010 237

23rd INTERNATIONAL CONGRESS OF GERMAN OPHTHALMIC SURGEONS

October 21st – 24th, 2010Congress Center Hamburg

FREE PAPER SESSION*

SCIENTIFIC POSTERS/ePOSTERS*

SURGICAL FILMS*

23rd International Congress of German Ophthalmic Surgeons, Congress Center Hamburg, October 21st - 24th, 2010

Name

Street

Country/Zip Code/City

Phone Fax

E-Mail

Please send me: a Preliminary Program

MCN Medizinische Congress-organisation Nürnberg AGNeuwieder Str. 990411 NÜRNBERGGERMANY

Organizer / Registration: MCN Medizinische Congressorganisation Nürnberg AG Neuwieder Str. 9, 90411 Nürnberg, Germany Phone: ++49/911/3931639, FAX: ++49/911/3931620, E-Mail: [email protected]

VIDEO LIVE SURGERY OCTOBER 21ST AND 22ND, 2010

MAIN TOPICS(Simultaneous translationEnglish - German)

Honorary Lectures

Cataract surgery

DOC – ISRS / AAO Symposium

Glaucoma surgery

Vitreoretinal surgery

Corneal surgery

Orbita, lacrimal and lid surgery

Forum Eye surgery in the developing countries

*DEADLINE June 15th, 2010

www.doc2010.de

Satu

rday

, 5 Ju

ne

Cour

ses a

nd W

etla

bs

239WOC® 2010

Sao Paulo

08:30 - 10:00 WOC-AAD-C-01

Differential Diagnosis of Macular Diseases

Chair: Gabriele E. Lang (Ulm/D)

Speakers: Arnd Gandorfer (Munich/D), Gabriele E. Lang(Ulm/D), Peter Walter (Aachen/D)

Course fees: 50 c / 75 c

Assessment and diagnosis of macular diseases ac-cording to clinical, angiographic, and OCT-findingswith practical guidelines for patient work-up andmanagement.

The exact diagnosis of macular diseases is impor-tant for decisions concerning treatment and prog-nosis. The differential diagnosis of maculardiseases however, is difficult. The most commonclinical findings, characteristica angiographic fea-tures, and OCT-findings of macular dystrophiesand different macular degenerations will be pre-sented. Besides the classical macular dystrophiesand age-related macular degeneration, which candisplay a highly variable image, more rare maculardiseases will also be addressed. The course will endwith an interactive macula quiz of particularly in-teresting cases.

08:30Age-related Macular DegenerationGabriele E. Lang (Ulm/D)

08:50Macular DystrophiesPeter Walter (Aachen/D)

09:10Different Macular DiseasesArnd Gandorfer (Munich/D)

09:30Interactive Macula QuizAll speaker

09:50Discussion

Sao Paulo

10:30 - 12:00 WOC-AAD-C-02

Glaucoma without High Pressure – Normal-Tension Glaucoma

Chair: Thomas S. Dietlein (Düsseldorf/D)

Speakers: Thomas S. Dietlein (Düsseldorf/D), Detlev Spiegel(Augsburg/D)


Optimisation of the diagnostics and treatment ofnormal pressure glaucoma.In this course the important pathomechanisms,which cause damage in normal-tension glaucomawill be explained so that the practising ophthal-mologist can take the necessary diagnostic stepsand start the necessary treatment. An extensivemedical history as well as a well-directed examina-tion on the slit-lamp already displays the mostvital information. Which additional information isnecessary and when it is necessary, as well aswhere such examinations take place, will be covered. When, how intensely, and in which ways intraocu-lar pressure should be lowered, and which addi-tional treatment options exist will also beexplained. Particularly the significance of vasoac-tive substances will be discussed. Examples of clini-cal cases will be presented and discussed.

Sao Paulo

14:00 - 15:30 WOC-AAD-C-03

Diabetic Retinopathy

Chair: Anselm Kampik (Munich/D)

Speakers: Anselm Kampik (Munich/D), Klaus-Dieter Lemmen(Düsseldorf/D), Michael W. Ulbig (Munich/D)


Teaching standardised treatment options accord-ing to ETDRS criteria

A presentation pathogenesis and stage classifica-tion of diabetic maculopathy with a diagnosis forlaser treatment with different laser wavelengths,followed by a discussion of the effects of risk fac-tors like pregnancy and high blood pressure, andthe assessment of intensified diabetes management with insulin pump or pancreastransplant, as well as a critical discussion of medic-inal treatment.


Satu

rday

, 5 Ju

ne

Cour

ses a

nd W

etla

bs240 WOC® 2010

Sao Paulo

16:00 - 17:30 WOC-AAD-C-04

Optic Disc Elevation – Differential Diagnosis andWork Up

Chair: Jan Schroeter (Berlin/D)

Speakers: Klaus Rüther (Berlin/D), Jan Schroeter (Berlin/D)


Swelling of the optic disc can have different causes.Besides an elevated intracranial pressure optic discdrusen, inflammatory and ischemic processes haveto be thought of. Hyperopia and a reduced disc sizeor tilted disc can also be causative. The morpholog-ical appearance of the optic nerve is mostly notspecific for the underlying causes, so functionaltesting and often cerebral imaging is necessary.The course will give an overview of differentpathologies leading to a swelling of the optic disc.Strategies to obtain the correct diagnoses and thenecessity and order of different examinations (e.g.CT, MRI, lumbar puncture) will be discussed.The most common diseases leading to a swellingof the optic disc will be presented in detail includ-ing ischemic anterior optic neuropathy, both thearteritic and non arteritic form, neuritis nervi optici, optic disc drusen, chronic and acute papilledema, compressive optic neuropathy, tumors of the optic nerve.The course is intended for ophthalmologist interested in neuroophthalmology and the differential diagnoses of optic disc swelling.

Room Istanbul

08:30 - 10:00 WOC-C-05

WetLab Refractive Surgery 1

Chair: Thomas Kohnen (Frankfurt/D)

Speakers: Ekkehard Fabian (Rosenheim/D), Jürgen Kamp-meier (Ulm/D), Thomas Kohnen (Frankfurt/D),Carlo Lackerbauer (Munich/D), Walter Sekundo(Marburg(D)


The surgical techniques (LASIK, PRK, LASEK, Epi-LASIK, phaco IOLs, Intacs, AK+ LRI) will be demonstrated in the KRC-Wet-Labs and the partici-pants will be able to practise them on pig eyes.

Room Istanbul

10:30 - 12:00 WOC-C-06

Wetlab Refractive Surgery 2

Chair: Gernot I. W. Duncker (Halle/D)

Speakers: Gernot I. W. Duncker (Halle/D), Bettina Jendritza(Mannheim/D), Markus Kohlhaas (Dortmund/D),Christopher Wirbelauer (Frankfurt/D)


The surgical techniques (LASIK, PRK, LASEK, Epi-LASIK, phaco IOLs, Intacs, AK+ LRI) will be demonstrated in the KRC-Wet-Labs and the partici-pants will be able to practise them on pig eyes. The emphasis is on the practical exercises in refractive techniques.

Room Istanbul

2010, 14:00 - 15:30 WOC-C-07

Wetlab: Endotamponades in Vitreoretinal Surgery –An Introduction to Beginners

Chair: Gisbert Richard (Hamburg/D), Borja Corcostegui(Barcelona/E), David S. H. Wong (Hong Kong/HK)

Speakers: Borja Corcostegui (Barcelona/E), Gisbert Richard(Hamburg/D), Lars Wagenfeld (Hamburg/D), DavidS. H. Wong (Hong Kong/HK)


The subject of this course is the handling of differ-ent endotamponades (gases, oils, and heavy liq-uids). The focus lies on practical Wet-Lab exerciseson pig eyes. This course is aimed at colleagues whoare familiar with the basics of vitrectomy, yet havelittle or no practical experience in the use of endo-tamponades.

GasendotamponadesGisbert Richard (Hamburg/D)

Heavy fluidesBorja Corcostegui (Barcelona/E)

SiliconoilLars Wagenfeld (Hamburg/D)

Heavy SiliconoilDavid S. H. Wong (Hong Kong/HK)


Satu

rday

, 5 Ju

ne

Cour

ses a

nd W

etla

bs

241WOC® 2010

Room Istanbul

16:00 - 17:30 WOC-C-08

Wetlab Surgical Measurement in the Early Phaseof Chemical and Thermal Eye Burns

Chairs: Hans Gert Struck (Halle/D), Laszlo Kiraly (Halle/D),Norbert Franz Schrage (Cologne/D)

Speakers: Norbert Franz Schrage (Cologne/D), Hans GertStruck (Halle/D)


Aim:Studying the management of surgical complica-tions with regards to early therapy followingmedium and severe chemical and thermal burns.Ophthalmologists should reach a high standard ofquality in these fundamental techniques.

Content:There will be exercises in the mechanical cleansingand rinsing of pig eyes with lime corrosion, fol-lowed by training in the surgical techniques ofperidotomy, peridectomy, necrosis excision, Tenon-plastic, amnioplasty, and keratoplasty according toPutschkowskaja. These fundamental techniques ofsurgical treatment will be practised on isolatedrabbit eyes and orbitae. Diagnosis and implemen-tation of these surgical techniques in new scientifi-cally founded concepts of early and follow-uptherapy of ocular chemical and thermal burns willbe discussed. This will be based on the longstand-ing clinical and research experience of the Halleand Aachen teaching hospitals.

Physiopathology of eye burns, Modulation of the biological reaction by antiinflammatory andsurgical therapyHans Gert Struck (Halle/D)

Mechanism and prognostic evaluation of corro-sives, Prognostic value of eye burns classificationNorbert Franz Schrage (Cologne/D)

Strategies in therapyHans Gert Struck, Norbert Franz Schrage (Halle/D, Cologne/D)

Salon 11/12

08:30 - 10:00 WOC-AAD-C-09

Corneal Degeneration / Dystrophy

Chair: Hans Eberhard Völcker (Heidelberg/D)

Speakers: Gerhard K. Lang (Ulm/D), Hans Eberhard Völcker(Heidelberg/D)


Clinical diagnosis and differential diagnosis ofcorneal dystrophies and corneal degenerations,taking into account histopathological findings aswell as genetic and treatment related aspects

Corneal degenerations can be a symptom of thegeneric ageing process or appear in combinationwith specific conditions. In particular these cornealtransformations, including the marginal ulcer, theirmorphology and treatment will be covered. As opposed to the degenerative transformations,which take place without any genetic predisposi-tion and increasingly apply to old age, the term'corneal dystrophy' includes hereditary, symmetric,and bilateral conditions, which occur both in iso-lated form as well as in combination with other systemic conditions. The epithelial, stromal, andendothelial dystrophies will be presented with particular attention paid to the clinical differentialdiagnosis, which takes genetic, morphological, andtreatment aspects into account.

Hall 9

10:30 - 12:00 WOC-C-10

Evidence-Based Ophthalmology – How to Get Itand How to Use It

Chairs: Richard Wormald (London/UK), Gianni Virgili (Florence/I)

Speakers: Jennifer Burr (Aberdeen/UK), David Friedman (Baltimore/USA), Iris Gordon (London/UK), Gianni Virgili (Florence/I), Richard Wormald (London/UK)


10:30EBM and EBO IntroductionRichard Wormald (London/UK)



WOC® 2010

Satu

rday

, 5 Ju

ne

Hall 9

16:00 - 17:30 WOC-C-12

Advanced Biaxial Microphaco and Coaxial Phaco /Microphaco Techniques in Challenging (White andSuprahard) Cataracts: A Video Course

Chair: Arup Chakrabarti (Trivandrum/IND)

Speakers: Amar Agarwal (Chennai/IND), Jorge L. Alió (Alicante/E), Arup Chakrabarti (Trivandrum/IND),Sri Ganesh (Bangalore/IND), Boris Malyugin(Moscow/RUS), Som Prasad (Wirral/UK)


Description: Biaxial micro incision cataract surgery, as well as coaxial microphacoemulsification are fast becoming increasingly popular techniques to dealwith cataracts. These techniques have been foundto be effective in standard cataract situations. However, the application of these techniques canalso be extended to deal with difficult situationsincluding white and suprahard cataracts. Thisvideo based course will present a rationale approach for biaxial microphacoemulsification andcoaxial phaco /microphaco in challenging whiteand suprahard cataracts. Fluid dynamics, instru-mentation, basic surgical techniques, simple andpractical hints to overcome difficulties will be discussed.

Objective:Attendees will be able to perform standard phacoas well as biaxial / coaxial microphacoemulsifica-tion for challenging cataracts.

16:00Introduction and Problems to Anticipate in a Whiteand Suprahard CataractArup Chakrabarti (Trivandrum/IND)

16:05Review of Dyes to Stain the Anterior Capsule, theStaining Techniques and Capsulorhexis in Whiteand Suprahard CataractsArup Chakrabarti (Trivandrum/IND)

16:15Coaxial Phaco in White and Suprahard CataractsArup Chakrabarti (Trivandrum/IND)

16:25C-MICS with the Newer MachinesTBA

10:40How to get EBO - Searching, Filtering, Synthesizingand DisseminatingRichard Wormald, Iris Gordon (London/UK)

11:00How to Use it - in clinic and operating theatreDavid Friedman (Baltimore/USA)

11:10How to Use it - Policy and GuidelinesJennifer Burr (Aberdeen/UK)

11:20Diagnostic test accuracy reviewsGianni Virgili (Florence/I)

11:30Discussion

Hall 9

14:00 - 15:30 WOC-AAD-C-11

Crosslinking of the Cornea: When, How and Why?

Chair: Claus Cursiefen (Erlangen/D)

Speakers: Claus Cursiefen (Erlangen/D), Gerd Geerling (Würzburg/D)


Crosslinking of the cornea is a new emerging tech-nique for surgical treatment of keratoconus. Aim ofthis course to outline the current indications forcorneal crosslinking in patients with keratoconusand beyond, to explain the surgical treatment itselfand postoperative care of patients and fincally todiscuss complications and their prevention andmanagement. The participant should be confidentafterwards to deal with patients having undergonecrosslinking of the cornea.

242Co

urse

s and

Wet

labs


WOC® 2010 243

Satu

rday

, 5 Ju

ne

Hall 10

10:30 - 12:00 WOC-C-14

Management of Complex Glaucoma

Chairs: Gerd Geerling (Würzburg/D), Franz Grehn (Würzburg/D), Maya Müller (Lübeck/D)

Speakers: Gerd Geerling (Würzburg/D), Franz Grehn (Würzburg/D), Thomas Klink (Würzburg/D), Maya Müller (Lübeck/D), Manfred Zierhut (Tübingen/D)


This course presents the management of complexglaucoma situations such as congenital glaucomaand the combination of glaucoma and lens, cornea,and retina mutations. The secondary glaucoma inuveitis will be addressed separately. Alongside conservative therapy, indications for surgery, thequestion of single or double procedure surgery, aswell as further features of surgical procedures andaftercare, will be dealt with.

10:30Congenital GlaucomaFranz Grehn (Würzburg/D)

10:40Uveitis and GlaucomaManfred Zierhut (Tübingen/D)

10:50Cataract and GlaucomaThomas Klink (Würzburg/D)

11:00Retinal disease and GlaucomaMaya Müller (Lübeck/D)

11:10Keratoplasty and GlaucomaGerd Geerling (Würzburg/D)

16:35C-MICS/B-MICS with the Newer Machines (Signature) for White and Suprahard CataractsSri Ganesh (Bangalore/IND)

16:45B-MICS / C-MICS with the Newer Machines (Stellaris) in White and Suprahard CataractsBoris Malyugin (Moscow/RUS)

16:55Biaxial Microphaco and Microphaconit-700 micronCataract Surgery in White and Suprahard CataractsAmar Agarwal (Chennai/IND)

17:05Learning Pearls, Pitfalls and Complications in Biaxial Microphacoemulsification and Coaxial Microphaco in White and Suprahard CataractsSom Prasad (Wirral/UK)

17:15Newer Micro-incision IOLs for Bi-Axial/Co-Axial MicrophacoJorge L. Alió (Alicante/E)

Hall 10

08:30 - 10:00 WOC-C-13

The Aging Lid – Functional Effects and their Treatment

Chair: Karl-Heinz Emmerich (Darmstadt/D)

Speakers: Karl-Heinz Emmerich (Darmstadt/D), Gabriele M. Emmerich (Darmstadt/D), Hans-Werner Meyer-Rüsenberg (Hagen/D), Uwe Peter Press (Trier/D)


Age-related changes of the lid have numerousfunctional and aesthetic consequences. A series oflid changes can thus lead to malpositioning of the lid with a variety of implications for vision andwettability of the eye as well as the lacrimalglands. Causes, implications and the demonstration of therapeutic surgical measures are the core andfocus of this course. The psychosomatic aspectswill also be outlined and discussed.

Cour

ses a

nd W

etla

bs

Satu

rday

, 5 Ju

ne

Cour

ses a

nd W

etla

bs244 WOC® 2010

Hall 10

14:00 - 15:30 WOC-C-15

Modern OCT imaging: Clinical Value and Perspectives

Chair: Ursula Schmidt-Erfurth (Vienna/A)

Speakers: Matthias Bolz (Vienna/A), Jay S. Duker(Boston/USA), Christopher Kiss (Vienna/A),Christian Prünte (Binningen/CH), Srinivas R. Sadda (Los Angeles/USA), Ursula Schmidt-Erfurth (Vienna/A)


The course “OCT – Present and Future” offers acompact state-of-the-art and comprehensive update regarding options and relevance of modernOCT-technology over a vast spectrum of retinal pathologies and expert insights.OCT is a milestonein ophthalmologic diagnostics with the opportu-nity of a non-invasive, high-resolution representa-tion of all retinal compartments e.g. vitreoretinalinterface, intraretinal layers and subretinal space.Already, conventional OCT provides important andclinically relevant information about the conditionof the central retina for diagnosis and therapeuticindication. Applications of OCT are all the frequentand severe retinal diseases such as age-related macular degeneration (AMD), diabetic retinal disease (DRP) and vascular pathologies. With theevolution of the high-resolution technology thevalue of OCT has increased significantly, since aprecise imaging of all details and, based on raster-scanning, a complete three-dimensional represen-tation at all locations became available.Accordingly, modern OCT offers a realistic andquantified analysis of diseases of the central retina.Hence, OCT has become one of the most impor-tant parameters in the anti-angiogenetic therapywith high relevance for indication, prognosis andlong-term management. For the understanding ofpathogenesis OCT provides essential novel insightse.g. in diabetic retinopathy.

14:00Overview on state-of-the-art technologyJay S. Duker (Boston/USA)

14:10OCT in AMDUrsula Schmidt-Erfurth (Vienna/A)

14:20OCT in diabetic macular diseaseMatthias Bolz (Vienna/A)

14:30OCT in retinal vascular diseaseChristopher Kiss (Vienna/A)

14:40OCT in macular surgeryChristian Prünte (Binningen/CH)

14:50Perspectives and developmentsSrinivas R. Sadda (Los Angeles/USA)

Hall 10

16:00 - 17:30 WOC-AAD-C-16

KRC Advanced Course for the Refractive Surgery

Chair: Thomas Kohnen (Frankfurt/D)

Speakers: Michael C. Knorz (Mannheim/D), Thomas Kohnen(Frankfurt/D), Thomas F. Neuhann (Munich/D)


Presenting the current developments in refractivesurgery

This course will present the state of affairs in thedevelopment of the refractive surgical method.Alongside this the discussion among participantsis a key element of this course. We are happy to discuss cases brought forward by participants.

Room 44

08:30 - 10:00 WOC-AAD-C-17

Episcleritis and Scleritis

Chair: Manfred Zierhut (Tübingen/D)

Speakers: Uwe Pleyer (Berlin/D), Manfred Zierhut (Tübin-gen/D)


Differentiation between the different sclera condi-tions and their differential diagnoses. Choice of aneffective treatment.

Following a brief outline of the basics and thepathophysiology of sclera conditions, the currentclassification of the different forms shall be evalu-ated. Furthermore, the diagnostically and differen-tially recommended examination techniques will


Satu

rday

, 5 Ju

ne

Cour

ses a

nd W

etla

bs

245WOC® 2010

be introduced. Lastly, locally and systemically applied medication (antiphlogistics, immunosup-pressants, biologica) as well as surgical options will be discussed. Participants are encouraged tointroduce their own problem patients.

Room 44

10:30 - 12:00 WOC-AAD-C-18

Diagnosis and Treatment of Peripheral Retinal Degeneration

Chair: Bernd Kirchhof (Cologne/D)

Speakers: Bernd Kirchhof (Cologne/D), Peter Wiedemann(Leipzig/D)


Classification and prognostic significance of themanifold manifestations of peripheral retinal degenerations with regards to the risk of amotio.

We shall define retina’s periphery and its anatomi-cal characteristics. We differentiate between peripheral retinal degeneration following primarilytrophic- and primarily traction-dependant dyspla-sia. We distinguish between peripheral retinal degenerations according to their significance forthe development of amotio. Aside from morpho-logical criteria, epidemiologial data is consulted tojustify the diagnosis of prophylactic retinopexy.

Room 44

14:00 - 15:30 WOC-AAD-C-19

Diagnosis and Treatment of Keratomycoses

Chair: Wolfgang Behrens-Baumann (Magdeburg/D)

Speakers: Wolfgang Behrens-Baumann (Magdeburg/D)


How do I recognise a keratomycosis? How do I testmy presumptive diagnosis? Treatment optimisa-tion in fungal keratitis

The characteristics of keratomycosis will be shownon example cases. Medical history, risk factors, andfungal occurrence will be discussed and advice onsecuring the diagnosis. Eventually antimycotics,their dosage, use and sensible application will becovered with regards to the different fungalstrains.

Room 44

16:00 - 17:30 WOC-AAD-C-20

Glaucoma Surgery Follow-up Care

Chair: Franz Grehn (Würzburg/D)

Speakers: Franz Grehn (Würzburg/D), Thomas Klink(Würzburg/D), Jochen Wahl (Mainz/D)


Optimising postoperative care with the aim ofmaximising the long-term success of glaucomasurgeries.

– Identification and treatment of postoperative complications

– Characteristic signs of postoperative scarring using standardised assessment of filtering bleb evaluation

– DD postoperative hypotony– DD postoperative increase in intraocular

pressure– 5-FU use in postoperative care– Needling of the filtering bleb– Possible revision surgeries

This course is aimed at ophthalmologists in hospi-tals and medical practices – in particular becausein the future most postoperative care will be donein outpatient departments or ophthalmic prac-tices.


Sund

ay, 6

June

Cour

ses a

nd W

etla

bs246 WOC® 2010

Room Istanbul

08:30 - 10:00 WOC-C-21

Wetlab Basic Course on Penetrating Corneal Grafting Techniques


Speakers: Gernot I. W. Duncker (Halle/D), Bernhard Nölle(Kiel/D), Berthold Seitz (Homburg/D), Frank Wilhelm (Schwerin/D)


The different surgical steps of penetrating kerato-plasty on the pig eye and regular corneoskleral buttons will be presented and practised in thisbasic course. Different trephine systems will beused. Tips and tricks regarding the surgical proce-dure will be given, and the suture technique will be practised extensively. This focus of this course lies on the practical applications.

Room Istanbul

10:30 - 12:00 WOC-C-22

Wetlab for the Advanced: Lamellar Grafting Techniques


Speakers: Gernot I. W. Duncker (Halle/D), Jörg. H. Krumeich(Bochum/D), Friedrich E. Kruse (Erlangen/D), Gerrit R. J. Melles (Rotterdam/NL)


This advanced course introduces the new tech-niques of lamellar keratoplasty, which will be practised and simulated on the pig’s eye. The characteristics of this surgical procedure as well astips for handling the individual methods will begiven, while there is an emphasis on their practicalapplication in order to familiarise the participantswith the new equipment.

Hall 8

08:30 - 10:00 WOC-AAD-C-23

Immunology of the Eye: Intraocular Inflammations

Chair: Uwe Pleyer (Berlin/D)

Speakers: Uwe Pleyer (Berlin/D), Stephan Thurau (Munich/D)


The aim of this course is to present the currentstate of knowledge with regards to immuno-dependant eye conditions and to offer rational decision-making advice with regards to diagnosisand treatment.

Intraocular inflammations are the subject focus.Upon briefly addressing pathophysiological basics,current aspects of diagnosis and treatment will bediscussed on clinical examples. Among others, thefollowing topics shall be covered:Diagnostic strategies for uveitis:When should (or shouldn't) one start diagnostics?Which types of patients indicate invasive diagnos-tics (e.g. ppV). Aspects of interdisciplinary cooperation, signifi-cance of the DRGs for diagnostics and treatment.Conservative treatment: Indications and imple-mentation. Systemic treatment - when? How? Monitoring andunwanted effects. Options and limits of “new”kinds of therapy (e.g. biologica?) (CME-Therapy).Surgical therapy: Indications and implementation(cataract/glaucoma).Is pseudophakia generally something to aim for?Characteristics of childhood perioperative care inintraocular surgeries Indications for ppV.Additionally participants are encouraged to intro-duce their own problem patients.

Room Istanbul

14:00 - 15:30 WOC-C-36

Modern Pars Plana Vitrectomy DryLab (Basics)

Chairs: Frank Koch (Frankfurt/D), Norbert Bornfeld(Essen/D), Helge Krüger (Frankfurt/D)

Speakers: Norbert Bornfeld (Essen/D), Lars-Olof Hattenbach(Ludwigshafen/D), Frank Koch (Frankfurt/D), Helge Krüger (Frankfurt/D), Klaus Lucke(Bremen/D), Stephan Nikolic (Hannover/D), Pankaj Singh (Frankfurt/D), Clemens Wagner(Mannheim/D)


Sunday, 6 June 2010

Sund

ay, 6

June

Cour

ses a

nd W

etla

bs

247WOC® 2010

The Virtual Reality Pars plana Vitrectomy DryLabwas developed in order to realise evidence-basedophthalmosurgical training. The strategies that ensure reliability and success of retina and vitreoussurgery as well as fundamental principles of intraocular surgical interventions in the vitreousbody will be trained and tested within the VR-magic-Vitrectomy simulator.Experienced colleagues will guide you through targeting strategies, methods of vitreous excisionin different retina/vitreous affections, vitreousmembrane detachment, as well as the intravitrealapplication of medication. The simulator will cap-ture a performance profile and your achievementswill be evaluated.

14:00EYESi technology, part 1Clemens Wagner (Mannheim/D)

14:10Abstract-to-real transferFrank Koch (Frankfurt/D)

14:20EYESi – Diagnosis and treatmentPankaj Singh (Frankfurt/D)

14:30Complication managementLars-Olof Hattenbach (Ludwigshafen/D)

14:40EYESi-ExpertiseStephan Nikolic (Hannover/D)

14:50VR in Aviation + OphthalmologyKlaus Lucke (Bremen/D)

Room Istanbul

16:00 - 17:30 WOC-C-37

Modern Pars Plana Vitrectomy DryLab (Advanced)

Chairs: Frank Koch (Frankfurt/D), Michael Janusz Koss(Frankfurt/D)

Speakers: Hermann O. C. Gümbel (Ulm/D), Hans Hoerauf(Göttingen/D), Frank Koch (Frankfurt/D), MichaelJanusz Koss (Frankfurt/D), Klaus Lucke (Bremen/D),Maya Müller (Lübeck/D), Markus Schill(Mannheim/D)


The Virtual Reality Pars plana Vitrectomy DryLabwas developed in order to realise evidence-based

ophthalmosurgical training. The strategies that ensure reliability and success of retina and vitreoussurgery as well as fundamental principles of intraocular surgical interventions in the vitreousbody will be trained and tested within the VR-magic-Vitrectomy simulator.Experienced colleagues will guide you through targeting strategies, methods of vitreous excisionin different retina/vitreous affections, vitreousmembrane detachment, as well as the intravitrealapplication of medication. The simulator will cap-ture a performance profile and your achievementswill be evaluated.

16:00EYESi technology, part 2Markus Schill (Mannheim/D)

16:10Deliberate PracticeFrank Koch (Frankfurt/D)

16:20Limitations of VR-TrainingHans Hoerauf (Göttingen/D)

16:30Guidelines based on expertiseHermann O. C. Gümbel (Ulm/D)

16:40EYESi-ExpertiseMaya Müller (Lübeck/D)

16:50VR in Aviation + OphthalmologyKlaus Lucke (Bremen/D)

Hall 8

14:00 - 15:30 WOC-AAD-C-24

Corneal Ulcers and Conjunctival Scarring. What to Do?

Chair: Elisabeth M. Messmer (Munich/D)

Speakers: Arnd Heiligenhaus (Münster/D), Elisabeth M.Messmer (Munich/D)


Instructions on diagnosis and treatment of problematic disease patterns

The correct diagnosis and treatment of the differ-ent types of corneal ulcers portrays quite a chal-lenge to the ophthalmologist. The differentialdiagnosis of conjunctival scarring, particularly inearly stages, can also be problematic.

Sunday, 6 June 2010

Sund

ay, 6

June

Cour

ses a

nd W

etla

bs248 WOC® 2010

1st part of the course: Systematic outline of the clinic, the diagnostic approach, as well as the treatment in pathogene-dependant, trophic and immunological corneal ulcers.

2nd part of the course: Etiology, clinic, diagnosis and differential diagnosisas well as conservative and operative treatmentoptions in conjunctival scarring.

Hall 8

16:00 - 17:30 WOC-AAD-C-25

Visual Agnosia and Other Central Visual Impairments

Chair: Ulrich Schiefer (Tübingen/D)

Speakers: Ulrich Schiefer (Tübingen/D)


Visual agnosias disturb the visual recognition ofe.g. objects (or related features), faces, places, pathsor letters. They are caused by lesions of higher vi-sual centers located in the parieto-temporal andoccipito-temporal cortical visual areas or their as-sociated subcortical connections. Given the well-vascularized tissue of the poststriate visual cortex,damage to vision in these regions is comparativelyuncommon (found in approximately 2% of cases ofposterior brain disease) and is often transient,managing to recover within a few weeks followingonset. Agnosias are primarily a neurological entitiy. How-ever, in case of visual agnosias the patient experi-ences “disturbances” in vision and will thereforeprimarily contact his eye doctor. A general ophthal-mologist might be somewhat puzzled by the obvi-ous discrepancy between normal morphologicalfindings and peculiar visual symptoms. Quite oftenpatients are threatened by this kind of visual dis-turbances and do not spontaneously report ontheir specific problems as they assign these as pre-cursors of progressive mental derangement. Ade-quate explanation of the cause for the visualsymptoms and information about the realisticchances of spontaneous recovery in visual functionare important elements of medical counselling.Where possible, the patient´s closests relativesshould be included in theses discussion as the tooneed to understand the specific problems of thepatient. The aim of this course is to make the ophthalmo-logical colleagues sensitive for typical signs andsymptoms of visual agnosias. Appropriate diagnos-tic and therapeutic care of such patients requires amultidisciplinary approach, including participation

by neurologists, neuroradiologists, neuropsycholo-gists and neuro-ophthalmologists. Adequate explanation of the cause for the visualsymptoms and information about the realisticchances of spontaneous recovery in visual functionare important elements of medical counselling.Where possible, the patients´ closest relativesshould be included in these discussions as they tooneed to understand their specific problems.

Salon 19

08:30 - 10:00 WOC-AAD-C-26

Complications in Plastic-Reconstructive and Aesthetic Surgery of the Lids and the Periorbital Region

Chair: Ulrich Schaudig (Hamburg/D)

Speakers: Gerd Geerling (Würzburg/D), Uwe Peter Press(Trier/D), Ulrich Schaudig (Hamburg/D)


Recognising and treating typical and crucial com-plications postoperatively and long-term followingsurgical procedures on the lids and the periorbitalregion

This new theoretical course aims to provide anoverview over possible complications according tothe systematic of lid-surgical procedures. What arethe causes of typical complications and how canthey be prevented as early as in the preoperativeplanning stage by choosing the appropriate surgi-cal approach? Which side-effects can occur thatare not considered to be complications? On theother hand, what is considered an actual complica-tion and how do I approach these patients? Whatare the indications for a surgical follow-up proce-dure? The management of complex developmentsand possible treatment will be addressed accord-ing to case studies.

Salon 19

10:30 - 12:00 WOC-AAD-C-27

The Interdisciplinary Context of Multiple Sclerosisand Myasthenia Gravis

Chair: Susanne Pitz (Mainz/D)

Speakers: Martin Eicke (Idar-Obenstein/D), Susanne Pitz(Mainz/D)


Sunday, 6 June 2010

Sund

ay, 6

June

Cour

ses a

nd W

etla

bs

249WOC® 2010

The presentation of current diagnostic and treat-ment strategies in multiple sclerosis and myasthe-nia gravis.

Patients suffering from multiple sclerosis (MS) andmyasthenia gravis are often treated interdiscipli-nary: While the ophthalmologist often makes thefirst diagnosis, the neurologist generally initiatestreatment. This often leads to differing diagnosticand treatment strategies in both areas of expertise.

Does every patient with acute neuritis nervi optici(NNO) for example require neurological examina-tion? Are MRIs (with or without contrast dye), clini-cal neurophysiology or lumbar punctures alwaysabsolutely necessary? How important is the intra-venous steroid treatment in acute NNOs and otheracute MS-episodes?What are the indicators for episode preventionwith Interferon-ß? Which diagnostic strategy ismost appropriate in response to suspected myasthenia? Is the Tensilon test absolutely necessary? How important are clinical neurophysi-ology and the identification of autoantibodies for acetylcholine receptors? Is a CT of the thoraxgenerally imperative? Which surgical treatmentsare currently possible?In this course we would like to evaluate currentconcepts regarding both conditions and give rational decision-making advice on typical ques-tion. This course is aimed at professional as well astrainee colleagues.

Salon 19

14:00 - 15:30 WOC-AAD-C-28

Ophthalmic Conditions in Third World countries /Ophthalmic Travel Medicine

Chair: Volker Klauss (Munich/D)

Speakers:Volker Klauss (Munich/D), Markus Schulze Schwering (Ahlen/D)


Motivation and further training for participants inthe field of ophthalmic conditions in the tropics.

Due to the rise in global travel of tourists and busi-nesspeople as well as an increase in internationalmigration, these days Germany is faced with moreand more cases of ophthalmic conditions that aretypically associated with tropical and subtropicalregions.

Fortunately German ophthalmologists display increasing interest in short-term and long-termwork in third world countries, within the world-wide Vision 2020 programme, 'The Right To Sight'.This course is intended to prepare German oph-thalmologists for imported conditions as well asbroaden their knowledge of epidemiology, pathol-ogy, and the diagnostics of such conditions and tothus provide some all-round preparation for work-ing abroad. Tips will be given on advising travellingpatients on the risks associated with the individualregions as well as on the concrete risks for patientssuffering from chronical ophthalmic conditions.The following conditions are considered the mostcrucial imported eye conditions: Trachoma, onchocerciasis, loiasis, leprosy, acute hemorrhagingconjunctivitis (Apollo), dengue fever, leishmaniasis,paratisoses like echinococcosis. Contacts for national and international organisa-tions for international developmental cooperation(International none Governemental Organizations)will be mentioned briefly.

Salon 19

16:00 - 17:30 WOC-AAD-C-29

Retinopathy of Prematurity – Clinical Diagnosisand Treatment

Chair: Heinrich Gerding (Olten/CH)

Speakers: Arnd Gandorfer (Munich/D), Heinrich Gerding(Olten/CH)


Optimisation of the ophthalmologic provisioningof premature infants

The course is intended to train participants for providing optimized clinical care for prematurechildren. The programme covers the necessaryknowledge on etiology, pathophysiology and classification of retinopathy of prematurity. Current international guidelines for performingscreening examinations of premature babies willbe presented and compared. Adequate examina-tion techniques of premature children and docu-mentation of clinical findings will be presented aswell as current and future treatment approachesincluding laser photocoagulation, cryotherapy, anti-VEGF injections, cerclage and vitrectomy.

Sunday, 6 June 2010

Mon

day,

7 Ju

ne

Cour

ses a

nd W

etla

bs250 WOC® 2010

Room Sydney

08:30 - 10:00 WOC-C-30

Sutureless = Happiness? Pearls and Pitfalls inTransconjunctival Vitreoretinal Surgery

Chair: Lars-Olof Hattenbach (Ludwigshafen/D)

Speakers: Carl-Friedrich Arndt (Reims/F), Stefan Dithmar(Heidelberg/D), Nicolas Feltgen (Göttingen/D),Lars-Olof Hattenbach (Ludwigshafen/D), MayaMüller (Lübeck/D), Siegfried Priglinger (Linz/A)


In sutureless vitreoretinal surgery, one must oftendeal with specific problems usually not encoun-tered with conventional vitrectomy systems. Thiscourse will be highlighted by interactive case dis-cussions as well as experienced faculty providingpitfalls and pearls of various sutureless transcon-junctival vitrectomy systems. Focus will be on spe-cific technical issues, typical or unsuspecteddifficulties, innovative treatment approaches, com-bined microincision cataract surgery, and compli-cating patient variables. Participants areencouraged to be a part of the discussion by pro-viding opinions on different treatment avenues.

Room Sydney

10:30 - 12:00 WOC-C-31

HRT and Spectral OCT in Glaucoma

Chairs: Reinhard O. W. Burk (Bielefeld/D), Claude Burgoyne(Portland/USA), Balwantray C. Chauhan(Halifax/CDN)

Speakers: Claude Burgoyne (Portland/USA), Reinhard O. W. Burk (Bielefeld/D), Balwantray C. Chauhan (Halifax/CDN), Kester Nahen (Smithfield/USA)


This course discusses and explains HRT glaucomadiagnostics. Structural parameters like papilla size,neuroretinal rim area, excavation can be captured.Macro-papillae with large excavation areas anddepth values must possess at least the neuroreti-nal rim parameters of normal papillae. Discrimi-nant functions, which can estimate the probabilityof the existence of glaucomatous visual field de-fects, will be assessed (FSM, RB). One option ofanalysis without interactive examination is the

glaucoma probability score (GPS). The validity ofthe HRT findings as the gold standard of three di-mensional papilla analysis is supported by the dataof high resolution optical coherence tomography(spectral OCT): localised reflectivity loss throughnerve fiber bundle loss, which are detected by HRT,correlate with the thinning of the nerve fiber layerin high resolution spectral OCTs.

10:30The HRT in glaucoma researchBalwantray C. Chauhan (Halifax/CDN)

10:45The development of the Spectral OCTKester Nahen (Heidelberg/D)

11:00Spectral OCT for the Evaluation of the laminacribrosaClaude Burgoyne (Portland/USA)

11:15Clinical use of HRT and Spectral OCT in GlaucomaReinhard O. W. Burk (Bielefeld/D)

Room Sydney

14:00 - 15:30 WOC-C-32

Laser Treatment of Retinal Diseases

Chair: Gabriele E. Lang (Ulm/D)

Speakers: Francesco Bandello (Milano/I), Hans Hoerauf (Göttingen/D), Gabriele E. Lang (Ulm/D)


Laser photocoagulation is still the gold standard inthe treatment of several retinal diseases. Diabeticretinopathy and retinal vein occlusions are dis-cussed in detail concerning diagnostic procedures,staging, indication and techniques of laser treat-ment. Other diseases like retinal holes, Coats disease, macroaneurysm, optic pits with serous detachment of the retina, central serous chori-oretinopathy and peripheral hemorrhagic exuda-tive chorioretinopathy are presented. The mostcommon mistakes in laser treatment are also discussed. Finally the combination of laser andpharmacological treatment of retinal diseases aredescribed.

14:00Laser Treatment of Diabetic Retinopathy, Vein Oc-clusions and Other DiseasesGabriele E. Lang (Ulm/D)

Monday, 7 June 2010

Mon

day,

7 Ju

ne

Cour

ses a

nd W

etla

bs

251WOC® 2010

14:40Combination of Laser with Pharmacological Treat-mentFrancesco Bandello (Milano/I)

15:05Common Mistakes in Laser TreatmentHans Hoerauf (Göttingen/D)

Room Sydney

16:00 - 17:30 WOC-C-33

Blepharoplasty of the Upper and Lower Eye Lids:Innovative Concepts for Excellent Surgical Results

Chair: Klaus G. Riedel (Munich/D)

Speakers: Hans-Werner Meyer-Rüsenberg (Hagen/D), Klaus G. Riedel (Munich/D)


Blepharoplasty for the correction of upper andlower dermatochalasis is, with increasing tenden-cies, the most popular form of cosmetic surgery.The success rate with regards to aesthetics andfunction, depends on the preoperatve analysis ofdiagnostic findings, individual choice of inscision,and an atraumatic surgical technique. Independ-ent from the chosen equipment, scalpel, high frequency needle or laser, modern blepharoplastyis comprised of more than the mere removal of excess skin. All types of tissue in the eyelids mayneed to be tackled: skin, muscle, lid band, orbitalseptum, and orbital fat compartments. The crucialpart is what remains on the lid, rather than what isremoved. The correct position oft the scin creasedetermines the method of surgical lid closure. Individual characteristics have to remain to achieveexcellent surgical results.

Room Istanbul

14:00 - 15:30 WOC-C-34

Wetlab Glaucoma Surgery for Beginners

Chair: Norbert Pfeiffer (Mainz/D)

Speakers: Walter Konen (Cologne/D), Norbert Pfeiffer(Mainz/D), Lutz E. Pillunat (Dresden/D), Manfred Tetz (Berlin/D), Hagen Thieme (Mainz/D),Jochen Wahl (Mainz/D)


Despite all the advances of medication-based glau-coma treatment, surgical intervention remains inevitable for many glaucoma patients. This courseteaches the fundamentals of preparation tech-nique, in particular of penetrating methods. The non-penetrating methods, however, shall beaddressed as well.The flap preparation in trabeculectomy, iridectomyas well as trabeculotomy will be practised on thepig's eye, after a brief theoretical introduction. Furthermore deep flap preparation during deepsclerectomy shall be demonstrated.This course is aimed at beginners in glaucoma sur-gery as well as offering the opportunity to reviseand expand upon previously gained knowledge onthe subject.

Room Istanbul

16:00 - 17:30 WOC-C-35

Wetlab Glaucoma Surgery for the Advanced

Chair: Norbert Pfeiffer (Mainz/D)

Speakers: Walter Konen (Cologne/D), Norbert Pfeiffer(Mainz/D), Lutz E. Pillunat (Dresden/D), Manfred Tetz (Berlin/D), Hagen Thieme (Mainz/D),Jochen Wahl (Mainz/D)


This course is aimed at the more experienced glau-coma surgeon. It expands upon the basics taughtin the beginners' course. Non-penetrating methodslike sclerectomy and viscocanalostomy will bedemonstrated and practised. Additionally the handling of implants like the Ahmed Valve andMolteno Implants will be demonstrated.

Monday, 7 June 2010

Mon

day,

7 Ju

ne

Cour

ses a

nd W

etla

bs252 WOC® 2010

Room 43

08:30 - 10:00 WOC-C-38

Update on Tonometry

Chair: Harry Mark (North Haven/USA)

Speakers: Harry Mark (North Haven/USA)


Synopsis:Year after year patents are issued for new tonome-ters, each claiming to be more accurate and com-fortable, though none measures true intra-ocularpressure. This course will present the latesttonometers and the evidence concerning the physical parameters of the eye that influence alltonometric reading. Clinical examples of their application in myopia, normal-tension glaucoma,and ocular hypertension will illustrate their utility.

Objective:At the end of this course attendees will be able toapply tonometric information more confidentlyand reliably in the diagnosis and management ofglaucoma, and decide when to obtain ancillarydata, such as corneal thickness. The course will alsohelp attendees choose a tonometer.

Introductiona. Many U.S. patent applications for new

tonometers annually.b. Brief history. Helmholtz’s first tonometer.c. Need for standard quantification

Geometry and physics a. Size and shape. 1. Acrophthalmos.

2. Brachophthalmos.b. Envelope. 1. Cornea 2. Sclera. 3. Optic foramen.c. Contents. 1. Aqueous. 2. Vitreous.d. Pressure from within (IOP).e. Pressure from without – the tonometer’sf. Imbert-Fick law: the elusive mmHg

Necessity of ancillary dataa. Central corneal thicknessb. Corneal curvaturec. Ocular volume (axial length, A and B scans)d. Elasticity (scleral thickness)e. Corneal hysteresisf. Terminology and reimbursement

Clinical applicationa. Glaucoma suspect, risk factors.b. Normal/low-tension glaucomac. Ocular hypertensiond. Gender differencese. Myopia and glaucoma

Conclusiona. Nomogramsb. Flow-chartc. Which tonometer is best.d. The future

Room 43

10:30 - 12:00 WOC-C-39

A Flexible Ring in a Corneal Pocket for the Treatment of Keratoconus and Myopia

Chairs: Albert Daxer (Linz/A), Haifa Mahmood(Manama/BRN)

Speakers: Albert Daxer (Linz/A), Millicent Grim (Dubai/UAE),Haifa Mahmood (Manama/BRN), Ali Rahji(Riyadh/SA), Pavel Studeny (Sokolov/CZ)


Objectives:Attendees will understand corneal intrastromalimplantations surgery (CISIS) using a flexible, continous ring implant placed within a closedcorneal pocket for the btreatment of keratoconusand myopia.

Description:The course will review clinically important aspectsof CISIS including surgical techniques, inclusion criteria, and nomograms, complications and sideeffects, case studies and statistical data. The surgi-cal techniques are demonstrated via educationalvideos.

Room 43

14:00 - 15:30 WOC-C-40

Modern Surgery of the Posterior Segment of theEye

Chairs: Joaquin Barraquer (Barcelona/E), Rafael Barraquer(Barcelona/E), Jeroni Nadal (Barcelona/E)

Speakers: Joaquin Barraquer (Barcelona/E), Rafael Barraquer(Barcelona/E), Javier Elizalde (Barcelona/E), Jeroni Nadal (Barcelona/E)


In this 90 minutes “multi-authored” Course thefollowing topics are discussed:

Monday, 7 June 2010

Mon

day,

7 Ju

ne

Cour

ses a

nd W

etla

bs

253WOC® 2010

1) Surgical management of proliferating vitreo-retinopathy with special emphasis on differenttechniques of peeling of the epiretinal andretroretinal membranes, the use of biological colorants and intraocular tamponnades.

2) Presentation of an update of modern surgical tech-niques in macular surgery, different options, use of biologic colorants and indications for peeling ofthe internal limiting membrane.

3)Biopsy techniques for cytogenic studies of uvealmelanoma, especially cytogenic phenotyping, anuniversally accepted procedure in ocular oncologyto evaluate the risk of metastatic desease in uvealmelanoma. Different approaches for microsurgicalprocedures to achieve the obtention of adequatetumor samples are described in detail.

4) Conservative resection of uveal melanoma is re-viewed on the basis of personal experience withdifferent techniques of local conservative resectionas a valid option in the management of selectedcases of uveal melanoma.

5) Finally: Ligature of afferent vessel for retinal hae-mangioma, a new surgical technique for manage-ment of yuxtapapillar capillar haemangioma isdescribed. Ligature of the afferent artery to thetumor has been performed and proved to be effec-tive to reduce the volume of the haemangiomaand exudative activity at the level of the posteriorpole. Images from the different authors’ personalcasuistics will be shown to illustrate the presenta-tions.

Ligature of afferent vessel for retinal hemangiomaJeroni Nadal (Barcelona/E)

Conservative resection of uveal melanomaRafael Barraquer (Barcelona/E)

Biopsy techniques for cytogenic study of uvealMelanomaJavier Elizalde (Barcelona/E)

Macular SurgeryJoaquin Barraquer, Jeroni Nadal (Barcelona/E)

Surgical management of proliferating vitreo-retinopathyJeroni Nadal (Barcelona/E)

Room 43

16:00 - 17:30 WOC-C-41

Complications in Vitreoretinal Surgery

Chairs: David S. H. Wong (Hong Kong/HK), Paul Sullivan(London/UK), Karl Ulrich Bartz-Schmidt (Tübingen/D)

Speakers: George William Aylward (London/UK), Keith Barton(London/UK), Karl Ulrich Bartz-Schmidt (Tübingen/D), Rubens Belfort, Jr. (São Paulo/BR),Carlos Pavesio (London/UK), Paul Sullivan (London/UK), Charles P. Wilkinson (Baltimore/USA),David S. H. Wong (Hong Kong/HK)


Per operative Complications of scleral buckling surgeryPaul Sullivan (London/UK)

Retinal Trauma from vitreoretinal surgeryKarl Ulrich Bartz-Schmidt (Tübingen/D)

Inflammation and Infection after vitreoretinal surgeryRubens Belfort, Jr. (São Paulo/BR)

Glaucoma after vitreoretinal surgeryKeith Barton (London/UK)

Complications of tamponade agentsDavid S. H. Wong (Hong Kong/HK)

Complications of vitrectomy for diabetic retinopathyCharles P. Wilkinson (Baltimore/USA)

Monday, 7 June 2010

Tues

day,

8 Ju

ne

Cour

ses a

nd W

etla

bs254 WOC® 2010

Hall 10

10:30 - 12:00 WOC-C-61

SD-OCT and AMD Treatment and Follow Up

Chair: Gabriel J. Coscas (Créteil/F)

Speakers: Gabriel J. Coscas (Créteil/F), Srinivas R. Sadda (Los Angeles/USA), Gisèle Soubrane (Créteil/F), Giovanni Staurenghi (Milano/I), Sebastian Wolf(Bern/CH)


10:30Principles of SD-OCT and advantages in AMDFlorence Coscas (Créteil/F)

10:45Differences of the SD-OCTsSebastian Wolf (Bern/CH)

11:00SD-OCT characteristics of choroidal neovasculariza-tion (Before, during and after treatment)Giovanni Staurenghi (Milano/I)

11:15SD-OCT analysis of Outer retinal layers changes(hyper-reflective dots: prognostic value duringmanagement of exudative AMD)Gabriel J. Coscas (Créteil/F)

11:30Polypoidal Vascular choroidopathy and AMDGisèle Soubrane (Créteil/F)

11:45Morphology and structure of retinal pigment ep-ithelium detachments in AMD (Before, during andafter treatment)Bruno Lumbroso (Roma/I)

Salon 11/12

14:00 - 15:30 WOC-C-63

Femtosecond (FS) Course in Ophthalmology

Chair: M. Garcia-Marcos (Malaga/E)

Speakers: Federico A. Aliste (Sevilla/E), M. Garcia-Marcos(Torre del Mar/E), Rafael Rubio (Malaga/E), Jose V. Rodriguez (Las Palmas/E), Alberto Villarrubia (Córdoba/E)


14:00Indications and advantajes with FSFederico Alonso Aliste (Sevilla/E)

14:10Lasik with FSRafael Rubio (Malaga/E)

14:20Intracorneal rings with FSJose Vicente Rodriguez (Las Palmas/E)

14:30Arcuates with FSM. Garcia-Marcos (Malaga/E)

14:40Keratoplasty with FSAlberto Villarrubia (Córdoba/E)

Room Istanbul

08:30 - 10:00 WOC-C-42

Wetlab Glaucoma Drain Implants

Chair: Hagen Thieme (Mainz/D)

Speakers: Thomas S. Dietlein (Düsseldorf/D), Hagen Thieme(Mainz/D), Christian K. Vorwerk (Magdeburg/D)


This course is aimed at experienced glaucoma sur-geons. Glaucoma implants are gaining more andmore acceptance as part of the repertoire of theglaucoma surgeon. This course shall introduce themost important models (Molteno, Ahmed Valve,and Baerveldt Implant) as well as convey skills forsafe implantation. Furthermore, alongside the episcleral models, chamber angle models will beaddressed and their practical application shall bepractised.


Tues

day,

8 Ju

ne

Cour

ses a

nd W

etla

bs

255WOC® 2010

Room Istanbul

10:30 - 12:00 WOC-C-43

Wetlab Phaco Course for Beginners

Chairs: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick(Bochum/D)

Speakers: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick(Bochum/D), Thomas S. Dietlein (Düsseldorf/D),Hagen Thieme (Mainz/D), Christian K. Vorwerk(Magdeburg/D)


This course will outline the individual stages ofphacoemulsification surgery in a step-by-step approach. In order to avoid and adjust complicatedsurgical procedures, individual viewpoints and approaches of the best respective methods will bepresented.

The incision types and architecture as well as theirrelevance, dependant on the individual circum-stances, will be addressed. Possible measures todeepen the anterior chamber, widen the pupil, cap-sulorhexis techniques, hydrodissection and hy-drodelineation will be introduced.

The different techniques of nucleusprocessing (e.g.Divide and Conquer, chop-techniques) will be addressed regarding the respective situations.There will be an introduction of the common in-traocular lenses and their implant characteristicsas well as the rules of conduct in complicated surgery progressions. Some advice will be given asto how to avoid decentration of the lens, lens de-fects and cataracta secundaria.

Room Istanbul

14:00 - 15:30 WOC-C-44

Wetlab Phaco Course for the Advanced

Chair: Gerd U. Auffarth (Heidelberg/D)

Speakers: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick(Bochum/D), Helmut Höh (Neubrandenburg/D),Gangolf Sauder (Stuttgart/D)


The generic problems of advanced surgeons will bepresented in theory and practice. After an introduc-tion of the individual preferred techniques of thecourse administrators the course will move on to

outline the appropriate techniques for complex cir-cumstances like narrow pupils, synechiae, hardlenses, mature and hypermature lenses, previousoperations, and loose zonulae. The ideal procedurewill be demonstrated both theoretically as well asby means of video clip examples. Avoidance andmanagement of generic complications like tear ofanterior capsule, capsular rupture, vitreous prolaps,zonular tear-off, loss of nucleus, IOL luxation,corneal burn, iris defects, and expulsive bleedingwill be discussed and practised. This course isaimed at advanced phaco-surgeons.

Room Istanbul

16:00 - 17:30 WOC-C-45

Wetlab Biaxial and Microcoaxial Phacoemulsifica-tion

Chairs: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick(Bochum/D)

Speakers: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick(Bochum/D), Ekkehard Fabian (Rosenheim/D), Helmut Höh (Neubrandenburg/D), Gangolf Sauder(Stuttgart/D)


This course shall provide user information for biax-ial as well as microcoaxial phacoemulsificationtechnique, various phacoemulsification equipmentand techniques, instruments, and appropriatemicro-incision-intraocular lenses. Following an in-troduction to the underlying technologies and rele-vant instruments, the diagnosis, aims, and limits ofbiaxial and microcoaxial phacoemulsification willbe discussed. After reviewing the advantages anddisadvantages of the different procedures, we willexplain in detail the practical implementations ofbi- and microcoaxial phacoemulsification includingthe necessary instruments, implant techniques andclinical findings of respective foldable lenses. Intra-and postoperative complications as well as theirprevention and management will be addressed.


Tues

day,

8 Ju

ne

Cour

ses a

nd W

etla

bs256 WOC® 2010

Room 42

08:30 - 10:00 WOC-C-46

Achieving Excellence: Teamwork in Cataract andRefractive Surgery

Chairs: Claes Feinbaum (Lund/S), Sudhir Patel (Alicante/E),Ewa Mrukwa-Kominek (Katowice/PL)

Speakers: Claes Feinbaum (Lund/S), Ewa Mrukwa-Kominek(Katowice/PL), Sudhir Patel (Alicante/E)


08:30Introduction – Key topics and chief aims of thecourseSudhir Patel (Alicante/E)

08:35Modern Cataract Surgery: Review of most populartechniques today & top tips to avoid complicationsEwa Mrukwa-Kominek (Katowice/PL)

08:45Modern Refractive Surgery: Review of most populartechniques today & top tips to avoid complicationsEwa Mrukwa-Kominek (Katowice/PL)

08:55The Why, What and Which of Pre-operative Assess-ment in Cataract Surgery: Referral criteria, patienteducation to avoid complications, essentials of clin-ical assessment, grading key clinical markersClaes Feinbaum (Lund/S)

09:05The Why, What and Which of Pre-operative Assess-ment in Refractive Surgery Surgery: Referral criteria,patient education to avoid complications, essen-tials of clinical assessment, grading key clinicalmarkersClaes Feinbaum (Lund/S)

09:15Essentials for Success after cataract surgery: Patient education = Patient satisfactionSudhir Patel (Alicante/E)

09:30Essentials for Success after refractive surgery: Patient education = Patient satisfactionSudhir Patel (Alicante/E)

09:45Wind up: Interactive question & answer sessionClaes Feinbaum, Sudhir Patel (Lund/S, Alicante/E)

Room 42

10:30 - 12:00 WOC-C-47

Corneal Imaging

Chairs: Rudolf F. Guthoff (Rostock/D), Edward Wylegala(Katowice/PL), Christophe Baudouin (Paris/F)

Speakers: J. Oscar Croxatto (Buenos Aires/RA), Rudolf F. Guthoff (Rostock/D), Pedram Hamrah(Boston/USA), Bartlomiej J. Kaluzny (Bydgoszcz/PL),Antoine Labbé (Paris/F), Edward Wylegala (Katowice/PL), Christophe Baudouin (Paris/F)


10:30Corneal innervation – new insights with confocalin-vivo microscopyRudolf F. Guthoff (Rostock/D)

10:40Application of confocal microscopy in infectiouskeratopathiesAntoine Labbé (Paris/F)

10:50Comparison of confocal and histopathological imagesJ. Oscar Croxatto (Buenos Aires/RA)

11:00Spectral vs time- domain OCT applying in differentDescemet membrane corneal pathologyEdward Wylegala (Katowice/PL)

11:10Swept source OCT for quantitative assessment ofthe corneaBartlomiej J. Kaluzny (Bydgoszcz/PL)

11:20In Vivo Imaging and Quantification of Corneal InflammationPedram Hamrah (Boston/USA)

Room 42

14:00 - 15:30 WOC-C-48

Current Concepts in the Management of RetinalVessel Occlusion

Chair: Lars-Olof Hattenbach (Ludwigshafen/D)


Tues

day,

8 Ju

ne

Cour

ses a

nd W

etla

bs

257WOC® 2010

Speakers: Stefan Dithmar (Heidelberg/D), Nicolas Feltgen(Göttingen/D), Lars-Olof Hattenbach (Ludwigshafen/D), Siegfried G. Priglinger Jr. (Linz/A)


Over the past years, various novel treatment strate-gies have expanded our options in the manage-ment of retinal vessel occlusion. However, there isstill no consensus among ophthalmologists aboutthe optimal approach.

This course provides an overview of the histo-pathologic and clinical features of retinal vein andretinal artery occlusion. Current concepts such asthe intravitreal administration of anti-VEGF (vascu-lar endothelial growth factor) drugs, surgical tech-niques including the cannulation of retinal vessels,or the use of thrombolytic or anticoagulant agentsare reviewed to determine whether these treat-ments are likely to improve major clinical out-comes. Case presentations will serve as an openforum for an interactive group discussion with re-gards to complicated clinical scenarios and treat-ment decisions.

Room 43

08:30 - 10:00 WOC-C-49

Current Management of Diabetic Macular Edema

Chair: Hans Hoerauf (Göttingen/D)

Speakers: Nicole Eter (Bonn/D), Nicolas Feltgen(Göttingen/D), Hans Hoerauf (Göttingen/D), Johann Roider (Kiel/D), Georg Spital (Münster/D)


The diabetic macular edema are one of the mostcrucial challenges of clinical everyday life and isbound to gain even more significance in the future,due to the continuous rise cases of diabetis mellitus. While vitrectomy and the introduction of the in-travitreal injection of Triamcinolon and Anti-VEFGmedication significantly broadened the therapeu-tic spectrum, straight-forward recommendationsare still lacking. Laser treatment is still consideredthe standard treatment for focal as well as diffuseforms. The lecturers shall present the differenttherapeutic approaches in detail, evaluate their significance according to current research and discuss diagnoses and determination in case studies with the participants.

Room 43

10:30 - 12:00 WOC-C-50

Management of the Ruptured Globe

Chairs: Arne Viestenz (Magdeburg/D), Ferenc Kuhn (Birmingham/USA)

Speakers: Gregorio Gabela (Quito/EC), Ferenc Kuhn (Birmingham/USA), David Pelayes (Buenos Aires/RA), Wolfgang F. Schrader (Nürnberg/D), Arne Viestenz (Magdeburg/D)


Globe ruptures have a very unfortunate prognosis.A prominent hyposphagma or monocle hematomaoften masks the sheltered globe rupture. Quick surgical dressing is crucial alongside the assuranceof the diagnosis, as there is a threat of posttrau-matic endophthalmitis and expulsive bleeding.In the first part this course will present guidance in diagnostic decision making and techniques ofprimary wound treatment as well as avoidable pitfalls. There will be a discussion of surgery videosof limbus-parallel ruptures, ruptures behind thestraight eye muscle, and atypical ruptures. Recommendations regarding the prevention ofposttraumatic endophthalmitis will be provided.The second part will address the controversies ofprimary vitrectomy (proactive regime) and pre-emptively indenting surgery, as well as the idealtime for surgical intervention, and the manage-ment of secondary complications.

10:30Surgery of traumatic macular holeDavid Pelayes (Buenos Aires/RA)

10:40Timing of surgery in ruptured globesWolfgang F. Schrader (Nürnberg/D)

10:50Primary wound repairGregorio Gabela (Quito/EC)

11:00Management of secondary complications afterglobe ruptureArne Viestenz (Magdeburg/D)

11:10Retinal surgery after globe ruptureFerenc Kuhn (Birmingham/USA)


Tues

day,

8 Ju

ne

Cour

ses a

nd W

etla

bs258 WOC® 2010

Room 43

14:00 - 15:30 WOC-C-51

Challenging Cases in Anterior Segment Surgery

Chair: Gerhard K. Lang (Ulm/D)

Speakers: Jochen Kammann (Davos/CH), Gerhard K. Lang (Ulm/D), Duy-Thoai Pham(Berlin/D), Peter Wagner (Ulm/D)


Challenges in anterior segment surgery can beboth extractive and refractive! Even with the mostmodern phaco techniques there are occasionallystill complicated anterior segment situations,which demand the modification of the standardtechniques and the preoperative planning of oper-ative strategies.

Topics:– Luxatio (ICCE, VKL) or Subluxatio lentis

(„slow-motion phaco“, stabilisation of the capsular bag), dense cataracts („catarocks“)

– Explantation/recentration and sutural fixation of IOLs

– Cataract surgery in combination with silicon oil drainage or perforating keratoplasty

– Iris hooks, capsular tension ring, iris diaphragm,aniridia lens– Watch the signs: “Pupillary-snap Sign“, “Spider-

web Sign“, “Argentina-flag Sign“, “Bounce Sign“,“Misled Fluid Sign“

– Iris sutures in traumatic mydriasis (iris sphinctersuture), iridodyalisis (refixation sutures)

– Anterior vitrectomy technique and “optic-capture” techniques

– Cataract surgery combined with pars plana vitrectomy

– Cyclodialysis occlusion

Course, video sequences, and interactive discussion

Room 43

16:00 - 17:30 WOC-C-52

Blepharoplasty II – Complication, Analysis, Management, and Prevention Strategies

Chair: Hans-Werner Meyer-Rüsenberg (Hagen/D)

Speakers: Hans-Werner Meyer-Rüsenberg (Hagen/D), Klaus G. Riedel (Munich/D)


In the Federal Republic of Germany an estimated10,000 blepharoplasties are done each year by doctors of various fields. Hence both surgically aswell as conservatively active ophthalmologists willbe faced with the issues arising from “less idealblepharoplasties”. In case studies, this course willpresent the possible complications, followed by ananalysis of the respective causes as well as possiblemanagement suggestions where they would beapplicable. Prevention strategies that can ensuresuccessful blepharoplasty will be discussed.

Room 44

14:00 - 15:30 WOC-C-54

The Optic Disc – Funduscopy, Perimetry, Laser Scanning Ophthalmoscopy

Chair: Alexander Friedrich Scheuerle (Heidelberg/D)

Speakers: Andreas G. Böhm (Radebeul/D), Alexander Friedrich Scheuerle (Heidelberg/D),Eckart Schmidt (Radebeul/D)


This interactive workshop illustrates differentpathologies of the optic disc and their specific diagnostic profile with a focus on glacoma.


Wed

nesd

ay, 9

June

Cour

ses a

nd W

etla

bs

259WOC® 2010

Oslo

13:00 - 14:30 WOC-C-55

Management of Vascular Ocular Emergencies

Chair: Nicolas Feltgen (Göttingen/D), Hansjürgen T. Agostini (Freiburg/D)

Speakers: Hansjürgen T. Agostini (Freiburg/D), Nicolas Feltgen (Göttingen/D), Andreas Hetzel(Freiburg/D), Wolf A. Lagrèze (Freiburg/D)


The goal of this course is to discuss the most fre-quent vascular emergencies of the eye and visualpathways with regard to symptoms, diagnosis andstate of the art therapies from both an ophthalmo-logical and a neurological point of view. Startingwith insights as to how patients perceive vascularmalfunction, the presentation will cover transitoryischemia of the retina, occlusion of retinal veinsand arteries, anterior ischemic neuropathy,apoplexy of the central visual system, and oculo-motor emergencies. This systematic course will include interactive elements and will focus on theinterdisciplinary management of these patients.

13:00IntroductionHansjürgen T. Agostini (Freiburg/D)

13:10More than just seeing worse – SymptomsAndreas Hetzel, Wolf A. Lagrèze (Freiburg/D)

13:20Retinal vein occlusionsNicolas Feltgen (Göttingen/D)

13:30Retinal artery occlusionsHansjürgen T. Agostini (Freiburg/D)

13:40AION, Tersons Syndrome, Motility disordersWolf A. Lagrèze (Freiburg/D)

13:50Central ischemia of the visual systemAndreas Hetzel (Freiburg/D)

Hall 10

08:30 - 10:00 WOC-C-56

Refractive Lens Surgery

Chair: Josef Wolff (Heppenheim/D)

Speakers: Stephan Kohnen (Aachen/D), Thomas Kohnen(Frankfurt/D), Anja Liekfeld (Potsdam/D), Walter Sekundo (Marburg/D), Josef Wolff (Heppenheim/D)


Within the scope of refractive surgery more andmore surgical procedures of the lens are being developed. This involves modern intraocular lenses,which are implanted either underneath the naturallens (phaco IOL) or following its extraction (RLA),depending on the respective diagnosis. Particularattention will be paid to diagnosis-specific and individual feasibilities in high myopia, hyperopia,astigmatism, and presbyopia, or their possiblecombinations. The individual procedures and lenstypes will be presented and evaluated and particu-larly– phaco IOLs – multifocal lenses– toric IOLs. will be covered.

Refractive lens surgery is also increasingly used incataract surgery. The respective options that arisefrom the choice of modern IOLs will also be evaluated in combination with cornea procedures.In particular this will cover:– multifocal lenses – toric IOLs – Astigmatism correction by choice of incision

and additional cornea procedures



WOC® 2010

Wed

nesd

ay, 9

June

Room 42

10:30 - 12:00 WOC-C-58

Current Trends in Management of Retinopathy ofPrematurity

Chairs: Venkatapathy Narendran (Coimbatore/IND), Rajvardhan Azad (New Delhi/IND), Mangat Dogra(Chandigarh/IND)

Speakers: Rajvardhan Azad (New Delhi/IND), Mangat Dogra(Chandigarh/IND), Venkatapathy Narendran (Coimbatore/IND), Kalpana Narendran (Coimbatore/IND), Parag K. Shah (Coimbatore/IND)


10:30IntroductionVenkatapathy Narendran (Coimbatore/IND)

10:35Pathogenesis and ClassificationParag K. Shah (Coimbatore/IND)

10:45Risk factors & ScreeningVenkatapathy Narendran (Coimbatore/IND)

10:55Laser in ROP: Indications & TechniqueMangat Dogra (Chandigarh/IND)

11:05Surgical management of ROPRajvardhan Azad (New Delhi/IND)

11:15Rehabilitaion of ROPKalpana Narendran (Coimbatore/IND)

Room 42

08:30 - 10:00 WOC-C-57

Laser in Retinal Diseases Dos and Donts

Chairs: Hans Hoerauf (Göttingen/D), Sebastian Wolf(Bern/CH), Peter K. Kaiser (Cleveland/USA)

Speakers: Diana Do (Baltimore/USA), Peter K. Kaiser (Cleveland/USA), Darius Moshfeghi (Stanford/USA),Johann Roider (Kiel/D), Gisèle Soubrane (Créteil/F),Sebastian Wolf (Bern/CH)


DRCR.net laser resultsDiana Do (Baltimore/USA)

Pattern scan laser technologyDarius Moshfeghi (Stanford/USA)

PDT-Combination therapy for AMDPeter K. Kaiser (Cleveland/USA)

Laser photocoagulation in choroidal neovascular-ization: is there still an indication?Gisèle Soubrane (Créteil/F)

SRT, temperature controlled laser, sublethal lasereffectes, scanning laser systemsJohann Roider (Kiel/D)

Combination therapy for DMESebastian Wolf (Bern/CH)

260Co

urse

s and

Wet

labs


WOC® 2010 261

Wed

nesd

ay, 9

June

Room 43

13:00 - 14:30 WOC-C-60

Diagnosing Melanocytic Tumours of the Uvea:New Techniques and Guidelines for Referral

Chairs: Michael Giblin (Sydney/AUS), Tero Kivelä(Helsinki/FIN), Michael H. Foerster (Berlin/D)

Speakers: James Augsburger (Cincinnati/USA), Norbert Bornfeld (Essen/D), Michael H. Foerster(Berlin/D), Michael Giblin (Sydney/AUS), Tero Kivelä (Helsinki/FIN), Carol L. Shields (Philadelphia/USA)


13:00The frequency and prognosis of melanocytic tumours of the uvea relative to sizeJames Augsburger (Cincinnati/USA)

13:10How large are small uveal melanomas when theyfirst metastasise?Tero Kivelä (Helsinki/FIN)

13:20How to recognise a small melanocytic lesion whichmay grow, and when to refer?Carol L. Shields (Philadelphia/USA)

13:30Optical coherence tomography and autofluo-res-cence in assessing melanocytic tumoursMichael H. Foerster (Berlin/D)

13:40When, why and how to biopsy a small melanocytictumour?Norbert Bornfeld (Essen/D)

13:50A small melanocytic tumour which needs treat-ment: radiotherapy or thermotherapy?Michael Giblin (Sydney /AUS)

Room 43

08:30 - 10:00 WOC-C-59

Introducing Pediatric Low Vision in Ophthalmology Practice

Chairs: Galton Carvalho Vasconcelos (Belo Horizonte/BR),Jill Keeffe (Melbourne/AUS)

Speakers: Galton Carvalho Vasconcelos (Belo Horizonte/BR),Lucienne Chaves Fernandes (Belo Horizonte/BR), Jill Keeffe (Melbourne/AUS), Linda Lawrence(Salina/USA)


Synopsis: This course will focus on the basic con-cepts of low vision in children, especially in infancy.It will review definitions in low vision, early identi-fication and assessment, the need of a multidisci-plinary team and aspects of the inclusion ofchildren with low vision. Two important themesare going to be reviewed: retinopathy of prematu-rity and congenital glaucoma. Discussion andquestions will be encouraged at the end. Thecourse is directed to general ophthalmologists andpediatric ophthalmologists. By the end of the course, attendees will be able tolearn (1) basic concepts of pediatric of low vision, (2)early and effective strategies to assess the principalcauses of low vision in children at an office setting,(3) the benefits of early intervention in pediatric lowvision, (4) the importance of continuous multidisci-plinary communication among different specialists.

08:30Early Identification and assessmentLinda Lawrence (Charleston/USA)

08:50Multidisciplinary teamGalton Carvalho Vasconcelos (Belo Horizonte/BR)

09:00InclusionJill Keeffe (Melbourne/AUS)

09:10Retinopathy of PrematurityJill Keeffe (Melbourne/AUS)

09:20Congenital GlaucomaLucienne Chaves Fernandes (Belo Horizonte/BR)

09:30DiscussionLinda Lawrence, Galton Carvalho Vasconcelos, Jill Keeffe, Lucienne Chaves Fernandes (Charleston/USA, Belo Horizonte/BR, Melbourne/AUS)

Cour

ses a

nd W

etla

bs

Wed

nesd

ay, 9

June

Cour

ses a

nd W

etla

bs262 WOC® 2010

Salon 11/12

10:30 - 12:00 WOC-C-62

Present Options in the Management of PrimaryRhegmatogenous Retinal Detachment: TeachingCourse with International Faculty

Chairs: Ingrid Kreissig (Mannheim/D), George William Aylward (London/UK), Harvey Lincoff (New York/USA)

Speakers: George William Aylward (London/GB), ThorstenBöker (Dortmund/D), Ingrid Kreissig (Mannheim),Harvey Lincoff (New York/USA), William F. Mieler(Chicago/USA), Shuichi Yamamoto (Sakura/J)


10:301. Diagnostics: 1.1. The 4 Rules to find the primarybreakIngrid Kreissig (Mannheim/D)

10:401.2. Lattice degeneration and breaks in the felloweye: What to do or not to do?George William Aylward (London/GB)

10:502. Minimal E.O. Surgery (Segm. Sponge(S),Nondrainage): Indications, complications, longtermresultsThorsten Böker (Dortmund/D)

11:003. Pneumatic Retinopexy: Indications, complica-tions, longterm resultsWilliam F. Mieler (Chicago/USA)

11:104. Cerclage With Drainage: A look at cerclage after50 yearsHarvey Lincoff (New York/USA)

11:205. Primary Vitrectomy: Rationale, indications, com-plications, longterm resultsShuichi Yamamoto (Sakura /J)

11:306. Reoperation: The 4 Rules to find the undetectedbreakIngrid Kreissig (Mannheim/D)

11:407. Comparison of Present Techniques for Repair ofPrimary Retinal Detachment: Morbidity, results,socio-economic issuesThorsten Böker (Dortmund/D)


Posters

WOC® 2010 263

Vorsprung durch Wissen

1. Mehr Know-howMonat für Monat neueste wissenschaftliche Erkenntnisse für Diagnostik und Therapie

2. Mehr FortbildungMit CME-Beiträgen Wissen auff rischen und Punkte sammeln

3. Mehr Benefi tBeiträge komfortabel und schnell online recherchieren

Name, Vorname

Straße, Hausnummer

PLZ, Ort

Datum, Unterschrift

0500

21

www.DerOphthalmologe.de

ò Ja, ich möchte die nächsten 3 Ausgaben der Zeitschrift Der Ophthalmologe kostenlos testen.

Sollte ich von der Zeitschrift nicht überzeugt sein, teile ich Ihnen dies innerhalb von 14 Tagen nachErhalt des 3. Heftes mit. Wenn ich die Zeitschrift weiterlesen möchte, brauche ich nichts zu tun und erhalte die Zeitschrift zum Preis von 327,- EUR inkl. 7% MwSt. (12 Hefte jhrl.) in 2010 für min-destens 1 Jahr (als Ärztin/Arzt in Aus- und Weiterbildung, Student/in 196,20 EUR inkl. 7% MwSt. – Nachweis anbei) zzgl. Versandkosten (Inland 26,- EUR/Ausland 68,- EUR). Das Abonnement kann ich bis 2 Monate vor Ende des Bezugszeitraumes kündigen. (Preisänderungen und Irrtümer vorbehalten)

Jetzt 3 Ausgaben

gratis testen!

Faxantwort: 0 62 21-3 45-42 29Oder einsenden an: Springer Customer Service Center GmbHHaberstraße 7 · D-69126 Heidelberg E-Mail: [email protected] · Tel.: 06221-345-4303

ò Ja, bitte senden Sie mir aktuelle Angebote und Newsletter gerne auch per E-Mail:

E-Mail

Ich bin tätig in ò Klinik ò Praxis

Springer-Verlag GmbH, Tiergartenstraße 17, 69121 Heidelberg

Zweigniederlassung der Springer-Verlag GmbH, Heidelberger Platz 3, 14197 Berlin · Amtsgericht Berlin-Charlottenburg, HRB 91881 B

Geschäftsführer: Derk Haank, Martin Mos, Peter Hendriks · Springer ist Teil der Fachverlagsgruppe Springer Science + Business Media

P-SA-008Benefits of using ASPHERIC implants in CataractsurgeryMohamed Attitich (Rabat/MA)

P-SA-009Bi-axial Prechoping with two 25 G cannulas at theiris plane.Arturo Pèrez-Arteaga (Tlalnepantla/MEX)

P-SA-010Comparison of biometric measurements with ultrasound and a new laser interference biometerin cataract eyesMike P. Holzer, Charlotte Jepsen, Tanja M. Rabsilber,Gerd U. Auffarth (Heidelberg/D)

P-SA-011Complication rate and risk factors for intraoperativecomplications in resident-performed phacoemulsifi-cation surgeryWolfgang Herrmann, Andrea briszi, Horst Helbig(Regensburg/D)

P-SA-012Correlation between risk factors and intraoperativecomplications in phacoemulsification surgery performed by traineesAnna Praidou, Evgenia Kanonidou, Matheos Antoniadis, Aggeliki Doudou, Sofia Androudi, Periklis Brazitikos (Thessaloniki/GR)

P-SA-013Does implantation of a Capsular Tension Ring incontext with phacoemulsification influence the refractive outcome in highly myopic eyes?Andrea Schild, Andre Rosentreter, Martin Hellmich,Thomas Dietlein (Cologne/D, Duesseldorf/D)

P-SA-014Ectopia Lentis – a vitreo-retinal surgical approachSeddiqu Salahim (Sana'a/ADN)

P-SA-015Effectiveness of Cataract Surgery with Phacoemulsification for NanophthalmosKaori Suzuki, Yukihiko Suzuki, Asaka Kudou, Mitsuru Nakazawa (Hirosaki/J)

P-SA-024Manual Small Incision Cataract Surgery (ManualSICS) – a friend in need is a friend indeedBhaskar Bhattacharyya (Kolkata/IND)

P-SA-025MRSA Endophthalmitis – A Wake-up Call for theOphthalmologistGerald Schultz (Indio/USA)

P-SA-026Multicenter and site-specific results on behaviourand performance of the Tecnis 1-Piece IOLChristopher Wirbelauer, Duy-Thoai Pham (Frankfurt(Oder)/D, Berlin/D)

Saturday, 5 June 2010 15:30 to 17:00

Posters

Poster exhibition of Poster P-SA-001 to P-SA-282.All poster authors will attend their posters from15:30 to 17:00 hrs.

Moderation Poster sessions on Saturday Chairs:Gerd Geerling (Wuerzburg)Dušica Pahor (Maribor)

Co-Chairs:Christoph M. E. Deuter (Tübingen)H. Burkhard Dick (Bochum)Michael Diestelhorst (Cologne)Stephan Eckert (Ulm)Lars-Olof Hattenbach (Ludwigshafen)Mathias Seeliger (Tübingen)Alexander Reis (Triesen)Heimo Steffen (Wuerzburg)

Cataract/Biometry 1 P01

P-SA-001Accuracy of IOLMaster in axial length measurementin silicone oil-filled eyesJing Sun, Situo Liang (Shanghai/CN)

P-SA-002Accuracy of the IOL calculation formula SRK/T vs. Haigis for the Acri.Smart 46LC (now CT Asphina409M)Ruediger Schmid, Holger Luedtke (Ulm/D)

P-SA-003Application of Femtosecond Laser in Cataract Surgery for the Creation of Multi-planar Self-Sealing Corneal IncisionsRoger Steinert, Enrique Baragan (Irvine/USA)

P-SA-004Application of Tokyo University Egogram in caseswith multifocal IOLHiroko Bissen-Miyajima, Shinichi Oki, Mami Yoshino, Izumi Kamei (Tokyo/J)

P-SA-005Argentina's Flag- phaco in an intumescent maturecataract (managing a run-out rhexis)Manish Mahendra (Kanpur/IND)

P-SA-006Astigmatism correction after cataract surgery, toric IOL vs conventional IOL + opposite clear corneal incisionsDaniel Nahra (Barcelona/E)

P-SA-007Axial length measurement in eyes with macularedema: A-scan ultrasound versus IOLMaster.Jing Sun, Situo Liang (Shanghai/CN)

Satu

rday

, 5 Ju

ne

Post

ers

265WOC® 2010

P-SA-027Office based cataract surgery Architectural andTechnical choices for an independence of hospitalisation structure Three Years of an innovative concept in France Efficiency, Quality andcosts.François Blondeau (Chateau d'Olonne/F)

P-SA-028Optimizing Fluidics using both Venturi and Peri-staltic Pumps during Phacoemulsification SurgeryUday Devgan (Los Angeles/USA)

P-SA-029Postoperative Ptosis following cataract surgeryYanin Suwan (Songkhla/T)

P-SA-030Reliable Presbyopia surgery with a toric bifocalMICS IOL (BIOL) – 2 years and 70 eyesDetlev Breyer (Duesseldorf/D)

P-SA-031Results of a prospective study to evaluate the quality of vision with two aberration-free asphericintraocular lenses (with and without blue light-filter) vs. a conventional spherical IOLMichael Wolter-Roessler, Michael Küchle (Lauf/D,Erlangen/D)

P-SA-032Safety and efficacy of phacoemulsification in various types of post uveitic cataractsManish Mahendra (Kanpur/IND)

P-SA-033Stenotrophomonas maltophilia endophthalmitisafter cataract extraction.Marcelino Rio Torres, Meisy Ramos Lopéz, Juan Raúl Hernández Silva (Habana/C)

P-SA-034Surgically induced astigmatism (SIA) after coaxialmicro incision cataract surgery (MICS) through2.2mm incision in comparison to small incision cataract surgery (SICS) through 3.0mm incisionBernhard Steinhuber, Lilly Speicher, Wolfgang Philipp (Innsbruck/A)

P-SA-035Technique for Centration of the Tecnis AsphericMulti-focal Lens Implant in the Visual Axis of Cataract Surgery PatientsUday Devgan (Los Angeles/USA)

P-SA-036The meaning of galactose metabolism for congenital cataract – a 12-year analysisChristoph Raum, Gabriele Gusek-Schneider, Anselm G. M. Jünemann (Erlangen/D)

Saturday, 5 June 2010 15:30 to 17:00Sa

turd

ay, 5

June

Post

ers

266 WOC® 2010

P-SA-037The power definition of multifocal IOL using IOLMaster and A-scan biometryMami Yoshino, Hiroko Bissen-Miyajima, Kunihiko Nakamura, Shinichi Oki (Tokyo/J)

P-SA-038Tilt and decentration of five kinds of aspheric IOLsin vivo from Scheimpflug imagingXiaojie Xing, Xin Tang, Hui Song (Tianjin/CN)

P-SA-039Toric IOL Versus Adjustable Incision for Treatment of Mild to Moderate Astigmatism in Phacoemulsifi-cationKhaled Kotb Ali (Cairo/ET)

P-SA-040Visual performance of +3.0D aspheric AcrySofReSTOR Apodized Diffractive IOL: A ProspectiveComparative TrialFang Tian, Hong Zhang (Tianjin/CN)

Cornea/Eye Bank: Surgical Therapy P02

P-SA-041A technique to salvage big-bubble deep lamellarkeratoplasty after inadvertent full-thickness trephinationSiamak Zarei-Ghanavati, Mehran Zarei-Ghanavati(Mashhad/IR)

P-SA-042Autologic Perforating KeratoplasyKhakima Karim-Zade, Safarali Mirsoev, Alexander Enikeev (Dushanbe/TAD)

P-SA-043Better visual outcomes using a microkeratome forendothelial donor lamella preparation duringDSAEK compared with the preparation using afemtosecond laserJan Markus Vetter, Melissa Faust, Walter Sekundo(Mainz/D)

P-SA-044Central and peripheral corneal iron deposits afterthe AcuFocus Intracorneal Inlay (ACI 7000) implantationGerhard Nix, Orang Seyeddain, Wolfgang Riha,Melchior Hohensinn, Günther Grabner, Alois Dexl,Elisabeth Messmer (Salzburg/A, Mänchen/D)

P-SA-045Clinical confirmation of DMEK possibility after previous DSEK surgeryRosa Gundorova, Oganes Oganesyan, Mary Smetanina, Daria Danilova (Moscow/RUS)

P-SA-046Clinical evaluation of highly aberrated eyes: the importance of the patient self perception.Juliane Paranhos (Goiania/BR)

P-SA-047Clinical Evaluation of non-Descemet’s Stripping Automated Endothelial Keratoplasty (nDSAEK)Toshinori masaki, Akira Kobayashi, Hideaki Yokogawa, Kazuhisa Sugiyama (Kanazawa/J)

P-SA-048Clinical outcomes after DMEK-S surgery combinedwith cataract extractionDeli Sivekova, Magdalena Vokrojova, KaterinaLiehneova, Magdalena Netukova, Pavel Studeny(Prague/CZ)

P-SA-049Clinical outcomes in patients 2 years after DMEK-SsurgeryPavel Studeny, Deli Sivekova, Katerina Liehneova,Magdalena Vokrojova, Michal Hyndrak (Prague/CZ)

P-SA-050Comparative study of steam cautery and subabla-tive Er:YAG laser therapy in microbial keratitisJuergen Kampmeier, Peter Wagner, Simone Stop-per, Eva Koler, Gerhard K. Lang, Detlef Russ (Ulm/D)

P-SA-051Comparison of corneal inflammation after flap creation using a mechanical microkeratome and a 200 kHz femtosecond laser – an in vitro organculture studyWolfgang Mayer, Armin Wolf, Martin Grüterich,Carlo Lackerbauer, Anselm Kampik, Daniel Kook(Munich/D)

P-SA-052Comparison of Pterygium Recurrence rate afterpterygium resection and conjunctival autograftwith additive phototherapeutic keratectomyJulia Promesberger, Sharmila Kohli, MatthiasSchmidt, Constantin E. Uhlig (Münster/D)

P-SA-053Complications after penetrating and lamellar keratoplasty at pations with outcomes of herpetickeratitisTetyana Gaydamaka, Galyna Drozhyna, Sergiy Grechko (Odessa/UA)

P-SA-054Conjunctival covering of autologus stem cells in thetreatment of the herpetic neurotrophic keratopathyEygene Ilyina, Pavel Bezditko (Kharkov/UA)

P-SA-055Corneal Intrastromal Implantation Surgery (CISIS)for KeratoconusAlbert Daxer (Ybbs/A)

P-SA-056Deep Anterior Lamellar Keratoplasty for PellucidMarginal Corneal DegenerationAbdullah Al-Turbaq (Riyadh/SA)

P-SA-057Deep Anterior Lamellar Keratoplasty for Treatmentof Herpetic Corneal ScarsBanu Torun Acar, Suphi Acar (Istanbul/TR)

P-SA-058Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) for Congenital Hereditary Endothelial Dystrophy (CHED)Ali Alrajhi (Riyadh/SA)

P-SA-059Disturbance of tight junction proteins in gelatinousdrop-like dystrophyEnken Gundlach, Claudia Auw-Hädrich, ConstantinUhlig, Thomas Reinhard (Freiburg/D)

P-SA-060DSAEK with Carriazo-Pendular-Mikrokeratome anda newly designed Artificial Anterior Chamber – firstclinical resultsJan Darius Unterlauft, Katharina Weller, JohannSchmiedl, Gunda Kann, Kasper Berit, Gerd Geerling(Wuerzburg/D)

P-SA-061DSAEK, Preparation of the donor tissue with theCarriazo-pendular-microkeratome and an artificialanterior chamber.Gregor Schaaf, Arash Amjadi, Norbert Schrage(Hürth/D, Cologne/D)

P-SA-062Evaluation of Three Lamellar Keratoplasty Techniques in Keratoconic Eyes: Results One YearAfter Surgery.Luigi Mosca (Rom/I)

P-SA-063Evolution of astigmatism in keratoconic eyes implanted with intracorneal ring segmentsDavid Pablo Piñero Llorens, Jorge Alió (Alicante/E)

P-SA-064Factors influencing the consent for cornea donationrequested via telephone interviewMartin Hermel, Andre Steinfeld, Sabine Salla,Nicole Hamsley, Peter Walter, Stefanie Stiel(Aachen/D)

P-SA-065Histopathologic changes after deep anterior lamellar keratoplasty (DALK) using the “big-bubbletechnique”Joachim Braun, Carmen Rummelt, Ursula Schlötzer-Schrehardt, Friedrich Kruse, Claus Cursiefen (Erlangen/D)

P-SA-066Impact of histopathological findings for the treatment strategy of Schnyder corneal dystrophy(SCD)Tobias Hager, Andrea Hasenfus, Berthold Seitz(Homburg/D)

Saturday, 5 June 2010 15:30 to 17:00

Satu

rday

, 5 Ju

ne

Post

ers

267WOC® 2010

Saturday, 5 June 2010 15:30 to 17:00

P-SA-077Regeneration of subepithelial nerve plexus and itscorrelation with corneal sensation after fs-LASIK: a 6 month follow-up studyAndrey Zhivov, Oliver Stachs, Philipp Martius, Marcus Blum, Wilfried Bissmann, Rudolf F. Guthoff(Rostock/D, Erfurt/D)

P-SA-078Remote results of deep lamellar keratoplasty (DLK)at keratoconus III-IV stage. Nadiya Bobrova, Elena V. Ivanovskaya, G. Droggina,Tetyana B. Gaydamaka, Borys M. Kogan(Odessa/UA)

P-SA-079Results of penetrating keratoplasty in keratoconusOmar Beltaief, Khalil Errais (Tunis/TN)

P-SA-080Rethinking Keratoconus with BiopticsSusan Senft, Dalel Tartak, Maria Tartak (Kailua-Kona/USA)

P-SA-081Salzmann s nodular degeneration on a cornealgraft twenty-one years after penetrating keratoplastyArnulf G. Schnaidt, Zisis Gatzioufas, Andreas C.Schröder, Ursula Löw, Susanne C. Goebels, Frank Schirra, Berthold Seitz (Homburg/D)

P-SA-082Superficial keratectomy, PTK and MMC as combined treatment option for Salzmann’s NodularDegenerationStephan Linke, Toam Katz, Gisbert Richard, R. Baile,Riad Khaireddin (Hamburg/D)

P-SA-083Surgical treatment for suppurative corneal ulcersHalina Sitnik (Minsk/BY)

P-SA-084Traumatic Wound Dehiscence after Deep AnteriorLamellar KeratoplastySiamak Zarei-Ghanavati, Mehran Zarei-Ghanavati(Mashhad/IR)

P-SA-085Treating hydrops keratoconus by epikeratoplastywith corneocompressionMukharram Bikbov, Guzel Bikbova (Ufa/RUS)

P-SA-086Visual perception changes and optical stability afterICRS implantation: Comparison between 4 monthsand 1 year after surgery.Juliane Paranhos, Paulo Schor (Goiania/BR, São Paulo/BR)

P-SA-067In vivo confocal microscopy of AcuFocus corneal inlaysWolfgang Riha, Orang Seyeddain, Melchior Hohensinn, Gerhard Nix, Günther Grabner,Elisabeth Messmer (Innsbruck/A, Munich/D)

P-SA-068Interface reflectivity measured by Pentacam and visual outcome following Descemet stripping automated endothelial keratoplasty (DSAEK) Sonja Ute Heinzelmann, Daniel Böhringer, Philip Maier, Thomas Reinhard (Freiburg/D)

P-SA-069lamellar corneal tattooing for better cosmetical appearance in corneal scarsSyska Widyawati, Johan Hutauruk (Jakarta/RI)

P-SA-070Long-term outcome of penetrating keratoplastycombined with simultaneous vitrectomy withouttemporary keratoprosthesisAmelie Pielen, Bernd Junker, Daniel Böhringer, Hansjürgen T. Agostini, Thomas Reinhard(Freiburg/D)

P-SA-071Morphological and Functional Correlations in Riboflavin UV A Corneal Collagen Cross-Linking forKeratoconusCosimo Mazzotta, Stefano Baiocchi, Rosario Denaro, Aldo Caporossi (Siena/I)

P-SA-072Nd:YAG laser supported superficial keratectomy fordeep band keratopathyHeinrich Holak, Katja Schielke, Malgorzata Jaworska, Nikolai Holak, Heinrich Holak (Salzgitter/D)

P-SA-073Outcomes after Type 1 Boston Keratoprosthesis andGlaucoma Tube ShuntJessica Wong, Thasarat Vajaranant, Jacob Wilensky,Jose de la Cruz (Chicago/USA)

P-SA-074Pneumodescematopexy using 6 % C3F8Sheshadri Mahajan (Nasik/IND)

P-SA-075Poor corneal wettability, its influence on surface ablations outcomes.Claes Feinbaum (Landskrona/S)

P-SA-076Recent tendencies in indications for penetratingkeratoplasty in BulgariaNikolay Surchev, Yordanka Kirilova, TatyanaHergeldzhieva-Fileva, Petja Vassileva (Sofia/BG)

Satu

rday

, 5 Ju

ne

Post

ers

268 WOC® 2010

Saturday, 5 June 2010 15:30 to 17:00

P-SA-096RDH5 Mutation Analysis in a Series of Israeli Patients Affected by Fundus Albipunctatus: Detection of Novel Mutations.Eran Pras, S. Ravech, D. Sharon, E. Banin, Y. Rotenstreich, I. Avni, A. Abu (Qiryat Ono/IL)

P-SA-097Single Nucleotide Polymorphisms in Promoter Region of Matrix Metalloproteinase 1, 2, and 3 inJapanese with High MyopiaHisako Hayashi, Hideo Nakanishi, Ryo Yamada,Kenji Yamashiro, Isao Nakata, Noriaki Shimada,Kyoto Ohno, Manabu Mochizuki, Mineo Ozaki,Shin Yoshitake, Shoji Kuriyama, Masaaki Saito, Tomohiro Iida, Nagahisa Yoshimura (Kyoto/J)

P-SA-098TGFBI gene mutations caused a corneal dystrophyin Ukranian familiesGalyna Drozhyna, Natalia Pasiechnikova, VladimirPampucha, Ljudmila Livchits, Tetyana Gaydamaka,Valerij Vit (Odessa/UA)

P-SA-099The 972G>C polymorphism of the hMYH gene inAMDJerzy Szaflik, Ewelina Synowiec, UrszulaKolodziejska, Jacek P. Szaflik, Janusz Blasiak(Warszawa/PL)

Glaucoma P04

P-SA-100One-Year Incidence of Dry Eye with Latanoprost(LAT) or Travoprost-Z (TRAV-Z) in Patients WithOpen-Angle Glaucoma (OAG) and Ocular Hyper-tension (OH)Sameer Kotak, Gail Schwartz, Joel Fain, Jack Mardekian (New York/USA)

P-SA-10123-gauge pars plana Vitrectomy for the Manage-ment of Malignant Glaucoma after Ex-PRESS MiniGlaucoma ShuntMounira J. Dridi, Mathias Maier, Jens Huber, Chris Patrick Lohmann, Aharon Wegner (Munich/D)

P-SA-102Ability of the Flashlight Test to Discriminate Be-tween Eyes with Open and Narrow AnglesCarolina Pelegrini Barbosa, Bruno Landgren, AlineKatia Siqueira Sousa, Tiago S. Prata, AugustoParanhos (São Paulo/BR)

P-SA-103Analysis of light-dark change of iris and anteriorchamber angle in the non-glaucoma subjects withor without exfoliation syndromeTakanori Mizoguchi (Nagasaki/J)

Genetics P03

P-SA-087A Novel Stop Codon Mutation in Rhodopsin Genein Two Indonesian Families with Autosomal Recessive Retinitis PigmentosaArief Kartasasmita, Akira Murakami, Keiko Fujiki,Takuro Fujimaki, Iwan Sovani, Erwin Iskandar (Bandung/RI, Tokyo/J)

P-SA-088ABCA4 and ROM1: Implications for modification of the PRPH2-associated macular dystrophy phenotypeCharlotte Poloschek, Michael Bach, Wolf Lagrèze,Esther Glaus, Johannes Lemke, Wolfgang Berger,John Neidhardt (Freiburg/D)

P-SA-089Clinical and Genetic Investigation of Isolated Microspherophakia in a Consanguineous TunisianFamilyOuechtati Farah, Ben Yahia Salim, Nouira Sonia,Chakroun Sonia, Abdelhak Sonia, Moncef Khairallah (Monastir/TN)

P-SA-090Detection of polymorphism in códon 72 of genep53 in glaucoma patients and its socio-economiccorrelationRodrigo Egidio, Francisco Rodrigues, Euler Franco,Katia Verolli (Goiania/BR)

P-SA-091Exclusion of known chromosomal loci in a familywith dominant optic atrophy: Evidence for novelgenetic background?Monika Oldak, Jacek P. Szaflik, Aneta Federowicz,Ewa Langwinska-Wosko, Kamil Szulborski, JoannaKosi ska, Rafal Ploski, Jerzy Szaflik (Warsaw/PL)

P-SA-092Mutation screening of CHX10 and RAX genes inChinese nanophthalmosJing Tao, Ningli Wang, Naiqing Weng, Bowen Zhao,Qian Liu (Beijing/CN)

P-SA-093Patient and Control Recruitments for Genetic Inves-tigation of Macular DiseasesDavid Liu, Scarlet Chan, Dennis Lam, Calvin Pang(Hong Kong/HK)

P-SA-094Polymorphism in codon of gene p53 in glaucomapatients and its correlation with systemic diseasesFrancisco Rodrigues, Rodrigo Egidio, Euler Franco,Katia Verolli (Goiania/BR)

P-SA-095Positional Cloning of Disease Gene in A ChineseXLRP PedigreeQingsong Yang, Ningli Wang, Hongyan Jia, Kai Ma,Liqin Gao (Beijing/CN)

Satu

rday

, 5 Ju

ne

Post

ers

269WOC® 2010

Saturday, 5 June 2010 15:30 to 17:00

P-SA-112Comparison of Dynamic Contour Tonometry vs.Goldmann Applanation Tonometry and Biometry of the Anterior Segment pre and post Cataract SurgeryMitja Alexander Heinrich, Achim Langenbucher,Wolfgang Behrens-Baumann, Arne Viestenz(Magdeburg/D, Homburg/D)

P-SA-113Comparison of functional and morphological diagnostics in glaucoma patients and healthy subjectsMatthias Klamann, Anja Grünert, Anna-Karina B.Maier, Florian M. A. Heußen, Sibylle Winterhalter,Antonia M. Joussen, Klaudia K. Huber (Berlin/D)

P-SA-114Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography to Detect the Retinal Nerve Fiber Layer Thickness in Primary AngleClosure GlaucomaMei-Ju Chen, Ching-Yu Chen, Catherine Jui-LingLiu, Ching-Kuang Chou, Shui-Mei Lee (Taipei/TJ)

P-SA-115Comparison of the effect of Latanoprost andTafluprost on 24-hour intraocular pressure in Normal-tension GlaucomaNoriko Yasuda, Kenji Nakamoto (Tokyo/J)

P-SA-117Correlation between central corneal thickness and retinal nerve fiber layer thickness in primaryopen-angle glaucoma patientsLachaya Orapiriyakul, Boonchai Wangsupadilok(Hatyai Songkhla/T)

P-SA-118Correlation Between Bleb Trabeculectomy Morphol-ogy with Intraocular Pressure in Primary GlaucomaDian Estu, Edi Supiandi, Widya Artini, Joedo P (Jakarta/RI)

P-SA-119Could smoking be regarded as an additional riskfactor in elder women with primary open angleglaucoma?Vicente Zanon-Moreno, Jose Javier Garcia-Medina,Maria A. Moreno-Nadal, Pedro Sanz-Solana, MariaD. Pinazo-Duran (Valencia/E)

P-SA-120Effect of anti-glaucoma therapy on 24-hour IOP forprimary glaucoma patients with open angle andangle closureShoichi Sawaguchi, Hiroshi Sakai, YoshikuniArakaki, Ichiko Medoruma, Eriko Tomoyose (Nishihara/J)

P-SA-104Arcuate scotoma suggests optic disc may be sinking in glaucomaSyed Hasnain (Porterville/USA)

P-SA-105Assessment of the ISNT Rule by Peripapillary RetinalNerve Fiber Thickness in Primary Open Angle andAngle-Closure GlaucomaTsung-Yu Ho, Ching-Yu Cheng, Catherine Jui-LingLiu, Pei-Jung Lee, Yu-Chieh Ko, Shui-Mei Lee(Taipei/TJ)

P-SA-106Associations of FOS Curve, False-Positive and False-Negative Responses with the Performance ofFully Automated Kinetic Perimetry (Program K) inVirtual PatientsShigeki Hashimoto, Chota Matsumoto, SachikoOkuyama, Sonoko Takada, Eiko Arimura, Fumi Tanabe, Jens Paetzold, Ulrich Schiefer,Yoshikazu Shimomura (Osaka-Sayama/J, Tübingen/D)

P-SA-107Bleb-related Infection after Filtering SurgeryShinya Komori, Nobumichi Takahashi, NobuhideHori, Akira Sawada, Kiyofumi Mochizuki, TetsuyaYamamoto (Gifu/J)

P-SA-108Clinical features of hypoperfusion retinopathy complicating neovascular glaucomaShihui Wei (Beijing/CN)

P-SA-109Clinical usefulness of CLOCK CHART® for detection of visual field abnormalities in patientswith glaucoma and macula diseasesMariko Shoji, Chota Matsumoto, SachikoOkuyama, Sonoko Takada, Eiko Arimura, Shigeki Hashimoto, Fumi Tanabe, Yoshikazu Shimomura (Osaka Sayama/J)

P-SA-110Color Doppler imaging correlations with quantitative analysis of the optic disc in primaryopen angle glaucoma.Corina Tudor (Sibiu/RO)

P-SA-111Comparing the effect of POAG serum on the protein profiles of neuroretinal cells and human trabecular meshwork cellsKatharina Bell, Gail Seigel, Lars Choritz, NorbertPfeiffer, Franz Grus (Mainz/D)

Satu

rday

, 5 Ju

ne

Post

ers

270 WOC® 2010

Saturday, 5 June 2010 15:30 to 17:00

P-SA-129Inter-Eye Symmetry of Corneal Biomechanical Properties in Glaucomatous EyesAnthony Realini, Robert Weinreb(Morgantown/USA, La Jolla/USA)

P-SA-130New options for glaucoma therapyTomislav Ivandic, Boris Ivandic (Munich/D)

P-SA-131Postural changes of intraocular pressure affect theinter-eye difference both in visual field damage andretinal nerve fiber layer thickness reduction in thesame patients with primary open-angle glaucoma.Junji Mizokami, Kumiko Ishikawa, Maiko Naka, Koji Hirai, Yuko Yamada, Makoto Nakamura, Akira Negi (Hyogo/J)

P-SA-132Quality of life (QOL) among patients with primaryopen angle glaucoma (POAG)Iman Fahmy, Manal H. Abu El Ela (Giza/ET)

P-SA-133Reliability of ICare tonometer in different measure-ment situationsGombos Katalin, Kalman Reka, Zsarnoti Katalin(Budapest/H)

P-SA-134Risk Factors for Progression to Advanced Glaucomain GhanaAndrew Francis, Michael Gyasi, Li Deng, Haiyan Gong (Boston/USA)

P-SA-135Role of functional single nucleotide polymorphismsof MMP-1, MMP-2 and MMP-9 in open angle glaucomasGeorg Mossböck, Martin Weger, Christoph Faschinger, Christina Zimmermann, Yosuf El-Shabrawi (Graz/A)

P-SA-136Seasonal Isolates from Bacteria in Bleb Surface of Eyes Trabeculectomized with Adjunctive Mitomycin CNobumichi Takahashi, Shinya Komori, ToshihikoKatada, Akira Sawada, Kiyofumi Mochizuki, Tetsuya Yamamoto (Gifu/J)

P-SA-137Selective Laser Trabeculoplasty: Hypotensive Efficacy, Anterior Chamber Inflammation and Postoperative PainPaolo Frezzotti, Ilaria Motolese, Sabrina Peruzzi,Vincenzo Mittica, Pietro Mittica, Mario Fruschelli,Eduardo Motolese (Siena/I)

P-SA-121Effect of soft contact lens fitting on the non-contact tonometry readings and corneal behaviorduring tonometry observed by high speed cameraYoshiaki Kiuchi, Joji Takenaka, Makoto Kaneko,Kenji Yamada, Takumi Gosho (Hiroshima/J)

P-SA-122Efficacy of Rho-kinase inhibition in reducing glial reactivity and promoting retinal ganglion cell (RGC)survival in vitroAysegül Tura, Karl-Ulrich Bartz-Schmidt, SigridHenke-Fahle (Lübeck/D, Tübingen/D)

P-SA-123Evaluation of peripheral anterior chamber depth of fellow eyes of acute angle closure by ScanningPeripheral Anterior Chmaber Depth AnalyzerYoshikuni Arakaki, Ichiko Medoruma, Michiko Yonahara, Eriko Tomoyose, Yuko Nakamura, Hiroshi Sakai, Shoichi Sawaguchi(Nishihara/J)

P-SA-124Exudative retinal detachment in a child with Sturge-Weber syndrome three years after trabeculotomy for congenital glaucomaIsabel Oberacher-Velten, Tina Dietrich, Roman Regler, Horst Helbig (Regensburg/D)

P-SA-125Glaucoma monitoring quality and its role in the disease progression.Oksana Vitovska (Kiev/UA)

P-SA-126Glaucoma Short-term Progression Detected by Retinal Thinning Assessed by Using Spectral-Domain Optical Coherence TomographySatoshi Mori, Masanori Hangai, Noriko Nakano,Masayuki Nukada, Hideo Nakanishi, Yuriko Kotera,Hanako Ikeda, Hajime Nakamura, Nonaka Atsushi,Nagahisa Yoshimura (Kyoto/J)

P-SA-127How to Preserve Conjunctiva During Glaucoma Surgery?Jorge Topete-Jimenez (Guadalajara/MEX)

P-SA-128In vitro evaluation of apoptic effects of single andcombined use of alpha tocopherol and current antifibrotics, in human tenon’s fibroblast and endothelium cellsKaya N. Engin, Bülent Yemi ci, Serap Erdem Kuruca,Ugur Serbes, Gül Özcan Arıcan, Kadriye Akgün Dar,Ebru Gürel, Selim Kocabora, Beyza Çetin, SabriyeKaradenizli (Istanbul/TR)

Satu

rday

, 5 Ju

ne

Post

ers

271WOC® 2010


turd

ay, 5

June

Post

ers

272 WOC® 2010

P-SA-147Color stimulator for electrophysiological investiga-tions in the human eyeDietmar Link, Sascha Klee, Bernd Ulrich Seifert, Jens Haueisen (Ilmenau/D)

P-SA-148Color-vision disturbances in patients with occlusivearterial disease with or without coronary heart diseaseCarl Erb, Eva-Maria Fischer, Stefanie Lichtenberg(Berlin/D)

P-SA-149Comparison of visual field indices of flimmerperimetry (Pulsar) with standard achromatic perimetry (Octopus 311) in patients with cyclic citrullinated peptide – positive rheumatoid arthritis(CCP-RA) in comparison to controls.Katja Göbel, Carl Erb (Berlin/D)

P-SA-150Contrast sensitivity, ocular higher-order aberration,and corneal surface light scattering after instillationof timolol maleate gel-forming solution and brinzolamide ophthalmic suspensionTakahiro Hiraoka, Masakazu Daito, FumikiOkamoto, Takahiro Kiuchi, Tetsuro Oshika(Tsukuba/J)

P-SA-151Functional and hemodynamic parameters in glaucoma patients with increased intraocular pressure.Elena Ponomareva, Armine Kazaryan, Ludmila Martinova (Moscow/RUS)

P-SA-152Functional estimates of inner retinal output andcorresponding measures of nerve fibre layer thickness in healthy eyesIeva Sliesoraityte, Bogomil Voykov, Eric Tröger,Anne Kurtenbach, Eberhart Zrenner (Tübingen/D)

P-SA-153Occult Macular Dystrophy – case reportDorota Pojda-Wilczek, Wanda Romaniuk (Katowice/P)

P-SA-154Optimization of electrode position in recordingmultifocal visually evoked potential in Japanese individualsKumiko Ishikawa, Junji Mizokami, Maiko Naka, Koji Hirai, Yuko Yamada, Makoto Nakamura, Akira Negi (Kobe/J)

P-SA-138The different changes of anterior segment aftercataract surgery in normal eyes and eyes with filtered primary angle closured glaucomaLi Mei, Xing Liu, Dandan Wang, Ye Yang, Yangfa Zeng, Jingjing Huang (Guangzhou/CN)

P-SA-139The Impact of Glaucoma Stage on the Ocular BiomechanicsMichael Haustein, Savvakis Hadjiraftis, Lutz E. Pillunat, Eberhard Spoerl (Dresden/D)

P-SA-140The Magnitude and Determinants of Intentionaland Non-Intentional Adherence to Glaucoma Medication in Individuals with GlaucomaXue Ling Chong, Tin Aung, Gwyneth Rees, Wan Ling Wong, Ecosse Lamoureux(Singapore/SGP)

P-SA-141The Prevalence of primary open-angle Glaucoma ina Moroccan population: 1182 casesNawal Jennane, Tarik El Alloussi, Youssef Zekraoui,Adil Megzari, Amina Berraho (Rabat/MA)

P-SA-142Trabeculectomy with Amniotic Membrane Transplantation in Refractory GlaucomaAsaad Ghanem, Ihab Nafie, Hatem El-Awady, Salah Mady (Mansoura/ET)

P-SA-143Variability of serum oxidative stress indicators according to biochemical datae and clinical parameters of glaucomaKaya N. Engin, Bülent Yemisci, Ulviye Yigit, Ahmet Agaçhan, Cihan Coskun (Istanbul/TR)

Physiological Optics/Psychophysics/ P05Electrophysiology

P-SA-144A New ERG Paradigm to Evoke S-cone PotentialsAndreas Schatz, Andre Messias, Robert Wilke, Eberhart Zrenner (Tübingen/D)

P-SA-145Application of a fundus-controlled color stimulatorfor selective cone excitationSascha Klee, Dietmar Link, Patrick Bessler, Jens Haueisen (Ilmenau/D)

P-SA-146Blue-blocking filters are of minor effect on retinal function as assessed with the multifocalelectroretinogramWolfgang Behrens-Baumann, Michael Hoffmann, F. Spors, Achim Langenbucher , Sven Walter, J. Reupsch, Arne Viestenz (Magdeburg/D, Homburg/D)

Saturday, 5 June 2010 15:30 to 17:00

Satu

rday

, 5 Ju

ne

Post

ers

273WOC® 2010

P-SA-164Comparison of Spectral-Domain Optical CoherenceTomography and Fundus Autofluorescence in Patients with Geographic AtrophyRamzi Gilbert Sayegh, Christian Simader, UlrikeScheschy, Alessio Montuoro, Christopher Kiss, Stefan Sacu, David Kreil, Christian Prünte, UrsulaSchmidt-Erfurth (Vienna/A)

P-SA-165Correlation between Visual Acuity and Spectral Domain Optical Coherence Tomography Features in Patients with Neovascular Age-related MacularDegenerationSandra Liakopoulos, Tina Ristau, Pearse A. Keane,Jared Updike, Alexander C. Walsh, Alicia Engin,Steffen Hillebrand, Bernd Kirchhof, SriniVas R.Sadda (Cologne/D, Los Angeles/USA)

P-SA-166Detection of Esterified Cholesterol in MurineBruch’s Membrane Wholemounts with a NovelCholesterol DyeMarie Christine Dettbarn, Martin Rudolf, Johannes Knobloch, Salvatore Grisanti (Lübeck/D)

P-SA-167Development of a Novel Method to Detect SingleNucleotide Polymorphism of Age-related Macu-lopathy Susceptibility 2 (ARMS2) Gene for ClinicalLaboratoriesKenji Yamashiro, Norimoto Gotoh, Hideo Nakanishi, Hisako Hayashi, Isao Nakata, Akitaka Tsujikawa, Atsushi Otani, Hiroshi Tamura,Sotaro Ooto, Nagahisa Yoshimura (Kyoto/J)

P-SA-168Differential Role of TNF-alpha Receptors in the development of choroidal neovascularizationIrina Semkova, Monika Jasielska, Xuan Shi, KristinaSchmidt, Dimitrios Karagiannis, Jerzy Mackiewicz,Norbert Kociok, Antonia M. Joussen(Duesseldorf/D, Berlin/D)

P-SA-169Do intravitreal ranibizumab injections for wet age-related macular degeneration affect the vitreo-macular interface?Sreekanth Sreekantam (Birmingham/UK)

P-SA-170Early effects of triamcinolone acetonide on matrixmetalloproteinases and endostatin in humanchoroidal neovascularizationOlcay Tatar, Kei Shinoda, Edwin Kaiserling, Gabor B. Scharioth, Grazia Pertile, Klaus Lucke,Claus Eckardt, Tillmann Eckert, Silvia Bopp, Bernd Kirchhof, Efdal Yoeruek, Salvatore Grisanti,Karl Ulrich Bartz-Schmidt (Tübingen/D, Bremen/D,Recklinghausen/D, Cologne/D, Lübeck/D, Tokyo/J)

P-SA-155Phosphene Thresholds Elicited by Transcorneal Electrical Stimulation in Healthy Subjects and Patients with Retinal DiseasesLubka Naycheva, Andreas Schatz, Tobias Röck,Gabriel Willmann, Karl Ulrich Bartz-Schmidt, Eberhart Zrenner, Florian Gekeler (Tübingen/D)

P-SA-156Relationship between reading performance andquality of a life in patients whith presbyopiaMaryna Shchadnykh, Olesya Zavoloka, PavelBezditko, Darya Zubkova (Kharkiv/UA)

P-SA-157The impact of individual Zernike coefficients onretinal image quality – a simulation studyJens Bühren, Thomas Kohnen (Frankfurt/D)

Retina: AMD P06

P-SA-158A computer-based documentation and data management system of clinically relevant parame-ters during repeated anti-VEGF injectionsCarsten H. Meyer, Hans-Martin Helb, Frank G. Holz(Bonn/D)

P-SA-159Age-Related Macular Degeneration in Patients withDiabetic RetinopathyNahoko Ogata, Tadanobu Yoshikawa, Tsuyoshi Otsuji, Masato Matsuoka, Kayako Matsuyama,Kanji Takahashi (Moriguchi/J)

P-SA-160Changes of Ocular Hemodynamics in Patients with Pathologicaltortuousity of the Internal CarotidArterySergey Avetisov, Tatyana Kiseleva, Sergey Vlasov,Alexandr Gavrilenko, Andrey Kuklin, Arsen Abramyan, Irina Omarganova (Moscow/RUS)

P-SA-161Characterization of a spontanously immortalizedcell line derived from neovascular CNV membranes(CNV-RPE)Maria Magdalena Guichard, Christoph Ehlken, Gottfried Martin, Hansjürgen Agostini (Freiburg/D)

P-SA-162Clinical experiences with loading doses of anti-VEGF Lucentis in the treatment of exsudative AMDMarkus Motschmann, A. Krappe, H.-W. Schlote, T. Brosius, D. Kersten (Haldensleben/D)

P-SA-163Comparison of intravitreal bevacizumab alone ver-sus combined with photodynamic therapy for smallCNV lesions of age-related macular degenerationMihoko Suzuki, Fumi Gomi, Miki Sawa, MotokazuTsujikawa (Suita/J)

Saturday, 5 June 2010 15:30 to 17:00

P-SA-180Inner Segment-Outer Segment Junctional Layer Integrity and Corresponding Retinal Sensitivity in Dry and Wet forms of Age-Related Macular DegenerationGennady Landa, Richard Rosen, Emily Su, Patricia Garcia, William Seiple, Alfonso Ponce,Jeanne Rosenthal, Ronald Gentile, Thomas Muldoon, Joseph Walsh (New York/USA)

P-SA-181Intravitreal Bevacizumab (Avastin) Treatment forNeovascular Age-related Macular Degeneration:Twelve-Month ResultsAndrius Cimbalas, Ausra Liveikiene, Rasa Sirtautiene, Kristina Kuoliene, Rimvydas Asoklis (Vilnius/LT)

P-SA-182Intravitreal injection of tyrosine kinase inhibitorPTK787 reduces the size of laser-induced chorioretinal neovascularisation in a mouse modelAnne Wiermann, Birthe Meyer-Rüsenberg, Sebastian Bigdon, Gisbert Richard, Oliver Zeitz,Michelle Berna (Munich/D, Hamburg/D)

P-SA-183Intravitreal ranibizumab therapy for exudative age-related macular degeneration (AMD) affectsthe retinal autoimmunity.Agnieszka Kubicka-Trzaska, Izabella Karska-Basta,Krzysztof Morawski, Bozena Romanowska-Dixon(Kraków/PL)

P-SA-184Late Outgrowth Endothelial Progenitor Cells in Patients with neovascular AMD and effect of Lucentis® treatmentMichelle Berna-Thill, Rebecca Grierson, FrankKunst, Nina Krüger, Birthe Meyer-Rüsenberg, Anne Wiermann, Marc Jean Berna, Gisbert Richard(Hamburg/D)

P-SA-185Mecamylamine reduces the size of laser inducedCNV in a mouse model and inhibits VEGFR-2 phosphorylation in vitroBirthe Meyer-Rüsenberg, Anne Wiermann, Sebastian Bigdon, Nina Krüger, Frank Kunst, Rebecca Grierson, Christos Skevas, Gisbert Richard,Marc J. Berna, Oliver Zeitz, Michelle Thill (Hamburg/D)

P-SA-186Morphological and functional response of the retinal pigment epithelium (RPE) after selectiveretina therapy (SRT) in cultivated porcine RPE-choroid explantsFelix Treumer, Yoko Miura, Johannes Baltz, AlexaKlettner, Ralf Brinkmann, Reginald Birngruber, Johann Roider, Jost Hillenkamp (Kiel/D)

P-SA-171Effect of Atorvastatin and Aspirin on the thresholdretinal sensitivity in patients with nonexudative age-related macular degenerationMaryna Karliychuk (Chernivtsi/UA)

P-SA-172Evaluation of Safety for Bilateral Same-day Intravitreal Injections of Anti-Vascular EndothelialGrowth Factor TherapyLuiz H. Lima (New York/USA)

P-SA-173Filtering blue light reduces light-induced oxidativestress, senescence, and accumulation of extracellu-lar matrix oroteins in human RPE cellsMarcus Kernt, Raffael Liegl, Katja Obholzer, Renate Scheler, Axel Walch, Aljoscha Neubauer,Kirsten Eibl, Armin Wolf, Michael Ulbig, Arndt Gandorfer, Anselm Kampik (Munich/D)

P-SA-174Fixation site and scotoma size in patients with retinal pigment epithelium tears after RanibizumabtreatmentKatja Christina Schielke, Tomas Ilginis (Aalborg/DK)

P-SA-175Focal Macular Electroretinograms after Photodynamic Therapy Combined with IntravitrealBevacizumabKohei Ishikawa, Shinsuke Ozawa, Yasuki Ito, Mineo Kondo, Hiroko Terasaki (Nagoya/J)

P-SA-176Geographic Atrophy in AMD: Junctional Zone Classified by High-resolution Spectral Domain OCTImagingMonika Fleckenstein, Steffen Schmitz-Valckenberg,Christian K. Brinkmann, Robert P. Finger, Peter Charbel Issa, Frank G. Holz (Bonn/D)

P-SA-177High resolution in vivo and in vitro imaging ofhuman RPE cells using structured illumination microscopyThomas Ach, Gerrit Best, Mira Ruppenstein,Christoph Cremer, Stefan Dithmar (Heidelberg/D)

P-SA-178Induction of the Angiopoietin/Tie System by oxidative Stress and LightArmin Wolf, Marcus Kernt, Wolfgang Mayer,Anselm Kampik, Claudia Priglinger-Alge (Munich/D)

P-SA-179Influence of vitreous on anti-VEGF therapy in patients with CNV secondary to AMD in the excitestudyUlrike Sponer (Vienna/A)

Satu

rday

, 5 Ju

ne

Post

ers

274 WOC® 2010

Saturday, 5 June 2010 15:30 to 17:00

P-SA-196Quantification of the therapeutic response of intraretinal, subretinal and subpigmentepithelialcompartments in exudative AMD during antiangiogenic therapyIsabelle Golbaz, Christian Ahlers, ChristopherSchütze, Sabine Schriefl, Ferdinand Schlanitz, Christian Simader, Christian Prünte, Ursula Schmidt-Erfurth (Vienna/A, Binningen/CH)

P-SA-197Screening for patient eligibility using fundus auto-fluorescence in a randomized interventional clinicaltrial for geographic atrophy secondary to age-related macular degenerationChristian Karl Brinkmann, Steffen Schmitz-Valckenberg, Monika Fleckenstein, Nina Stratmann,Florian Alten, Glenn J. Jaffe, Thomas C. Hohman,Frank G. Holz (Bonn/D)

P-SA-198SDOCT and angiography related prognostic factorsfor visual acuity outcome after Ranibizumab in patients with neovascular AMDTina Ristau, Dzenita Smailhodzic, Steffen Hillebrand, Jared Updike, Alexander C. Walsh,Bernd Kirchhof, SriniVas R. Sadda, Sandra Liakopoulos (Cologne/D, Los Angeles/USA)

P-SA-199Serum Uric Acid Levels and its Association WithAge-Related Macular Degeneration (ARMD)Siddharth Subramani, Sim Ee Khor, Bethel IndiraLivingstone, Utkarsh V. Kulkarni (Aberdeen/UK)

P-SA-200Short-term progression of neovascular AMDMarion Munk, Christopher Kiss, Florian Sulzbacher,Stefan Eisenkoelbl, Wolfgang Huf, Ursula Schmidt-Erfurth (Vienna/A)

P-SA-201Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Bevacizumab for Neovascular Age-related MacularDegenerationGuoge Han, Junyi Wang, Changzheng Chen,Yiqiao Xing, An Huai Yang (Wuhan/CN)

P-SA-202Sorafenib Reduces Expression of VEGF-Receptor 1/2and Prevents Human Retinal Pigment EpitheliumCells from Light-Induced Over-Expression of VEGFMarcus Kernt, Raffael Liegl, Christoph Hirneiss,Aljoscha Neubauer, Claudia Alge-Priglinger, Kirsten Eibl, Carl-Arnold Lackerbauer, MichaelUlbig, Anselm Kampik, Armin Wolf (Munich/D)

P-SA-187Morphometry of Cell Phenomena in HistologicalSections of Geographic Atrophy due to Age-relatedMacular DegenerationJoshua Torrent Despouy, Anna Wagner, SalvatoreGrisanti, Susan Vogt, Russell Read, Christine Curcio,Martin Rudolf (Lübeck/D)

P-SA-188Natural course of pigment epithelium detachment(PED) during induction treatment with Anti-VEGFtherapy for neovascular age-related macular degenerationJohann Rüping, Nicole Eter, Christos Haritoglou,Anselm Kampik, Armin Wolf (Munich/D)

P-SA-189New insights of the underestimated impairment ofquality of life in age-related macular degeneration –a review of the literatureBirthe Meyer-Rüsenberg, Gisbert Richard (Hamburg/D)

P-SA-190Non-responders to ranibizumab in the treatment ofneovascular age-related macular degenerationChristina Kramann, Katrin Lorenz, Isabella Zwiener,Bernhard Stoffelns, Norbert Pfeiffer (Mainz/D)

P-SA-191One year results of prospective, multi-center studyof photodynamic therapy for polypoidal choroidalvasculopathyTomohiro Iida, Ophthalmic PDT study group(Fukushima/J)

P-SA-192Oxidative DNA damage in patients with age-relatedmacular degenerationOrhan Ates, Osman Ceylan, Hamit Alp, Sedat Azizi,Bekir Ondas (Erzurum/TR)

P-SA-193Peripheral Exudative Hemorrhagic Chorioretino -pathyGuido Kürzinger, Gabriele E. Lang (Ulm/D)

P-SA-194Peripheral Fundus Autofluorescence is increased inAMDTamer Wasfy, Carolin Fischer, Johann Rüping, Armin Wolf, Michael Ulbig, Anselm Kampik, Marcus Kernt (Munich/D)

P-SA-195Pigment epithelial detachments in AMD evaluatedby spectral domain OCT, near-infrared reflectance,fluorescein and indocyanine green angiographyChristoph Clemens, Carolin Milojcic, Frank G. Holz,Nicole Eter (Bonn/D)

Satu

rday

, 5 Ju

ne

Post

ers

275WOC® 2010


turd

ay, 5

June

Post

ers

276 WOC® 2010

P-SA-211Twelve-month Safety and Visual Acuity Outcome of a Pilot Study Exploring Ranibizumab Combinedwith Proton Beam Irradiation as Treatment for Exudative Age-Related Macular DegenerationSusanna Park, Inder Daftari, Theodore Phillips,Lawrence Morse (Sacramento/USA)

P-SA-212Verteporfin photodynamic therapy in combinationwith anti-VEGF ranibizumab therapy in AMD patients: Second year outcomes in the MONTBLANC studyPaolo Lanzetta, on behalf of the MONT BLANCstudy group (Udine/I)

P-SA-213Vision related quality of life after intravitreal injection of Anti-VEGF – is "better" really "better"?Daniela Claessens, Bernd Kirchhof (Cologne/D)

P-SA-214Visual Acuity and Fixation Correlation in Age-related Macular DegenerationAlbert Caramoy, Sabine Schröder, Jonathan Foerster, Sascha Fauser, Bernd Kirchhof (Cologne/D)

Strabismus P07

P-SA-215A case of superior oblique palsy caused by endo-scopic paranasal sinus surgeryTakashi Negishi, Akiko Hikoya, Yoko Tsuchiya, Mayu Sawada, Yoshihiro Hotta, Miho Sato (Hamamatsu/J)

P-SA-216Alerted Functional Connectivity of Primary VisualCortex in Adult Comitant Strabismus using resting-functional MRIXiaohe Yan, Xiaoming Lin, Yuan Zhou, Lijuan Xu,Tianzi Jiang, Yingming Chen, Shaojie Song (Munich/D)

P-SA-217Characteristics and Outcomes of Inferior Rectus Recession under Topical Anesthesia in Thyroid Myopathy using Absorbable versus Non-AbsorbableSutures.Ingrid Franco, Sonal Farzavandi, Seah Lay Leng,Choo Chai Teck, Chee Soon Phaik (Singapore/SGP)

P-SA-218Clinical study of the binocular visual function instrabismus patients between before and after strabismus surgeryFang Zhang (Wenzhou/CN)

P-SA-219Clinical usefulness and the accuracy of ‘DistanceKrimsky method’ for the distance deviation measurementKwang Sic Joo, Nam Ju Moon (Seoul/ROK)

P-SA-203The analysis of the NEI-VFQ-25 as an EvaluationTool for the Quality of Life of Russian Patients withAge-Related Macular Degeneration.Alla Lisochkina, Yury Astakhov, Nina Vanchakova,Pavel Nechiporenko, Tatyana Kuznetsova (Saint-Petersburg/RUS)

P-SA-204The assessment of matrix metalloproteinases 3gene 5A/6A (-1171) polymorphism in age-relatedmacular degenerationRasa Liutkeviciene, Giedre Sinkunaite, Sandrita Simonyte, Abdonas Tamosiunas, Dalia Zaliuniene,Vytautas Jasinskas, Olivija Gustiene, Vaida Mizariene, Diana Zaliaduonyte-Peksiene,Vaiva Lesauskaite (Kaunas/LT)

P-SA-205The Effect of Oxidative Stress on Components ofthe Endothelial GlycocalyxArmin Wolf, Marcus Kernt, Mathias Jacob, KirstenEibl, Anselm Kampik, Claudia Alge-Priglinger (Munich/D)

P-SA-206The influence of vitreomacular adhesion on efficacyof treatment of neovascular age-related maculardegeneration with intravitreal bevacizumab injectionsMojca Urbancic, Polona Jaki Mekjavic, AleksandraKraut, Mojca Globocnik Petrovic (Ljubljana/SI)

P-SA-207The Influence of Vitreomacular Interaction on theDevelopment of Exudative Age-Related MacularDegeneration: 4-Year-Results of a LongitudinalStudySebastian Waldstein, Ulrike Sponer, ChristianSimader, Stefan Sacu, Ursula Schmidt-Erfurth (Vi-enna/A)

P-SA-208The macular mapping test as tool for vision assessment and monitoring of anti-VEGF therapy inpatients with NV-AMDNikolaus Feucht, Werner Eisenbarth, Christian Enders, Manfred MacKeben, Mathias Maier (Munich/D)

P-SA-209The progression rate of wet age-related macular degeneration after inicial treatment withbevacizumabLiga Radecka, Guna Laganovska (Riga/LV)

P-SA-210The structural changes in the central retina in patients with age-related macular degeneration.Ganna Kruglova, Pavel Bezdetko (Kharkov/UA)

Saturday, 5 June 2010 15:30 to 17:00

Satu

rday

, 5 Ju

ne

Post

ers

277WOC® 2010

P-SA-231Transposition of the Inferior Oblique under InferiorRectus Insertion for Treating Patients with DoubleElevator PalsyLejin Wang, Juan Bu, Jing Li, Yanlei Jia, Mei Sun(Beijing/CN)

Uveitis/Intraocular Inflammation, P08 Microbiology/Immunology

P-SA-232A culture independent metagenomic analysis ofcontact lens storage caseHiroshi Eguchi, Tomomi Kuwahara, TatsuroMiyamoto (Tokushima/J)

P-SA-233Advantages of 55 degree lens in compare with 30 degree lens in Wide-Angle Imaging in HRA2-Spectral OCT and Angiograph in 10 uveitis patientsUndine Simmet, Mathias Maier, Chris PatrickLohmann, Nikolaus Feucht (Munich/D)

P-SA-234Anti Tumor Necrosis Factor Monoclonal Antibodies(Infliximab) in Treatment of Behcet’s DiseaseMaja Zivkovic (Nis/SRB)

P-SA-235Antiendotoxin immunity in patients with HLA-B27 –associated endogenous anterior uveitisGanna Kopayenko, Gennadiy Zhaboedov, Nanuli Ivanova (Simferopol/UA)

P-SA-236Causes of visual loss in Uveitis in the 21st century.Paul Muambi B. Kabasele, S. R. Taylor, J. Singh, C. Hooper, Susan Lightman (London/UK)

P-SA-237Changes in the Eyes in Patients with JuvenileRheumatoid ArthritisMarko Zlatanovic (Nis/SRB)

P-SA-239CMV-Retinitis: A review of treatment proceduresbetween 1996 and 2009Claudia Metz, Eva Biewald, Bernhard Jurklies, Norbert Bornfeld (Essen/D)

P-SA-240Common sense to prevent endophthalmitisAlbert Galand (Neupré/B)

P-SA-241Commparison of three methods of imaging thecentral retina in chronic uveitis patients: StratusOCT, Spectralis OCT and HRT retina modulEva Jakob, Alexander Scheuerle, Stephan Schulz,Friederike Mackensen (Heidelberg/D)

P-SA-220Congenital - infantile esotropia vs. refractive errorsBranko Stankov, Milorad Ljutica, Radovan Stojkovic,Darko Bubalo, Vinko Regoda (Beograd/SRB)

P-SA-221Disruption of white matter tract integrity in adultcomitant strabismus: A diffusion tensor imagingstudy.Xiaohe Yan, Xiaoming Lin, Qifeng Wang, Tianzi Jiang, Yingming Chen (Munich/D)

P-SA-222Influence of Intermuscular Septum on Eye MovementFumiko Kishimoto, Hiroshi Ohtsuki (Ibara/J)

P-SA-223Intended Undercorrection in Surgical Managementon Adult Intermittent ExotropiaApatsa Lekskul, Apatsa Lekskul (Bangkok/T)

P-SA-224Interocular suppression and visual acuity development during occlusion therapy of amblyopic patients aged between 5 and 16 yearsStephan Kämmerling, Iris Bachert, Julia Kracht,Marc Lüchtenberg, Maria Fronius (Frankfurt/D)

P-SA-225Intracystic 70% isopropyl alcohol injection for postoperative conjunctival inclusion cysts.Mihir Kothari (Mumbai/IND)

P-SA-226Mechanisms of binocular fusion in patients with superior oblique paresisKristina Irsch, David Guyton, Murilo Roggia, Pittaya Phamonvaechavan, Howard Ying (Baltimore/USA)

P-SA-228Stereoacuity before and after neutral zone shiftingin congenital nystagmus with vertical compensatoryhead postureWei Zhang (Tianjin/CN)

P-SA-229Strabismus in pathologic myopesManabu Mochizuki, Kyoko Ohno-Matsui, AkikoTanaka, Yuko Shibata, Muka Moriyama, KengoHayashi, Takashi Tokoro, Makiko Yamashita, NoriakiShimada (Tokyo/J)

P-SA-230The role of inferior oblique myectomy in improvingocular nystagmusMomen Moustafa (Cairo/ET)

Saturday, 5 June 2010 15:30 to 17:00

P-SA-251Inflammatory cytokine responses to tuberculin andretinal autoantigens in vitro from a patient withBacillus Calmette-Guérin-induced uveitisAylin Garip, Maria Diedrichs-Möhring, CorneliaDeeg, Stephan Thurau, Gerhild Wildner (Munich/D)

P-SA-252Interleukin-18 gene polymorphisms in Chinese patients with Vogt Koyanagi Harada diseaseTimothy Lai, Pancy Tam, Chenghong Lan, Sylvia Chiang, Carmen Chan, Chi-Pui Pang, Dennis Lam (Kowloon/HK)

P-SA-253Intravitreal rituximab for primary intraocular lymphomaErmioni Panidou, Rainer Guthoff, M. Griebel(Wuerzburg/D)

P-SA-254Long-term results of therapy with mycophenolatemofetil in non-infectious uveitisDeshka Doycheva, Christoph Deuter, Nicole Stuebiger, Manfred Zierhut (Tübingen/D)

P-SA-255Monitoring uveitis patients with the digital 200°-widefield-angiography system Optomap®faEva Jakob, Bianca Dobner, Christian Kahlert, Stefan Dithmar (Heidelberg/D)

P-SA-256Necrotizing sarcoid granulomatosis: oular manifestation in three childrenClaudia Schumacher, Anne Lohr, Martin Roesel,Norbert Wagner, Arnd Heiligenhaus (Münster/D)

P-SA-257Nuclear factor- B inhibitor, dehydroxy methylepoxyquinomicin, ameliorates experimental autoimmune uveoreitnitis in miceDaiju Iwata (Sapporo/J)

P-SA-258Ocular cysticercosis – a pediatric clinical reportGil Calvão-Santos, Joel Ferreira, José Guilherme-Monteiro, José Salgado-Borges(São Mamede de Infesta/P)

P-SA-259One and a half blind eye in a tuberculosis patient: a case reviewRona A. Nasaruddin, Wan Haslina Wah, Ropilah Abdul Rahman, Ropilah Abdul Rahman(Kuala Lumpur/MAL)

P-SA-260Outcome of phacoemulsification for uveitic cataractin Vogt-Koyanagi Harada (VKH) diseaseVictoria Wong, Rose Chan, Carmen Chan, Timothy Lai (Kowloon/HK)

P-SA-242Depigmentation of peripapillary crescent in Vogt-Koyanagi-Harada diseaseYumiko Yamaguchi, Tomohiro Otani, Shoji Kishi(Maebashi/J)

P-SA-243Elevated levels of heparin binding epidermalgrowth factor-like growth factor in aqueous humorof patients with acute anterior uveitisSalvador Garcia-Delpech, Stephanie Rohrweck,David Salom, Patricia Udaondo, Maria Jesus Lopez-Prats, Manuel Diaz-Llopis (Valencia/E)

P-SA-244Endogenous Candida Endophthalmitis: Outcomesfrom Early VitrectomyLavnish Joshi, Ahmed Sallam, Aldrin Khan, Peter McCluskey, William A Lynn, Kiran Manku, Sue Lightman (London/UK)

P-SA-245Endophthalmitis Caused by Pseudomonas aeruginosa in TaiwanKuan-Jen Chen, Ming-Hui Sun (Taoyuan/TJ)

P-SA-246Episcleral osseous lesionMelanie Jäger, Birgit Lorenz (Giessen/D)

P-SA-247Expression of toll like receptors in Behçet’s disease with refractory uveitis following infliximabtreatmentTakeshi Kezuka, Masaru Takeuchi, Naoyuki Yamakawa, Yoko Okunuki, Yoshihiko Usui, Jun-ichi Sakai, Hiroshi Goto (Tokyo/J)

P-SA-248Favourable outcome after cataract surgery with IOL implantation in selected JIA associated uveitispatientsRafael Grajewski, Beatrix Zurek-Imhoff, Martin Roesel, Carsten Heinz, Arnd Heiligenhaus(Cologne/D, Münster/D)

P-SA-249Fuchs Heterochromic Uveitis: a Review of 27 CasesJenzeri Salah, Jelliti Bechir, Attia Sonia, Haj TaherOlfa, Zouid Sonia, Moncef Khairallah (Monastir/TN)

P-SA-250Indocyanine Green Angiography in Acute VogtKoyanagi Harada Disease: Signs at Presentation andtheir Evolution under TreatmentKahloun Rym, Hasnaoui Wafa, Gargouri Salma, Zaouali Sonia, Ben Yahia Salim, Moncef Khairallah(Monastir/TN)

Satu

rday

, 5 Ju

ne

Post

ers

278 WOC® 2010

Saturday, 5 June 2010 15:30 to 17:00

P-SA-271Spectral Domain Optical Coherence Tomography(SD-OCT) and time domain (TD) in ToxoplasmicRetinochoroiditisBruno Diniz, Mariann Midori Yabiku, Carlos Alexandre Garcia Filho, Rafael Ernane Andrade,Rubens Belfort Jr (São Paulo/BR)

P-SA-272Spectrum of Ocular Tuberculosis in Selayang HospitalHanizasurana Hashim, Shelina Oli Mohamed, Roslin Azni Aziz, Tara Mary George, Nor FarizaNgah (Kuala Lumpur/MAL)

P-SA-273Spontaneous fungal endophthalmitis in healthymanKeembiyage Dayawansa, Jayantha Edirisooriya(Kandy/CL)

P-SA-274Subthreshold Micropulse Diode Laser Treatment forUveitic Macular EdemaBruno Diniz, Carolina Pelegrini Barbosa, Daniel Lavinsky, Tiago Arantes, Rubens Belfort Jr.(São Paulo/BR)

P-SA-275Successful Treatment of Acute Annular OuterRetinopathy with Combination of Oral CiclosporinA and PrednisoloneNor' Ain Mohd Rawi, Othmaliza Othman, WanHaslina Wan Abdul Halim, Che Muhaya Mohamad(Kuala Lumpur/MAL)

P-SA-276Susceptibility trends of Staphylococcus epidermidisand Staphylococcus aureus ocular isolates – A fouryear study.Evgenia Kanonidou, Christina Kanonidou, Anna Praidou, Vasilios Konidaris, Paraskevi Zotta,Irini Chatziralli, Nikolas Ziakas (Thessaloniki/GR)

P-SA-277Sympathetic ophthalmia following pars plana vitrectomyRegine Augsten, Bernhard Theiß, Jens Dawczynski,Ulrich Voigt, Ekkehart Königsdörffer (Jena/D)

P-SA-278The Immunohistological Comparison of VitreousBody Injection in both Autologous and Homolo-gous Forms with Hyalgan in Rabbits Knee JiontsMahnaz Mosallaei, Negar Azarpira, Morsal Mehriar(Shiraz/IR)

P-SA-279The Value of Real-time PCR in Cytomegalovirus-associated anterior segment inflammationMichiko Kandori, Keiko Yakura, Naoki Komatsu,Chizu Touge, Yoshifumi Ikeda, Dai Miyazaki, Yoshitsugu Inoue (Yonago/J)

P-SA-261Patient with previously undiagnosed AutoimmuneHypophysistis (AH) presenting with bilateral recurrent cystoid macular oedema (CMO) secondary to Intermediate uveitisVenkat Kotamarthi, Muhammad Amjad, Arun Sachdev (Manchester/UK)

P-SA-262Preoperative treatment of posttraumatic endophthalmitisDauletbekov Daniyar, Daniyar Dauletbekov (Almaty/KZ)

P-SA-263Primary intraocular lymphoma, a diagnostic challenge. Case reportClaudia Zorn, Alexander Erben, Eva Glaser, MathiasMaier, Chris Patrick Lohmann, Elen Büschlepp, Uwe Pleyer, Korinna Jöhrens (Munich/D)

P-SA-264Prognostic factors and Outcomes in EndogenousKlebsiella pneumoniae EndophthalmitisMarcus Ang, Aliza Jap, Soon-Phaik Chee (Singapore/SGP)

P-SA-265Rat-to-human transmission of cowpox infectionwith membraneous conjunctivitisSilke Brüx, H. Kramp, H. Teutloff, M. Knorr, F. Hessler (Kalkar/D)

P-SA-266Reemergence of ocular syphilis – two atypical casesof ocular syphilisDiamar Pardo-López, Ana Marina Suelves-Cogollos,Stephanie Rorhweck, Ruth López-Lizcano, SalvadorGarcía-Delpech, Manuel Díaz-Llopis (Valencia/E)

P-SA-267Retinal Pigment Epithelium Layer Changes in Vogt-Koyanagi-Harada Disease Using Scanning LaserOphthalmoscopy Indirect ViewingSatoshi Ishiko, Reiko Kinouchi, Eiichi Sato, Yuji Kato, Akitoshi Yoshida (Asahikawa/J)

P-SA-268Rituximab in the treatment of refractory ophthalmicWegener’s GranulomatosisSimon Taylor, Lavnish Joshi, Alan Salama, CharlesPusey, Sue Lightman (London/UK)

P-SA-269Scleritis necrotizing: A case Report about a patientwith Wegener granulomatosisGraciela Graneros (San Miguel de Tucuman/RA)

P-SA-270Serous Retinal Detachment Secondary to AcuteToxoplasmic Retinochoroiditis.Gargouri Selma, Zaouali Sonia, Ammari Wafa, Jelliti Bechir, Messaoud Riadh, Moncef Khairallah(Monastir/TN)

Satu

rday

, 5 Ju

ne

Post

ers

279WOC® 2010

Sunday, 6 June 2010 15:30 - 17:00Saturday, 5 June 2010 15:30 to 17:00

P-SA-280Transeptal Triamcinolone Injection In The Manage-ment of Non-Infectious UveitisHarvey Uy (Makati City/RP)

P-SA-281Visual loss in Behçet’s disease.Jasmin Singh, Simon Taylor, Miles Stanford, SusanLightman (London/UK)

P-SA-282Vogt-Koyanagi-Harada disease simulating acuteposterior multifocal placoid pigment epitheliopathyNoriko Nishikawa, Reiko Kinouchi, Satoshi Ishiko,Akitoshi Yoshida (Asahikawa/J)

Satu

rday

, 5 Ju

ne

Post

ers

280 WOC® 2010

Poster exhibition of Poster P-SU-001 to P-SU-277.All poster authors will attend their posters from15.30 to 17.00 hrs.

Moderation Poster sessions on Sunday Chairs:Alexander A. Bialasiewicz (Doha)Antonia M. Joussen (Berlin)

Co-Chairs:Oliver Ehrt (Munich)Anselm G. M. Jünemann (Erlangen)Franz H. Grus (Mainz)Carsten H. Meyer (Bonn)Susanne Pitz (Mainz)Susanne Butros (Ulm)Philip Maier (Freiburg)Jürgen Kampmeier (Ulm)Claus Cursiefen (Erlangen)

Anatomy/Pathology P09

P-SU-001Adenoid cystic carcinoma of the inferior medialeyelid.Anima Buehler (Freiburg/D)

P-SU-002Aspects regarding the arterial vascularization of theoptic nerveCarmen Bolintineanu, Sorin Bolintineanu, Alina Sisu, Izabella Sargan, Loredana Stana, Luminioara Rosu (Timisoara/RO)

P-SU-003Biometrics: Anatomy of the human eyeHector Barajas (Mexico City/MEX)

P-SU-004Central Corneal Thickness, Lamina Cribrosa andPeripapillary Scleral Histomorphometry in ChineseEyesRuojin Ren (Beijing/CN)

P-SU-005Computed tomographic diagnosis in the tumoralpathology of orbitsCarmen Bolintineanu, Sorin Bolintineanu, Monica Vaida, Elena Pop, Corina Matu, Iulia Ciobanu (Timisoara/RO)

P-SU-006Lens artifacts in human fetal eyesMartina C. Herwig, Annette M. Müller, Frank G. Holz, Karin U. Loeffler (Bonn/D)

P-SU-007Mixed lid tumour with an anusual high fraction oflipomatous tissueSylvia Stadler, Claudia Auw-Hädrich (Freiburg/D)

Sunday, 6 June 2010 15:30 - 17:00

Post

ers

281WOC® 2010

Sund

ay, 6

June

P-SU-018The Redwing-D Knowledgebase: ComprehensivePatent Informatics for Ocular Drugs and Diagnosticsfrom 1970 OnwardHermann Mucke, Eva Mucke, Peter M. Mucke (Vi-enna/A)

Conjunctiva/Contact Lenses P11

P-SU-020A novel usage of pterygium tissue as an autologousgraft in treating necrotising scleritisOthmaliza Othman, Norshamsiah Md Din, Howe Sen Kok (Kuala Lumpur/MAL)

P-SU-021Contact lens dry eye: new therapeutic approach.Lorenzo Mannucci (Padova/I)

P-SU-022Decreased bioavilability of thioredoxin may contribute to oxidative stress in the lens of diabetesMarjorie Lou (Lincoln/USA)

P-SU-023Development and antigen-related modulation ofconjunctiva-associated lymphoid tissue (CALT)Sebastian Siebelmann, Uta Gehlsen, SalvatoreGrisanti, Maya Mueller, Philipp Steven (Lübeck/D)

P-SU-024Doxycycline Effect in the Cytokine Profile and in the Pro/Anti-apoptotic proteins in pterygia derived cellsMiguel Angel Vazquez Membrillo, Araceli Rojas-Diaz, Ximena Mira-Lorenzo, Atzin Robles-Contreras, Iliana Peñaloza-Roman, Ellery Lopez-Star,Teresa Valdez-Gonzalez, Francisco Martinez-Castro,Maria del Carmen Jimenez-Martinez, Victor ManuelBautista De Lucio (Edo Mex/MEX)

P-SU-025Effect of Pterygium Surgery on Corneal TopographyBanu Torun Acar, Suphi Acar (Istanbul/TR)

P-SU-026Effects of chemical disinfection contact lens caresolutions on Acathamoeaba castellaniJacek P. Szaflik, Lidia Chomicz, Gabriela Oledzka,Jerzy Szaflik (Warszawa/PL)

P-SU-027Extensive Conjunctival Lymphangioma. A case report.Markus van Son, Magdalena Sara Tönz, StephanMichels, Bernhard Schuknecht, Stephan Estermann(Zurich/CH)

P-SU-028Fitting contact lenses in childhoodBeata Kettesy, Annamária Nagy, András Berta (Debrecen/H)

P-SU-008The eye: Atlas of anatomical historyHector Barajas (Mexico City/MEX)

P-SU-009The spectrum of histopathological diagnoses innon-infectious orbital inflammation.Hazlita Isa, L. T. Tan, S. R. J. Taylor, P. J. Luthert,Susan Lightman (London/UK)

Biochemistry/Pharmacology P10

P-SU-010An Analysis of Corneal Anesthesia Data fromPatents Reveals Information Not Represented in thePeer Review LiteratureHermann Mucke, Eva Mucke, Peter M. Mucke (Vi-enna/A)

P-SU-011Biochemical analysis of indocyanine green and infracyanine green solutions: pH, anions, osmo-larity, precipitation and decomposition productsEduardo Rodrigues, Fernando Marcondes Penha,Elaine de Paula Fiod Costa, Mauricio Maia, CarstenH. Meyer, Michel Eid Farah (Florianopolis/BR,Bonn/D)

P-SU-012Detection of CXCR4 and CXCR7 at the ocular surface and in the lacrimal apparatusJulia Dieckow, Ute Schulze, Friedrich Paulsen(Halle/D)

P-SU-013Different Effects of PDGF and TGF-beta on fibroblast contractility and cell morphologyTobias Meyer-ter-Vehn (Wuerzburg/D)

P-SU-014Glucocorticoid-induced changes of Na+, K+-ATPase in lens: effect by a glucocorticoid receptor antagonistGuoli Xie, Hong Yan (Xi'an/CN)

P-SU-015Increased Oxidative DNA damage and Lipid Peroxidation in Cultured Orbital Fibroblasts fromPatients with Graves’ OphthalmopathyChieh-Chih Tsai, Hui-Chuan Kau, Shu-Ching Kao,Shu-Mei Lee (Taipei/TJ)

P-SU-016Metabonomics in ophthalmologyAnna Midelfart (Trondheim/N)

P-SU-017The Effects of Prostaglandin Analogues on intracellular Ca2+ concentrations in EP-Receptor-Deficient Mice Ciliary ArteriesSanae Abe (Akita/J)

Sunday, 6 June 2010 15:30 - 17:00

Cornea/Eye Bank: Basics P12

P-SU-037Anisotropic Swelling Behavior of the CorneaToyoaki Matsuura, Masahiko Annaka, Futoshi Taketani, Eiichi Yukawa, Tokuko Hara, Yoshiaki Hara(Kashihara /J)

P-SU-038Cell morphology and pluripotency marker expression in limbal epithelial stem cells cultured indifferent mediaHenning Thomasen, Emre Türkeli, Mikk Pauklin,Klaus-Peter Steuhl, Daniel Meller (Essen/D)

P-SU-039Confocal Microscopy in Chronic and Delayed Mustard Gas KeratopathySiamak Zarei-Ghanavati, Mohammad-Reza Jafarinasab, Mojgan Rezaei-Kanavi, Farid Karimian,Mohammad-Reza Soroush, Mohammad-Ali Javadi(Mashhad/IR)

P-SU-040Effects of Selenium on Endothelial cells of mid-termstored corneas in the rabbitChen Qu (Shanghai/CN)

P-SU-041Evaluation of a medium with human AB-serum forxenofree cornea preservationBurkhard von Jagow, Christian Ohrloff, HalvardBönig (Frankfurt/D)

P-SU-042Expression of stem cell markers in conjunctival intraepithelial neoplasiasAnne Pester, Mikk Pauklin, Henning Thomasen,Friedrich Otterbach, Kurt Werner Schmid, Klaus-Peter Steuhl, Daniel Meller (Essen/D)

P-SU-043Expression of the RAGE-receptor system and its ligands in Fuchs endothelial corneal dystrophyHans Sebastian Walter, Stephan Hoffmann, D.Hasenfus, Berthold Seitz (Karlsruhe/D, Homburg/D)

P-SU-044Preliminary study of mesenchymal stem cells derived from murine corneal stromaXiu-Jun Song, Jian-Min Lu (Shijiazhuang/CN)

P-SU-045Regulatory T cells as therapeutic option followingkeratoplasty in baby ratsJohannes Schwartzkopff, Christian Jarsch, LauraBredow, Yvonne Kern, Daniel Böhringer, ThomasReinhard (Freiburg/D)

P-SU-046The Role of TNF-Rp-55 and TNF-Rp-75 on the Angiogenesis and Lymphangiogenesis in CornealNeovascularizationJohannes Gonnermann (Duesseldorf/D)

P-SU-029High risk of pseudomonas infection in contact lensinduced keratitis in Eastern IndiaSuman Saha, Jayangshu Sengupta, Archana Khetan(Kolkata/IND)

P-SU-030Impression Cytology in SLK: A Diagnostic GuidelineNibaran Gangopadhyay, Jayangshu Sengupta,Archana Khetan, Suman Saha, Merle Fernandes(Kolkata/IND)

P-SU-031Intravital multidimensional two-photon microscopyreveals rapid cellular dynamics in conjunctiva-associated lymphoid tissuePhilipp Steven, Uta Gehlsen, Sebastian Siebelmann,Norbert Koop, Regina Orzekowsky-Schroeder, Salvatore Grisanti, Gereon Hüttmann (Lübeck /D)

P-SU-032Isolation, Characterization and Functional Activityof Adult and Fetal Human Conjunctival EpithelialProgenitorsNick Di Girolamo, Jeanie Chui, Sarah Davies, Denis Wakefield (Sydney/AUS)

P-SU-033Myopia Control and the Future of Ortho-kKen Kopp (Mesa/USA)

P-SU-034Non invasive multi-dimensional two-photon microscopy enables optical characterization of keyplayers in ocular surface inflammationUta Gehlsen, Gereon Huettmann, ReginaOrzekowsky-Schroeder, Norbert Koop, Sebastian Siebelmann, Philipp Steven (Lübeck/D)

P-SU-035Patterns of contact lenses wearing among studentsand attitudes towards a future refractive surgery.Evgenia Kanonidou, Anna Praidou, ChristinaKanonidou, Paraskevi Zotta, Vasilios Konidaris, Irini Chatziralli, Nikolas Ziakas (Thessaloniki/GR)

P-SU-036Topical cyclosporine A 0.05% in the treatment ofsevere vernal keratoconjunctivitis in Vietnamese patients.Tho Nguyen (Ho Chi Minh/VN)

Sund

ay, 6

June

Post

ers

282 WOC® 2010

Sunday, 6 June 2010 15:30 - 17:00

P-SU-057Ophthalmia Neonatorum: The true extent of thedisease?Jaswant Sandhu, Kwok Yin Chan, Stephanie Hardy(Wolverhampton/UK)

P-SU-058Personal costs in retinal diseases – a cost of illnessstudyGabriele Porz, Hendrik P. N. Scholl, Frank G. Holz,Robert P. Finger (Brohl-Lützing/D, Bonn/D)

P-SU-059Population-based study of microaneurysm numberand distribution in the macula of Chinese type 2 diabetics with early diabetic retinopathyWilliam Tao-Hsin Tung, Jorn-Hon Liu, Ch-Ming Liu(Taipei/TJ)

P-SU-060Prevalence and risk factors for myopia in collegestudents in Shanghai.Jing Sun, Xianqun Fan, Jibo Zhou (Shanghai/CN)

P-SU-061Prevalence of anisometropia among 18 year oldstudents in PolandEwa Majdanik, Damian Czepita (Szczecin/P)

P-SU-062Prevalence of cataract blindness and visual impairment in Russian city.Sergey Branchevskiy, Khristo Takhchidi, Igor Malov(Samara/RUS, Moscow/RUS)

P-SU-063Prevalence of Demodex folliculorum and Demodexbrevis on eyelashes in a Polish populationAndrzej Grobelny, Damian Czepita (Szczecin/P)

P-SU-064Prevalence of diabetes and diabetic retinopathy inNigeria: results from the Nigeria National Blindnessand Visual Impairment SurveyFatima Kyari, Selvaraj Sivasubramaniam, TundePeto, Clare Gilbert, The Nigeria National Blindnessand Visual Impairment Study Group (London/UK)

P-SU-065The impact of visual impairment and eye diseaseson quality of life in Taiwanese patients utilizing eyecare servicesJen-Chieh Lin, Mei-Shu Lai (Taipei/TJ)

P-SU-066The prevalence and causes of visual impairment inSichuan Province: findings from the China SecondNational Sample Survey on DisabilityMin Wei, Sophia Pathai, Ying Chuan Fan (NewYork/USA)

Epidemiological Studies P13

P-SU-047Associations Between Dietary Factors and Intra-ocular PressureLaurence Lim, Seang Mei Saw (Singapore/SGP)

P-SU-048Common causes of visual handicap and blindnessin the registered blind people from the region ofEastern HerzegovinaCeklic Lala, Slobodanka Latinovic (Sarajevo/BIH,Novi Sad/SRB)

P-SU-049Early detection and treatment of eye diseases inchildren in PolandBeata Chrzanowska, Alina Bakunowicz-Lazarczyk(Bialystok/PL)

P-SU-050Epidemiology of ocular casualty among the Egyptian population: a five year retrospective studyHany Elmekawey, Abueleinen K. G. Khaled, Abdelmaboud M. Mohamed, Khafagy A. Amr(Giza/ET)

P-SU-051Factors related to Sunlight Exposure and the Long-term Incidence of Cataract and Cataract Surgery –The Blue Mountains Eye StudyGowri Kanthan, Paul Mitchell, Elena Rochtchina, Jie Jin Wang (Strathfield/AUS, Sydney/D)

P-SU-052Global Inequality in Eye Health: Country LevelAnalysis from the Global Burden of Disease StudyKoichi Ono, Yoshimune Hiratsuka, Akira Murakami(Tokyo/J)

P-SU-053LOXL1 gene polymorphisms and glaucoma secondary to familial amyloidotic polyneuropathy inJapaneseToshiyuki Kyomoto, Takanobu Kikuchi, TeruyoshiMiyahara, Toshinori Murata, Kana Tojo, Shu-ichiIkeda (Matsumoto/J)

P-SU-054Normal Intraocular Pressure, Corneal diameter, andCupping In NewbornsOsama Badeeb (Jeddah/SA)

P-SU-055Ocular Hypertension Lorraine-France study (HOLF)Olivier Henckes, Toufic Maalouf, Michel Helfenstein, Franck May, Jean Luc George (Nancy/F)

P-SU-056Ophthalmia Neonatorum: Clinical Features, Outcomes and Under-reported Notification in aLarge UK General HospitalManjit Singh Mehat (Birmingham/UK)

Sund

ay, 6

June

Post

ers

283WOC® 2010

Epidemiology P14

P-SU-067An Overview of Shih-Pai Eye StudyWen-Ming Hsu, Ching-Yu Cheng, Tung-Mei Kuang,Pei-Yu Lin, Catherine Jui-Ling Liu, Shih-Jen Chen,Jorn-Horn Liu (Taipei/TJ)

P-SU-068Burden and severity of ophthalmic zoster in 2007 inFrance: a hospital studyGilles Berrut, Xavier Bresse, Karine Bloch, JérômeFernandes, Alexandre Vainchtock (Nantes/F)

P-SU-069Epidemiology of Primary Glaucoma in the KyrgyzRepublicOlzhobai Dzhumagulov (Bishkek/KIS)

P-SU-070Epidemiology of Pterygium in Aged Population inBeijing Country, ChinaQingfeng Liang, Liang Xu (Beijing/CN)

P-SU-071Ophthalmic Zoster in the UK: Burden in SecondaryCare (2007)Ian Power, Xavier Bresse, Azharul Mannan, Christopher Morgan (Lyon/F)

P-SU-072Prevalence of HIV-associated ophthalmic diseaseamong patients enrolling for antiretroviral treat-ment in India: implications for baseline ophthalmicscreeningSophia Pathai, Alaka Deshpande, Clare Gilbert,Stephen Lawn (New York/USA)

P-SU-073The influence of selected environmental factors onthe frequency of refractive errors among school-age children.Magdalena Dalz, Maria Dalz (Pozna /PÖ)

Ethics/Medical History/Traffic Ophthalmology P15

P-SU-074“MÜR D”: A Turkish Ophthalmology Textbook inXVth Century AnatoliaDo an Ceyhan (Van/TR)

P-SU-075Albrecht von Graefe - "Father of glaucoma"Milan Ivanisevic, Lovro Bojic, Robert Stanic, Petar Ivanisevic (Split/HR)

P-SU-076Folk Treatment of Eye Diseases using MedicinalHerbs in CroatiaVjekoslav Dorn (Zagreb/HR)

P-SU-077Saints and the EyeMuhammad Younis, Ahmad Mansour, Joseph Walsh (Manchester/RL)

P-SU-078The Fate of Injured and Persecuted Ophthalmo-logists as well as Persons Closely Related to Ophthalmology in National Socialism (1933-1945),Particularly Dealing with those of Jewish Faith orHeritage.Udo Hennighausen (Heide/D)

External Disease P16

P-SU-079A no suture conjunctival graft approach to pterygium surgeryAneesur Rahman (Petaling Jaya/MAL)

P-SU-080Blepharitis therapy with the topical anti-inflamma-tory macrolide antibiotic Azithromycin 1.5%Antonio Bergua, Matthias Zenkel, Jeanette Gabel(Erlangen/D)

P-SU-081Effective Treatment of Ligneous Conjunctivitis withTopical Plasminogen ConcentratesAbdullah Al-Turbaq (Riyadh/SA)

P-SU-082Investigative study of new cases of Acanthamoebakeratitis: an emergent infection in the managementof external ocular diseasesDenise Freitas, Fabio R. S. Carvalho, Juliana F. Camargo, Annette S. Foronda (Sao Paulo/BR)

P-SU-083Long-term assessment of pterygium surgery byconjunctival autograft with fibrin adhesive.Eduardo Conesa, Esther Mata, Carlos De Pablo,Cristina Montón (Madrid/E)

P-SU-084Morganella Morganii Conjunctivitis: Case ReportMaria Fernanda Abalem de Sá, Leticia de CastroMoura Brasil, Marcio Penha Morterá Rodrigues,Daniella Socci da Costa (Rio de Janeiro/BR)

P-SU-085Ocular rosacea: Glycomics analysis of tear andsaliva for disease biomarkers.Ana Carolina Vieira, Sureyya Ozcan, Hyun Joo Ann,Carlito Lebrilla, Mark Mannis (Rio de Janeiro/BR)

P-SU-086Predictive factors of keratoplasty in keratoconusNestor Cortes Mora, David Galarreta, FernandoSánchez-Mannarelli, Alejandro Portero-Benito,Belen Carrasco, David Peña, Jesus Merayo-Lloves(Valladolid/E)

Sunday, 6 June 2010 15:30 - 17:00Su

nday

, 6 Ju

ne

Post

ers

284 WOC® 2010

P-SU-087Prevention and treatment of meibomian gland dysfunctionMaria Pimenidi (Moscow/RUS)

P-SU-088Tear proteomic analysis of dry eye syndrom in type2 diabetes mellitus patientsBing Li, Minjie Sheng, Feng Liu, Guoquan Yan, Anjuan Lin, Weifang Wang, Yanhong Li, Chunlei Xie, Fei Zhao (Shanghai/CN)

P-SU-089The effect of vancomycin eye ointment forMRSA/MRSE ocular surface infectionMasahiko Fukuda, Chie Sotozono, Masao Ohishi,Keiko Yano, Hideki Orikasa, Yoshikazu Shimomura(Osaka-Sayama/J)

P-SU-090The Efficacy of Topical Levofloxacin 0.5% in Treating Levofloxacin-Resistant PseudomonasAeruginosa Induced KeratitisKianti Darusman (Jakarta/RI)

P-SU-091The Expression of Matrix Metallo Proteinase-1(MMP-1) in Primary Pterygium After Subconjunc-tival Injection of Triamcinolone Acetonide and Mitomycin CSuhardjo Suhardjo, Ayu Suryaningsih Oetoyo, Dharmawan M Sophian (Yogyakarta/RI)

P-SU-092Unilateral epidemic keratoconjunctivitis with membrane formationMentor Gorani, Merita Ilazi, Mentor Ilazi (Prishtina/KS)

Glaucoma: Basics P17

P-SU-093Agmatine and oxidative stress-induced cytotoxicityin primary retinal ganglion cells and Müller glialcellsSamin Hong, Chan Yun Kim, Yoko Iizuka, Gong Je Seong (Seoul/ROK)

P-SU-094Comparison of IgG and IgM Autoantibody Patternsin Glaucoma PatientsSabine Beck, Nils Boehm, Marcus Schlich, Joachim Richter, Karin Pfirrmann, Norbert Pfeiffer,Franz Grus (Mainz/D)

P-SU-095FGF plays a regulatory role in the early stages of the ciliary body development.Justyna Klos-Rola, Tomasz Zarnowski, Jeanette Hyer(Lublin/PL)

P-SU-096Involvement of glutamate in retinal degenerationinduced by pressure elevation in isolated retinaMakoto Ishikawa, Yukitoshi Izumi, Takeshi Yoshitomi (Akita/J)

P-SU-097Malignant Melanoma and the Use of Latanoprost:A Risk AssessmentCharles Tressler, Robert Wiseman, Theresa Dombi,Bart Jessen, Kui Huang, Kenneth Kwok, Ken Salatka, Barbara Wirostko (New York/USA)

P-SU-098Matrix-metalloproteinases and their inhibitors inthe aqueous humor of glaucoma patients: effect ofantiglaucoma drugsMatthias Zenkel, Jasmina Djordjevic-Jocic, Piotr Lewczuk, Anita Krysta, Anselm Jünemann,Friedrich Kruse, Johannes Kornhuber, Ursula Schlötzer-Schrehardt (Erlangen/D)

P-SU-099Morphological changes of trabeculectomy specimens in patients with uveitic glaucoma.Carsten Heinz, Ozan Tektas, Arnd Heiligenhaus,Elke Lütjen-Drecoll (Münster/D, Erlangen/D)

P-SU-100Plasminogen activator inhibitor-1 in the aqueoushumor of patients with pseudoexfoliation syn-drome with or without glaucomaKonstantinos Zinelis, Ioannis Tsinopoulos, Nikolaos Kopsachilis, Sebastian Weiß, Rolf Winter,Michael Wolfgang Meyer (Hannover/D)

P-SU-101Possible stress factors working on retinal nervefibers at the scleral rim.Jens Georg Hetland (Oslo/N)

P-SU-102Pro370Leu mutant myocilin impairs mitochondrialfunctions in human trabecular meshwork cellsYuan He (Xi'an/CN)

P-SU-103Proteome analyses of HMGB-1 in a rat experimen-tal glaucoma model and its role in neurodegene-rationMaurice Schallenberg, Harut Melkonyan, Guang-Yu Li, Solon Thanos (Essen/D, Münster/D)

P-SU-104Retinal ganglion cells in the Experimental Auto-immune Glaucoma Model die through apoptosisStephanie C. Joachim, Oliver W. Gramlich,Zacharias Loos, Panagiotis Laspas, Vanessa D. Stahl,Norbert Pfeiffer, Franz H. Grus (Mainz/D)

Sunday, 6 June 2010 15:30 - 17:00

Sund

ay, 6

June

Post

ers

285WOC® 2010

Sunday, 6 June 2010 15:30 - 17:00Su

nday

, 6 Ju

ne

Post

ers

286 WOC® 2010

P-SU-113Trial of Static program for AMA’s Visual Field Score by Humphrey Custom Program compared toGoldmann measurementJunko Kamo, Ryo Harada (Kofu/J)

P-SU-114Visual outcome of long-term survivors with inbornerror of metabolismHideki Oohashi (Isehara/J)

Neuro-Ophthalmology P19

P-SU-115A case of hypertrophic pachymeningitis with opticneuritis-like symptomsSachi Abe, Akira Sugano, Teiko Yamamoto, Takeo Kato, Manabu Wada, Takamasa Kayama,Sunao Takemura, Hidetoshi Yamashita (Yamagata/J)

P-SU-116A case of Miller Fisher syndromeIlona Ryseck (Hamburg/D)

P-SU-117A case report about mucormycosis in sinus sphenoidalis misdiagnosed to apical orbital syndrome result from tumorShihui Wei (Beijing/CN)

P-SU-118A Case Report: Recurrence of an Orbital TumorV. Nandini, Z. A. Zurina, N. Vairavan, V. Waran(Kuala Lumpur/MAL)

P-SU-119A proposal about pseudo-Barre-Lieou syndromeMasayoshi Kajita (Tokyo/J)

P-SU-120Abducens ocular neuromyotonia in a patient withnasopharyngeal carcinoma following concurrentchemo-radiotherapyHui-Chuan Kau, Chieh-Chih Tsai (Taipei/TJ)

P-SU-121Acute zonal occult outer retinopathy presentedwith annular scotoma and periphlebitis in a Japanese girlMasashi Nishimura, Naohiro Ikeda, Tomohiro Ikeda,Akiko Masuda, Osamu Mimura (Nishinomiya/J)

P-SU-122Alpha2-adrenergic receptors ans their core involvement in the process of axonal regenerationin the retinaVerena Prokosch, Lambros Panagis, Gerd-FabianVolk, Caterina Dermon, Solon Thanos (Münster/D)

P-SU-105Substrate elasticity modulates TGF-beta signaling inhuman trabecular meshwork cellsHong Han, Thomas Wecker, Franz Grehn, Schlunck Günther (Wuerzburg/D)

P-SU-106The effect of central corneal thickness on intraocular pressure measurements by Goldmannapplanation tonometer and non-contact tonometerin a military hospitalYener Celik, Levent Ersoy (Istanbul/TR)

Low Vision P18

P-SU-107Association between quality of life and changes invisual acuity in Japanese patients with low visionMeiko Yanagisawa, Satoshi Kato, Shiho Kunimatsu,Megumi Kobayashi, Makiko Ochiai, Nobuyuki Shoji(Tokyo/J)

P-SU-108Development and validation of The Eye Clinic Opinion Satisfaction (TEC-OS) questionnaire forLow Vision AidSakshi Mehrotra, Abhas Mehrotra(Chandigarh/IND)

P-SU-109Educational Inclusion at a Private University inBrazil: Accessibility and Pedagogical Aspects in theHumanities, Economics and Business and Scienceand Engineering CoursesM. Cristina de O. Regina (Campinas/BR)

P-SU-110Efficacy of dexamethasone intravitreal implant forthe treatment of uveitis based on patient-reportedvision function outcome measuresJonathan W. Kowalski, Heather Gelhorn, Rupali K.Naik, Anne Rentz, Harry Cui, Careen Lowder,Rubens Belfort Jr., Steven Foster, Sue Lightman,Scott M. Whitcup (Irvine/USA, Cologne/D, São Paulo/BR, London/UK, Irvine/USA)

P-SU-111First results of the IOL-Vip system – Visual rehabili-tation of patients with low-vision due to severeage-related macular degenerationRamin Khoramnia, Christoph Winkler von Mohrenfels, Josefina Salgado, Barbara Schwaiger,Michaela Engel, Chris Lohmann (Munich/D)

P-SU-112Language development in children with retinopathyof prematurityGalton Carvalho Vasconcelos, Erika Parlato Oliveira,Janaina Couto Sacramento, Silmara de Abreu Melgaço (Belo Horizonte/BR)

Sunday, 6 June 2010 15:30 - 17:00

Sund

ay, 6

June

Post

ers

287WOC® 2010

P-SU-134Crossed Quadrant Homonymous Hemianopia PostMyocardial Infarction: A Case ReportIndira Nadras, Norlelawati Abu, Bethel Livingstone(Seremban/MAL)

P-SU-135Demanding treatment of neuromyelitis optica inJapanese patientAya Sakamoto, Masashi Nishimura, Shuhei Kasama,Keiko Tanaka, Osamu Mimura (Nishinomiya/J)

P-SU-136Diffusion tensor imaging (DTI)-based white mattermapping in children with amblyopia: underdevelop-ment of optic radiation studyHong Yan, Yongxing Xing, Guangbing Cui, Junjie Zhi (Xi'an/CN)

P-SU-137Evaluating visual field states in patients with opticneuropathy: VEP measurements in relative defectvisual fieldEileen Poloski, Nicole Dettler, Bernhard A. Sabel,Christoph S. Herrmann, Carolin Gall(Magdeburg/D)

P-SU-138Experimental mouse model of optic neuritisShihui Wei (Beijing/CN)

P-SU-139First report of primitive neuroectodermal tumorsoriginally in Optic nerveShihui Wei (Beijing/CN)

P-SU-140Fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy.Thalia Vasiliou, Marion Kaup, Niklas Plange, Andreas Remky (Aachen/D)

P-SU-141High titres of serum anti-aquaporin-4 (AQP4) antibody after successful plasmapheresis in AQP4-positive optic neuritisEiji Murotani, Shinji Ohkubo, Mayumi Sakurai,Kazuhisa Sugiyama, Mitsuhiro Kawano, Mineo Takagi, Keiko Tanaka (Kanazawa/J)

P-SU-142Idiopathic Bilateral Iris AtrophyElizabeth Palkovacs, Karl Golnik (Cincinnati/USA)

P-SU-143Incidence of cerebral venous sinus thrombosis inpatients with idiopathic intracranial hypertension.Shihui Wei (Beijing/CN)

P-SU-123Analysis of ocular motor dysfunctions related tomultiple sclerosisShihui Wei (Beijing/CN)

P-SU-124Bilateral vitreous hemorrhages predict poor vision inShaken Baby Syndrome in Japan.Yuri Kobayashi, Makiko Itou, Michiko Tanaka,Tadashi Yokoi, Sachiko Nishina, Shizuko Ohba,Makiko Okuyama, Noriyuki Azuma (Tokyo/J)

P-SU-125Cerebrospinal fluid dynamics between the basal cisterns and the perioptic space in patients with papilledemaHanspeter Killer, Gregor Jaggi, Neil Miller, Luca Remonda (Aarau/CH)

P-SU-126Characteristic of Ocular Motor Disorder Patients in Neuroophthalmology Division, DR Ciptoman-gunkusumo Hospital, 2006-2008Syntia Nusanti (Jakarta/RI)

P-SU-127Clinical analysis of amaurosis fugax caused by cardiovascular and cerebrovascular diseaseShihui Wei (Beijing/CN)

P-SU-128Clinical Analysis of Different Ocular Changes in Intraocular Anecurysm of Different LocationsShihui Wei (Beijing/CN)

P-SU-129Clinical analysis of mucormycosis 9 – A case reportShihui Wei (Beijing/CN)

P-SU-130Clinical analysis of ocular manifestations related toTakayasu arteritisShihui Wei (Beijing/CN)

P-SU-131Clinical characteristic and optimization of treatmentof optico-kinetic disadaptation syndrome in children with perinatal encephalopathy.Sevinj Salmanova, Elmar Kasimov, Sima Huseynova(Baku/ASE)

P-SU-132Comparison of Retinal Nerve Fiber Layer Measure-ments Using Time Domain and Spectral DomainOptical Coherence Tomography in Optic NerveHead DrusenFrancisco J. Muñoz-Negrete, Laura Guerrero, Gema Rebolleda, Elena Jarrín (Madrid/E)

P-SU-133Correcting Strabismus in Patients with CentralNervous System LesionsJuan Bu, Lejin Wang, Jing Li, Xin Tian (Beijing/CN)

Sunday, 6 June 2010 15:30 - 17:00Su

nday

, 6 Ju

ne

Post

ers

288 WOC® 2010

P-SU-153Phosphene thresholds during repetitive transorbitalalternating current stimulation (rtACS) relate to severity of vision loss in patients with optic neuropathyRomualda Michalik, Carolin Gall, Anton B. Federov,Stephan Brandt, Bernhard A. Sabel (Kleinmachnow/D, Magdeburg/D)

P-SU-154Pituitary ectopia in a case of bilateral optic nervehypoplasia-A case reportTsui-Kang Hsu (Taipei/TJ)

P-SU-155Pituitary Tumor Apoplexy – Long-term Follow-upMarketa Machackova, Dagmar Hejcmanova, Ivan Latr (Hradec Kralove/CZ)

P-SU-156Preliminary exploration of intracranial aneurysmswith ophthalmic symptomsShihui Wei (Beijing/CN)

P-SU-157Preliminary report of contrast sensitivity values afteridiopathic optic neuritisShihui Wei (Beijing/CN)

P-SU-158Relationship between anti-aquaporin-4 antibodyand anti-myelin oligodendrocyte glycoprotein antibody in patients with optic neuritisRyusaku Matsuda, Takeshi Kezuka, Yoshimiti Matsunaga, Yoshihiko Usui, Naoyuki Yamakawa,Keiko Tanaka, Hiroshi Goto (Tokyo/J)

P-SU-159Relationship between Macular Ganglion Cell Complex Parameters and Visual Field Sensitivity inChiasmal CompressionShinji Ohkubo, Tomomi Higashide, Hisashi Takeda,Eiji Murotani, Kazuhisa Sugiyama (Kanazawa/J)

P-SU-160Restoration of vision restoration: training improvesvisual fields in glaucoma – a double-blind, randomized, placebo-controlled clinical trialBernhard A. Sabel, Julia Gudlin (Magdeburg/D)

P-SU-161Restoration of vision: Improvements of parafovealvisual field are associated with increased readingspeed after training of light detection in patientswith homonymous visual field defectsDaniela Komm, Bernhard A. Sabel, Carolin Gall(Magdeburg/D)

P-SU-162Restoration of vision: development of a pre-clinicalmodel for repetitive transorbital alternating currentstimulation after optic nerve crushPetra Henrich-Noack, Nadine Voigt, Sylvia Prilloff,Bernhard A. Sabel (Magdeburg/D)

P-SU-144Internuclear Ophthalmoplegia as an Initial Manifes-tation of Multiple Sclerosis – A Case ReportFilipa Rodrigues, Cláudia Costa-Ferreira, ManuelaAmorim, Raquel Soares, José Salgado-Borges(Aveiro/P)

P-SU-145Lymphocytic hypophysitis presenting as optic neuritisKatja Christina Schielke, Sophie Anna Holak, Linda M. Buchanan, J. Angus Scott (Aalborg/DK,Berlin/D)

P-SU-146Multifocal Photopic Negative Response (mfPhNR)and Visual Field (VF) in patients with optic nerve lesionsAri Kamei, Eiichiro Nagasaka (Oshu/J)

P-SU-147Multiple Meningiomatosis, Mesencephalic VenousAnomaly and Cerebral Calcifications: Ocular Manifestations. Clinical CaseFrancisco Javier Hernandez Martinez, PurificacionPiñas Garcia, Araceli Trueba Lawand (Sevilla/E)

P-SU-148Multipotent Neural Progenitor Cells Support Regeneration Of Axons Within The Rat Optic NerveCarolin Chiwitt, Petar Charalambous, Mirjam Augustin, Solon Thanos (Münster/D)

P-SU-149Ocular clinical characteristics in Lymphocytic hypophysitisShihui Wei (Beijing/CN)

P-SU-150Ocular complications with acoustic neuroma surgical resectionMuhammad Amjad, A. Garrick, I. Marsh, C. Noonan (Manchester/UK)

P-SU-151Ophthalmic Herpes Zoster: Natural history, morbidity, treatment and preventionPeter Wutzler, Arnd Heiligenhaus, Angus Thomson,Isabelle Bertrand (Jena/D, Münster/D, Lyon/F)

P-SU-152Optic Disc Drusen-diagnose, clinical manifestations,and prognosisSonja Cekic, Gordana Stankovic Babic, Jasmina D- ordevic Jocic, Jovica Mršic, Ivan Jovanovic(Nis/SRB)

Sunday, 6 June 2010 15:30 - 17:00

Sund

ay, 6

June

Post

ers

289WOC® 2010

P-SU-174Vision- and health- related quality of life in strokepatients with homonymous visual field defects depend on severity of visual function lossCaroline Wagenbreth, Gabriele H. Franke, Bernhard A. Sabel, Carolin Gall (Magdeburg/D)

P-SU-175Vision- and health-related quality of life before and after vision restoration training in cerebrallydamaged patients.Anja Lindig, Bernhard A. Sabel, Carolin Gall (Oldenburg/D, Magdeburg/D)

P-SU-176Visual Field Deficit in Patient with the Optic NerveDrusen and the Pineal Cyst-case reportAna Pepic, Biljana Draganic, Jelena Mladenovic, Dusanka Mrvos-Cobeljic (Belgrade/SRB)

P-SU-177Visual fields, visual acuity and driving performancein patients with pituitary adenoma before and aftersurgeryEvelin Schneider, Gwendolyn Gramer, Eugen Gramer (Wuerzburg/D)

P-SU-178Visual functions assesment in case of functioningpituitary micraodenomasBrigita Budiene, Rasa Liutkeviciene, Rita Lukauskiene, Kestutis Sinkunas (Kaunas/LT)

New Technology, Bioengineering, P20Nanotechnology

P-SU-179Classification of Ophthalmic Viscoelastic Devicesusing the Weissenberg NumberBernd-Kristof Müller, Helmut Ritter, Yong KeunKim, Dirk-Henning Menz (Duesseldorf/D)

P-SU-180Comparison Between Simulated and Real Ablationsin Customized Contact LensLuciana de Matos, Claudia Francesconi, Enos de Oliveira, Luis Alberto Vieira de Carvalho(São Carlos/BR)

P-SU-181Cultivation of human cornea cells on the surface ofsiloxan-gidrogel contact lenses.Oleg Germanovich Makeev, Sergey AleksandrovichKorotkih, Elena Stepanovna Knyazeva, Maxim Gerasimov, Anastasya Evgenevna Zvereva(Ekaterinburg/RUS)

P-SU-182Effects of riboflavin and UV irradiation on sclerarigidityMuka Moriyama, Kyoko Oono, Ikuo Morita, Manabu Motizuki, Sakuya Tamada, Takuya Kisimoto, Akio Yasuda (Tokyo/J)

P-SU-163Retrospective analysis of optic neuritis among thepatients of multiple sclerosisShihui Wei (Beijing/CN)

P-SU-164Study of the threshold defect of branch retinal veinocclusionShihui Wei (Beijing/CN)

P-SU-165Study of visual evoked potential with irregular pattern stimulation in normal human subjectS. M. Shushtarian, Sara Mohammadi, M. J. Motamedi, T. Davari (Tehran/IR)

P-SU-166Study of visual function and retinal morphology inthe mice model of experimental optic neuritisShihui Wei (Beijing/CN)

P-SU-167The analysis of clinic characters of slightly indirecttraumatic optic neuropathyShihui Wei (Beijing/CN)

P-SU-168The clinical research of correlation factors of abducens nerve paralysis of 47 hospitalized patientsShihui Wei (Beijing/CN)

P-SU-169The Contribution of Ultrasound to the Diagnosisand Follow-Up of Giant Cell Arteritis. A Pilot StudyAna Suelves, J. I. Tembl, Enrique España-Gregori,Stephanie Rohrweck, Diamar Pardo-Lopez, Salvador Garcia-Delpech, Patricia Udaondo, Manuel Díaz-Llopis (Xirivella/E, Valencia/E)

P-SU-170The situation of ocular ischemic diseases cured bycarotid artery endarterectomyShihui Wei (Beijing/CN)

P-SU-171To analyse the clinical features of The diseases inoccipital lobeShihui Wei (Beijing/CN)

P-SU-172To analyse the correlation of the of the lesions in visual pathway posterior to the chiasm with eyesymptom.Shihui Wei (Beijing/CN)

P-SU-173VEP and other visual functions before and after surgical excision of tumors compressing anterior visual pathway.Jawahar Lal Goyal, Lanalyn Thangkhiew, Usha Yadava (Noida/IND)

Sunday, 6 June 2010 15:30 - 17:00Su

nday

, 6 Ju

ne

Post

ers

290 WOC® 2010

Oculoplasty/Orbita/Lids/Lacrimal System P21

P-SU-191A case of congenital tarsal kink syndrome treatedwith everting suturesAristeidis Konstantinidis, Kave Vahdani, James Benzimra, Khaik Kee Peh, Vladimir Thaller(Plymouth/UK)

P-SU-192A case report on the management of an orbital foreign bodyLivia Teo, Audrey Looi, Lay Leng Seah(Singapore/SGP)

P-SU-193A Modified Container with Drainage Tube for Secondary Reconstruction of Severe Contracted EyeSocketMing Lin, Xianqun Fan (Shanghai/CN)

P-SU-194A novel disease-specific quality of life questionnaireclosely correlates with objective parameters inGraves orbitopathyKatharina A. Ponto, George J. Kahaly, Susanne Pitz,Gerhard Hommel, Norbert Pfeiffer (Mainz/D)

P-SU-195Amniotic membrane grafting in Epidermal nevussyndromeBrahm Guliani, Shreekant Damgude, Anuj Mehta,Krishan Malik, Vishnu Gupta (Coimbatore/IND)

P-SU-196An unusual course of a case with “orbital cellulitis”Jan Köhler, Thomas Büchner, Burkhard Wiechens(Hannover/D)

P-SU-197Anthropometry of the Arabian eyesAmal Bukhari (Jeddah/SA)

P-SU-198Ascending Nasolacrimal System Obstruction in apediatric age patient with Lichen Planus.Pelin Kaynak-Hekimhan, Serhat Imamoglu, Can Ozturker, Birsen Gokyigit, Ahmet Demirok,Omer Faruk Yilmaz (Istanbul/TR)

P-SU-199Basal Cell Carcinoma of the Eyelid in YoungWomanLidija Perez (Bitola/MK)

P-SU-200Benign fibrous histiocytoma of the eyelidStephan Eckert, Gerhard Klaus Lang (Ulm/D)

P-SU-183Evaluation of conjunctival circulation using scanning laser ophthalmoscopeMichiya Takamatsu, Takashi Sone, Yoshiaki Kiuchi(Hiroshima/J)

P-SU-184FLASH software to improve basic ophthalmologicaleducation: Retinoscopy Trainer and GoldmannPerimetry TrainerHeiko Wassill, Birgit Lorenz, Thomas Stoll, Mini Köhler, Thomas Kowarsch (Giessen/D)

P-SU-185Injectabilty of viscoelastic solutionsDirk-Henning Menz, Yong Keun Kim, Cora Keil(Königsbrunn/D)

P-SU-186One year experience with a novel tonometer andcontact glass disinfection device (Tonoclean)Aljoscha Neubauer, Ronald Spaltmann, WernerReis, Christoph Hirneiss (Munich/D)

P-SU-187Optical coherence tomography assisted anteriorsegment surgery – OCTAASSGabor Scharioth (Recklinghausen/D)

P-SU-188Quantitative proteomic analysis of human aqueoushumor by mass spectrometryAndreas Pollreisz, Marion Funk, Florian P. Breitwieser, Stefan Sacu, André Mueller, Melanie Planyavsky, Jacques Colinge, Michael Georgopoulos, Keiryn L. Bennett, Guilio Superti-Furga, Ursula Schmidt-Erfurth (Vienna/A)

P-SU-189Surface Quality Characteristics of Intraocular LensesAssessed by Atomic Force MicroscopyPartha Biswas, Koel Choudhury, Subhrangshu Sengupta, Ajoy Paul, Rashmi Mukherjee(Kolkata/IND)

P-SU-190Which physical actuation principles are suitable fordriving the optics of an implantable mechatronicaccommodation system?Thomas Martin, Ulrich Gengenbach, Georg Bretthauer, Rudolf Guthoff (Eggenstein-Leopoldshafen/D, Karlsruhe/D, Rostock/D)

Sunday, 6 June 2010 15:30 - 17:00

Sund

ay, 6

June

Post

ers

291WOC® 2010

P-SU-212How accurate is clinical and radiological evaluationof orbital lesions in comparison to orbital biopsy?Antigoni Koukkoulli (Leeds/UK)

P-SU-213In Vivo Efficacy of Bone Marrow Stromal CellsCoated Beta-Tricalcium Phosphate for the Reconstruction of Orbital Defects in the CanineHuifang Zhou, Xianqun Fan, Caiwen Xiao (Shanghai/CN)

P-SU-214Late presentation of congenital nasolacrimal ductobstruction. Can be cured by simple probing?Osama Shalaby, M. Ashraf El Desouky (Tanta/ET)

P-SU-215Lid reconstruction without local blood supply – a new method combining Hughes-flap, skin graftand tarso-marginal graft for lower lid defects extending into the canthusFalk Sommer (Dresden/D)

P-SU-216Looi Suture Technique for Anchoring the LateralTarsal Strip to the Orbital WallJoy Chan, Audrey Looi (Singapore/SGP)

P-SU-217Management of orbital venous malformation withintralesional injection of Pingyangmycin:a primarystudyRenbing Jia (Shanghai/CN)

P-SU-218Metastases in oropharyngeal carcinomaLutz Becker (Ulm/D)

P-SU-219Minimally invasive surgery of blepharoptosis byshort-pulsed CO2 laser irradiation with Muellermuscle tucking and visual function improvement.Kazuhiko Dannoue, Nobuyuki Miyata, Eiichi Okada,Satoki Ueno (Kawasaki/J)

P-SU-220Minor conjunctivitis expands to fulminant necroticfasciitis due to infection with Streptococcus pyogenesInez Brunotte, Sebastian Weiß, KonstantinosZinelis, Rolf Winter, Michael Meyer (Hannover/D)

P-SU-221Modified Staged Correction For Blepharophimosis-Ptosis-Epicanthus Inversus SyndromeXin Song, Xianqun Fan (Shanghai/CN)

P-SU-222Moh’s Micrographic Surgery for Chinese Patientswith Eyelid Basal Cell CarcinomaTerence Goh, David Liu, Kelvin Chong, Ben Wong,Gary Tse, HK Ng, Dennis Lam (Kowloon/HK)

P-SU-201Comparative experimental study of biological integration of different implantation materials usedfor orbital surgeryTatiana Bakaeva, Anatoly Fedorov, Yaroslav Grusha(Moscow/RUS)

P-SU-202Conjunctival alterations in ocular pemphigoid: a confocal laser-scanning microscopy study.Giulia Renieri, Eva Hecht, Esther von Stebut-Borschitz, Norbert Pfeiffer, Susanne Pitz (Mainz/D)

P-SU-203Correction of Telecanthus and ptosis in Patientswith the Blepharophimosis SyndromeAshok Grover (New Delhi/IND)

P-SU-204Dig deeper into the tear proteome: advanced protein profiling in dry eye patientsKlaus Thomas Ude, Nils Boehm, Michaela Wiegand,Norbert Pfeiffer, Franz Grus (Mainz/D)

P-SU-205Dry Eye and PterygiumKhakima Karim-Zade, Zukhra Akhrorova(Dushanbe/TAD)

P-SU-206Dry Eye Disease Activity Log – A New Tool in Management of Patients with Dry Eye DiseaseJayant Venkatramani Iyer, Hak Tien Louis Tong (Singapore/SGP)

P-SU-207Early Gold Weight Implants in the management ofparalytic lagophthalmosEsther Mata, Eduardo Conesa, Carlos De Pablo(Madrid/E)

P-SU-208Effects of Botulinum Toxin-A in Orbicularis OculiMuscle of Patients with Blepharospasm – PilotStudyTammy Osaki, Midori Osaki, Suely Marie, Rubens Belfort, Jr., Teissy Osaki (Sao Paulo/BR)

P-SU-209Evaluation of Motility in Primary pegged anophthalmic implantHadi Khazaei (Bangalore/IND)

P-SU-210Granulocytic sarcoma of lacrimal gland precedingthe blast phase of acute non-lymphoblasticleukemia.Jutarat Pomsathit (Bangkok/T)

P-SU-211Histopathologic evaluation of eyelid lesions: When to order, when to omit?Yasser Y. M. Hassan Al-Faky (Riyadh/SA)

Sunday, 6 June 2010 15:30 - 17:00Su

nday

, 6 Ju

ne

Post

ers

292 WOC® 2010

P-SU-234Reconstruction of Severe Anophthalmic Orbits andAtresic Eye Sockets after Enucleation and Irradia-tion of Retinoblastoma by Vascular AnastomosedFree Dorsal Flap Transplantation and AutogenousDermal Fat ImplantationXiaoping Bi, Xianqun Fan, Huifang Zhou (Shanghai/CN)

P-SU-235Recurrent preseptal cellulitis of the upper eye lidTeresa Wacker, Gerhard K. Lang, Peter Wagner,Stephan Eckert (Ulm/D)

P-SU-236Sinus thrombosis as intracranial complication ofphlegmon of orbit.Darya Zubkova, Pavel Bezditko, Maryna Shchadnykh, Olesya Zavoloka (Kharkiv/UA)

P-SU-237Spontaneous lid repair technique for medial canthalbasocelular carcinoma.Amalia Amadora Ascarza (Cap Fed Bs As/RA)

P-SU-238Spontaneous recovery of fronto-orbital blow infracture in a childYefei Wang, Xianqun Fan, Huifang Zhou, Caiwen Xiao (Shanghai/CN)

P-SU-239Surgical correction and prevention of complicationsin congenital blepharoptoses complicated by vertical motility disordersSvetlana Tronina, Nadiya Bobrova (Odessa/UA)

P-SU-240Surgical therapy of bilateral upper eyelid ptosis in a case of Kearns-Sayre syndromeChristian Flöhr, Thomas Büchner, Burkhard Wiechens (Hannover/D)

P-SU-241Ten-year follow-up of a case series of primary epithelial neoplasms of the lacrimal gland: clinicalfeatures, surgical treatment and histopathologicfindingsRenato Damasceno (Erlangen/D)

P-SU-242The Eyelid and Orbit Nomogram in Indian eyes: A randomized cross sectional studyPrashant Yadav, Neelam Pushker, Varun Gogia,Shikha Gupta, Mandeep Bajaj, Bhavna Chawla,Mahesh Chandra (New Delhi/IND)

P-SU-243The importance of axial globe projection in the pathogenesis of involutional lower eyelid malpositionRenato Damasceno (Erlangen/D)

P-SU-223Mucosal spread of sebaceous cell carcinoma andconjunctival melanoma through the lacrimal systemto the ethmoid sinus and nose.Manpreet Chhabra, Jill Melicher Larson, Jeffrey Nerad (Cincinnati/USA)

P-SU-224Myxofibrosarcoma of the orbitSharifah Intan Syed Osman (Selangor/MAL)

P-SU-225New technique for recanalisation of nasolacrimalductMirsad Ibisevic (Sarajevo/BIH)

P-SU-226Oculoplastic reconstruction of the periocular regionafter severe facial burns – a case reportPeter Galambos, Hans-Werner Meyer-Rüsenberg,Ulrich Schaudig (Hamburg/D)

P-SU-227One-step surgical management of severe orbito-temporal neurofibromatosisJin Li, Xianqun Fan (Shanghai/CN)

P-SU-228Ophthalmic Complications and their AvoidanceDuring Functional Endoscopic Sinus SurgeryImtiaz Chaudhry, Yonca Arat, Waleed Al-Rashed, Elsanusi Elzaridi, Adel Alsuhaibani, ManalBouhaimad, Milton Boniuk (Riyadh/SA,Houston/USA)

P-SU-229Orbital apex syndrome in Songklanagarind hospitalOrapan Aryasit (Songkhla/T)

P-SU-230Primary non-Hodgkin's lymphoma of the lacrimalsac: a case reportNatha Chongpison (Bangkok/T)

P-SU-231Profound visual loss in a patient receiving periorbital treatments of poly-(L)-lactic acidSteve Roberts, Bryan Arthurs, Mark Gans, Jean Deschenes, Mashad Darvish (Montreal/CDN)

P-SU-232Quantitative Morphometry of Orbit in ChineseAdults by a Three-dimensional ReconstructionMethodYongrong Ji (Shanghai/CN)

P-SU-233Raising the quality of life in an ageing Society byOculplastic Surgery – challenge and potential forthe Oculoplastic SurgeonHüseyin Aral, Daniel Martin Handzel (Cologne/D)

Sunday, 6 June 2010 15:30 - 17:00

Sund

ay, 6

June

Post

ers

293WOC® 2010

P-SU-253Effect of ultraviolet A1 and infrared A irradiation on viability and vascular endothelial growth factorsecretion of retinal pigment epithelial cells.Stefan Koinzer, Alexa Klettner, Felix Treumer,Agatha Schwarz, Christian Jantschitsch, Kirstin Reinecke, Johann Roider (Kiel/D)

P-SU-254Generation of retinal pigment epithelial cells fromhuman induced pluripotent stem cellsTim U. Krohne, Mandy Lehmann, David F. Friedlander, Alison Dorsey, Wenlin Li, Ding Sheng,Martin Friedlander (La Jolla/USA)

P-SU-255Generation of transgenic zebrafish lines withhuman rhodopsin mutationsMotokazu Tsujikawa, Yuzuru Sasamoto, Nagakazu Matsumura, Takeshi Nakao (Suita/J)

P-SU-256GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophinsMaurice Schallenberg, Petar Charalambos, Uwe Schröer, Solon Thanos (Essen/D, Münster/D)

P-SU-257Involvement of P2X7 receptors in the hypoxia-in-duced death of rat retinal neuronsTetsuya Sugiyama, Hidehiro Oku, Maho Shibata,Masayuki Fukuhara, Shota Kojima, Tsunehiko Ikeda(Takatsuki/J)

P-SU-258Laminin and other Basement Membrane ProetinsAlterations in the Mouse Retina of three differentdiabetic mouse strainsElizabeth Abari, Alexander Kunze, Irina Semkova,Norbert Kociok, Ursula Hartmann, Mats Paulsson,Antonia M. Joussen (Duesseldorf/D, Berlin/D)

P-SU-259Linoleic acid stimulates monocyte chemoattractantfactor (MCP)-1 expression through toll-like receptor4 and NF-kappaB signal transduction pathway inretinal pigment epithelial cellsChang-Hao Yang, I-Mor Fang, Chung-May Yang(Taipei/TJ)

P-SU-260Macrophage mediated VEGF expression in retinalneovascularizationKristina Schmidt, Tina Lucas, Michael Piekarek, Sabrina Klein, Elizabeth Abari, Irina Semkova, Norbert Kociok, Sabine A. Eming, Antonia M.Joussen (Duesseldorf/D, Berlin/D)

P-SU-261Pharmacological Study of Proliferative Vitreo-retinopathyWu Wen-Chuan (Kaohsiung City/TJ)

P-SU-244The importance of being earnestBipasha Mukherjee (Chennai/IND)

P-SU-245The management of orbital cavernous haemangionas – a case series studyMorgan Yang, Chai Teck Choo, Audrey Looi, Lay Leng Seah (Singapore/SGP)

P-SU-246The role of CD40-CD154 interaction in the pathogenesis of Graves’ orbitopathy (GO)Melissa Thanos, Elena Ströher, Erich Gulbins, Klaus Peter Steuhl, Joachim Esser, Anja Eckstein(Essen/D)

P-SU-247The use of Desmarres clamp for controlled bleeding during excision of lid lesionsTsiang Ung, Jonathan Chan, Ben While, Tahir Farooq (Sheffield/UK)

P-SU-248The use of FloSeal® in external DCRRalf Ungerechts, Melanie Jäger, Hans-WernerMeyer-Rüsenberg, Karl-Heinz Emmerich (Darmstadt/D, Hagen/D, Giessen/D)

P-SU-249Transcanalicular diode laser dacryocystorhinostomy(TDCR) – methods, indications and first resultsLeonard Holbach, Anselm G. M. Jünemann, Mansour Tarif, Ludwig M. Heindl, Rudolf Walker,Reinhard Thyzel, Friedrich Kruse (Erlangen/D)

P-SU-250Ultrasound Biomicroscopic Evaluation of theLacrimal Drainage SystemYasser Y. M. Hassan Al-Faky (Riyadh/SA)

P-SU-277Psycho-emotional status of vegetative dysfunctionin patients With Sjoegren’s SyndromeBoris Kogan (Odessa/UA)

Retina: Basics P22

P-SU-251ApoA-I Mimetic Peptide Reduces Lipid Depositionin Murine Bruch’s Membrane after Intravitreal InjectionMartin Rudolf, Mark E. Clark, Jeffrey D. Messinger,Salvatore Grisanti, David Garber, Christine A. Curcio (Lübeck/D, Birmingham/USA)

P-SU-252Characterisation of Primary Adult Human RetinalMicrogliaBalini Balasubramaniam, Elizabeth Nicholson, Debra A. Carter, Eric J. Mayer, Andrew D. Randall,Andrew D. Dick (Bristol/UK)

Sunday, 6 June 2010 15:30 - 17:00Su

nday

, 6 Ju

ne

Post

ers

294 WOC® 2010

P-SU-272Transdifferentiation and the involvement of Müllerglial cells in epiretinal cell proliferation of idiopathicmacular holesRicarda G. Schumann, Markus Schaumberger,Kirsten Eibl, Christos Haritoglou, Anselm Kampik,Arnd Gandorfer (Munich/D)

Retina: Trauma/Emergencies P23

P-SU-273Soccer: one sport, two eye injuriesGil Calvão-Santos, Joel Ferreira, João Chibante, António Gomes da Rocha, José Salgado-Borges(São Mamede de Infesta/P)

P-SU-274Subjective and Objective Visual Disability Assessment in Patients with Open Globe InjuriesMayuri Bhargava, Usha Vasu (Bangalore/IND)

P-SU-275Traumatic retinal detachment: our surgical approachVolha Yarmak, Tatsiana Imshenetskaya (Saslauje/BY, Minsk/BY)

P-SU-276Valsalva Retinopathy after vigorous sexual activityunder the influence of SildenafilAndre Schafia, Zisis Gatzioufas, Kouris Ninios, Ursula Löw, Berthold Seitz (Homburg/D)

P-SU-262Photoreceptor Cell Death in a Zebrafish Model ofAutosomal Dominant Retinitis PigmentosaTakeshi Nakao, Motokazu Tsujikawa (Suita/J)

P-SU-263Progression of Diabetic Retinopathy and diabeticnephropathy are they parallelA Alghadyan (Alkhober/SA)

P-SU-264Protective Effects of Tempol Against IndocyanineGreen Induced Toxicity In RatsTomasz Choragiewicz, Andreas Schatz, GabrielWillmann, Bogomil Voykov, Florian Gekeler, MichalFiedorowicz, Frank Schuettauf, Tomasz Zarnowski,Robert Rejdak, Sebastian Thaler (Lublin/PL, Tübingen/D)

P-SU-265Regulation of the casein kinase - 2 in retinal pigment epithelial cellsStephan Hoffmann, Hans-Sebastian Walter,Berthold Seitz, Mathias Montenarh (Homburg/D)

P-SU-266Replacement of photoreceptor cells in dystrophicadult retinas by cell transplantationGila Jung, Gisbert Richard, Xiaoli Yang, Marius Ader, Udo Bartsch (Hamburg/D)

P-SU-267Retinal damage in Kimba mouse modelLi Cairui, Ali Rahman Ireni, May Lai Choo (Dali/CN)

P-SU-268Systemic regulation of renin expression in the reti-nal pigment epitheliumOlaf Strauss, Marisa Brockmann, Christian Meyer,Vladimir Todorov, Michael Desch, Armin Kurtz,Vladimir Milenkovic (Regensburg/D, Bielefeld/D)

P-SU-269The Diabetic Retinopathy as a Cause of Visual Acuity DecreaseIhar Zabarouski, Tatsiana Imshanetskaya, Galina Semak, Inna Malinouskaya (Minsk/BY)

P-SU-270The distribution and characteristics of bone mar-row-derived cells in the retina during physiologicaland pathological angiogenesisKeiko Kataoka, Koji M. Nishiguchi, Shu Kachi, Hiroko Terasaki (Nagoya-city/J)

P-SU-271Towards a stem cell-based intraocular delivery system for therapeutically relevant gene productsUdo Bartsch, Gila Jung, Stephan Linke, KristofferWeber, Boris Fehse, Bettina Petrowitz (Hamburg/D)

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

Post

ers

295WOC® 2010

P-MO-007In vivo confocal microscopy of fungal keratitis – a case reportSimon Trpin, Levin Vrhovec, Tomaz Gracner (Maribor/SI)

P-MO-008Tear Film Osmolarity and Dry Eye Severity Index in Patients with Rheumatoid Arthritis or SjögrenSyndromeMarc Schargus, Franziska Wolf, Ben Sulivan, MartinFeuchtenberger, Gerd Geerling (Wuerzburg/D)

P-MO-009The Effect of Topical Cyclosporine A Comparedwith Preservative-free Artificial Tears in Dry Eye SyndromeChoun-Ki Joo (Seoul/ROK)

P-MO-010The effect of wide incision cataract surgery tocorneal sensibility and dry eyeParamastri Arintawati (Hiroshima/J)

P-MO-011The Value of Real-Time Polymerase Chain Reactionfor the Diagnosis and Treatment of AcanthamoebaKeratitisYoshifumi IKeda, Keiko Yakura, Ryu Uotani, Fumie Otani, Atsuko Miyake, Ryoko Ishikura, DaiMiyazaki, Yoshitsugu Inoue, Tsuyoshi Mito, Atsushi Shiraishi, Yuichi Ohashi, Yusuke Saeki, Kenji Yagita (Yonago/J)

Cornea/Eye Bank: Medical Therapy P25

P-MO-012Antibiotic resistance and clinical outcome in cultureproven cases of microbial keratitis over a 5-year periodLevin Vrhovec, Simon Trpin, Dusica Pahor (Maribor/SI)

P-MO-013Changing trends of bacterial keratitis after penetrating keratoplasty in Saudi ArabiaSamar Al-Swailem, Michael Wagoner, M. Bridget Zimmerman, John Sutphin (Riyadh/SA)

P-MO-014Clinical Performance of an Osmoprotective Formulation for Dry Eye TherapyPeter Simmons, Joseph Vehige, Alan Sasai, Cindy Carlisle-Wilcox, Melissa Blue, Francis Lai(Irvine/USA)

P-MO-015Efficacy of postoperative immunosuppression afterkeratoplasty in herpetic keratitisAnna-Karina Maier, Sevil Özlügedik, Jessica Rottler,Matthias Klamann, Sibylle Winterhalter, Klaudia Huber, Florian Heussen, Antonia Joussen(Duesseldorf/D)

Poster exhibition of Poster P-MO-001 to P-MO-298.All poster authors will attend their posters from15:30 to 17:00 hrs.

Moderation Poster sessions on Monday Chairs:Gerd U. Auffarth (Heidelberg), ChairSalvatore Grisanti (Lübeck), Chair

Co-Chairs:Florian Birnbaum (Freiburg)Silvia Bopp (Bremen)Andrea Hassenstein (Hamburg)Bernhard Jurklies (Essen)Anja Liekfeld (Potsdam)Mathias Maier (Munich)Frank H. W. Tost (Greifswald)Rainer Guthoff (Wuerzburg)Hansjürgen T. Agostini (Freiburg)

Cornea/Eye Bank: Diagnostics P24

P-MO-001A challenging case of perforated corneal ulcer in Stevens-Johnson syndrome treated with conjunctival hoodRajeeb Alam, Syed A. Hassan, Halim Khan, Rezaul Karim (Dhaka/BD)

P-MO-002A novel method to detect subclinical keratoconus:corneal volume measurements with pentacam system.Hasan Basri Cakmak, Nagihan Ugurlu, NurullahCagıl, Hüseyin Simavlı, aban im ek (Ankara/TR)

P-MO-003Bilateral herpetic keratouveitis: a case report withatypic presentatıonOsman Ceylan, Tugrul Akin, Orhan Ates(Erzurum/TR)

P-MO-004Congenital Hereditary Stromal Dystrophy (CHSD): A diagnostic and management challengeRajeeb Alam (Dhaka/BD)

P-MO-005Determination of significant variables for keratoconus grading by factor analysisNagihan Ugurlu, Hasan Basri Cakmak, NurullahCagıl, Elif Damar, aban im ek (Ankara/TR)

P-MO-006Evaluation of corneal topographic features andcorneal aberrations of keratoconus using ROC (Receiver Operating Characteristic) curvesOmar Salamanca, Alejandro de la Torre (Cali/CO)

Monday, 7 June 2010 15:30 - 17:00

Glaucoma: Diagnostics P26

P-MO-055The effect of anterior chamber depth on intraocularpressure after uneventful phacoemulsification innonglaucomatous eyesTansu Gonen, Kadircan Keskinbora, Fatih Horozoglu (Tekirdag/TR)

P-MO-027A case report of trabeculectomy for high intraocular pressure with hemodialysisYukinobu Okajima, Tetsuo Tochikubo, Hiroshi Watanabe (Tokyo/J)

P-MO-028A comparison of clinical diagnostic accuracy between Octopus standard automated perimetry,Pulsar perimetry, Moorfields Motion DisplacementTest and Heidelberg Retinal Tomography in glaucoma detection.Justyna Oleszczuk, Ciara Bergin, Eamon Sharkawi(Warsaw/PL)

P-MO-029Analysis of parapapillary fundus autofluorescenceusing modified fundus photography and scanninglaser ophthalmoscopyRicarda Wienrich, Achim Langenbucher, WolfgangBehrens-Baumann, Arne Viestenz (Magdeburg/D)

P-MO-030Angle closure glaucoma managed with lens extrac-tion and viscodissection of the angle: a comparisonof anterior segment OCT and UBM.Trushar Patel, Imran Masood, TK Jonathan Chan(Sheffield/UK)

P-MO-031Clinical Use of Transpalpebral Diaton Tonometryafter Keratophotorefractive SurgeriesAlla Illarionova, Tair Dzafarly (Moscow/RUS)

P-MO-032Comparison of Fourier Domain Optical CoherenceTomography (FD-OCT) Measurements in SubjectsWith and Without Pupil DilationEsther Hoffmann (Mainz/D)

P-MO-033Comparison of optic disc topographic measure-ments using Fourier-Domain optical coherence tomography and confocal scanning laser ophthal-moscopy in glaucoma patients and normal subjectsAndreas Schulze, Julia Lamparter, Stefan Günther,Norbert Pfeiffer, Esther Hoffmann (Mainz/D)

P-MO-034Correlations of Retinal Nerve Fiber Layer and Gan-glion Cell Complex Measurements Using Fourier-Domain Optical Coherence Tomography with VisualField Loss in Japanese Glaucoma PatientsMotohiro Shirakashi, Kiyoshi Yaoeda, Haruki Abe(Niigata/J)

Mon

day,

7 Ju

ne

296 WOC® 2010

P-MO-016Immunosuppression with Mycofenolate Mofetil(MMF) in high-risk keratoplastiesJessica Rottler, Maier Anna-Karina, Sevil Özlügedik,Florian Heussen, Matthias Klamann, Klaudia Huber-van der Velden, Sybille Winterhalter, Antonia Joussen (Essen/D)

P-MO-017Management of keratopathies by tear substitutes:the right protocol.Lorenzo Mannucci (Padova/I)

P-MO-018Mesenchymal Stem Cells Prolong the Survival ofCorneal Allograft in Rats by Inhibiting Th1-depen-dent Immune ResponseXiaomin Zhang, Chunna Jiao, Xiaorong Li,Shaozhen Zhao (Tianjin/CN)

P-MO-019Optical quality of the cornea following collagencross-linking for keratoconusMartin Baumeister, Jens Bühren, Thomas Kohnen(Frankfurt/D)

P-MO-020Photodynamic Therapy of Corneal Neovasculariza-tion with VerteporfinAbdullah Al-Turbaq (Riyadh/SA)

P-MO-021The effect of human and rabbit serum on the recovery of the wounded corneal surface in the Ex vivo Eye Irritation testNorbert Schrage (Cologne/D)

P-MO-022The influence of 0.15 % hyaluronic acid solution(OXYAL) treatment on ocular aberrations in dry eyepatientsAnna Rogowska-Godela, Katarzyna Buczak-Gasinska, Ewa Mrukwa-Kominek (Katowice/PL)

P-MO-023Topical Gancyclovir 0,15% Ophthalmic Gel for Herpes Keratitis TreatmentCamila Geraissate, Heloisa Nascimento, RubensBelfort Jr, Denise Freitas (Sao Paulo/BR)

P-MO-024Treatment of dry eye caused by inadequate lid closure.Claes Feinbaum (Landskrona/S)

P-MO-025UVA-Riboflavin Collagen Crosslinking in CornealUlcerSebastian Kupferschmid, Gerhard K. Lang (Ulm/D)

Post

ers

Monday, 7 June 2010 15:30 - 17:00

P-MO-043Imaging of Nerve Fiber Layer Defects in Glaucomausing Speckle Noise-reduced Spectral-domain Optical Coherence TomographyMasayuki Nukada, Masanori Hangai, Satoshi Mori,Noriko Nakano, Yuriko Kotera, Hideo Nakanishi,Hanako Ikeda, Hajime Nakamura, Atushi Nonaka,Nagahisa Yoshimura (Anshuyamakawatyo/J)

P-MO-044Iris Color & Central Corneal Thickness in Glaucoma.Does Blue Iris portend Thick Cornea?Sriram Sonty, Sindhura Pisipati, Afzal Ahmad (Flossmoor/USA)

P-MO-045Learning Curve of Flicker Defined Form PerimetryJulia Lamparter, Andreas Schulze, Ann-ChristinSchuff, Norbert Pfeiffer, Esther M. Hoffmann(Mainz/D)

P-MO-046Low hysteresis, low pachymetry, low Goldmanntonometry in healthy and glaucomatous Mexicanpatients: comparison of Goldmann, pascal and ocular response analyzerJesús Jiménez-Roman, Oscar Albis-Donado, Daniel de la Torre-Tovar (Mexico City/MEX)

P-MO-047Macular ganglion cell complex in glaucomaJose Javier Garcia-Medina, Manuel Garcia-Medina,Francisca Fernandez de Benito, Vicente Zanon-Moreno, Maria Dolores Pinazo-Duran (Huercal-Overa/E, Almeria/E)

P-MO-048Normal Tension Glaucoma – Mislead Diagnosis;case presentationAlina Popa Cherecheanu, Ruxandra Pascu, MihaiGhita (Bucharest/RO)

P-MO-049Optic neuropathy in Alzheimer’s disease versusglaucomatous optic neuropathyFatmire Berisha, Gilbert T. Feke, Clement L. Trempe,J. Wallace McMeel, Norbert Pfeiffer, Charles L. Schepens (Mainz/D)

P-MO-050Post traumatic 360 degree recession angle glaucomaLuís Abegão Pinto, Ana Amaral, Paula Leitão, Joana Ferreira, João Lisboa (Belas/P)

P-MO-051Racial Differences in Central Corneal Thickness inNarrow Angle Glaucoma Patients and correlationwith the Severity of Glaucoma from a CommunityPracticeAfzal Ahmad, Sriram Sonty, Sindhura Pisipati (Flossmoor/USA)

Mon

day,

7 Ju

ne

297WOC® 2010

P-MO-035Dark adaptation and macular blood flow in patientswith primary chronic open-angle glaucoma, pseu-doexfoliation glaucoma or congenital glaucoma.Zisis Gkatzioufas, Marilita Moschos, Ursula Löw,Christian Jonescu-Cuypers, Berthold Seitz (Hom-burg/D)

P-MO-036Detection of psychophysical and structural abnormalities in an outpatient setting using frequency doubling technology (FDT) perimetry,scanning laser polarimetry (GDx-VCC), and opticalcoherence tomography (Stratus OCT)Daniel Herzog, Joachim Herzog, Nicola Rauch,Lorenz Barleon, Norbert Pfeiffer, Esther Hoffmann(Mainz/D)

P-MO-037Differences in corneal biomechanics of patientswith unilateral open angle glaucomaChristoph Hirneiss (Munich/D)

P-MO-038DynamicContourTonometry, Goldmann Applana-tion Tonometry and TonoPen vs. intracameral read-ings – A Comparison of three measurement devicesin patients with corneal pathologiesMatthias Neuburger, Philip Maier, Florian Birnbaum,Juliane Großwendt, Sonja Lautebach, Daniel Böhringer, Thomas Reinhard, Jens F. Jordan(Freiburg/D)

P-MO-039EDMAGS (Evonik-Degussa-Mainz-Glaucoma-Study)IV: The Glaucoma Probability Score of the Heidel-berg Retina Tomograph (HRT 3.0) as a ScreeningUnit for GlaucomaLorenz Barleon, Claudia Deters, Esther Hoffmann,Jochen Wahl, Peter Morfeld, Andrea Lichtmeß,Sibylle Haas-Brähler, Rolf Breitstadt, Norbert Pfeiffer(Mainz/D)

P-MO-040Electrophysiological Detection of Glaucoma usingSilent Substitution TechniquePatrick Bessler, Sascha Klee, Ulrich Kellner, JensHaueisen (Ilmenau/D)

P-MO-041Evaluation of filtering blebs using the “Wuerzburgbleb classification score” compared to other clinicalfindingsSandra Furrer, Marc Töteberg-Harms, Cornelia Hirn,Peter Paul Ciechanowski, Jens Funk (Zurich/CH)

P-MO-042Factors Associated with Retinal Nerve Fiber LayerThickness Measurements Using Scanning Laser Polarimetry with Variable Corneal Compensationand Enhanced Corneal Compensation in NormalJapanese SubjectsTakayuki Tanaka, Motohiro Shirakashi, KiyoshiYaoeda, Haruki Abe (Niigata/J)

Post

ers

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

298 WOC® 2010Po

ster

s

P-MO-062Central Corneal Thickness as a Parameter in Patients with Glaucoma or Ocular Hypertension:Results of the German MoviX SurveyInes Ecke, Claudia Guzy, Richard Stodtmeister (Rodalben/D)

P-MO-063Comparison of Latanoprost and Timolol in Pediatric Glaucoma Patients: a Phase 3, 12-week,Double-Masked Multicenter StudyTomoko Maeda, Katherine Chi-Burris, BarbaraWirostko, PANDA Study Group (San Diego/USA)

P-MO-064Comparison of the effects of tafluprost and latanoprost on intraocular pressure and ocular surface findingsKatsuyoshi Suzuki, Takeshi Sagara, Hideaki Yoshino,Masako Nakayama, Miho Enoki, Shinji Hirano, Norihisa Takahashi, Kayoko Tokuhisa, Yasuhito Ishida, Shinichiro Teranishi, Rie Matsuda,Atsuko Tanaka, Teruo Nishida (Ube-city/J)

P-MO-065Effect of a new audible and visual reminder systemon adherence with topical ocular therapyManuel Hermann, Lebriz Ersoy, Michael Diestel-horst (Cologne/D)

P-MO-066Efficacy of Selective Laser Trabeculoplasty as first-line treatment of primary open-angle glaucoma inMoroccan patientsYoussef Zekraoui, Adil Megzari, Tarik El Alloussi,Othmane Bourmani, Abdelkarim Boulanouar,Amina Berraho (Rabat/MA)

P-MO-067Evaluation of 24-hour post-dose efficacy of travo-prost-timolol and latanoprost-timolol fixed-combi-nations in patients with open-angle glaucomaNavroop Gill, David B. Yan (Toronto/CDN)

P-MO-068Intravitreal injection of bevacizumab for neovascular glaucoma post vitrectomy.Aya Oi, Tetsuo Tochikubo, Yuka Suzuki, Hiroshi Watanabe (Tokyo/J)

P-MO-069Mikelan® LA 2% ophthalmic solution Phase 4 – investigation of the effectiveness and safety Kazuhide Kawase (Gifu/J)

P-MO-070Ocular Hypotensive Efficacy of Bimatoprost(0.03%) over a 64 Hour Period in Patients with Elevated Intraocular PressureMuthusamy Malaravan, Dushyantha Wariyapola(Dehiwala/CL)

P-MO-052Role of optical coherence tomography in measuringretinal nerve fibre thickness in normal subjects andpatients of open angle glaucomaArif Adenwala (Sharjah/UAE)

P-MO-053Screening method for visualisation of a glaucoma-tous ciliary body conditionVi tor Morkhat, Maryia Morkhat (Vitebsk/BY)

P-MO-054Simultaneous GDX & OCT Imaging in Glaucoma-tous eyes with Disc Hemorrhages showing VisualField Defects preceding Disc Damage on Imagingwith minimum 6 Months Follow-up.Sriram Sonty, Afzal Ahmad (Flossmoor/USA)

P-MO-056The usefulness of anterior segment optical coher-ence tomography for evaluation of the iridocornealangle width before and after laser peripheral iridotomy in a cohort of 150 narrow-angle glau-coma patientsEwa Mielniczuk, Ewa Mrukwa-Kominek, Lukasz Drzyzga, Wanda Romaniuk (Katowice/PL)

P-MO-057The Visual Disability Likelihood Score: Comparisonwith Standard Measures of VisionGeorge L. Spaeth (Philadelphia/USA)

Glaucoma: Medical Therapy P27

P-MO-058Comparison of the effects of travoprost plus timololpreserved with either benzalkonium chloride (BAK)or polyquad (PQ) on cultured human ocular surfaceepithelial cellsDavid A. Ammar, Malik Y. Kahook (Aurora/USA)

P-MO-059Comparison of the Effects of Travoprost Preservedwith Benzalkonium Chloride (BAK) Versus Polyquad(PQ) on Cultured Human Ocular Surface EpithelialCellsDavid A. Ammar, Malik Y. Kahook (Aurora/USA)

P-MO-060A randomized crossover study comparing efficacyof latanoprost and travoprost in open-angle glaucoma.Akira Sawada, Tetsuya Yamamoto (Gifu/J)

P-MO-061Cataract and ocular hypertension in children on inhaled corticosteroid therapyAdel Aljazzaf (Kuwait/KWT)

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

299WOC® 2010

Post

ers

P-MO-079Buckling surgery for retinal detachment in Nairobi,Kenya between 2005 and 2009: case seriesK. H. Martin Kollmann, Oscar M. Onyango, Patrick T. Nyaga, Carl-Ludwig Schönfeld(Nairobi/EAK, Munich/D)

P-MO-080Knowledge, skills and productivity of primary eyecare providers in TanzaniaPaul Courtright (Moshi/EAT)

P-MO-081Ocular multibacillary leprosy profile among Filipinosreleased from multi-drug therapyRonnie Manaysay, Ian Paredes (Manila/RP)

P-MO-082Prevalence and Causes of Decreased Vision in aTunisian Diabetic PopulationBen Yahia Salim, Messaoud Riadh, Hasnaoui Wafa,Khochtali Ines, Jenzeri Salah, Moncef Khairallah(Monastir/TN)

P-MO-083Prevention of traumatic corneal ulcer – an intervention project in a rural province in CambodiaManfred Mörchen, Sun Sarin, M. P. Upadhyay(Phnom Penh/K)

P-MO-084Pseudophakic rhegmatogenous retinal detachmentin a large Asian tertiary eye centre – a cohort studyDesmond Quek, Shu Yen Lee, Hla Myint Htoon,Chong Lye Ang (Singapore/SGP)

P-MO-085Renaissance of the slit-lampMarcus-Matthias Gellrich (Kellinghusen/D)

P-MO-086The Offer of Cataract Surgery: Determinants of Acceptance following Outreach Eye Clinics in SouthIndia.David G. Kupitz, Frank G. Holz, Seetha Chandrasekhar, Bharath Balasubramaniam, R. V. Ramani, Robert P. Finger (Bonn/D)

P-MO-087Translating successes at Aravind to sub SaharanAfricaSusan Lewallen, Thulasiraj Ravilla (Moshi/EAT)

P-MO-088Vitreoretinal Training program Munich – Nairobi: 10 years of experienceCarl-Ludwig Schönfeld, Oscar M. Onyango, Patrick T. Nyaga, K. H. Martin Kollmann, VolkerKlauss, Anselm Kampik (Munich/D, Nairobi/EAK)

P-MO-071Patient- and Physician-Reported Satisfaction Follow-ing Treatment with Bimatoprost 0.01% or Vehiclein Patients with Glaucoma or Ocular Hypertension(OHT)E. Randy Craven, Ton Lin, Thomas K. Mundorf,Michael Tepedino, Ronald Frenkel, John G. Walt,Ching-chi Liu, Amy L. Batoosingh (Parker/USA)

P-MO-072Patient Satisfaction Before and After Changing Ocular Hypotensive Therapy to Latanoprost/TimololFixed-Combination (LTFC)Kristian Gerstmeyer, Friedhelm Leverkus, CarstenOliver Schmidt, Thomas Kohlmann (Minden/D)

P-MO-073Prospective, Observational Study of the Long-termEffect of Latanoprost/Timolol Fixed Combination(LTFC) in Patients with Glaucoma or Ocular Hyper-tensionOliver Schwenn, Barbara Heckmann, Claudia Guzy(Frankfurt/D)

P-MO-074Relationship Between Patient Tolerability and Efficacy When Switching from Dorzolamide/Timololto Brimonidine/Timolol Fixed Combination in theTreatment of Open Angle GlaucomaJacqueline Freudenthal, Dan Pericak, Susan Simonyi, David B. Yan (Toronto/CDN)

P-MO-075Retrobulbar hemodynamics after oculopressionwith and without prior Dorzolamide treatmentKlaudia Huber-van der Velden, Matthias Klamann,Andreas Remky (Cologne/D, Aachen/D, Berlin/D)

P-MO-076Toxicological evaluation of preservative-containingand preservative-free prostaglandin analogs on the3D-reconstituted corneal epithelium (SkinEthic™)systemHong Liang (Paris/F)

P-MO-077Treatment of Glaucomatous Visual Fields by NovelNutritional Supplement: Comparison of Group andIndividual Approach.Meir Gorban (Givataim/IL)

International Ophthalmology P28

P-MO-078Are wet and dry labs old fashioned?Jorge Topete-Jimenez, Gerardo Gabriel Perez-Solorzano, Ivan Dario Sanchez-Amaya (Guadalajara/MEX)

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

300 WOC® 2010Po

ster

s

P-MO-099Optical visual acuity simulation with a virtual eyemodel based on cubic spline reconstruction of thecornea.Luis Moreno, Jorge Alió, Antonio Fimia (Alicante/E)

P-MO-100Prototype for evaluating surgical corneal residualastigmatismLiliane Ventura, Homero Schiabel, Jean-Jacques DeGroote, Sidney Julio Faria e Sousa (Sao Carlos/BR)

P-MO-101Prototype for evaluation of UVA natural protectionof the corneaLiliane Ventura, Victor A. C. Lincoln, Homero Schiabel, Sidney Julio Faria e Sousa (Sao Carlos/BR)

P-MO-102Silicone oil as carrier for drug-delivery – interactionbetween silicone oil and corticosteroidsBenjamin Braun, Thorsten Lechner, Ulrike Wolf,Hans Hoerauf, Dirk-Henning Menz (Hipstedt/D,Göttingen/D)

P-MO-103The Impact of Free Access on Citations to the Vision LiteraturePamela Sieving (Bethesda/USA)

P-MO-104The learning curve on ophthalmologic surgery: experimental model versus traditional and practicalmodelEglis Esteban García Alcolea (Ciudad Habana/C)

P-MO-105Whether the traditional idea of treatment of theopening injury of the anterior chamber needs to bechanged?Zhizhong Ma (Beijing/CN)

Refractive Surgery/Refraction P30

P-MO-131Personal experience with Toric ARTIFLEXCamille Budo (Sint-Truiden/B)

P-MO-106Advanced Cataract Surgery with Multifocal IOL Implantation: Two-Year Follow-UpMatteo Piovella (Monza/I)

P-MO-107Advanced Surface Ablation in High Myopia atJoGJA Lasik Center “Dr.Yap” Eye HospitalWasisidi Gunawan (Jogjakarta/RI)

P-MO-108Bilateral acute angle-closure glaucoma after implan-tation of an angle-supported anterior chamber lenseMatthias Schmidt, Julia Promesberger, ConstantinE. Uhlig (Münster/D)

Miscellaneous P29

P-MO-089A case of mucosa-associated lymphoid tissue(MALT) lymphoma with difficulties of remove dueto infiltration into extraocular musclesYuka Suzuki, Tetsuo Tochikubo, Aya Oi, HiroshiWatanabe (Tokyo/J)

P-MO-090Acupuncture and Chinese herb for Dry Eye diseaseYing-Ling Chen, Mark Chun-Cheng Hou, Lun-Chien Lo, Chang-Pin Lin (Changhua/TJ)

P-MO-091Anterior OCT diagnostic possibilities in conjunctivaltumors and filtering blebsMykolas Pajaujis, Rimvydas Asoklis, Donatas Petroska (Vilnius/LT)

P-MO-092Bibliometric Analysis in Ophthalmology: journal impact factor change over the last decadeMuhammad Younis, Ahmad Mansour, George Mollayes (Manchester/RL)

P-MO-093Central corneal thickness, intraocular pressure and degree of myopia in a myopic population ofSoutheast SpainManuel Garcia-Medina, Jose Javier Garcia-Medina,Francisca Fernandez de Benito, Vicente Zanon-Moreno, Maria Dolores Pinazo-Duran (Almeria/E)

P-MO-094Comparison of Intraocular Pressure after MinimalIncision Cataract Surgery Using the Soft-shell Technique and various Ophthalmic Viscoelastic Devices including the dual OVDs Sealing TechniqueTakao Tanaka (Tokyo/J)

P-MO-095Influence of eye concomitant pathology on the surgery complications frequency at the followingoperationsOlga Levanova (Kirow/RUS)

P-MO-096Isaac Newton on the Eye and VisionHarry Mark (North Haven/USA)

P-MO-097Lifesaving Ophthalmology – Case reports of youngpatients with intracerebral tumoration diagnosedby an ophthalmologistStephanie Rohrweck, Ana Suelves, Diamar Pardo,Salvador Garcia-Delpech, David Salom, PatriciaUdaondo, Manuel Diaz-Llopis (Valencia/E)

P-MO-098Ocular infections due to Methicillin-resistantstaphylococcus aureusCecilia Moeller, M. C. S. Yu, P. Bispo, A. S.Moriyama, A. C. Pignatari, A. L. Höfling-Lima (SãoPaulo/BR)

Post

ers

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

301WOC® 2010

Post

ers

P-MO-118Effect of the amount of myopic correction on long-term changes of higher-order wavefront aberrations after advanced surface ablation-photorefractive keratectomy (ASA-PRK)Sang-Bumm Lee, Jin-Seon Kim, Jun-yeup Lee(Daegu/ROK)

P-MO-119Effects of Femtosecond Laser-assisted Multilayer Intrastromal Ablation in the Mid-peripheral Cornea:Clinical Findings in Two PatientsZhen-Yong Zhang, Xing-Ru Zhang, Ren-Yuan Chu(Shanghai/CN)

P-MO-120Evaluation of Keratometry: Natural cornealchanges, measurement accuracy, influence of incision sizes and their effect for toric IOL calculationsWolfram Wehner (Nürnberg/D)

P-MO-121Extended depth of focus intra-ocular lens toleranceto typical corneal aberrationsAlex Zlotnik, Ido Raveh, Shai Ben Yaish, OrenYehezkel, Michael Belkin, Zeev Zalevsky(Hashomer/IL)

P-MO-122Female/male differences in acceptance and satisfaction of multifocal IOLsMagda Rau (Cham/D)

P-MO-123Femtosecond laser assisted astigmatic keratotomy(Femto-AK) for high postkeratoplasty astigmatism:one-year follow-upLaszlo Kiraly, Anna Sasse, Gernot Duncker (Halle/D)

P-MO-124First results after the light-adjustable-lens implantationTobias Neuhann, Elisabeth Jakobs (Munich/D)

P-MO-125Improvement of precise axis marking for TIOLs atthe slit-lamp with the assistance of a special ocularWolfram Wehner (Nürnberg/D)

P-MO-126Intracor Presbyopic Correction Combined withCataract SurgeryCarlos Gutierrez-Amoros (La Coruña/E)

P-MO-127Intrastromal Correction of Presbyopia with Femtosecond LaserWilhelm Großmann (Duisburg/D)

P-MO-128Lasik in High HyperopiaDiego de Ortueta (Recklinghausen/D)

P-MO-109Cataract surgery with implantation of the M-FLEX630F multifocal IOL with +3,0 and +4,0 dioptersaddition for near.Ewa Mrukwa-Kominek, Pawel Stala, KatarzynaBuczak-Gasinska (Katowice/PL)

P-MO-110Choosing a proper aspheric IOL designs for an individual eyeStefan Pieh, Werner Fiala (Vienna/A)

P-MO-111Clinical outcomes of LASIK for high hyperopia:+4.00 to +7.50 DDan Reinstein, Timothy Archer, Marine Gobbe (London/UK)

P-MO-112Comparison of different presbyopia treatments: Refractive lens exchange with multifocal intraocularlens implantation Vs. LASIK MonovisionAnte Barisic, Nikica Gabric, Iva Dekaris, IvanaRomac, Maja Bohac, Branka Juric, Vlade Glavota(Zagreb/HR)

P-MO-113Complications of lamellar keratorefractive surgeryVolodymyr Usov, Elena Dragomyretskaya(Odessa/UA)

P-MO-114Correction of corneal astigmatism in cataract andrefractive lens surgery – 3-month-results with theAcri.Comfort 646 TLCDaniel Martin Handzel, Raimund M. Remmel, Claudia M. Dardenne, Detlev R. H. Breyer (Bonn/D)

P-MO-115Correction of irregular astigmatism in post trans-planted corneas with topography based photore-fractive keratectomy (Topolink)G. Macedo, Rossen Hazarbassanov, E. Martinez, A. L. Höfling-Lima (Sao Paulo/BR)

P-MO-116Correction of post-keratoplasty astigmatism withastigmatic keratotomy using the femtosecond laserDaniel Kook, Jens Bühren, Anna Sophia Bauch,Oliver Klaproth, Victor Derhartunian, ThomasKohnen (Munich/D, Frankfurt/D)

P-MO-117Effect of mitomycin C on refractive results afterlaser-assisted subepithelial keratectomy to correctmyopia.Montserrat Garcia-Gonzalez, Marta Ibarz-Barbera,Esther Arranz-Marquez, Laura De Benito-Llopis,Miguel A. Teus (Madrid/E)

Post

ers

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

302 WOC® 2010Po

ster

s

P-MO-141Toric multifocal IOL after twice penetrating injuryHans-Jürgen Buchwald, Gerhard K. Lang (Ulm/D)

P-MO-142Up-regulation of the production of interferon-gamma and the gene expression of the inducibleno-synthase after excimer laser ablation in ratcorneasJavier Prada, Thanh Ngo-Tu (Berlin/D)

P-MO-143Visual Recovery After Corneal Enhancement in Either Femtosecond or Microkeratome CreatedFlapsMarta Ibarz, Montserrat Garcia-Gonzalez, Laura de Benito, Miguel Teus (Madrid/E)

P-MO-144Wavefront Analysis of centration in HyperopicLASIK: Line of Sight vs. Visual AxisUwe Oberheide, Georg Gerten, Karl Schmiedt,Omid Kermani (Cologne/D)

P-MO-145What lies Beneath?Dipanjan Pal, Alokesh Ganguly (Kolkata/IND)

Retina/Chorioidea/RPE/Vitreous P31

P-MO-146One-year follow-up of the treatment of SRH inAMD with combined 23-gauge core vitrectomy andinjection of rtPA, expansile gas and bevacizumabCarolin Perz, Julia Konrad, Nikolaus Feucht, Chris Patrick Lohmann, Mathias Maier (Munich/D)

P-MO-147Choroidal Folds in Supra venacaval obstruction; A case ReportMohamed Naved Abdul Karim, Deepa S. Rathore,Peter Baranyovits (Kettering/UK)

P-MO-148Corneal epitheliopathy following Trabeculectomywith intraoperative 5-Fluorouracil (5FU) or Mitomycin C (MMC) and postoperative adjunctive5-Fluorouracil in 381 PatientsConstantin Reiter, S. Wimmer, A. Schultheiss,Thomas Klink, Franz Grehn, Gerd Geerling(Wuerzburg/D)

P-MO-149Differential diagnosis of rod or cone dystrophyusing optical coherence tomographyMidori Yokochi, Shoji Kishi (Maebashi/J)

P-MO-150Effect of HDAC Inhibitors on Retinal CellsShalesh Kaushal (Worcester/USA)

P-MO-129LASIK with Optimized Prolate Ablation Profile (OPA)versus LASIK with Conventional Ablation Profileusing NIDEK Platform. 12 Months ResultsAlaa El Danasoury (Jeddah/SA)

P-MO-130Lens Surgery Inclusion Criteria for Glaucoma Prevention in Eyes with shallow ACD and NarrowAngleMatteo Piovella (Monza/I)

P-MO-132PRK and Off Flap Epi-Lasik in Different Age atJoGJA Lasik Center “Dr.Yap” Eye HospitalRinanto Prabowo (Jogjakarta/RI)

P-MO-133Quality of vision and quality of life after implanta-tion with the multifocal Diffractiva® Diff-s IOL in a series of 200 eyes with cataract.Serge Zaluski (Perpignan/F)

P-MO-134Refractive Surgery to the RescueArun Gulani (Jacksonville/USA)

P-MO-135ReStor Multifocal Lens in Radial Keratotomy EyesArun Gulani (Jacksonville/USA)

P-MO-136Shape change of crystalline lens of human eyesafter accommodationXiaobing Wang, Qinghua Chen, Aizhen Liu, Ping Liu (Beijing/CN)

P-MO-137Sudden changes in intraocular pressure during flappreparation: Comparison between 4 femtosecondlasers and one microkeratome in porcine eyesJan Markus Vetter, Christian Teping, Wolf E. Weingärnter, David Garcia-Bardon, Adrian Gericke,Paul R. Preussner, Walter Sekundo (Mainz/D)

P-MO-138The influence of high order aberrations (HOAs) on the dynamic visual acuity (DVA) between pre-and post LASIK.Futoshi Taketani, Toyoaki Matsuura, Tokuko Hara,Yoshiaki Hara (Kashihara Nara/J)

P-MO-139Tilt, Decentration and anterior chamber depth ofICL: Result of an one year periodYunwoong Chung, Sung Kun Chung (Seoul/ROK)

P-MO-140Topographical changes after Myopic LASEKDiego de Ortueta (Recklinghausen/D)

Post

ers

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

303WOC® 2010

Post

ers

P-MO-160New genetic approaches to understandingchoroidal neovascularization in relation to VascularEndothelial Growth Factor (VEGF) And Brain Derived Neurotrophic Factor (BDNF) expression insuper p53 mice.Maria D. Pinazo-Duran, Roberto Gallego-Pinazo, Vicente Zanon-Moreno, Sheila Pons-Vázquez, Jose Javier Garcia-Medina, Ignacio Vinuesa Silva,Manuel Serrano (Valencia/E)

P-MO-161Photodynamic therapy (PDT) for the treatment ofcorneal neovascularization in childrenM. Fortunato, Giuseppe Carollo, R. Maggi, A.Ubaldi, L. Buzzonetti (Palermo/I)

P-MO-162Picture of macula in optical coherence tomographyin retinal detachment in children with various etiology – description of casusErita Filipek, Lidia Nawrocka, Maria Forminska-Kapuscik, Ewa Mrukwa-Kominek, Ewa Pieczara(Katowice/PL)

P-MO-163Retinal nerve fiber layer thickness following parsplana vitrectomy for rhegmatogenous retinal detachmentYuta Ueno, Fumiki Okamoto, Yoshifumi Okamoto,Tetsuro Oshika (Tsukuba/J)

P-MO-164Spontaneous closure of postoperative persisting full thickness macular holeKaren Schaal, Till Oppermann, Johann Roider, Stefan Dithmar (Heidelberg/D, Kiel/D)

P-MO-165Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathyIchiro Maruko, Yukinori Sugano, Akira Ojima, Tetsuju Sekiryu, Tomohiro Iida (Fukushima/J)

P-MO-166Sub-Tenon Injection of Triamcinolone Acetonidewithout oral steroid in Vogt-Koyanagi-Harada syndromeMariko Enoki, Shoji Kishi (Maebashi/J)

P-MO-167The application of silicone saccus lacrimalis supporting tube in nasal endoscopic dacryocystorhinostomy (DCR)Jin Lu Fan, Di Lu (Heng Yang/CN)

P-MO-168The characteristics of coloboma of the choroid with optical coherence tomographyLi Juanjuan (Kunming/CN)

P-MO-151Effects of VEGF-antagonists on RPE cells in vitroAlexa Klettner, Tim Meyer, Friederike Möhle,Daniela Wesch, Dieter Kabelitz, Johann Roider(Kiel/D)

P-MO-152Evaluation of Ophthalmic complications in type II diabet mellitus Babol-IranAbbas Soleymani, Amin Gorjizadeh, S. R. Hosseini(Babol/IR)

P-MO-153Impaired retinal blood flow in patients with type 2diabetes mellitus and chronic kidney diseaseTaiji Nagaoka, Atsushi Takahashi, Eiichi Sato, Kenji Sogawa, Tsuneaki Omae, Seigo Nakabayashi,Akihiro Ishibazawa, Ichiro Tanano, Tomofumi Tani,Akitoshi Yoshida (Asahikawa/J)

P-MO-154Internal limiting membrane which could be peeledover the optic nerve head in vitreous surgery foroptic disc pit maculopathyToshiyuki Fujiwara (Akita/J)

P-MO-155Intraocular WormTri Wahyu Widayanti, Angela Nurini Agni (Yogyakarta/RI)

P-MO-156Macrophages in the ultrastructure of PDR membranes and subretinal AMD membranes- a possible role in neoangiogenesis.Christina Nicolaeva Vidinova, PravoslavaGougoutchkova, Kalin Vidinov (Sofia/BG)

P-MO-157Modulation of cytokine expression by protein tyrosine phosphatase inhibition in retinal pigmentepithelial cellsDavid Arthur Märker, Renate Foeckler, Vladimir Milenkovic, Olaf Strauss, Horst Helbig,Tina Dietrich (Regensburg/D)

P-MO-158Monitoring Disease Progression in Macular Telangiectasia Type 2 on Spectral-Domain OpticalCoherence TomographySönke Baumüller, Peter Charbel Issa, Hendrik P. N.Scholl, Steffen Schmitz Valckenberg, Frank G. Holz(Bonn/D)

P-MO-159Morning Glory Disc anomaly with cystic appear-ance in orbit and retinal detachment in a prematureinfantSusanne Butros, Gerhard K. Lang, Cecilia Setiobudi,Hans-Jürgen Buchwald (Ulm/D)

Post

ers

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

304 WOC® 2010Po

ster

s

P-MO-177Effect of Intravitreal ranibizumab (Lucentis) in thetreatment of various causes of macular edema.Hany Elmekawey, Amr Khafagy Amr, Khaled AboElenein Khaled, Safwat Elkady Safwat (Giza/ET)

P-MO-178Effects of Intravitreal Injection of Anti-VEGF Agentson Macular edema due to Retinal Vein OcclusionEriko Kirii, Teiko Yamamoto, Hitomi Miura,Hidetoshi Yamashita (Yamagata/J)

P-MO-179Efficacy of Intravitreal Bevacizumab Combined withPhotodynamic Therapy for Polypoidal ChoroidalVasculopathyFumi Gomi, Miki Sawa, Taku Wakabayashi, YuzuruSasamoto, Mihoko Suzuki, Motokazu Tsujikawa(Suita/J)

P-MO-180Efficiency in combined usage of local and generalcorticosteroid therapy during acute phase of Vogt-Koyanagi-Harada diseasesGunay Rustambayova (Baku/ASE)

P-MO-181Experience with Avastin (bevacizumab) for Radiation Maculopathy and Optic NeuropathyPaul Finger (New York/USA)

P-MO-182Exsudative Retinal Detachment Associated WithSystemic SclerodermaAnna Cucera, Gabriele E. Lang, Gerhard K. Lang(Ulm/D)

P-MO-183Extended sub retinal hemorrhage secondary to intravitreus bevacizumab.Ruben Edel Martínez Serrano, Jose Luis Estrada Rodríguez (Querétaro/MEX)

P-MO-184Hemodilution Therapy in Central Retinal Artery OcclusionB. A. Ehrhardt, Guido R. K. Kürzinger, Gabriele E.Lang (Ulm/D)

P-MO-185Intravitreal Bevacicumab injection in ROP – case series of 6 infantsBjörn Harder, Jost B. Jonas, Frank Schlichtenbrede(Mannheim/D)

P-MO-186Intravitreal bevacizumab for the treatment of macular edema secondary to central retinal vein oc-clusionPhalangthep Prapatjukkit, Mansing Rattanasukon(Bangkok/T)

P-MO-169The relationship between Peripheral Neuropathyand Diabetic Retinopathy in an Asian population(The Singapore Malay Eye Study)Gavin Tan, Yingfeng Zheng, Chee Weng Fong, E Shyong Tai, Su Chi Lim, Charumathi Sabanayagam, Tien Y. Wong (Singapore/SGP)

P-MO-170The time till ganglion cell death during ischemia occurs can be extended by vitrectomy with a neuroprotective irrigation solutionMaximilian Schultheiss, Martin Spitzer, HannahRuschenburg, Hannah Ruschenburg, Peter Heiduschka, Charlotte Frank, Kai Januschowski,Karl Ulrich Bartz-Schmidt, Peter Szurman(Stuttgart/D, Tübingen/D)

P-MO-171Vasoproliferative retinal tumour – Case reportSarah Pfrommer, Mathias Maier, Christian Mayer,Verena Engelmann, Chris Patrick Lohmann (Munich/D)

P-MO-172Vision-related quality of life and visual function following vitrectomy and triamcinolone injectionfor diabetic macular edemaAyami Masuda, Fumiki Okamoto, Takahiro Hiraoka,Tetsuro Oshika (Tsukuba/J)

P-MO-173Visual outcomes of pleoptics for anisomyopic amblyopia with myelinated retinal nerve fibersFumiko Ikeda, Shoji Kishi (Maebashi/J)

Retina: Medical Therapy P32

P-MO-174A study of in vivo laser-tissue interaction and healing response from 20 ms versus 100 ms pulsePascal® photocoagulation burnsMahiul Muqit, George R. Marcellino, David B. Henson, Jane Gray, Lorna B. Young, Niall Patton,Stephen J. Charles, George S. Turner, Paulo E.Stanga (Manchester/UK)

P-MO-175Acute retinal necrosis – a case reportPiotr Oleksy, Izabella Karska-Basta, Agnieszka Ku-bicka-Trz ska, Joanna Kobylarz, Bozena Ro-manowska-Dixon (Krakow/PL)

P-MO-176Cellular structure and morphofunctional conditionof corneal epithelium at Zymosan activated autoserum application in complex treatment ofbacterial keratitisTatyana Volkovich (Vitebsk/BY)

Post

ers

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

305WOC® 2010

Post

ers

P-MO-195Manchester Study of Single-session Pascal® Targeted Retinal Photocoagulation [MTRAP] usingWidefield Optos® Angiography in Proliferative Diabetic RetinopathyPaulo Stanga, Mahiul Muqit, David Henson, George Marcellino, Jane Gray, Rita McLauchlan,Lorna Young, Niall Patton, Stephen Charles,George Turner (Manchester/UK)

P-MO-196Micropulse versus bevacizumab in central serousretinopathyIsabell Beger, Michael Koss, Frank Koch (Frankfurt/D)

P-MO-197Nature or Nurture – Retinal Pigment Epithelial Detachments and Tears Treated with RanibizumabHelena Cilliers, Li Ping Chow, Theocharis Papanikolaou, Douglas Newman (Oxford/UK)

P-MO-198Open-Label Phase 2 Study of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Edema (DME) in Vitrectomized Patients: Interim ResultsDavid S. Boyer, Sunil Gupta, David Faber, Ching-Chi Liu, Xiao-Yan (Joanne) Li, Scott M.Whitcup (Los Angeles/USA, Irvine/USA)

P-MO-199PI3K/Akt mediates the expression of type collageninduced by TGF-β in human retinal pigment epithelial cellsKatsuhiko Yokoyama, Kenichi Kimoto, Toshiaki Kubota (Yufu/J)

P-MO-200Posterior subtenon’s triamcinolone acetonide injection in a patient with hypertensive optic neuropathyHeeyoon Cho, Insuk Song, Byung Ro Lee(Kyungggi-do/ROK)

P-MO-201Posterior vitreous detachment following intravitrealdrug injectionUlrich Geck, Nicole Pustolla, Husnia Baraki, Hans Hoerauf (Göttingen/D)

P-MO-202Randomised control trial to evaluate the preferredmethod of anaesthesia for intravitreal injectionsSudipto Bhatta, Sakkaf Ahmed Aftab, Raazia Janjua, Aamir Pasha Siddiqui (Sheffield/UK)

P-MO-203Safety profile of diabetic macular edema patientstreated over 12 months with ranibizumab in theRESOLVE studyJustus G. Garweg, on behalf of the RESOLVE studygroup (Bern/CH)

P-MO-187Intravitreal Bevacizumab for treatment of choriodalneovascularization secondary to Best’s disease in a4-year-old childKatrin Lorenz, Bernhard Stoffelns, Christina Kramann, Norbert Pfeiffer, Heike Elflein (Mainz/D)

P-MO-188Intravitreal bevacizumab treatment of choroidalneovascularization secondary to pathologic myopia(PM) in Japanese patients.Kengo Hayashi, Kyoko Ohno-Matsui, MukaMoriyama, Noriaki Shimada, Wakako Hayashi,Manabu Mochizuki (Tokyo/J)

P-MO-189Intravitreal Dexamethasone as a Coadjuvant Therapy with for Ranibizumab Loading Phase inChoroidal NeovascularizationCristina Marin-Lambies, Roberto Gallego-Pinazo,Rosa Dolz-Marco, Andrea Diaz, Sebastian Martinez-Castillo, Manuel Diaz-Llopis (Valencia/E)

P-MO-190Intravitreal injections of ranibizumab in patientswith diabetic macular edema resistant to focal/gridlaser treatment.Sofia Aggeli, Marios Giannakopoulos, Olga Makri,Panagiotis Vasilakis, Constantine Georgakopoulos,Nikolaos Pharmakakis (Patras/GR)

P-MO-191Intravitreal ranibizumab in retinal macroaneurysmAndrea Wenkstern, Heike Petersen (Uzwil/CH)

P-MO-192Intravitreal Ranibizumab Treatment for Macular Diseases: a tertiary eye centre experienceMary Ho, David T. L. Liu, Vincent Y. W. Lee, Chi-Lai Li, Dennis S. C. Lam (Hong Kong /HK)

P-MO-193Levels of intravitreal cytokines in patients with diabetic retinopathy given injection of anti-vascularendothelial growth factor antibody prior to vitrectomyYukihiko Suzuki, Kaori Suzuki, Yasuhiro Miyagawa,Hitoshi Yamazaki, Mitsuru Nakazawa (Hirosaki/J)

P-MO-194Macular function and photopic negative responseafter single injection of intravitreal bevacizumab formyopic neovascularizationAkiko Takahashi, Kohei Ishikawa, Shinji Ueno, Yasuki Ito, Mineo Kondo, Hiroko Terasaki(Nagoya/J)

Post

ers

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

306 WOC® 2010Po

ster

s

P-MO-213Therapeutic effect of oral bisphosphonate onchoroidal neovascularization in the human eye.Shigeru Honda, Takayuki Nagai, Naoshi Kondo,Masahide Fukuda, Sentaro Kusuhara, Yasutomo Tsukahara, Akira Negi (Kobe/J)

P-MO-214Topical use of Ketorolac 0.5% for pain control inpatients undergoing intravitreal administration ofdrugsOlga Makri, Panagiotis Vasilakis, Sofia Aggeli, Marios Giannakopoulos, Artemis Exarchou, Nikolaos Pharmakais, Constantine Georgakopoulos(Patras/GR)

P-MO-215Transient choroidal thinning after intravitreal injection for myopic choroidal neovascularizationYukari Jo, Yasushi Ikuno (Suita/J)

P-MO-216Treatment of Retinitis Pigmentosa with 9-cis retinal –a Clinical TrialYgal Rotenstreich, Aviv Shaish, Gili Ferman-Atar,Dror Harats, Michael Belkin (Kfar Bilu/IL)

P-MO-217Warfarin and intra-vitreal injections: Practice in theUnited KingdomNishant Kumar, Stathis Liazos, Christopher Baddon(London/UK)

Retina: Surgical Therapy P33

P-MO-218Macular pucker surgery with and without delamination of the internal limiting membraneChristoph Krüger (Cologne/D)

P-MO-219Anatomic and functional outcome after surgical removal of idiopathic macular epiretinal membraneLee Po-Yen, Wu Wen-Chuan (Kaohsiung/TJ)

P-MO-220Case report: bullous retinoschisis invading the macula in a patient with high hyperopiaMaria Heynemann, Stefan Mennel, Walter Sekundo(Giessen/D)

P-MO-221Clinical management modalities for premacularhemorrhages associated with Valsalva retinopathyJoaquin Castro-Navarro, Ieva Sliesoraityte, CarmenGonzález-Castaño (Oviedo/E, Tübingen/D)

P-MO-222Comparison of anatomical success rate of primaryvitrectomy and scleral buckling procedure in rhegmatogenous retinal detachmentChristos Haritoglou, Ulrich Brandlhuber, Carolin Fischer (Munich/D)

P-MO-204Serum-VEGF-levels in premature infants after intravitreal application of bevacizumab for retinopathy of prematurityIsabel Oberacher-Velten, Roman Regler, Viola Radeck, Horst Helbig (Regensburg/D)

P-MO-205Six months results of intravitreal bevacizumab versus triamcinolone for the treatment of macularedema caused by retinal vein occlusion: a retrospective analysisPatricia Kook, Eva Schäffner, Nikolaus Feucht,Mathias Maier, Chris P. Lohmann (Munich/D)

P-MO-206Strategies for successful ex vivo genetic engineeringof pigment epithelial cellsSandra Johnen, Christiane Stickelmann, MichaelStöcker, Peter Walter, Gabriele Thumann(Aachen/D)

P-MO-207The benefit of a therapeutical core Vitrectomyusing the Intrector in exudative AMDSlawomir Cisiecki, Michael Koss, KatharinaSchramm, Janusz Michalewski, Frank Koch(Lodz/PL, Frankfurt/D)

P-MO-208The effect of intravitreal Bevacizumab on the treatment of central serous chorioretinopathyHakyoung Kim (Seoul/ROK)

P-MO-209The efficiency of intravitreal triamcinolone acetonide for persistent conventionally treated diabetic macular edemaHasan Arzoallxhiu, Isak Jurik (Prizren/KS)

P-MO-210The Learning Curve for Performing Focal Laser with the NAVILASMichael Ulbig, Michael Ober, Aljoscha Neubauer,Marcus Kernt, Anselm Kampik, William Freeman,Igor Kozak (Munich/D)

P-MO-211The practice of intravitreal triamcinolone acetonideat a district general hospital in EnglandGulrez Ansari, Mehul Damani, Karima Nesnas,Manju Chandran, Geeta Menon (Fleet/UK)

P-MO-212The relationship between spectral-domain opticalcoherence tomography findings and injection frequency of bevacizumab in exudative age-relatedmacular degenerationKaori Sayanagi (Osaka/J)

Post

ers

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

307WOC® 2010

Post

ers

P-MO-233Indocyanine Green (ICG) Increases Light-InducedOxidative Stress, Senescence, and Accumulation ofExtracellular Matrix Proteins in Human RPE CellsJohann Rüping, Christos Haritoglou, Rafael Liegl,Christoph Hirneiss, Aljoscha Neubauer, Arnd Gandorfer, Michael Ulbig, Anselm Kampik,Marcus Kernt (Munich/D)

P-MO-234Intraocular pressure changes immediately after intravitreal injection of Triamcinolone Acetonideand RanibizumabGul Arikan, A. Osman Saatci, F. Hakan Oner(Izmir/TR)

P-MO-235Intraocular Pressure Elevation after Vitrectomy forProliferative Diabetic RetinopathyFumiki Okamoto, Yumi Hasegawa, Yoshimi Sugiura,Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J)

P-MO-236Macular changes in spectral domain OCT aftermembrane peelingBernd Junker, Amelie Pielen, Daniel Böhringer, Hansjürgen T. Agostini, Lutz Lothar Hansen, Nicolas Feltgen (Freiburg/D, Göttingen/D)

P-MO-237Management of Submacular Hemorrhage Associated with Retinal Pigment Epithelial DetachmentKwang-Soo Kim, Yu-Cheol Kim (Daegu/ROK)

P-MO-238New approaches of treatment of rhegmatogenousretinal detachment with inferior breaks.Galyna Levytska, Stanislav Rodin, Zoya Rozanova,Nikolay Umanets, Ivan Levitsky (Odessa/UA)

P-MO-239Ophthalmodynamometric pressure in eyes with proliferative diabetic retinopathyYoshimi Sugiura, Fumiki Okamoto, Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J)

P-MO-240Perfect mixture? Siluron 2000 – The new premiumendotamponadeHakan Kaymak, Christian Lingenfelder, Wilfried Kugler, Nadine Hagedorn (Ulm/D)

P-MO-241Persistent Fetal Vasculature in the last ten years:what are the surgical outcomes?Hannah Chiu, Peter Kertes, Wai-ching Lam (Richmond Hill/CDN)

P-MO-242Pneumatic retinopexy for the repair of retinal detachmentsNazmiye Erol, Seyhan Topbas, Ela Gündüz (Eskisehir/TR)

P-MO-223Comparison of standard and 23g vitrectomy in the treatment of epiretinal membranes – a crosssectional studyCaroline Gummersbach, Norbert Schrage, Andreas Cordes (Bergisch Gladbach/D, Cologne/D)

P-MO-224Correlation between autofluorescence, macularsensitivity and external limiting membrane structureafter macula-off retinal detachment repairMario R. Romano, Vito Romano, Martina Angi, Ciro Costagliola, Paolo Vinciguerra (Milano/I)

P-MO-225Correlation between macular hole size and postoperative visual outcome in eyes with idiopathic macular holesMasahiro Ishida, Atsuya Takeuchi, Seiji Takagi, Goji Tomita, Shinobu Takeuchi (Tokorozawa/J)

P-MO-226Crosslinked hyaluronic acid as a slow release systemfor dexamethasoneCharlotte Frank (Tübingen/D)

P-MO-227Design and clinical results of the Mirror TelescopicImplant LMI-SI for the treatment of pseudophakiceyes that suffer also from AMD.Isaac Lipshitz, Amar Agarwal (Hertzlia/IL,Chennai/IND)

P-MO-228Early emulsification of 2000er silicone oil in minimalinvasiv transconjunctival vitreoretinal surgeryMathias Maier, Verena Engelmann, Sarah Pfrommer, Carolin Perz, Chris Patrick Lohmann(Munich/D)

P-MO-229Effect of intravitreal bevacizumab injection beforevitrectomy on proliferative diabetic retinopathyLi Cairui (Dali/CN)

P-MO-230Effect of vitrectomy for idiopathic macular hole or epiretinal membrane on peripapillary retinalnerve fiber layer.Eiko Tsuiki, Mao Kusano, Kiyoshi Suzuma, Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J)

P-MO-231Endogenous fungal endophthalmitis in intravenousdrug abusersXhevat Lumi, Mojca Urbancic, Rok Grcar (Ljubljana/SI)

P-MO-232Hso as 1st choice in complicated retinal detachment: Checkmate in two moves!Cesare Forlini, Paolo Rossini, Matteo Forlini(Ravenna/I)

Post

ers

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

308 WOC® 2010Po

ster

s

P-MO-253Subretinal versus preretinal application of r-TPA totreat subretinal macular hemorrhageStefan Mennel (Marburg/D)

P-MO-254Surgical and visual outcome after autologous plasmin assisted vitrectomy for stage5 retinopathyof prematurityYasutomo Tsukahara, Hisanori Imai, Shigeru Honda,Mizuki Tagami, Sentaro Kusuhara, Akira Negi(Kobe/J)

P-MO-256Tear film stability in the early postoperative periodof 23-gauge microincision vitrectomyTaichi Takahata, Azusa Fujikawa, Kiyoshi Suzuma,Noritake Miyamura, Takashi Kitaoka (Nagasaki/J)

P-MO-257The Effect of Intravitreal Bevacizumab Injection inDiabetic Patients with Macular Edema ReceivingCataract SurgeryLi-chung John Chi, Wen-Chen Wu (Kaohsiung/TJ)

P-MO-258The finding of MRI in vitreous humor injected silicone oilHiroshi Watanabe, Aya Ooi, Yuka Suzuki, Tetuo Tochikubo (Tokyo/J)

P-MO-259The outcome of primary pneumatic retinopexyKaveh Vahdani, Georgios Makrygiannis, AristeidisKonstantinidis, Vasant Raman (Plymouth/UK)

P-MO-260The outcome of TPPV in patients with retinal detachment with ILM peeling comparing to the patients with no membrane peeling.Malgorzata Pietras-Trzpiel, Tomasz Choragiewicz,Tomasz Zarnowski, Robert Rejdak (Lublin/PL)

P-MO-261The Relevant Factors of Macular Holes ClosureTypes in Patients of Idiopathic Macular Holes afterPars Plana VitrectomyJunyi Wang, Guoge Han, Haifeng Mei, Yiqiao Xing,Anhuai Yang (Wuhan/CN)

P-MO-262Treatment effects in treating diabetic macularedema by single intravitreal bevacizumabJia-Kang Wang (Taipei/TJ)

P-MO-263Treatment efficiency in serous pigment epithelialdetachment in age related macular degenerationMatthias Schmidt, Steffi Jeep, Constantin E. Uhlig(Münster/D)

P-MO-243Quantification of Changes in Horizontal Distortionof Macular Topography after Surgical Removal ofIdiopathic Epiretinal MembranesHyeong Gon Yu (Seoul/ROK)

P-MO-244Retinal Re-Detachment After Primary Buckling SurgeryRoman Regler, Mohamed Afia, Horst Helbig,Carsten Framme (Regensburg/D)

P-MO-245Retinal Re-Detachment after Scleral Buckling ProcedureFrank Schlichtenbrede, Babara Bort, Alexander Decker, Jost B. Jonas (Mannheim/D)

P-MO-246Retrospective review of retinal detachment in Hong KongCheuk Ki Chan (Hong Kong/HK)

P-MO-247Rhegmatogenous retinal detachment cases withdecreased visual acuity postoperatively.Hirofumi Kinoshita, Kiyoshi Suzuma, Noritake Miyamura, Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J)

P-MO-248Scleral buckling for retinal detachment with subretinal fibrosisSofia Androudi, Anna Praidou, Evangelia Tsironi,Vassilis Konidaris, Evgenia Kanonidou, Periklis Brazitikos (Thessaloniki/GR)

P-MO-249Sequential epiretinal membrane removal with internal limiting membrane peeling in brilliant blueG-assisted macular surgeryRicarda G. Schumann, Arnd Gandorfer, Kirsten Eibl, Paul B. Henrich, Anselm Kampik, Christos Haritoglou (Munich/D)

P-MO-250Siderosis secondary to intraocular foreign body.Ruben Edel Martínez Serrano, Jose Luis Estrada Rodríguez (Querétaro/MEX)

P-MO-251Subclinical choroidal detachment at sclerotomysites after 23-gauge vitrectomy – analysis with anterior segment Optical Coherence TomographyRainer Guthoff, Heidi Riederle, Berit Kasper, Winfried Goebel (Wuerzburg/D)

P-MO-252Subjective auditory perceptions during vitreo-retinalsurgery under local anaesthesiaFariha Shafi, Randhir Chavan, Mark Hero (Coventry/UK)

Post

ers

Monday, 7 June 2010 15:30 - 17:00

Mon

day,

7 Ju

ne

309WOC® 2010

Post

ers

Trauma P35

P-MO-272Anatomical outcome and prognostic factors following intraocular foreign body removalRodney John Morris, Saravanan Veerappan Rathinasabapathy, Narendran Venkatapathy, Parag Shah, Dheepha M. (Coimbatore/IND)

P-MO-273Blunt Trauma Caused by a Tea-towel – Is drying up really this dangerous!Charalambos Tossounis, Luke Clifford, Mehrdad-Sam Attaran, David Farnworth (Portsmouth/UK)

P-MO-274Clinical manifestation of epithelial downgrowth 48 years after penetrating eye traumaAnne Mellein, André Rosentreter, Inga Wedemeyer,Thomas S. Dietlein (Cologne/D)

P-MO-275Cluster bomb ocular injuriesAhmad Mansour, Muhammad Younis, AymanGhaddar, Ahmad Mokaddam, Mohamad Al Hajj-Ali(Beirut/RL)

P-MO-276Comparison of ocular trauma indices in gradingseverity of injury and predicting visual disabilityafter open globe injuriesMayuri Bhargava, Usha Vasu (Bangalore/IND)

P-MO-277Iatrogen ocular affections after application of 2-Octyl CyanoacrylateBirgit Große, Anna Cucera, Sebastian Kupferschmid, Gerhard K. Lang (Ulm/D)

P-MO-278Outcome after severe blunt trauma of the eyeballdue to battery explosionKatarina Hurtikova, Leonie Troeber, Susanne C.Goebels, Ursula Löw, Frank Schirra, Berthold Seitz(Homburg/D)

P-MO-279Pediatric Ocular Trauma: The Analysis of Causesand Outcomes from a Tertiary Eye Centre in EasternIndia.Radha Das, Kumar Saurabh, Sudipta Das, Deepak Agrawal (Kolkata/IND)

P-MO-280Predicting visual outcome after an open globe injury using ocular trauma score (OTS)Gowri Supramaniam, S. E. Khor, M. M. Choo,Bethel I. Livingstone (Seremban/MAL)

P-MO-264Treatment of massive subretinal hematoma associated with age-related macular degenerationusing pars plana vitrectomy combined with intentional giant retinal tear formationEisuke Ishizaki, Atsuko Nakaizumi, Masanori Fukumoto, Takaki Sato, Masahiro Minami, Mari Ueki, Tsunehiko Ikeda (Takatsuki/J)

P-MO-265Ultra-early histological alteration of the retina following photocoagulation treatment in diabeticretinopathy as measured by Spectral domain opticalcoherence tomographyLong Su, Hao Kang, Hong Zhang, Xiaorong Li(Tianjin/CN)

P-MO-266Vitrectomy in patients with familial amylidoticpolyneuropathy to recover good visual acuityAkira Imai, Teruyoshi Miyahara, Toshinori Murata(Matsumoto/J)

P-MO-267Vitrectomy vs Photocoagulation in Patients withOptic Disc PIT Associated Maculopathy – Case Reports.Izabella Karska-Basta, Agnieszka Kubicka-Trzaska,Piotr Oleksy, Joanna Kobylarz, Boz. ena Romanowska-Dixon (Kraków/PL)

P-MO-268Vitreoretinal Surgeries with Subconjunctival Anesthesia in Anticoagulated PatientsAmina Malik (Cincinnati/USA)

Teleophthalmology P34

P-MO-269Automated detection of hard exudates in retinalimagesParnian Kasae, Alfredo Ruggeri (Padova/I)

P-MO-270Integration of a teleophthalmology service (electronic referrals with imaging) into a regionalophthalmology unitJames Cameron, Shyamanga Borooah, Roshini Sanders (Edinburgh/UK)

P-MO-271Nonmydriatic Screening for Diabetic Retinopathy by Ultra-Widefield Scanning Laser Ophthalmoscopy(Optomap) Compared to ETDRS 7-Field ImagingIndrawati Hadi, Aljoscha Neubauer, Florian Pinter,Stefanie Guthmann, Christos Haritoglou, MichaelUlbig, Anselm Kampik, Marcus Kernt (Munich/D)

Post

ers

Monday, 7 June 2010 15:30 - 17:00M

onda

y, 7

June

310 WOC® 2010Po

ster

s

P-MO-290Myopia Control in Teenager Population by Corneal Refractive Therapy (CRT): Results of 4 yearsFollow-upAndriy Kovalov, Oksana Averyanova (Kiev/UA)

P-MO-291Our experience with PDT for the management ofcorneal neovascularization in childrenGiuseppe Carollo (Palermo/I)

P-MO-292Outcome of penetrating keratoplasty (PKP) afterfungal keratitis in Middle Delta region of EgyptOsama Shalaby, Rabab El Seht, M. Sameh ElShorbagy (Tanta/ET)

P-MO-293Parameters for personal approval of cornea donationJulia Promesberger, Constantin E. Uhlig (Münster/D)

P-MO-294Reduced Endothelial Cell Loss following Limbo-KeratoplastyLaura Bredow, Daniel Böhringer, JohannesSchwartzkopff, Thomas Reinhard (Freiburg/D)

P-MO-295Severe conjunctival cicatrisation with limbal stemcell failure following bone marrow transplantationRichard J. Symes, Caroline L. Furness, Bronwen E.Shaw, Andrena McElvanney (London/UK)

P-MO-296The changes of the clinical manifestations and tearcytokines after the treatment with Tears again® ondry eye syndromeKwang Sic Joo, Du Hwan Oh, In Ki Park, Yeoun Sook Chun, Jae Chan Kim (Seoul/ROK)

P-MO-297The Meibomian glands – a “hair without a hairshaft” – cytokeratin expression of the Human Meibomian glandsErich Knop, Milena Ludescher, Nadja Knop(Berlin/D, Hannover/D)

P-MO-298Therapeutic Descemet Sparing Anterior Kerato-plasty:The best choice?Jayangshu Sengupta, Dipanjan Pal, ArchanaKhetan, Suman Saha, Nibaran Gangopadhyay,Merle Fernandes (Kolkata/IND)

P-MO-281Severe self-induced ocular mutilation as the firstepisode of psychosisDagmar Hejcmanova, Lisa Catherine Bytton Díaz,Marketa Machackova, Michaela Hulkova (Hradec Kralove/CZ)

P-MO-282Soccer-related ocular trauma in a tertiary ophthal-mologic center in BrazilCristina Miyamoto, Elisabeth Nogueira Martins (São Paulo/BR)

P-MO-283Treatment of corneal iron-containing foreign bodiesVolodymyr Usov, Tatyana Zhmud (Odessa/UA)

Cornea/Eye Bank P36

P-MO-284Analysis of the efficiency of various applicationmethods of ophthalmic medicationKwang Sic Joo, Du Hwan Oh, Nam Ju Moon,Yeoun Sook Chun, Jae Chan Kim (Seoul/ROK)

P-MO-285Candida Keratitis: The new enemyNibaran Gangopadhyay, Jayangshu Sengupta,Archana Khetan, Suman Saha, Merle Fernandes(Kolkata/IND)

P-MO-286Cultivation of rabbit acinar lacrimal gland cells ondenuded and undenuded amniotic membrane withand without co-cultivation of 3T3 fibroblastsKarsten Kasper, Stefan Schrader, Doris Deininger,Gerd Geerling (Wuerzburg/D)

P-MO-287Effects of bone marrow mesenchymal stem cells on cell proliferation and growth factors expressionof limbal epithelial cells in vitroNan Hu, Xiaohong Mao (Nantong/CN)

P-MO-288Evaluation of the need for and benefit of a communication training for consent for cornea donation by telephoneStephanie Stiel, Sabine Salla, Andre Steinfeld, Peter Walter, Lukas Radbruch, Martin Hermel(Aachen/D)

P-MO-289Keratoconus coexisting with pigment dispersionsyndrome – the cases reportJustyna Izdebska, Anna Kaminska, AgnieszkaCzeszyk-Piotrowicz, Joanna Jedrzejczak-Mlodziejewska (Warsaw/PL)

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00

Tues

day,

8 Ju

ne

311WOC® 2010

Post

ers

P-TU-008Comparison of Tecnis 1-piece multifocal vs. monofocal intraocular lenses: a prospective clinicalmulticentre studyTanja M. Rabsilber, Annett Mannsfeld, Julia Villalba,Il-Joo Limberger, Mike P. Holzer, Gerd U. Auffarth(Heidelberg/D)

P-TU-009Defocus Curve Profiles of Patient’s ImplantedBinocularly with Refractive, Binocularly with Diffractive, or with a Combination of Diffractive-Refractive Intraocular LensesPhill Buckhurst, Sunil Shah, James Wolffsohn (Birmingham/UK)

P-TU-010Differences in reading performance using theSalzburg Reading Desk (SRD) after multifocal andmonofocal intraocular lens implantationMax Rasp, Gerhard Nix, Alois Dexl, Ana BelenPlaza, Jorge Alió, David Pablo Piñero Llorens, Günther Grabner (Salzburg/A, Alicante/E)

P-TU-011Effective followability and less BSS consumptionwith combined peristaltic and venturi pump duringphaco emulsificationEkkehard Fabian (Rosenheim/D)

P-TU-012Endothelial cell integrity, phaco efficiency and nuclear fragment control using Ellips transversalphaco with Venturi pump VS longitudinal phacowith peristaltic pump.Matteo Piovella (Monza/I)

P-TU-013Factors influencing corneal biomechanical changesfollowing microincision cataract surgery (MICS) andstandard coaxial phacoemulsificationJorge Alió, Maria Cecilia Gertrudis Agdeppa, David Pablo Piñero Llorens, Jose Luis RodriguezPrats, Francisco Amparo (Alicante/E)

P-TU-014Functional vision in presbyopia correcting IOLs.Randomized Double Masked Clinical Trial comparing Dual optic accommodating IOL vs multifocal IOLRicardo Alarcon, Victor Bohorquez, Ivan Osma (Bogota/CO)

P-TU-015Influence of ocular spherical aberration on opticalquality after cataract surgery depending on intraocular lens asphericityChristian Hofmann, Oliver Klaproth, Jens Bühren,Thomas Kohnen (Frankfurt/D)

Poster exhibition of Poster P-TU-001 to P-TU-265.All poster authors will attend their posters from15.30 to 17.00 hrs.

Moderation Poster sessions on TuesdayChairs:Katrin Engelmann (Chemnitz)Sekundo, Walter (Marburg)

Co-Chairs:Marcus Blum (Erfurt)Stefan Clemens (Greifswald)Carl Erb (Berlin)Hermann O. C. Gümbel (Ulm)Christos Haritoglou (Munich)Gerald Langmann (Graz )Frank Schirra (Homburg/Saar)Ulrich Mester (Sulzbach)Daniel Mojon (St. Gallen)

Cataract/Biometry 2 P37

P-TU-0013-year position stability of an angle-supported foldable hydrophobic acrylic phakic intraocular lensevaluated by Scheimpflug photographyOliver Klaproth, Thomas Kohnen (Frankfurt/D)

P-TU-002Asymmetric phacobisectionAlmazbek Botbaev (Bishkek/KIS)

P-TU-003Brown Cataract – A challenge to the Ophthalmologist!Swati Zawar (Nashik/IND)

P-TU-004Changes in anterior chamber depth and refractivepower after cataract surgery with or without simultaneous vitreous surgery.Mao Kusano, Eiko Tsuiki, Kiyoshi Suzuma, Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J)

P-TU-005Clinical and functional analysis of the phacoe-mulsification results in the cataract extraction ofdifferent etiologyIvanov Gheorghe (Chisinau/MD)

P-TU-006Clinical impact of spherical aberration on contrastsensitivity of different intraocular lensesHanno Goeppert, Andreas Christian Schroeder,Welk Stephanie, Frank Schirra, Karin Brueckner,Achim Langenbucher, Berthold Seitz (Homburg/D)

P-TU-007Clinical impact of spherical aberration on focaldepth of different intraocular lensesSarah Kuehlmeyer, Andreas Christian Schroeder,Eva Filser, Tobias Hager, Christian Jonescu-Cuypers,Hans Sebastian Walter, Achim Langenbucher,Berthold Seitz (Homburg/D)

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00Tu

esda

y, 8

June

312 WOC® 2010

P-TU-025Oculentis LENTIS Mplus: A new concept of multifocal intraocular lens technologyGerd U. Auffarth, Tanja M. Rabsilber, R. Philips, Jan Novák (Heidelberg/D)

P-TU-026Optivis™ Multifocal Progressive Diffractive Lens:Three Months Clinical OutcomesMatteo Piovella (Monza/I)

P-TU-027Outcomes with Refractive and Diffractive multifocalintra ocular lensDandapani Ramamurthy (Coimbatore/IND)

P-TU-028Performance of three biometry devices in patientswith different grades of age-related cataractGeorgios Mylonas, Stefan Sacu, Wolf Bühl, MarkusRitter, Michael Georgopoulos, Ursula Schmidt-Erfurth (Vienna/A)

P-TU-029Postoperative Capsular Block Syndrome – AnteriorSegment Optical Coherence Tomography FindingsAmy L. Wong (Hong Kong/HK)

P-TU-030Postoperative Results after Implantation of a toricIOL (B1AWTY) for small corneal astigmatismAndreas K. Cordes, Norbert F. Schrage (Cologne/D)

P-TU-031Pseudophakic “nuclear cataract”Andreas Christian Schroeder, Christian Lingenfelder,Hans Sebastian Walter, Gregory Dame, BertholdSeitz (Homburg/D)

P-TU-032Quality of information about Cataract on the internetMarkus Groppe, Kwesi Amissah-Arthur, Achmed El-Amir, Vaughan Tanner (High Wycombe/UK)

P-TU-033Refractive surpriseJuliana Helou, Anna Cucera, Gerhard K. Lang(Ulm/D)

P-TU-034Results of Low Contrast visus in AT.Lisa 366 D ImplantationHarry Domack (Schweinfurt/D)

P-TU-035State of art hands on surgical training made easyVikas Mahatme (Nagpur/IND)

P-TU-016Influence of surgically induced corneal sphericalaberration on retinal image quality after cataractsurgeryThomas Kohnen, Oliver Klaproth, Christian Hofmann, Jens Bühren (Frankfurt/D)

P-TU-017Intracameral white mass associated with anterioruveitis in a patient with anterior polar cataractUlrich Brandlhuber, Armin Wolf, Christos Haritoglou, Daniel Kook (Munich/D)

P-TU-018Intraocular lens power calculation following INTRACORTanja M. Rabsilber, Annett Mannsfeld, Angela Ehmer, Wolfgang Haigis, Gerd U. Auffarth, Mike P. Holzer (Heidelberg/D)

P-TU-019Intraoperative and clinical results of phaco-emulsification with ultrasound ellips through2.2mm incision for hard cataractAhmed Assaf (Kairo/ET)

P-TU-020Iris claw (Verisyse®/Artisan®) intraocular lens implantation in cases with subluxated lenses due toMarfan syndrome.George Voyatzis, Bushra Al-Deiri, Alan Fitt (Peterborough/UK)

P-TU-021Long-term results after bilateral congenital cataractsurgery – pars plana lensectomy versus ECCE andIOL implantationImad Hakim, Wolfgang Mayer, Daniel Kook, Guenther Rudolph, Anselm Kampik (Munich/D)

P-TU-022Misleading axial length measurements due to adense posterior vitreous surface membrane in a diabetic patient – case reportChristoph Fidel Mayer, Michaela Velikay-Parel(Graz/A)

P-TU-023Morphometric Analysis of Cornea Endothelial PostPhacoemulsification Viscoadaptive Compare toMedium Viscosity Combines with Chondroitin SulphateAmir Shidik (Jakarta/IR)

P-TU-024Near, intermediate and distance vision outcomeswith the Crystalens HD accommodating intraocularlensAna Belen Plaza, Jorge Alió, David Pablo PiñeroLlorens (Alicante/E)

Post

ers

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00

Tues

day,

8 Ju

ne

313WOC® 2010

P-TU-046Prophylactic Treatment for Cytosine Arabinoside(Ara-C) induced KeratoconjunctivitisWilliam Sheehan, Amit Patel (Bristol/UK)

P-TU-047Report of our graft-versus-host-disease consultationhourKatharina Hauer, Philipp Eberwein, DanielBöhringer, Thomas Reinhard, Hans Mittelviefhaus(Freiburg/D)

P-TU-048Toxicity of ranibizumab (Lucentis®) to culturedhuman corneal endothelial cells in vitroMichael Wolfgang Meyer, Stephan Reichl, Katharina Bauer, Inez Brunotte, KonstantinosZinelis, Sebastian Weiß, Rolf Winter (Hannover/D)

P-TU-049Treatment of traumatic corneal abrasion: A threearm, prospective, randomized studyMoreno Menghini, Pascal Knecht, Claude Kaufmann, Ronald Kovacs, Stephanie Watson,Klara Landau, Martina Bösch (Zurich/CH)

P-TU-050Update on ocular graft-versus-host-disease (GVHD) –report of the consensus conference on chronicGVHDTina Dietrich, Claus Cursiefen, Daniel Wolff (Regensburg/D, Erlangen/D)

Glaucoma: Miscellaneous P39

P-TU-051Analysis of intraocular pressure measurements influenced by corneal curvatures and thicknessesamong three tonometries.Sheng-Yao Hsu, Rong-Kung Tsai (Kaohsiung/TJ)

P-TU-052Assessment of Ciliary body area in pupil blockPeter Good (Birmingham/UK)

P-TU-053Cerebrospinal Fluid Pressure in Glaucoma.Ruojin Ren (Beijing/CN)

P-TU-054Comparison of Cost and Distribution of Patientsafter Different Initial Treatments for Primary OpenAngle GlaucomaHye Bin Yim, Tong Yun Kwag, Jee Hyun Kwag,Yeon Deok Kim, Aman Shah B. Abdul Majid, Kui Dong Kang (Incheon/ROK)

P-TU-055Correlation of Vision Threatening Glaucoma withprolonged and unmonitored use of Topical SteroidsRekha Khandelwal, Shivani Bidaye, Suresh Ughade,Mohana Majumdar (Nagpur/IND)

P-TU-036Surgically-induced astigmatism in phacoemulsifi-cation: 2.2mm versus eleven scalpel blade clearcorneal incisionsHermelino Oliveira Neto, Israel Cardoso Neto,Ronald Fonseca Reis, José Bessa Jr (Feira de Santana-Bahia/BR)

P-TU-037Visual Function in Patient’s Implanted with the New Lentis Mplus Multifocal Intraocular LensSunil Shah, Phill Buckhurst, James Wolffsohn (Birmingham/UK)

P-TU-038Visual outcomes following microincision cataractsurgery (MICS) in Kuantan, MalaysiaThevi Thanigasalam (Temerloh/MAL)

P-TU-039Vizualisation of Anterior Segment Whit Sd-Oct Rt-100Lukan Mishev (Sofia/BG)

Cornea/Eye Bank: Miscellaneous P38

P-TU-040Bilateral Cornea Plana in two siblings: ManagementVishnu Gupta, Anuj Mehta, Shreekant Damgude,Rupsanchita Das, Brahm Guliani, Krishan Malik(Coimbatore/IND)

P-TU-041Bilateral Esclerocornea, case reportRuben Edel Martínez Serrano, Alejandra EtualinGonzález, Jose Luis Estrada Rodríguez (Querétaro/MEX)

P-TU-042Cosmetic corneal tattooing (in corneal opacities)using new pigmentChitra Pande, Vikas Mahatme (Nagpur/IND)

P-TU-043Influencing corneal wound healing after cornealburn using amniotic membrane and mesenchymalstem cells.Philipp Eberwein, Andreas Heidt, JohannesSchwartzkopff, Yvonne Kern, Daniel Böhringer,Thomas Reinhard (Freiburg/D)

P-TU-044Keratitis and corneal ulceration due to contactlensesMichael R. R. Böhm, Inga Domenghino, Holger Busse, Ralph-Laurent Merté (Münster/D)

P-TU-045Outcomes of amniotic membrane transplantationin chemical injuries of ocular surfaceSwati Tomar (Jaipur/IND)

Post

ers

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00Tu

esda

y, 8

June

314 WOC® 2010

P-TU-065Canaloplasty outcome analysis by anterior segmentoptical coherence tomographyThomas Theelen, Cathrien A. Eggink (Nijmegen/NL)

P-TU-066Capsule exzision and Ologen™ implantation for revision after glaucoma drainage device surgeryAndre Rosentreter, Anne C. Mellein, Walter W.Konen, Thomas S. Dietlein (Hürth/D, Cologne/D)

P-TU-067Cataract surgery for acute angle closure secondaryto scleral bucklingKodo Medoruma, Ichiko Medoruma, Hideo Nakamura, Shoichi Sawaguchi (Nishihara-cho Okinawa-ken/J)

P-TU-068Clinical Results of Selective Laser Trabeculoplasty in Open-Angle Glaucoma in Japanese Eyes: Comparison of 180 Degree with 360 Degree SLTMaho Shibata, Tetsuya Sugiyama, Osamu Ishida,Mari Ueki, Shota Kojima, Takaaki Okuda, Tsunehiko Ikeda (Takatsuki/J)

P-TU-069Combined Phaco-Trabeculectomy for ProgressiveNormal-Tension Glaucoma Associated with HighMyopiaAtsuya Miki, Aya Terubayashi, Shinichi Usui, Kenji Matsushita, Yasushi Ikuno (Osaka/J)

P-TU-070Conditions of preoperative and early postoperativeintraocular pressure for predicting the lower pressure control in a trabeculectomy.Satoshi Okimoto, Yoshiaki Kiuchi, Junichi Kawahara(Hiroshima/J)

P-TU-071Endoscopic cyclophotocoaguation combined withphacoemulsificationZora Ignjatovic, Zoran Kuljaca, Katarina Misailovic,Maja Beko, Nada Radovic, Andjela Tolic(Selgrade/SRB)

P-TU-072Evaluation of Filtering Blebs after Trabeculectomyusing Anterior Segment Optical Coherence TomographyAkiko Narita, Jiro Seguchi (Okayama/J)

P-TU-073Express Shunt in selected glaucoma patients – First resultsClaudia Rebel, Mario Matthaei, Johannes Steinberg, Maren Klemm (Hamburg/D)

P-TU-074Glaucoma and penetrating keratoplasty afterpseudomonas corneal infectionCarolina Pallás (Barcelona/E)

P-TU-056Depression and sleep disorders in progressed glaucoma: an indication for melatonergic antidepressants?Christos Skevas, Agorastos Agorastos, MarioMatthaei, Christina-Georg Huber, Oliver Zeitz, Gisbert Richard, Maren Klemm (Hamburg/D)

P-TU-057Free floating iris cyst at the anterior eye chamber.Wolfram Hofmüller, Arne Viestenz, Sven Walter,Wolfgang Behrens-Baumann (Magdeburg/D)

P-TU-058Intraocular pressure after phacoemulsification in eyes with exfoliative glaucoma and primaryopen-angle glaucomaTomaž Gracner, Nenad Špicka, Mojca Hudovernik,Bojan Gracner, Dušica Pahor (Maribor/SI)

P-TU-059Masked, Randomized, Parallel Comparison of Physician and Patient Reported Outcomes (PROS)after Switching to Bimatoprost 0.03% vs Continuing on Latanoprost 0.05%.Ehsan Sadri, Ronald Frenkel, Jodi Luchs, MichaelRotberg, Thomas K. Mundorf, John G. Walt, Ching-chi Liu, Amy L. Batoosingh (Newport Beach/USA)

P-TU-060The Humanistic and Economic Burden of Glaucoma: An UpdateSteven M. Kymes, Gail Schwartz, Richard G. Fiscella, Caroline Burk, Vaishali D. Patel (St. Louis/USA)

P-TU-061The Relationship Between Obstructive Sleep ApneaSyndrome and GlaucomaGul Arikan, Mehmet Ozgur Zengin, Ibrahim Oztura,Uzeyir Gunenc, Mehmet Ergin (Izmir/TR)

P-TU-062Unusual presentation of unilateral acute angle closure glaucoma on a childKarunarathna Rajapaksha, Keembiyage Dayawansa(Kandy/CL)

Glaucoma: Surgical Therapy P40

P-TU-063Ahmed valve implantation in refractory glaucomasecondary to sturge-weber syndrome: case seriesOthmaliza Othman, Wan Haslina Wan Abdul Halim,Norshamsiah Md Din, Ropilah Abdul Rahman(Kuala Lumpur/MAL)

P-TU-064Application of gelatin hydrogel and chymase inhibitor in a canine filtration surgery modelShota Kojima, Tetsuya Sugiyama, Maho Shibata,Denan Jin, Shinji Takai, Yasuhiko Tabata, TsunehikoIkeda (Takatsuki/J)

Post

ers

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00

Tues

day,

8 Ju

ne

315WOC® 2010

P-TU-075High-frequency ultrasound evaluation of Schlemm’sCanal and suture traction after CanaloplastyAnne Brüggemann, Joshua Torrent Despouy,Swaantje Peters, Salvatore Grisanti, Maya Mueller(Lübeck/D)

P-TU-076Investigation of a modified PNIPAAm hydrogel forportential use in drug-eluting glaucoma drainagedevicesHagen Thieme, Robert Roskamp, Maria Wegner,Norbert Pfeiffer, Lars Choritz (Mainz/D)

P-TU-077Mid-term outcome of inferior-approch trabeculotomytakuro matsuba (Osaka/J)

P-TU-078Non Penetrating Deep Sclerectomy – BetweenSafety and EfficacyDorin Chiselita, Alina Cantemir, Irina Ilies (Ia i/RO)

P-TU-079Selective Laser Trabeculoplasty for Uveitis InducedElevated Intraocular PressureHyoung Sub Shim, Taehyuk Koh, Hwang Ki Kim,Yong Ho Sohn (Incheon/ROK)

P-TU-080Trabeculectomies in Eyes with Glaucoma in a Patient with Osteogenesis ImperfectaJulia Rosbach, Norbert Pfeiffer, Katharina A. Ponto,Katrin Lorenz, Urs Vossmerbaeumer, Hagen Thieme(Mainz/D)

P-TU-081Two-years Follow-up of Trabeculectomy withBiodegradable 3D Porous Collagen-Glycosamino-glycan Scaffold for Treatment of Refractory GlaucomaHenry Shen-Lih Chen, Wei-Cherng Hsu (Taipei/TJ)

P-TU-082YAG-laser-goniopuncture after deep sclerectomy –a morphologic analysisMatthias Keserü, Gisbert Richard, Maren Klemm(Hamburg/D)

Oncology P41

P-TU-083Adjuvant topical treatment of recurrent conjunctivalsquamous cell carcinoma with Mitomycin COrlin Velinov, Holger Busse, Ralph-Laurent Merté(Münster/D)

P-TU-084Adult onset asthma and periocular xanthogranu-loma associated with reactive lymphoid hyperplasia:one case reportRimvydas Asoklis, Laura Butkiene, Ona Garlaite,Donatas Petroska (Vilnius/LT)

P-TU-085Breast cancer metastasis to the choroid in a malepatient – case reportArkadiusz Pogrzebielski, Piotr Oleksy, Izabella Karska-Basta, Bo ena Romanowska-Dixon(Kraków/P)

P-TU-086Choroidal Mets. Enucleation?Jorge Topete-Jimenez, Jorge Topete-Jimenez(Guadalajara/MEX)

P-TU-087Clinical and Imaging Features in Metastatic UvealTumorsXiaoda Bi (Shanghai/CN)

P-TU-088Combined Treatment T2N0M0 Patients withChoroidal Melanoma with 106RU+106RH Plaques and Transpupillary Thermotherapy (TTT)Larisa Naumenko (Minsk/BY)

P-TU-089Congenital simple hamartoma of the retinal pigment epitheliumGregor Willerding, Hilmar Tillack, JoachimWachtlin, Nikolaos E. Bechrakis, Michael H. Foerster(Berlin/D, Innsbruck/A)

P-TU-090Conjunctival Melanoma. Origin from primary acquired melanosis (PAM) and nevus shows less riskfor melanoma-related death than origin de novo.Carol Shields, Jeremy Markowitz, Irina Belinsky,Nina George, Hal Schwartzstein, Sara Lally, Arman Mashayekhi, Jerry Shields (Philadelphia/USA)

P-TU-091CyberKnife: a new treatment option for uvealmelanomasUlrich Christoph Schaller, Martin Nentwich, Annemarie Klingenstein, Berndt Wowra, AlexanderMuacevic, Anselm Kampik (Munich/D)

P-TU-092Differential diagnosis of iris and/or ciliary bodymelanoma.Bozena Romanowska-Dixon, Anna Markiewicz, Barbara Jakubowska (Krakow/P)

P-TU-093Differential diagnosis of proptosis in childhoodMonica Lang, Andreas Chantzaras, Karl-Heinz Emmerich (Darmstadt/D)

P-TU-094Diverse Clinical Spectrum of Bilateral Diffuse UvealMelanocytic Proliferation Syndrome.Camila Simoes, Zelia Correa, James Augsburger(Cincinnati/USA)

Post

ers

Post

ers

Post

ers

P-TU-095Endoresection of large choroidal melanoma afterstereotactic radiotherapyStefan Christmann (Cologne/D)

P-TU-096Evaluation of Bulbus Shift after Retrobulbar Anesthesia in Cyberknife Radiosurgery for the Ther-apy of Large Uveal MelanomaMartin M. Nentwich, Christoph Fürweger, Alexander Muacevic, Berndt Wowra, AnnemarieKlingenstein, Anselm Kampik, Ulrich C. Schaller(Munich/D)

P-TU-097Expression of Galectin-3 and Epha2 in metastaticand non-metastatic uveal melanomasJulia Lüke, Vlatka Vukoja, Tim Brandenbusch,Matthias Lüke, Aysegül Tura, Martin Rohrbach, Salvatore Grisanti (Lübeck/D, Tübingen/D)

P-TU-098Expression of ocular mucins in conjunctivalmelanoma, conjunctival compound naevi and normal conjunctivaVinodh Kakkassery, Claudia Gavranic, Johannes Holle, Antonia Joussen (Berlin/D)

P-TU-099Eye manifestation of Waldenström’s macroglobu-linemiaAntje Zimmermann, Melanie Jäger (Linden/D)

P-TU-100Factors influencing the course of pediatric orbitalmalignancy in Third world countries – Issues beyond the therapeutic regimenJayanta Das (Guwahati/IND)

P-TU-101Giant papillary conjunctivis as primary manifestation of a non-Hodgkin lymphomaSusanne C. Goebels, Andrea Hasenfus, Leonie Troeber, Arnulf Schnaidt, Frank Schirra,Berthold Seitz (Homburg/D)

P-TU-102Identification of ionizing radiation-responsive micro RNAs in uveal melanoma cellsYixiong Zhou, Xianqun Fan (Shanghai/CN)

P-TU-103Incidence and Recurrence Rates of Ocular SurfaceSquamous Neoplasia in Gaborone, Botswana: 1998 to 2007Oathokwa Nkomazana (Gaborone/RB)

P-TU-104Malignant Triton Tumor Without Von Reckling-hausen’s Neurofibromatosis in a 16-year-old Indonesian Girl: A Case ReportNeni Anggraini, Rino Pattiata (Jakarta/RI)

P-TU-105Masquerade Syndrome Caused by Intraorbital Lymphoma – Two Case ReportsDarko Ler, Jozica Baralic, Senad Pozder, Jasna Muhovic-Bejtic, Ibrahim Paco (Sarajevo/BIH)

P-TU-106MicroRNA-200 Is Commonly Repressed in Conjunc-tival MALT Lymphoma and Potentiates Expressionof Cyclin E2Jiping Cai (Shanghai/CN)

P-TU-107Myxoid/Round Cell Conjunctival Liposarcoma: A Case ReportGiuri Stela, Raica Marius, Munteanu Mihnea,Munteanu Gheorghe (Timisoara/RO)

P-TU-108Optical coherence tomographic features of opticdisc melanocytoma in Chinese patientsJasmine WS Ngai (Hong Kong /HK)

P-TU-109Optical Coherence Tomography – Pathological Correlation of Optic Disc MelanocytomaPaul Finger, Sribhargava Natesh, Tatyana Milman(New York City/USA, Bangalore/IND)

P-TU-110Orbital metastasis from colorectal cancerBenjamin Perez, Nicolas Leon-Gonzalez, Nicolas Leon-Perez, Abelardo Rodriguez-Reyes(Mexico/MEX)

P-TU-111Outpatient Cytologic Evaluation of Ocular SurfaceSquamous NeoplasiaEkaterina A. Semenova, Tatyana Milman, Paul T.Finger, Madhavi Kurli, Susan Schneider, SribhargavaNatesh, Codrin E. Iacob, Steven A. McCormick(Moscow/RUS)

P-TU-112Pars plana lensectomy in External Beam Radio-therapy induced Cataract in RetinoblastomaMarkus Holdt, Barbara Schaperdoth-Gerlings,Christine Jurklies, Norbert Bornfeld (Essen/D)

P-TU-113Photodynamic therapy – a novel therapeutic approach for superficial eyelid basal cell carcinomaJan Ricar, Renata Ricarova, P. Cetkovska, K. Pizinger (Pilsen/CZ)

P-TU-114Presence of tumor cells in the bloodstream, beforeand after surgical intervention in uveal melanomaGeorgios Charitoudis, Vasileios Petousis, Ronny Schuster, Ulrich Keilholz, Michael H. Foerster, Nikolaos E. Bechrakis (Berlin/D, Innsbruck/A)

Tuesday, 8 June 2010 15:30 - 17:00Tu

esda

y, 8

June

316 WOC® 2010Po

ster

s

Post

ers

P-TU-115Recent progress in radiotherapy for optic nervetumorXiaoda Bi (Shanghai/CN)

P-TU-116Regression patterns and visual acuity of macular tumours following chemoreduction for Retino-blastomaChristina Weiss, Christine Jurklies, Regina Wieland,Angelika Eggert, Wolfgang Sauerwein, Norbert Bornfeld (Essen/D)

P-TU-117Retinoblastoma in Belarus: today's approachHanna Furmanchuk (Minsk/BY)

P-TU-118Rho-kinases-associated glioma migration effects on neuronal cell bodies and fibers in vitroVera Clemens, Solon Thanos (Münster/D)

P-TU-119Serum panel for detection of metastasis in uvealmelanoma patientsDaniela Süsskind, Ayse Tura, Michael Partsch, Karl Ulrich Bartz-Schmidt, Sigrid Henke Fahle (Tübingen/D)

P-TU-120Signet ring cell carcinoma of the lid in a youngwomanEva Glaser, Christian Mayer, Ramin Khoramnia,Gregor Weirich, Chris Patrick Lohmann (Munich/D)

P-TU-121The clinical and histopathological study of conjunctival and corneal tumorsPham Thi Khanh Van (Ha Noi/VN)

P-TU-122The main tumor-associated retinal symptoms,caused by small uveal melanoma: the correlationanalysis.Svetlana Saakyan, Natalya Urovskaya(Moscow/RUS)

P-TU-123The miR-17-92 gene is amplified and overexpressedin retinoblastomaEva Biewald, Harald Stephan, Pieter Mestdagh, Johannes Hubertus Schulte, Alexander Schramm,Angelika Eggert, Norbert Bornfeld (Essen/D)

P-TU-124The role of HPV serotype 16 and 18 in OSSNAgus Supartoto, Syenny Budi Handoko, Sri YuliHandayani (Yogyakarta/RI)

P-TU-125The role of transpupillary thermotherapy in combined treatment of retinoblastoma.Svetlana V. Saakyan, Ekaterina A. Semenova,Robert A. Tatzkov, Olga A. Ivanova (Moscow/RUS)

P-TU-126Treatment of retinal detachment occuring afterbrachytherapy of uveal melanomas: triamcinoloneacetonide vs pars plana vitrectomyTheodora Gkika, Mete Gök, Michael Freistühler,Harun Akgül, Dirk Flühs, Wolfgang Sauerwein, Norbert Bornfeld (Essen/D)

P-TU-127Tumor-Associated Lymphangiogenesis in the Development of Conjunctival Malignant MelanomaLudwig M. Heindl, Carmen Rummelt, Leonard Holbach, Gottfried Naumann, Friedrich Kruse, Claus Cursiefen (Erlangen/D)

P-TU-128UBM in intraocular tumorsAnna Markiewicz, Bozena Romanowska-Dixon, Barbara Jakubowska (Krakow/P)

Pediatric Ophthalmology & Genetics P42

P-TU-129A case of aniridia with a unilateral lens malpositionMayu Sawada, Miho Sato, Akiko Hikoya, Chunxia Wang, Shinsei Minoshima, NoriyukiAzuma, Yoshihiro Hotta (Shizuoka/J)

P-TU-130Analysis of abnormal head postures in pediatric patientsSteffi Tech, Christina Gerth (Rostock/D)

P-TU-131Anterior segment dysgenesis, report of Mexicanfamily.Ruben Edel Martínez Serrano, Alejandra EtualinGonzález (Querétaro/MEX)

P-TU-132Beta-blockers as the new treatment method in capillary orbital and adnexal hemangioma.Gabriela Gondova (Bratislava/SK)

P-TU-133Case Series on Phthiriasis Palpebrum in childrenShing Kin Yau, Tak Yau Tam (Kowloon/HK)

P-TU-134Clinical Characteristics of Taiwanese Children withoptic neuritisMing-Hui Sun (Taoyuan/TJ)

P-TU-135Congenital eye anomalies in children with mixedcognation of parentsKhakima Karim-Zade, Abdujamil Toshmatov, Rano Kholmatova, A. Rakhmonov, H. Mirsakhanova(Khujand/TAD)

Tuesday, 8 June 2010 15:30 - 17:00

Tues

day,

8 Ju

ne

317317WOC® 2010

Post

ers

Post

ers

P-TU-136Congenital Unilateral Absence of Superior Rectuswithout Craniofacial AnomalyMohammad Reza Talebnejad, Mahnaz Mosallaei(Shiraz/IR)

P-TU-137Development of Ocular Optical Components andRefractive Error in InfantsPing Wang (Changsha/CN)

P-TU-138Endovitreal melphalan as local retinoblastoma (RB)chemotherapy Nadiya Bobrova, T. A. Sorochynska (Odessa/UA)

P-TU-139Epidemiological, clinical and therapeutic aspects ofcongenital glaucoma: a report of 159 casesAdil Megzari, Bencherifa Fatiha, Berraho Amina(Rabat/MA)

P-TU-140Etiological Aspects of Congenital Cataract: CaseStudy of 107 Cases (179 Eyes)Tarik El Alloussi, Imane Ahmiti, Sanaa Haddad,Obaida El Yamouni, Ramzia Sebbah, Sanaa Idrissi-Alami, Mostapha El Mrabh, FatihaBenchérifa, Amina Berraho (Rabat/MA)

P-TU-141Factors affecting recurrence in successfully treatedcases of anisometropic amblyopiaShraddha Puranik, Rohit Saxena, Vimla Menon,Pradeep Sharma, Swati Phuljhele (New Delhi/IND)

P-TU-142Genetic homogeneity and phenotypic variability inEast Asian patients with achromatopsiaJoo Hyun Choi, Yoon Jeon Kim, Hyun Taek Lim,Hyejin Lee (Seoul/ROK)

P-TU-143Lay vision screening: Can the Plusoptix visionscreener replace the LEA symbol chart and randomdot stereotest?Joannah Vaughan, David Wheeler, Allison Summers(Portland/USA)

P-TU-144Long term preservation of visual function in hereditary mucoepithelial dysplasiaVenkata Avadhanam, Keith Martin (London/UK)

P-TU-145Morphological and functional outcomes in one-year-old patients following diode laser photocoagu-lation for retinopathy of prematurity – a prospectivestudy at ho chi minh city eye hospitalThao Nguyen Uyen Vo (Ho Chi Minh/VN)

P-TU-146Myofibroma of the Conjunctiva Invading theCornea in InfancyGerassimos Lascaratos, Manish Gupta, Laura Bridges, Mary MacRae (Edinburgh/UK)

P-TU-147Neonatal Marfan syndrome – A rare form with limited diagnostic and therapeutic opportunitiesNicola Rauch, Daniel Herzog, Heike Elflein, Pfeiffer Norbert (Mainz/D)

P-TU-148Nystagmus secondary to drug exposure in uteroManish Gupta, Gerassimos Lascaratos, Alan Mulvihill, Brian Fleck, Nick George (Edinburgh/UK)

P-TU-149Open Globe Injuries in ChildrenMarlene Schörkhuber, Mona Schneider, Werner Wackernagel, Andreas Wedrich (Linz/A)

P-TU-150Outcome of probing or intubation for congenitalnaso-lacrimal duct obstruction in NHS Lothian – Six year AuditManish Gupta, Gerassimos Lascaratos, MaryMacRae, Alan Mulvihill, Brian Fleck (Edinburgh/UK)

P-TU-151Outcomes of ROP treatment in Extremely Low Birth Weight (ELBW) infantsDavid Gunn, David Cartwright, Glen A. Gole(Windsor/AUS)

P-TU-152Parinaud oculoglandular syndromeAneta Skupin, Melanie Jäger, Birgit Lorenz(Giessen/D)

P-TU-153Penetrating Keratoplasty in a 6 week Child with Peters anomaly – a case report.Andreas K. Cordes, Axel Schmitz, Norbert Schrage(Cologne/D)

P-TU-154Peripapillary choroidal neovascularization (CNV) associated with optic nerve drusen in 13-year-oldchild – options for anti-VEGF therapyAndrzej Dmitriew, Anna Gotz-Wieckowska, Joanna Siwiec-Proscinska (Poznan/P)

P-TU-155Phenotype variability in a family with microph-thalmia and colobomaChristina Gerth, Kathy Williamson, Rudolf F. Guthoff, David R. FitzPatrick, Veronica van Heyningen (Rostock/D, Edinburgh/UK)

Tuesday, 8 June 2010 15:30 - 17:00Tu

esda

y, 8

June

318 WOC® 2010Po

ster

s

Post

ers

P-TU-156Primary intraocular lens implantation in pediatriccataract with posterior lenticonus-case report.Krystyna Kanigowska, Miroslawa Gralek(Warsaw/PL)

P-TU-157Radial pupillotomy for treatment of extreme pupillary ectopiaNina Bobisch, Norbert Schrage, Andreas Cordes(Cologne/D)

P-TU-158Refraction Anomalies in Children of KazakhstanTursungul Botabekova (Almaty/KZ)

P-TU-159Screening Results of First Class Primary SchoolsChildren in AlbaniaEnno Qerimi (Durres/AL)

P-TU-160Spectral domain optical coherence tomography images of serous retinal detachment associatedwith optic disc pit in a 7-year-old childAnu Maudgil, Jonathan Chan (Sheffield/UK)

P-TU-161Structural and functional outcomes of prematureinfants screened for retinopathy of prematurity in a tertiary-care hospital in MalaysiaMay May Choo, U-teng Chan, Nurliza Khaliddin,Ayu Saad Mas (Kuala Lumpur/MAL)

P-TU-162The Factors affecting Pattern Visual Evoked Poten-tial in AmblyopesJun-ho Choi, Sun-young Jang, Song-hee Park(Seoul/ROK)

P-TU-163The phenomenon of movement perception in congenital nystagmus: clinical studies and possibleimplications concerning the suppression of oscillopsiaBarbara Käsmann-Kellner, Berthold Seitz (Homburg/D)

P-TU-164To know the awareness amongst the children &their parents regarding the conditions causingchildhood blindness between age-group 0-18years.Seema Deshmukh, Vikas Mahatme, Sanyogita Joshi (Nagpur/IND)

P-TU-165Treating amblyopia: are we beginning too late?Carlos Eduardo Resende Gomes, Galton CarvalhoVasconcelos, Sabrina Cavaglieri, Henderson Celestino de Almeida (Conselheiro Lafaiete/BR)

P-TU-166Ultrastructural investigation of cornea wound healing in full-thickness and 2/3 depth suturesNadiya Bobrova, Valeriy Vit, Natalia Dumbrova, Natalia Molchanyuk, Vasiliy Shevchyk, Tatiyana Romanova (Odessa/UA)

P-TU-167Unilateral optic nerve aplasia associated with microphthalmos – A case reportGordana Stankovic-Babic (Nis/SRB)

P-TU-168Unproportional microphthalmia in a child withHallermann-Streiff syndromeWerner Schmidt (Giessen/D)

P-TU-169Use of Spectral Domain OCT to Image PediatricMacular and Posterior Pole PathologyNaz Raoof, Tsiang Ung, Julie Bailey, T. K. Chan(Sheffield/UK)

Retina: Diagnostics P43

P-TU-170A comparison between mydriatic digital fundusphotographs and fundus fluorescein angiogram inthe diagnosis of proliferative diabetic retinopathyearlyShobana Nadarajah (Petaling Jaya/MAL)

P-TU-171Assessment of the Retinal Nerve Fiber Layer Thick-ness with Optical Coherence Tomography in Eyeswith Various Degrees of Optic Nerve Head DrusenUrszula Gajdzik-Gajdecka, Ewa Mrukwa-Kominek,Wanda Romaniuk (Katowice/PL)

P-TU-172Association between the ocular involvement andcardiovascular involvement or the distribution ofskin and mucous membrane lesions in patients withpseudoxanthoma elasticum.Hiroshi Tamura, Akitaka Tsujikawa, Hideo Nakanishi, Kenji Yamashiro, Sotaro Ooto, AtsushiOtani, Atsushi Utani, Nagahisa Yoshimura (Kyoto/J)

P-TU-173Atypical retinal changes in sympathetic ophthalmia.Galina Vashkevich, Olga Sashneva, TatsianaImshenetskaya, Irina Puchkova, EleonoraParhovchenko, Arkadyi Puchkov (Minsk/BY)

P-TU-174Blind spot enlargement syndrome in acute zonaloccult outer retinopathy (AZOOR)Ramona Verena Neutzner, Melanie Jäger, Birgit Lorenz (Giessen/D)

Tuesday, 8 June 2010 15:30 - 17:00

Tues

day,

8 Ju

ne

319319WOC® 2010

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00

Post

ers

Tues

day,

8 Ju

ne

320 WOC® 2010

P-TU-184How to Cope with Segmentation Errors in Measurement of Macular Thickness with SpectralDomain Optical Coherence TomographyByung Ro Lee, Yumi Song, Yong Woon Shin(Seoul/ROK)

P-TU-185Influence of lens opacities due to cataract on thedetection of drusen in SD-OCTSabine Schriefl, Rupert Menapace, Christian Ahlers,Eva Stifter, Danielle Boullanger, Isabelle Golbaz, Ferdinand Schlanitz, Ursula Schmidt-Erfurth(Vienna/A)

P-TU-186Interchangeability between different scan protocolsof Spectralis optical coherence tomography in normal eyesYaroslava Chopovska, Stephan Wismann, Melanie Jäger, Birgit Lorenz (Giessen /D)

P-TU-187In-vivo choroidal thickness imaging after PDTLyudmyla Metzger, Horst Helbig, Maria-AndreeaGamulescu (Zwiesel/D, Regensburg/D)

P-TU-188Macular Hole: 10 and 20-mhz ULTrasound Imagesand Spectral-Domain Optical Coherence TomographyJuliana Bottós, Virginia Torres, Liliane Kanecadan,Andrea Martinez, Nilva Moraes, Norma Allemann(Barcelona/E)

P-TU-189Myelinated retinal nerve fibersKaoutar El Ouazzani Chahdi, Mohamed Benharbit,Ibtissam Mansouri, Halima Saadiya Mouhdi,Youssef Amrani, Btissam Ouazzani Tnachri, Wafae Ibrahimy, Rajae Daoudi (Rabat/MA)

P-TU-190New screening method using unreflective transillumination ophthalmoscopy in diagnosis ofchorioretinal pathologyMaryia Morkhat, Vi tor Morkhat (Vitebsk/BY)

P-TU-191Non-mydriatic Ultra-widefield Scanning Laser Ophthalmoscopy (Optomap) versus 2 field fundusphotography in diabetic retinopathyKristine Kaldefoss, Lala Ceklic, Aljoscha Neubauer,Stefanie Guthmann, Christos Haritoglou, Anselm Kampik, Michael Ulbig, Marcus Kernt (Munich/D)

P-TU-192OCT signs in refractory diabetic macular oedema.Ina Malinouskaya, Tatiana Imshanetskaya, Igor Zaborovski (Minsk/BY)

P-TU-175Changes of the ocular fundus in patients withamaurosis fugaxVakhramova Natalia, Ramazanova Lya(Moscow/RUS)

P-TU-176Comparison of Selective Pixel Profiling (SPP) andImage Tracked Averaging for Signal to Noise Enhancement in Optical Coherance TomographyCarl Glittenberg, Ilse Krebs, Kerstin Steindl, Sarah Moussa, Eva Smretschnig, Susanne Binder(Vienna/A)

P-TU-177Correlation of OCT and intraoperative vitreouscharacteristics in full-thickness macular holes.Magdalena Tönz, Stephan Michels, Matthias Becker(Zurich/CH)

P-TU-178Correlation of Peripheral Findings in wide-field Fundusphotography and high-resolution OCT withthe Progression Rate in Areas of Geographic Atrophy due to dry Age-Related Macular Degenera-tionUte Wolf-Schnurrbusch, Simon Rothenbuehler,Volker Enzmann, Sebastian Wolf (Bern/CH)

P-TU-179Does Foveal Thickness Predict Microalbuminuria inDiabetics ?Wan Haslina Wah, Muhaya Mohamed (Kuala Lumpur/MAL)

P-TU-180Dynamic retinal vessel analysis – how different parameters create a whole pictureInes Lanzl, Konstantin Kotliar (Munich/D)

P-TU-181Effects of the intraocular dye brilliant blue mixedwith Glucose on the isolated superfused bovineretinaKai Januschowski, Sebastian Mueller, Jolene Hayes,Matthias Lüke, Peter Szurman (Tübingen/D,Lübeck/D)

P-TU-182Foveal Thickness and Diabetic Retinopathy in Type 2 Diabetes Mellitus: A Comparative Study inUniversiti Kebangsaan Malaysia Medical Centre(UKMMC), Malaysia.Wan Haslina Wah, Ropilah Abdul Rahman, Muhaya Mohamed (Kuala Lumpur/MAL)

P-TU-183Fundus autofluorescence imaging using ultra-wide-field scanning laser ophthalmoscopy in patientswith geographic atrophy secondary to age-relatedmacular degenerationKatharina Lammersdorf, Monika Fleckenstein,Frank G. Holz, Steffen Schmitz Valckenberg(Bonn/D)

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00

Post

ers

Tues

day,

8 Ju

ne

321321WOC® 2010

P-TU-202Long-term outcome and risk factors for recurrencein untreated patients with central serous chorioretinopathyAndrew Fok, Poemen Chan, Timothy Lai, Yolanda Yip, Dennis Lam (Hong Kong/HK)

P-TU-203Long-term follow-up of extrafoveal retinal holesfollowing internal limiting membrane peelingMira Ruppenstein, Thomas Ach, Stefan Dithmar(Heidelberg/D)

P-TU-204Microperimetric assessment of fundus alterationscharacteristic for Pseudoxanthoma ElasticumNina Peters, Robert P. Finger, Peter Charbel Issa,Hendrik P. N. Scholl, Frank G. Holz (Bonn/D)

P-TU-205Morphological and elecrophysiological changes ofretinal structure after treatement with Dipiperonshown by Fourier Domain OCTDaria Loos, Jens Huber, Patricia Kook, Chris P. Lohmann (Munich/D)

P-TU-206Relationship between retinal nerve fiber layer thickness and visual field function in HIV-infectedpatients without retinitisTiago Arantes, Claudio Garcia, Ivan MaynartTavares, Paulo Augusto Arruda Mello, Cristina Muccioli (Sao Paulo/BR)

P-TU-207Retinal phototoxicity after phacoemulsificationEva-Maria Lackner, Christoph Fidel Mayer, Andreas Wedrich (Graz/A)

P-TU-208Retinal transplantation therapy for rd1 miceMichiko Mandai, Kohei Homma, Masayo Takahashi(Kobe/J)

P-TU-209Risk Factors for Retinal Breaks in Patients withSymptom of FloatersApichart Singalavanija (Bangkok/T)

P-TU-210Study of vitreoretinal adhesion in exudative age-related macular degeneration treated with antiVEGFAndrea Diaz Barron, Mª Dolores Pilar Vicente Fernandez, Cristina Marín Lambies, Rosario FonsMartinez (Valencia/E)

P-TU-211Subconjunctival Reflux and Need for Paracentesisafter Intravitreal Injection of 0.1 ml Bevacizumab:Comparison between 27 gauge and 30 gauge NeedleAlireza Mirshahi, Katrin Lorenz (Mainz/D)

P-TU-193Outer photoreceptor layer thickness obtained byspectral domain optical coherence tomography innormal eyes and variable macular diseasesByung Ro Lee, Yong Woon Shin, In Seok Song,Yumi Song (Seoul/ROK)

P-TU-194Reproducibility of Fluorescence Lifetime Imaging(FLIM) at the Human Retina based on Multi-Exponential Component FitAlexander Dietzel, Matthias Klemm, Edgar Nagel,Dietrich Schweitzer, Jens Haueisen (Ilmenau/D)

P-TU-195Usefulness of monochromatic conversions to bluecomponent in digital color photographs in branchretinal vein occlusion.Takeya Kohno, Yoshio Okazaki, Manabu Yamamoto, Norito Miki, Hisashi Iwami, Makoto Yamaguchi, Shinsuke Ataka, Michiko Hirabayashi,Kunihiko Shiraki (Osaka/J)

Retina: Miscellaneous P44

P-TU-196Automatic Dosimetry Control for Gentle RetinalPhotocoagulationRalf Brinkmann, Kerstin Schlott, Stefan Koinzer,Lars Ptaszynski, Marco Bever, Alex Baade, ReginaldBirngruber, Johann Roider (Lübeck/D, Kiel/D)

P-TU-198Desferrioxamine Related Maculopathy after a singledoseMohamed Naved Abdul Karim, Satish Chadha,Delicia Jayakumar, Trudi Blamires (Kettering/UK)

P-TU-199Efficacy and ocular drug distribution using the dexamethasone intravitreal implant in a monkeymodel of macula edemaJames Burke, Ton Lin, Kai-Ming Zhang, WerhnerOrilla, Clayton Spada, Maria Escobar, CorineGhosn, Joan-En Chang Lin, Rhett M. Schiffman,Larry Wheeler, Scott M. Whitcup (Irvine/USA)

P-TU-200Endogenous Candida chorioretinitis in a healthy infantMakiko Ito, Tadashi Yokoi, Yuri Kobayashi, Sachiko Nishina, Noriyuki Azuma (Tokyo/J)

P-TU-201Estimation of the Incidence of Vascular Anomaliesin Eyes with Optic Nerve Head Drusen.Urszula Gajdzik-Gajdecka, Ewa Mrukwa-Kominek,Malgorzata Machalska, Jadwiga Pietrzycka, Magdalena Smuzynska (Katowice/PL)

Post

ers

Tuesday, 8 June 2010 15:30 - 17:00

Post

ers

Tues

day,

8 Ju

ne

322 WOC® 2010

Retina: Vascular Diseases P46

P-TU-220Adiponectin suppresses adherent leukocytes in retinal vessels induced by a high-fat diet.Yasuhiro Ito, Shintaro Nakao, Yoshihisa Okamoto,Souska Zandi, Hidenobu Tanihara (Kumamoto/J)

P-TU-221Bevacizumab (Avastin®) for ocular metastasis ofgastric cancerThoralf Wecke, Manuela Hinz, Christian Vorwerk,Wolfgang Behrens-Baumann (Magdeburg/D)

P-TU-222Capillary Nonperfusion in Vascularized Retina inAggressive Posterior Retinopathy of Prematurityand Efficacy of Preoperative Laser PhotocoagulationIncluding Vascularized Retina Posterior to the RidgeTadashi Yokoi, Makiko Ito, Sachiko Nishina, Yuri Kobayashi, Noriyuki Azuma (Tokyo/J)

P-TU-223Central vein occlusion and hypertensive crisiscaused by a previously unkown renal artery stenosisin a case of fibromuscular dysplasiaChristian Flöhr, Jörg Hattingen, Burkhard Wiechens(Hannover/D)

P-TU-224Cilioretinal arteries in diabetic eyes are associatedwith increased retinal blood flow velocity and occurrence of diabetic macular edemaGennady Landa, Richard Rosen, WendewesssenAmde, Jeanne Rosenthal, Joseph Walsh (New York/USA)

P-TU-225Clinically significant macular edema in diabetic patients with hypertensionNoriko Miyamoto, Kazuhiro Ishida, Yasuo Kurimoto(Kobe/J)

P-TU-226Coagulation disorders and the risk of retinal veinocclusion: a subgroup analysisClaudia Hattenbach, Inge Scharrer, Lars-Olof Hattenbach (Ludwigshafen/D)

P-TU-227Concentrations of unbound bevacizumab in theaqueous of untreated fellow eyes after a singleintravitreal injection in humansCarsten H. Meyer, Frank G. Holz, Tim U. Krohne(Bonn/D)

P-TU-228Correlation of leaking microaneurysms with retinalthickening in diabetic retinopathyLukas Reznicek, Marcus Kernt, Christos Haritoglou,Michael Ulbig, Anselm Kampik, Aljoscha Neubauer(Munich/D)

P-TU-212The occurrence of ptosis following posterior subtenons injection of triamcinolone acetonideHannah Sharma, Katie Isaac, Samer Elsherbiny(Birmingham/UK)

P-TU-213Treatment of peripapillary choroidal neovasculariza-tions in early childhoodMichael R. R. Böhm, Matthias Schmidt, Constantin E. Uhlig (Münster/D)

Retina: RPE Diseases P45

P-TU-214Changes in Macular Morphology and Functionafter Half Dose Verteporfin-PDT for Central SerousChorioretinopathyRuka Uetani, Kohei Ishikawa, Piao Chang-Hua, Yasuki Ito, Mineo Kondo, Hiroko Terasaki(Nagoya/J)

P-TU-215Characteristics of Vitelliform Macular Dystrophy in AdultsStefan J. Lang, Guido R. K. Kürzinger, Gabriele E. Lang (Ulm/D)

P-TU-216Correlation between retinal sensitivity, tested by microperimetry, and the status of underlyinginner/outer segment junctional photoreceptor layer,assessed by Spectral Domain Optical Coherence Tomography in Central Serous RetinopathyRichard Rosen, Gennady Landa, Joseph Nezgoda,Emily Su, Patricia Garcia, Alfonso Ponce, Thomas Muldoon, Ronald Gentile, Joseph Walsh(New York/USA)

P-TU-217One-year follow-up of iatrogenic iodate retinopathyLars Wagenfeld, Gisbert Richard, Oliver Zeitz (Hamburg/D)

P-TU-218Spectral Domain Optical Coherence Tomographystudy of morphological features of Stargardt’s Disease and its correlation with Central Visual FunctionMayuri Bhargava, Sribhargava Natesh, Naresh Kumar Yadav, Anand Vinekar, Rajani Battu,Shailaja L (Bangalore/IND)

P-TU-219The effect of acetazolamide treatment on cystoidmacular edema and visual function in retinitis pigmentosaAntje S. Bernd, Andreas Schatz, Bogomil Voykov,M. Dominik Fischer, Martin Wiesen, Ieva Sliesoraityte, Eberhart Zrenner (Tübingen/D)

Post

ers

Tues

day,

8 Ju

neTuesday, 8 June 2010 15:30 - 17:00

Post

ers

323323WOC® 2010

P-TU-238Intravitreal Bevacizumab in Macular Edema ofBranch Retinal Venous occlusionSatyen Deka (Guwahati/IND)

P-TU-239Is iris fixation of IOL in patients with aphakia anddiabetic retinopathy the right indication?Joerg Christian Schmidt (Marburg/D)

P-TU-240Low glomerular filtration rate is associated withmore advanced diabetic retinopathyVesna Jaksic, Milka Mavija, Svetislav Milenkovic,Ivan Stefanovic, Dijana Risimic (Beograd/SRB)

P-TU-241M3 muscarinic acetylcholine receptors mediatecholinergic responses in murine retinal arteriolesAdrian Gericke, Jan Sniatecki, EvgenyGoloborodko, Franz Grus, Jürgen Wess, NorbertPfeiffer (Mainz/D)

P-TU-242Monolateral macular hemorrhage in systemic lupuserythematosusOrlin Velinov, Michael Frosch, Constantin Uhlig(Münster/D)

P-TU-243Netrin-4 and Its Receptors Have an Impact onNeoangiogenesis in the Mouse RetinaSabrina Klein, Liang Yong, Irina Semkova, Elizabeth Abari, Kristina Schmidt, Norbert Kociok,Klaus Meyer, Wiliam J. Brunken, Manuel Koch, Antonia Joussen (Duesseldorf/D, New York/USA)

P-TU-244Patterns of macular edema in high resolution OCT scans and response to bevacizumab therapy inretinal vein occlusionMira Ruppenstein, Alexandra Hoeh, Karen Schaal,Thomas Ach, Stefan Dithmar (Heidelberg/D)

P-TU-245Predictors for Visual Outcome after Anti-VEGF Therapy of Central Retinal Vein Occlusion andBranch Retinal Vein OcclusionUte Wolf-Schnurrbusch, Carsten Framme, Simon Rothenbuehler, Sebastian Wolf (Bern/CH)

P-TU-246Retinal microglia in the mouse model of oxygen-induced retinopathyFranziska Fischer, Gottfried Martin, Hansjürgen Agostini (Freiburg/D)

P-TU-247Retinal vasculitis as a paraneoplasic syndrome inthe context of a gastric adenocarcinomaPurificacion Piñas Garcia, Luis Castillon Torre, Francisco Javier Hernandez Martinez (Sevilla/E)

P-TU-229Correlation of macular pigment distribution in type2 idiopathic macular telangiectasia and morpho-logic abnormalities detected by spectral-domainOCTMiki Sawa, Yuzuru Sasamoto, Motokazu Tsujikawa,Fumi Gomi (Suita/J)

P-TU-230Diabetic retinopathy and maculopathy in metabolicsyndromeMilka Mavija, Zoran Mavija, Vesna Jaksic, SvetislavMilenkovic, Dijana Risimic, Tanja Veselinovic, Natalija Kosanovic-Jakovic (Banjaluka/BIH,Beograd/SRB)

P-TU-231Dysregulation of Bone Marrow Derived EndothelialProgenitor Cell Bioactivity via VEGF Triggers Abnormal Vascular Development of MurineRetinopathy of PrematurityYoshihiro Nakagawa, Masuda Haruchika, Rie Ito,Takahiro Suzuki, Kenji Kawai, Takayuki Asahara (Isehara/J)

P-TU-232Effect of Intravitreal Angiogenesis Inhibitors on Hyperreflective Exudative Foci in Diabetic MacularEdema Documented by Optical Coherence TomographyChristoph Mitsch, Berthold Pemp, Gabor Deak,Sonja Prager, Gerald Schmidinger, ChristophScholda, Matthias Bolz, Ursula Schmidt-Erfurth (Vi-enna/A)

P-TU-233Effect of intravitreal bevacizumab on retinal vein diameter in branch retinal vein occlusionTomohiro Otani, Yumiko Yamaguchi, Shoji Kishi(Maebashi/J)

P-TU-234Effect of nutrition on development of cataract anddiabetic retinopathy in type II diabetic rat modelHeeyoon Cho, Yunjeong Lee, Yeonhee Noh(Kyungggi-do/ROK)

P-TU-235Extensive internal limiting membrane peeling andgas tamponade for submacular hemorrhage associ-ated with ruptured retinal arterial macroaneurysmShigeki Suzuki (Kounosu/J)

P-TU-236Haemodilution Therapy in Central Retinal Vein OcclusionJens Ulrich Werner (Ulm/D)

P-TU-237In vivo OCT characterization of ischemic retina indiabetic retinopathyLukas Reznicek, Marcus Kernt, Christos Haritoglou,Anselm Kampik, Michael Ulbig, Aljoscha Neubauer(Munich/D)

Post

ers

Post

ers

P-TU-248Risk evaluation in patients with acute non-arteriiticcentral retinal artery occlusionStefanie Pantenburg, A. Pielen, B. Junker, A. Wolf,B. Jurklies, K. Kampik, N. Feltgen (Goettingen/D,Essen/D, Wuerzburg/D)

P-TU-249Role of Intravitreal Bevacizumab in Diabetic Vitreous HemorrhageSatyen Deka (Guwahati/IND)

P-TU-250Spontaneous exophthalmus due to a carotid sinuscavernosus fistula – successful interventionell treatment with GDC coils in three patientsJörg Hattingen, Jan Köhler, Richard Glombik, Andreas Schwartz, Ekkehard Gmelin, BurkhardWiechens (Hannover/D)

P-TU-251Systemic diseases associated with central retinalvein occlusionMarianne Shahsuvaryan (Yerevan/ARM)

P-TU-252The association between the oxidative stress-related gene polymorphisms and the diabeticretinopathy in Type2 DiabetesShinko Nakamura, Shigehiko Kitano (Tokyo/J)

P-TU-253The characteristics of acute retinal necrosis with optical coherence tomographyLi Juanjuan (Kunming/CN)

P-TU-254The effect of placental growth factor splice variantson the neovascularization in the mouse retinaNorbert Kociok, Daniel Hoffmann, Elizabeth Abari,Sabrina Klein, Kristina Schmidt, Sabine Eming, Antonia Joussen (Duesseldorf/D, Berlin/D)

P-TU-255The effects of Intravitreal Bevacizumab for cystoidmacular edema (CME) due to retinal vein occlusionsMehrdad-Sam Attaran (Hannover/D)

P-TU-256The Roles of Artery-vein Relation of an Arteriove-nous Crossing and Vein Bifurcation in Branch Retinal Vein OcclusionQingyuan Liang (Toronto/CDN)

P-TU-257The use of intravitreal bevacizumab in Coats patientsChoi Mun Chan (Singapore/SGP)

P-TU-258Time course of the effect of bavacizumab on macular edema in central retinal vein occlusionMehrdad-Sam Attaran (Hannover/D)

Vision 2020 – Prevention of Blindness P47

P-TU-259Case Study-Short term Impact and lessons of a systematic eye care development interventionKolawole Ogundimu, Elizabeth Elhassan, Suleiman Buhari (Accra7GH)

P-TU-260Community eye health of Pediatric age group in the slums area of one of the Metropolis of Eastern IndiaKhandkar Fariduddin (Kolkata/IND)

P-TU-261Five Year Cataract Surgical Rate in Shanghai, China from 2005 to 2009Jianfeng Zhu (Shanghai/CN)

P-TU-262Outcome of trachoma treatment in chidren andtheir families from a public school – Barbalha City,Ceará, BrazilVitor Luna De Sampaio, Clarice Maria Pinheiro Callou, Carlos Teixeira Brandt, Luíza Stella CorreiaFerreira, Eduardo José Pinheiro Callou (Barbalha/BR)

P-TU-263Preoperative Visual Acuity of Eyes UndergoingCataract Surgery in Rural and Urban NepalReeta Gurung, Mohan Krishna Shrestha, AndreasMueller, Sanduk Ruit (Kathmandu/NEP)

P-TU-264Prevention of Diabetic Blindness in Rural China by Multiple ApproachesZhizhong Ma (Beijing/CN)

P-TU-265Tibet's (almost) forgotten children – How a blindperson made blind children readSibylle Scholtz, Gerd U. Auffarth (Ettlingen/D, Heidelberg/D)

Tuesday, 8 June 2010 15:30 - 17:00Tu

esda

y, 8

June

324 WOC® 2010

325WOC® 2010

Adm

inis

trat

ive

Mee

tingsAdministrative

MeetingsThursday, 3 June 2010

14:00 – 16:00 VOL-SitzungSalon 21

15:00 – 17:00 TropfschulungSalon 22

17:30 – 18:30 Initiativkreis Glaukom des BVASalon 22

Friday, 4 June 2010

12:15 – 13:45 Meeting der Initiativgruppe zur Früherkennung diabetischer Augenerkrankungen (IFdA)Salon 19

16:00 – 17:30 Sitzung der Kommission QualitätssicherungSalon 21

11:30 – 13:30 Arbeitskreis klinischer Fragen des wissenschaftlichen Beirats der Pro Retina Deutschland e.V.Salon 22

14:00 – 15.30 17. Arbeitstreffen der Sektion DOG-Ophthalmo-plastische und rekonstruktive ChirurgieSalon 22

18:00 – 20:00 Arbeitskreis Psychosomatik in der AugenheilkundeSalon 22

12:30 – 14:00 Vorstandsitzung der Retinologischen GesellschaftRaum 46

16:30 – 17:00 Sitzung der Sektion DOG-NeuroophthalmologieRoom 46


14:00 – 17:00 ICO World Ophthalmology Roundtable on Leadership Development (WORLD) and ICO General AssemblyHall 7

07:15 – 14:00 AOI Meeting and LuncheonRadio Tower Lounge 1

12:15 – 13:45 Mitgliederversammlung der Sektion DOG-KorneaVIP Lounge 1

14:00 – 15:30 Arbeitsgruppe Internet und medizinische InformationsverarbeitungSalon 11/12

16:00 – 18:00 Sitzung der Sektion DOG-Gewebetransplantation und BiotechnologieSalon 11/12

12:30 – 13:30 Mitgliederversammlung der Bielschowsky-GesellschaftSalon 13/14

12:30 – 13:45 Sitzung der Sektion DOG-GlaukomSalon 15/16

16:30 – 18:00 Meeting der Deutschen Ophthalmologischen ChefärzteRoom 56

Sunday, 6 June 2010

08:00 – 11:00 Meeting BVA-LeitlinienkomissionSalon 20

12:00 – 13:30 Sitzung der Sektion DOG-Internationale OphthalmologieSalon 20

10:00 – 15:00 Meeting Augenärztegenossenschaft Brandenburg e. G.Room 24

12:00 – 14:00 Sitzung der MakulakommissionSalon 22

326 WOC® 2010

Adm

inis

trat

ive

Mee

tings Administrative

Meetings09:00 – 10:00 Studientreffen zur FANCY-Studie

Room 4512:00 – 13:45 ICO Education Committee

Room 46

Monday, 7 June 2010

06:30 – 08:15 World Ophthalmic Education ColloquiumHall 7 (only upon invitation)

12:15 – 13:45 General Assembly of the DOGHall 4/5

12:00 – 13:45 ICO Fellowships Alumni ReceptionSalon 11/12

08:30 – 10:00 Treffen der Woche des SehensSalon 19

10:30 – 12:30 Treffen der Vision 2020 InitiativgruppeSalon 19

14:00 – 15:30 Mitgliederversammlung der Sektion Uveitis der DOGSalon 19

09:30 – 12:00 Herausgebersitzung Der Ophthalmologe 2010Salon 20

14:00 – 15:30 Kommissionssitzung Refraktive ChirurgieSalon 20

16:00 – 17:30 EBO Executive BoardSalon 20

14:30 – 15:30 Uveitis Award 2010Salon 21

16:00 – 17:00 General Assembly European Vision InstituteSalon 21

12:30 – 13:30 EVICR.net MeetingSalon 22

14:30 – 16:00 Meeting Steering Committee European Vision InstituteRoom 37

14:00 – 16:00 ICO Advisory Group on Sub-Saharan AfricaRoom 45

Tuesday. 8 June 2010

14:00 – 18:00 Meeting der International Agency for the Prevention of BlindnessSalon 20


11:30 – 13:00 Award Ceremony and Handover of DOG Presidency Roof Garden

Com

pany

Sym

posi

a

327WOC® 2010

In Alphabetical Order of Company Names

Aeon Astron Breakfast Symposium

Saturday, 5 June 2010 07:15 – 08:15 Hall 9

Can MMC be replaced?ologen® for eye tissue repair

Chair: Julio Lin, VP, Aeon Astron Europe B.V.

07:15 - 07:20 Opening Michael Lai, CEO, Aeon Astron Europe B.V.

07:20 - 07:35 Introduction of ologen® Collagen Matrix Jessie Ni, PhD, Aeon Astron Europe B.V.

07:35 - 07:50 500 Experiences with ologen® Collagen Matrix in TrabeculectomyProf. Markus Kohlhaas, MD, Germany

07:50 - 08:05 Use of ologen® Collagen Matrix in Strabismus Sur-geryProf. Emilio C. Campos, MD, Italy

08:05 - 08:15 General Discussion Julio Lin, VP, Aeon Astron Europe B.V.

Alcon Lunch Symposium

Saturday, 5 June 2010 12:30 – 13:30Hall 2

Changing the Standard of Care in Cataract Surgery

Chair: Prof. Rudy M.M.A. Nuijts

Prevalence of Astigmatism and Impact on VisionProf. James Wolffsohn, United Kingdom

Management of Astigmatism in Cataract SurgeryProf. Peter Szurman, Germany

Practical Experience with ACRYSOF® ToricProf. Rudy M.M.A. Nuijts, Netherlands

Integrating ACRYSOF® Toric in Your Daily PracticeDr. Bret Fisher, United States

Changing the Cataract Surgery Standard of Care:The Belgium CaseProf. Philippe Kestelyn, Belgium

Alcon Lunch Symposium

Sunday, 6 June 2010 12:30 – 13:30Hall 2

Individualizing The Management of Glaucoma

Moderators: Prof. Kuldev Singh, USA Prof. Norbert Pfeiffer, Germany

Patient Profiling to Individualize Glaucoma TherapyDr. Francisco Goñi, Spain

Clinical Trial Results: Travoprost Timolol Fixed CombinationProf. Norbert Pfeiffer, Germany

New Fixed Combination Therapeutic offeringsProf. Gábor Holló, Hungary

Alternative Preservatives in Topical Glaucoma MedicationsProf. Christophe Baudouin, France

Glaucoma Surgery with Ex-PRESS® Mini GlaucomaShunt Prof. Carlo E. Traverso, Italy

Allergan Lunch Symposium


RetinaNew Approaches to the Management of MacularEdema

Chairs: Prof A. Kampik, MD/ Prof. G. Coscas, MD

12:30 – 12:32Introduction and WelcomeProf. A. Kampik, MD

12:32 – 12:43Inflammation – A Major Contributor to the Etio-logy of Macular EdemaProf. G. Soubrane, MD PhD

12:43 – 12:54Steroids in the Management of Macular EdemaYoung Hee Yoon, MD

12:54 – 13:06New Options for the Management of MacularEdemaDr. J. A. Haller, MD

13:06 – 13:18Steroids in the Management of UveitisProf. S. Lightman, MD PhD

327

Com

pany

Sym

posi

a

WOC® 2010

13:18 – 13:30Management of Macular Edema in Clinical Practice – Combination Treatment (an option forthe future)Dr. A. Loewenstein, MD

Allergan Breakfast Symposium

Monday, 7 June 2010 07:15 – 08:15Hall 4/5

Glaucoma Symposium Optimal Glaucoma Management

Chairs: Prof. Anders Heijl, MD/ Prof. Remo Susanna Jr, MD

07:15 Introduction and WelcomeProf. Anders Heijl, MD / Prof. Remo Susanna Jr, MD

07:18Optimal Glaucoma Management – the Patient inFocus Prof. Remo Susanna Jr, MD

07:31Rate of Progression – a Measure for Optimal Management of our Glaucoma Patients Prof. Anders Heijl, MD

07:44Successfully Optimizing First Line Therapy in GlaucomaProf. David B. Yan, MD

07:57Optimal Glaucoma Management – is Fixed combination the Solution for the Progressing Patients?Prof. Luca Rossetti, MD

08:10ClosureProf. Anders Heijl, MDProf. Remo Susanna Jr, MD

Bausch + Lomb Surgical

Saturday, 5 June 2010 12:30 – 13:30Bausch+Lomb-Stand, 12 A/16

Meet the expert – Meet Stellaris PC

Bausch + Lomb Lunch Symposium

Friday, 4 June 2010 12:30 – 13:30Hall 8

Circle of Nutritional CompetenceAMD und Mikronährstoffe: Stand der Wissenschaftund welchen Einfluss haben sie?(AMD and micronutrients - status quo in scienceand their influence)

Chair: Prof. Dr. Ulrich Welge-Lüßen, Erlangen

1. "Oxidativer Stress in der Pathogenese der AMDund der Einfluss von Mikronährstoffen" Prof. Dr. Ulrich Welge-Lüßen, Erlangen

2. „Klinische Evidenz für den Einsatz von Mikronähr-stoffen bei AMD – ein aktueller Überblick“ PD Dr. Erdem Ergun, Wien

3. „Welche Rolle spielen genetische Faktoren bei AMD und können Mikronährstoffe diese positiv beeinflussen?“Prof. Dr. André Reis, Erlangen

Bausch + Lomb Lunch Symposium

Sunday, 6 June 2010 12:30 – 13:30Hall 4/5

Inflammation following standard cataract surgery – is it still an issue?

Welcome & IntroductionChair: Prof. Dr. Jorge Alio, Spain

Prevention of serious infection and inflammationfollowing standard cataract surgeryProf. Dr. Uwe Pleyer, Germany

Early detection and treatment of endophthalmitisProf. Dr. Jorge Alio, Spain

Prevention and treatment of cystoid macular oe-dema following cataract surgery David Spalton, UK

Concluding remarks Prof. Dr. Jorge Alio, Spain

328

Com

pany

Sym

posi

a

329329WOC® 2010

BAYER Schering Pharma Lunch Symposium

Sunday, 6 June 2010 12:30 – 13:30Hall Oslo

An Update on VEGF Trap-Eye

Chairs: Frank Holz (Germany), Ursula Schmidt-Erfurth(Austria)

Introduction

Biology of VEGF Trap-EyeGeorges von Degenfeld (Germany)

Phase II results in AMDPeter Kaiser (USA)

Phase III trials in AMDYuichiro Ogura (Japan)

Development for other indicationsJost B. Jonas (Germany)

Summary

Chibret Lunch Symposium

Friday, 4 June 2010 12:45 – 13:45Hall 4/5

Ohne BAC zum Therapiererfolg - die Kunst desWeglassens

Chair: Prof. Dr. Günther K. Krieglstein

Talk 1: Zur Logik der Konservierungsstoff-FreiheitProf. Dr. Günther K. Krieglstein, Germany

Talk 2: Vorteile von konservierungsmittelfreien Antiglau-komatosa für Augenärzte und PatientenPD Dr. Elisabeth M. Messmer, Germany

Talk 3: Konservierungsmittelfreie Glaukomtherapie: fürwen ist sie notwendig und sinnvoll?Prof. Dr. Norbert Pfeiffer, Germany

GEUDER LS Lunch-Symposium

Saturday, 5 June 2010 12:30 – 13:30Hall Stockholm

GEUDER Lunch-Symposium

1. Patient-focused refractive Micro-Incisional CataractSurgeryBest practices and insider tips to increase patient’ssatisfaction Prof. Gerd U. Auffarth, MD

2. Sutureless Vitrectomy with UnoColorline TrocarSystem and Hattenbach Screw-Cut Technique First encouraging experiences with the new screw-cut technique for self-sealing transcon-junctival sclerotomies Prof. Lars-Olof Hattenbach, MD

3. Endotamponades: Air, Gas or Silicone Oil? Indications, Contraindications and Best PracticesFine-needle aspiration biopsy of intraocular tumors: new toolsDavid E. Pelayes MD, PhD

HeidelbergEngineering Lunch Symposium

Sunday, 6 June 2010 12:30 – 13:30Hall Stockholm

HeidelbergEngineering Lunch Symposium: Eye to Eye

Chair: Dr. Stephan Schulz

Multimodal imaging in wet AMD

Blue Laser Fundus autofluorescence imaging in advanced dry AMD – new concepts for emergingtherapies

Heidelberg Edge Perimeter (HEP) in clinical practice

Definition of glaucomatous progression in structural and functional imaging

Com

pany

Sym

posi

a

330 WOC® 2010

MERCK Lunch Symposium (German)

Friday, 4 June 2010 12:30 – 13:30Hall 4/5

Ohne BAC zum Therapiererfolg – die Kunst desWeglassens

Talk 1: Das eine tun, ohne das andere zu lassen: Erhalt desGesichtsfeldes und der Augenoberfläche bei Glaukompatienten"N.N.

Talk 2: Konservierungsmittelfreie Glaukomtherapie: fürwelche Patienten sind BAC-freie Präparate sinnvoll?N.N.

Talk 3: Vorteile von konservierungsmittelfreien Antiglaukomatosa für Augenärzte und Patienten N.N.

MERCK Lunch Symposium (International)


"Preservative Free Therapy: Addressing UnmetNeeds in the Treatment of Glaucoma" Chair: Dr. Robert Weinreb, US

Talk 1:Ocular Surface Disease and the Effects of Preserved Glaucoma TreatmentsDr. Malik Kahook, US

Talk 2: Prevalence of Ocular Surface Disease in GlaucomaPatientsDr. Robert Weinreb, US

Talk 3: Introducing a Novel Preservative Free GlaucomaTreatmentDr. Carlo Traverso, Italy

Talk 4: Tafluprost Phase IIIb Clinical ReviewDr. Norbert Pfeiffer, Germany

MERCK Evening Symposium (International)

Sunday, 6 June 2010 18:00 – 19:00Hall 3

Current concepts and new data for the management of glaucoma in the 21st century

Chair:Dr. Norbert Pfeiffer, Germany

Talk 1: Managing risk factors of the patient with uncontrolled IOPDr. Stefano Miglior, Italy

Talk 2: Understanding 24-hour IOP fluctuation: new dataon known glaucoma therapies Dr. Tasos Konstas, Greece

Talk 3: Predictors of visual field progression Dr. Antonio Martinez, Spain

Talk 4: Preserving eye health with preservative-free glaucoma therapiesDr. Cindy Hutnick, Canada

MSD Ophthalmics Lunch Symposium

Saturday, 5 June 2010 12:10 - 13:00Hall 3

Preservative Free Therapy: Addressing UnmetNeeds in the Treatment of Glaucoma

Chair: Dr. Robert Weinreb, US

Talk 1: Ocular Surface Disease and the Effects of PreservedGlaucoma Treatments Dr. Malik Kahook, US

Talk 2: Prevalence of Ocular Surface Disease in GlaucomaPatientsProf. Dr. Robert Weinreb, US

Talk 3: Introducing a Novel Preservative Free GlaucomaTreatmentDr. Carlo Traverso, Italy

Talk 4: Tafluprost Phase IIIb Clinical ReviewProf. Dr. Norbert Pfeiffer, Germany

Com

pany

Sym

posi

a

331331WOC® 2010

MSD Ophthalmics Evening Symposium

Sunday, 6 June 2010 18:00 - 19:30Hall 3

Current concepts and new data for the manage-ment of glaucoma in the 21st century

Chair: Prof. Dr. Norbert Pfeiffer, Germany

Talk 1: Managing risk factors of the patient with uncontrolled IOPDr. Stefano Miglior, Italy

Talk 2: New Clinical Evidence on 24-Hour IOP Manage-ment Prof. Dr. Tasos Konstas, Greece

Talk 3: Predictors of visual field progressionDr. Antonio Martinez, Spain

Talk 4: Preserving eye health with preservative-free glaucoma therapiesDr. Cindy Hutnick, Canada

NOVARTIS Lunch Symposium

Sunday, 6 June 2010 12:30 – 13:30Hall Abu Dhabi

Improving vision for patients with DME: New Compelling Evidence

Chair: Gabriele Lang, Germany

12:30 Epidemiology & current evidence for treatmentsuccess of ranibizumab in diabetic macular edemapatients in the Phase II RESOLVE study (includingQ&A) Gabriele Lang, Germany

12:40 Improving vision with ranibizumab in patientswith diabetic macular edema in the Phase III RESTORE study (including Q&A) Paul Mitchell, Australia

13:05 Further clinical trial evidence of treating patientswith diabetic macular edema (including Q&A) Neil M. Bressler, USA

NOVARTIS Lunch Symposium

Friday, 4 June 2010 13.00 – 14.00Hall Stockholm

Therapie neovaskulärer Erkrankungen:AMD-Therapie unter real life Bedingungen / DMEund RVO – Aufbruch zu neuen Ufern

Vorsitz: Prof. Anselm Kampik, München

BOON – ein integratives Monitoring-Model für intravitreale InjektionstherapienProf. Nicole Eter, Bonn

Ranibizumab-Therapie bei neovaskulärer AMD:Neue Ergebnisse der WAVE-StudieDr. Robert Finger, Bonn

Therapie des diabetischen Makulaödems – aktuelleAspekte und Ergebnisse der RESTORE StudieProf. Antonia Joussen, Charité Berlin

Anti-VEGF Therapie und Laserkoagulation bei Venenastverschlüssen – Beobachtungen aus derBranch Retinal Vein Occlusion Associated MacularEdema Studie (R.A.B.A.M.E.S.)Prof. Lars-Olof Hattenbach*, Ludwigshafen

*Weitere Autoren: Feltgen N, Pielen A, Hansen LL, Lorenz K, Pfeiffer N,Hoerauf H, Jünemann C, Höhn F, Kreutzer T, Priglinger S, Mirshahi A

OCULUS Breakfast Symposium

Sunday, 6 June 2010 07:15 – 08:15 Hall 7

Corneal measurement for keratoconus detection

New methods of evaluation of anterior segmentdata for keratoconus detection, refractive procedu-res as well as for glaucoma specialists are demons-trated. The results of a preliminary study are presented.Prof. Dr. Renato Ambrósio Jr., Brasil

Com

pany

Sym

posi

a

332 WOC® 2010

OCULUS Lunch Symposium

Friday, 4 June 2010 12:45 – 13:45Hall 7

Die OCULUS Pentacam und das Nidek OCT –Innovative Diagnostik im täglichen Einsatz

12:45 Uhr: Premiumdiagnostik mit der OCULUS PentacamDr. Alexander Petzold, Leipzig

13:15 Uhr: Die optische Kohärenztomografie (OCT) in der augenärztlichen Praxis Dr. Gernot Petzold, Kulmbach

Pfizer Breakfast Symposium

Monday, 7 June 2010 07:15 – 08:15Hall Sao Paulo

Patient Perspective on DME:Maximizing Quality of Life in the Management ofDiabetic Macular Edema (DME)

Chair: Rohit Varma, MD, MPH

07:15 – 07:25: Chair's Welcome and IntroductionRohit Varma, MD, MPH

07:25 – 07:30: Living with DME: A Patient Testimony

07:30 – 07:50: Evaluating the Whole Patient: OME, Quality of Lifeand Associated ComorbiditiesSeenu M. Hariprasad, MD

07:50 – 08:10: Economic Burden of DME: A UK PerspectivePeter H. Seanlon, MBBS, FRCP, DCH

08:10 – 08:15: Concluding Remarks and QuestionsRohit Varma, MD, MPH

Pfizer Lunch Symposium

Saturday, 5 June 2010 13:10 – 14:00Hall Sao Paulo

Glaucoma – The Linkage between Function,Functioning and Quality of Life

Chair: Norbert Pfeiffer, MD

12:30 – 12:35: Chair's Welcome and IntroductionNorbert Pfeiffer, MD

12:35 - 12:45: Structure and FunctionRobert N. Weinreb, MD

12:45 – 13:00: Vision Functioning (Observed)George l. Spaeth, MD

13:00 – 13:10: Patient-Reported FunctioningRohit Varma, MD, MPH

13:10 - 13:20 Management DecisionsIvan Goldberg, MB, BS, FRANZCO, FRACS

13:20 – 13:30 Concludlng Remarks and QuestionsNorbert Pfeiffer, MD

Pfizer Evening Symposium

Sunday, 6 June 2010 18:00 – 19:30Hall Sao Paulo

A Fresh Look at DME: An Interactive Discussion onInterdisciplinary Management of Diabetic MacularEdema (DME)

Chair: Tien Wong, MD, MPH, PhD

18:00 – 18:15: Chair’s Welcome and IntroductionTien Wong, MD, MPH, PhD

18:15 – 18:35: Evaluating DME and Associated Comorbidities: A Comprehensive Clinical ApproachMassimo Porta, MD, PhD

18:35 – 18:55: Current Management of DME: Monitoring ProgressionUrsula Schmidt-Erfurth, MD

18:55 - 19:15:Current Management of DME: Treatment

ConsiderationsLloyd P. Aielto, MD. PhD

19:15 – 19:30: Is Current Management Effective?Tien Wong, MD, MPH, PhD

Com

pany

Sym

posi

a

333333WOC® 2010

SANTEN Lunch Symposium

Sunday, 6 June 2010 12:30 – 13:30Hall 3

Progress in Glaucoma Management: where are we now?

Chair: Prof. Migdal

Is glaucoma screening effective? Prof. Dr. N. Pfeiffer

Dry eye, glaucoma and eye dropsProf. Dr. Christophe Baudouin

Further IOP reduction within the normal range -the role of prostaglandins in NTGProf. Dr. M. Aihara

How do preservative-free prostaglandins compare? – a clinical overviewProf. Dr. Lutz E. Pillunat

SANTEN Lunch Symposium

Monday, 7 June 2010 12:30 – 13:30 Hall 7

LEVOFLOXACIN in the Prevention and Treatment of Ocular Infections

Chair: Prof. Richard L. Abbott

Ocular Pharmacokinetics: Principles and Fluorocinolole Related ImplicationsProf. Urtti

The treatment of bacterial keratitisProf. Richard L. Abbott

The influence of fluoroquinolones on corneal endothelial cellsProf. Oshika

Prevention of endophthalmitis in cataract surgeriesDr. Chan

Zeiss Breakfast Symposium

Sunday, 6 June 2010 07:15 – 08:45 Roof Garden

New Frontierts in OCT Imaging

Chair: José Cunha-Vaz, MD, PhD

Change Analysis: Using OCT to manage MacularDisease"José Cunha-Vaz, MD, PhD

Visualizing the Vitreoretinal Interface with OCT:Understanding the Role of Epiretinal Membranesin Retinal Disease.Alain Gaudric, MD

New OCT Applications for Glaucoma: Optic NerveHead Analysis and RNFL ProgressionGiacomo Savini, MD

Learn how the experts apply the new featuresfrom Cirrus HD-OCT to optimize daily clinicalcare. The panelists will discuss how HD-OCT is providing more and better information for the diagnosis and management of retina and glaucoma disease.

Zeiss Lunch Symposium

Friday, 4 June 2010 12:30 – 13:30 Roof Garden

AAD/DOG Lunch Symposium – Zukunft willkom-men! Die Grundsäulen einer erfolgreichen Augen-arztpraxis

Chair: Dr. Martin A. Zeitz, Henning Goebel

Speakers:Dr. Martin A. Zeitz, optimed GmbH Düsseldorf Henning Goebel, optimed GmbH Düsseldorf

Der Gesundheitsmarkt ändert sich rasant. Hier-durch entstehen nicht nur Risiken, sondern auchChancen für die Augenärzte. Die politischen Rah-menbedingungen und der zunehmende Wettbe-werb machen es erforderlich, die Weichen jetztrichtig zu stellen und die eigene Praxis fit für dieZukunft zu machen.Erfahren Sie im Zeiss-Lunchsymposium, wie SieIhre Augenarztpraxis erfolgreich positionieren können:Strategieentwicklung, Workflow-Optimierungsowie Marketing und Servicequalität werden darüber entscheiden, ob Ihr „Unternehmen Augen-arztpraxis“ in fünf Jahren zu den Gewinnern oderden Verlierern zählen wird.

Com

pany

Sym

posi

a

WOC® 2010


Saturday, 5 June 2010 12:30 – 13:30 Roof Garden

Cataract Workflow Innovations

Chair: Wolfgang Haigis, PhD

Modern Biometry for the Problems of today and tomorrowWolfgang Haigis, PhD

Clinical Experience with the new IOLMaster 500Oliver Findl, MD

Innovative Management of Astigmatism Cor-rection with ZEISS Toric SolutionDominique Piétrini, MD

How to improve Outcomes and optimize SurgicalWorkflow with the Monofocal Aspheric CT AS-PHINA 613P Preloaded IOL and the SkyJet AdvancedInjector in small IncisionsNN


Monday, 7 June 2010 12:30-13:30 Roof Garden

ReLEx and Laser Blended Vision - the start of a newera in refractive surgery

Chair: Dan Reinstein, MD

Laser Blended Vision – the Safest and Most Effective Solution for Emmetropic, Myopic and Hyperopic PresbyopiaDan Reinstein, MDPatient Satisfaction after Laser Blended VisionPeter Brincker, MD

ReLEx – a New Method of Laser Vision CorrectionEntered the MarketJesper Hjortdal, MD

Femtosecond Lenticule Extraction in HyperopicCases – Where are we today?Marcus Blum, MD

Minimally Invasive ReLEx Procedures in Low, Moderate and High MyopiaRupal Shah, MD

Ocular Wavefront Changes after ReLEx ProceduresIgor Solomatins, MD

Come and see two exciting topics introduced byCarl Zeiss.

With ReLEx a unique method of vision correctionby femtosecond-only laser application is now avai-lable. Its current application and also future poten-tial will be addressed. Laser Blended Vision provides age optimized treat-ment as a new option of the MEL 80 / CRS-Masterplatform. Very well received by the surgeons, wewill hear about its results and patient satisfaction.

ZIEMER Breakfast Symposium

Saturday, 5 June 2010 07:15 – 08:15 Hall 8

GALILEI USER MEETING

Chair: Dr. Jennifer Lewis

07:15 - 07:30Highlights of GALILEI Software and Showcase ofGALILEI Presentations at the ASCRS 2010Jennifer Lewis, PhD

07:30 - 07:45Clinical Applications of the GALILEI (Keratoconus,Refractive Surgery and Lamellar Surgery)Pavol Vesely, MD

07:45 - 08:00GALILEI in a Refractive Practice: Identification of Keratoconus Suspects and other risk cases. Comparison of available methods.Markus Pölzl, MD

08:00 - 08:15Discussion

The symposium is open for all WOC/DOG atten-dees interested in the GALILEI Dual ScheimpflugAnalyzer.

334

Oth

er S

ympo

sia

(in G

erm

an)

335WOC® 2010

Patientensymposium des Deutschen Blinden- undSehbehindertenverbandes und des AllgemeinenBlinden- und Sehbehindertenvereins Berlin:Risiken, Forschung, Therapien – die Augenheil-kunde im Jahr 2010This Symposium will be held in German

Raum StockholmDonnerstag, 3. Juni 2010 09:00-13:00 Uhr

Patientensymposium

Prof. Dr. Carl Erb, Schlosspark-Klinik BerlinProf. Dr. Nicole Eter, Universitäts-Augenklinik BonnDr. Robert Finger, Universitäts-Augenklinik BonnDr. Christine Stamm, Beratungsstelle für Sehbehin-derte Berlin

Kursinhalte

Moderation: Dr. Christine Stamm

09:00 Uhr Begrüßung

09:05 Uhr Prof. Dr. Carl Erb, Schlosspark-Klinik Berlin Allgemeinerkrankungen und ihre Auswirkungenauf das Auge

10:00 Uhr Dr. Robert Finger, Universitäts-Augenklinik Bonn:Der Weltkongress der Augenheilkunde in Berlin –zum Stand der Forschung zur Verhütung von Blind-heit im Jahr 2010

10:45 Uhr Pause

11:15 Uhr Prof. Dr. Nicole Eter, Universitäts-Augenklinik Bonn: Neue Therapien zur Behandlung der Makula-Degeneration – neue Hoffnung?

12:15 Uhr Fragen und Antworten

13:00 Uhr Ende der Veranstaltung

Maximale Teilnehmerzahl: 350

Anmeldung erforderlich unter Tel. 030 / 895 88-0(Allgemeiner Blinden- und SehbehindertenvereinBerlin)

Teilnahmegebühren: keine

Symposium FR-01 zur Verleihung des Sicca-Förderpreises 2010 desRessorts Trockenes Auge im BVA: Aktuelle Forschung zum Trockenen AugeThis Symposium will be held in German

Sao PauloFriday, 4 June 2010 11:00 - 13:30

Der Sicca-Förderpreis des Ressorts Trockenes Augeim BVA in einer Gesamthöhe von 20.000 Euro wird nun mittlerweile seit 10 Jahren von Bausch &Lomb | Dr. Mann Pharma Berlin gestiftet. Er dientder Unterstützung, Motivation und interdisziplinä-ren Zusammenarbeit junger Forscherinnen undForscher im deutschsprachigen Raum auf diesem Sektor. Im Rahmen des Symposiums werden aktu-elle Forschungsprojekte zum Trockenen Auge undErkrankungen der Augenoberfläche präsentiert.

Chairs:Horst Brewitt (Hannover/D)Thomas Kaercher (Heidelberg/D)

11:00 IL FR-01-01Kultivierung und Charakterisierung adulterStammzellen der TränendrüsePhilipp Ackermann (Halle/Saale)

11:05 IL FR-01-02Osmolarität des Tränenfilms bei Augengesundenund Patienten mit Trockenem AugeMeral Bulgen, Elisabeth M. Messmer (München)

11:10 IL FR-01-03Behandlung von Patienten mit Keratokonjunktivi-tis sicca mit AugenakupunkturAnna Cucera (Ulm)

11:15 IL FR-01-04Die Relevanz von Harnstoff im Tränenfilm bei derPathogenese der Konjunctivitis siccaMatthias Dunse (Halle/Saale)

11:20 IL FR-01-05Untersuchungen zur Wirkung von Kräften der extrazellulären Umgebung auf Wachstum und Differenzierung von humanen CorneazellenPhilipp Eberwein (Freiburg)

11:25 IL FR-01-06Verbesserung des Überlebens allogener Epithel-transplantate durch GentherapieThomas Armin Fuchsluger, Klaus-Peter Steuhl, S. Ergun (Boston/USA, Essen)

11:30 IL FR-01-07Induktion von humoraler und zellulärer Immun-antwort der Augenoberfläche durch lokale Anti-gen-ApplikationUta Gehlsen (Lübeck)

335

Oth

er S

ympo

sia

(in G

erm

an)

WOC® 2010

11:35 IL FR-01-08Epidemiologie der okulären Graft versus HostDisease und Verlaufsbeobachtung unter immun-suppressiver Therapie mit der Fragstellung nachder Rolle der BecherzellenEva Jakob (Heidelberg)

11:40 IL FR-01-09Ist die Replikation von Hornhaut-Endothelzellenduch lentiviralen Gentransfer induzierbar?Daniel Kampik (Würzburg)

11:45 IL FR-01-10Einfluss potentiell osmoprotektiv wirksamer Tränenersatzpräparate auf die Osmolarität desTränenfilms beim HundRegina M. E. Korth, Gwendolyna Romkes, Corinna Eule (Berlin)

11:50 IL FR-01-11Pollen-Enzyme schädigen menschliche Tränenflüs-sigkeit und Bindehautzellen – Ein Ansatz zum Ver-ständnis des SNAK (saisonale nicht-allergischeKonjunktivitis)-SyndromsDieter Franz Rabensteiner, Eva-Maria Spreitzhofer,Jutta Horwath-Winter, Otto Schmut (Graz/A)

11:55 IL FR-01-12iBlink – Ein Computer basierter Ansatz zur Diag-nose und Therapie des Bildschirm-assoziierten Trockenen AugesDieter Franz Rabensteiner, Jutta Horwath-Winter,Otto Schmut (Graz/A)

12:00 IL FR-01-13Konzentrationsbestimmung von ausgewählten antimikrobiellen Peptiden und Surfactantprotei-nen in der Tränenflüssigkeit von Neugeborenen,Kindern und ErwachsenenGesa Friederike Schäfer (Magdeburg)

12:05 IL FR-01-14Prospektive Studie zur Evaluierung der Tränenfil-mosmolarität als Verlaufsparameter des trocknenAuges bei Patienten mit allogener Stammzell-transplantation und Graft versus Host Reaktion(GvHD) mittels der TearLab OsmometrieMarc Schargus, Gerd Geerling (Würzburg)

12:10 IL FR-01-15SP-G und SP-H – zwei neue unbekannte SurfactantProteine des TränenfilmsMartin Schicht, Lars Bräuer (Halle/Saale)

12:15 IL FR-01-16Co-Kultur menschlicher Bindehautzellen mit teilungsfähigen subkonjunktivalen Fibroblasten:Simulation einer Stammzellnische für konjunkti-vale ProgenitorzellenStefan Schrader, Maria Notara, Michèle Beaconsfield, Stephen J. Tuft, Gerd Geerling, Julie T. Daniels (Lübeck, London/GB, Würzburg)

12:20 IL FR-01-17Eine neue therapeutische Strategie bei entzündli-chen Erkrankungen der Augenoberfläche? – Diegezielte Hemmung antigenpräsentierender Zellendurch Sanglifehrin A.Johannes Schwartzkopff (Freiburg)

12:25 IL FR-01-18Konjunktiva-assoziiertes lymphatisches Gewebe(CALT) – ein Epiphänomen?Sebastian Siebelmann (Lübeck)

12:30 IL FR-01-19Die Bedeutung von Feinstaub und UV-Licht für dieEntwicklung eines Umwelt induzierten TrockenenAugesKatrin Sturmbauer, Dieter Franz Rabensteiner, Otto Schmut (Graz/A)

12:35 IL FR-01-20Modifikation der Expression von Stammzell- undPluripotenzmarkern in limbalen epithelialenStammzellen durch unterschiedliche KulturmedienHenning Thomasen, Klaus-Peter Steuhl, Daniel Meller (Essen)

12:40 IL FR-01-21Randomisert kontrollierte Studie zur Verwendungvon autologem Serum zur Prävention einer Augenoberflächenstörung bei adjuvanter 5-Fluorouracil-Injektion nach filtrierender Glau-komchirurgieJan Darius Unterlauft, Karsten Kasper, Gerd Geerling (Würzburg)

336

337WOC® 2010

Soci

al P

rogr

am

Official Social Program

Opening Ceremony

Saturday, 5 June 2010, 18:30 - 20:00 ICC, Hall 1

Do not miss the WOC® 2010 Opening Ceremony, Saturday 5 June 2010 at 6.30pm

Follow us and discover past, present and future during the Opening Ceremony:– Pay tribute to our ancestor Albrecht von Graefe– Explore the iconic Berlin, the vibrant capital of Germany and its “Queen”– Look into the future with WOC® 2012 to be held in Abu Dhabi, United Arab

Emirates.

Join us in welcoming the “Who is Who” of ophthalmology marching in and comingfrom across the world and be part of the promotion of scientific excellence reflectedthroughout the International Award Ceremony.Featured in HD sequences, the beauty of the Eye will be omnipresent during theOpening Ceremony and strives to represent the vision and mission of our fascina-ting profession. Admire the breathtaking pictures of Eyeland Design. Enjoy phantas-tic music and entertainment.The WOC® Reception is the perfect get-together for the international ophthalmolo-gist community and allied specialties to meet old friends and make new ones in afriendly atmosphere.On behalf of the International Council of Ophthalmology, the German Society ofOphthalmology, the German Academy of Ophthalmology and both, the WOC® 2010Executive Committee and Scientific Programme Committee, we take pleasure inwelcoming you to this key event.

Prof. Dr. Gerhard K. Lang Bruce E. Spivey, MD, MS, MedPresident of the DOG International Council of OphthalmologyPresident WOC® 2010 President

see also p. 39

WOC®Reception

Saturday, 5 June 2010, 20:00 - 22:00 ICC, Hall 2

WOC® in Concert

Sunday, 6 June 2010, 20:00 - 21:30Venue: French Church of Friedrichstadt (French Cathedral)/ Französische Friedrichstadtkirche am Französischen Dom, directly at the Gendarmenmarkt. Tube Station on the U2 Line: Französische Str.

Entrance freeNo bus transfer

Organizers: Georg Fischer Varvitsiotis (Conductor) and Franz Grehn

Ophthalmologists play for Ophthalmologists

The musicians play masterpieces fromCarl Philipp Emmanuel Bach Léon BoëllmannLeopold MozartWolfgang Amadeus MozartJohann Joachim QuantzRobert SchumannLouis VierneLudwig van Beethoven

see also p. 41

WOC®toberfest

Monday, 7 June 2010, 7:30- 12:00

WOC®toberfest will be a typical Bavarian-like Oktober-fest with beer, German food and entertainment. You should not miss this special social highlight!

We cordially invite you to come and join us for a Bavarian-style Oktoberfest at the WOC®toberfest inthe Hangar II of Tempelhof Airport. With traditional Oktoberfest brass band music, beer and Bavarian specialties, we plan to enjoy a lively, intercultural evening. Of course, there will also be non-alcoholicdrinks and vegetarian food. We are offering some otherattractions for adults and children so as to celebratethis WOC®toberfest as a family party.

All participants are also most welcome to wear theirown national dress at this event, as wearing differentand colorful national dresses conveys a sense offriendly solidarity.

Our motto for the evening is: meet old friends and make new friends in a relaxed and friendly atmosphere.

If you are interested in participating in sightseeing tours please go to the congress’website at www.woc2010.org/social-program/sightseeing-tours and contact theagency “Interklassik” by quoting "WOC® 2010". The Interklassik team will also behappy to advise you concerning the organisation of pre and post congress tours. Interklassik Concierge & Event GmbH

E [email protected] T +49 (30) 2044 540 F + 49 (30) 2045 2675

Program for AccompanyingPersons

338 WOC® 2010

Soci

al P

rogr

am

Info

rmat

ion

for A

utho

rsInformation forAuthors

Opening hours of the Media CheckThe central Media Check is located in Main Lobby, Lobby Level

Thursday, 3 June 2010 7:00 – 19:00 Friday, 4 June 2010 7:00 – 18:30 Saturday, 5 June 2010 6:30 – 18:30 Sunday, 6 June 2010 6:30 – 18:30 Monday, 7 June 2010 6:30 – 18:30Tuesday, 8 June 2010 7:00 – 18:30Wednesday, 9 June 2010 7:30 – 14:00

Speaking Times Lectures free paper session: 9 minutesOral presentation: 7 minutes

In order to guarantee a smooth organization of the entire program, all speakers arerequested to keep to their allocated presentation times. The chairperson of eachsession will be entitled to interrupt a presentation if a speaker exceeds the time allocated.

Videos Video presentations are an important and effective mean of displaying scientific results. Therefore, the best seven videos will be displayed and discussed during thevideo session on Sunday, 6 June, 14:00 – 15:30 in the Radio Tower Lounge 2.The WOC will publish awarded videos on its homepage. Therefore, authors whowould like to make their video available to the WOC are requested to consider thatthe videos do not show any data which are subject to payment for copyrights andtechnical reproduction.The WOC® 2010 Video Award of the DOG, donated by Carl Zeiss Meditec VG, will be granted at the end of the Video Session with Presentation of Awards (Sunday, 6 June, 14:00 – 15:30).

Poster Presentation Poster presentations are an important and effective means of displaying scientificresults. Printed posters will be displayed in indicated sessions and E-posters during the entire congress. First authors of posters must be present at their poster at the times indicatedbelow. Chairpersons will check the presence of poster authors.Each day three outstanding posters will be awarded an amount of 300 c each.

All posters must be prepared in English.

Standard poster walls will be available in the Poster Exhibition. The maximum size of a poster is DIN A0 (84.10 cm wide x 118.90 cm high).Adhesive material and staff will be available to poster authors from the Poster HelpDesk in the poster exhibition area.The organisers will remove posters that will not have been removed by the times indicated below.

Poster PresentationPoster P-SA-001 to P-SA-282 and P-SU-001 to P-SU-277 must be mounted on Saturday, 5 June 2010, 8:30 and removed on Sunday, 6 June 2010, 17:30.Poster P-MO-001 to P-MO-298 and to P-TU-001 to P-TU-265 must be mounted onMonday, 7 June 2010, 8:30 and removed on Tuesday, 8 June 2010, 17:30.

339WOC® 2010

Poster Session with DiscussionFirst authors are requested to attend their posters for questions and discussions asfollows: P-SA-001 to P-SA-282Saturday, 5 June 2010, 15:30 – 17:00 at the posterP-SU-001 to P-SU-277Sunday, 6 June 2010, 15:30 – 17:00 at the posterP-MO-001 to P-MO-298Monday, 7 June 2010, 15:30 – 17:00 at the posterP-TU-001 to P-TU-265Tuesday, 8 June 2010, 15:30 – 17:00 at the poster

Electronic PostersIn addition to the conventional poster presentation, a facility for all delegates toview any poster on a LCD display screen during the entire congress will be available. To optimize the preparation of this presentation, all authors are asked to observethe following requirements: Maximum five pages (without animation) in MicrosoftPowerPoint. All images and graphics should be. Posters will be displayed in land-scape format with a screen resolution of 1024 x 768 dpi. (Powerpoint On-Screenshow 4:3)

Projection Facilities A central Media Check will be available during the entire congress. Own laptops cannot be connected in the rooms. All presentations must be uploaded in advanceto the network.All authors will receive a separate e-mail from M Events Cross Media GmbH with access information and instruction. Presentations that are attached to an email cannot be processed. Only MS-Powerpoint (XP and higher) and PDF presentationswith video formats as specified on the upload site are permitted for this conference.Do not forget to bring your video files as they cannot be embedded into the presen-tation.Please submit your files at least 2 hours before your talk. If you speak in the first session in the morning please submit your files the day before or use the internetupload. You may check and/or alter your presentation yourself in the Media Check (ICCLounge) up to two hours prior to your presentation.Please note that the M Events staff members cannot revise your presentation.For the submission of your presentation on site, CDs, USB Sticks, or similar will be accepted.

After the conference all submitted files will be deleted from all storage media.

Information forAuthors

340 WOC® 2010

Info

rmat

ion

for A

utho

rs

Publication of Scientific Papers of DOG membersScientific contributions that have been accepted for oral presentation have to behanded in in publishable format for peer reviewing no later than 31 October 2010.Publication is possible in either German or English.

Please send your manuscript to the respective editors:Contributions in German for review by the journal "Der Ophthalmologe" should be submitted online only. Full details concerning submission are available at:www.DerOphthalmologe.de or directly at: www.editorialmanager.com/deop/

Editor-in-ChiefProfessor Frank G. HolzUniversitäts-Augenklinik BonnErnst-Abbe-Str. 253127 Bonn

Contributions in German for review by the journal "Klinische Monatsblätter fürAugenheilkunde" should be sent online to:http://mc.manuscriptcentral.com/klimo

Editors-in-ChiefProfessor Gerhard K. Lang, Professor Gabriele E. LangUniversitäts-Augenklinik UlmPrittwitzstr. 4389075 Ulm

Contributions in English for review by the journal "Graefe’s Archive for Clinical and Experimental Ophthalmology" should be submitted online only. Full details concerning submission are available at:www.di-ep.com or directly at:http://editorialmanager.com/graefes

Editor-in-ChiefProfessor Bernd KirchhofKlinikum der Universität zu KölnZentrum für AugenheilkundeKerpener Str. 6250924 Cologne

Copyright for oral presentations to be made at the congress by DOG members be-longs to the society. Therefore authors of oral presentations are obliged to submittheir contributions for review and publication to one of the following journals: "DerOphthalmologe", "Klinische Monatsblätter für Augenheilkunde" or "Graefe’s Archivefor Clinical and Experimental Ophthalmology". Upon request, the presentation mayalso be published in another journal. In this case, the author is asked to send an informal application to the Secretary of the DOG. Contributions published in otherjournals shall annotate: "presented at the 108th DOG Congress".All authors are kindly asked to observe the "Instructions for Authors" of the respective journals. Manuscripts not accepted for publication after the review process will be returned to the respective author with the reviewers’ evaluation.

Information forAuthors

341WOC® 2010

Info

rmat

ion

for A

utho

rs

DOG Membership

Colleagues who wish to become members of the German Society of Ophthalmology(DOG) can do so by clicking on „membership“ at www.dog.org. Please complete theonline application form, or download the form, complete it and send it to:

Geschäftsstelle der DOG e.V.Platenstr. 180336 MunichTel. +49 (89) 5505 768-14Fax +49 (89) 5505 768-11E-Mail [email protected]

Opening hoursMonday to Friday: 8:00-12:30

Annual Membership Fees

Consultants / specialists – national and international, c 200who do not belong to any of the following groupsMedical students in training (assistant doctors), c 100

Consultants / specialists and medical students c 100from neighbouring Eastern European countriesPensionary members c 100

Paying members of the DOG will automatically receive a copy of the journal DerOphthalmologe – or alternatively the English language journal Graefe’s Archive forClinical and Experimental Ophthalmology at no extra cost. If Der Ophthalmologeis chosen, Graefe’s Archive for Clinical and Experimental Ophthalmology can be ordered at a reduced annual rate of c 60.

Copies of journals received at reduced rates are exclusively for the personal use of DOG members and may not be passed on to libraries or institutes.

342 WOC® 2010

DOG

Mem

bers

hip

343WOC® 2010

Gra

nts F

ranc

e 20

10

Travel and accommodation Grants France 2010European Symposium

DOG and SFO would like to extend and intensify the scientific cooperation and exchange between Germany and France. For this purpose, a joint symposium will be organized at the annual SFO and DOG congress, the topic of this symposium generally being the topic of the preceding congress in the respective country.Young physicians in practice and/or research are invited to submit their contributi-ons, which should be related to the topic of the symposium. The contributionsshould possibly be the result of a real German-French cooperation. A DOG/SFO commission will select up to four articles of all the submitted abstracts.

The first authors will receive from his/her society a travel allowance of c 1000,- toparticipate in the congress. In addition, the first author of the respective best abstract will receive a grant of c 2000,- to be used for a stay of several weeks in ahospital of the other country. Language skills are welcome, but not an absolute requirement.The official languages of the DOG-Congress are German and English, those of theSFO-Congress French and English.

Applications including a short description (20 – 25 lines) should be sent to: [email protected]

You will find more detailed information about application and deadlines on theDOG-Homepage http://www.dog.org/foerderung/stipendien.html

Reise – und Aufenthaltsstipendium Frankreich 2010Europäisches Symposium

DOG und SFO wollen die Zusammenarbeit und den Austausch zwischen Deutsch-land und Frankreich auch auf wissenschaftlichem Gebiet weiter intensivieren. ImRahmen der Kongresse beider Fachgesellschaften findet dazu jeweils ein gemeinsa-mes Symposium statt. Thema ist jeweils das Kongressthema des vorausgehendenKongresses im jeweils anderen Land.Junge, klinisch und/oder wissenschaftlich tätige Mitarbeiter/innen werden aufge-fordert, freie Beiträge einzureichen, die zum Thema des jeweiligen Symposiums passen sollten. Besonders wünschenswert wäre es, falls diese Arbeiten das Ergebniseiner realen deutsch-französischen Zusammenarbeit dokumentieren.Aus den eingereichten freien Beiträgen wählt die Kommission der DOG/SFO bis zuvier Beiträge aus.

Die Erstautoren/innen erhalten von ihrer Fachgesellschaft einen Reisekostenzu-schuss zu dem jeweiligen Kongress in Höhe von c 1.000,-. Der Erstautor des jeweils besten Beitrags erhält zusätzlich einen Reisekostenzu-schuss in Höhe von c 2.000,-, der für einen mehrwöchigen Aufenthalt an einer Klinik des jeweiligen anderen Landes zu verwenden ist. Sprachkenntnisse sind will-kommen, aber nicht Bedingung. Die Kongresssprachen der DOG-Kongresse sind Deutsch und Englisch, die der SFO-Tagungen Französisch und Englisch.

Anträge inkl. einer Kurzbeschreibung von max. 20 bis 25 Zeilen Text sind per E-Mailzu richten an: [email protected]

Details zur Bewerbung, Abgabefristen sowie den genauen Themen der Symposienwerden auf der DOG Homepage http://www.dog.org/foerderung/stipendien.html veröffentlicht.

Dr. R. Kaden Verlag Der Ophthalmologe unter den Verlagen

www.kaden-verlag.de

345WOC® 2010

Spon

sors

and

Exh

ibito

rs

Sponsors and Exhibitors

1a Medico GmbH 15 B/381st Q Deutschland GmbH & CO. KG 15 A/15A. R. C. Laser GmbH 15 A/12AAO American Academy of Ophthalmology EF 08Aaren Scientific, Inc. 17 B/27Abbott Medical Optics Inc. 15 A/03Accutome, Inc. 17 A/10Aeon Astron Europe B. V. 15 A/26ADTA 15/02AKRUS GmbH 12 B/21ALBOMED GmbH 15 A/34ALCHIMA 15 A/19Alcon Laboratories, Inc. 12 B/30Allergan Inc. 14/07anteis SA 15 B/48APAO EF 13APAO 2011 EF 03Appasamy Associates 17 B/48argus Individuell Optic GmbH 17 B/42asico 15 B/53Association for Research in Vision and Ophthalmology EF 12ASCRS Media 17 A/14Der Augenspiegel 12 A/12AuroLab 12 B/25Bausch & Lomb 12 A/16Bayer Schering Pharma AG 14/09Biermann Verlag 14/08BioResonator 15 B/54Bio Tech 14/04Block Optic Ltd. 15 A/16BOD EF/22Bohus Biotech AB 15 B/51bon Optic Vertriebsgesellschaft mbH 15 B/50brumaba GmbH & Co. KG 14/15Caruso & Freeland 17 B/43Christoffel-Blindenmission 17 B/56CCS Pawlowski GmbH 17 A/31Cochrane Eyes and Vision Group 17 A/22Chibret GmbH 14/06Clarity Medical Systems 17 B/34concept ophthalmologie EF 17Civilian Research & Development Foundation 17 A/21CROMA-PHARMA Dtl. GmbH 15 A/04Cataract & Refractive Surgery Today 17 A/23CSO Costruzione Strumenti Oftalmici S.r.l. 15 B/50Deutscher Blinden- und Sehbehindertenverband e.V. 17 B/50Deutsche Gesellschaft für Gewebetransplantation gGmbH 12 A/17Dioptex GmbH 12 B/28DMG Deutsche Myastenie Gesellschaft e.V. 17 B/74Dockx Medical B.V. 17 B/67DOMILENS GmbH 15 B/41DOMS Eye-Technology GmbH & Co. KG 17 A/31D.O.R.C. International b.v. 12 B/33Deutsche Uveitis Arbeitsgemeinschaft e. V. 17 B/63

The WOC® 2010 gratefully acknowledges the support of all Sponsors and Exhibitors

Company Hall Area/Number


Dual Laser Ltd. OY 15 B/52European Journal of Ophthalmology EF/07Ellex 14/12Elektronik & Präzisionsbau Saalfeld GmbH 17 A/31ESCRS EF 05EVER EF 14Eyemaginations 12 A/01Eyemetrics Optic Service AG 15 A/16Eyetec GmbH 15 A/16FCI France Chirurgie Instrumentation 12 B/27Ferrara Ophthalmics 12 B/26FIDUS 12 B/39Frastema S.R.L. 17 B/42Gebauer Medizintechnik GmbH 17 B/77GEUDER AG 15 A/17Grüner Laser Products GmbH & Co. KG 15 A/05Haag-Streit International 13/01Heidelberg Engineering GmbH 15 B/44Heine Optotechnik GmbH & Co. KG 17 B/70Albert Heiss GmbH & Co. KG 12 B/20Heuser Ophthalmologie und Medizintechnik 12 B/31HEXAL AG 14/03HOYA Surgical Optics GmbH 14/14, 15 A/01HumanOptics AG 12 B/22Icare Finland Oy 15 A/20ICO International Council of Ophthalmology EF 06ifa Systems AG 12 A/18Initiative Auge e.V. Main Foyer ICCInsight Instruments, Inc. 12 A/06integration.ag 12 A/18IOA International Orthoptic Association 17 A/24IRIDEX Corporation 15 A/07iVIS Technologies s.r.l. 17 B/45Jaypee Brothers Medical Publishers Pvt. Ltd. 17 B/29JCAHPO 17 A/18Jen-Ophthalmo 17 A/31Katena Products, Inc. 15 A/02Keeler Ltd. 15 A/27Kowa Europe GmbH 15 B/50Franz Kuschel 17 B/72LCA Pharmaceutical 15 B/40Leica Microsystems AG 15 A/32Lightmed Corporation 17 B/68LUMENIS (Germany) GmbH 17 B/33Dieter Mann GmbH 15 A/08Mani, INC. 15 B/36MEACO EF 02Medizingeräte + Chirurgiebedarf GmbH 15 A/30Mathme Eye Bank Eye Hospital India 17 A/20med_tec Medizintechnik Vertriebs-GmbH 15 A/19MEDA CO., LTD 17 B/76Medical Workshop 12 B/42Medicel AG 15 A/21Medicontur Medical Engineering Ltd. 15 B/48Mediphacos 12 A/07MED-LOGICS, INC. 15 B/43medways e.V. 17 A/31Merck Sharp & Dohme 14/06Metrovision 17 B/47


346 WOC® 2010

Spon

sors

and

Exh

ibito

rs


Micro Technologie Ophtalmique SA 15 A/24MID Labs, Inc. 15 A/29Morcher GmbH 15 B/37Moria SA 15 A/19MSD 14/06NeoMedix Corporation 17 B/54NeoVista Inc 17 A/07New World Medical, Inc. 17 B/75Nidek Co., Ltd. 15 A/11Novartis Pharma GmbH 14/11Novartis Pharma AG 14/11Ocular Instruments 15 A/06Ocular Surgery News / SLACK EF 19Oculentis GmbH 17 A/11OCULUS Optikgeräte GmbH 15 A/10OD-OS GmbH 12 A/05Oertli Instrumente AG 15 B/45OGI Ophthalmologische Geräte und Instrumente 12 B/42OIS 17 A/15OmniVision GmbH 12 B/37OPHTEC BV 17 A/06Ophthalmic Design GmbH 17 A/04OphthaSWISS AG 15 A/34OPKO Instrumentation 15 B/46Optima Pharmazeutische GmbH 15 B/50OptiMedica International Pte. Ltd. 17 A/12Optitech Eye Care 14/02Opto Global Pty Ltd 15 A/19Optopol Technology 12 A/09Optos GmbH 12 A/13Optovue, Inc. 17 A/35OTE Ophthalmology Time Europe EF 18Peschke Medizintechnik GmbH 15 B/56Pfizer Ophthalmics 12 B/35Pharma Stulln GmbH 14/01Plusoptix GmbH 15 A/33Precision Vision 17 B/52Prevor GmbH 15 A/22ProRetina 17 A/17PXE EF/21Quantel Medical 12 A/14Rayner Intraocular Lenses Ltd. 17 A/36Reichert Ophthalmic Instruments 17 B/44Right Mfg. Co.Ltd. 15 B/50Roland Consult 15 B/35Rowiak GmbH 12 A/17Fritz Ruck 12 A/10RUMEX International Co. 15 A/23S. Karger AG Basel EF 10Santen 16/01Schairer 17 A/02SCHWIND 17 A/03SFO EF/15SOE EF 16SOE 2010 EF 16Sonomed, Inc. 17 B/53SOOFT Italia S.p.A. 15 B/50Stiftung Auge Main Foyer ICCSurgitrac Co. Ltd. 15 A/25


347WOC® 2010

Spon

sors

and

Exh

ibito

rs


SUZHOU KANGJIE MEDICAL INSTRUMENT CO., LTD. 17 B/28Synergetics Germany GmbH 12 B/29T.MED GmbH 12 A/10Takagi Seiko Co., Ltd. 17 B/41Théa 15 A/14Georg Thieme Verlag KG 12 A/02 Thrombogenics 17 A/37Titan Surgical 15 A/28Tomey GmbH 15 B/55Topcon Europe B.V 17 A/05TRB CHEMEDICA AG 15 B/47TRIOPTICS GmbH 17 B/49Trusetal Verbandstoffwerk GmbH 12 B/32U.S. IOL / Stephens Instruments 17 A/26UFSK-International OSYS GmbH 12 B/23Ulrich Zuhnemer KG 12 B/42URSAPHARM Arzneimittel GmbH & Co. KG 12 A/11Vision 2020 EF 11Visiontech Medical Optics Ltda. 12 B/41Volk Optical Inc. 15 A/27VRmagic GmbH 15 B/42W2O Medizintechnik AG 12 B/20WEFIS GmbH 12 B/40Wexler Surgical 17 A/38WGA World Glaucoma Association EF 20Wirmsberger & Böhm 17 A/01Wisepress, Ltd. 17 B/73WOC 2012 EF/01WOC 2014 EF 04Carl Zeiss Meditec AG 13/02ZIEMER OPHTHALMIC SYSTEMS AG 17 B/40

Status: 29 April 2010

E-Posters and Internet Hall 17

Congress Bags Hall 17


348 WOC® 2010

Spon

sors

and

Exh

ibito

rs

349WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

Plan Industrial Exhibition Overview

350 WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

Hall 12

351WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

8 m

Hall 12

Cof

fee

Shop

Pfiz

er

Akr

us

Alc

on

ifa inte

grat

ion

ag

Med

i-ph

acos

OD

-OS

Om

niVi

sion

Opt

opol

Opt

osQ

uant

el

Urs

apha

rm

Visi

onte

ch

W2O

Albe

rt H

eiss

CATE

RING

CATE

RING

CATE

RING

Hum

anO

ptic

s

Fidu

sD

iopt

exFC

IFe

rrar

aSy

ner-

getic

sW

EFIS

OG

IM

edic

al W

orks

hop

U. Zu

hnem

er

Auro

Lab

Heu

ser

Trus

etal

T.M

edFr

itz R

uck

Haa

g-St

reit

DO

RC

Dt.

Ges

.G

eweb

e-tr

ansp

lant

.Row

iak

Gm

bH

Baus

ch &

Lom

b

12 A

/05

12 A

/06

12 A

/07

12 A

/09

12 A

/10

12 A

/12

12 A

/13

12 A

/11

12 A

/16

12 A

/14

12 A

/17

12 A

/18

12 B

/25

12 B

/26

12 B

/27

12 B

/28

12 B

/29

12 B

/22

12 B

/23

12 B

/20

12 B

/21

12 B

/30

12 B

/39

12 B

/40

12 B

/41

12 B

/42

12 B

/37 12

B/3

5

12 B

/31

12 B

/32

12 B

/33

13/0

1

UFS

K

Auge

n-sp

iege

l

Insi

ght

Inst

r.

12 A

/02

Thie

me

Eyem

agi-

natio

ns

12 A

/01

Haa

g-St

reit

13/0

1

Hall 15

352 WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

Die

ter

Man

n

Crom

aPh

arm

a

Geu

der

Dom

ilens

Thea

Nid

ekO

culu

sA.

R.C

.

1st

Q

bon

Opt

icKo

wa

Euro

peO

ptim

aC.

S.O

S.O

.O.F

:TRig

ht O

n

Eyet

ec/

Bloc

k O

ptic

E

yem

etric

s

Hal

l 16

Sant

enCoff

eeSh

op

Ice

Shop

Albo

med

Oph

thaS

wis

s

Dua

l Las

erM

ani M

ed-L

ogic

sM

IDLa

bsO

ertli

Mor

-ch

er1a

Med

ico

Bohu

sRol

and

Cons

ult

Tita

nSu

rg.

Volk

Keel

erVR

mag

ic

Hall15

Ocu

lar

Inst

r.

Irid

ex

TRB

Chem

edic

a

Grü

ner

Lase

r

Aeon

Surg

i-tr

ac

Hei

delb

erg

Engi

neer

ing

M+

C

Leic

a

med

_tec

Opt

o G

loba

lM

oria

/ A

lchi

mia

MTO

Med

icon

tur

ante

is

LCA

Icar

e

Tom

ey

Prev

orM

edic

el

15 A

/04

15 A

/05

15 A

/08

15 A

/07

15 A

/10

15 A

/11

15 A

/14 15

A/1

615

A/1

5

15 A

/19

15 A

/20

15 A

/21

15 A

/24

15 A

/25 1

5 A/2

615

A/2

315

A/2

2

15 A

/12 15

A/1

7

15 A

/27

15 A

/28

15 A

/30

15 A

/06

15 A

/29

15 A

/32

15 A

/33

15 A

/34

15 B

/35

15 B

/41

15 B

/36

15 B

/37

15 B

/38 15

B/4

4

15 B

/42

15 B

/43

15 B

/45

15 B

/51

15 B

/52

15 B

/53

15 B

/55

15 B

/56

15 B

/48

15 B

/47

15 B

/46

15 B

/50

15 B

/40

16/0

1

Plus

optix

OPK

ORum

ex

Pesc

hke

asic

o

BioR

eso-

nato

r15

B/5

4

AMO

Abb

ott

Kate

na

15 A

/02

15 A

/03

Hall 17

353WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

Hall 14

354 WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

Mer

ckChi

bret

Nov

artis

Hall14

Hal

l 13

Hoy

a

Bier

man

n

Opt

i-te

ch

Zeis

s

Alle

rgan

Coffee

Shop

Hex

al

ICC

elle

x

Phar

ma

Stul

ln

Haa

g-St

reit

Haa

g-St

reit

Baye

r Sc

herin

g

14/0

1

13/0

1 13/0

2

13/0

1

14/0

214

/04

14/0

6

14/0

7

14/0

3

14/0

8

14/1

1 14/0

9

14/1

214

/14

brum

aba 14

/15

Bio

Tech

Alco

n

Hoy

aKa

tena

15 A

/01

15 A

/02

ADTA

15 /

02

Entrance Foyer ICC

355WOC® 2010

Indu

stria

l Exh

ibito

n Pl

ans

A S I A P A C I F I C A C A D E M Y O F O P H T H A L M O L O G Y C O N G R E S S20-24 MARCH 2011 SYDNEY CONVENTION AND EXHIBIT ION CENTRE / SYDNEY AUSTRALIA

A N I N T E R N A T I O N A L F O C U S O N O P H T H A L M O L O G Y

With great pleasure, we invite our colleagues and the ophthalmic industry throughout the world to Sydneyfor the 2011 Congress of the Asia Pacific Academy of Ophthalmology.

The Scientific Program Committee is assembling an exciting and stimulating scientific program, which will enableboth comprehensive ophthalmologists and sub-specialists the opportunity to update their knowledge and skills.

Australia and New Zealand have a long history of world-class expertise in clinical practice and ophthalmologicalresearch. This, combined with the warm and relaxed ‘Aussie’ spirit, will ensure your Congress experience isprofessionally enhancing and personally rejuvenating.

We encourage our global colleagues and the international ophthalmic industry to join us, to participate and toexperience our unique Australian hospitality. Your journey to Sydney will be more than worthwhile,

professionally and personally.

A/Prof Ivan Goldberg Prof Frank Martin Prof Charles McGheeCongress President Chairman, Congress Chairman, Scientific

Sponsorship and Exhibition Program Committee

Scientific Program will include: International guest speakers on all subspecialties • Live Cataract and Refractive Surgery • Symposia • Workshops

Sponsorship and exhibition packages are now available. The floorplan is also available for preview and space selection. For

more information on sponsorship and exhibition opportunities please email [email protected]

Key Dates• Registration and Abstract Submission now open online• Abstract submissions deadline 22 October 2010• Early-bird registrations close 15 January 2011

Your invitation to Sydney in 2011.

www.apaosydney2011.com

357WOC® 2010

Info

rmat

ionInformation from

A to ZA

Accommodation/Hotel ReservationBerlin's hotel landscape is one of the most up-do-date in Europe. In the last 10 yearsthe number of hotel beds in the city has more than doubled. Berlin now has nearly100,000 hotel beds at its disposal. Almost all the large hotels chains are already present on the Spree or plan to come to the German capital.

Hotel rooms in various price categories have been booked for WOC® 2010 by HRS,the worldwide hotel reservation service.

The HRS homepage is available in 32 languages. The list of search result can be tailored according to different search criteria such as distance to the congressvenue, hotel category, currency etc. You will also find more information by clickingon the hotels listed after your request. Hotel reservations can be made via HRS atthe congress website www.woc2010.org.

Furthermore, the participants of the WOC® 2010 have the possibility to book one ofthe three headquarter hotels, Westin Grand, Adlon, Hilton, see also atwww.woc2010.org.

B

Business CenterThe Business Center of the ICC is situated in the entrance hall and offers a full rangeof services including faxing, copying, printing, telephone cards, etc. Opening hours during WOC® 2010: From 08:00 to 18:00 (on 9 June until 14:00).

C

Cancellation PolicyCancellations of registration will only be accepted in writing sent to the PCO byemail or fax. The notification must include all relevant information regarding thebank account to which a possible refund may be remitted. In case of cancellationbefore 10 May 2010 registration fees will be refunded minus a handling fee of c 50.After this date there will be no refund.

Car ParkA total of 12,000 parking spaces are available on and around the grounds. The par-king garage of the ICC provides 650 parking spaces. Elevators and cash desk machi-nes are located at the south entrance of the ICC. Prices are as follows:Rate per hour: c 2.00 / Rate per day: c 7.50

ClimateBerlin enjoys pleasant, sunny summers when days are long and temperatures cansometimes exceed 25 to 30°C, also in June. However the summer months are alsounpredictable and days can rapidly change from sunshine to cloud. Rain can fall allyear round.

Cloak RoomServices for checking in coats and luggage will be available in the entrance hall ofthe ICC.

ClothingClothing is informal for all occasions. Raincoat and umbrella might be helpful.

CME Credits/CertificationThe congress will be accredited by the respective Accreditation Council for Continuing Medical Education for Germany and Europe to provide continuing medical education credits for physicians.

358 WOC® 2010

Info

rmat

ion Information from

A to ZCongress bags

Every participant will get a voucher for one congress bag which can be picked up inHall 17 b.

Congress OrganizerProfessional Congress Organizer (PCO)Please do not hesitate to contact the PCO if you require any additional informationor assistance.

Porstmann Kongresse GmbH (PCO)Alte Jakobstr. 7710179 Berlin,GermanyT +49 30 28 44 99 0F +49 30 28 44 99 11E [email protected]

Opening Hours of the PCO Counter on siteWednesday, 2 June 2010 16:00 to 18:00 Thursday, 3 June 2010 07:00 to 19:00 Friday, 4 June 2010 07:00 to 18:30 Saturday, 5 June 2010 06:30 to 18:30Sunday, 6 June 2010 06:30 to 19:30 Monday, 7 June 2010 06:30 to 18:30 Tuesday, 8 June 2010 07:00 to 18:30 Wednesday, 9 June 2010 07:30 to 14:00

Telefon (on site)T +49 30 3038-81 800F +49 30 3038-81 801

Congress programThe final program of the WOC® 2010 will be available in the congress bags (Hall 17 b).

Congress VenueICC - Internationales Congress Centrum BerlinMessedamm 2214055 BerlinGermanywww.icc-berlin.com

CurrencyThe currency in Germany is Euro (c).Please visit www.oanda.com for the latest currency rate.

E

ElectricityIn Germany electricity is supplied at 220 V/50 Hz.Please note that for some devices from foreign countries converters will be needed.

ExhibitionThe commercial exhibition will be located in halls 12, 13 and 14, 15, 16 and 17 of theBerlin Fairground (Messe Berlin). The exhibition area will also house catering areasand the poster exhibition from Friday through Tuesday.

The opening hours of commercial exhibition are as follows:

Friday, 4 June 2010 09:00 – 17:00Saturday, 5 June 2010 09:00 – 17:00Sunday, 6 June 2010 09:00 – 17:00Monday, 7 June 2010 09:00 – 17:00Tuesday, 8 June 2010 09:00 – 17:00

359WOC® 2010

Info

rmat

ionInformation from

A to ZH

How to travel to Berlin – by plane, by train, by car

By Plane75 different airlines operate flights to Berlin from112 destinations in 44 countries.Berlin has two airports:– Tegel Airport (TXL) in the North-West of the city. Distance to City West: 5 km/

to City East: 8 km– Schönefeld Airport (SXF) in the South of Berlin. Distance to City West: 22 km/

to City East: 18 km

By TrainBerlin can by easily reached from all directions by rapid InterCityExpress (ICE), InterCity (IC), EuroCity (EC) and InterRegio (IR) trains. central stations are Haupt-bahnhof and Ostbahnhof.

Travel time from... to Berlin (ICE connections)

Departure from Travel timeAmsterdam 6 hBrussels 7 h 40 minDüsseldorf 4 h 09minFrankfurt /Main 3 h 29minHamburg 2 h 10minCologne 4 h 18minCopenhagen 7 h 25minLeipzig 1 h 31minLondon 10 h 32minMunich 6 h 19minParis 9 h 09minPrague 5 hWarsaw 5 h 49minVienna 9 h 49minZurich 8 h 17min

More information is available at the counters of the Deutsche Bahn (DB) and on thehomepage www.bahn.de

By CarThe motorway network radiates out of Berlin in the form of a star.

– From Munich, Frankfurt/Main and Dortmund use the A 10 Berliner Ring then the A 115 (Avus) Stadtautobahn (citymotorway).

– From Hamburg or Rostock use the A 10 then the A 111.– From Dresden, Cottbus and Frankfurt/Oder use the A 10 then the A 113 and A 100.

Please note that for all cars a special sticker is required to drive into the city centresince Berlin has been declared as environmental zone on 1st January 2008. The ICC is located outside of the environmental zone. Further information also in Englishavailable at:www.berlin.de/umweltzone.e you

360 WOC® 2010

Info

rmat


A to ZK

Kids Club - Room 35, ICCIn order to support the work life balance, the WOC® 2010 is offering day care for children up to the age of 14 years. Accordinglyfurnished rooms will be available in the congress center where professional and certified educators will offer your children an attractive and varied program.As the number of places is limited we recommend you to registeryour child in time.Last minute registration for your children will be possible on site,please come to the PCO counter in the ICC.

Opening hours3 June - 9 June 2010, 08:00 am - 06:00 pm

L

Language

The official language of the Congress is English. No simultaneous interpretation willbe offered. AAD in German, WOC in English

LiabilityThe PCO Porstmann Kongresse GmbH acts solely as an agent and is not liable forany losses, accidents, injuries to persons or damage to property of any kind. Thisdoes not affect the liability of persons or companies charged with providing the relevant service. Oral arrangements require a written confirmation. The sole court ofjurisdiction is Berlin.Delegates accept the above mentioned conditions by registering for the congress.

Local timeGermany is on Central European Time (CET) and is one hour ahead of GreenwichMean Time, 6 hours ahead of Eastern Standard Time and 9 hours ahead of PacificStandard Time. Summer Time extends from the last Sunday in March to the lastSunday in October.

P

ParkingA total of 12,000 parking spaces are available on and around the grounds. The parking garage of the ICC provides 650 parking spaces. Elevators and cash desk machines are located at the south entrance of the ICC.

Prices are as follows:Rate per hour: c 2.00 Rate per day: c 7.50

361WOC® 2010

Info

rmat

ionInformation from

A to ZPress ServiceThe press office staff welcomes all journalists to the WOC® 2010 congress in Berlin,Germany. Journalists will be admitted free of charge and may participate in all sessions.A valid press card is necessary for your registration which will be accomplished inthe press office (rooms 31, 32, 33 on the East Gallery) where you will also receive yourconference badge. All necessary information regarding the conference, its speakers,press conferences as well as background material will here be available as well. Thepress office can be used as a workplace.

On-site Press Office Our Opening Hours:

Thursday, 3 June 2010 08:00 to 18:00 Friday, 4 June 2010 08:00 to 18:00 Saturday, 5 June 2010 08:00 to 17:00 Sunday, 6 June 2010 07:00 to 18:00 Monday, 7 June 2010 07:15 to 17:00 Tuesday, 8 June 2010 08:15 to 17:00 Wednesday, 9 June 2010 08:15 to 14:00

Our Contact Data on site:T +49 (0)30 3038-81802F +49 (0)30 3038-81803

Our Contact Data:Press Office WOC® 2010Silke Stark/Corinna SpirgatP.O.B. 30 11 2070451 Stuttgart, GermanyT +49 (0)711 8931-572 or -293F +49 (0)711 8931-167E [email protected], [email protected]

The WOC® 2010 press office staff is available before, during and after the congress.Journalists who are interested in interviews with speakers or specialists or need additional background information should contact the press office. Camera crewsare kindly asked to pre-register with the press office as well.

Official WOC® 2010 Press Conferences

Press Conference WOC® 2010Date: Thursday, 3 June 2010, 12:00 to 13:00Room: Radio Tower Lounge 2(At the radio tower courtyard: entrance “Kleiner Stern”, access via hall 17) The press conference is held in German.

International Press Conference WOC® 2010Date: Tuesday, 8 June 2010, 12:15 to 13:15 Room: ICC Berlin, Room 43 (located on the press level on the walkway)The press conference is held in English.

EuroTimes, official media partner WOC® 2010Mr. Colin KerrESCRS, Temple HouseTemple RoadBlackrock, Co DublinIrelandT: +353 12091100F: +353 [email protected]

362 WOC® 2010

Info

rmat


A to ZR

RegistrationMembership of the German Society of Ophthalmology (DOG)/Professional Associa-tion of German Ophthalmologists (BVA) or confirmation of any oral presentation,video or poster does not automatically include the registration for the WOC® 2010.Therefore, all members of the DOG/BVA and all speakers are requested to registerprior to the congress. Registration can be made solely online. Please note the regis-tration and payment terms. Bookings that are liable to pay have to be balanced im-mediately by credit card or direct debit payment (only for German bank accounts) atthe end of the registration. Your billing information including credit card numberswill be automatically encrypted by SSL and therefore prevent any unauthorized orunscrupulous persons from prying into the transmission.

Please register via the congress homepage www.woc2010.org.

After having completed your online registration you will automatically receive an invoice including a booking confirmation and your personal barcode via email.Please print this barcode. The barcode will enable you to print your name badge at a self-service terminal on site without having to line up.

Registration Fees On-site registration fee from 11 May 2010 Entire congress

Delegates c 650

Members of the German Society of Ophthalmology c 325(DOG)/ Professional Association of German Ophthalmologists in Practice (BVA)

Residents1 c 525(up to 35 years of age)

Students1 c 70

Accompanying Persons c 70

Industry and Research Attendees c 650

Day Ticket/Pass c 250(available for one day only)

Day Ticket/Pass for Members of the DOG/BVA c 125(available for one day only)

WOC®toberfest c 80Children from 7 to 14 years c 25(free up to 6 years)

1 Residents/Students: The barcode will not be activated before a valid certificate (official certificate of the head of department including the date of birth/ student IDvalid for June 2010) will have been submitted via email ([email protected]) or fax (+49 30 284499-11) to Porstmann Kongresse GmbH. Late submission will not be accep-ted. Please send your certificate at your earliest convenience after online registration.

363WOC® 2010

Info

rmat

ionInformation from

A to ZRegistration of GroupsRegistration of groups can be made via the congress website www.woc2010.org by using the official registration system. Please add new participants via one mainaccount and use personal email addresses in order to create personal barcodes foreach participant. If you have any question or need assistance, please contact thePCO via [email protected]

Restaurants, Bars and NightlifeBerlin is a dynamic, cosmopolitan and creative city and the capital of Germany. Eastmeets West, tradition and innovation coexist in the metropolis at the heart of achanging Europe. Berlin is characterized by its turbulent past and offers today amultitude of cultural places of interests, restaurants as well as a vibrant nightlife.Please find several recommendations and addresses on the congress’ website atwww.woc2010.org

S

Sightseeing

A number of sightseeing tours will be offered by Interklassik Concierge & EventGmbH, see at www.woc2010.org. or send an email to [email protected] provides also tickets for theatre, opera or other cultural events.

Sponsorship Opportunities & ExhibitionSee the Sponsor’s and Exhibitor’s list on page 345.For details, please contact: Mr. Thomas HausfeldEmail: [email protected]

Smoking PolicyPlease note that smoking is prohibited in the Congress Center.

T

TransportationBerlin offers excellent public transportation facilities. The BVG, Berlin’s public trans-port system, operates Bus, U-Bahn (underground) and S-Bahn (city train). To go tothe ICC from the city it is necessary to use the ticket for the AB zone (single fare ticket), there are several stops (Bus, U- and S-Bahn) nearby. The ICC is located next tothe city motorway close to the Kaiserdamm in the West of Berlin.

Fare Zone AB

Short trip c 1.30(up to three stations with U- and S-Bahn or up to six stations with bus and tram)

Single ticket c 2.10(valid two hours in the same direction, zone AB)

4-Trip Ticket c 8.00(valid two hours in the same direction, zone AB)

Day ticket c 6.10(valid to 3:00 hrs at the following day, zone AB)

7-Day Pass c 26.20(The 7-Day Pass is valid on seven consecutive calendar days. Validity begins on thefirst day of the validity period printed on the card or from the time of validation andends on the seventh calendar day, at 24:00)

Please note that Schönefeld Airport is out of the fare zone AB. A ticket for the farezone ABC (c 2.80) has to be bought in order to get to the congress venue or to thecity center. (Day ticket zone fare ABC, c 6.50).

Further information:www.bvg.de

364 WOC® 2010

Info

rmat


A to ZArrival at the venue ICC by using public transportation:

A search function on the BVG website helps you to individually organize your journey by public transport: www.fahrinfo-berlin.de

U-Bahn / S-Bahn / Bus In the direction of Stop / Stationline number

U2 S+U Pankow <–> U Ruhleben Kaiserdamm

S41 Circle line (clockwise) Messe Nord/ICC

S42 Circle line (counterclockwise) Messe Nord/ICC

S46 Königs Wusterhausen <–> Westend Messe Nord/ICC

S75 Wartenberg <–> Spandau Messe Süd (Eichkamp)

S5 Strausberg Nord <–> Olympiastadion Messe Süd (Eichkamp)

BUS M49 Heerstraße/Nennhauser Damm <–> S+U Zoologischer Garten S Messe Nord/ICC

BUS X34 Kladow, Kaserne Hottengrund<–> S+U Zoologischer Garten S Messe Nord/ICC

BUS X49 Staaken, Hahneberg <–> S Messe Nord/ICC S Messe Nord/ICC

BUS 104 Neu-Westend, Brixplatz <–> Stralau, Tunnelstraße Messegelände/ICC

BUS 139 Hakenfelde, Werderstraße <–> S Messe Nord/ICC S Messe Nord/ICC

365WOC® 2010

366 WOC® 2010

Information fromA to Z

Tourist Information – Berlin WelcomeCard

This special offer contains a public transport ticket for the City Railway (S-Bahn),subway (U-Bahn), tram and bus, plus local train services, for 2, 3 or 5 days in Berlin orin Berlin and Posdam. The WelcomeCard also provides savings of up to 50 % on over140 top sights and cultural highlights.

Berlin (AB fare zones incl. Tegel Airport) Berlin and Potsdam (ABC fare zonesValid for one Person incl. Tegel and Schönefeld Airports)

(Children under 6 years travel free) Valid for one adult and max. 3 children up o 14 years

48 hrs for c 16.50 48 hrs for c 18.50

72 hrs for c 22 72 hrs for c 25

5 Days for c 29.50 5 days for c 34,50

Please find further information at www.berlin-welcomecard.de.

Info

rmat

ion

367WOC® 2010

Info

rmat

ionInformation from

A to ZV

VenueThe World Ophthalmology Congress 2010 - WOC® 2010 will be held at:ICC – Berlin (Internationales Congress Centrum)Messedamm 22, 14055 Berlin, Germany

For more information, please visit the ICC website www.icc-berlin.com

The ICC Berlin (Internationales Congress Centrum Berlin) ranks among the biggest,most advanced and most successful congress venues in the world.With its 80 halls and rooms seating between 20 and 9,100, its versatile facilities, superb technical installations and comprehensive range of services, ICC Berlin is theperfect choice for any convention, show or concert.

368 WOC® 2010

Adverts Inside Front Cover

Inside Back Cover

Outside Back Cover

2

216

356

44

52

6

90

238

344

62

12

38

128

40

66

20

132

174

264

42

30

236

Bookmark

Allergan Inc.

Pfizer

Carl Zeiss Meditec AG

Alcon Laboratories, Inc.

APAO 2010

APAO 2011

ARVO

Der Augenspiegel

Bausch & Lomb

DGII 2011

DOC 2010

Dr. Kaden Verlag

EVER 2010

International Council of Ophthalmology (ICO)

Merck Sharp & Dohme

Novartis Pharma GmbH

OCULUS Optikgeräte GmbH

Ophthalmology Times Europe

Pifzer

SFO 2011

SIXT

Springer-Verlag GmbH

Star Alliance

WOC 2012

WOC 2014

International Council of Ophthalmology (ICO)

Info

rmat

ion

369WOC® 2010

Auth

or In

dexA

Abari E. P-SU-258P-SU-260P-TU-243P-TU-254

Abbott R. L. SU-20-01SU-76SU-76-06MO-57ES-05ES-05-02

Abboud E. TU-66-07Abdeen Z. WE-16-04Abdou A. TU-71-05Abdul Karim M. N. P-MO-147

P-TU-198Abdul Majid A. S. B. P-TU-054Abdul Rahman R. MO-31-04

P-SA-259P-SA-259P-TU-063P-TU-182

Abe H. P-MO-034P-MO-042

Abe S. P-SU-017P-SU-115

Abegão Pinto L. MO-73-02P-MO-050

Abiose A. SU-32-03Abramoff M. SA-24-04

SU-62-04SU-74TU-56TU-56-02

Abrams J. TU-30-06Abramson D. H. SA-36-02

MO-77-03WE-24-05

Abramyan A. P-SA-160Abri S. SU-61-06Abu A. P-SA-096Abu El Einen K. G. MO-25-10

WE-40-10Abu El Ela M. H. P-SA-132Abu N. P-SU-134Abuh S. WE-35-01Acar S. P-SA-057

P-SU-025Accorinti M. TU-50-01Ach T. P-SA-177

P-TU-203P-TU-244SU-38-02TU-34-07

Acheampong A. MO-67-02Acidereli E. MO-79-04Ackermann P. FR-01-01Ackland P. MO-62-07Aclimandos W. MO-55

MO-55-04Acosta R. MO-62-03Adamis A. P. MO-63-01

SA-36-04Adelman R. TU-28-03Ademola-Popoola D. WE-35-01Adenis J.-P. TU-06

TU-06-02TU-41-13WE-12-03

Adenwala A. P-MO-052Ader M. P-SU-266Adhami-Moghadam F.SU-17-05Afia M. P-MO-244Aftab S. A. P-MO-202

Agaçhan A. P-SA-143Agafonova E. MO-78-06Agarwal A. SA-07

SA-07-02 SA-32-08SU-14-01SU-45-07TU-39-05TU-46WE-17WE-18-04P-MO-227WOC-C-12-07

Agarwal A. SA-07-03TU-46-02

Agarwal P. MO-74-01Agarwal R. MO-74-01

TU-30-10Agdeppa M. C. G. P-TU-013Aggeli S. P-MO-190

P-MO-214Agni A. N. P-MO-155

TU-35-10Agorastos A. P-TU-056Agostini H. T. TU-48-01

Po-MOP-SA-070P-SA-161P-MO-236P-TU-246 WOC-C-55WOC-C-55-01WOC-C-55-04

Agrawal D. P-MO-279Agrawal S. S.-M. MO-74-01Aguilar E. TU-36-05Ahlers C. MO-27-01

TU-37-06P-SA-196P-TU-185

Ahmad A. P-MO-044P-MO-051P-MO-054

Ahmad I. MO-17-06Ahmed I. K. SU-14-07

MO-73TU-13TU-13-08TU-46-03

Ahmiti I. P-TU-140Aiello L. P. MO-63-02Aihara LS-17-03Aisenbrey S. MO-24-07

MO-67-03Ajaiyeoba A. WE-16-09

WE-41-08Ajayi B. WE-16-09

WE-41-08Ajayi B. G. K. SU-74-04Akahoshi T. WE-18-02Akar M. SU-81-07Akesby J. MO-67-03Akgül H. MO-24-05

MO-77-04P-TU-126

Akhrorova Z. P-SU-205Akin T. P-MO-003Akova Y. SU-27-01Al Alawi E. K. SU-55-02Al Arrayed H. SA-26-08Al Hajj-Ali M. P-MO-275Al Sawidi K. MO-24-01Alam R. P-MO-001

P-MO-004Alarcón I. I. TU-29-05

Alarcon R. P-TU-014SA-27-03

Albert T. SU-37-05Albis-Donado O. P-MO-046Albou-Ganem C. TU-80-09Al-Deiri B. P-TU-020Al-Faky Y. Y. M. H. P-SU-211

P-SU-250Alfayez M. TU-81-06Alfonso J. F. SU-13-03

MO-15TU-74

Alge-Priglinger C. P-SA-202P-SA-205

Alghadyan A. P-SU-263Alió J. L. SA-01-06

SU-10SU-10-01SU-13SU-20-02SU-35-07SU-59-05MO-15MO-15-01MO-39MO-39-03MO-57-03MO-66MO-66-01MO-66-04TU-25-07TU-39TU-39-04TU-41-01TU-44-06TU-46-04TU-75-02TU-78-02TU-80-07TU-80-08TU-82-07WE-01WE-11-04WE-18P-MO-099P-SA-063P-TU-010P-TU-013P-TU-024WOC-C-12-09

Alipour F. TU-31-08Aliyeva S. MO-31-07Aljazzaf A. P-MO-061Allemann N. P-TU-188Allen D. MO-20-01

TU-82-05Allikmets R. SA-32-04Almazan A. MO-75-07Alonso Aliste F. WOC-C-63-01Alonso Mesonero M. SU-42-02Alp H. P-SA-192Alqahtani J. P-SA-021AlRajhi A. SA-19

SU-65-06MO-30MO-64WE-16P-SA-058

Al-Rashed W. P-SU-228Alsaeidi R. TU-33-03Alsuhaibani A. P-SU-228

SU-42-05Al-Swailem S. P-MO-013Altaweel M. M. MO-76-04Alten F. P-SA-197

370 WOC® 2010

Auth

or In

dex Al-Turbaq A. P-MO-020

P-SA-056P-SU-081

Alvarez de Toledo J. P. SU-70-09SU-70-11SU-70-18TU-81-02

Alves M. R. SU-74-01Alwan A. WE-25-07Amado D. WE-41-05Amansakhatov S. SU-35-09Amar R. TU-80-09Amaral A. MO-73-02

P-MO-050Amazigo U. SU-32-04Amberger R. TU-34-07Ambrecht A.-A. WE-34-03Ambrósio Jr. R. SA-04-02

SU-59-03TU-64-02 BS-04-01

Amde W. P-TU-224Amina B. P-TU-139

TU-31-05Amini P. SA-32-09Amiryan A. MO-77-02Amissah-Arthur K. P-TU-032Amjad M. P-SA-261

P-SU-150Amjadi A. P-SA-061Ammar D. A. P-MO-058

P-MO-059Amorim M. P-SU-144Amouroux-Gicquel N. SU-37-08Amparo F. P-TU-013

SA-27-11Amr A. P-MO-177Amr K. A. P-SU-050Amrani Y. P-TU-189Anderson L. D. TU-66Andrade R. E. MO-32-06

P-SA-271Andrew E. TU-34-06Andrews R. TU-65-04Andrews R. SU-38

MO-47-07Androudi S. MO-74-03

MO-76-10P-MO-248P-SA-012

Ang C. L. P-MO-084Ang M. P-SA-264Anggraini N. P-TU-104Angi M. MO-76-09

P-MO-224Anglade E. SU-37-03Ann H. J. P-SU-085Annaka M. P-SU-037Ansari G. P-MO-211Ansari-Astaneh M.-R. SU-36-10Anticic M. TU-81-03Antipova J. WE-39-01Antoniadis M. P-SA-012Apte R. TU-23-04Arafa L. SA-28-05Araie M. MO-22

MO-22-06TU-16-06TU-43-06

Arakaki Y. P-SA-120P-SA-123

Aral H. P-SU-233Aramberri Agesta J. SU-16-02Arantes T. P-SA-274

P-TU-206SU-27-08

Arat Y. P-SU-228Archer T. C. SA-04-03

TU-80-04 TU-80-10 P-MO-111

Arden G. MO-32-08Arevalo J. F. SA-41

SA-41-01SA-41-05SU-50-05MO-02-06MO-72-03TU-45-01WE-29WE-29-01

Arıcan G. Ö. P-SA-128Arikan G. P-MO-234

P-TU-061Arimura E. P-SA-106

P-SA-109Arintawati P. P-MO-010Arliani N. SA-26-10Armitage J. O. SU-19

SU-19-01TU-19-01 TU-40-02TU-81

Arnold A. C. WE-41Arranz-Marquez E. P-MO-117Arruda Mello P. A. P-TU-206Arrufat S. SU-39-02Artal P. SA-05

SA-05-01SU-60-02

Arteaga A. P. TU-25WE-18-05

Artes P. MO-14-03Arthurs B. P-SU-231Artini W. P-SA-118Artunay O. MO-67-03Aryasit O. P-SU-229Arzoallxhiu H. P-MO-209Asahara T. P-TU-231Asbell P. A. SU-09Ascarza A. P-SU-237Ashaye A. O. SU-74-04

WE-16-09Ashraf El Desouky M. P-SU-214Aslanova V. TU-29-04Asoklis R. TU-49-06

P-MO-091P-SA-181P-TU-084

Asp S. SU-47-03Assaf A. P-TU-019

SA-27-09Astakhov Y. MO-68-06

P-SA-203SA-28-07TU-33-07

Asteriades S. MO-75-08Astle W. F. MO-58

MO-59-03MO-59-06TU-66TU-66-01TU-66-02

Ataka S. P-TU-195Ates O. P-MO-003

P-SA-192Atsushi N. P-SA-126Attar M. MO-67-02Attaran M.-S. P-MO-273

P-TU-255P-TU-258

Attitich M. P-SA-008Auffarth G. U. SU-10

SU-10-05SU-15-04SU-45-05WE-10-02Po-MO P-SA-010P-TU-008P-TU-018P-TU-025P-TU-265WOC-C-43WOC-C-44WOC-C-45

Augsburger J. J. SU-34-07 MO-77-06 P-TU-094 WOC-C-60-01

Augsten R. P-SA-277Augustin A. J. MO-16

MO-16-03MO-72MO-72-05SA-34-03

Augustin M. P-SU-148Aung T. SA-31

SU-08-05P-SA-140

Auw-Hädrich C. MO-33MO-33-02SA-18-06SU-12-04P-SA-059P-SU-007

Avadhanam V. P-TU-144Averyanova O. P-MO-290

TU-31-02Avetisov S. P-SA-160Avni I. P-SA-096Awe B. TU-03-08Awh C. C. TU-18-05Aydin P. SA-38-12

MO-41MO-41-04TU-08TU-08-05TU-38-02TU-65TU-65-01

Aylward G. W. SU-48SU-51MO-29-05TU-23TU-23-02TU-69WOC-C-62WOC-C-62-02

Ayorinde O. WE-16-09Azad R. WE-37

WE-38WE-38-06WOC-C-58WOC-C-58-05

Azarpira N. P-SA-278Aziz R. A. P-SA-272Azizi S. P-SA-192Azuara-Blanco A. SU-03

SU-03-03Azuma N. P-SU-124

P-TU-129P-TU-200P-TU-222

371WOC® 2010

Auth

or In

dexB

Baade A. P-TU-196Babak J. SA-31-08Babu K. SU-57-03Babu N. P-MO-255Bach M. SA-38-10

SU-02-03SU-11SU-11-04WE-20-06P-SA-088

Bacharach J. TU-30-03Bachert I. P-SA-224Bachmann B. MO-17-02

TU-05-02Baddon C. P-MO-217Badeeb O. P-SU-054

TU-30-08Bae E.-h. SU-47-01Baerveldt G. SU-06

SU-06-05TU-30

Bagheri A. SU-61-02Baig N. B. SA-28-03Baile R. P-SA-082Bailey J. P-TU-169Bainbridge J. W. B. SU-25-01

MO-67-04Baiocchi S. P-SA-071

SU-35-03Baiyeroju R. WE-16-09Bajaj M. P-SU-242Bakaeva T. P-SU-201Bakunowicz-Lazarczyk A. P-SU-049

SU-55-07Balasubramaniam B. P-MO-086

P-SU-252Baldeschi L. SU-22

SU-22-04MO-82-03

Baltz J. P-SA-186Banandur P. SU-74-02Bandello F. SA-34

SA-34-05SU-50-06MO-32-01MO-32-02 MO-72-04MO-75-04MO-75-05TU-32-01 TU-35TU-35-01 WOC-C-32-02

Banerjee D. MO-35-02Banin E. P-SA-096Banker A. MO-67-03Bao Y. Z. SU-74-07Barabino S. SA-20-06

SU-35SU-37-06

Baradaran-Rafiee A. SU-36-10Baragan E. P-SA-003Barajas H. P-SU-003

P-SU-008Barak A. WE-28

WE-28-06Baraki H. P-MO-201Baralic J. P-TU-105Baran I. TU-31-08Baranyovits P. P-MO-147Barbazetto I. MO-77-03Barbosa C. P. P-SA-102

P-SA-274

Barisani-Asenbauer T. SU-27-02 MO-76-06TU-50TU-50-06

Barisic A. P-MO-112SU-47-06TU-81-03

Barkana Y. SA-12-05SA-31-09

Barleon L. P-MO-036P-MO-039

Barraquer J. SU-70SU-70-01SU-70-03SU-70-04SU-70-12SU-70-14SU-70-16SU-70-17SU-70-19WOC-C-40WOC-C-40-02

Barraquer M.-E. SU-70SU-70-02SU-70-05SU-70-13

Barraquer R. SU-70SU-70-07SU-70-08SU-70-10WOC-C-40WOC-C-40-04

Barreto F. SU-27-08Barrows J. M. MO-62-06Barry P. SA-06

SA-06-02Barton K. SU-06-04

MO-31MO-65MO-65-06MO-65-08TU-13-07WOC-C-41-04

Bartsch D.-U. SA-32-09P-SU-266P-SU-271

Bartz-Schmidt K. U. SA-06MO-24-07 MO-75TU-34-09P-MO-170P-SA-155P-SA-170P-SA-122P-TU-119 WOC-C-41WOC-C-41-02

Basel C. WE-37-07Batoosingh A. L. P-MO-071

P-TU-059TU-30-02TU-30-03TU-30-05

Batta H. WE-16-04Battu R. P-TU-218

SU-62-07Bauch A. S. P-MO-116Bauchiero L. TU-79-06Baudouin C. TU-31

TU-49TU-49-03WOC-C-47LS-17-02

Bauer D. MO-76-01Bauer K. P-TU-048

Bauer L. MO-28-09Bauer S. MO-26-04Baumann B. MO-27-01

MO-27-02TU-37-06

Baumeister M. P-MO-019Baumgarten S. SU-44-10Bäumler W. TU-32-09Baumüller S. P-MO-158

TU-35-08Bautista De Lucio V. M.P-SU-024Bayramoglu S. SA-31-06Beaconsfield M. FR-01-16

SU-76SU-76-02MO-11TU-41TU-41-12WE-32WE-33WE-33-03

Bechir J. MO-32-05P-SA-249P-SA-270

Bechrakis N. E. MO-03-06SU-34SU-43-01WE-24WE-24-08P-TU-089P-TU-114

Beck S. P-SU-094SA-28-04

Becker L. P-SU-218Becker M. P-TU-177Becker M. D. SU-27

SU-27-02Bedri A. SA-37-03

TU-42Beger I. P-MO-196Behar F. WE-15

WE-15-02Behrens A. TU-79-07Behrens-Baumann W. SU-28

SU-28-02WE-37-06P-MO-029P-SA-112P-SA-146P-TU-057P-TU-221WOC-AAD-C-19

Beiko G. SA-27 SA-27-04TU-46-03WE-18-07

Bek T. TU-56-04Bekibele C. SU-74-05

WE-16-09WE-41-08

Beko M. P-TU-071Belfort Jr R. SA-41-02

SU-20-07SU-34-04SU-40SU-64MO-03MO-03-03MO-32MO-32-01MO-32-02MO-32-06 MO-50MO-50-01MO-75-04

372 WOC® 2010

Auth

or In

dex TU-32-01

TU-35-11P-SA-271P-SA-274P-SU-110P-SU-208 P-MO-023WOC-C-41-03

Belfort Neto R. MO-33-06SU-57-01

Belin M. W. SU-17-11Belinsky I. P-TU-090Belkin M. P-MO-121

P-MO-216SU-38-05

Bell K. P-SA-111Bellucci R. MO-40-07Belshi A. SU-42Beltaief O. P-SA-079Benchérifa F. P-TU-140Benelli U. SU-37-05Bengtsson B. MO-13-04

MO-14-02Benharbit M. P-TU-189Benítez del Castillo Sánchez J. M. TU-79-02Bennett K. L. SA-27-02

P-SU-188Benz M. S. SU-49-02Benzimra J. P-SU-191Berendschot T. T. J. M. TU-33-08Berger A. SU-36-09Berger W. P-SA-088Bergin C. P-MO-028Bergmanson J. TU-21-06Bergua A. P-SU-080Berisha F. P-MO-049Berit K. P-SA-060Berna M. J. P-SA-182

P-SA-184P-SA-185

Bernardes N. SU-74-01Berna-Thill M. P-SA-184Bernd A. S. P-TU-219Bernstein P. TU-30-01Berraho A. P-MO-066

P-SA-141P-TU-140

Berrocal A. WE-29-08Berrut G. P-SU-068Berta A. P-SU-028

SU-75SU-75-06

Bertone C. SA-10-03Bertrand I. P-SU-151Berzas C. SU-09Besch D. TU-34-09Bessa Jr J. P-TU-036Bessler P. P-MO-040

P-SA-145Best G. P-SA-177Beuerman R. MO-35-05

SU-37-04Bever M. P-TU-196Bezditko P. P-SA-210

SA-31-08MO-35-08P-SA-054P-SA-156P-SU-236

Bhandary S. MO-28-05Bhargava M. MO-67-10

P-MO-276P-SU-274P-TU-218SU-62-07

Bhatta S. P-MO-202Bhattacharyya B. P-SA-024Bhisitkul R. B. TU-23

TU-23-06Bi X. P-SU-234

P-TU-087P-TU-115SU-42-10

Bialasiewicz A. A. SA-14SA-14-05Po-SU

Bianchi P. E. SA-10-03Bidaye S. SU-81-06

MO-73-06P-TU-055

Biewald E. P-SA-239P-TU-123

Bigdon S. P-SA-182P-SA-185

Bikbov M. P-SA-085TU-31-03

Bikbova G. P-SA-085TU-31-03

Binder C. TU-78-05Binder S. SA-03

SA-03-02SA-32SU-49-07TU-03-03TU-45TU-48TU-48-04P-TU-176

Birnbaum F. MO-30MO-30-04TU-81Po-MOP-MO-038

Birngruber R. SU-38MO-79-04 TU-36-08P-SA-186P-TU-196

Birulya I. SA-28-07Bischoff G. SA-13-04

SA-14MO-59MO-59-07

Bispo P. P-MO-098Bissen-Miyajima H. SU-14

SU-14-05P-SA-004P-SA-037

Bissmann W. P-SA-077Biswas J. MO-74

MO-74-10TU-47-05WE-30WE-30-03

Biswas P. P-SU-189WE-34-05

Blakeman A. SU-44-05Blamires T. P-TU-198Blanch R. MO-28-04Blanco-Mateos G. SU-12-01

SU-42-02Blasiak J. P-SA-099Bleeker J. C. SU-34-08Bleich S. SA-28-08Bloch K. P-SU-068Blomberg L. SU-75-07Blondeau F. P-SA-027Bloomer M. SU-35-02Blue M. P-MO-014Blum M. TU-80-02

Po-TUP-SA-077

Blumenkranz M. S. MO-29-04MO-32-01MO-32-02MO-75-04TU-32-01 TU-54TU-54-05

Bobisch N. P-TU-157Bobrova N. F. SU-55

SU-55-04P-SA-078P-SU-239P-TU-138P-TU-166

Bock R. SA-29-04Bodaghi B. SA-08-06

SU-27SU-33SU-33-03 MO-76-09TU-50TU-50-04TU-60TU-60-02TU-83WE-09-06

Boehm N. MO-73-10P-SU-094P-SU-204SA-28-04

Boeker T. WOC-C-62-08Boes T. SU-39-04Bohac M. P-MO-112

SU-47-02SU-47-06

Böhm M. R. R. P-TU-044P-TU-213

Bohorquez V. P-TU-014SA-27-03

Böhringer D. SU-19SU-19-02SU-37-03 TU-19-05P-MO-038P-MO-236P-MO-294P-SA-068P-SA-070P-SU-045P-TU-043P-TU-047

Boiko E. V. WE-28-03Bojic L. P-SU-075Böker T. WOC-C-62-03Bokhorst A. G. TU-19-07Boland M. SU-03-02

SU-05-03WE-04-02

Bolintineanu C. P-SU-002P-SU-005

Bolintineanu S. P-SU-002P-SU-005

Bolz M. MO-27-02P-TU-232 WOC-C-15-03

Bönig H. P-SU-041Boniuk M. P-SU-228Booth A. P. TU-30-09Bopp S. Po-MO

P-SA-170Borasio E. MO-19-02Borderie V. TU-19-06

373WOC® 2010

Auth

or In

dexBornfeld N. SU-39

SU-39-01 SU-39-04 SU-43-02MO-24-05 MO-77MO-77-04 TU-09TU-22WE-24-03P-SA-239P-TU-112P-TU-116P-TU-123P-TU-126WOC-C-36WOC-C-60-05

Borooah S. P-MO-270Borras T. MO-53-07Borruat F. SU-29-06

WE-20-04Bort B. P-MO-245Bösch M. P-TU-049Boscia F. TU-28-01Botabekova T. P-TU-158Botbaev A. P-TU-002

SA-27-08Bottós J. P-TU-188Boucard C. SU-44-09Bouhaimad M. P-SU-228Boulanouar A. P-MO-066Boullanger D. P-TU-185Bourmani O. P-MO-066Bouzouaya C. SU-37-07Boyer D. S. P-MO-198

TU-37-07Bradley J. TU-31-08Branchevskiy S. P-SU-062Brandenbusch T. P-TU-097Brandlhuber U. P-MO-222

P-TU-017Brandt S. P-SU-153Bras D. TU-82-02Bräuer L. FR-01-15Braun B. P-MO-102Braun J. SA-40-01

P-SA-065Brazitikos P. SU-48-04

MO-74-03P-MO-248P-SA-012

Bredow L. P-MO-294P-SU-045

Breitstadt R. P-MO-039Breitwieser F. P. P-SU-188Brennan M. W. MO-81-02Bresse X. P-SU-068

P-SU-071Bretthauer G. SA-27

MO-79-07MO-79-08P-SU-190

Brewitt H. FR-01Breyer D. R. H. SU-80-02

P-SA-018P-SA-030P-MO-114

Brezin A. P. MO-11-07Brian G. WE-16-01Bridges L. P-TU-146Brinkmann C. K. P-SA-176

P-SA-197Brinkmann R. P-SA-186

P-TU-196TU-36-08

Briszi A. P-SA-011Brock K. SU-74-01Brockmann M. P-SU-268Brodie A. SU-75-10Bron A. J. SA-20

SA-20-02SU-63SU-63-05

Brosius T. P-SA-162Brucker A. J. SA-33

SU-51-02MO-45-06

Brueckner K. P-TU-006Bruggemann A. SA-31-04

P-TU-075Bruijning J. MO-10-06Brummeisl W. MO-31-10Brunken W. J. P-TU-243Brunner U. TU-34-09Brunotte I. P-SU-220

P-TU-048Brüx S. P-SA-265Bu J. P-SA-231

P-SU-133Bubalo D. P-SA-220Buchanan L. M P-SU-145Büchner T. P-SU-196

P-SU-240Buchwald H. SU-45-03

P-MO-141P-MO-159

Buckhurst P. P-TU-009P-TU-037

Buckley E. G. TU-07-02Buczak-Gasinska K. P-MO-109

P-MO-022Budenz D. SU-04-01Budiene B. P-SU-178Budo C. SU-79-03

MO-40-03P-MO-131

Buehler A. P-SU-001Buehler K. J. MO-62

MO-62-01Buhari S. P-TU-259

SU-74-08Bühl W. MO-67-07

P-TU-028Bühren J. SA-13-05

MO-35-07P-MO-019P-MO-116P-SA-157P-TU-015P-TU-016

Bukhari A. P-SU-197Bulgen M. FR-01-02Burau H. WE-39-08Burgess B. L. MO-77-05Burgess G. WE-41-09Burggraaff M. C. MO-10-02Burgoyne C. WE-07-07

WE-39WOC-C-31WOC-C-31-03

Burian G. MO-68-02TU-35-01

Burk C. P-TU-060Burk R. O. W. WOC-C-31

WOC-C-31-04Burke J. MO-75-07

P-TU-199Burlutsky G. SU-73-03

Burnier M. N. MO-33MO-33-01SU-57SU-57-02

Burr J. SA-21-06WOC-C-10-04

Burzer S. SA-32-10Busch M. MO-76-01Büschlepp E. P-SA-263Busin M. SU-78-05Busse H. P-TU-044

P-TU-083Butkiene L. P-TU-084Butros S. P-MO-159

TU-81-02Buznyk O. TU-81-08Buzzonetti L. P-MO-161Bynoe L. MO-67-03Bytton Díaz L. C. P-MO-281Byun Y. J. SA-25-02

C

Cagıl N. P-MO-002P-MO-005

Cai J. P-TU-106Cairui L. P-MO-229

P-SU-267TU-36-10

Cakmak H. B. P-MO-002P-MO-005

Caligaris L. SU-74-01Callahan D. SU-27-03Calvão-Santos G. P-SA-258

P-SU-273Camargo J. F. P-SU-082Cameron J. P-MO-270Campos E. C. SU-55-03

SU-76-04 MO-09-01

Canan G. TU-26-03Cantemir A. P-TU-078Cantor L. TU-30-06Canut I. SU-70-06

SU-70-16Capo H. MO-78-01Capone A. MO-29-02

SU-48-06Caporossi A. P-SA-071

SU-35-03Caprioli J. TU-30-01

TU-30-03 TU-63 WE-07-03

Caramoy A. P-SA-214TU-34-04

Cardoso Neto I. P-TU-036Carlisle-Wilcox C. P-MO-014Carollo G. P-MO-161

P-MO-291Carassa R. SA-11-05Carlton J. SA-47-02

SA-47-03Carrasco B. P-SU-086

TU-35-09Carreño E. SU-34-10

SU-34-11Carriazo C. TU-74Carter D. A. P-SU-252Cartwright D. P-TU-151Carvalho F. R. S. P-SU-082

374 WOC® 2010

Auth

or In

dex Carvalho

Vasconcelos G. SU-74-06P-SU-112P-TU-165WOC-C-59WOC-C-59-02WOC-C-59-06

Casella A. M. MO-32-06Caspi R. R. SU-31-01Cassoux N. SU-67-07Castilla M. TU-29-05Castillon Torre L. P-TU-247Castin R. MO-68-07Castro-Navarro J. P-MO-221Castro-Paiz M. MO-75-06Cate H. SU-05-02Cavaglieri S. P-TU-165Cekic S. P-SU-152Ceklic L. P-TU-191Celestino deAlmeida H. P-TU-165Celik Y. P-SU-106Cernák A. SU-17

TU-19Çetin B. P-SA-128Cetkovska P. P-TU-113Ceyhan D. P-SU-074Ceylan O. P-MO-003

P-SA-192Chadha S. P-TU-198Chai Teck C. P-SA-217Chakrabarti A. WOC-C-12

WOC-C-12-01WOC-C-12-02WOC-C-12-03

Chakravarthy U. MO-45Chamot L. SU-34-02Chan A. S. Y. SU-57-06Chan C. C. MO-76

TU-53TU-53-04P-SA-252P-SA-260

Chan C. K. P-MO-246Chan C. K. M. TU-35-07Chan C. M. L. SA-14-07

SU-37-04MO-64-04P-TU-257

Chan C. Y. N. WE-41-06Chan J. P-SU-216

P-SU-247P-TU-160

Chan K. Y. P-SU-057SU-42-04

Chan P. P-TU-202Chan R. P-SA-260Chan S. P-SA-093Chan T. K. P-TU-169

ES-05-04Chan T. K. J. P-MO-030Chan U.-t. P-TU-161Chandra M. P-SU-242Chandrakumar M. SU-44-05Chandran M. P-MO-211Chandra Sekhar S. P-MO-086Chang L. MO-32-03Chang S. MO-24-03Chang-Hua P. P-TU-214Chantzaras A. P-TU-093Chanudet E. SU-67-02Charalambos P. P-SU-256

P-SU-148Charalel R. WE-40-08

Charbel Issa P. MO-27-06P-MO-158P-SA-176P-TU-204TU-35-08

Charitoudis G. P-TU-114Charles S. J. P-MO-195

P-MO-174Chatziralli I. P-SA-276

P-SU-035Chaudhri A. TU-37-05Chaudhry I. P-SU-228Chauhan A. SU-09-04Chauhan B. SU-02-04

WOC-C-31WOC-C-31-01

Chaum E. SU-62-04Chaumet-Riffaud P. TU-41-07Chavan R. P-MO-252Chaves Fernandes L. SU-74-06Chavez-Mondragon E. SU-79-02Chawla B. P-SU-242Chee Chew Y. SA-44

SA-44-04Chee S. P. MO-50-06

TU-60TU-60-03TU-73TU-73-03TU-83 P-SA-264

Cheeseman R. SU-40-02Chen C. P-SA-201

SU-74-09Chen C.-Y. P-SA-114Chen D. F. MO-53-01Chen E. MO-67-03Chen H. S.-L. P-TU-081Chen J. SU-38-10Chen K.-J. P-SA-245Chen M.-J. P-SA-114Chen Q. P-MO-136Chen Rundle A. MO-67-06

TU-29-09Chen S.-J. P-SU-067Chen T.-h. MO-24-02Chen X. SU-36-05Chen Y. P-SA-216

P-SA-221Chen Y.-L. P-MO-090Cheng A. C. SU-60

TU-64-03Cheng C.-Y. P-SA-105

P-SU-067Cheng L. SA-32-09Chentsova E. SU-35-06Cheung C. SU-41-02Chew P. SA-30-02Chhabra M. P-SU-223Chi L.-c. J. P-MO-257Chiang F. WE-16-04Chiang M. SA-29

MO-04-04Chiang S. P-SA-252Chibante J. P-SU-273Chibisova A. N. SU-44-06Chi-Burris K. P-MO-063Chin K. TU-35-02Chiselita D. SA-31

P-TU-078Chiu H. P-MO-241

WE-37-03Chiwitt C. P-SU-148Cho H. P-MO-200

P-TU-234TU-29-07

Choi J. H. P-TU-142SU-55-06P-TU-162

Chomicz L. P-SU-026Chong K. P-SU-222Chong L. P. WE-08Chong X. L. P-SA-140Chongpison N. P-SU-230Choo C. T. SA-44-07

P-SU-245Choo M. L. P-SU-267Choo M. M. P-MO-280

P-TU-161Chopovska Y. P-TU-186Choragiewicz T. P-SU-264

P-MO-260Choritz L. P-SA-111

P-TU-076Chou C.-K. P-SA-114Choudhary R. WE-34-05Choudhury K. P-SU-189Chow D. TU-18-06Chow L. P-MO-197Christmann S. P-TU-095Chryssafis C. MO-75-08Chrzanowska B. P-SU-049Chu D. SU-27-03Chu R.-Y. P-MO-119Chui J. P-SU-032Chun Y. S. P-MO-284

P-MO-296Chung H. WE-14-06Chung S. K. P-MO-139

TU-25-04Chung Y. P-MO-139Chunhong G. WE-16-02Ciechanowski P. P. P-MO-041

WE-39-04Cilliers H. P-MO-197Cimbalas A. P-SA-181Cinatl J. MO-32-10Ciobanu I. P-SU-005Cisiecki S. MO-27-05

P-MO-207Claerhout I. TU-44-04Claessens D. P-SA-213Claoué C. SU-13

SU-13-02Claringbold T. WE-02-02Clark A. WE-40-09Clark M. E. P-SU-251Clarke J. C. K. SA-21-05Clemens C. P-SA-195

TU-33-02Clemens S. SA-29-02

SU-80-04Po-TU

Clemens V. P-TU-118Clifford L. P-MO-273Coady P. MO-76-08Cochener B. SU-36

SU-36-01TU-41TU-76-04WE-32

Cohen J. S. MO-08-05TU-30-05

Cohn H. C. MO-13Colangelo L. SU-42

WE-12-07Colenbrander A. MO-23

MO-23-01

375WOC® 2010

Auth

or In

dexColin J. SU-36

SU-58MO-40MO-40-05TU-46-04

Colinge J. P-SU-188SA-27-02

Collin J. R. O. SA-42SA-42-05TU-68-04WE-12WE-12-06WE-33WE-33-06

Colvard M. SU-10-06Conesa E. P-SU-083

P-SU-207Congdon N. G. MO-51

MO-51-07WE-36WE-36-01

Conlon J. MO-62-04Constable I. MO-56

TU-54-06Contarini P. TU-31-09Conte M. SA-28-02Conzelmann I. SU-79-07Coral-Ghanem C. WE-21-01Corcostegui B. WOC-C-07

WOC-C-07-02Cordeiro M. F. SU-01-03

TU-15TU-15-02

Cordes A. K. TU-27-03TU-27-06P-MO-223P-TU-157P-TU-030P-TU-153

Cornelissen F. SU-44-09Corrêa Z. M. SU-34-07Correa de Carvalho C. SU-74-06Correa Z. MO-77-06

P-TU-094Correia Ferreira L. S. P-TU-262Corriveau C. MO-77-08Cortes M. TU-34-11Cortes Mora N. P-SU-086

TU-35-09Cortese M. SU-17-11Coscas F. WOC-C-61-01Coscas G. J. TU-29

TU-67-07TU-71TU-71-01WE-11WE-11-02WOC-C-61WOC-C-61-04LS-08

Coskun C. P-SA-143Costa E. SU-73-04Costa V. P. TU-16-05Costa-Ferreira C. P-SU-144Costagliola C. P-MO-224Coupland S. E. SU-12-05

SU-39-09SU-67SU-67-04MO-18MO-33-03TU-40-02TU-53TU-53-01

Couroucli X. SU-55-09

Courtney R. SU-55-05Courtright P. SA-37-07

SU-74-03 MO-51-06P-MO-080

Couto Sacramento J. P-SU-112Couturier J. SU-39-02Crabb D. P. MO-14-04Craig J. TU-43-01Crane I. J. SU-31-04Craven E. R. P-MO-071

TU-30-02Cremer C. P-SA-177Creuzot-Garcher C. MO-55-02

TU-49-04Cristóvão L. M. SU-73-04Crossland M. D. MO-10-05Crowston J. TU-30-04Croxatto J. O. TU-70-05

WOC-C-47-03Cruysberg J. R. M. TU-33-08Cucera A. FR-01-03

P-MO-182P-MO-277P-TU-033

Cui G. P-SU-136Cui H. P-SU-110

TU-35-11Cui H.-P. WE-39-06Cullen J. MO-26-06Cumberland P. SU-73-07Cummings A. TU-64-05Cummings T. J. SU-12-02

TU-70-06TU-70-07

Cunha J. P. WE-41-05Cunha-Vaz J. MO-45

MO-45-04MO-61MO-61-02TU-44TU-44-01

Cunnigham E. T. MO-46-05TU-60-01

Cuny C. SA-28-06TU-36-03

Curcio C. A. P-SA-187P-SU-251

Curnow S. J. SU-31-03TU-17

Cursiefen C. SU-78TU-41-05Po-SUP-SA-065P-TU-050P-TU-127 WOC-AAD-C-11

Cvenkel B. TU-30-04Cvintal V. SU-45-01Czepita D. P-SU-061

P-SU-063Czeszyk-Piotrowicz A. P-MO-289

D

da Silva J. MO-67-04Daftari I. P-SA-211Dahl P. TU-19-02Dai Y. SU-74-09Daito M. P-SA-150Dalz M. P-SU-073

P-SU-073Damani M. P-MO-211Damar E. P-MO-005

Damasceno R. P-SU-241P-SU-243

Damato B. D. SU-12-05SU-39-09 MO-18-02MO-44-02TU-22TU-40-02TU-40-03WE-23-07

Dame G. P-TU-031Damgude S. P-SU-195

P-TU-040D'Amico D. J. SA-36

MO-29TU-45

Damico L. A. MO-68-05Dana R. SU-38-06Danieliene E. SU-36-02Danielius R. SU-36-02Daniels J. T. FR-01-16Daniil Z. MO-76-10Danilova D. P-SA-045

SU-35-06Daniyar D. P-SA-262Dannoue K. P-SU-219Daoudi R. P-TU-189Dapena I. TU-31-01Dar K. A. P-SA-128Dardenne C. M. P-MO-114Dart J. K. G. SU-28

SU-28-01MO-35MO-49-06TU-49-02

Darusman K. P-SU-090Darvish M. P-SU-231Das J. P-TU-100

WE-40-03Das R. P-MO-279

P-TU-040Das S. P-MO-279Das T. P. MO-56-05

SA-03-06Dashevsky A. SU-35-11Dauletbekov D. P-SA-262Davari T. P-SU-165Davies S. P-SU-032Dawczynski J. P-SA-277Daxer A. SU-35-08

P-SA-055WOC-C-39

Day S. H. MO-42-08Dayawansa K. SU-80-01

MO-25-09P-SA-273P-TU-062

de Abreu Melgaço S. P-SU-112De Benito-Llopis L. P-MO-117

P-MO-143de Boer J. MO-74-05De Carvalho J. H. SU-74-06de Castro Moura Brasil L. P-SU-084de Faber J.-T. SU-52-06

MO-69MO-69-04

de Freitas D. MO-50-07MO-57MO-57-01 TU-31-09P-MO-023P-SU-082

de Groot J. TU-83De Groote J.-J. P-MO-100

376 WOC® 2010

Auth

or In

dex de Juan, Jr. E. TU-45-03

de Keizer R. J. W. SU-34-08SU-42-09

de Klein A. SU-39-05de la Cruz J. P-SA-073de Laey J.-J. TU-11de la Torre A. P-MO-006de la Torre-Tovar D. P-MO-046de la Paz M. SU-70-18de Matos L. P-SU-180De Moraes G. V. MO-13-05

MO-31-11 SA-12-02

de O. Regina M. C. P-SU-109SU-40-04

de Oliveira E. P-SU-180de Ortueta D. P-MO-128

P-MO-140De Pablo C. P-SU-083

P-SU-207de Paula Fiod Costa E. P-SU-011de Sá M. F. P-SU-084De Smedt S. SU-38-04de Smet M. D. MO-46-03

SU-33-02de Souza Pena A. WE-21-06Deak G. P-TU-232Decaudin D. MO-76

TU-53-05Decker A. P-MO-245Deeg C. A. TU-17-05

P-SA-251DeForge L. MO-68-05Deininger D. P-MO-286Deissler H. TU-36-07Dejiao L. SA-31-05Deka S. P-TU-238

P-TU-249Dekaris I. P-MO-112

SU-47-02SU-47-06TU-81-03

Dekel I. SA-31-09Del Amo Freire J. P-SA-023Del Monte M. A. SU-52Dembovetskaya A. SU-55-04Demirok A. P-SU-198Denaro R. P-SA-071

SU-35-03Deng L. P-SA-134Denisova E. SU-41-07Derhartunian V. P-MO-116Dermon C. P-SU-122Desai P. TU-81-07Desch M. P-SU-268Deschenes J. P-SU-231Deshmukh S. P-TU-164

SU-55-08Deshpande A. P-SU-072Desjardins L. SA-09

SA-09-04SU-39 SU-39-02MO-75-01TU-41-08WE-23WE-24WE-24-01WE-37

Deters C. P-MO-039Dettbarn M. C. P-SA-166Dettler N. P-SU-137

Deuter C. M. E. SU-27-04MO-46-04TU-53TU-53-06WE-30-06Po-SAP-SA-254

Deva J. SA-15-04Devgan U. TU-46-02

P-SA-028P-SA-035

Dexl A. P-SA-044P-TU-010SA-26-06

Dharmasena A. SU-35-05Dhibi H. A. MO-70-01Dhillon B. SU-44-04

WE-34-03Di Girolamo N. MO-64-02

P-SU-032Diaz A. P-MO-189Diaz Barron A. P-TU-210Diaz-Llopis M. MO-11-09

P-MO-097P-MO-189P-SA-243P-SA-266P-SU-169

Dib E. MO-32-09Dichtl M. SU-17-07Dick A. D. P-SU-252Dick H. B. SA-19-04

SU-45MO-19MO-19-03MO-66-06 TU-25-07WE-01-06WE-02Po-SAWOC-C-43 WOC-C-45

Dickenson A. J. SU-22-02MO-82

Dieckow J. P-SU-012Diedrichs-Möhring M. P-SA-251Diesenberger D. SU-17-07Diestelhorst M. Po-SA

P-MO-065Dietlein T. S. P-SA-013

P-MO-274P-TU-066 WOC-AAD-C-02

Dietrich T. P-MO-157P-SA-124P-TU-050

Dietzel A. P-TU-194Diez-Andino P. SU-34-10Dimaras H. SU-41-11

SU-74-02WE-37-03

Diniz B. P-SA-271P-SA-274

Dirisamer M. SU-17-07Dithmar S. SA-43

SA-43-03 SU-38-02MO-03 TU-34-07P-MO-164P-SA-177P-SA-255P-TU-203P-TU-244

Djordjevic-Jocic J. P-SU-098

Dmitriew A. P-TU-154Do D. MO-01-04

MO-75-06WE-38-01 WOC-C-57-01

Dobner B. P-SA-255SU-27-02

Dobrowolski D. MO-35-03SA-31-03SU-35-10

Doga A. MO-26-05SU-36-04

Dogra M. WOC-C-58WOC-C-58-04

Dolgoff R. MO-08-02Dolgopolov I. WE-35-02Dolz-Marco R. P-MO-189Domack H. P-TU-034Dombi T. P-SU-097Domenghino I. P-TU-044Domingues I. MO-73-02Dominika J. MO-35-03

SA-31-03Dong C. SA-32-03Dong G. SU-67-02Donner R. TU-37-06Donshik P. MO-59-02

TU-26-02D- ordevic J. P-SU-152Dorecka M. TU-36-09Dorn V. P-SU-076Dorrell M. I. TU-36-05Dorsey A. P-SU-254Dou H. WE-35-10Doubal F. SU-44-04Doudou A. P-SA-012Doughty M. J. SU-75-04Douglas R. TU-06-04Downie R. SU-74-02

WE-37-03Doycheva D. P-SA-254Draca N. TU-81-03Draeger J. A. SA-31-10Draganic B. P-SU-176Dragomyretskaya E. P-MO-113Drenser K. A. WE-29-07Drexler W. MO-61

MO-61-03Dridi M. J. P-SA-101Drnovšek-Olup B. MO-28-11

MO-78Droggina G. P-SA-078Droutsas K. TU-31-01Drozhyna G. P-SA-053

P-SA-098Dryja T. P. SU-27-03Drzyzga L. P-MO-056Du M.-Q. SU-67-02Dua H. S. SU-35

SU-75-10MO-17MO-17-03TU-81-07

Duarte Silva E. J. SU-42-02Dubovy S. MO-77-08Ducournau D. TU-01

TU-01-03Duerksen R. SU-64-07

SU-65-04TU-57-05

Dugel P. TU-34-10 WE-38-04

Duker J. S. WOC-C-15-01Dumbrova N. P-TU-166Dunavölgyi R. MO-67-07

377WOC® 2010

Auth

or In

dexDuncker G. I. W. SU-47

TU-21TU-61-03TU-61-06 P-MO-123WOC-C-06WOC-C-21WOC-C-22

Dunse M. FR-01-04Dupps Jr. W. J. SU-59-01

MO-39MO-39-01WE-03-01

Duquesnoy R. J. SU-19SU-19-03

Dutton G. SA-10SA-10-01SU-44-04

Dydykina S. TU-32-09Dzafarly T. P-MO-031Dzhumagulov O. P-SU-069Dziegielewski K. MO-27-05

E

Eagle Jr R. C. SU-34-05 MO-33-04

Eberwein P. FR-01-05P-TU-043P-TU-047

Ebner R. WE-40-01WE-40-01

Eckardt A. MO-78-03Eckardt C. P-SA-170Ecke I. P-MO-062Eckert S. Po-SA

P-SU-200P-SU-235

Eckert T. P-SA-170Eckstein A. K. MO-82-03

SU-22SU-22-03P-SU-246

Edelman J. L. MO-75-06Edirisooriya J. P-SA-273Edmond J. C. SU-52-07Edward D. P. MO-43

MO-43-03MO-43-07MO-43-09TU-40-04

Eggert A. P-TU-116P-TU-123

Eggink C. A. P-TU-065Eghtedari M. P-SA-238

P-SA-238Egidio R. P-SA-090

P-SA-094Eguchi H. P-SA-232

TU-31-10Eha J. TU-41-10Ehlers W. H. MO-43-05

MO-44-07MO-59-01MO-59-06TU-21

Ehlken C. P-SA-161Ehmer A. P-TU-018Ehrhardt B. A. P-MO-184Ehrlich R. TU-30-06Ehrt O. SA-47

SA-47-05SU-18-04MO-51Po-SU

Eibl K. P-MO-249P-SA-173P-SA-202P-SA-205P-SU-272TU-25-08

Eid Farah M. MO-32-09P-SU-011

Einolahi B. SU-36-10Eisenbarth W. P-SA-208Eisenkoelbl S. MO-68-03

P-SA-200El Alloussi T. P-MO-066

P-SA-141P-TU-140

El Danasoury M. A. SA-01-08SA-26 SA-26-01SU-59SU-59-06TU-39-06TU-64-04P-MO-129

El Defrawy H. H. E. D. WE-40-10El Hage S. TU-21-06El Mrabh M. P-TU-140El Ouazzani Chahdi K. P-TU-189El Seht R. P-MO-292El Shorbagy M. S. P-MO-292El Yamouni O. P-TU-140El-Amir A. P-TU-032El-Ashry M. WE-34-03El-Awady H. P-SA-142El-Baz A. SA-28-05Elboraey M. G. E. WE-40-10Elfakey Y. SU-42-05Elflein H. P-MO-187

P-TU-147WE-41-02

Elhassan E. P-TU-259Elizabeth Hale J. TU-25-01Elizalde J. WOC-C-40-03Elizondo A. SU-09-07El-Lakkany R. TU-32-02Ellis-Behnke R. G. MO-47-05

MO-53-05TU-15-06

Ells A. WE-09-02El-Maghraby A. WE-16Elmekawey H. P-MO-177

P-SU-050WE-40-10

El-Shabrawi Y. P-SA-135Elsherbiny S. P-TU-212Elshiwy H. E. MO-25-10Elzaridi E. P-SU-228Eming S. A. P-TU-254

P-SU-260Emmerich K.-H. SU-71

SU-71-06MO-78MO-78-10P-SU-248P-TU-093 WOC-C-13

Enders C. P-SA-208Endl E. MO-79-01Endo T. TU-32-08Engel M. P-SU-111Engelbert M. MO-24-03Engelmann K. TU-19-08

Po-TUEngelmann V. P-MO-171

P-MO-228Engin A. P-SA-165

Engin K. N. P-SA-128P-SA-143SA-31-06

Engle E. SA-45SA-45-02MO-71-02

Enikeev A. P-SA-042Enoki M. P-MO-064

P-MO-166Enzmann V. P-TU-178Eppelin A. MO-48-05Epstein D. TU-76-07

TU-78TU-78-01

Epstein D. MO-45-01Erb C. SU-46-06

TU-13Po-TUP-SA-148P-SA-149

Erben A. P-SA-263Ergin M. P-TU-061Ergun S. FR-01-06Ermilov V. MO-68-08Ernest P. H. TU-75-05Erol N. P-MO-242Errais K. P-SA-079Ersoy L. P-MO-065

P-SU-106Escobar M. P-TU-199Eshmambetov A. SA-27-08Eskelin S. MO-77-08Esmaeli B. SU-67-05

TU-40-05España-Gregori E. P-SU-169Espinoza R. MO-23-06Esser J. SU-22-05

P-SU-246Essig H. MO-78-03

SU-38-09Estermann S. P-SU-027Estrada Rodríguez J. L. P-MO-183

P-MO-250P-TU-041

Estu D. P-SA-118Eter N. MO-79-01

TU-33-02TU-69WE-34WE-34-04P-SA-188P-SA-195

Etualin González A. P-TU-041P-TU-131

Etya'ale D. SA-37-02SA-48SA-48-01SU-65-03

Eule C. FR-01-10Eun-kyoung K. TU-25-02Exarchou A. P-MO-214

F

Faal H. SA-37-02SA-48-04

Faber D. P-MO-198Fabian E. WE-10-04

P-TU-011Fahmy I. P-SA-132Fain J. P-SA-100Falk N. SU-27-03Fan J. L. P-MO-167Fan L. TU-66-04

378 WOC® 2010

Auth

or In

dex Fan X. SU-17-09

SU-42-06SU-42-10MO-25-07P-SU-060P-SU-193P-SU-213P-SU-221P-SU-227P-SU-234P-SU-238P-TU-102

Fan X.Q. SA-44SA-44-08

Fan Y. C. P-SU-066Fang I.-M. P-SU-259Fang S. K. SA-30

SA-30-07Fantes F. SA-11

SA-11-02Farah M. E. MO-32-06Farah O. P-SA-089Faria e Sousa S. J. P-MO-100

P-MO-101Fariduddin K. P-TU-260Farkas A. SU-75-02

TU-31-07Farnworth D. P-MO-273Farooq T. P-SU-247Farrar J. WE-15

WE-15-03Farvili E. SA-27-07Farzavandi S. MO-69-06

P-SA-217Faschinger C. MO-12-04

P-SA-135Fasina O. WE-16-09Fass O. N. SU-81-01Fatiha B. P-TU-139Fauser S. P-SA-214Faust M. P-SA-043Fazelipour S. SU-17-05Fazzi E. SA-10

SA-10-03Fechtner R. MO-13-06

WE-07WE-07-05

Federov A. P-SU-153Federowicz A. P-SA-091Fedorov A. P-SU-201

SU-44-06Fedorov A. B. SU-44-08Fehse B. P-SU-271Feinbaum C. P-MO-024

P-SA-075 WOC-C-46WOC-C-46-04WOC-C-46-05WOC-C-46-08

Feiner L. MO-67-06Feke G. T. P-MO-049Felix C. TU-30-05Feltgen N. P-MO-236

P-TU-248TU-29-08 WOC-C-55WOC-C-55-03

Feng X. WE-35-10Fengyuan S. SA-44-01Ferman-Atar G. P-MO-216Fernandes J. P-SU-068Fernandes L. C. WOC-C-59-05

WOC-C-59-06

Fernandes M. P-MO-285P-MO-298P-SU-030

Fernandez A. P. MO-15-06Fernandez de Benito F.P-MO-047

P-MO-093Fernelius C. TU-40-06Ferrara D. SA-32-04Ferreira J. MO-73-02

P-MO-050P-SA-258P-SU-273WE-41-05

Ferrone P. TU-18-09Ferry J. SU-67-02Feucht N. P-MO-146

P-MO-205P-SA-208P-SA-233SA-32-10TU-35-05

Feuchtenberger M. P-MO-008Fiala W. P-MO-110Fichter N. MO-34-04Fiedorowicz M. P-SU-264Fielder A. MO-04-06

TU-66Figueroa M. S. LS-08-03

TU-48-02Filipek E. P-MO-162Filipi H. MO-44-06Filser E. P-TU-007Fimia A. P-MO-099

TU-82-07Fimmers R. SU-73-08Findl O. SU-16

SU-16-01MO-43-04TU-75-06TU-76-01

Finger P. T. MO-77-08TU-35TU-35-02TU-40TU-40-01P-MO-181P-TU-109P-TU-111

Finger R. P. SU-64SU-73-08 SU-74MO-27-06 TU-14-04TU-35-08P-MO-086P-SA-176P-SU-058P-TU-204

Fingerle V. SU-24-03Fintelmann R. SU-35-02Fiol-Silva Z. SA-16

TU-26-05Fiscella R. G. P-TU-060Fischer C. P-MO-222

P-SA-194Fischer E.-M. P-SA-148Fischer F. P-TU-246Fischer M. D. P-TU-219Fischer-Harder K. WE-16-01Fishkind W. J. SA-05

SA-05-06TU-25-09

Fitt A. P-TU-020Fitzke F. W. TU-55-06FitzPatrick D. R. P-TU-155

Flammer J. SA-12SA-12-04SA-21-02MO-31 MO-73-03WE-11-03

Flanagan J. G. MO-14-01Fleck B. P-TU-148

P-TU-150Fleckenstein M. P-SA-176

P-SA-197P-TU-183WE-34-08

Fleming A. SU-62-06Fleming A. D. TU-29-03

TU-56-05Fletcher D. C. TU-14

TU-14-02Flöhr C. P-SU-240

P-TU-223Flohr F. TU-67-04Flores-Limas S. SU-61-04Flühs D. MO-77-04

P-TU-126Foeckler R. P-MO-157Foerster A. M. H. TU-34-04Foerster J. P-SA-214Foerster M. H. SA-35

SU-43-03MO-24WE-23-06WOC-C-60WOC-C-60-04P-TU-089P-TU-114

Fok A. P-TU-202Fong C. W. P-MO-169Fons Martinez R. P-TU-210Forlini C. SU-45-06

MO-24-10 TU-02-02WE-26-03WE-27-06P-MO-232

Forlini M. MO-24-10P-MO-232

Forminska-Kapuscik M. P-MO-162Foronda A. S. TU-31-09

P-SU-082Forrester J. V. SU-19-05

SU-31SU-31-05MO-01-06

Förster C. MO-28-10Fortunato M. P-MO-161Foster A. SU-65-01Foster C. S. SU-27-03Foster P. SU-08

SU-08-01SU-08-06

Foster S. P-SU-110TU-35-11

Foulks G. SU-63SU-63-03WE-22

Fox K. SU-62-04Framme C. SA-32

SA-32-02P-MO-244P-TU-245

Franceschetti A. SA-15SA-15-01SU-46SU-46-03

379WOC® 2010

Auth

or In

dexFrancesconi C. P-SU-180

Francis A. P-SA-134Francis P. J. SU-25-02Franco E. P-SA-090

P-SA-094Franco I. P-SA-217Francuz T. TU-36-09Frank C. P-MO-170

P-MO-226Franke G. H. P-SU-174Frech M. SU-56-04Freedman S. SU-41-03

SU-55-05Freeman W. R. P-MO-210

TU-34-11SA-32-09SU-38-01

Freistühler M. MO-24-05MO-77-04P-TU-126

Freitas H. SU-74-01Frenkel R. P-MO-071

P-TU-059TU-30-03

Frentz M. MO-28-08SU-17-02SU-17-08

Fresina M. SU-55-03Freudenthal J. P-MO-074Freund K. B. SA-32-04Frezzotti P. P-SA-137Friberg T. MO-63-03Friedlander D. P-SU-254Friedlander M. P-SU-254

TU-36-05Friedman D. SA-23

SA-23-02SA-24SA-24-05WOC-C-10-03

Fröhlich S. J. WE-36WE-36-07

Fronius M. P-SA-224Frosch M. P-TU-242Fruschelli M. P-SA-137Frutos J. M. SU-34-10Fu T. SU-44-05Fu Y. SU-17-09Fuchsluger T. FR-01-06

SU-38-06Fujikado T. WE-14-03Fujikawa A. P-MO-256Fujiki K. P-SA-087Fujimaki T. P-SA-087Fujimoto J. G. MO-61-05Fujiwara T. P-MO-154

SA-32-06Fukuda M. MO-35-01

P-MO-213P-SU-089

Fukuhara M. P-SU-257Fukumoto A. SA-31-07Fukumoto M. P-MO-264Funk J. MO-31-02

P-MO-041WE-39-04

Funk M. P-SU-188SA-27-02

Furmanchuk H. P-TU-117Furness C. L. P-MO-295Furrer S. P-MO-041Furuta M. SU-34-09

TU-22-01Fürweger C. P-TU-096Fyodorov A. MO-78-07

G

Gabel J. P-SU-080Gabel V.-P. MO-42

TU-34-09Gabela G. WOC-C-50-03Gabric N. P-MO-112

SU-47-02SU-47-06 TU-02-04TU-81-03

Gabryte E. SU-36-02Gajdzik-Gajdecka U. P-TU-171

P-TU-201Galambos P. P-SU-226Galand A. P-SA-240Galarreta D. P-SU-086

TU-35-09Gall C. P-SU-137

P-SU-153P-SU-161P-SU-174P-SU-175SU-44-06SU-44-08

Gallego-Pinazo R. P-MO-160P-MO-189

Gallenga P. E. TU-41WE-32

Gallie B. L. SU-41-11SU-74-02MO-77WE-24WE-24-06WE-37-03

Gamaly T. SU-47-10Gamulescu M.-A. SA-32-02

P-TU-187Gandhi R. WE-04

WE-04-03Gandolfi S. SA-11

SA-11-01Gandorfer A. SU-49-01

WE-34-06P-MO-233P-MO-249P-SA-173P-SU-272WOC-AAD-C-01-03WOC-AAD-C-01-04

Ganesh S. WOC-C-12-05Gangopadhyay N. P-MO-285

P-MO-298P-SU-030

Ganguly A. SU-81-02MO-31-03P-MO-145TU-13-06

Gans M. P-SU-231Ganssauge M. MO-67-03Gao L. P-SA-095

SA-32-03Gao X.-R. WE-39-06Garber D. P-SU-251Garcia C. P-TU-206

SU-27-08Garcia P. MO-27-03

P-SA-180P-TU-216TU-37-09

García Alcolea E. E. P-MO-104García-Alvarez C. SU-34-10

SU-34-11

García Arumí J. MO-29-06SU-50-07TU-48TU-48-05

García-Barberán I. SU-70-14Garcia-Bardon D. P-MO-137García-Delpech S. TU-41

TU-41-06WE-32P-MO-097P-SA-243P-SA-266 P-SU-169

García-Feijoó J. MO-66-07Garcia Filho C. A. P-SA-271Garcia-Gonzalez M. P-MO-117

P-MO-143Garcia-Marcos M. WOC-C-63

WOC-C-63-04Garcia-Medina J. J. P-MO-047

P-MO-093P-MO-160P-SA-119

Garcia-Medina M. P-MO-047P-MO-093

Garczorz W. TU-36-09Garg P. SU-28-04Garg S. SU-62-04Garip A. P-SA-251Garlaite O. P-TU-084Garms C. WE-25Garrett Q. SU-17-04Garrick A. P-SU-150Garway-Heath T. SU-01

SU-01-02MO-14MO-14-06WE-07-04

Garweg J. G. SU-24SU-24-02 MO-25-05MO-74TU-50-03P-MO-203

Gatinel D. SA-01-07SU-47MO-37-03

Gatzioufas Z. SU-69P-SA-081P-SU-276

Gaudric A. SU-48SU-49

Gavranic C. P-TU-098Gavrilenko A. P-SA-160Gayathri R. MO-74-10Gaydamaka T. P-SA-053

P-SA-078P-SA-098

Ge J. MO-22-07Geck U. P-MO-201Gedde S. SA-21-03Geerling G. FR-01-14

FR-01-16FR-01-21SU-63-07MO-64MO-64-05TU-79TU-79-09Po-SAP-MO-008P-MO-148P-MO-286P-SA-060 WOC-C-14WOC-C-14-05

380 WOC® 2010

Auth

or In

dex Gehlsen U. FR-01-07

P-SU-023P-SU-031P-SU-034

Geinoz J. SU-38-04Gekeler F. P-SA-155

P-SU-264TU-34-09

Gelhorn H. P-SU-110Geller S. TU-34-02Gellrich M.-M. P-MO-085Gellrich N.-C. MO-78-03

SU-38-09Gengenbach U. MO-79-07

MO-79-08P-SU-190

Gentile R. MO-27-03P-SA-180P-TU-216

Georgakopoulos C. P-MO-190P-MO-214

George J. L. P-SU-055George N. P-TU-090

P-TU-148George T. M. P-SA-272Georgiou T. SU-35-01Georgopoulos M. P-SU-188

P-TU-028SA-27-02

Geraissate C. P-MO-023Gerasimov M. P-SU-181Gerding H. TU-37-04

WOC-AAD-C-29Gericke A. P-MO-137

P-TU-241Gerinec A. SU-41

MO-05-04 MO-73MO-73-01

Gerstmeyer K. P-MO-072Gerten G. P-MO-144

SA-27-07Gerth C. P-TU-130

P-TU-155Ghaddar A. P-MO-275Ghanem A. P-SA-142

SA-28-05Gheorghe I. P-TU-005Gheorghe M. P-TU-107Ghita M. P-MO-048Ghosn C. MO-75-07

P-TU-199Giancardo L. SU-62-04Giannakopoulos M. P-MO-190

P-MO-214Giblin M. TU-22-02

WOC-C-60WOC-C-60-06

Gicquel J.-J. SU-37-08SU-75-10TU-81-07

Giebel A. SU-78-08Giegengack M. SU-79-06

MO-79-03Giers U. WE-40-06Gilbert C. MO-07

MO-07-01MO-51MO-51-01 WE-16-06P-SU-064P-SU-072

Gilbert S. TU-57TU-57-06

Gill N. P-MO-067Gillies M. MO-32-02

MO-75-04MO-75-05TU-32-01

Gini G. TU-01-06TU-27TU-27-05TU-27-06WE-27-07

Girkin C. A. MO-13-01Giuliari G. P. MO-35-09Gkatzioufas Z. P-MO-035Gkika T. MO-24-05

MO-77-04P-TU-126

Glänzel W. MO-45-02Glaser E. P-SA-263

P-TU-120Glasser A. MO-39-02Glaus E. P-SA-088Glavota V. P-MO-112Glekov I. WE-35-02Glittenberg C. P-TU-176Globocnik Petrovic M. P-SA-206Glombik R. P-TU-250Gloor B. P. SU-46-02

TU-65Gmelin E. P-TU-250Gminski J. TU-36-09Goatman K. SU-62-06

TU-29-03 TU-56-06

Gobbe M. P-MO-111TU-80-04TU-80-10

Göbel A. P. WE-34-08Göbel K. P-SA-149Goebel W. P-MO-251Goebels S. C. P-MO-278

P-SA-081P-TU-101

Goeppert H. P-TU-006Goerig M. SU-40-05Goes F. J. TU-75

TU-75-04Goetz A. E. SU-40-05Gogia V. P-SU-242

TU-32-04Goh M. MO-26-06Goh S. Y. MO-74-08Goh T. P-SU-222Gök M. MO-24-05

P-TU-126Gokyigit B. P-SU-198Golbaz I. MO-27-01

P-SA-196P-TU-185

Goldberg I. SA-30MO-08-03TU-30-04 TU-43-03

Goldberg R. SU-42-05Goldstein M. H. TU-26Gole G. A. P-TU-151Golnik K. SU-40

MO-41MO-41-01MO-41-07MO-42-05MO-44-05MO-59-05P-SU-142

Goloborodko E. P-TU-241Gologorsky D. MO-77-08

Golovin A. WE-39-01Golshahi A. TU-33-09Goltz C. SA-29-02Goltz H. SU-44-05Gomes da Rocha A. P-SU-273Gomez L. SA-32-09Gomez de Liano R. MO-09-06

TU-59-05Gomi F. P-MO-179

P-SA-163P-TU-229SA-25-04

Goncalves J. TU-21-05Gondova G. P-TU-132Gonen T. P-MO-055Gong H. P-SA-134Goñi Foncillas F. J. MO-54

MO-54-01Gonnermann J. P-SU-046González-Castaño C. P-MO-221Good P. P-TU-052Goodale M. SA-10-02Gopovtzova O. WE-35-02Gorani M. P-SU-092Gorban M. P-MO-077Gorby M. MO-08-07Gordillo L. MO-51-02Gordon I. WOC-C-10-02Gorjizadeh A. P-MO-152Gos R. MO-68-09Gosho T. P-SA-121Goswami M. K. MO-67-05Gothwal V. K. MO-23-04Goto H. SU-57-05

TU-73-04P-SA-247P-SU-158

Gotoh N. P-SA-167Gottlieb C. MO-76-08Gottlob I. SU-23

SU-23-01SU-55MO-06MO-06-02

Gottsch J. D. TU-81Gottschling P. F. SA-28-06

TU-36-03Gotz- Wieckowska A. P-TU-154Götzinger E. MO-27-01

TU-37-06Gougoutchkova P. P-MO-156Gourgoulianis K. MO-76-10Goyal J. L. P-SU-173Grabner G. SA-02-01

SA-26-06SU-47MO-38MO-38-01P-SA-044P-SA-067P-TU-010

Gracner B. P-TU-058Gracner T. P-MO-007

P-TU-058Gräf M. SA-38-06

SA-47-04SU-18SU-18-03TU-59WE-41

Gragoudas E. S. MO-63Graham E. MO-03

MO-03-02Grajewski R. MO-11-02

P-SA-248

381WOC® 2010

Auth

or In

dexGralek M. P-TU-156

Gramer E. TU-16P-SU-177

Gramer G. P-SU-177Gramlich O. W. SA-28-06

TU-36-03TU-36-06 P-SU-104

Grandin J. TU-81-05Graneros G. P-SA-269Gray J. P-MO-174

P-MO-195Gray S. MO-67-06

TU-29-09Grcar R. P-MO-231Grechko S. P-SA-053Gregor Z. J. MO-02

MO-02-01MO-67-04

Gregory D. G. SA-17-04Grehn F. SA-11-05

SU-06-02SU-07SU-07-02MO-08 P-MO-148P-SU-105WOC-C-14WOC-C-14-01WOC-AAD-C-20

Greveniotis P. SU-35-01Grieb P. TU-77-03Griebel M. P-SA-253Grierson R. P-SA-184

P-SA-185Grigg M. SU-24-01

MO-76-08Grisan E. SU-62-01Grisanti S. SA-31-04

SU-51-04MO-79-04 Po-MOP-SA-166P-SA-170P-SA-187P-SU-023P-SU-031P-SU-251P-TU-075P-TU-097

Grobelny A. P-SU-063Groll J. MO-79-01Groppe M. P-TU-032Große B. P-MO-277Große Darrelmann B. SA-25-08Großmann W. P-MO-127Grossniklaus H. E. SA-43

SA-43-02SU-43-04SU-57-04MO-33TU-22-03TU-70-03

Großwendt J. P-MO-038Group the AJCC-UICC Study TU-40-07Grover A. SA-44

SA-44-05MO-78-05P-SU-203

Grucha Y. MO-78-07Grünert A. P-SA-113Grupcheva C. SA-14-04

Grus F. H. SA-28-04 SA-28-06MO-22MO-22-05MO-73-10Po-SUP-SA-111P-SU-094P-SU-204P-TU-241P-SU-104TU-36-03TU-36-06

Grusha Y. MO-78-04MO-78-06MO-78-08P-SU-201

Grüterich M. MO-35-04P-SA-051

Grzybowski A. SU-46-07Gu H. MO-75-09Gudlin J. P-SU-160Güell J. L. SA-05-02

SU-77MO-40-01TU-76TU-76-02

Guenther T. WE-41-03Guerrero L. P-SU-132Guichard M. M. P-SA-161Guilherme-Monteiro J.P-SA-258Gul A. SA-40

SA-40-06MO-74

Gulani A. SU-80-03P-MO-134P-MO-135

Gulbins E. P-SU-246Guliani B. P-SU-195

P-TU-040Gümbel H. O. C. TU-09-03

WE-28-01Po-TUWOC-C-37-04

Gummersbach C. P-MO-223Gunawan W. P-MO-107Gundlach E. P-SA-059Gundorova R. P-SA-045Gündüz E. P-MO-242Gündüz Ö. U. TU-21-02Gunenc U. P-TU-061Gunn D. P-TU-151Günther S. P-MO-033

P-SU-105Gupta A. K. SU-44-07Gupta M. P-TU-146

P-TU-148P-TU-150

Gupta N. MO-53-04TU-15TU-15-03WE-13-01

Gupta S. MO-79-06P-MO-198P-SU-242TU-30-10

Gupta S. K. MO-74-01Gupta V. P-SU-195

P-TU-040Gürel E. P-SA-128Gurung R. P-TU-263Gusek-Schneider G. P-SA-036

SU-41-09Gustiene O. P-SA-204Guth H. MO-79-07

Guthmann S. P-MO-271P-TU-191

Guthoff R. Po-MOP-MO-251P-SA-253

Guthoff R. F. SA-16SA-46SA-46-09 SU-32SU-38SU-56-04 MO-34MO-34-05MO-79-05MO-79-07MO-79-08 WE-12WE-12-01P-SA-077P-SU-190P-TU-155 WOC-C-47WOC-C-47-01

Gutierrez-Amoros C. P-MO-126Guymer R. TU-37-03Guyton D. P-SA-226Guzy C. P-MO-062

P-MO-073Gyasi M. P-SA-134

H

Haas A. WE-08-02Haas-Brähler S. P-MO-039Haase V. H. TU-36-05Habela M. SA-16-05Haddad D. TU-71-04

WE-25-04Haddad S. P-TU-140Hadi I. P-MO-271Hadipour Jahromy M. SU-17-05Hadjiraftis S. P-SA-139Haefliger E. A. TU-03

TU-75TU-75-01

Hafez M. SU-42-07Hafezi F. SU-59

SU-59-04Hagedorn N. P-MO-240Hager A. MO-67-09Hager T. P-SA-066

P-TU-007Hahn I. MO-79-01Hahn U. TU-03-08Haigis W. MO-20-02

TU-10TU-10-02TU-82 TU-82-03P-TU-018

Hakim I. P-TU-021WE-34-06

Halberstadt M. MO-25-05Haldipurkar S. WE-17-02Halfter W. TU-34-06Halle M. TU-33-06Haller J. A. SU-50-03

MO-32-01MO-32-02MO-75-04TU-32-01 LS-08-04

Ham L. TU-31-01Hamoudi R. A. SU-67-02

382 WOC® 2010

Auth

or In

dex Hampejsková L. SU-41-11

SU-74-02Hamrah P. WOC-C-47-06Hamsley N. P-SA-064Han G. P-MO-261

P-SA-201Han H. P-SU-105Han J.-F. Su-54-04Handayani S. Y. P-TU-124Handoko S. B. P-TU-124Handzel D. M P-SU-233

P-MO-114Hangai M. P-MO-043

P-SA-126Hansen L. L. TU-29-08

WE-34P-MO-236

Hara T. P-MO-138P-SU-037

Hara Y. P-MO-138P-SU-037

Harada R. P-SU-113Harats D. P-MO-216Harder B. P-MO-185Hardy S. P-SU-057Haritoglou C. SU-38-01

SU-49-03TU-25-08TU-33-03WE-34-06Po-TUP-MO-222P-MO-233P-MO-249P-MO-271P-SA-188P-SU-272P-TU-017P-TU-191P-TU-228P-TU-237

Haritoglou I. SU-34-06Harris A. TU-16

TU-16-01TU-30-06

Hartmann K. SA-32-09SU-38-01TU-34-11

Hartmann U. P-SU-258Hartnett M. E. SU-41-03Haruchika M. P-TU-231Hasegawa Y. P-MO-235Hasenfus A. P-SA-066

P-TU-101Hasenfus D. P-SU-043Hashad Y. MO-68-02

TU-35-01Hashim H. P-SA-272Hashimoto S. P-SA-106

P-SA-109Hasnain S. P-SA-104Hass P. E. MO-68-05Hassan A. O. SA-37-03

SA-37-05SA-37-06TU-42-01

Hassan S. A. P-MO-001Hassan T. S. MO-72-06

TU-18TU-18-01TU-45-04

Hassenstein A. SA-25-08Po-MO

Hathaway M. MO-27-03Hattenbach C. P-TU-226

Hattenbach L.-O. MO-28-07 TU-29TU-29-08Po-SAP-TU-226WOC-C-30WOC-C-36-04WOC-C-48

Hattingen J. P-TU-223P-TU-250

Haueisen J. P-MO-040P-SA-145P-SA-147P-TU-194

Hauer K. P-TU-047Haughney P. MO-68-05Haustein M. P-SA-139Hawlina M. SU-11

SU-11-03MO-42MO-42-02MO-55MO-55-07TU-02-05

Hayashi H. P-SA-097P-SA-167

Hayashi K. P-MO-188P-SA-229

Hayashi W. P-MO-188Hayes J. P-TU-181Hazarbassanov R. M. SU-17-03

P-MO-115Hazarika M. MO-28-05He M. SU-08-07

MO-52-04WE-36-04

He Y. P-SU-102Healey P. SA-30-06

TU-43Hecht E. P-SU-202Heckmann B. P-MO-073Hediger A. MO-31-02Hedges T. R. SA-38-11

WE-20WE-20-02

Heegaard S. SU-12-06SU-34SU-67-01TU-70TU-70-04

Hefner L. TU-37-04Hegde K. SU-74-02Heidt A. P-TU-043Heiduschka P. MO-36-06

P-MO-170Heier J. MO-32-01

MO-32-02MO-75-04TU-32-01

Heijl A. SU-02SU-02-01MO-14TU-43-02 BS-09-01BS-09-03

Heiligenhaus A. SU-27SU-27-02SU-27-06SU-27-07MO-11-06 MO-21MO-21-05 MO-49MO-74-04MO-74-07

MO-76-01 TU-50TU-50-02P-SA-248P-SA-256P-SU-099P-SU-151

Heimann H. SU-48-03TU-23TU-23-03WE-35

Heindl L. M. SA-29-01P-SU-249TU-40-07 P-TU-127

Heinrich M. A. P-SA-112Heinz C. SU-27-02

MO-11-05MO-74-04MO-74-07 TU-60TU-60-07P-SA-248P-SU-099

Heinzelmann S. U. TU-19-09P-SA-068

Hejcmanova D. P-MO-281P-SU-155

Helb H.-M. SA-25-07MO-43-02MO-67-09WE-34-04 P-SA-158

Helbig H. SA-32-02SU-79TU-09-04TU-23-05TU-32P-MO-157P-MO-204P-MO-244P-SA-011P-SA-124P-TU-187

Helfenstein M. P-SU-055Hellebrand H. SU-61-03Hellmich M. P-SA-013Hellstrom A. MO-04-01Helou J. P-TU-033Helvestone E. SU-52-04

TU-59TU-59-02

Henckes O. P-SU-055Hendrikse F. SU-48-05Hengerer F. SU-15-05Henke Fahle S. P-TU-119

P-SA-122Hennig A. TU-24-04Hennig M. MO-76-01Hennighausen U. P-SU-078Henrich P. B. MO-24-06

P-MO-249Henrich-Noack P. P-SU-162Henson D. B. P-MO-195

P-MO-174Hepper D. TU-80-06Herbort C. P. SA-08-04

SU-33-05Hergeldzhieva-Fileva T. SU-17-01

SU-62-09 SU-64-03 SU-81-04P-SA-076

Heriot W. WE-08-06

383WOC® 2010

Auth

or In

dexHerman W. SU-81-01

Hermann M. P-MO-065Hermel M. P-MO-288

P-SA-064Hernaez-Ortega M. C. MO-75-02Hernandez Martinez F. P-SU-147Hernandez Martinez F. J. P-TU-247Hernández Silva J. R. P-SA-023

P-SA-033Hernandez-Boussard T. WE-40-08Herndon L. W. TU-13-03Hernowo A. SU-44-09Hero M. P-MO-252Herrmann C. SU-44-08Herrmann C. S. P-SU-137Herrmann W. P-SA-011

SA-32-02Herwig M. C. P-SU-006Herzog D. MO-31-07

P-MO-036P-TU-147

Herzog J. P-MO-036Hessler F. P-SA-265Hetland J. P-SU-101Hetzel A. WOC-C-55-02

WOC-C-55-06Heußen F. M. A. P-SA-113

P-MO-015P-MO-016

Heynemann M. P-MO-220Higashide T. P-SU-159Hikoya A. A. P-SA-215

P-TU-129Hilgers R.-D. TU-32-05Hillebrand S. P-SA-165

P-SA-198Hillenkamp J. P-SA-186

TU-32-09TU-36-08

Hingst V. MO-34-03Hintschich C. SA-42

SA-42-04MO-82WE-33WE-33-05

Hinz M. P-TU-221Hirabayashi M. P-TU-195Hirai K. P-SA-131

P-SA-154Hirakata A. SA-25-05Hirano S. P-MO-064Hiraoka T. P-MO-172

P-MO-235P-MO-239P-SA-150

Hiratsuka Y. P-SU-052Hirn C. MO-31-02

P-MO-041WE-39-04

Hirneiss C. P-MO-037P-MO-233P-SA-202P-SU-186

Hirota A. SU-38-07Hirsch-Kauffmann Jokl D. SU-46

SU-46-04Hisatomi T. SA-43-01Hitzenberger C. MO-27-01

MO-27-02 MO-61-04TU-37-06

Hjortdal J. SU-47-03 TU-72-02

Hn M. MO-74-10Ho M. P-MO-192Ho T.-Y. P-SA-105Hoang-Xuan T. MO-49-05Hoeh A. E. P-TU-244

SU-38-02TU-34-07

Hoerauf H. TU-12TU-29-08P-MO-102P-MO-201WOC-C-32-03WOC-C-37-03WOC-C-49WOC-C-57

Hoffmann D. P-TU-254Hoffmann E. M. SU-01

SU-01-01MO-13MO-31-07 TU-41-10 P-MO-032P-MO-033P-MO-036P-MO-039P-MO-045

Hoffmann M. P-SA-146Hoffmann P. TU-82-04Hoffmann S. P-SU-043

P-SU-265Höfling-Lima A. L. P-MO-098

P-MO-115Hofmann C. P-TU-015

P-TU-016Hofmüller W. P-TU-057Hohensinn M. P-SA-044

P-SA-067SA-26-06SA-26-09

Hoh S. T. MO-13-02Hohman T. C. WE-34-08

P-SA-197Höhn F. MO-28-07

TU-29-08Holak H. P-SA-072

P-SA-072SU-44-10SU-44-10

Holak N. P-SA-072SU-44-10

Holak S. A. P-SU-145Holbach L. M. SU-57

MO-18MO-18-03TU-40-07P-SU-249P-TU-127

Holbroook J. T. MO-76-04Holden B. A. WE-36-02Holder G. E. SU-11

SU-11-05Holdt M. P-TU-112Holladay J. T. SA-01-02

MO-39-04TU-10TU-10-01TU-80TU-80-01

Holland D. TU-80-06Holland G. N. MO-21-01

MO-76-08TU-60-04

Hollander D. TU-30-06

Holle J. P-TU-098Holló G. MO-60

MO-60-05Holmström G. WE-09

WE-09-01Holopainen J. M. SU-37

TU-80-05Holz E. R. TU-45-08Holz F. G. SA-25-07

SA-33SA-43-04 SU-50-04SU-51-03SU-73-08 MO-27-06 MO-45MO-45-03MO-68MO-68-02 TU-29-10TU-33-02TU-35-08WE-34-08 WE-38-05P-MO-158P-MO-086P-SA-158P-SA-176P-SA-195P-SA-197P-SU-006P-SU-058P-TU-183P-TU-204

Holzchuh N. WE-21-03WE-22

Holzer M. P. SA-02-03SU-45-05SU-80TU-62-03P-SA-010P-TU-008P-TU-018

Home S. WE-34-05Homma K. P-TU-208Hommel G. P-SU-194Hommer A. B. MO-12

MO-12-02MO-54-03

Honda S. P-MO-213P-MO-254

Hong L. Su-54-04Hong S. P-SU-093Hong S.-M. MO-67-08Hooper C. P-SA-236Hooymans J. SU-44-09Hopkins A. D. SU-32

SU-32-06TU-57-07

Hopkinson A. SU-75-10Hori N. P-SA-107Hornegger J. TU-56Hornykewycz K. WE-39

WE-39-05Horozoglu F. P-MO-055Horwath-Winter J. FR-01-11

FR-01-12Hosseini S. R. P-MO-152Hosseini H. MO-67-03Hotta Y. P-SA-215

P-TU-129Hou M. C.-C. P-MO-090Hou X. R. SU-74-07Hovakimyan M. MO-79-05

SU-56-04

384 WOC® 2010

Auth

or In

dex Hovanesian J. TU-46-01

Hoyng C. B. TU-33-08Hsieh Y.-T. TU-32-06Hsu S.-Y. P-TU-051Hsu T.-K. P-SU-154Hsu W.-C. P-TU-081Hsu W.-M. P-SU-067Hsueh S. SA-32-09Htoon H. M. P-MO-084

TU-81-09Hu N. P-MO-287Hu W. K. SU-17-10Hu X.-W. SU-54-04Hu Y. WE-35-10Huang B. TU-82-01Huang J. P-SA-138Huang K. P-SU-097Huang P. MO-73-09Huang S. TU-18-08Huang Y. SU-67-02Huang Z.-L. MO-67-03Huber C.-G. P-TU-056Huber J. P-SA-101

P-TU-205Huber K. P-MO-015

P-SA-113Huber-van der Velden K. P-MO-016

P-MO-075Hudovernik M. P-TU-058Huf W. P-SA-200Hulkova M. P-MO-281Humayun M. TU-18

TU-18-03TU-45-05WE-14-01WE-15-05

Hungerford J. WE-23WE-24-04

Hunter D. G. SA-45-03MO-71

Hunter M. SU-68-01Huo Y.-J. MO-73-09Hurtikova K. P-MO-278Huseynova S. P-SU-131Hutauruk J. P-SA-069Hüttmann G. MO-79-01

MO-79-04MO-79-05P-SU-031P-SU-034

Hwang L.-J. WE-41-09Hyer J. P-SU-095Hyndrak M. P-SA-049

SU-75-02Hyvärinen L. SA-10-04

I

Iacob C. E. P-TU-111Iakymenko S. SU-35-04

TU-81-08Ibarz-Barbera M. P-MO-117

P-MO-143Ibisevic M. P-SU-225

SU-27-09Ibrahim M. WE-37-01Ibrahim O. SA-26-03Ibrahimy W. P-TU-189Ichimura K. SU-67-02Ideguchi K. SU-38-07Idrissi-Alami S. P-TU-140Ignjatovic Z. P-TU-071

Iida T. P-MO-165P-SA-097P-SA-191

Iijima H. MO-27-10Iizuka Y. P-SU-093Ikeda F. P-MO-173Ikeda H. P-MO-043

P-SA-126Ikeda N. P-SU-121Ikeda S.-i. P-SU-053Ikeda T. P-SU-121Ikeda T. P-SU-257

P-MO-264P-TU-064P-TU-068

Ikeda Y. TU-54-04P-MO-011P-SA-279

Ikuno Y. P-MO-215P-TU-069SA-25-04

Ilako D. R. SA-37SA-37-03SA-37-06

Ilazi M. P-SU-092P-SU-092

Ilginis T. P-SA-174Ilies I. P-TU-078Illarionova A. P-MO-031Ilyina E. P-SA-054Imai A. P-MO-266Imai H. P-MO-254Imaizumi M. SU-56-03Imamoglu S. P-SU-198Imamura Y. SA-32-04

SA-32-06Imshanetskaya T. MO-24

MO-24-04MO-27-08P-SU-275 P-SU-269P-TU-192P-TU-173

Inatomi T. WE-05-04Ines K. P-MO-082Ing M. WE-37-02Inoue M. SA-25-05Inoue Y. MO-35-01

P-MO-011P-SA-279

Investigators for the LUMINATE MO-76-03Iomdina E. MO-26-04Iranmanesh R. MO-77-03Ireni A.-R. P-SU-267Irkec M. MO-60

MO-60-04Irsch K. P-SA-226Irschick E. MO-35-04Isa H. P-SU-009Isaac K. P-TU-212Isaacson P. G. SU-67-02Ishibashi T. SA-43

TU-54-04Ishibazawa A. P-MO-153Ishida K. P-TU-225Ishida M. P-MO-225Ishida O. P-TU-068Ishida Y. P-MO-064Ishikawa K. P-MO-194

P-SA-131P-SA-154P-SA-175P-TU-214

Ishikawa M. P-SU-096

Ishiko S. P-SA-267P-SA-282

Ishikura R. P-MO-011Ishizaki E. P-MO-264Iskandar E. P-SA-087Ismailova D. MO-78-06

MO-78-08Isquierdo Jr. L. MO-57-05Ito M. P-TU-200

P-TU-222SU-47-09

Ito R. P-TU-231Ito Y. P-MO-194

P-SA-175P-TU-214P-TU-220

Itou M. P-SU-124Ivanchenko Y. MO-78-06

MO-78-07Ivandic B. P-SA-130Ivandic T. P-SA-130Ivanisevic M. P-SU-075Ivanisevic P. P-SU-075Ivanova N. P-SA-235Ivanova O. A. P-TU-125Ivanovskaya E. V. P-SA-078Ivarsen A. SU-47-03Iwami H. P-TU-195Iwata D. P-SA-257Iyer J. V. P-SU-206Izdebska J. P-MO-289

TU-31-06Izquierdo L. MO-15-07

TU-74-01Izquierdo N. MO-81-03

J

Jaafar M. SU-52SU-52-02

Jabs D. A. MO-76-04Jackson M. L. MO-23-08Jackson T. TU-34-10Jacob M. P-SA-205Jacobi C. SA-16-03Jacobs D. S. TU-31-08Jacobson L. SA-10-05Jafarinasab M.-R. P-SU-039Jaffe G. J. P-SA-197Jäger M. P-TU-152

P-SA-246P-SU-248P-TU-099P-TU-174P-TU-186

Jager M. J. SA-35SU-53-02

Jaggi G. MO-73-03P-SU-125

Jägle H. SU-72SU-72-04

Jaki Mekjavic P. P-SA-206Jakob E. FR-01-08

P-SA-241P-SA-255

Jakobs E. P-MO-124Jakobsen J. E. SU-07

SU-07-01Jaksic V. P-TU-230

P-TU-240Jakubowska B. P-TU-092

P-TU-128James D. K. SU-75-10

385WOC® 2010

Auth

or In

dexJan J. MO-58

TU-56-01Jang S.-y. P-TU-162Janjua R. P-MO-202Jankov M. R. MO-57-06

TU-64Jansonius N. M. SA-31

SA-31-02SU-44-09

Jantschitsch C. P-SU-253Januleviciene I. TU-16-02

P-SA-116Januschowski K. P-MO-170

P-TU-181Jap A. P-SA-264Jarrín E. P-SU-132Jarsch C. P-SU-045Jasek M. C. TU-30-04Jasielska M. P-SA-168Jasinskas V. P-SA-204Javadi M.-A. P-SU-039Javate R. M. SA-44-06

SU-71SU-71-05TU-06-05

Jaworska M. P-SA-072Jayakumar D. P-TU-198Jedrzejczak-Mlodziejewska J. P-MO-289Jeep S. P-MO-263Jeng B. SU-35-02Jenkins A. TU-29-02Jennane N. P-SA-141Jepsen C. P-SA-010Jeremy W. TU-34-06Jessen B. P-SU-097Ji J. MO-25-07Ji Y. P-SU-232Jia H. P-SA-095Jia R. P-SU-217

SU-42-03Jia Y. P-SA-231Jiang L. SU-44-02Jiang T. P-SA-216

P-SA-221Jiang W. SU-55-09Jiao C. P-MO-018Jiao J. MO-32-01

MO-32-02MO-75-04TU-32-01

Jimenez- Martinez M. d. C. P-SU-024Jimenez R. SA-27-11Jiménez-Roman J. P-MO-046Jin X.-y. TU-31-04Jin D. P-TU-064Jin E.-H. MO-67-08Jo Y. P-MO-215Joachim S. C. P-SU-104

SA-28-06TU-36-03TU-36-06

Job O. TU-08-01TU-08-05

Jobke S. SU-44-06Johnen S. P-MO-206

TU-37-08Johnson R. S. TU-36-05Johnston S. TU-66-06Jöhrens K. P-SA-263Jonas J. B. SA-12

SA-12-03 SU-73-06MO-47-02

TU-16-03WE-07-01P-MO-185P-MO-245

Jonasson F. MO-60-01Jonescu-Cuypers C.-P. SU-68-06

SU-69-04P-MO-035P-TU-007

Jonuscheit S. SU-75-04Joo C.-K. P-MO-009

TU-25-02Joo K. S. P-MO-284

P-MO-296P-SA-219

Jordan J. F. TU-63TU-63-06P-MO-038

Joshi L. TU-65-07P-SA-244P-SA-268

Joshi S. P-TU-164Josifova T. TU-34-03Josselin P. M. SU-36-01Joussen A. M. SU-27-07

MO-01MO-72-08TU-32-05TU-33 Po-SUP-SA-113P-SA-168P-SU-258P-SU-260 P-MO-015P-MO-016P-TU-098P-TU-243P-TU-254

Jovanovic I. P-SU-152Juanjuan L. P-MO-168

P-SA-019P-TU-253WE-41-04

Jünemann A. G. M. SA-28-08 MO-12MO-12-01TU-37-05 TU-77TU-77-02WE-39-09 Po-SUP-SA-036 P-SU-098P-SU-249

Jünemann C. TU-29-08Jung G. P-SU-266

P-SU-271Junker B. P-MO-236

P-SA-070P-TU-248

Jürgens C. SA-29-03Juric B. P-MO-112Jurik I. P-MO-209Jurklies B. Po-MO

P-SA-239P-TU-248

Jurklies C. P-TU-112P-TU-116

Jurkunas U. SU-38-06Jurowski P. MO-68-09Jyothi S. MO-32-08

K

Ka Fat, Thomas T. MO-68-10Kabasele P. M. B. P-SA-236Kabelitz D. P-MO-151Kaçaniku G. SU-64-01Kachalina G. MO-27-07

SU-36-04Kachi S. P-SU-270Kadinskaya M. SA-28-07Kador P. TU-82-02Kaercher T. FR-01

WE-22Kahaly G. J. P-SU-194Kahlert C. P-SA-255Kahook M. Y. P-MO-058

P-MO-059Kaiser P. K. SA-22-02

SU-34-04TU-18TU-18-02TU-37 TU-37-01WE-38WE-38-03WOC-C-57WOC-C-57-03

Kaiserling E. P-SA-170Kajita M. SA-15-06

P-SU-119Kakizaki H. SA-44-02Kakkassery V. P-TU-098Kaldefoss K. P-TU-191Kalinina Ayuso V. MO-74-05Kalogeropoulos C. MO-74-03Kalua K. TU-57-04Kaluzny B. J. WOC-C-47-05Kalyani P. MO-76-08Kamei A. P-SU-146Kamei I. P-SA-004Kamei M. TU-30-07Kaminska A. P-MO-289

TU-31-06Kammann J. TU-25Kämmerling S. P-SA-224Kamo J. P-SU-113Kampik A. SU-38-01

SU-50SU-51MO-11MO-31-10MO-35-04MO-66-02MO-75-03 TU-25-08TU-33-03TU-34-11 TU-41TU-41-02TU-42WE-11WE-11-01WE-16-03 WE-32WE-34-06P-SA-051P-SA-173P-SA-178P-SA-188P-SA-194P-SA-202P-SA-205P-SU-272 P-MO-088P-MO-210

386 WOC® 2010

Auth

or In

dex P-MO-233

P-MO-249P-MO-271P-TU-021P-TU-091P-TU-096P-TU-191P-TU-228P-TU-237 WOC-AAD-C-03LS-08LS-08-01

Kampik D. FR-01-09Kampik K. P-TU-248Kampmeier J. Po-SU

P-SA-050Kanamori A. MO-73-05Kandelman S. SU-75-03

TU-74-05Kandori M. P-SA-279Kanecadan L. P-TU-188Kaneda K. SU-38-07Kaneko M. P-SA-121Kang H. P-MO-265Kang J. H. WE-40-02Kang K. D. P-TU-054Kang S. TU-25-04Kanigowska K. P-TU-156Kann G. P-SA-060Kanonidou C. P-SA-276

P-SU-035Kanonidou E. P-MO-248

P-SA-012P-SA-276P-SU-035

Kanpolat A. SA-13TU-21-01

Kanthan G. P-SU-051SU-73-03

Kao S.-C. P-SU-015Kapica A. MO-68-09Kaplan J. MO-07-05Kar D. MO-24-03Karacorlu M. TU-08-03

TU-08-05WE-37

Karadenizli S. P-SA-128Karagiannis D. P-SA-168Karahan E. SA-31-06Karam E. SA-38-05

SU-18-02Karim R. P-MO-001Karimian F. P-SU-039Karim-Zade K. P-SA-042

P-SU-205P-TU-135

Kara-José N. SA-14-02Karliychuk M. P-SA-171Karnowski T. SU-62-04Karska-Basta I. P-SA-183

P-MO-175P-MO-267P-TU-085

Kartasasmita A. P-SA-087Kasae P. P-MO-269Kasama S. P-SU-135Kashii S. SU-29

SU-29-02SU-40WE-04-06

Kashiwagi K. MO-22-03Kasimov E. P-SU-131Kaskaloglu M. TU-02

TU-02-03

Käsmann-Kellner B. SU-68-02SU-69-02 WE-37-07P-TU-163

Kasmiya M. TU-25-01Kasparov A. MO-78-08Kasper B. P-MO-251Kasper K. FR-01-21

P-MO-286Kassel J. MO-08-06Katada T. P-SA-136Kataev M. WE-12-02Katalin G. P-SA-133Katalin Z. P-SA-133Kataoka K. P-SU-270Katargina L. A. SU-41-07Kato S. P-SU-107Kato T. P-SU-115Kato Y. P-SA-267Katowitz J. A. MO-34

MO-34-06Katschke Jr. K. J. MO-68-05Katz L. J. TU-30-05Katz T. P-SA-082

SU-75-05Kau H.-C. P-SU-015

P-SU-120Kaufmann C. P-TU-049Kaulen P. TU-63-08Kaup M. P-SU-140

TU-63-05Kaushal S. P-MO-150

WE-35-05Kawahara J. P-TU-070Kawai K. P-TU-231Kawano M. P-SU-141Kawasaki A. SU-29-05

WE-20-05Kawasaki R. TU-29-02Kawase K. P-MO-069Kayama T. P-SU-115Kaymak H. P-MO-240Kaynak-Hekimhan P. P-SU-198Kayode SA-37-05Kazakova D. TU-63-01Kazanskaya O. TU-37-08Kazaryan A. P-SA-151Kazlauskas A. SU-38-06Keane P. A. P-SA-165Kedar S. WE-04-04Kee C. SA-28-09Keeffe J. MO-52

MO-52-05WOC-C-59WOC-C-59-03WOC-C-59-04WOC-C-59-06

Keeley S. WE-40-07Keenan T. WE-16-04Keil C. P-SU-185Keilholz U. P-TU-114Keindl T. K. SU-61-06Kelley R. F. MO-68-05Kellner S. TU-33-09Kellner U. SU-11-01

TU-33-09P-MO-040

Kempen J. H. MO-76-04Kermani O. P-MO-144

SA-27-07TU-82-09

Kern T. SA-34-02Kern Y. P-SU-045

P-TU-043

Kernt M. P-MO-210P-MO-233P-MO-271P-SA-173P-SA-178P-SA-194P-SA-202P-SA-205P-TU-191P-TU-228P-TU-237SU-38-01TU-25-08

Kersten D. P-SA-162Kertes P. P-MO-241Keserü M. P-TU-082Keskinbora K. MO-23-07

P-MO-055Ketring K. TU-82-02Kettesy B. P-SU-028Keuchel S. MO-48-01Keul H. MO-79-01Key J. E. SA-14

SA-14-01Kezirian G. M. TU-78

TU-78-04Kezuka T. P-SA-247

P-SU-158Khairallah M. MO-32-05

TU-60-05P-MO-082P-SA-089P-SA-249P-SA-250P-SA-270

Khaireddin R. P-SA-082Khakpour S. SU-17-05Khaled A. E. P-MO-177Khaled A. K. G. P-SU-050Khaliddin N. P-TU-161Khalifa M. SU-47-08Khalilia N. WE-16-04Khan A. P-SA-244Khan H. P-MO-001Khan M. D. TU-42-03Khan S. MO-77-08Khan W. MO-35-10Khandelwal P. SA-20-04Khandelwal R. SU-81-06

MO-73-06P-TU-055

Kharoubi A. TU-33-06Khatana A. K. TU-30-02Khaw P. T. SU-06

SU-06-01SU-72-02MO-07-03MO-53MO-53-06

Khazaei H. P-SU-209Khetan A. MO-35-02

P-MO-285P-MO-298P-SU-029P-SU-030

Khetan V. WE-24-02Kholmatova R. P-TU-135Khoo C. Y. SA-15

SA-15-05Khor S. E. P-MO-280

P-SA-199Khoramnia R. P-SU-111

P-TU-120Ki C. S. SA-28-09

387WOC® 2010

Auth

or In

dexKibata Githeko A. MO-62

MO-62-05MO-62-08

Kikkawa D. O. SU-22SU-22-06

Kikuchi T. P-SU-053Kilangalanga N. J. SA-37-07Kilic E. SU-39-05Killer H. MO-73-03

P-SU-125Kim I. MO-63-04Kim Y. M. SA-25-02Kim C. S. SA-28-09Kim C. Y. P-SU-093

SA-28-09Kim D. S. WE-40-02Kim H. P-MO-208Kim H. J. SA-28-09Kim H. K. P-TU-079Kim J. C. P-MO-284

P-MO-296Kim J. S. SA-32-09

SU-38-01TU-34-11

Kim J.-o. SU-47-01Kim J.-S. P-MO-118Kim K.-S. P-MO-237Kim R. SU-27-03Kim Y. D. P-TU-054Kim Y. J. P-TU-142

SU-55-06Kim Y. K. P-SU-179

P-SU-185Kim Y. Y. SA-28-09Kim Y.-C. P-MO-237Kimoto K. P-MO-199

TU-32-03Kimura H. SA-31-07King A. J. MO-31-08Kinoshita H. P-MO-247Kinoshita S. SA-16

SA-16-01SU-38SU-78-09MO-17-01MO-49MO-49-01MO-66-08TU-05-08

Kinouchi R. P-SA-267P-SA-282

Kiraly L. P-MO-123 WOC-C-08

Kirchhof B. SA-36-07MO-16-04MO-27MO-48MO-48-06MO-70MO-70-05TU-03 TU-32-05TU-34-04 WE-08P-SA-165P-SA-170P-SA-198P-SA-213P-SA-214WOC-AAD-C-18

Kirii E. P-MO-178Kirilova Y. P-SA-076

SU-17-01SU-62-09

Kiseleva T. P-SA-160SA-25-01WE-34-09

Kishi S. P-MO-149P-MO-166P-MO-173P-SA-242P-TU-233

Kishimoto F. P-SA-222Kisimoto T. P-SU-182Kiss C. TU-37-10

MO-68-03P-SA-164P-SA-200 WOC-C-15-04

Kitano S. P-TU-252Kitaoka T. P-MO-230

P-MO-247P-MO-256P-TU-004

Kiuchi T. P-SA-150Kiuchi Y. P-SA-121

P-SU-183P-TU-070SU-38-07

Kivelä T. SU-34MO-33-05MO-55-06MO-60-07 MO-77-08TU-22-04TU-40WE-23WOC-C-60WOC-C-60-02

Kiyosaki K. SU-56-03Klamann M. P-MO-015

P-MO-016P-MO-075P-SA-113

Klancnik J. MO-77-03MO-32-03

Klaproth O. MO-25-02P-MO-116P-TU-001P-TU-015P-TU-016

Klassen H. MO-53-02Klatt C. SA-25-06Klauss V. SA-37-05

SU-65SU-74TU-57TU-57-03 WE-16-03P-MO-088WOC-AAD-C-28

Klaver C. TU-14-05Klee S. P-MO-040

P-SA-145P-SA-147

Klein H. SA-32-09Klein M. L. MO-63-05Klein S. P-SU-260

P-TU-243P-TU-254

Klemm M. P-TU-056P-TU-073P-TU-082P-TU-194WE-39-02

Klett A. SA-42SA-42-01

Klettner A. MO-28-01P-MO-151P-SA-186P-SU-253TU-32-09TU-36-08

Klevering B. J. TU-33-08Klingenstein A. P-TU-091

P-TU-096SU-34-06

Klink T. SU-07-03SU-45P-MO-148 WOC-C-14-03

Klintworth G. SU-12TU-70TU-70-01

Klos-Rola J. P-SU-095WE-39-09

Klyce S. D. SA-16-04WE-03-06

Knecht P. P-TU-049Knobloch J. P-SA-166Knop E. SA-20

SA-20-01SU-63-01P-MO-297

Knop N. SA-20SA-20-03P-MO-297

Knorr M. P-SA-265Knorz M. C. SA-26

SA-26-05SU-13-06MO-38MO-38-05TU-03-06 TU-82-06WE-01WE-03-03

Knyazeva E. S. P-SU-181Ko Y.-C. P-SA-105Kobayashi A. SA-18-04

P-SA-047Kobayashi M. P-SU-107Kobayashi Y. P-SU-124

P-TU-200P-TU-222

Kobylarz J. P-MO-175P-MO-267

Kocabora S. P-SA-128Koch D. D. SU-10-04

SU-16MO-37MO-37-02

Koch F. MO-32-10 TU-01-08TU-77-07P-MO-196P-MO-207 WOC-C-36WOC-C-36-02WOC-C-37WOC-C-37-02

Koch H.-R. WE-17WE-17-06

Koch M. P-TU-243Kociok N. P-SA-168

P-SU-258P-SU-260P-TU-243P-TU-254

Kocur I. SU-65SU-65-07TU-71-02

388 WOC® 2010

Auth

or In

dex Koffler B. H. SU-09

SU-09-06WE-22-03

Kofoed P. MO-67-03Kogan B. P-SA-078

P-SU-277Koh A. MO-56-03Koh H. J. SA-25-02Koh T. P-TU-079Kohl S. MO-06-03Köhler J. P-SU-196

P-TU-250Köhler M. P-SU-184Kohlhaas M. SA-13

SA-13-01Kohli S. P-SA-052Kohlmann T. P-MO-072Kohnen S. SU-14-06

WE-10-01WOC-C-56-03

Kohnen T. SA-07SA-07-01SU-15SU-15-01MO-25-02MO-35-07 MO-40MO-40-02TU-03-05TU-09-01TU-46-01TU-61TU-61-02TU-61-06WE-03-07WE-10WE-10-03P-MO-019P-MO-116P-SA-157P-TU-001P-TU-015P-TU-016 WOC-C-05WOC-AAD-C-16WOC-C-56-02

Kohno T. P-TU-195Koinzer S. P-SU-253

P-TU-196Koizumi I. SU-74-01Kojima S. P-SU-257

P-TU-064P-TU-068

Kok H. S. P-SU-020Kokemueller H. SU-38-09

MO-78-03Koler E. P-SA-050Koleva-Georgieva D. SA-25-10Kolker A. SU-38-05Koller T. SU-58Kollmann K. H. M. SA-37

SA-37-01SA-37-02SA-37-05SA-37-08P-MO-079P-MO-088

Kolodziejska U. P-SA-099TU-31-06

Komatsu N. P-SA-279Komm D. P-SU-161Komori S. P-SA-107

P-SA-136Kompella U. B. MO-47-04

Kondo M. P-MO-194P-SA-175P-TU-214

Kondo N. P-MO-213Konen W. MO-65-05

P-TU-066Kong S. J. TU-25-04Konidaris V. P-MO-248

P-SA-276P-SU-035

Königsdörffer E. P-SA-277Konrad J. P-MO-146Konstantinidis A. P-MO-259

P-SU-191TU-30-09

Konstas A. MO-12-06SU-69-05

Konstas A. G. P. MO-60-06WE-13

Kook D. MO-35-04MO-35-07P-MO-116P-SA-051P-TU-017P-TU-021

Kook M. S. SA-28-09 MO-22-04

Kook P. P-MO-205P-TU-205

Koop N. P-SU-031P-SU-034

Kopayenko G. P-SA-235Kopp K. P-SU-033Kopsachilis N. P-SU-100Korber N. TU-13-01Kornhuber J. P-SU-098

SA-28-08Korobelnik J.-F. SA-06-03Korotkih S. A. P-SU-181Korth R. M. E. FR-01-10Korwitz U. MO-48

MO-48-04Kosanovic-Jakovic N. P-TU-230Kose D. SU-81-06Koshitz I. MO-26-04Kosinska J. P-SA-091Koss M. J. MO-32-10

TU-77-08P-MO-196P-MO-207 WOC-C-37

Kostenko P. TU-63-09Kotak S. P-SA-100Kotamarthi V. P-SA-261Kotb Ali K. P-SA-039Kotera Y. P-MO-043

P-SA-126Kothari M. P-SA-225

SU-61-05Kotliar K. MO-26-04

P-TU-180SU-35-11TU-33-06TU-35-05

Kotoula M. MO-76-10Koukkoulli A. P-SU-212Kovacs R. P-TU-049Kovalov A. P-MO-290

TU-31-02Kowalski J. W. MO-75-05

P-SU-110WE-35-04

Kowarsch T. P-SU-184

Kozak I. P-MO-210P-MO-210SU-38-01TU-34-11

Kozeis N. SU-69-01Kozobolis V. SU-69-03Kracht J. P-SA-224Kramann C. MO-73-10

P-MO-187P-SA-190

Kramar E. SU-61-06Kramp H. P-SA-265Kranebitter N. MO-35-04Krantz K. MO-78-01Kranz-Opgen-Rhein B. SU-17-02Krappe A. P-SA-162Kraut A. P-SA-206Kravchuk E. SA-25-01

WE-34-09Krawczyk A. SU-41-10Krebs I. P-TU-176Kreil D. P-SA-164Kreiner C. F. WE-12

WE-12-05Kreissig I. WOC-C-62

WOC-C-62-01WOC-C-62-07

Krema H. MO-35-09Kreutzer T. TU-33-03

TU-29-08Kriechbaum K. MO-32-07Krieglstein G. K. SA-11

SA-11-06SA-21SA-28SU-05SU-05-01TU-03-01

Krishna P. V. MO-05-03Krogmann F. SU-46

SU-46-05Krohne T. U. TU-29-10

TU-36-05 P-SU-254P-TU-227

Kroisamer J.-S. TU-37-10Krueger R. R. MO-39-05

SA-01-03SA-02SU-60-01TU-39-02

Krug M. MO-79-04Krüger A. MO-79-05Krüger C. P-MO-218Krüger H. WOC-C-36Krüger N. P-SA-184

P-SA-185Kruglova G. P-SA-210Krupin T. MO-12

MO-12-05SA-12-07

Kruse F. E. SA-28-08SU-17SU-77SU-78-07MO-17MO-17-04MO-18-06TU-05-06 TU-37-05TU-40-07WE-05-06P-SA-065P-SU-098P-SU-249P-TU-127

389WOC® 2010

Auth

or In

dexKruse K. TU-35-08

Krysta A. P-SU-098Ksiazek S. MO-42-07

MO-43-08Kuang T.-M. P-SU-067Kubicka-Trzaska A. P-SA-183

P-MO-175P-MO-267

Kubota A. SU-17-06Kubota T. P-MO-199

SU-56-03TU-32-03

Kuchenbecker J. WE-10-06Küchle M. P-SA-031Kuchynka P. TU-31-07Kudou A. P-SA-015Kuehlmeyer S. P-TU-007Kugler W. P-MO-240Kuhn D. SA-15

SA-15-02Kuhn F. TU-01-07

TU-28TU-28-08WE-26WE-26-02WE-26-06WE-27WE-27-01WE-28WE-28-08WOC-C-50WOC-C-50-05

Kujala E. TU-40-08Kuklin A. P-SA-160Kuljaca Z. P-TU-071Kulkarni U. V. P-SA-199Kumagami T. P-MO-230

P-MO-247P-TU-004

Kumar A. MO-06-05TU-32-04

Kumar N. P-MO-217SU-40-02

Kumar S. SU-30-02 SU-62-07MO-58-05TU-56

Kumaramanickavel G. TU-55-03Kumaran S. MO-79-06

SU-44-07Kunert K. TU-80-02Kunimatsu S. P-SU-107Kunst F. P-SA-184

P-SA-185Künster A. SU-74-10Kunze A. P-SU-258Kuoliene K. P-SA-181Kuper H. WE-16-04Kupferschmid S. SU-45-03

P-MO-025P-MO-277

Kupitz D. G. P-MO-086Kuppermann B. D. SA-22

SA-22-01 MO-68-04TU-18-04TU-47

Kuri J. V. MO-15-09Kurihara T. TU-36-05Kurimoto Y. P-TU-225Kuriyama S. P-SA-097Kurli M. P-TU-111Kuroda S. SA-31-07Kurtenbach A. P-SA-152Kurtz A. P-SU-268

Kuruca S. E. P-SA-128Kurup S. K. SU-79-06

MO-67-03MO-79-03

Kurz H. SU-17-08Kürzinger G. R. K. P-SA-193

P-MO-184P-TU-215

Kusano M. P-MO-230P-TU-004

Küstner M. SU-80-04Kusuhara S. P-MO-213

P-MO-254Kuwahara T. P-SA-232Kuznetsova T. P-SA-203Kwag J. H. P-TU-054Kwag T. Y. P-TU-054Kwok K. P-SU-097Kyari F. P-SU-064Kychenthal A. WE-29-04Kymes S. M. MO-52-03

P-TU-060Kyomoto T. P-SU-053

L

Labbé A. WOC-C-47-02Lacey J. SU-05

SU-05-02Lackerbauer C.-A P-SA-051

P-SA-202Lackner E.-M. P-TU-207Laganovska G. MO-25

P-SA-209Lagrèze W. A. SA-47-01

SU-72SU-72-03 P-SA-088WOC-C-55-02WOC-C-55-05

Laguía M. TU-82-07Lai F. P-MO-014Lai M.-S. P-SU-065Lai T. MO-02-03

MO-56MO-56-08P-SA-252P-SA-260P-TU-202

Lai W. W. MO-43-06Laidlaw D. A. H. SU-49-04Lala C. P-SU-048Lally S. P-TU-090Lam W. C. SU-41-02

P-MO-241Lamard M. SU-36-01Lambert S. R. TU-07-03Lammer J. MO-27-02Lammersdorf K. P-TU-183Lamminen H. SU-30

SU-30-03Lamoureux E. P-SA-140Lamparter J. P-MO-033

P-MO-045Lan C. P-SA-252Landa G. MO-27-03

P-SA-180P-TU-216P-TU-224TU-37-09

Landau K. SA-38SA-38-01SU-23-03 SU-61-08TU-08TU-08-05WE-11-06P-TU-049

Landgren B. P-SA-102Lang G. E. MO-02

MO-02-08SA-43-05TU-11 TU-36-07TU-46 TU-81-02P-MO-182P-SA-193P-TU-215WOC-AAD-C-01-01WOC-AAD-C-01-01WOC-AAD-C-01-04WOC-AAD-C-01-05WOC-C-32WOC-C-32-01

Lang G. K. SU-45-03SU-53SU-53-03SU-54SU-56SU-79-07TU-46 TU-81-02P-MO-025P-MO-141P-MO-159P-MO-182P-MO-277P-SA-050P-SU-200P-SU-235P-TU-033WOC-C-51

Lang G. L. P-MO-184Lang M. P-TU-093Lang S. P-TU-215Lange C. MO-67-04Langenbucher A. SA-19-01

WE-03-04P-SA-146P-MO-029P-SA-112P-TU-006P-TU-007

Langer P. D. TU-27TU-27-01TU-27-06

Langman M. E. SU-37-08Langmann A. SU-23-04Langmann G. Po-TULangwinska-Wosko E. P-SA-091Lankenau E. MO-79-04Lanzetta P. P-SA-212Lanzl I. M. MO-26

MO-26-03MO-26-04P-TU-180TU-33-06TU-35-05

Lappas A. TU-34-04Larkin D. F. P. TU-20

TU-20-02

390 WOC® 2010

Auth

or In

dex LaRoche R. SU-52-03

Lascaratos G. P-TU-148P-TU-150P-TU-146WE-34-03

Laspas P. P-SU-104SA-28-06

Laties A. M. WE-41-09Latinovic S. P-SU-048

TU-02-01Latr I. P-SU-155Lautebach S. P-MO-038Lavinsky D. P-SA-274Lawn S. P-SU-072Lawrence L. WOC-C-59-01

WOC-C-59-06Lay Leng S. SA-44-03

P-SA-217Lazutina E. TU-81-07

SU-75-10Leach N. TU-21-06Lebrilla C. P-SU-085Lebuisson D. A. TU-80-09Lechner T. P-MO-102Lee A. G. SA-38

SA-38-04SU-29SU-29-04MO-41-06MO-42MO-42-01MO-42-04TU-08-02TU-08-05

Lee B. R. SU-45-02SU-80-07SU-81-05P-MO-200P-TU-184P-TU-193TU-29-07

Lee H. P-TU-142Lee J. P. MO-09

MO-09-04TU-59-03

Lee J.-y. P-MO-118Lee P. MO-52

MO-52-01Lee P.-J. P-SA-105Lee S. Y. P-MO-084Lee S.-B. P-MO-118Lee S.-M. P-SA-105

P-SA-114P-SU-015

Lee T. MO-77-03Lee V. Y. W. WE-19-08

P-MO-192Lee W.-K. MO-56-04Lee Y. P-TU-234Leese G. P. TU-29-03Lehmann M. P-SU-254LeHoang P. MO-76-09Leitão P. MO-73-02

P-MO-050Lekskul A. P-SA-223

P-SA-223Le Mesurier R. WE-16-02Lemke J. P-SA-088Lemmen K.-D. SU-76

SU-76-05TU-09TU-34

Lemp M. A. WE-22-05Lenz B. SA-28-08Leon-Gonzalez N. P-TU-110

Leon-Perez N. P-TU-110Leonardi M. WE-13-06Ler D. P-TU-105Lerner F. TU-43-05Lesauskaite V. P-SA-204Leung D. Y.-l. SA-28-03Leung Y. L. D. SA-12-06Levanova O. P-MO-095Leverkus F. P-MO-072Levinson R. D. SA-40-04

TU-47-04Levitsky I. P-MO-238Levold F. MO-79-01Levy C. SA-09-05Levytska G. P-MO-238Lewallen S. SA-37-04

SA-48-03P-MO-087

Lewando-Hundt G. WE-40-07Lewczuk P. P-SU-098Leys A. MO-02

MO-02-02Li B. P-SU-088

SU-41-04Li C. TU-36Li C.-L. P-MO-192Li G.-Y. P-SU-103Li H. MO-73-09Li J. P-SA-231

P-SU-133P-SU-227

Li Q. WE-39-06Li R. SU-47-04Li W. P-SU-254Li X. SA-34

SA-34-07MO-56MO-56-06

Li X. MO-74-02P-MO-018P-MO-265SU-37-04

Li X. X. SU-74-07Li X.-Y. MO-32-01Li X.-Y. MO-32-02

MO-68-04Li X.-Y. MO-75-04

P-MO-198TU-32-01

Li X.-Y. TU-35-11Li Y. MO-75-07

P-SU-088Li Y. SU-56-01

SU-62-04Li Z. MO-67-06Liakopoulos S. P-SA-165

P-SA-198Liang H. P-MO-076Liang Q. P-SU-070

P-TU-256TU-31-04

Liang S. P-SA-001P-SA-007

Liao X. WE-39-06Liazos S. P-MO-217Lichtenberg S. P-SA-148Lichter P. SU-20

SU-20-04SU-21

Lichtmeß A. P-MO-039Lieb W. E. Po-SULiebmann J. M. MO-13

MO-31-11

Liegl R. P-MO-233P-SA-173P-SA-202TU-25-08

Liehneova K. P-SA-048P-SA-049SU-75-02

Liekfeld A. Po-MOWOC-C-56-01

Liesegang T. J. MO-21MO-21-06

Lietman T. M. TU-71-06Liggett P. TU-45Lightman S. TU-35-11

TU-65TU-65-02P-SA-236P-SA-244P-SA-268P-SA-281P-SU-009P-SU-110LS-08-05

Lim H. T. P-TU-142SU-55-06

Lim L. SA-15-03Lim L. MO-35-05

P-SU-047Lim L. TU-81-09Lim S. MO-65-02Lim S. C. P-MO-169Lim T. H. MO-32-04Lima L. H. P-SA-172

SA-32-04Limberger I.-J. P-TU-008Lin X. P-SA-221Lin A. P-SU-088Lin C.-P. TU-78-03

P-MO-090Lin J.-C. P-SU-065Lin J.-E. C. MO-67-02

P-TU-199Lin M. P-SU-193Lin P.-Y. P-SU-067Lin T. MO-75-07

P-MO-071P-TU-199

Lin X. P-SA-216Lincoff H. WOC-C-62

WOC-C-62-05Lincoln V. A. C. P-MO-101Lindell J. SU-38-04Lindfield R. WE-16-04

WE-16-06Lindig A. P-SU-175Lindsell B. MO-08-08Lingenfelder C. P-MO-240

P-TU-031Link D. P-SA-145

P-SA-147Linke S. P-SA-082

P-SU-271Linke S. SU-75-05Lipener C. TU-21-04Lipshitz I. SA-05-03

SA-32 SA-32-08P-MO-227

Lisboa J. MO-73-02P-MO-050

Lisch W. SA-18TU-81-02

Lisochkina A. MO-68-06P-SA-203TU-33-07

391WOC® 2010

Auth

or In

dexLittle B. TU-46-02

Liu A. MO-76-08P-MO-136

Liu C. MO-22-08MO-75-05P-MO-198

Liu C. J.-L. P-SA-105P-SA-114P-SU-067

Liu C.-C. MO-68-04Liu C.-c. P-MO-071

P-TU-059TU-30-02TU-30-03

Liu C.-M. P-SU-059Liu D. P-SA-093

P-SU-222Liu D. T. L. P-MO-192Liu F. P-SU-088Liu H. MO-74-09Liu J. WE-13-02Liu J.-H. P-SU-059

P-SU-067Liu N. MO-75-09

Su-54-04Su-54-04

Liu N. P. SA-25-03Liu P. P-MO-136Liu Q. P-SA-092

SU-56-05Liu R. SU-17-10Liu S. SA-20-04Liu W. SA-32-03

TU-47-06Liu X. P-SA-138Liu Y. TU-24-05Liu Z. WE-35-08Liutkeviciene R. P-SA-204

P-SU-178Livchits L. P-SA-098Liveikiene A. P-SA-181Livingstone B. I. P-SU-134

P-MO-280P-SA-199

Ljutica M. P-SA-220Lo L.-C. P-MO-090Loewenstein A. MO-16-05

MO-32MO-32-02 MO-50MO-50-02MO-68-04MO-32-01MO-75-04TU-32-01WE-35-04LS-08-06

Löffler K. U. SU-12MO-43MO-44P-SU-006

Lohmann C. P. SA-32-10 SU-35MO-27-04 TU-35-05P-MO-146P-MO-171P-MO-205P-SA-101P-SA-233P-SA-263 P-SU-111P-MO-228P-TU-120P-TU-205

Lohmann D. SA-09SA-09-01

Lohr A. P-SA-256Lommatzsch A. TU-09-05Lommatzsch P. K. SU-43-05Longstaff S. MO-73-04Looi A. P-SU-192

P-SU-216P-SU-245

Loos D. P-TU-205Loos Z. P-SU-104Lopes M. d. F. SU-74-01Lopez Galvez M. I. TU-35-09Lopez-Lara F. J. SU-34-10López-Lizcano R. P-SA-266Lopez-Prats M. J. P-SA-243Lopez-Star E. P-SU-024Lorenz B. SA-10

SA-45-01SU-41MO-04MO-05MO-06MO-06-01MO-07MO-07-06TU-07TU-07-05TU-55TU-55-04P-SA-246P-SU-184 P-TU-152P-TU-174P-TU-186

Lorenz K. MO-73-10P-MO-187P-SA-190P-TU-080P-TU-211TU-29-08

Lossbrandt U. SA-28-04SA-28-04

Lotfi A. TU-81-04Lou J. MO-68-04Lou M. P-SU-022Loukopoulos V. TU-37-04Lovisolo C. F. SA-04-01Löw U. P-MO-035

P-MO-278P-SA-081P-SU-276

Lowder C. Y. SA-41-04 MO-50-05TU-35-11P-SU-110

Loyet K. MO-68-05Lu D. P-MO-167Lu J. MO-25-07Lu J.-m. P-SU-044Lu N. TU-34-08Lu W. SU-17-09Lubatschowski H. SU-75-07

MO-38-03Lubimova N. V. SU-41-07Lucas T. P-SU-260Luchs J. P-TU-059Lüchtenberg M. P-SA-224Lucke K. TU-01

TU-01-02 P-SA-170WOC-C-36-06WOC-C-37-06

Luco C. SA-38SA-38-03SU-18MO-81MO-81-04

Ludescher M. P-MO-297Ludgate M. SU-22-01

MO-82Luedtke H. P-SA-002Luhmann U. MO-67-04Lukas J. SU-56-04Lukauskiene R. P-SU-178Lüke J. P-TU-097Lüke M. MO-36-05

P-TU-097P-TU-181

Lumbroso B. WOC-C-61-06Lumi X. P-MO-231Luna de Sampaio V. P-TU-262Luna E. SU-74-01Lundström M. SU-16

SU-16-05MO-79-02

Luo M. MO-25-07Luthert P. J. P-SU-009Lütjen-Drecoll E. P-SU-099Luyten G. SU-34-08Lyia R. SU-40-06

P-TU-175Lyngholm M. SU-47-03Lynn W. A. P-SA-244

M

M. Dheepa P-MO-272M. Chibisova J. SU-44-06Ma K. P-SA-095

SA-25-03Ma L.-b. MO-24-02Ma Z. P-MO-105

P-TU-264Maalouf T. P-SU-055Maar B. MO-77-03Macedo G. P-MO-115Machackova M. P-MO-281

P-SU-155Machalska M. P-TU-201MacKeben M. P-SA-208Mackensen F. SA-40

SA-40-05SU-27-02SU-27-07MO-27-09MO-76-03 TU-50-05P-SA-241

Mackenzie G. E. WE-36-05Mackert M. MO-35-04Mackey D. MO-71-04Mackiewicz J. P-SA-168MacLaren R. E. SA-03

SA-36-06TU-36WE-14WE-14-04

MacRae M. P-TU-146P-TU-150

Madrigal R. TU-82-07Mady S. P-SA-142Maeda N. WE-21-05Maeda T. P-MO-063Maeda-Chubachi T. SU-55-05Magalhaes Jr. O. MO-32-09Magauran D. WE-16-04

392 WOC® 2010

Auth

or In

dex Maggi R. P-MO-161

Mahajan s. P-SA-074Mahatme V. P-TU-035

P-TU-042P-TU-164SU-41-08SU-55-08

Mahendra M. SU-80-06P-SA-005P-SA-032

Mahendradas P. MO-67-03Maher L. WE-16-01Mahmood H. WOC-C-39Mahmoud T. MO-24-09Maia M. MO-32-09

P-SU-011Maier A.-K. SU-27-07

P-SA-113P-MO-015P-MO-016

Maier M. MO-27-04P-MO-146P-MO-171P-MO-205P-MO-228Po-MOP-SA-101P-SA-208P-SA-233P-SA-263P-TU-205SA-32-10TU-35-05

Maier P. MO-30-01SU-78-03TU-19TU-72-04Po-SUP-MO-038P-SA-068

Majdanik E. P-SU-061Majumdar M. SU-81-06

P-TU-055Makeev O. G. P-SU-181Maklakova I. SU-35-06Makri O. P-MO-190

P-MO-214Makrygiannis G. P-MO-259Malaravan M. P-MO-070

TU-35-03Malbrán E. SU-20-05Malik A. P-MO-268Malik K. P-SU-195

P-TU-040Malinouskaya I. P-SU-269

P-TU-192Malinowska U. SU-41-10Mallipatna A. SU-41-11

SU-74-02 TU-40-09

Malov I. P-SU-062Malyugin B. SU-14

SU-14-04SU-45-04SU-64-02TU-46-04TU-82 TU-82-11WOC-C-12-06

Manaysay R. P-MO-081Mandai M. P-TU-208Mandal A. K. TU-43-04Mandic Z. MO-25

WE-39-07Manku K. P-SA-244

Mannan A. P-SU-071Mannis M. P-SU-085Mannsfeld A. P-TU-008

P-TU-018Mannucci L. P-MO-017

P-SU-021Manquez M. E. MO-77-09

TU-22-05Mansberger S. L. SU-03-01Mansour A. SU-81-07

MO-50-03MO-67-03P-MO-092P-MO-275P-SU-077

Mansouri I. P-TU-189Manzanas L. TU-35-09Mao X. P-MO-287Marcellino G. R. P-MO-195

P-MO-174Mardekian J. P-SA-100Marie S. P-SU-208Marín Lambies C. P-TU-210Marínez-Giralt O. TU-29-05Marinho A. A. P. MO-40-06Marinkovic M. SU-34-08Marin-Lambies C. P-MO-189Marioneaux S. J. MO-81-06Mariotti S. P. TU-71-02Marius R. P-TU-107Mark H. WOC-C-38

WOC-C-38-01WOC-C-38-02WOC-C-38-03WOC-C-38-04WOC-C-38-05P-MO-096

Märker D. A. P-MO-157Markiewicz A. MO-78-02

P-TU-092P-TU-128

Markowitz J. P-TU-090Marsh I. P-SU-150Marshall J. WE-02Martin F. MO-69

MO-69-01Martin G. P-SA-161

P-TU-246Martin K. MO-53-03

P-TU-144Martin L. TU-66-03Martin T. SA-40-02

TU-17-01P-SU-190

Martinez A. P-TU-188Martinez E. P-MO-115Martinez M. R. SA-25-09Martínez Serrano R. E. P-MO-183

P-MO-250P-TU-041P-TU-131

Martinez-Castillo S. P-MO-189Martinez-Castro F. P-SU-024Martinova L. P-SA-151Martins E. N. P-MO-282Martius P. P-SA-077Maruko I. P-MO-165Marx-Gross S. TU-25-10Mas A. S. P-TU-161Masaki T. P-SA-047Masayoshi K. TU-21-07Mashayekhi A. P-TU-090

SU-34-09Mason I. SA-37-06

Masood I. MO-73-04P-MO-030

Massin P. MO-29-01SU-50-02

Masuda A. P-MO-172P-SU-121

Mata E. P-SU-083P-SU-207

Mathenge W. SA-37-04SA-37-06SU-74-03

Matsuba T. P-TU-077Matsuda R. P-MO-064

P-SU-158Matsumoto C. P-SA-106

P-SA-109Matsumura N. P-SU-255Matsunaga Y. P-SU-158Matsuoka M. P-SA-159Matsushita K. P-TU-069

TU-30-07Matsuura T. P-MO-138

P-SU-037Matsuyama K. P-SA-159Matt G. MO-67-07Matthaei M. P-TU-056

P-TU-073WE-39-02

Matu C. P-SU-005Matveeva I. WE-35-02Maudgil A. P-TU-160Maumenee I. H. TU-55

TU-55-01Mavija M. P-TU-230

P-TU-240Mavija Z. P-TU-230Max R. MO-27-09

SU-27-02May F. P-SU-055Maychuk N. SU-36-04Mayer C. P-MO-171

P-TU-120Mayer C. F. P-TU-022

P-TU-207Mayer E. J. P-SU-252Mayer W. MO-35-04

P-SA-051P-SA-178P-TU-021WE-34-06

Maynart Tavares I. P-TU-206Mayorga Argañaraz E. MO-41-02

MO-42-06MO-44MO-44-01

Mazzotta C. P-SA-071SU-35-03

McCannel C. A. MO-44-08McCannel T. MO-77-05McCluskey P. TU-65-05

TU-73TU-73-07

McCluskey P. P-SA-244McCormick S. A. P-TU-111McCranor L. TU-30-06McDonald M. MO-38-06

WE-02WE-02-07

McDonnell P. TU-78-07TU-80

McElvanney A. P-MO-295McKeown C. MO-78-01McLauchlan R. P-MO-195McMeel J. W. P-MO-049McNamee P. TU-29-03

393WOC® 2010

Auth

or In

dexMcRae S. SU-60

Md Din N. P-SU-020P-TU-063

Medeiros F. A. MO-22Medina N. H. SU-74-01Medoruma I. P-SA-120

P-SA-123P-TU-067

Medoruma K. P-TU-067Megzari A. P-MO-066

P-SA-141P-TU-139TU-31-05

Mehat M. S. P-SU-056Mehdizadeh M. MO-73-08Mehriar M. P-SA-278Mehrotra A. P-SU-108Mehrotra S. P-SU-108Mehta A. P-SU-195

P-TU-040Mehta K. R. TU-46-01Mei H. P-MO-261Mei L. P-SA-138Meier M. MO-58-04Meier P. TU-28-07Meigen T. SU-11-02Meindl A. SU-61-03Melamed S. SU-38-05

TU-13-04Melicher Larson J. P-SU-223Melki S. A. WE-13-07Melkonyan H. P-SU-103Mellein A. C. P-MO-274

P-TU-066Meller D. FR-01-20

SA-17MO-49-04WE-05WE-05-07P-SU-038P-SU-042

Melles G. R. J. SU-78-04TU-05-07TU-31-01

Meltendorf S. WE-37-06Mély R. SA-14-06

TU-26TU-26-04

Menapace R. SA-05SA-05-04 MO-60-08TU-03-02P-TU-185

Mendoza C. SA-38-13WE-20-01

Menghini M. P-TU-049Menke M. SU-61-08Mennel S. MO-67-09

P-MO-220P-MO-253

Menon G. P-MO-211Menon V. MO-79-06

P-TU-141SU-44-07

Mensink H. W. SU-39-05Mentkevich G. WE-35-02Menz D.-H. P-MO-102

P-SU-179P-SU-185

Merayo-Lloves J. TU-79-03P-SU-086

Merchant A. SU-74-02Merle H. TU-27-06Mermoud A. SU-38-04Merriam J. SA-32-04

Merté R.-L. P-TU-044P-TU-083

Messias A. P-SA-144Messinger J. D. P-SU-251Messmer E. M. FR-01-02

SU-12-03 MO-35-04TU-49TU-49-05TU-70TU-70-02WOC-AAD-C-24P-SA-044P-SA-067

Mestdagh P. P-TU-123Mester U. WE-19

WE-19-07Po-TU

Metz C. P-SA-239Metzger L. P-TU-187Meyer C. P-SU-268Meyer C. H. SA-25-07

TU-29-10MO-32-09MO-67-09Po-SUP-SA-158P-SU-011P-TU-227

Meyer K. P-TU-243Meyer M. MO-75-10

P-SU-220Meyer M. W. P-SU-100

P-TU-048Meyer T. P-MO-151Meyer-Rüsenberg B. P-SA-182

P-SA-184P-SA-185P-SA-189

Meyer-Rüsenberg H.-W. SU-42

MO-78-10 TU-06TU-06-03P-SU-226P-SU-248 WOC-C-52

Meyer-ter-Vehn T. P-SU-013Michael S. SU-35-01Michaelis M. MO-32-10Michalewska Z. MO-27-05

TU-33-10Michalewski J. MO-27-05

P-MO-207TU-33-10

Michalik R. P-SU-153Michalik-Wójcik A. MO-78-02Michalke B. TU-37-05Michelle T. SU-44-04Michels R. SU-61-08

TU-29-06Michels S. MO-67-09

P-SU-027P-TU-177TU-29-06

Michelson G. SA-29SA-29-05SU-62MO-53

Midelfart A. P-SU-016Midena E. MO-18-04

WE-23-04Midori Yabiku M. P-SA-271

Mieler W. F. SA-25 SA-35SA-41-08SU-20-09MO-02-04MO-16MO-16-02MO-72-02WOC-C-62-04

Mielniczuk E. P-MO-056Migdal C. MO-54

LS-17Mihnea M. P-TU-107Miki A. P-TU-069

TU-30-07Miki N. P-TU-195Milenkovic S. P-TU-230

P-TU-240Milenkovic V. P-MO-157

P-SU-268Miliauskaite L. P-SA-116Miller J. MO-63-06Miller M. SU-55Miller N. MO-73-03

P-SU-125Miller W. TU-21-06Milman T. P-TU-109

P-TU-111Milojcic C. P-SA-195

TU-33-02WE-34-04

Mimura O. P-SU-121P-SU-135

Minami M. P-MO-264Minavi A. TU-21-06Minoshima S. P-TU-129Mintz-Hittner H. A. MO-04-07Miraglia O. TU-21-03Mira-Lorenzo X. P-SU-024Miranda Hernandez I. P-SA-023Mirlay R. P-SA-016Mironow A. MO-73-03Mirsakhanova H. P-TU-135Mirshahi A. MO-28-07

P-TU-211TU-29-08TU-63-10

Mirsoev S. P-SA-042Misailovic K. P-TU-071Misefari W. SA-10-03Miserocchi E. SA-08-07Mishev L. P-TU-039Mitchell P. SA-12-01

SU-73-03MO-03-01MO-56-09TU-35WE-36-03WE-38WE-38-02WE-40P-SU-051

Mito T. P-MO-011Mitra A. K. WE-15-04Mitsch C. P-TU-232Mittelviefhaus H. SU-81

P-TU-047Mittica P. P-SA-137Mittica V. P-SA-137Miura H. P-MO-178Miura Y. P-SA-186

TU-36-08Miyagawa Y. P-MO-193Miyahara T. P-MO-266

P-SU-053

394 WOC® 2010

Auth

or In

dex Miyake A. P-MO-011

Miyake K. SU-20-08Miyamoto C. P-MO-282Miyamoto N. P-TU-225Miyamoto T. P-SA-232

TU-31-10Miyamura N. P-MO-247

P-MO-256Miyata N. SU-80-05

P-SU-219Miyazaki D. P-MO-011

P-SA-279Mizariene V. P-SA-204Mizoguchi T. P-SA-103Mizokami J. P-SA-131

P-SA-154Mladenovic J. P-SU-176Möbius H. MO-28-09Mochizuki K. P-SA-107

P-SA-136Mochizuki M. TU-47-03

TU-60-06P-MO-188P-SA-097P-SA-229

Módis L. TU-72TU-72-05

Moeller C. P-MO-098Mohamad C. M. P-SA-275Mohamed A. M. P-SU-050Mohamed M. MO-74-08

P-TU-179P-TU-182

Mohamed S. TU-35-07Mohammadi S. P-SU-165Mohammed I. TU-81-07

SU-75-10Mohan R. R. MO-47-03Mohd Rawi N. A. P-SA-275Möhle F. P-MO-151Mohney B. SU-55-10Mojon D. SU-23

SU-72SU-72-01MO-66MO-66-01MO-66-03WE-20Po-TU

Mokaddam A. P-MO-275Molchanyuk N. P-TU-166Mollayes G. P-MO-092Monnet D. MO-11-01Montemagno C. MO-47-09Montenarh M. P-SU-265Montón C. P-SU-083Montuoro A. P-SA-164Moon N. J. P-MO-284

P-SA-219Moore A. T. WE-35Moorthy B. SU-55-09Mooy C. M. SA-43-06Moraes N. P-TU-188Morales P. H. SU-64-04Morawski K. P-SA-183Morax S. MO-34-07Mörchen M. P-MO-083Moreno L. P-MO-099

TU-80-08TU-82-07

Moreno-Nadal M. A. P-SA-119Morfeld P. P-MO-039Morgan C. P-SU-071Mori S. P-MO-043

P-SA-126

Morita H. TU-32-03Morita I. P-SU-182Moriyama A. S. P-MO-098Moriyama M. P-MO-188

P-SA-229P-SU-182SU-56-03

Morkhat M. P-MO-053P-TU-190

Morkhat V. P-MO-053P-TU-190

Morlet N. WE-40-09Morris R. J. P-MO-272

SU-62-03Morse L. P-SA-211Morsy M. TU-25-06Mortada H. MO-70-02

SU-68-04TU-01-05WE-28WE-28-05

Morton J. WE-40-08Mosallaei M. P-SA-278

P-TU-136Mosca L. P-SA-062Moschos M. P-MO-035Moshfeghi A. WE-40-08Moshfeghi D. TU-54-03

WE-40-08 WOC-C-57-02

Mosqueda P. SA-25-09Mossböck G. P-SA-135Moster M. MO-65-04Mosuro A. WE-16-08Motamedi M. J. P-SU-165Motizuki M. P-SU-182Motolese E. P-SA-137Motolese I. P-SA-137Motschmann M. P-SA-162Mouhdi H. S. P-TU-189Moussa S. P-TU-176Moustafa M. P-SA-230Moutsouris K. TU-31-01Mrochen M. SU-60

SU-60-06MO-38-04

Mrsic J. P-SU-152Mrukwa-Kominek E. SU-75-01

P-MO-022P-MO-056P-MO-109P-MO-162P-TU-171P-TU-201WOC-C-46WOC-C-46-02WOC-C-46-03

Mrvos-Cobeljic D. P-SU-176Muacevic A. P-TU-091

P-TU-096Muccioli C. SU-27-08

MO-32-06 WE-30-01P-TU-206

Mucke E. P-SU-010P-SU-018

Mucke H. P-SU-010P-SU-018

Mucke P. M. P-SU-010P-SU-018

Mueller A. P-SU-188P-TU-263SU-74-03WE-16-02

Mueller I. WE-41-03

Mueller M. P-SU-023P-TU-075

Mueller S. P-TU-181Muhd Zafran bin Shamsudin M. Z. TU-35-10Muhit M. MO-51-04Muhovic -Bejtic J. P-TU-105Mukherjee B. P-SU-244

SU-37-09Mukherjee R. P-SU-189Muldoon T. MO-27-03

P-SA-180P-TU-216TU-37-09

Müller A. SA-27-02Müller A. M. P-SU-006Müller B.-K. P-SU-179Müller H. MO-48-03Müller M. SA-31-04

MO-79-04WE-10-05WOC-C-14WOC-C-14-04WOC-C-37-05

Mulvihill A. P-TU-150P-TU-148

Munana J. SU-74-03Munch I. C. SA-32-05Mundorf T. K. P-MO-071

P-TU-059TU-30-02

Mundt H. W. TU-57-01Munier F. SA-09-02

SA-18SA-18-01

Munk M. MO-68-03P-SA-200

Muñoz M. F. SU-34-11Muñoz-Negrete F. P-SU-132Muqit M. P-MO-174

P-MO-195Muraine M. TU-04-03Murakami A. P-SA-087

P-SU-052Murakami Y. TU-54-04Murata T. P-MO-266

P-SU-053Murenzi J. SU-74-03Murillo-Correa C. SU-61-04Murjaneh S. TU-25-01Murotani E. P-SU-141

P-SU-159Murray A. MO-69-02

TU-67-06TU-68-03

Murray P. I. MO-11-08TU-47TU-83WE-30WE-30-05

Murray T. G. SA-25 MO-77-08TU-22-06TU-45-06

Murta J. N. MO-57-02TU-76-03WE-11-07

Murthy G. V. S. SU-74-05Murube del Castillo D. J. TU-41-09

TU-79TU-79-01

Mylonas G. MO-32-07P-TU-028

395WOC® 2010

Auth

or In

dexN

Nadal J. WOC-C-40WOC-C-40-01WOC-C-40-02WOC-C-40-05

Nadarajah S. P-TU-170Nadras I. P-SU-134Nafie I. P-SA-142Nagai T. P-MO-213Nagaoka T. P-MO-153Nagasaka E. P-SU-146Nagata M. SA-31-07Nagel E. P-TU-194Nagel J. MO-79-07Nagel J. A. MO-79-08Nagori S. SU-34-09Nagpal P. N. SU-20-06Nagy A. P-SU-028Nagy Z. Z. TU-72-03Nahen K. WOC-C-31-02Nahra D. P-SA-006Naidoo K. SA-37-02

SA-48-05WE-36WE-36-06

Naik R. K. P-SU-110Najm-Tehrani N. SU-74-02Naka M. MO-73-05

P-SA-131P-SA-154

Nakabayashi S. P-MO-153Nakada C. SU-56-03Nakagawa Y. P-TU-231Nakaizumi A. P-MO-264Nakamoto H. SU-38-07Nakamoto K. P-SA-115Nakamura H. P-MO-043

P-SA-126P-TU-067

Nakamura K. P-SA-037Nakamura M. MO-73-05

P-SA-131P-SA-154

Nakamura S. P-TU-252Nakamura Y. P-SA-123Nakanishi H. P-MO-043

P-SA-097P-SA-126P-SA-167P-TU-172

Nakano N. P-MO-043P-SA-126

Nakao S. P-TU-220Nakao T. P-SU-255

P-SU-262Nakata I. P-SA-097

P-SA-167Nakayama M. P-MO-064Nakazawa M. P-MO-193

P-SA-015Nan B. WE-40-02Naranjo-Tackman R. SA-02-02Nardi M. SU-37-05Narendran K. WOC-C-58-06Narendran V. WOC-C-58

WOC-C-58-01WOC-C-58-03

Narita A. P-TU-072Nasaruddin R. A. P-SA-259Nascimento H. P-MO-023Nasri A. SU-81-07Nasser Z. SU-41-02Natalia V. P-TU-175

Natarajan S. MO-81-05WE-28-04

Natesh S. MO-67-10P-TU-109P-TU-111P-TU-218

Nau J. TU-34-10Naumann G. O. H. SU-56

TU-68P-TU-127

Naumenko L. P-TU-088Naus N. SU-39-05Naval C. I. WE-34-07Nawrocka L. P-MO-162Nawrocki J. MO-27-05

TU-01-04TU-33-10TU-77-10

Naycheva L. P-SA-155Nechiporenko P. MO-68-06

P-SA-203TU-33-07

Nefedova D. SA-28-07Negi A. MO-73-05

P-MO-213P-MO-254P-SA-131P-SA-154

Negishi T. P-SA-215Neidhardt J. P-SA-088Neira W. TU-80-05Nelson S. F. MO-77-05Németh J. SU-28

SU-37TU-02TU-02-06

Nentwich M. M. P-TU-091SU-34-06SU-61-03WE-16-03P-TU-096

Neophytou P. SU-35-01Nerad J. P-SU-223Nesnas K. P-MO-211Ness T. SU-27-07

MO-50MO-50-04

Netto C. SA-28-02Netukova M. P-SA-048

TU-31-07Neubauer A. MO-75-03

MO-75-08P-MO-210P-MO-233P-MO-271P-SA-173P-SA-202P-SU-186P-TU-191P-TU-228P-TU-237SU-38-01TU-33-03TU-34-11

Neuburger M. P-MO-038TU-63-06

Neudorfer B. SU-61-06Neugebauer A. SA-45

SA-45-04Neuhann I. MO-16-06Neuhann T. P-MO-124

SU-47-05

Neuhann T. F. SA-13SA-19-03SA-26SU-13SU-13-01MO-37MO-37-01TU-03-04TU-24TU-46-01TU-75-03

Neutzner R. V. P-TU-174Newman D. P-MO-197Nezgoda J. P-TU-216Ng H. K. P-SU-222Ng J. WE-40-09Ngah N. F. P-SA-272Ngai J. W. S. P-TU-108Ngo-Tu T. P-MO-142Nguyen N. X. TU-14

TU-14-01Nguyen Q. D. SU-27-03

MO-01MO-03-04MO-32-09 MO-46-02MO-75-06TU-29-09 WE-35

Nguyen T. P-SU-036Nicholson E. P-SU-252Nikolic S. WOC-C-36-05Ninios K. P-SU-276Nischal K. K MO-05

MO-05-02Nishi M. MO-57-04Nishi O. TU-75Nishida K. SU-17-06Nishida T. P-MO-064Nishiguchi K. M. P-SU-270Nishikawa N. P-SA-282Nishimura M. P-SU-121

P-SU-135Nishina S. P-SU-124

P-TU-200P-TU-222

Nitta N. TU-32-03Nix G. P-SA-044

P-SA-067P-TU-010SA-26-06

Nkomazana O. P-TU-103Nkumbe H. SA-37

SA-37-01SA-37-04SA-37-07

Nobrega M. J. MO-32-06Noh Y. P-TU-234Nölle B. SU-27-10Nomoto H. P-SA-020Nonaka A. P-MO-043Noonan C. P-SU-150Norbert P. P-TU-147Noske W. WE-39-08Notara M. FR-01-16Novák J. P-TU-025Novak Laus K. WE-39-07Nowak M. MO-68-09Nowinska A. MO-35-03

SA-31-03Ntountas Y. SU-71-04Nuijts R. SU-15

SU-15-02SU-58-04TU-82-10

396 WOC® 2010

Auth

or In

dex Nukada M. P-MO-043

P-SA-126Nusanti S. P-SU-126

TU-36-04Nussenblatt R. SU-31

SU-31-06MO-46MO-46-01 MO-76-08TU-17TU-17-03

Nutheti R. SU-34-09Nyaga P. T. P-MO-079

P-MO-088

O

Ober M. MO-75-03P-MO-210

Oberacher-Velten I. MO-58MO-58-01P-MO-204P-SA-124

Oberheide U. P-MO-144SA-27-07TU-82-09

Obholzer K. P-SA-173TU-25-08

O'Brien T. SA-06SA-06-01

Obstbaum S. A. TU-04TU-04-01

Ochiai M. P-SU-107Ocklenburg C. TU-32-05Odrobina D. MO-27-05Oehler S. TU-80-03Oelckers S. MO-79-04Oestreicher J. SU-71

SU-71-01MO-78-09

Oetoyo A. S. P-SU-091Ofner J. TU-37-06Oganesyan O. P-SA-045Ogata N. P-SA-159Ogun O. A. WE-16-09

WE-41-08Ogundimu K. SA-37-06

SU-74-08P-TU-259

Ogundipe B. WE-16-09Ogura Y. MO-01

TU-37-02Oh D. H. P-MO-284

P-MO-296Ohashi Y. P-MO-011Ohba S. P-SU-124Ohishi M. P-SU-089Ohji M. SU-48-07Ohkubo S. P-SU-141

P-SU-159Ohno K. P-SA-097Ohno S. TU-73

TU-73-05WE-30-02

Ohno-Matsui K. MO-01-01MO-24P-MO-188P-SA-229

Ohrloff C. P-SU-041Ohtsuki H. P-SA-222Oi A. P-MO-068

P-MO-089P-SA-017

Ojima A. P-MO-165

Okada A. A. TU-73-08Okada E. SU-80-05

P-SU-219Okajima Y. P-MO-027Okamoto F. P-MO-163

P-MO-172P-MO-235P-MO-239P-SA-150

Okamoto Y. P-MO-163P-TU-220

Okazaki Y. P-TU-195O´Keefe M. MO-07-02Oki S. P-SA-004

P-SA-037Okimoto S. P-TU-070Oku H. P-SU-257Okuda T. P-TU-068Okunuki Y. P-SA-247Okuyama M. P-SU-124Okuyama S. P-SA-106

P-SA-109Olali C. MO-31-08Olawoye S. WE-16-09Oldak M. P-SA-091Oledzka G. P-SU-026Oleksy P. P-MO-175

P-MO-267P-TU-085

Oleszczuk J. P-MO-028Olfa H. T. P-SA-249Oli Mohamed S. P-SA-272Olivares C. Q. WE-34-07Oliveira Neto H. MO-32-06

P-TU-036Olivier J. MO-31-05Olivier M. M. G. MO-81-01Olsen T. TU-10

TU-10-04Olson J. SA-29Olson J. SU-62-06Olson J. A. TU-29-03Olson R. J. MO-25-04

TU-68TU-68-06

Oluleye T. WE-16-09Olusanya B. SU-74-04

WE-16-09Omae T. P-MO-153Omarganova I. P-SA-160Omran M. S. SU-55-02Ondas B. P-SA-192Ondiveeran V. R. TU-14

TU-14-03Oner F. H. P-MO-234Ong L. MO-26-06Ono K. P-SU-052Onyango O. M. P-MO-079

P-MO-088Oohashi H. P-SU-114Ooi A. P-MO-258Oono K. P-SU-182Ooto S. P-SA-167

P-TU-172Ophir A. SA-25-09Ophthalmic PDT study group P-SA-191Oppermann T. P-MO-164Orapiriyakul L. P-SA-117Orgül S. TU-16

WE-13-05Orikasa H. P-SU-089Orilla W. P-TU-199Orozco M. SU-42-07

Orzekowsky-Schroeder R. P-SU-031

P-SU-034Osaki M. P-SU-208Osaki T. P-SU-208

P-SU-208Osborne N. N. TU-15-01Oshika T. P-MO-163

P-MO-172P-MO-235P-MO-239P-SA-150 ES-05-03

Oshima Y. TU-30-07Osma I. P-TU-014Ossma-Gomez I. L. MO-15

MO-15-03SU-13-05

Oster S. SU-38-01TU-34-11

Otani A. P-SA-167P-TU-172

Otani F. P-MO-011Otani T. P-SA-242

P-TU-233Othman O. MO-74-08

P-SA-275P-SU-020P-TU-063

Otsuji T. P-SA-159Otterbach F. P-SU-042Ouazzani Tnachri B. P-TU-189Owoaje E. SU-74-04Owoeye F. WE-35-01Ozaki M. P-SA-097Ozawa S. P-SA-175Ozcan S. P-SU-085Özkan S. B. MO-09

MO-09-05Özlügedik S. P-MO-015

P-MO-016Oztura I. P-TU-061Öztürk C. SA-31-06Ozturker C. P-SU-198Özyurt O. SA-31-06

P

Paco I. P-TU-105Paetzold J. P-SA-106Pahor D. MO-26

MO-26-02 Po-SAP-MO-012P-TU-058

Pajaujis M. P-MO-091Pakalnis V. A. TU-28-02Pal D. SU-81-02

MO-31-03P-MO-145P-MO-298TU-13-06

Palanker D. TU-54-01Palis G. MO-41-05

MO-42-03MO-44-04

Palkovacs E. P-SU-142Pallás C. P-TU-074

TU-63-02Pallerla S. SU-73-09Pallikaris I. G. TU-76-06

WE-02-04Palomino C. MO-15-04Pampucha V. P-SA-098

397WOC® 2010

Auth

or In

dexPan Y. MO-25-07

Panagakis G. SA-32-02Panagis L. P-SU-122Pande C. P-TU-042Pande M. SU-13-04Pandova M. SU-73-01Pang C. P-SA-093Pang C.-P. MO-56-02

P-SA-252Panidou E. P-SA-253Panos L. TU-36-06Pantenburg S. P-TU-248Papanikolaou T. P-MO-197Paques M. SU-01-04Paranhos J. P-SA-046

P-SA-086Paranhos Jr. A. P-SA-102Pardo D. P-MO-097Pardo-Lopez D. P-SU-169

P-SA-266Paredes I. P-MO-081Parhovchenko E. P-TU-173Paridaens D. SU-39-05Paris V. TU-59Park C. K. SA-28-09Park I. K. P-MO-296Park K. H. SA-28-09

SA-30-04Park K.-u. SU-47-01Park S. P-SA-211

TU-32-07Park S. C. SA-28-09

MO-47-08Park S.-h. P-TU-162Parlato Oliveira E. P-SU-112Parrozzani R. WE-23-08Parsa C. F. WE-41-01Partsch M. P-TU-119Parviz B. A. MO-47-01Pascu R. P-MO-048Pasiechnikova N. P-SA-098Paskaleva D. SU-81-04Pasquale L. R. MO-71-06

TU-16-04WE-40-02

Pastuszka M. MO-68-09Patel A. P-TU-046Patel S. TU-80-07

WOC-C-46WOC-C-46-01WOC-C-46-06WOC-C-46-07WOC-C-46-08

Patel T. MO-73-04P-MO-030

Patel V. D. P-TU-060Patelli F. TU-01-01

TU-45-09Paterson C. A. TU-27-06Pathai S. P-SU-066

P-SU-072Pattiata R. P-TU-104Patton N. P-MO-174

P-MO-195Pauk M. TU-81-03Pauklin M. SA-17-07

P-SU-038P-SU-042

Paul A. P-SU-189WE-34-05

Pauleikhoff D. TU-09-05TU-37

Paulig S. SA-27-05Paulin Huerta J. M. SU-79-02

MO-15-08

Paulsen F. SU-63-02P-SU-012

Paulsson M. P-SU-258Paulus D. SU-30

SU-30-04Pavesio C. SA-08

SA-08-02MO-76-02

Pavlin C. J. MO-35-09Pavlovskaya A. WE-35-02Peckham C. SU-73-07Pedanova E. MO-27-07Pe'er J. SA-46

SA-46-01SU-39SU-39-07SU-67SU-67-08MO-18-05TU-22-07

Pefkianaki M. MO-76-10Peh K. K. P-SU-191Pelayes D. SU-43-06

WE-27WE-27-04WOC-C-50-01

Pellegrini G. MO-17WE-05-02

Pemp B. P-TU-232Peña D. P-SU-086Peñaloza-Roman I. P-SU-024Peng J. Su-54-04Penha F. M. MO-32-09

P-SU-011Penha Morterá Rodrigues M. P-SU-084Pepic A. P-SU-176Pereyra-Munoz N. SU-61-04

SU-79-02Perez B. MO-77-07

P-TU-110Perez L. P-SU-199Perez V. L. SA-17-02Pèrez-Arteaga A. P-SA-009

TU-82-08Perez Fernandez C. TU-35-09Perez-Solorzano G. G. P-MO-078Pericak D. P-MO-074Perros P. MO-82

MO-82-01Pertile G. P-SA-170Perulasamy N. SA-24

SA-24-03Peruzzi S. P-SA-137Perz C. P-MO-146

P-MO-228Pesavento R. MO-67-03Pester A. P-SU-042Pesudovs C. WE-01-03Peters A. MO-28-01Peters N. P-TU-204Peters S. SA-31-04

MO-36-04P-TU-075

Peters T. N. TU-62-01TU-62-06

Petersen H. P-MO-191Peto T. SU-62-01

TU-44-05P-SU-064

Petousis V. P-TU-114Petrarca R. TU-34-10Petric Vickovic I. WE-39-07Petroska D. P-MO-091

P-TU-084Petrovski B. WE-35-09

Petrowitz B. P-SU-271Petzold A. LS-04

LS-04-01Petzold G. LS-04

LS-04-02Pezzente M. SU-41-11

SU-74-02Pfeifenbring S. SU-44-10Pfeiffer N. SA-23

SA-24SA-28-04SA-28-06 SU-03SU-03-04SU-73 MO-13-07MO-31-07MO-73-10 TU-29-08TU-36-03TU-36-06TU-41-10 TU-44TU-44-03WE-13P-MO-033P-MO-036P-MO-039P-MO-045P-MO-049P-MO-187P-SA-111P-SA-190P-SU-094P-SU-104P-SU-194P-SU-202P-SU-204P-TU-076P-TU-080P-TU-241 WOC-C-34WOC-C-35LS-17-01

Pfenninger L. TU-29-06Pfirrmann K. P-SU-094Pfister M. MO-32-10Pfrommer S. P-MO-171

P-MO-228SA-32-10TU-35-05WE-35-06

Pham D.-T. SU-14SU-14-02TU-82WE-10P-SA-026

Phamonvaechavan P. P-SA-226Pharmakakis N. P-MO-214

P-MO-190Philip S. SU-62-06

TU-29-03Philipp W. P-SA-034Philips R. P-TU-025Phillips T. P-SA-211Phuljhele S. P-TU-141Pieczara E. P-MO-162Pieh C. SU-23

SU-23-07Pieh S. P-MO-110

SA-26-04Piekarek M. P-SU-260Pielen A. P-MO-236

P-SA-070P-TU-248TU-29-08

398 WOC® 2010

Auth

or In

dex Pietras-Trzpiel M. P-MO-260

Pietrzycka J. P-TU-201Pignatari A. C. P-MO-098Pikulski Z. MO-27-05Pilavas J. TU-37-09Pillunat L. E. MO-73

WE-07WE-07-08WE-39-05 P-SA-139 LS-17-04

Pimenidi M. P-SU-087Piñas Garcia P. P-SU-147

P-TU-247Pinazo-Duran M. D. P-SA-119

P-MO-047P-MO-093P-MO-160

Pinchuk L. SU-42-07Piñero Llorens D. P. P-SA-063

P-TU-010P-TU-013P-TU-024SA-27-11SU-35-07

Pinheiro Callou C. M. P-TU-262Pinheiro Callou E. P-TU-262Pinies J. A. MO-75-02Pinter F. P-MO-271Pinto L. A. WE-41-05Piotrowski J. SU-55-10Piovella M. TU-25-03

TU-41-04TU-76-05P-MO-106P-MO-130P-TU-012P-TU-026

Piperno-Neumann S. SU-39-02Pircher M. MO-27-01

MO-27-02Pircher M. TU-37-06Pisipati S. P-MO-044

P-MO-051Pitz S. MO-82-03

WE-40WE-40-01WE-41-02Po-SUP-SU-194P-SU-202WOC-AAD-C-27

Pivetti P. TU-50-01Pizinger K. P-TU-113Plager D. A. TU-07-04Plange N. P-SU-140

TU-63-05Plant G. SA-38-07

SU-18SU-18-06SU-44TU-08-04TU-08-05

Planyavsky M. P-SU-188SA-27-02

Plaza A. B. P-TU-010P-TU-024SA-27-11TU-82-07

Pleyer U. MO-11-04 MO-74-06SU-24SU-24-04 SU-27-07SU-33SU-33-04TU-20TU-20-03TU-38TU-38-03TU-47 P-SA-263WOC-AAD-C-23

Ploski R. P-SA-091Poelzl M. TU-80-06Pogrzebielski A. MO-78-02

P-TU-085Pojda-Wilczek D. P-SA-153

WE-37-05Polling J. R. TU-59-06Pollock A. SU-44-04Pollreisz A. P-SU-188

SA-27-02Poloschek C. P-SA-088Poloski E. P-SU-137Polyakov V. WE-35-02Pomsathit J. P-SU-210Ponce A. TU-37-09

MO-27-03P-SA-180P-TU-216

Ponomareva E. P-SA-151Pons-Vázquez S. P-MO-160Ponto K. A. P-SU-194

P-TU-080Ponzin D. TU-19-03Pop E. P-SU-005Popa Cherecheanu A. P-MO-048Poposka D. TU-29-05Poposki V. TU-29-05Portero-Benito A. P-SU-086

SU-34-10SU-34-11

Porz G. P-SU-058Posarelli C. SU-37-05Pöttgen J. SA-25-08Pournaras C. J. SU-48-01

TU-34TU-48TU-48-03

Power I. P-SU-071Po-Yen L. P-MO-219Pozder S. P-TU-105Prabowo R. P-MO-132Prada J. P-MO-142Prager S. G. P-TU-232

MO-32-07Praidou A. MO-74-03

P-MO-248P-SA-012P-SA-276P-SU-035

Prajna N. V. TU-24TU-24-06TU-57-02

Prakoso H. WE-17-05Prapatjukkit P. P-MO-186Pras E. P-SA-096Prasad S. WOC-C-12-08Prata T. S. P-SA-102Prause J. U. SA-46

SA-46-06SU-67-01

Preen D. WE-40-09

Prescott G. J. TU-29-03Preuss M. WE-41-03Preussner P.-R. SA-04

TU-82-04P-MO-137

Price F. W. SU-78SU-78-01

Price M. O. TU-05-05Priglinger Jr. S. G. SU-17-07

SU-61-06TU-25-07TU-29-08 WE-27-02

Priglinger-Alge C. P-SA-178Prilloff S. P-SU-162Proença R. SU-73-04Prokofyeva E. SU-73-05Prokosch V. P-SU-122Promesberger J. P-MO-108

P-MO-293P-SA-052

Prünte C. TU-37-10MO-67-07P-SA-164P-SA-196 WOC-C-15-05

Ptaszynski L. P-TU-196Puccioni M. WE-33-01Puchkov A. P-TU-173Puchkova I. P-TU-173Puech M. TU-10-03Pulido J. S. SU-67-09

TU-53-02Puranik S. P-TU-141Pusey C. P-SA-268Pushker N. P-SU-242Pustolla N. P-MO-201

Q

Qerimi E. P-TU-159Qu C. P-SU-040Quaranta-Leoni F. SA-42-03Quek D. P-MO-084Quellec G. TU-56-03Quinn A. TU-25-01Quinn G. SU-41-03Quiroz-Mercado H. WE-29-06Qureshi M. B. TU-42

TU-42-04

R

Rabensteiner D. F. FR-01-11FR-01-12FR-01-19

Raber S. SU-55-05Rabsilber T. M. SU-45-05

P-SA-010P-TU-008P-TU-018P-TU-025

Rad F. M. MO-28-10Radbruch L. P-MO-288Radeck V. P-MO-204Radecka L. MO-68

P-SA-209Radford J. SU-67-02Radovic N. P-TU-071Rahi J. WE-40-07Rahi J. S. SU-07

SU-07-04SU-73-07

399WOC® 2010

Auth

or In

dexRahman A. P-SU-079

Rainer G. MO-32-07Rajan M. TU-46-03Rajapaksha K. P-TU-062Rakhmonov A. P-TU-135Ralfkiaer E. SU-67-01Rama P. MO-17-05Ramaesh K. SU-75-04Ramamurthy C. SA-26-07Ramamurthy D. P-TU-027

SA-26-02Raman V. P-MO-259Ramani R. V. SU-64-06

MO-10P-MO-086

Ramke J. WE-16-01Ramos F. TU-31-09Ramos Lopéz M. P-SA-033Ramulu P. MO-08-01Randall A. D. P-SU-252Randleman J. B. SU-59

SU-59-02MO-38MO-38-07

Rao G. N. SA-37-03SU-65-02WE-25WE-25-02

Rao K. MO-28-05Rao L. MO-28-05Rao N. A. SU-24

SU-24-06SU-57TU-73-01

Rao N. P. MO-77-05Rao S. K. TU-24-01

WE-19WE-19-04

Raoof N. P-TU-169Rasmussen M. L. R. SA-46-05Rasp M. P-TU-010Rathore D. S. P-MO-147Rattanasukon M. P-MO-186Rau M. P-MO-122Rauch N. P-MO-036

P-TU-147Raum C. P-SA-036Raus P. P. M. SU-37-07

TU-79-08Raut R. MO-77-08Ravech S. P-SA-096Raveh I. P-MO-121Ravilla T. P-MO-087Razzaq L. SU-34-08Read R. P-SA-187Realini A. WE-13-04

P-SA-129Rebel C. P-TU-073

WE-39-02Rebolleda G. P-SU-132Reed D. M. WE-40-02Rees G. P-SA-140Reese J. MO-31-01Regler R. P-MO-204

P-MO-244P-SA-124

Regoda V. P-SA-220Rehder J. R. C. L. SU-45-01Reichard M. SU-56-04Reichl S. P-TU-048Rein D. B. MO-52-02Reinecke K. P-SU-253

Reinhard T. SA-19SA-19-02 SU-37-03SU-78TU-20-05TU-31 TU-63-06P-MO-038P-MO-294P-SA-059P-SA-068P-SA-070P-SU-045P-TU-043P-TU-047

Reinstein D. Z. SA-04SA-04-04TU-62-03TU-80 TU-80-04TU-80-10P-MO-111

Reis A. Po-SAReis R. F. P-TU-036Reis W. P-SU-186Reiter C. P-MO-148Reitsamer H. SA-28

MO-12-03Rejdak R. SA-28-08

TU-37-05TU-77TU-77-01P-MO-260P-SU-264

Reka K. P-SA-133Remeijer L. MO-21-04

SU-28-05Remky A. P-MO-075

P-SU-140TU-63-05

Remmel R. M. P-MO-114Remonda L. MO-73-03

P-SU-125Ren R. P-SU-004

P-TU-053Ren X. MO-74-02Renieri G. P-SU-202Rentz A. MO-75-05

P-SU-110WE-35-04

Repka M. X. SA-47SA-47-06SU-52SU-52-05

Resende Gomes C. E. P-TU-165Reupsch J. P-SA-146Revicki D. MO-75-05

WE-35-04Rezaei-Kanavi M. P-SU-039Reznicek L. P-TU-228

P-TU-237Rheinschmitt L. MO-79-08Riadh M. MO-32-05

P-MO-082P-SA-270

Ricar J. P-TU-113Ricardo P. WE-21-04

WE-22-02Ricarova R. P-TU-113

Richard G. SU-75-05 MO-61MO-61-01TU-32P-SA-082P-SA-182P-SA-184P-SA-185P-SA-189P-SU-266P-TU-056P-TU-082P-TU-217WOC-C-07WOC-C-07-01

Richards F. SU-32-05Richards J. E. WE-40-02Richards S. SA-20-04Richter J. P-SU-094Rieck P. SA-05-05Riedel K. G. WOC-C-33Riederle H. P-MO-251Riemann C. D. TU-45-07Riese J. TU-37-04Riha W. P-SA-044

P-SA-067SA-26-06

Ringens P. J. MO-55-01Rio Torres M. SU-64-05

P-SA-023P-SA-033

Rios R. SU-75-09Risimic D. P-TU-230

P-TU-240Ristau T. P-SA-165

P-SA-198Ritch R. SA-12

SA-21 MO-31-11MO-47MO-60-03TU-43-07TU-68-02

Ritter F. MO-79-08Ritter H. P-SU-179Ritter M. P-TU-028Rizk H. I. R. WE-40-10Rizk A. SU-61-09Rizzo R. TU-14-06Rizzo S. MO-16

MO-16-01Rizzuto P. R. MO-81-07Roberts P. SU-42-04Roberts S. P-SU-231Roberts T. WE-17-01Robinson M. MO-67-02

MO-75-06TU-35-11

Robles-Contreras A. P-SU-024Roca J. SA-41

WE-29WE-29-02

Rochtchina E. P-SU-051Röck T. P-SA-155Rodin S. P-MO-238

TU-29-04Rodrigues F. P-SA-090

P-SA-094Rodrigues E. MO-32-09

P-SU-011Rodrigues E. B. MO-67-09Rodrigues F. P-SU-144Rodriguez de la Rua E. TU-35-09Rodriguez Prats J. L. P-TU-013

SA-27-11

400 WOC® 2010

Auth

or In

dex Rodriguez-Reyes A. P-TU-110

Rogers J. MO-27-03Roggia M. P-SA-226Rogmann J.-P. SU-40-05Rogowska-Godela A. P-MO-022Rohit S. TU-59-01Rohrbach J. M. TU-81-02

P-TU-097Rohrschneider K. MO-23

MO-23-03MO-27-09

Rohrweck S. P-MO-097P-SA-243 P-SA-266P-SU-169

Roider J. SA-25SA-25-06SU-27-10SU-45MO-28-01 MO-36MO-36-03TU-32-09TU-36-08P-MO-151P-MO-164P-SA-186P-SU-253P-TU-196WOC-C-57-05

Rojanapongpun P. SA-30SA-30-03

Rojas-Diaz A. P-SU-024Rolfs A. SU-56-04Romac I. P-MO-112Romaniuk W. P-MO-056

P-SA-153P-TU-171TU-36-09

Romano M. R. P-MO-224Romano V. P-MO-224Romanova T. P-TU-166Romanowska-Dixon B.MO-77

MO-78-02 P-SA-183 P-MO-175P-MO-267P-TU-085P-TU-092P-TU-128

Romanowski E. G. MO-21-02Roman-Roman S. SU-39-02Romkes G. FR-01-10Rootman J. TU-40-02Rosbach J. P-TU-080Rose G. MO-34

MO-34-01SA-46-07

Rösel M. MO-74-04MO-74-07P-SA-248P-SA-256

Rosen E. S. MO-19MO-19-01MO-37MO-37-04

Rosen R. P-SA-180P-TU-216P-TU-224TU-37-09MO-27-03

Rosenbaum J. T. SA-40SA-40-03

Rosenthal J. TU-37-09P-SA-180P-TU-224

Rosenthal P. TU-31-08Rosentreter A. P-MO-274

P-SA-013P-TU-066

Roskamp R. P-TU-076Rosman M. WE-40-04Rosner M. SA-46-02Rossetti L. BS-09-05Rossi T. WE-26-04Rossini P. SU-45-06

MO-24-10P-MO-232

Rosu L. P-SU-002Rotberg M. P-TU-059Rotchord A. MO-31-08Rotenstreich Y. P-MO-216

P-SA-096SU-38-05

Rothenbuehler S. P-TU-178P-TU-245WE-34-10

Rothova A. MO-74-05TU-47-01TU-83

Rothweiler F. MO-32-10Rottler J. P-MO-015

P-MO-016Rovner B. MO-68-07Roy S. SU-38-04Rozanova Z. P-MO-238Rozenberg F. MO-76-09Rubin G. S. MO-10

MO-10-04Rubio R. G. MO-67-06

TU-29-09 WOC-C-63-02

Rubis V. MO-27-08Rücker I. MO-28-10

SU-38-09Rücker M. MO-78-03

SU-38-09Rüdiger H. SU-34-06Rudnitzki F. MO-79-01Rudolf M. P-SA-166

P-SA-187P-SU-251

Rudolph G. SU-61SU-61-03TU-33-03P-TU-021

Rüfer F. MO-28-01Ruggeri A. P-MO-269

SU-62-01Ruit S. P-TU-263Ruiz Rodríguez Y. P-SA-023Ruksenas O. SU-36-02Rummelt C. P-SA-065

P-TU-127Rüping J. P-MO-233

P-SA-188P-SA-194

Ruppenstein M. P-SA-177P-TU-203P-TU-244SU-38-02TU-34-07

Ruschenburg H. P-MO-170P-MO-170

Russ D. P-SA-050Rustambayova G. P-MO-180Ruttig A. MO-74-04Ryan S. J. TU-46Rybakova E. SA-14-03Rym K. MO-32-05

P-SA-250Ryseck I. P-SU-116

S

Saad A. SA-01-07Saakyan S. V. P-TU-122

P-TU-125SU-34-03

Saatci A. O. P-MO-234Sabanayagam C. P-MO-169Sabel B. A. P-SU-153

P-SU-175SU-44-06P-SU-137P-SU-160P-SU-161P-SU-162P-SU-174SU-44-08WE-41-03

Saburina I. SU-35-06Sachdev A. P-SA-261Sachdev M. S. TU-46-03Sachs H. TU-34-09Sacko D. SA-37-03Sacu S. MO-67-07

MO-68-03P-SA-164P-SA-207P-SU-188P-TU-028SA-27-02

Sadda S. R. P-SA-165P-SA-198

Sadri E. P-TU-059TU-30-03

Sadun A. MO-03-05Saeger M. SA-25-06

SU-27-10Saeki Y. P-MO-011Safwat E. P-MO-177Sagara T. P-MO-064Saha S. MO-35-02

P-MO-285P-MO-298P-SU-029P-SU-030

Sahel J.-A. SU-25SU-25-04MO-75TU-41-07TU-44TU-44-02WE-11-08

Saif Y. S. S. WE-40-10Saito M. P-SA-097Sakai H. P-SA-120

P-SA-123Sakai J.-I. P-SA-247Sakamoto A. P-SU-135Sakurai M. P-SU-141Sala E. TU-80-08Salah J. P-MO-082

P-SA-249Salahim S. P-SA-014Salama A. P-SA-268Salamanca O. P-MO-006Salatka K. P-SU-097Salgado-Borges J. P-SA-258

P-SU-111P-SU-144P-SU-273

Salim B. Y. P-MO-082P-SA-089P-SA-250

Salla S. P-MO-288P-SA-064

Sallam A. P-SA-244

401WOC® 2010

Auth

or In

dexSalma G. P-SA-250

Salmanova S. P-SU-131Salom D. MO-11-03

TU-41-11P-MO-097P-SA-243

Salvi M. G. MO-82-02Samaan M. SU-70-15Samanta S. K. WE-16-07Sampaio P. C. SU-45-01Samson C. M. SU-27-03Sanchez M. J. SU-45-05Sanchez Sanchez M. T. TU-35-09Sanchez-Amaya I. D. P-MO-078Sánchez-Mannarelli F. P-SU-086

SU-34-11Sanders R. P-MO-270Sandhu J. P-SU-057

SU-42-04Sandkull P. MO-77-08Sänger J. MO-48-02Sano K. SA-25-05Santini R. SU-81-07Santos-Jimenez S. MO-23-05Santos-Pérez J. SU-42-02Sanz-Solana P. P-SA-119Saornil M. A. SU-12

SU-34-10SU-34-11

Sapieha M. MO-01-03Saragoussi J.-J. TU-80-09Sargan I. P-SU-002Sargent N. WE-16-04Sarin S. P-MO-083Saroj N. MO-67-06

TU-29-09Sasai A. P-MO-014Sasamoto Y. P-MO-179

P-SU-255P-TU-229TU-30-07

Sashneva O. P-TU-173Sasongko M. B. TU-29-02Sasse A. P-MO-123Sato E. P-MO-153

P-SA-267TU-31-09

Sato G. TU-14-06Sato M. MO-69-05

P-SA-215P-TU-129

Sato T. P-MO-264Satoh H. TU-32-03Sauder G. MO-31-06Sauerbrey M. SU-32-02Sauerwein W. MO-77-04

P-TU-116P-TU-126

Saule S. SU-39-06Saurabh K. P-MO-279Saveleva A. SA-31-08Saw S. M. P-SU-047

WE-40-04Sawa M. SA-25-04

TU-26-01P-MO-179P-SA-163P-TU-229

Sawada A. P-MO-060P-SA-107P-SA-136

Sawada M. P-SA-215P-TU-129

Sawaguchi S. P-SA-120P-SA-123P-TU-067

Sawant S. D. MO-74-10Sawatzki B. TU-20

TU-20-04Saxena R. MO-74-01

MO-79-06P-TU-141SU-44-07TU-30-10

Saxena S. SA-25-07Sayanagi K. P-MO-212

SU-34-04Sayegh R. G. TU-37-10

P-SA-164Scarpi M. SA-28-02Schaaf G. P-SA-061Schaal K. P-MO-164

P-TU-244Schäfer G. F. FR-01-13Schaefer T. WE-21

WE-21-02Schaeffer K. SU-61-08Schäffner E. P-MO-205Schafia A. P-SU-276Schalenbourg A. SU-34-02Schallenberg M. P-SU-103

P-SU-256Schaller U. C. P-TU-091

P-TU-096SU-34-06WE-16-03

Schallhorn S. C. SA-01-01Schaperdoth-Gerlings B. P-TU-112Schargus M. FR-01-14

P-MO-008Scharioth G. TU-63-03

TU-63-10 WE-18P-SA-022P-SA-170P-SU-187

Scharrer A. TU-03Scharrer I. P-TU-226Schatz A. P-SA-144

P-SA-155P-SU-264P-TU-219

Schaudig U. P-SU-226 WOC-AAD-C-26

Schaumberger M. P-SU-272SU-34-06

Schefler A. MO-77-08Scheler R. P-SA-173Schepens C. L. P-MO-049Scheschy U. TU-37-10

P-SA-164Scheuerle A. F. P-SA-241

WOC-C-54Schiabel H. P-MO-100

P-MO-101Schiavi C. MO-09

MO-09-03MO-69MO-69-03

Schicht M. FR-01-15Schiefer U. SU-02

SU-02-02MO-14MO-14-07TU-08TU-08-05 P-SA-106WOC-AAD-C-25

Schielke K. C. P-SA-072P-SA-174P-SU-145

Schiestl C. SU-61-08Schiffman R. M. P-TU-199

TU-30-01TU-30-05TU-35-11

Schilcher K. SU-17-07Schild A. P-SA-013Schill M. WOC-C-37-01Schippling S. SA-25-08Schirra F. SA-20-05

Po-TUP-MO-278P-SA-081P-TU-006P-TU-101

Schittkowski M. P. WE-12-04Schlanitz F. G. P-SA-196

P-TU-185MO-27-01

Schlich M. MO-73-10P-SU-094SA-28-04

Schlichtenbrede F. P-MO-185P-MO-245

Schlote H.-W. P-SA-162Schlott K. P-TU-196Schlötzer-Schrehardt U. SA-28-08

SU-56-08MO-60MO-60-02TU-37-05P-SA-065P-SU-098

Schmetterer L. MO-22-01MO-58-03

Schmickler S. TU-03-08Schmid K. W. P-SU-042Schmid R. P-SA-002Schmidinger G. P-TU-232

SA-26-04Schmidt C. O. P-MO-072Schmidt D. SU-40-07Schmidt J. C. MO-67-09

WE-26-05P-TU-239

Schmidt K. P-SA-168P-SU-260P-TU-243P-TU-254

Schmidt M. P-MO-108P-MO-263P-SA-052P-TU-213

Schmidt W. P-TU-168Schmidt-Erfurth U. SA-27-02

SA-34SA-34-04MO-27-01MO-27-02MO-32-07MO-67-07MO-68-03 MO-72-07MO-75TU-37-06TU-37-10WE-08-03P-SA-164P-SA-196P-SA-200P-SA-207P-SU-188

402 WOC® 2010

Auth

or In

dex P-TU-028

P-TU-185P-TU-232WOC-C-15WOC-C-15-02

Schmidt-Trucksäss A. TU-33-06Schmiedl J. P-SA-060Schmiedt K. P-MO-144

SA-27-07Schmitz A. P-TU-153Schmitz Valckenberg S. P-MO-158

P-TU-183WE-34-08P-SA-176P-SA-197

Schmut O. FR-01-11FR-01-12FR-01-19

Schnaidt A. G. P-TU-101P-SA-081

Schneider E. P-SU-177Schneider M. P-TU-149Schneider S. P-TU-111Schnyder C. SU-38-04Scholda C. P-TU-232Scholl H. P. N. SU-51-05

SU-73-08MO-27MO-27-06 TU-35-08P-SU-058P-MO-158P-TU-204

Scholtz S. P-TU-265Schönfeld C.-L. P-MO-079

P-MO-088Schöpfer K. SU-36-09Schor P. TU-64-01

P-SA-086Schorderet D. SA-18-02Schörkhuber M. P-TU-149Schossau T. SU-79-06

MO-79-03Schrader S. FR-01-16

P-MO-286Schrader W. F. SU-80

MO-28TU-28TU-28-06WE-26WE-27WE-27-05WOC-C-50-02

Schraermeyer U. WE-15WE-15-01

Schrage N. F. SU-17-02SU-17-08SU-62SU-62-08MO-28-08 TU-27TU-27-04TU-27-06TU-32-05P-MO-021P-MO-223P-SA-061P-TU-153P-TU-157P-TU-030 WOC-C-08WOC-C-08-02WOC-C-08-03

Schramm A. MO-78-03P-TU-123

Schramm K. P-MO-207Schranz E. MO-67-07Schriefl S. MO-27-01

P-SA-196P-TU-185

Schröder A. C. P-SA-081P-TU-006P-TU-007P-TU-031

Schröder S. P-SA-214Schröer U. P-SU-256Schroeter J. WOC-AAD-C-04Schubert C. SA-32-04Schuchard R. A. TU-14-06Schuemie M. J. SU-54-01Schuettauf F. MO-36-07

TU-77-04P-SU-264

Schuff A.-C. P-MO-045Schuknecht B. P-SU-027Schulte J. H. P-TU-123Schultheiss A. P-MO-148Schultheiss M. P-MO-170Schultz G. P-SA-025Schulz S. P-SA-241Schulze A. P-MO-033

P-MO-045Schulze U. P-SU-012Schumacher C. MO-74-04

P-SA-256Schumann R. G. TU-25-08

P-MO-249P-SU-272

Schuster R. P-TU-114Schütze C. P-SA-196

TU-37-06Schwaiger B. P-SU-111Schwartz A. P-TU-250Schwartz G. P-SA-100

P-TU-060Schwartz R. SA-25-08Schwartz S. TU-18-07Schwartzkopff J. FR-01-17

P-MO-294P-SU-045P-TU-043

Schwartzstein H. P-TU-090Schwarz A. P-SU-253Schwarz T. SU-74-10Schwechheimer H. SU-53

SU-53-01Schweitzer D. P-TU-194Schwenn O. P-MO-073Scotland G. TU-29-03Scott J. A. P-SU-145Scott R. A. H. MO-28-04

WE-28-02Seah L. L. P-SU-192

P-SU-245Sebbah R. P-TU-140Seeliger B. SU-62-08Seeliger M. SU-25-06

Po-SASeguchi J. P-TU-072Seibel B. S. SU-16-03Seifert B. U. P-SA-147Seiff S. TU-06

TU-06-01TU-68-01

Seigel G. P-SA-111Seiler T. SU-58-06

SU-60-04MO-38-02MO-39TU-39

TU-62TU-62-05TU-64WE-01-05WE-03-05

Seiple W. P-SA-180Seira P. SU-38-04Seitz B. SA-18-05

SA-19SA-19-06SU-68SU-68-07SU-69MO-30-02MO-35TU-12WE-03WE-21 WE-37-07P-MO-035P-MO-278P-SA-066P-SA-081P-SU-043P-SU-265P-SU-276P-TU-006P-TU-007P-TU-031P-TU-031P-TU-101P-TU-163

Sekiryu T. P-MO-165Sekundo W. SA-02

SU-36-09TU-80-02 Po-TUP-MO-137P-MO-220P-SA-043WOC-C-56-04

Selma G. P-SA-270Semak G. P-SU-269Semenova E. A. P-TU-111

P-TU-125SU-34-03

Semkova I. P-SA-168P-SU-258P-SU-260P-TU-243

Sen H. N. MO-76-08Seneadza A. SA-37-04

SA-37-07Senft S. P-SA-080Sengupta J. MO-35-02

P-MO-285P-MO-298P-SU-029P-SU-030

Sengupta S. P-SU-189WE-34-05

Seong G. J. P-SU-093Serbes U. P-SA-128Seregard S. SU-39-08

SU-75MO-18MO-18-01 MO-77-08MO-81-09TU-40 TU-40-02WE-23-01

Serova N. WE-04-05Serrano M. P-MO-160Setiobudi C. P-MO-159Seyam N. WE-16-04

403WOC® 2010

Auth

or In

dexSeyeddain O. P-SA-044

P-SA-067SA-26-06

Shaarawy T. M. SU-06SU-06-03SU-08-04MO-54-04TU-13TU-13-06

Shafi F. P-MO-252Shah K. MO-73-06Shah P. P-MO-272Shah P. K. WOC-C-58-02Shah R. SU-36-03Shah R. S. SA-01-05

SA-02-04Shah S. P-TU-009

P-TU-037WE-16-06

Shahin M. TU-32-02TU-33-05

Shahsuvaryan M. P-TU-251Shaikh S. MO-76-07Shaish A. P-MO-216Shalaby M. H. MO-25-10Shalaby O. P-MO-292

P-SU-214Shami M. MO-67-03Shandurkov I. SU-62-09

SU-81-04Shao C. SU-17-09Shao-Min Zhang S. MO-14-05Sharkawi E. P-MO-028Sharma H. P-TU-212Sharma P. MO-79-06

P-TU-141SU-44-07SU-44-07

Sharon D. P-SA-096Sharp P. F. SU-62-06

TU-29-03Shaw B. E. P-MO-295Shaw J. TU-29-02Shchadnykh M. MO-35-08

P-SA-156P-SU-236

Shchypun S. TU-81-08Sheehan W. P-TU-046Sheng D. P-SU-254Sheng M. P-SU-088Sherwood M. SU-06-06Shetta S. SU-68

SU-68-03MO-70MO-70-04

Shetty B. MO-67-10SU-62-07

Shetty R. MO-67-10Shevchyk V. P-TU-166Shi D. SU-17-06Shi W. SU-74-09Shi X. P-SA-168Shibata M. P-SU-257

P-TU-064P-TU-068

Shibata Y. P-SA-229Shidik A. P-TU-023Shields C. L. SA-36-03

SA-41-03SU-34-05SU-34-09SU-39-10SU-39-11 MO-77-07TU-22-08TU-32

TU-34WE-23-09WOC-C-60-03P-TU-090

Shields J. SA-09-03SA-41-07SU-12-07 SU-34-05SU-34-09SU-39-10MO-02-05MO-33-07 MO-77-07TU-22P-TU-090

Shih S. SU-17-04Shim H. s. P-TU-079Shimada N. P-MO-188

P-SA-097P-SA-229

Shimajiri S. TU-32-03Shimizu K. SU-47-09Shimomura Y. MO-35-01

P-SA-106P-SA-109P-SU-089

Shimonura Y. WE-22-06Shin Y. W. SU-80-07

SU-81-05P-TU-193P-TU-184

Shinoda K. P-SA-170Shiraishi A. P-MO-011Shirakashi M. P-MO-034

P-MO-042Shiraki K. P-TU-195Shoji M. P-SA-109

P-SU-107Shoshani Y. TU-30-06Shpak A. MO-27-07Shrestha M. K. P-TU-263Shriver E. SU-81-03

MO-78-01Shu V. TU-30-05Shushtarian S. M. P-SU-165Shusterov Y. SU-36-06Siddig M. MO-28-02

TU-25-05Siddiqui A. P. P-MO-202Sidik M. WE-41-07Siebelmann S. FR-01-18

P-SU-023P-SU-031P-SU-034

Siesky B. TU-30-06Sieving P. A. MO-71-01

P-MO-103Signorini S. G. SA-10-03Sihota R. SA-30-01Sikivou B. WE-16-01Silva E. SA-09

SA-09-06Simader C. TU-37-10

P-SA-164P-SA-196P-SA-207

Simavlı H. P-MO-002Simmet U. P-SA-233Simmons P. P-MO-014

SU-17-04Simões C. C. SU-34-07

MO-77-06P-TU-094

Simon M. C. TU-36-05Simons B. SU-55-05Simonyi S. P-MO-074

Simonyte S. P-SA-204Simpson E. R. SU-43-07

MO-35-09 TU-40-10

Simsek S. P-MO-002P-MO-005

Simsonsen F. SU-62-08Singalavanija A. P-TU-209Singer M. MO-68-04

WE-34WE-34-02

Singh A. SU-34-04Singh A. D. SA-46-04

SU-43SU-43-08 MO-66-09WE-23-03

Singh J. TU-65-06P-SA-236P-SA-281

Singh K. SU-08-02MO-65-01TU-43

Singh P. WOC-C-36-03Sinkunaite G. P-SA-204Sinkunas K. P-SU-178Sinyavsky O. WE-39-01Sirtautiene R. P-SA-181Sisu A. P-SU-002Sit A. J. WE-13-03Sitnik H. SU-75

P-SA-083Sivaprasad S. MO-32-08Sivasubramaniam S. P-SU-064Sivekova D. P-SA-048

P-SA-049SU-75-02TU-31-07

Sivkova N. MO-28MO-28-03SA-25-10

Siwiec-Proscinska J. P-TU-154Sjahreza E. WE-41-07Sjo L. D. SU-67-01Skaat A. SU-38-05Skevas C. P-SA-185

P-TU-056Skorpik C. SA-26-04Skupin A. P-TU-152Slade S. G. SU-36

SU-36-08SU-60-05TU-39-07TU-61-06TU-75-07

Slakter J. MO-32-03Sliesoraityte I. P-MO-221

P-SA-152P-TU-219

Sloper J. MO-09-02Smailhodzic D. P-SA-198Smetanina M. P-SA-045Smigielski J. MO-68-09Smiles J. SU-79-01Smith J. R. SU-67-06

TU-17-02TU-53-03

Smith R. E. WE-30WE-30-04

Smretschnig E. P-TU-176Smuzynska M. P-TU-201Snead D. R. J. MO-28-04Sniatecki J. P-TU-241Soares R. P-SU-144Sobaci G. WE-28-07Socci da Costa D. P-SU-084

404 WOC® 2010

Auth

or In

dex Soderberg P. TU-68-05

Sodi A. WE-40-01Sogawa K. P-MO-153Sohn Y.-h. P-TU-079Soleymani A. P-MO-152Soliman M. SU-68-05Soliman W. MO-67-03Solonina S. WE-39-01Solorzano A. O. TU-74-07Sommer A. SA-23-01

SA-48-02SU-04SU-04-04

Sommer F. P-SU-215Sone T. P-SU-183

SU-38-07Song H. P-SA-038Song I. P-MO-200

P-TU-193Song S. P-SA-216Song X. P-SU-221Song X.-j. P-SU-044Song Y. SU-45-02

SU-80-07P-TU-184P-TU-193

Sonia A. MO-32-05P-SA-089P-SA-249

Sonia C. P-SA-089Sonia N. P-SA-089Sonia Z. P-SA-249

P-SA-250P-SA-270

Sonty S. P-MO-044P-MO-051P-MO-054

Soon Phaik C. P-SA-217Sophian D. M. P-SU-091Sorenson J. MO-32-03Sorochynska T. A. P-TU-138Soroush M.-R. P-SU-039Soto-Pedre E. MO-75-02Sotozono C. P-SU-089Soubrane G. SA-33

MO-67WE-08-01WOC-C-57-04WOC-C-61-05LS-08-02

Sourlas V. MO-76-10Sousa A. K. S. P-SA-102Sovani I. P-SA-087Spada C. P-TU-199Spaeth G. L. P-MO-057

TU-30-01TU-43-08

Spahn K. WE-25WE-25-01

Spaide R. F. MO-32-03SA-32-06SA-32-04

Spaide T. C. SA-32-06Spalek T. MO-27-01Spaltmann R. P-SU-186Spalton D. SU-15-03Sparholt J. SU-09-01Speeg-Schatz C. SU-23-02Speicher L. P-SA-034Spicka N. P-TU-058Spiegel D. SA-21-07

SA-28TU-13-02

Spierer A. MO-19-04Spierings E. SU-19-04

MO-35

Spitzer M. S. MO-36MO-36-02P-MO-170

Spivey B. E. TU-46WE-16

Spoerl E. SA-13-03WE-07-06 WE-39-05P-SA-139

Spöler F. MO-28-08SU-17-08

Sponer U. P-SA-179P-SA-207

Spors F. P-SA-146Spreitzhofer E.-M. FR-01-11Springer C. MO-27-09Sprunger D. SU-52-01

MO-69Sreekantam S. P-SA-169Sriharanathan P. TU-63-07Srinivasan K. P-MO-255Srivastava S. MO-74-01

TU-30-10Stachs O. MO-79-05

P-SA-077SU-56-04

Stadler S. P-SU-007Stahl V. D. P-SU-104

TU-36-03TU-36-06

Stala P. P-MO-109Stalmans P. TU-33-04Stana L. P-SU-002Standefer J. E. SA-24-02Stanford M. R. TU-47-02

P-SA-281Stanga P. E. P-MO-195

P-MO-174Stanic R. P-SU-075Stankov B. P-SA-220Stankovic Babic G. P-SU-152

P-TU-167Stanzel B. SA-03-05Starikova A. V. SU-41-07Stark W. MO-25

MO-25-01Staurenghi G. SU-38-02

WOC-C-61-03Stavrakas P. MO-67-04Stefanovic I. P-TU-240Stefánsson E. SA-34-01

SU-50-01SU-53SU-54SU-54-02TU-38-01

Steffen H. SU-23-06Po-SA

Stegmann R. MO-05-05 MO-31-05WE-19WE-19-01

Stehr F. WE-37-09Stein J. D. SU-04-02

MO-22-02MO-31WE-40-02

Steinberg J. P-TU-073WE-39-02

Steindl K. SA-03-03P-TU-176

Steinert R. MO-66-05TU-46-04P-SA-003

Steinfeld A. P-MO-288P-SA-064

Steinhuber B. P-SA-034Steinkogler F. J. SU-71-02Stela G. P-TU-107Stephan H. P-TU-123Stephanie W. P-TU-006Stern M. SU-37-04Steuhl K.-P. FR-01-06

FR-01-20SU-81MO-41P-SU-246P-SU-038P-SU-042

Steven P. MO-79-04MO-79-05P-SU-023P-SU-031P-SU-034

Stevens J. D. SA-01-04Stewart J. A. TU-30-04Stewart W. C. TU-30-04Stickelmann C. P-MO-206Stieger K. MO-06-06

TU-55-05Stiel S. P-MO-288

P-SA-064Stifter E. P-TU-185Stitt A. MO-01-05Stöcker M. P-MO-206Stodtmeister R. P-MO-062

WE-39-05Stodulka P. TU-25-07Stoffelns B. M. P-MO-187

P-SA-190SU-36-09

Stojanovic A. TU-64-06WE-02-03

Stojkovic R. P-SA-220Stoll T. P-SU-184Stone E. MO-71-03Stonecipher K. G. SU-60-03Stopa P. TU-37-05Stopper S. P-SA-050Stout T. SU-25

SU-25-05TU-29

Straatsma B. R. MO-77-05 TU-67TU-67-02

Strack C. MO-79-01Stratmann N. P-SA-197Strauss O. P-MO-157

P-SU-268Strauß R. SU-17-07Ströher E. P-SU-246Struck H. G. WOC-C-08

WOC-C-08-01WOC-C-08-03

Studeny P. SU-75-02 SU-78-06TU-31-07P-SA-048P-SA-049

Study Group Rotterdam Ocular 39-05Study Group HSV Kit MO-35-01Study Group on behalf of the DENALI TU-37-01Study Group on behalf of the LUMINATE MO-76-05

SU-27-04Study Group on behalf of the MONT BLANC P-SA-212Study Group on behalf of the RESTORE WE-38-02

405WOC® 2010

Auth

or In

dexStudy Group on

behalf of the SECURE TU-37-03Study Group PANDA P-MO-063Study Group The Nigeria National Blindness and Visual Impairment P-SU-064Study Group on behalf of the EVEREST MO-32-04Stuebiger N. P-SA-254Stulting A. MO-02-07Stulting R. D. WE-01-04Sturm T. TU-40-07Sturm V. SU-61-08Sturmbauer K. FR-01-19Su E. P-SA-180

P-TU-216Su L. P-MO-265Suarez E. MO-15

MO-15-02Subramani S. P-SA-199Subramanian P. WE-04

WE-04-02Sudharshan S. MO-74-10Suelves A. P-MO-097

P-SU-169Suelves-Cogollos A. M. P-SA-266Sugano A. P-SU-115Sugano Y. P-MO-165Sugar E. A. MO-76-04Sugiura Y. P-MO-235

P-MO-239Sugiyama K. P-SA-047

P-SU-141P-SU-159

Sugiyama T. P-SU-257P-TU-064P-TU-068

Suh W. SA-28-09Suhardjo S. P-SU-091

SA-26-10Suleman H. SU-75-10

TU-81-07Sulivan B. P-MO-008Sullivan D. A. SA-20-04

SU-63SU-63-04

Sullivan P. TU-28TU-28-04WOC-C-41WOC-C-41-01

Sullivan T. WE-33-02Sulzbacher F. MO-68

MO-68-03P-SA-200

Summers A. P-TU-143Sun C.-b. WE-35-08Sun J. P-SA-001

P-SA-007P-SU-060

Sun L. SU-61-10Sun M. P-SA-231Sun M.-H. P-SA-245

P-TU-134Sunaric-Megevand G. MO-55-03Sundari S. SA-26-10Sunder-Plassmann G. WE-40-01Suntay A. T. WE-34-07Supartoto A. P-TU-124Superti-Furga G. P-SU-188

SA-27-02Supiandi E. P-SA-118Supramaniam G. P-MO-280Surchev N. P-SA-076

SU-17-01

SU-62-09Suryono A. TU-63-04Susanna, Jr R. BS-09-01

BS-09-02MO-13-03TU-43

Süsskind D. MO-24-07P-TU-119

Sutphin J. P-MO-013Suwan Y. P-SA-029Suzuki K. P-MO-064

P-MO-193P-SA-015

Suzuki M. P-MO-179P-SA-163

Suzuki S. P-TU-235Suzuki T. P-TU-231Suzuki Y. P-MO-068

P-MO-089P-MO-193P-MO-258P-SA-015

Suzuma K. P-MO-230P-MO-247P-MO-256P-TU-004

Syed Osman S. I. P-SU-224Symes R. J. P-MO-295Synowiec E. P-SA-099Szaflik J. P-SA-091

P-SA-099P-SU-026SU-41-10TU-31-06

Szaflik J. P. SA-16-02SU-41-10TU-31-06 TU-72-01P-SA-091P-SA-099P-SU-026

Szetu J. WE-16-01Szulborski K. P-SA-091Szuminski M. SU-55-07Szurman P. MO-36

MO-36-01TU-09-02TU-28-05WE-08-05WE-26-01P-MO-170P-TU-181P-TU-181

T

Tabata Y. P-TU-064Tabbara K. F. TU-73-02Tabin G. SA-27

TU-24-02WE-25-06

Tadayoni R. SU-49-05Tadic V. WE-40-07Tagami M. P-MO-254Tai E. S. P-MO-169Takada S. P-SA-106

P-SA-109Takagi M. P-SU-141Takagi S. P-MO-225Takahashi A. P-MO-153

P-MO-194Takahashi K. P-SA-159Takahashi M. WE-14-05

P-TU-208

Takahashi N. P-MO-064P-SA-107P-SA-136

Takahata T. P-MO-256Takai S. P-TU-064Takamatsu M. P-SU-183Takeda H. P-SU-159Takeda N. TU-36-05Takemura S. P-SU-115Takenaka J. P-SA-121Taketani F. P-MO-138

P-SU-037Takeuchi A. P-MO-225Takeuchi M. P-SA-247Takeuchi S. P-MO-225Takhchidi E. K. TU-02-07Takhchidi K. P. MO-26

MO-26-05P-SU-062SU-47-07

Talamo J. H. SA-27-10 SU-58-02

Talebnejad M. R. P-TU-136Talwar N. WE-40-02Tam P. P-SA-252Tam T. Y. P-TU-133Tamada S. P-SU-182Tamayo G. TU-39-01Tamosiunas A. P-SA-204Tamura H. P-SA-167

P-TU-172Tan L. T. P-SU-009Tan D. T. H. SU-78-02

MO-35-05MO-64MO-64-06TU-05-03TU-81-09

Tan G. P-MO-169Tanabe F. P-SA-106

P-SA-109Tanaka A. P-MO-064

P-SA-229Tanaka K. P-SA-017

P-SU-135P-SU-141P-SU-158

Tanaka M. P-SU-124Tanaka T. P-MO-042

P-MO-094Tanaka Y. SU-17-06Tanano I. P-MO-153Taneri S. TU-80-03Tang X. P-SA-038Tani T. P-MO-153Tanihara H. P-TU-220Taniuchi S. SA-25-05Tanner V. P-TU-032Tanyildizi Y. MO-35-06Tao H. SU-56-02Tao J. P-SA-092

SU-56-05Tappeiner C. MO-74-07Tarassoly K. MO-78-09Tarif M. P-SU-249Tartak D. P-SA-080Tartak M. P-SA-080Taryam M. O. MO-70

MO-70-03MO-81-08

Tasman W. MO-68-07Tassignon M.-J. SU-20-03

MO-05MO-05-01MO-20

406 WOC® 2010

Auth

or In

dex MO-20-04

MO-55MO-55-05TU-68TU-76TU-76-09WE-11-05WE-17-03

Tatar O. P-SA-170Tatzkov R. A. P-TU-125Tavassol F. MO-78-03

SU-38-09Tawara A. TU-32-03Tay W. T. WE-40-04Taylor D. MO-07

MO-41-03Taylor H. R. SU-65

SU-65-05 MO-64-01TU-71-03WE-25-05WE-40-09

Taylor S. TU-65-03P-SA-268P-SA-281

Taylor S. R. J. P-SA-236P-SU-009

Tech S. P-TU-130Tehrani N. SU-41-02Teimann U. TU-81-02Teixeira Brandt C. P-TU-262Tektas O. P-SU-099Tello C. MO-31-11Tembl J. P-SU-169Temprano J. SU-70-19ten Cate H. MO-74-05Tennant M. SU-62-04Teo L. P-SU-192Tepedino M. P-MO-071

TU-30-05Teping C. P-MO-137Teranishi S. P-MO-064Terasaki H. P-MO-194

P-SA-175P-SU-270P-TU-214

Terubayashi A. P-TU-069Tervo T. TU-80-05Tetz M. SU-16-04

TU-04TU-04-02WE-10-07

Teus M. A. P-MO-143P-MO-117

Teutloff H. P-SA-265Thaler S. TU-77-06

P-SU-264Thaller V. P-SU-191Tham C. C. Y. SA-21-04

SA-30-05SU-08SU-08-03MO-08

Thangappan A. SU-34-09Thangkhiew L. P-SU-173Thanigasalam T. P-TU-038Thanos M. P-SU-246Thanos S. SU-69

SU-69-06MO-76-01 WE-35-06P-SU-103P-SU-122P-SU-148P-SU-256P-TU-118

Theelen T. TU-33TU-33-08P-TU-065

Theiß B. P-SA-277Theodoridou A. MO-74-03Therese L. K. MO-74-10Thi Khanh Van P. P-TU-121Thieme H. MO-65

MO-65-03TU-63WOC-C-42P-TU-076P-TU-080

Thiemeyer D. MO-27-09Thill M. P-SA-185Thomas S. SU-39-04Thomasen H. FR-01-20

SA-17-05P-SU-038P-SU-042

Thomson A. P-SU-151Thouvenin D. SA-47Thulasiraj R. D. SA-48

TU-42-02TU-52-05

Thumann G. SA-03-04TU-37TU-37-08P-MO-206

Thurau S. SA-08TU-17WE-09WE-09-05P-SA-251

Thygesen J. MO-54MO-54-02

Thyzel R. P-SU-249TU-25-07

Tian F. P-SA-040Tian L. SU-47-04Tian X. P-SU-133Tilikete C. SA-38-09

SU-18-05Tillack H. P-TU-089Timmermann M. TU-37-04Ting D. WE-40-09Ting S. J. SU-44-04Ting S. W. SU-44-04Tinh N. X. MO-04-03Tint N. L. TU-81-07Tjia K. F. MO-20-03

WE-18-03Tobin K. SU-62-04Tochikubo T. P-MO-027

P-MO-068P-MO-089P-MO-258P-SA-017

Toda R. SU-38-07Todorov V. P-SU-268Tojo K. P-SU-053Toker E. SU-09-03

WE-22-01Tokoro T. P-SA-229Tokuhisa K. P-MO-064Toledo de Paula C. H. SU-74-06Tolic A. P-TU-071Tomalla M. MO-31-01

TU-25-11Tomar S. P-TU-045

SA-32-07Tomita G. P-MO-225Tomoyose E. P-SA-120

P-SA-123Tong H. T. L. P-SU-206

Tong L. SU-37-04WE-40-04

Tönz M. S. P-TU-177TU-29-06P-SU-027

Topbas S. P-MO-242Topete-Jimenez J. P-MO-078

P-SA-127P-TU-086P-TU-086

Torrent Despouy J. P-SA-187P-TU-075SA-31-04

Torres Suarez E. TU-33-09Torres V. P-TU-188Torun Acar B. P-SA-057

P-SU-025Toshmatov A. P-TU-135Toshniwal N. SU-38-08

SU-79-04Tossounis C. P-MO-273Tost F. H. W. SA-29

SA-29-02SU-80-04TU-26TU-26-06Po-MO

Töteberg-Harms M. MO-31-02P-MO-041WE-39-04

Tou N. TU-32-03Touge C. P-SA-279Toyokawa N. SA-31-07Trajanoski Z. SA-27-02Tranos P. MO-75-08Trauzettel-Klosinski S. TU-14-01

WE-04WE-04-01

Traverso C. E. SA-11-03Trempe C. L. P-MO-049Trese M. T. SU-49

SU-49-08SU-50SU-72-05MO-29-03WE-09WE-09-03WE-29-05

Tressler C. P-SU-097WE-41-09

Treumer F. MO-28-01P-SA-186P-SU-253SA-25-06TU-32-09TU-36-08

Trevino A. SA-25-09Trimmel J. MO-62

MO-62-02WE-25-03

Troeber L. P-MO-278P-TU-101

Tröger E. MO-27-06P-SA-152SU-73-05

Tronina S. P-SU-239Troyanovsky R. WE-39-01Trpin S. P-MO-007

P-MO-012Trueba Lawand A. P-SU-147Tsai C.-C. P-SU-015

P-SU-120Tsai H. Y. TU-04-04Tsai J. C MO-65

MO-65-07SU-05-04

407WOC® 2010

Auth

or In

dexTsai R. J.-F. WE-05

WE-05-03Tsai R.-K. P-TU-051Tsai S. MO-75-07Tse D. SU-42-07

SU-81-03MO-78MO-78-01

Tse G. P-SU-222Tse J. MO-78-01Tseng S. C. G. SA-17

SA-17-03 MO-64-03TU-74TU-74-02TU-74-04WE-05-01

Tsinopoulos I. P-SU-100Tsirbas A. SA-42-02

SU-42-08Tsironi E. MO-74-03

MO-76-10P-MO-248

Tso M. O. M. MO-43MO-43-01MO-44MO-44-01

Tsuchiya Y. P-SA-215Tsuiki E. P-MO-230

P-TU-004Tsujikawa A. P-SA-167

P-TU-172Tsujikawa M. P-MO-179

P-SA-163P-SU-255P-SU-262P-TU-229SA-25-04

Tsukahara Y. P-MO-213P-MO-254

Tsukiyama J. WE-22-07Tsumura T. P-SA-020Tu E. SU-28-03Tuchen S. WE-37-06Tudor C. P-SA-110Tufail A. SU-51-01Tuft S. J. FR-01-16Tuisku I. SA-04-05Tulidowicz-Bielak M. WE-39-09Tung W. T.-H. P-SU-059Tuomi L. WE-34-02Tura A. P-SA-122

P-TU-097P-TU-119

Turan N. SA-31-06Turbin R. TU-27-02

TU-27-06Türkeli E. P-SU-038Turner G. S. P-MO-195

P-MO-174Tuulonen A. MO-58

MO-58-02TU-52

U

Ubaida Mohien C. SA-27-02Ubaldi A. P-MO-161Udaondo P. TU-41-03

P-MO-097P-SA-243P-SU-169

Ude K. T. P-SU-204Ueki M. P-MO-264

P-TU-068

Uemura A. MO-01-02Ueno S. P-MO-194

P-SU-219Ueno Y. P-MO-163Uetani R. P-TU-214Ughade S. MO-73-06

P-TU-055Ughi G. SU-62-01Ugurbas S. H. TU-79

TU-79-05Ugurlu N. P-MO-002

P-MO-005Uhlig C. E. P-SA-059

P-TU-242P-MO-108P-MO-263P-MO-293P-SA-052P-TU-213

Ukety T. SU-32-01Ulbig M. MO-75-03

P-MO-210P-MO-233P-MO-271P-SA-173P-SA-194P-SA-202P-TU-191P-TU-228P-TU-237SU-38-01TU-33-03WE-34-06

Umanets N. P-MO-238Unal M. WE-33-04Ung T. P-SU-247

P-TU-169Ungerechts R. MO-78-10

P-SU-248Unterlauft J. FR-01-21

P-SA-060Uotani R. P-MO-011Upadhyay M. P. P-MO-083Updike J. P-SA-165

P-SA-198Urbancic M. P-MO-231

P-SA-206Urovskaya N. P-TU-122Urtti A. ES-05-01

WE-15-06Ushakova T. WE-35-02Usov V. P-MO-113

P-MO-283Usui S. P-TU-069Usui Y. P-SA-247

P-SU-158Utani A. P-TU-172Uthoff D. SU-79-05

TU-80-06Uwaydat S. MO-67-03Uxó M. SU-70-12

SU-70-17Uy H. TU-25-09

MO-24-08P-SA-280

V

Vahdani K. P-MO-259P-SU-191TU-30-09

Vaiceliunaite A. SU-36-02Vaida M. P-SU-005Vainchtock A. P-SU-068Vajaranant T. P-SA-073

Vakalis A. MO-75-08Valdez-Gonzalez T. P-SU-024Valet V. MO-27-04Valsky V. V. SU-34-03Valverde-Collar C. SU-34-10van den Does P. MO-74-05van der Wees J. TU-31-01van Gils W. SU-39-05van Heyningen V. P-TU-155van Lookeren Campagne M. MO-68-05van Meurs J. SA-36

SU-51-06TU-03-07

van Nispen R. M. A. MO-10-01van Rens G. MO-10

MO-10-03MO-23MO-23-02

van Rij G. MO-20MO-79TU-05-04

van Setten G. TU-79-04van Son M. P-SU-027Vanchakova N. P-SA-203VandenHoven C. SU-41-11

SU-74-02Vani A. WE-34-03Vargas A. B. P-SA-023Vargas J. M. MO-15-05

TU-74TU-74-03TU-74-06

Varma R. TU-52-01Vasconcelos Santos D. V. SU-24-05Vashkevich G. MO-27-08

P-TU-173Vasilakis P. P-MO-190

P-MO-214Vasiliou T. P-SU-140Vasold R. TU-32-09Vassileva P. I. SU-17-01

SU-62-09 SU-64SU-81-04TU-02TU-02-08P-SA-076

Vasu U. P-MO-276P-SU-274

Vaughan J. P-TU-143Vazquez Membrillo M. A. P-SU-024Veckeneer M. A. SA-36-05Veerappan Rathinasabapathy S. P-MO-272Végh M. SU-09-02Vehige J. P-MO-014

SU-17-04Vejarano L. F. SU-38-03

WE-18-06Velikay-Parel M. P-TU-022Velinov O. P-TU-083

P-TU-242Vemuganti G. SA-46-03

SU-67SU-67-03

Vengris M. SU-36-02Venkatapathy N. P-MO-272

SU-62-03Venter J. WE-01-02Ventura L. P-MO-100

P-MO-101Verdaguer J. SU-20

408 WOC® 2010

Auth

or In

dex SU-21

SU-21-01TU-67TU-67-01TU-67-05

Vergés C. TU-61TU-61-05TU-61-06

Verjans G. M. G. M. MO-21MO-21-03

Verolli K. P-SA-090P-SA-094

Verstraeten T. C. SU-51-08Veselinovic T. P-TU-230Vetter J. M. P-MO-137

P-SA-043Vicente Fernandez M. D. P. P-TU-210Vicente Rodriguez J. WOC-C-63-03Vidinov K. P-MO-156Vidinova C. N. P-MO-156Vieira A. C. P-SU-085Vieira de Carvalho L. A. P-SU-180

TU-31-09Viestenz A. WE-37-06

P-MO-029P-SA-112P-SA-146P-TU-057WOC-C-50WOC-C-50-04

VIEW 2 investigators TU-37-02Vijayalakshmi P. MO-07-04

MO-51-05Vilaplana D. TU-29-05Villada J. R. TU-82-03Villalba J. P-TU-008Villani G. M. TU-14-06Villarrubia A. WOC-C-63-05Vilupuru A. MO-75-07Vinciguerra P. SU-58-03

TU-78TU-78-08WE-02-01P-MO-224

Vinekar A. SU-62-07MO-04MO-04-05P-TU-218

Vinuesa Silva I. P-MO-160Virgili G. WOC-C-10

WOC-C-10-05Visser N. TU-82-10Vit V. P-SA-098

P-TU-166Vitovska O. P-SA-125Vlasov S. P-SA-160

WE-34-09Vo T. N. U. P-TU-145Vogt S. P-SA-187Vogt U. SU-09-05Voigt N. P-SU-162Voigt U. P-SA-277Vokrojova M. P-SA-048

P-SA-049TU-31-07

Völcker H. E. SU-56WOC-AAD-C-09

Vold S. D. TU-13-05Volk G.-F. P-SU-122Volkovich T. P-MO-176

von Hanno T. MO-67-03von Holstein S. L. SA-46-08von Jagow B. P-SU-041von Stebut-Borschitz E. P-SU-202Vorwerk C. K. TU-15

TU-15-04P-TU-221

Vossmerbaeumer U. P-TU-080TU-80-02

Voyatzis G. P-TU-020Voykov B. P-SA-152

P-SU-264P-TU-219

Vrhovec L. P-MO-007P-MO-012

Vucic D. SU-45-05Vukoja V. P-TU-097

W

Wabbels B. K. SU-23-05Wachtlin J. P-TU-089Wacker T. P-SU-235Wackernagel W. SU-43-09

P-TU-149Wada M. P-SU-115Wafa A. MO-32-05

P-SA-270Wafa H. P-MO-082

P-SA-250Wagenbreth C. P-SU-174Wagenfeld L. P-TU-217

WOC-C-07-03Wagner A. P-SA-187Wagner C. WOC-C-36-01Wagner N. P-SA-256Wagner P. SU-79

SU-79-07P-SA-050P-SU-235

Wagoner M. P-MO-013Wah W. H. MO-74-08

P-SA-259P-TU-179P-TU-182

Wahab T. A. SU-47-08Wahl J. P-MO-039

TU-41-10TU-82-04

Wakabayashi T. P-MO-179TU-30-07

Wakefield D. SA-08SA-08-01P-SU-032

Walch A. P-SA-173Waldstein S. P-SA-207Walker R. P-SU-249

TU-25-07Wallace D. SU-41-03Walsh A. C. P-SA-165

P-SA-198Walsh J. MO-27-03

P-SA-180P-SU-077P-TU-216P-TU-224TU-37-09

Walsh M. SA-28-10Walt J. G. P-MO-071

P-TU-059Walter A. SA-32-02Walter H. S. P-SU-043

P-TU-007P-TU-031P-SU-265

Walter P. MO-27 TU-37-08P-MO-206P-MO-288P-SA-064WOC-AAD-C-01-02WOC-AAD-C-01-04

Walter S. P-SA-146P-TU-057WE-37-06

Wan Abdul Halim W. H. P-SA-275

P-TU-063Wang C. P-TU-129

WE-35-10Wang D. P-SA-138wang F. SU-73-02Wang F. WE-39-06Wang J. P-MO-261

P-SA-201Wang J. J. P-SU-051

SU-73-03TU-29-02

Wang J.-K. P-MO-262Wang K. SU-74-07Wang L. P-SA-231

P-SU-133Wang N. SU-56-05

TU-34-08P-SA-092P-SA-095

Wang N. SA-30-08TU-52-02

Wang P. P-TU-137Wang Q. P-SA-221Wang W. P-SU-088Wang X. P-MO-136

SU-36-07Wang Y. P-SU-238

SU-42-10SU-74-09

Wang Z. Su-54-04SU-61-07SU-61-07

Wangsupadilok B. P-SA-117Waqar S. TU-25-01Waran V. P-SU-118Waring G. MO-37-05

TU-25-07TU-62-02TU-78-06WE-02-06

Wariyapola D. P-MO-070TU-35-03

Wasfy T. P-SA-194Wasielica-Poslednik J. MO-31-07Wasmuth S. MO-76-01Wassill H. P-SU-184Watanabe H. P-MO-027

P-MO-068P-MO-089P-MO-258P-SA-017

Watkins M. SU-40-03 TU-66-06

Watson P. G. SU-20SU-21-02

Watson S. P-TU-049Webb T. TU-82-02Weber A. TU-63-05Weber B. H. F. SU-25-03Weber K. P-SU-271Weber S. SU-39-04

409WOC® 2010

Auth

or In

dexWecke T. P-TU-221

WE-37-06Wecker T. P-SU-105Wedemeyer I. P-MO-274Wedrich A. WE-08

SU-17-07P-TU-149P-TU-207

Weger M. P-SA-135Wegner A. P-SA-101Wegner M. P-TU-076Wehner W. P-MO-120

P-MO-125TU-25-07

Wei M. P-SU-066Wei S. SU-44

SU-44-01SU-44-03P-SA-108P-SU-117P-SU-123P-SU-127P-SU-128P-SU-129P-SU-130P-SU-138P-SU-139P-SU-143P-SU-149P-SU-156P-SU-157P-SU-163P-SU-164P-SU-166P-SU-167P-SU-168P-SU-170P-SU-171P-SU-172

Wei Y.-h. SU-55-09Weichselberger A. MO-68-02

TU-35-01Weidemann A. TU-36-05Weikert M. P. MO-39-06Weil D. WE-12-08Weimer P. MO-27-09Weinberger D. MO-68-04Weindler J. WE-39-03Weingärnter W. E. P-MO-137Weinitz S. TU-33-09Weinreb R. N. SA-21-01

MO-13-08WE-13WE-13-08P-SA-129

Weirich G. P-TU-120Weiss C. P-TU-116Weiß S. MO-75-10

P-SU-100P-SU-220P-TU-048SU-37-03

Weitz R. MO-27-03Welch J. MO-67-03Welge-Lüßen U. MO-31-10

MO-73-07Welkoborsky H.-J. MO-28-09Weller K. P-SA-060Welty D. MO-67-02Wen J. MO-24-02Wen-Chuan W. P-MO-219

P-SU-261Weng N. P-SA-092

SU-56-05Wenkstern A. P-MO-191Werner J. U. P-TU-236

Werner L. SU-15SU-15-06

Wesch D. P-MO-151Wess J. P-TU-241West S. TU-52-04

WE-40-05Westekemper H. SA-17-06Wetzel B. MO-27-02Wheeler D. P-TU-143Wheeler L. MO-75-07

P-TU-199While B. P-SU-247Whitcup S. M. MO-32-01

MO-32-02MO-67-02MO-68-04MO-75-04MO-75-05MO-75-07P-MO-198P-SU-110P-TU-199TU-32-01TU-35-11WE-35-04

White V. A. TU-40-02Wiafe B. MO-59-04

TU-66-05Wickham L. SU-48-02Wickstrom K. SU-63-06Widayanti T. P-MO-155Widyawati S. P-SA-069Wiechens B. MO-28-09

MO-28-10P-SU-196P-SU-240P-TU-223P-TU-250

Wiedemann P. SA-36SU-45MO-02-09MO-29TU-36

Wiegand M. P-SU-204Wieland E. MO-45-05Wieland R. P-TU-116Wienrich R. P-MO-029Wiermann A. P-SA-182

P-SA-184P-SA-185

Wiesen M. P-TU-219Wiesmann C. MO-68-05Wiggs J. L. MO-71

MO-71-05WE-40-02

Wildner G. SA-08-05SU-31SU-31-02TU-17-04P-SA-251

Wilensky J. P-SA-073Wilhelm B. TU-34-09Wilhelm F. WE-27-03Wilhelm H. SA-38-08

SU-29SU-29-03SU-44MO-44-03

Wilke M. WE-16-03Wilke R. MO-27-06

P-SA-144SU-73-05TU-34-09

Wilkens L. MO-28-10

Wilkinson C. P. SA-41SA-41-09TU-69WOC-C-41-06

Will F. SU-75-07Willcox M. SU-17-04Wille D. TU-81-10Willerding G. P-TU-089Willert A. SA-19-04Williams G. J. SU-62-06

TU-29-03Williams J. TU-30-06Williams K. A. SA-18-03

TU-19-04Williamson K. P-TU-155Willmann G. P-SA-155

P-SU-264Wilson P. WE-40-01Wilson S. E. WE-01-01

WE-03WE-03-02

Wimmer S. P-MO-148Windischbauer E. SU-61-06Winkler von Mohrenfels C. P-SU-111

SA-32-10Winter K. WE-16-03Winter R. MO-75-10

P-SU-100P-SU-220P-TU-048SU-75-07

Winterhalter S. P-MO-015P-MO-016P-SA-113SU-27-07

Wirbelauer C. WE-10-08P-SA-026

Wirostko B. P-MO-063P-SU-097SU-55-05WE-41-09

Wirtz C. WE-35-07Wiseman R. P-SU-097Wismann S. P-TU-186Wissen A. SA-25-06

SU-27-10Witt M. SU-56-04Wittekind C. TU-40-07Wiyogo I. WE-39-10Wodong S. MO-28-06Wölbert M.-K. SA-25-08Wolf A. MO-35-04

P-SA-051P-SA-173P-SA-178P-SA-188P-SA-194P-SA-202P-SA-205P-TU-017P-TU-248TU-25-08WE-34-06

Wolf F. P-MO-008WE-41-03

Wolf S. TU-11 WE-34-10P-TU-178P-TU-245WOC-C-57WOC-C-57-06WOC-C-61-02

Wolf U. P-MO-102

410 WOC® 2010

Auth

or In

dex Wolfensberger T. J. SU-49-06

MO-29MO-29-07MO-67TU-45-02

Wolff D. P-TU-050Wolff J. WOC-C-56Wolffsohn J. P-TU-009

P-TU-037Wolfram C. SU-73

TU-52Wolf-Schnurrbusch U. P-TU-178

P-TU-245WE-34-10

Wollensak G. SU-46-01Wolter-Roessler M. P-SA-031Wong H. S. MO-31-04Wong A. L. P-TU-029Wong A. M. F. SU-44-05Wong B. P-SU-222Wong D. SU-48-08Wong D. S. H. SA-34-06

WOC-C-07WOC-C-07-04 WOC-C-41WOC-C-41-05

Wong H. S. MO-74-08Wong J. P-SA-073Wong P. WE-34-02Wong T. Y. MO-56-01

TU-29-02WE-40-04P-MO-169

Wong V. P-SA-260Wong W. L. P-SA-140Woo C.-m. SU-47-01Wormald R. SA-21

SU-04SU-04-03SU-76-01TU-23-01TU-30WOC-C-10WOC-C-10-01WOC-C-10-02

Wotherspoon A. C. SU-67-02Wowra B. P-TU-091

P-TU-096Wree A. SU-56-04Wrobel W. TU-34-09Wu L. SA-41-06

MO-72MO-72-01WE-29WE-29-03

Wu P. MO-68-05Wu W.-C. P-MO-257

TU-36-01WuDunn D. TU-30-06Wulff A. J. SA-25-08Wutzler P. P-SU-151Wykes W. TU-29-03Wylegala E. SA-31-03

SU-35-10MO-30MO-30-03 MO-35-03WE-05WE-05-05WOC-C-47WOC-C-47-04

Wyman M. TU-82-02

X

Xiang N. SU-17-10Xiao C. SU-42-06

MO-79MO-79-09P-SU-213P-SU-238

Xie C. P-SU-088Xie G. P-SU-014Xie L. TU-36-02Xie T. MO-47-06

TU-39-03Xing X. P-SA-038Xing Y. P-MO-261

P-SA-201P-SU-136

Xu J. MO-75-09Xu L. P-SA-216

P-SU-070SU-73-06

Xu X. MO-77-10

Y

Yadav N. K. MO-67-10P-TU-218

Yadav P. P-SU-242Yadava U. P-SU-173Yagita K. P-MO-011Yaish S. B. P-MO-121Yakura K. P-MO-011

P-SA-279Yamada K. P-SA-121Yamada R. P-SA-097Yamada Y. P-SA-131

P-SA-154Yamaguchi M. P-TU-195Yamaguchi Y. P-SA-242

P-TU-233Yamaji H. P-SA-020Yamakawa N. P-SA-247

P-SU-158Yamamoto M. P-TU-195Yamamoto T. P-MO-060

P-MO-178P-SA-107P-SA-136P-SU-115

Yamamoto S. WOC-C-62-06Yamashiro K. P-SA-097

P-SA-167P-TU-172

Yamashita H. P-MO-178P-SU-115

Yamashita M. P-SA-229Yamazaki H. P-MO-193Yan D. B. P-MO-067

P-MO-074 BS-09-04

Yan G. P-SU-088Yan H. P-SU-014

P-SU-136SU-61-10

Yan X. P-SA-216P-SA-221

Yanagisawa M. P-SU-107Yanai R. WE-22-04Yang Q. P-SA-095Yang A. P-MO-261Yang A. h. P-SA-201Yang C.-H. WE-08-04

P-SU-259

Yang C.-M. P-SU-259Yang J.-Y. MO-67-08Yang M. P-SU-245Yang P. TU-73-06Yang X. P-SU-266Yang Y. P-SA-138Yang Y.-S. MO-67-08Yannuzzi L. MO-32-03

SA-32-04Yano K. P-SU-089Yao K. WE-35-08Yaoeda K. P-MO-034

P-MO-042Yarmak V. MO-24-04

MO-27-08P-SU-275

Yasuda A. P-SU-182Yasuda N. P-SA-115Yasuno Y. SA-25-04

MO-61-06Yau S. K. P-TU-133Yee Murahashi W. MO-67-06

TU-29-09Yehezkel O. P-MO-121Yemisci B. P-SA-128

P-SA-143SA-31-06

Yetik H. SU-41Yeung A. M. TU-81-07Yigit U. P-SA-143Yilmaz O. F. P-SU-198Yim H. B. P-TU-054Ying H. P-SA-226Yip Y. P-TU-202Yiu S. C. SA-17-01Yoeruek E. P-SA-170Yogesan K. SU-30

SU-30-01Yokochi M. P-MO-149Yokogawa H. P-SA-047Yokoi T. P-SU-124

P-TU-200P-TU-222

Yokoyama K. P-MO-199Yokoyama T. TU-59-04Yonahara M. P-SA-123Yong L. P-TU-243Yoon J. U. SA-25-02Yoon Y. MO-32-01Yoon Y.-H. SU-45-02

MO-32-02MO-75-04MO-75-05TU-32-01

Yoshida A. P-MO-153P-SA-267P-SA-282

Yoshikawa T. P-SA-159Yoshimura N. P-MO-043

P-SA-097P-SA-126P-SA-167P-TU-172

Yoshino H. P-MO-064Yoshino M. P-SA-004

P-SA-037Yoshitake S. P-SA-097You Q. SU-73-06Younesian M. SU-17-05Young L. P-MO-195Young L. B. P-MO-174Young M. J. TU-15-05

TU-30Younis M. P-MO-092

P-MO-275P-SU-077

411WOC® 2010

Auth

or In

dexYu A. MO-31-10

Yu F. MO-76-08Yu H. SA-32-03Yu H. G. P-MO-243Yu M. SU-74-09Yu M. C. S. P-MO-098Yuan J. SU-17-10Yuen H. K. L. SU-71-03Yuen J. WE-40-09Yuen L. MO-26-06

TU-81-09Yukawa E. P-SU-037Yung C. W. TU-30-06Yuzawa M. MO-56-07

Z

Za Z. P-SU-118Zabarouski I. P-SU-269Zaborovski I. P-TU-192Zagórski Z. SU-37

TU-49TU-49-01TU-67TU-67-03

Zaidman G. W. SU-79-06MO-79-03

Zakynthinos E. MO-76-10Zaldivar R. MO-40

MO-40-04TU-61TU-61-04TU-61-06

Zalevsky Z. P-MO-121Zaliaduonyte-Peksiene D. P-SA-204Zaliuniene D. P-SA-204Zaluski S. P-MO-133Zandi S. P-TU-220Zanon-Moreno V. P-MO-047

P-MO-093P-MO-160P-SA-119

Zapata J. SU-79-02Zarbin M. SA-03

SA-03-01MO-47MO-79

Zare M. SU-36-10Zarei-Ghanavati M. P-SA-041

P-SA-084Zarei-Ghanavati S. P-SA-041

P-SA-084P-SU-039SU-36-10

Zarnowski T. TU-77-05WE-39-09P-SU-095P-SU-264P-MO-260

Zavoloka O. MO-35-08P-SA-156P-SU-236

Zawar S. P-TU-003Zegans M. MO-76-08Zeimer R. SU-62-02Zeitz C. MO-06

MO-06-04Zeitz O. SU-61

P-SA-182P-SA-185P-TU-056P-TU-217

Zekraoui Y. P-MO-066P-SA-141

Zeng Y. P-SA-138Zengin M. O. P-TU-061Zenkel M. P-SU-080

P-SU-098Zenteno Ruiz J. C. SU-61-04Zeschnigk M. SU-39

SU-39-03SU-39-04

Zetterström C. TU-07-06TU-25TU-76TU-76-08

Zeyen T. WE-07WE-07-02

Zhaboedov G. P-SA-235Zhang C. MO-73-09Zhang F. P-SA-218

SA-25-03Zhang H. P-MO-265

P-SA-040Zhang J. SU-47-04Zhang J.-d. MO-24-02Zhang K.-M. P-TU-199Zhang S. S.-M. MO-73-09Zhang W. P-SA-228

SU-61-01Zhang X. MO-74-02

P-MO-018Zhang X.-R. P-MO-119Zhang Z.-Y. P-MO-119Zhao B. P-SA-092

SU-56-05Zhao F. P-SU-088Zhao J. WE-37-04Zhao J. SA-23

SA-23-04SU-73TU-52TU-52-03

Zhao L. TU-34-08Zhao S. MO-74-02

P-MO-018SU-37-04

Zhekov O. SU-55-04Zhen Kiat T. MO-26-06Zheng Y. P-MO-169Zhi J. P-SU-136Zhivov A. P-SA-077Zhmud T. P-MO-283Zhng Z. MO-24-02Zhou H. P-SU-213

P-SU-234P-SU-238

Zhou J. P-SU-060Zhou L. SU-37-04Zhou Y. P-SA-216

P-TU-102Zhou Y.-h. SU-47-04Zhu J. P-TU-261Zhutdieva M. SU-35-09Ziakas N. P-SA-276

P-SU-035Ziemssen F. SA-22

SA-22-04MO-67-03

Zierhut M. SA-08-03 SU-27-07MO-46MO-49-03MO-76 MO-76-05TU-83WE-42 P-SA-254WOC-C-14-02WOC-AAD-C-17

Zillikens D. MO-49-02Zimmer-Galler I. E. SU-62-02Zimmerman M. B. P-MO-013Zimmermann A. P-TU-099Zimmermann C. P-SA-135Zin A. SU-61

MO-04MO-04-02MO-51-03

Zinelis K. MO-75-10P-SU-100P-SU-220P-TU-048SU-75-07

Zivkovic M. P-SA-234Zlatanovic M. P-SA-237Zlotnik A. P-MO-121Zografos L. SU-34-02

TU-22-09WE-23-05WE-24-07

Zoric Geber M. WE-39-07Zorn C. P-SA-263

P-TU-205Zotta P. P-SA-276

P-SU-035Zrenner E. SA-38

SA-38-02SU-25SU-73-05TU-34-09TU-37-05TU-77-11WE-14WE-14-02 WE-20WE-41P-SA-144P-SA-152P-SA-155P-TU-219

Zsolt B. WE-17-04Zubkova D. MO-35-08

P-SA-156P-SU-236

Zurek-Imhoff B. MO-76-01P-SA-248

Zvereva A. E. P-SU-181Zweifel S. A. MO-31-02

SA-32-06Zwiener I. P-SA-190

Responsible for the Content WOC® 2010 Congress PresidentProfessor Gerhard K. Lang, Ulm, Germany

WOC® 2010 Program DirectorProfessor Gabriele E. Lang, Ulm, Germany

Content handling and advertsProfessional Congress Organizer (PCO)Monika PorstmannPorstmann Kongresse GmbHAlte Jakobstr. 7710179 Berlin, GermanyT: +49 30 28 44 99 0F: +49 30 28 44 99 [email protected]

CreditsPage 34, 35: Roman LorenzPage 39: www.fotolibrary.dePage 39: Eyeland Design NetworkPage 41: Torsten GeorgePage 43: Herbert Spichtinger/CorbisPage 367: ICC

DesignBüro Roman Lorenzdesign allianceMunichwww.designalliance.de

Production and PrintingMediaService GmbHBärenDruck und WerbungFranz-Mehring-Platz 110243 Berlin

DisclaimerThe titles and contents of the presentations as well as the authors’ names as listed on the following pages have been printed according to the files sent by thepresenters themselves. The organizer is not responsible for spelling mistakes.

World Ophthalmology Congress® and WOC® 2010 are registered trade names of theInternational Council of Ophthalmology (ICO).The WOC® 2010 logo design and corporate identity are protected by copyright.The rights of use lie with the German Ophthalmology Society (DOG). The use by athird party requires the express approval of the DOG.

Subject to alteration without notice.

Status as per April 2010

Last minute changes of the scientific program will be included in the online versionat www.woc2010.org.

Imprint

413WOC® 2010

414 WOC® 2010

Notes

415WOC® 2010

Notes

416 WOC® 2010

Notes

We see what’s coming.Pfizer Ophthalmics is advancing the future of eye health. Exploring new molecular entities designed to address unmet medical needs. Investing in stem cell therapies. Developing innovative polymer-based drug delivery. Creating a diverse portfolio that delivers a promising outlook for the future of eye care.

OUR VISION IS CLEAR.

Visit us at booth 12 B/35

© 2010 Pfizer Inc. All rights reserved.XLU01040

>

through innovation

Look forward. Envision.

As a committed pioneer in the field of ophthalmology, we supply

innovative technologies and application-oriented solutions which

enable doctors to improve the quality of life of their patients.

An ophthalmic world with Carl Zeiss as your partner supporting your goals with ...

Sharply focused solutions for growing patient demands.

Higher efficiency and faster process support.

Better quality of care.

Visit our booth in Hall 13 and envision new opportunities in the world to see.

Get more information at our website: www.meditec.zeiss.com/woc

Carl Zeiss Meditec AG

Phone: +49 36 41 22 00

Fax: +49 36 41 22 01 12

www.meditec.zeiss.com

[email protected]

WOC2010_FinalProgram

Documents

industrial exhibitionoslo

hall 3rooms42

industrial exhibitionhall

afterdiscontinuationof

hall levelmedia checkrooms

overt cardiac failure

cardiac failures

months treatment